data_2jsz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jsz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.69 150.52 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -97.91 155.54 17.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 123.038 1.399 . . . . 0.0 108.748 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -120.87 66.49 0.85 Allowed 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HE3' HG23 ' A' ' 150' ' ' THR . 2.0 ttmt 57.35 36.75 27.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.55 -21.27 0.27 Allowed Glycine 0 CA--C 1.497 -1.088 0 O-C-N 118.751 -2.468 . . . . 0.0 111.116 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.33 163.61 34.02 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.64 157.46 55.48 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.986 3.124 . . . . 0.0 110.118 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.42 137.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.248 1.419 . . . . 0.0 107.317 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.601 ' H ' ' HG3' ' A' ' 123' ' ' GLU . 27.1 m -74.99 151.18 38.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.605 1.162 . . . . 0.0 109.138 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 mt -113.09 143.92 43.52 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.4 165.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 158.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.73 -172.41 14.51 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.449 1.027 . . . . 0.0 113.3 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -116.63 158.52 23.6 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.304 1.441 . . . . 0.0 107.659 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.45 127.27 32.05 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.76 163.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 127.441 2.297 . . . . 0.0 107.505 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -137.04 169.29 18.03 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.339 -0.851 . . . . 0.0 111.487 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.97 137.09 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.397 165.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.37 -23.25 30.83 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.312 1.91 . . . . 0.0 112.387 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -71.84 151.09 43.7 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.648 0.779 . . . . 0.0 109.856 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -73.86 126.97 31.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 146.93 93.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 118.023 -0.989 . . . . 0.0 108.371 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.592 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 31.4 Cg_exo -52.81 -25.77 28.31 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 121.943 1.762 . . . . 0.0 115.528 -172.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' CE1' ' A' ' 27' ' ' PHE . 26.1 t0 61.26 89.47 0.08 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 129.375 3.07 . . . . 0.0 118.232 -170.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -131.19 -166.76 1.75 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.437 -2.04 . . . . 0.0 107.175 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.436 ' H ' ' HB3' ' A' ' 27' ' ' PHE . 5.4 m -125.08 143.57 50.85 Favored 'General case' 0 N--CA 1.406 -2.651 1 C-N-CA 134.53 5.132 . . . . 0.0 107.21 -170.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.58 171.07 18.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 129.253 3.021 . . . . 0.0 103.768 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.33 146.34 25.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -67.17 162.36 22.66 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 119.822 1.192 . . . . 0.0 108.106 162.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.38 -11.63 4.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.67 165.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 m -98.06 4.8 49.19 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.951 2.1 . . . . 0.0 112.795 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 75.42 33.89 0.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.852 1.661 . . . . 0.0 112.094 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.18 153.8 35.72 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.51 141.74 48.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.092 -1.005 . . . . 0.0 108.921 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -139.64 145.1 38.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 168.42 18.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.251 0.621 . . . . 0.0 111.247 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -37.13 65.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.343 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.27 -35.07 49.14 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.7 -42.51 61.15 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.318 1.056 . . . . 0.0 109.845 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.87 -30.09 71.07 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 112.05 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -10.73 19.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.563 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -11.99 6.22 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.041 1.292 . . . . 0.0 112.878 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.68 164.79 34.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.661 1.73 . . . . 0.0 107.073 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.06 120.42 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -126.72 138.9 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.5 mt -100.88 144.82 12.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.27 132.16 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -121.32 100.09 6.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.08 134.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 60' ' ' CYS . 0.4 OUTLIER -137.6 161.54 59.83 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.66 -57.38 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.151 1.901 . . . . 0.0 111.594 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 164.4 33.08 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.844 2.058 . . . . 0.0 106.38 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.418 ' HA ' ' HG ' ' A' ' 60' ' ' CYS . 10.3 tt -94.93 -15.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.656 1.571 . . . . 0.0 112.985 -168.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.97 -1.75 53.33 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.555 ' HG1' ' NH2' ' A' ' 129' ' ' ARG . 3.2 p -78.99 3.41 17.27 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 118.815 -2.428 . . . . 0.0 115.318 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.36 -52.37 0.83 Allowed Glycine 0 CA--C 1.54 1.61 0 CA-C-O 117.771 -1.571 . . . . 0.0 113.194 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -30.29 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 122.282 3.041 . . . . 0.0 111.34 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HG ' ' HA ' ' A' ' 55' ' ' ILE . 1.9 m -58.65 -31.89 68.58 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.673 -0.642 . . . . 0.0 112.035 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.633 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 15.1 t70 -55.54 -50.3 70.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.885 0.874 . . . . 0.0 108.753 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.93 -13.79 5.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.622 0.576 . . . . 0.0 112.306 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.516 HE22 ' HG2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -99.28 -75.81 0.56 Allowed 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -59.43 -40.2 86.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 123.597 1.665 . . . . 0.0 111.489 -159.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.262 1.7 tpt180 -76.1 -49.89 16.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.176 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -57.34 -38.72 74.54 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -58.45 -41.1 84.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.763 0.825 . . . . 0.0 109.945 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -57.5 -45.26 85.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.326 0.966 . . . . 0.0 111.556 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -70.98 -48.63 52.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.026 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.35 -38.21 86.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.572 0.349 . . . . 0.0 110.671 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.04 86.05 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.507 -0.745 . . . . 0.0 111.402 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.69 88.49 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.762 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -70.75 -36.4 73.11 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.587 0.755 . . . . 0.0 111.396 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mp -62.4 -41.48 98.7 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 123.192 0.597 . . . . 0.0 109.97 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 -37.36 3.4 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.491 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -140.23 85.32 2.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.34 1.07 . . . . 0.0 109.575 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.29 172.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -127.93 144.2 51.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.4 t -144.41 139.22 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.51 161.26 35.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.464 0.65 . . . . 0.0 109.312 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.6 m -122.01 148.5 44.74 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.8 mt -132.9 134.74 57.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 m -132.13 159.9 37.57 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.438 0.695 . . . . 0.0 110.671 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.49 39.62 0.92 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 109.18 167.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -133.66 168.69 18.23 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.107 1.363 . . . . 0.0 108.804 -166.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 136.04 96.45 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.073 0.949 . . . . 0.0 110.536 -171.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.97 -42.39 64.71 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.365 2.043 . . . . 0.0 111.903 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -72.84 -30.07 63.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.059 -1.026 . . . . 0.0 112.672 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.87 98.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.503 1.047 . . . . 0.0 108.627 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.1 -46.23 78.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.09 75.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.79 0.805 . . . . 0.0 108.982 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -70.3 -44.95 67.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.775 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 61' ' ' ASP . 69.3 t90 -53.98 -41.44 67.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.1 -46.98 84.83 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.265 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.25 -38.89 97.19 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.839 0.712 . . . . 0.0 111.753 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.13 93.4 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.738 0.815 . . . . 0.0 110.751 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -87.7 -17.15 32.39 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.84 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.72 56.08 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 119.29 0.95 . . . . 0.0 112.132 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mm -71.35 142.76 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.279 1.432 . . . . 0.0 107.443 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.66 -36.59 0.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.09 1.356 . . . . 0.0 110.637 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -79.86 -18.62 50.28 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.838 -1.164 . . . . 0.0 112.988 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -117.13 150.29 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.38 138.97 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 p -93.88 150.62 20.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.713 1.205 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.6 mt -141.65 157.51 44.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.339 1.456 . . . . 0.0 107.406 -170.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -121.64 109.72 15.1 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.518 -1.364 . . . . 0.0 109.09 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 109' ' ' ARG . 25.0 t0 -84.06 -10.1 58.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.927 1.291 . . . . 0.0 110.333 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -32.55 -25.34 0.0 OUTLIER 'General case' 0 C--N 1.347 0.458 1 C-N-CA 132.148 4.179 . . . . 0.0 115.246 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -97.82 -38.12 9.57 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -151.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.21 -7.72 0.62 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 125.82 1.95 . . . . 0.0 107.859 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.414 ' HE1' ' CD2' ' A' ' 120' ' ' TYR . 7.5 mmm 59.09 12.67 2.55 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 125.494 1.518 . . . . 0.0 109.561 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.1 -42.74 77.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.622 ' HA ' ' CD2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -64.79 -57.63 8.4 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 125.052 1.341 . . . . 0.0 110.573 177.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.9 93.94 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 118.9 -1.619 . . . . 0.0 111.474 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.2 -53.28 51.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.666 1.186 . . . . 0.0 109.778 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.37 77.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.7 0.66 46.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.026 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.19 44.62 95.37 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.55 1.068 . . . . 0.0 111.712 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.92 -6.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.882 0.873 . . . . 0.0 112.168 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.414 ' CD2' ' HE1' ' A' ' 111' ' ' MET . 0.3 OUTLIER -70.84 118.82 14.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 165.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 51.2 mt -82.06 105.94 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -53.14 -41.34 65.02 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 112.037 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.601 ' HG3' ' H ' ' A' ' 12' ' ' THR . 1.5 mm-40 -80.1 -11.77 59.73 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.727 1.211 . . . . 0.0 111.632 -171.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.08 -23.06 6.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.886 0.766 . . . . 0.0 112.54 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 61.15 38.9 16.56 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.935 1.35 . . . . 0.0 114.332 -168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.76 145.35 48.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -168.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.08 142.57 52.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.1 17.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.624 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.555 ' NH2' ' HG1' ' A' ' 57' ' ' THR . 72.5 mtt85 -95.98 111.69 23.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 m -150.78 168.13 25.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.79 156.87 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.153 0.888 . . . . 0.0 109.316 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -141.41 159.73 41.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.57 1.148 . . . . 0.0 108.015 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.02 143.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -134.65 125.28 26.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -165.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.69 164.57 23.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.614 1.165 . . . . 0.0 109.087 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.32 -14.13 16.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.481 1.912 . . . . 0.0 112.988 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.96 -9.69 59.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.499 -1.376 . . . . 0.0 111.977 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.14 25.95 65.25 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.453 -1.405 . . . . 0.0 111.476 -168.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -89.71 142.51 27.62 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 118.821 1.311 . . . . 0.0 108.973 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.2 t -72.56 122.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 t -94.77 -31.59 4.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 126.27 1.828 . . . . 0.0 108.845 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -152.99 149.22 27.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.31 144.65 28.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 168.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.28 142.29 23.95 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.353 1.061 . . . . 0.0 108.525 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.46 108.17 10.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.401 HG23 ' HD3' ' A' ' 153' ' ' PRO . 17.5 t -62.8 123.94 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -60.82 -12.6 11.37 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.264 -1.35 . . . . 0.0 112.646 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -134.74 115.18 13.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.54 1.536 . . . . 0.0 107.381 -172.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.16 -25.88 68.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.212 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.422 HG23 ' HE3' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -80.69 1.72 28.95 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.616 1.566 . . . . 0.0 113.95 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.36 164.26 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.94 2.496 . . . . 0.0 106.429 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -129.95 155.06 81.18 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 121.4 -0.812 . . . . 0.0 109.187 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.516 ' HG2' HE22 ' A' ' 63' ' ' GLN . 37.9 Cg_endo -66.86 168.89 15.87 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.536 2.157 . . . . 0.0 110.24 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.82 122.08 38.23 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.162 -1.586 . . . . 0.0 107.098 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.546 ' CZ ' ' HG2' ' A' ' 66' ' ' ARG . 19.7 p90 -59.3 -23.2 62.24 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.226 1.81 . . . . 0.0 112.824 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.43 -36.15 71.0 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.699 1.136 . . . . 0.0 109.842 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -60.22 -57.69 24.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.023 0.929 . . . . 0.0 113.16 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.59 -26.77 28.04 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 120.663 0.909 . . . . 0.0 111.224 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -49.42 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 108.493 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -63.96 -34.14 77.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.006 0.821 . . . . 0.0 111.204 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.31 66.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.59 0.756 . . . . 0.0 110.934 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.18 -44.99 67.61 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.444 -0.785 . . . . 0.0 110.421 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.427 ' O ' ' HE2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -62.13 -23.61 66.66 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.67 -28.03 65.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.477 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.0 -25.79 13.94 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.002 -1.475 . . . . 0.0 113.702 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -73.53 -13.37 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.113 1.324 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 163' ' ' LYS . 7.1 mmtt . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.659 -2.115 . . . . 0.0 110.624 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 122.766 1.269 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.92 151.63 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.659 169.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -113.84 160.78 18.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.337 1.055 . . . . 0.0 109.687 173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.87 46.84 1.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.493 1.117 . . . . 0.0 108.673 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 42.33 63.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.608 1.963 . . . . 0.0 111.94 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.1 -25.58 0.18 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.571 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 171.81 43.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.271 0.938 . . . . 0.0 110.822 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.09 159.71 52.2 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.567 2.844 . . . . 0.0 111.076 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.54 133.61 45.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 124.125 0.97 . . . . 0.0 109.119 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -68.83 134.64 49.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.695 0.798 . . . . 0.0 110.481 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.23 146.59 23.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.398 1.479 . . . . 0.0 108.496 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -74.33 -65.02 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.25 169.52 54.65 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.509 0.576 . . . . 0.0 112.047 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.61 166.3 22.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.759 0.79 . . . . 0.0 110.611 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.48 120.09 18.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.75 152.5 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -128.15 158.06 39.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.251 1.02 . . . . 0.0 110.642 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.38 144.51 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.962 0.905 . . . . 0.0 108.813 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.38 19.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.646 1.117 . . . . 0.0 112.451 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.15 155.97 39.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.62 1.21 . . . . 0.0 109.872 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -74.02 136.19 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 157.92 30.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 122.987 0.515 . . . . 0.0 111.21 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -53.52 -27.42 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.969 3.113 . . . . 0.0 116.985 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 t0 51.91 78.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.255 1.422 . . . . 0.0 113.548 -169.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -139.15 -176.9 4.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.771 1.228 . . . . 0.0 110.636 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -125.64 152.31 45.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 110.994 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 m -140.39 170.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.791 2.436 . . . . 0.0 106.909 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.26 147.67 22.71 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.971 -1.08 . . . . 0.0 108.184 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.9 p -70.81 170.58 12.22 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -61.79 -9.25 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.633 -1.292 . . . . 0.0 112.524 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 m -105.83 12.09 31.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.476 1.91 . . . . 0.0 111.204 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.41 47.4 8.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.172 1.789 . . . . 0.0 111.209 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.9 140.44 51.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.99 135.09 56.25 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.537 -0.727 . . . . 0.0 111.153 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -137.29 141.57 41.93 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -126.65 157.21 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -169.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -54.48 -34.44 61.59 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.48 1.112 . . . . 0.0 111.132 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.56 67.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.51 -38.11 62.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.68 0.792 . . . . 0.0 110.331 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 mtt -66.43 -27.05 67.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.62 1.168 . . . . 0.0 111.013 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.19 -15.48 3.87 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.776 0.83 . . . . 0.0 113.142 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.54 -18.79 56.91 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.4 1.0 . . . . 0.0 113.849 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -152.48 160.56 43.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.347 1.573 . . . . 0.0 108.758 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.92 118.87 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.9 m -126.64 132.52 51.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.492 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.2 mt -93.05 142.51 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -126.89 128.62 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 125.553 1.541 . . . . 0.0 106.944 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 m -126.32 98.53 5.49 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.292 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.16 131.33 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.7 147.17 47.65 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.929 0.786 . . . . 0.0 111.827 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -65.21 133.54 35.68 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.3 2.0 . . . . 0.0 108.545 168.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m 44.44 -133.4 0.71 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.349 1.06 . . . . 0.0 111.073 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.5 tt -163.46 178.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.208 2.203 . . . . 0.0 106.15 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t0 56.09 38.98 30.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.072 1.749 . . . . 0.0 112.245 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.1 p -81.8 11.94 4.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.468 1.107 . . . . 0.0 111.646 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 -59.68 4.78 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 125.408 1.48 . . . . 0.0 109.761 -169.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.38 -8.7 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.55 -23.9 63.27 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.551 1.069 . . . . 0.0 111.274 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.19 -33.61 76.14 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.852 -1.155 . . . . 0.0 111.444 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.25 11.9 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.043 0.937 . . . . 0.0 111.899 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -134.92 -91.51 0.32 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.429 1.092 . . . . 0.0 108.481 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -54.59 -44.25 72.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.41 1.484 . . . . 0.0 112.297 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -67.61 -52.04 43.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -42.6 85.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.663 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.48 -37.87 79.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.378 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -59.58 -46.16 89.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.897 1.226 . . . . 0.0 111.609 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.74 -51.77 31.26 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.56 -36.52 84.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.502 -0.749 . . . . 0.0 111.078 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.655 -0.653 . . . . 0.0 111.668 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.16 66.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.486 1.039 . . . . 0.0 110.761 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -69.63 -41.49 75.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 0.0 110.058 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.2 -39.77 93.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.627 0.771 . . . . 0.0 110.144 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -73.49 2.67 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 125.821 1.677 . . . . 0.0 110.33 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -88.42 41.31 1.0 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.559 1.143 . . . . 0.0 112.088 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 164.7 15.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.467 1.107 . . . . 0.0 108.109 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.51 145.25 50.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.53 145.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.474 -0.766 . . . . 0.0 108.941 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -131.54 158.39 41.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.607 1.163 . . . . 0.0 108.544 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.1 m -127.59 144.84 51.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.44 113.68 23.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 p -76.15 162.31 28.1 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.87 0.843 . . . . 0.0 110.123 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 -9.96 59.72 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -154.03 -31.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -169.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.83 111.26 10.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 120.412 1.46 . . . . 0.0 111.835 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.41 -31.65 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.903 1.735 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -71.26 -38.52 71.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.01 74.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.006 1.275 . . . . 0.0 110.844 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.13 -27.04 68.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.535 . . . . 0.0 111.438 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.19 82.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.465 0.575 . . . . 0.0 110.391 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -74.33 -39.96 62.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.549 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -52.66 -45.94 66.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.443 0.565 . . . . 0.0 109.81 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.78 -45.75 73.94 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.212 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.2 94.05 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.68 76.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.695 0.747 . . . . 0.0 110.406 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -73.77 -33.69 64.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.312 0.645 . . . . 0.0 112.34 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.24 37.71 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.72 145.02 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.11 -38.63 0.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.214 1.005 . . . . 0.0 112.789 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -74.74 -24.45 58.72 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.809 0.732 . . . . 0.0 112.408 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.1 158.94 10.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.25 134.45 34.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -87.56 154.37 20.67 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 mt -146.84 171.62 14.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 128.523 2.729 . . . . 0.0 106.076 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -150.97 142.33 23.36 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 119.656 -1.902 . . . . 0.0 109.06 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.63 -33.38 73.84 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 168.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.5 t60 55.79 -67.1 0.02 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 129.734 3.214 . . . . 0.0 113.981 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -149.44 0.11 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.302 1.441 . . . . 0.0 112.15 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.15 -39.9 90.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.253 0.933 . . . . 0.0 110.515 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 62.42 -23.55 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 129.523 3.129 . . . . 0.0 114.72 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.84 -43.96 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 121.05 1.75 . . . . 0.0 111.203 -170.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -64.65 -55.31 20.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.48 93.07 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 122.951 0.31 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.04 -47.59 73.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.615 -0.932 . . . . 0.0 110.273 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.06 -31.03 58.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.894 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.88 9.99 3.14 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.26 0.482 . . . . 0.0 112.071 172.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.91 -15.41 5.11 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 120.8 -1.187 . . . . 0.0 114.363 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.94 -25.49 30.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.053 1.427 . . . . 0.0 112.051 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.98 109.04 1.98 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.45 1.477 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.81 107.33 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -49.98 -45.66 51.84 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.75 1.22 . . . . 0.0 110.139 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.57 -16.27 62.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.519 1.128 . . . . 0.0 113.107 -171.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 mt -128.27 -16.82 4.38 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.517 1.127 . . . . 0.0 112.393 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.14 36.77 27.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.425 1.09 . . . . 0.0 109.417 -168.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.3 tp -126.08 147.06 49.67 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.159 1.383 . . . . 0.0 107.714 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.27 134.27 35.57 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.73 156.31 17.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.908 1.683 . . . . 0.0 111.955 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -83.22 116.66 22.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -162.14 168.44 22.54 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.935 0.894 . . . . 0.0 109.092 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.71 145.99 18.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 O-C-N 121.791 -0.568 . . . . 0.0 109.917 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -140.82 161.31 38.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.307 1.043 . . . . 0.0 109.581 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t -136.06 140.75 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.15 136.07 52.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.785 1.634 . . . . 0.0 108.122 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -75.77 166.76 23.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.213 1.005 . . . . 0.0 108.886 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.61 -23.01 57.91 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.254 -0.904 . . . . 0.0 112.588 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -76.06 -3.47 36.08 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.822 -1.174 . . . . 0.0 112.124 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.47 75.34 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.125 0.869 . . . . 0.0 112.096 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -92.56 143.94 25.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.45 130.86 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.4 t -104.93 -31.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.917 1.687 . . . . 0.0 109.409 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -152.28 149.12 28.34 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.82 139.23 24.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -149.08 134.13 18.13 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -114.29 126.05 54.59 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.5 t -70.0 136.69 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -67.48 -9.97 47.21 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.12 117.36 18.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.49 67.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 111.838 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.3 p -72.03 -10.59 59.99 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.88 1.672 . . . . 0.0 112.726 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -120.06 158.46 26.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 109.617 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -106.49 152.73 40.74 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.857 0.863 . . . . 0.0 111.082 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.08 154.58 57.43 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.592 2.194 . . . . 0.0 109.373 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.27 121.39 25.02 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -53.84 -26.56 25.02 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.262 1.425 . . . . 0.0 113.262 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -62.17 -33.61 74.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.778 0.717 . . . . 0.0 111.16 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -59.32 -56.79 32.36 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.178 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.57 -28.52 31.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 121.046 1.409 . . . . 0.0 111.851 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -48.45 88.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.529 1.059 . . . . 0.0 108.81 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.01 -31.06 72.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.888 0.767 . . . . 0.0 111.12 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -51.09 35.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.646 0.378 . . . . 0.0 111.36 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.47 -44.5 71.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -29.31 65.16 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.485 0.714 . . . . 0.0 111.67 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.58 71.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.498 0.719 . . . . 0.0 112.019 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.4 mt -99.16 -36.05 9.8 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.63 0.91 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.703 0.801 . . . . 0.0 109.897 173.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 87.0 mt -137.69 166.48 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -115.37 155.25 27.71 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.068 1.304 . . . . 0.0 110.195 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -124.88 65.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.789 1.236 . . . . 0.0 108.175 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 pttt 39.09 50.44 1.81 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.813 2.045 . . . . 0.0 113.972 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.92 -27.3 0.13 Allowed Glycine 0 CA--C 1.523 0.594 0 CA-C-O 119.523 -0.598 . . . . 0.0 112.669 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.71 45.71 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 117.998 0.899 . . . . 0.0 111.294 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.09 157.8 28.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.599 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.37 131.8 40.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 126.553 1.941 . . . . 0.0 106.378 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -76.0 160.6 29.67 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.13 0.972 . . . . 0.0 109.858 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 138.04 54.25 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.23 128.42 38.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.69 -159.73 18.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 123.555 0.598 . . . . 0.0 112.201 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -126.03 155.09 42.03 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.289 1.036 . . . . 0.0 109.045 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.54 152.76 43.62 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 168.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.64 146.33 31.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.19 158.94 34.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.44 0.696 . . . . 0.0 110.837 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.37 139.54 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.077 0.951 . . . . 0.0 108.856 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -18.15 53.33 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.792 1.187 . . . . 0.0 112.346 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -77.21 153.95 33.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.013 1.406 . . . . 0.0 109.98 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -75.29 127.61 33.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 169.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.29 150.78 78.73 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.653 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.17 -30.3 49.98 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.816 3.01 . . . . 0.0 115.625 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 51.63 88.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.557 1.943 . . . . 0.0 113.965 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.02 168.27 19.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.376 1.07 . . . . 0.0 110.405 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.2 157.34 19.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.321 1.448 . . . . 0.0 112.375 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.85 157.69 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.942 2.497 . . . . 0.0 106.279 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tp -86.22 138.08 32.14 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.954 -1.091 . . . . 0.0 108.972 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.8 p -71.18 167.44 19.37 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -65.44 -17.03 64.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.476 -1.39 . . . . 0.0 110.887 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -81.08 0.78 34.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.805 1.642 . . . . 0.0 111.374 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 mt 69.26 34.06 3.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.54 1.536 . . . . 0.0 111.404 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.77 163.06 20.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.668 1.187 . . . . 0.0 108.264 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.3 137.21 37.26 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -134.03 149.94 51.2 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -143.04 165.47 27.28 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.91 -35.57 64.28 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 111.939 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.1 -29.11 56.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.204 1.002 . . . . 0.0 113.146 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -81.14 -40.45 23.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.395 1.078 . . . . 0.0 110.762 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.69 -42.3 91.37 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -66.19 -0.79 2.71 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.67 -16.5 30.45 Favored Glycine 0 CA--C 1.54 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 112.488 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -140.25 158.54 43.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.534 1.533 . . . . 0.0 107.366 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.73 120.28 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -125.46 136.31 53.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.881 -169.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.21 139.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mm -120.55 133.76 66.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -125.99 94.43 4.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.333 1.053 . . . . 0.0 108.696 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.06 124.08 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.82 162.42 55.36 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.41 1.484 . . . . 0.0 107.799 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.02 -59.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.955 1.77 . . . . 0.0 110.315 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.8 m -152.41 160.32 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.581 2.353 . . . . 0.0 106.887 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.29 17.16 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -126.95 14.38 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.891 1.276 . . . . 0.0 110.42 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -73.51 -12.41 60.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.899 1.28 . . . . 0.0 112.713 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.15 -50.77 4.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.808 1.194 . . . . 0.0 110.213 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.68 -25.77 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 118.173 0.987 . . . . 0.0 112.073 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.7 p -53.42 -37.99 63.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.309 1.044 . . . . 0.0 112.257 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.98 -43.75 67.38 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.138 0.975 . . . . 0.0 110.787 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.98 43.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.155 0.982 . . . . 0.0 112.441 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -106.67 -55.01 2.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.189 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -64.78 -40.04 94.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.864 1.211 . . . . 0.0 112.348 -169.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -63.06 -49.3 75.09 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.029 -1.044 . . . . 0.0 109.335 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -67.01 -36.04 81.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.165 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -59.5 -43.86 93.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.75 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -58.08 -46.79 84.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.495 1.043 . . . . 0.0 111.343 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.58 -46.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -69.16 -33.31 73.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.296 -0.878 . . . . 0.0 110.721 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.92 96.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.526 0.603 . . . . 0.0 110.892 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.863 0.756 . . . . 0.0 111.144 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -65.48 -39.76 92.32 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.092 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.02 -45.75 84.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.598 1.09 . . . . 0.0 110.114 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 -4.93 75.22 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.796 1.189 . . . . 0.0 114.433 170.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -153.8 55.1 0.73 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.473 . . . . 0.0 109.831 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.33 168.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -127.76 140.81 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.6 t -137.34 139.79 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -128.71 162.84 26.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.886 0.851 . . . . 0.0 109.502 170.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.5 m -129.11 143.99 51.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 mt -130.87 134.95 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.4 m -138.95 157.0 46.81 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.414 1.086 . . . . 0.0 110.436 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.99 54.32 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -140.41 162.93 34.15 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.651 1.581 . . . . 0.0 107.891 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.34 137.08 95.32 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.46 -32.08 80.56 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.015 1.81 . . . . 0.0 111.269 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -29.44 62.3 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.275 -0.891 . . . . 0.0 111.461 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -45.23 67.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.96 1.255 . . . . 0.0 109.709 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.26 -44.07 79.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.305 1.042 . . . . 0.0 111.714 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.27 -39.96 95.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.387 -0.821 . . . . 0.0 111.894 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -67.16 -39.06 86.44 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -53.95 -51.81 62.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.433 0.693 . . . . 0.0 109.428 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.0 m -60.11 -36.45 77.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.852 0.751 . . . . 0.0 111.231 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.06 -19.56 72.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.954 -0.914 . . . . 0.0 113.548 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.25 -25.17 24.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.168 1.484 . . . . 0.0 111.571 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -124.13 -16.28 6.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.64 1.176 . . . . 0.0 113.08 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.44 22.24 77.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.242 -0.755 . . . . 0.0 112.198 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mt -55.99 140.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -143.33 -35.89 0.38 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.65 1.18 . . . . 0.0 111.807 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -76.48 -17.14 59.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 111.448 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.26 153.98 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.65 150.64 50.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 p -111.77 148.02 34.42 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -171.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.1 mt -138.72 145.25 40.05 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.215 1.006 . . . . 0.0 109.192 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.3 m -107.82 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.516 0.674 . . . . 0.0 109.827 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -81.36 -14.55 57.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.512 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -42.43 -39.92 2.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.761 2.424 . . . . 0.0 114.192 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -119.74 24.05 10.79 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.251 1.021 . . . . 0.0 110.266 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -136.26 -45.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.787 0.835 . . . . 0.0 110.461 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.1 -15.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.15 2.98 . . . . 0.0 114.898 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 m -62.86 -50.57 70.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.329 1.422 . . . . 0.0 111.871 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.92 -46.84 85.9 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.214 0.916 . . . . 0.0 110.162 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.36 99.08 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.89 -42.97 80.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.295 -0.532 . . . . 0.0 109.955 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.56 92.06 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.37 -0.831 . . . . 0.0 112.035 -169.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.11 -1.35 52.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.687 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.63 54.06 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 119.385 0.993 . . . . 0.0 112.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.4 28.87 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.993 1.317 . . . . 0.0 110.46 -170.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -119.84 117.41 28.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.85 112.54 19.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.36 -43.53 83.59 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.595 1.958 . . . . 0.0 111.234 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.4 -43.61 66.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.388 0.275 . . . . 0.0 110.476 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.09 -22.09 31.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 56.59 37.62 28.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.889 0.876 . . . . 0.0 108.697 -168.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.162 1.385 . . . . 0.0 108.056 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.9 150.67 42.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.398 0.618 . . . . 0.0 110.75 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -177.21 2.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.554 1.169 . . . . 0.0 112.232 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.45 101.21 7.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 102.034 -3.321 . . . . 0.0 102.034 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -156.51 167.88 29.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -169.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.13 144.93 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -141.04 159.91 41.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.706 0.802 . . . . 0.0 109.825 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.5 t -135.56 144.45 33.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.3 mt -130.24 123.11 29.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.536 1.534 . . . . 0.0 107.961 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.97 166.23 11.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.158 0.983 . . . . 0.0 108.714 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.51 -20.99 59.45 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.153 -0.967 . . . . 0.0 113.397 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -80.45 -10.68 59.74 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.593 -1.317 . . . . 0.0 112.247 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.58 18.05 69.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.399 -0.813 . . . . 0.0 111.179 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -75.66 132.21 40.42 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.34 125.7 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.97 -10.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -153.55 144.06 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.85 138.69 22.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.08 149.94 29.38 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 109.201 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -129.57 108.19 10.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.72 123.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -68.43 -11.29 59.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -135.28 124.87 25.09 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 108.375 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.87 66.09 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 p -84.52 16.6 3.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 112.017 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -137.23 170.32 16.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.161 2.185 . . . . 0.0 107.954 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.25 164.11 42.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.706 1.203 . . . . 0.0 110.617 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.52 173.64 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.305 2.67 . . . . 0.0 112.258 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -113.91 120.11 39.57 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -53.08 -28.48 25.27 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.526 1.53 . . . . 0.0 112.845 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -58.85 -36.18 74.14 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.496 0.589 . . . . 0.0 111.12 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -67.59 -52.95 24.56 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.677 -170.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.98 -32.94 27.31 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.842 1.336 . . . . 0.0 111.846 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.16 -48.3 79.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-N 119.25 0.932 . . . . 0.0 109.54 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.08 -39.55 92.81 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.508 0.594 . . . . 0.0 110.545 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.216 -0.303 . . . . 0.0 111.603 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.57 -52.2 41.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.532 0.733 . . . . 0.0 110.168 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.13 69.58 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.133 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.454 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.55 -32.02 69.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.374 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.57 -35.85 19.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.796 0.838 . . . . 0.0 111.556 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.4 -40.43 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.451 0.701 . . . . 0.0 111.302 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 18.7 pttp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.336 0.516 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.68 150.86 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -77.56 161.33 27.95 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.905 -1.122 . . . . 0.0 108.797 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -138.15 109.38 6.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 39.03 51.3 1.89 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 111.583 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.22 5.47 79.88 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.519 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.08 142.33 13.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 120.299 2.05 . . . . 0.0 109.966 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 149.41 63.27 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 CA-C-N 120.61 2.205 . . . . 0.0 112.006 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.91 141.37 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.095 1.358 . . . . 0.0 109.432 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -78.07 147.79 34.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.391 1.476 . . . . 0.0 110.115 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.04 147.32 41.38 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.871 1.668 . . . . 0.0 106.842 175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -67.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.572 0.624 . . . . 0.0 111.222 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 173.02 36.24 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.561 0.534 . . . . 0.0 112.331 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.9 152.3 37.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.78 114.29 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.818 1.19 . . . . 0.0 108.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.5 160.52 20.49 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.98 135.06 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -15.29 60.26 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.736 1.16 . . . . 0.0 112.704 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -70.59 147.23 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.619 1.71 . . . . 0.0 109.137 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -87.03 117.8 25.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 152.1 40.57 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -169.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.42 -24.66 36.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.373 3.382 . . . . 0.0 116.542 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 52.74 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.633 1.973 . . . . 0.0 114.324 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.12 -172.98 2.82 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.411 1.484 . . . . 0.0 108.872 172.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 m -122.92 154.76 37.92 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.946 0.899 . . . . 0.0 110.082 -168.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.02 165.02 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.096 2.158 . . . . 0.0 106.796 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tp -89.59 142.54 27.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -69.16 166.91 17.28 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -65.24 -4.13 4.83 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.71 -1.243 . . . . 0.0 111.941 168.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.3 m -115.01 17.68 16.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.102 2.161 . . . . 0.0 111.332 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.1 mt 65.59 37.77 5.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 113.021 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -122.83 157.09 33.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.03 143.24 35.84 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.739 -1.226 . . . . 0.0 109.167 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.04 142.98 32.91 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -138.51 167.03 22.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.516 -171.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tt -57.78 -35.97 71.53 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.96 -0.463 . . . . 0.0 111.188 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.93 54.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.896 . . . . 0.0 113.073 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.46 -37.87 19.26 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.402 1.081 . . . . 0.0 110.718 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.46 -39.37 91.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.96 0.904 . . . . 0.0 110.244 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -67.5 -0.25 3.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.65 -17.07 40.08 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 120.751 -1.218 . . . . 0.0 113.003 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -144.92 166.63 24.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.299 1.84 . . . . 0.0 106.678 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.18 116.68 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 m -125.51 139.35 53.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.809 0.338 . . . . 0.0 110.635 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 mt -103.13 141.77 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.67 95.81 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 125.92 1.688 . . . . 0.0 107.21 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -73.38 145.51 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.82 137.85 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 pt -141.56 150.12 56.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -48.83 10.15 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.986 1.79 . . . . 0.0 111.951 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -156.07 149.11 24.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 tt -79.33 3.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -89.13 -3.9 58.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.28 1.032 . . . . 0.0 111.964 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -65.5 -10.38 34.0 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.922 -1.111 . . . . 0.0 113.399 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.7 -50.1 4.35 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.323 1.44 . . . . 0.0 111.994 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.7 -2.83 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.919 0.888 . . . . 0.0 112.349 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -49.85 -31.5 12.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.369 1.468 . . . . 0.0 110.058 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.48 -50.74 51.81 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.853 1.261 . . . . 0.0 111.92 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.52 79.71 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.612 0.365 . . . . 0.0 110.921 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -85.43 -8.51 58.35 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.648 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -141.01 -60.91 0.49 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.861 1.21 . . . . 0.0 112.47 -169.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -71.87 -43.72 64.97 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.483 -1.386 . . . . 0.0 110.064 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.56 -35.98 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.998 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -62.46 -36.88 83.85 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.555 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -57.37 -45.98 83.87 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.752 1.16 . . . . 0.0 110.323 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.75 -50.18 65.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.831 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -32.18 72.78 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.134 -0.979 . . . . 0.0 110.929 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.98 93.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.911 0.884 . . . . 0.0 111.166 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.26 99.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.202 0.455 . . . . 0.0 109.947 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -65.13 -35.73 82.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.28 0.632 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -62.42 -19.4 63.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.168 0.987 . . . . 0.0 113.225 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.3 -43.27 3.11 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.497 1.046 . . . . 0.0 112.054 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -149.95 126.3 10.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.851 1.261 . . . . 0.0 108.563 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -165.52 174.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.354 2.262 . . . . 0.0 105.379 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -129.41 138.57 51.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -140.54 140.4 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -134.33 167.35 20.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.493 1.117 . . . . 0.0 109.493 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.4 m -131.63 144.15 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.82 141.85 43.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -142.5 156.78 45.18 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.021 0.528 . . . . 0.0 111.452 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.88 50.95 1.87 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.663 1.185 . . . . 0.0 108.047 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -142.71 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.328 1.451 . . . . 0.0 107.787 -169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.41 140.6 72.47 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 111.882 -168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.49 -39.72 45.25 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.93 3.087 . . . . 0.0 114.498 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -74.42 -28.04 60.89 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.74 0.7 . . . . 0.0 111.604 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.27 -44.2 84.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.447 1.021 . . . . 0.0 108.941 172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -48.26 74.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.663 0.785 . . . . 0.0 111.095 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -41.21 97.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.416 0.553 . . . . 0.0 111.451 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -63.77 -41.48 97.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.103 0.561 . . . . 0.0 109.787 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -56.21 -48.48 76.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.416 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 66.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.882 0.764 . . . . 0.0 110.865 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.19 98.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.38 85.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.857 0.829 . . . . 0.0 110.758 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -86.69 -11.07 52.28 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.539 0.736 . . . . 0.0 112.672 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.48 27.85 68.79 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.182 0.901 . . . . 0.0 111.903 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.4 mt -76.54 147.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.188 0.995 . . . . 0.0 108.943 -174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.65 -39.08 0.47 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 111.849 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -11.18 59.86 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.335 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.32 155.44 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -135.27 134.41 39.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -89.14 151.08 22.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.181 0.992 . . . . 0.0 108.777 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 mt -141.59 166.18 25.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.78 2.032 . . . . 0.0 107.388 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.93 123.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -80.4 36.23 0.36 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.561 1.172 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -66.04 -10.43 39.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.738 1.615 . . . . 0.0 111.671 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -79.1 63.29 3.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.456 1.503 . . . . 0.0 108.743 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t0 47.05 44.83 15.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.818 2.047 . . . . 0.0 112.691 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 83.1 mmm 48.73 23.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.192 2.197 . . . . 0.0 114.127 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -63.64 -37.14 86.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.075 -1.016 . . . . 0.0 112.977 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.65 -48.86 62.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 109.65 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.3 61.63 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.33 -49.51 77.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.891 0.845 . . . . 0.0 109.24 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.7 -39.1 80.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.41 -3.08 21.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 113.2 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.26 62.75 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.322 0.965 . . . . 0.0 112.61 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.52 1.08 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.64 1.22 . . . . 0.0 112.449 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -90.89 120.28 31.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.9 mt -82.25 108.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -54.96 -38.53 67.86 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.159 1.383 . . . . 0.0 110.908 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -75.47 -10.85 59.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 112.628 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 mt -134.29 -19.77 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 53.42 42.17 32.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 109.17 -167.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -119.6 148.08 43.75 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.39 1.476 . . . . 0.0 107.249 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 tp -91.9 139.04 31.05 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.04 172.37 10.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.085 0.954 . . . . 0.0 111.13 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ttm105 -101.67 21.17 14.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.922 0.889 . . . . 0.0 111.475 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 m -58.66 176.31 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.285 2.234 . . . . 0.0 113.89 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.47 147.62 16.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.542 -1.349 . . . . 0.0 108.568 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.83 165.18 26.21 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 109.884 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.29 145.02 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.4 mt -131.0 130.21 43.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.431 -168.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.19 168.23 10.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 109.365 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.79 -14.61 22.67 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.207 -0.933 . . . . 0.0 113.511 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -93.8 6.82 47.15 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.539 -1.351 . . . . 0.0 111.743 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.61 22.28 73.29 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.865 -1.147 . . . . 0.0 111.978 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.78 135.53 34.5 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.695 1.248 . . . . 0.0 107.78 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.72 115.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.89 -34.25 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -162.05 144.72 11.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.219 1.808 . . . . 0.0 107.105 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.84 147.94 34.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.895 0.878 . . . . 0.0 108.725 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.26 135.16 26.76 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.053 1.341 . . . . 0.0 107.704 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -106.81 18.7 21.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.051 1.74 . . . . 0.0 112.951 -168.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.1 m 49.21 -16.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 130.193 3.397 . . . . 0.0 118.376 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 m 55.02 -7.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.048 2.939 . . . . 0.0 116.05 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.51 126.15 11.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.056 1.342 . . . . 0.0 112.649 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 80.9 p -93.43 12.8 23.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.148 1.34 . . . . 0.0 112.211 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.17 163.93 15.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.592 1.557 . . . . 0.0 109.765 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -124.65 157.43 65.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.224 1.41 . . . . 0.0 108.714 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.89 -167.49 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.346 2.697 . . . . 0.0 108.646 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -124.2 116.45 22.71 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -47.46 -29.0 2.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.954 2.101 . . . . 0.0 113.897 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.21 -36.49 77.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.15 0.432 . . . . 0.0 110.969 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -58.52 -58.21 20.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.801 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -24.15 23.1 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-O 116.814 -1.411 . . . . 0.0 112.553 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -47.22 94.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 121.332 1.878 . . . . 0.0 109.066 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.53 -34.84 79.17 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 110.855 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.5 62.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.672 0.389 . . . . 0.0 111.625 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.23 -48.44 70.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.631 0.772 . . . . 0.0 111.171 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -31.45 68.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.962 0.505 . . . . 0.0 111.515 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.28 -30.76 71.8 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.054 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.73 -39.29 7.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.682 0.674 . . . . 0.0 112.548 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.22 -23.49 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.161 0.585 . . . . 0.0 111.208 178.535 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.286 16.2 mt 73.65 162.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.699 2.4 . . . . 0.0 111.068 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 p -125.02 165.87 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.812 2.045 . . . . 0.0 108.767 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -136.5 105.37 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt 31.4 56.81 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.115 2.166 . . . . 0.0 114.545 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.52 13.06 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.608 169.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.78 159.87 29.89 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.327 1.564 . . . . 0.0 110.501 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.16 156.73 37.99 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.108 2.539 . . . . 0.0 112.164 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.18 -161.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.926 1.691 . . . . 0.0 106.862 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.0 m -149.13 152.31 35.9 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.284 -1.51 . . . . 0.0 108.219 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.45 138.06 47.33 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.191 1.397 . . . . 0.0 108.406 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.65 -17.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.1 175.88 24.44 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.41 150.61 44.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.096 0.951 . . . . 0.0 111.794 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.37 123.37 26.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 168.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.75 162.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.892 1.224 . . . . 0.0 110.123 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -123.26 156.39 35.31 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.475 1.51 . . . . 0.0 107.72 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.07 135.1 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.34 68.52 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.473 -1.182 . . . . 0.0 112.998 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.02 149.73 49.78 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 108.976 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.35 128.23 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 169.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.98 142.38 92.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.353 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.42 0.41 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.703 1 C-N-CA 126.102 4.535 . . . . 0.0 119.204 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.28 65.24 1.31 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.816 1.293 . . . . 0.0 111.902 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -74.67 164.54 26.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.568 1.547 . . . . 0.0 109.805 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.0 m -130.58 136.57 49.02 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.93 155.11 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.013 1.725 . . . . 0.0 106.618 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -85.39 139.11 31.81 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -70.99 164.87 24.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -67.08 -3.4 7.3 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.852 -1.155 . . . . 0.0 111.594 168.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -97.87 5.24 49.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.415 1.886 . . . . 0.0 111.836 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 63.31 42.72 6.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.82 1.248 . . . . 0.0 111.294 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.97 164.46 20.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -84.14 144.94 28.68 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 120.729 -1.232 . . . . 0.0 109.872 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -138.23 156.32 47.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.95 2.1 . . . . 0.0 106.092 171.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 p -149.48 169.8 20.06 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.293 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -47.02 -43.89 19.99 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.776 0.83 . . . . 0.0 111.347 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -30.57 66.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.949 0.9 . . . . 0.0 112.8 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.91 -40.27 60.97 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.382 0.673 . . . . 0.0 110.426 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.5 mtt -67.74 -25.08 65.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.283 1.033 . . . . 0.0 111.62 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -55.77 -14.84 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.225 1.01 . . . . 0.0 113.622 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.29 -23.27 57.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.754 -1.026 . . . . 0.0 113.672 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -151.77 156.86 41.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.677 1.739 . . . . 0.0 109.517 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.1 122.21 8.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 168.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.5 m -125.96 130.47 51.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.63 0.372 . . . . 0.0 110.923 -168.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.4 mt -89.71 141.43 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 mm -118.74 131.61 71.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -127.42 84.45 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.418 1.087 . . . . 0.0 108.16 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.9 143.65 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.73 169.95 9.77 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 106.989 169.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.27 -54.88 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.82 1.68 . . . . 0.0 110.812 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 m -151.37 170.37 19.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.409 2.284 . . . . 0.0 107.563 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -149.3 81.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.954 0.883 . . . . 0.0 109.206 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.68 6.42 1.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 t -152.64 -170.03 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.941 1.297 . . . . 0.0 107.782 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.28 -52.44 3.78 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.75 -29.68 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 117.897 0.849 . . . . 0.0 112.316 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.4 -24.7 64.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.688 0.676 . . . . 0.0 112.485 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -139.53 -95.68 0.16 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.191 0.997 . . . . 0.0 108.718 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.54 6.34 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.597 1.959 . . . . 0.0 114.581 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -87.7 -44.43 11.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.463 1.105 . . . . 0.0 108.353 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.0 m -51.31 -41.74 60.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.43 1.092 . . . . 0.0 112.393 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -65.28 -45.27 85.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -69.15 -39.23 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -56.73 -40.86 76.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.221 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -59.59 -46.09 89.95 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-N 119.348 0.977 . . . . 0.0 111.416 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.45 -55.72 16.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.392 0.677 . . . . 0.0 109.354 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 27.2 mm-40 -60.08 -40.97 91.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.859 0.754 . . . . 0.0 110.778 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.17 69.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.203 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.67 70.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.572 1.078 . . . . 0.0 110.299 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.93 -41.65 86.66 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.726 174.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.85 -40.78 92.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 110.551 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 -66.62 2.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.951 1.739 . . . . 0.0 110.939 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.69 45.36 1.19 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.725 1.61 . . . . 0.0 111.782 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.65 166.4 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.152 1.381 . . . . 0.0 107.734 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -132.24 146.08 51.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.28 145.32 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.31 155.37 47.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 108.706 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.4 m -117.23 145.81 43.67 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.29 138.05 53.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -140.48 159.18 42.76 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.973 0.909 . . . . 0.0 110.23 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.01 54.66 1.72 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -143.11 161.54 37.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.887 1.275 . . . . 0.0 108.757 -169.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.86 138.43 85.35 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.015 0.926 . . . . 0.0 108.93 -169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.25 -34.27 88.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.619 2.213 . . . . 0.0 112.129 -170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -73.86 -29.05 61.9 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.361 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.97 86.3 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.955 0.798 . . . . 0.0 109.381 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -62.89 -42.64 99.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.328 -0.232 . . . . 0.0 111.123 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.87 84.57 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.696 0.398 . . . . 0.0 111.25 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -63.5 -45.72 89.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -60.66 -40.32 91.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.503 0.321 . . . . 0.0 110.436 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.1 m -63.97 -46.1 86.14 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.005 -0.434 . . . . 0.0 111.315 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.38 94.63 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.65 67.67 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.871 0.868 . . . . 0.0 111.999 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -108.25 -4.89 17.15 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.897 0.879 . . . . 0.0 112.345 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.21 30.65 56.76 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.725 0.679 . . . . 0.0 111.528 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -72.19 143.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.412 1.085 . . . . 0.0 108.675 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.67 -38.38 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.619 1.168 . . . . 0.0 112.87 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -73.35 -21.13 60.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 112.342 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.48 157.79 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.22 143.77 36.18 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 p -96.86 149.96 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.79 0.836 . . . . 0.0 109.521 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.5 mt -137.7 139.4 40.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.592 1.157 . . . . 0.0 108.664 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.7 m -102.06 122.23 43.71 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.427 1.091 . . . . 0.0 108.874 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -104.23 -7.36 20.14 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.669 0.787 . . . . 0.0 111.825 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.51 -27.16 47.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.855 1.262 . . . . 0.0 112.817 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -62.33 -32.04 72.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -146.2 -8.24 0.53 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 50.63 31.02 5.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.421 1.488 . . . . 0.0 112.629 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 m -58.22 -55.47 34.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.296 -0.877 . . . . 0.0 111.136 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -67.26 -40.21 86.19 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.92 -45.09 32.19 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 126.337 1.922 . . . . 0.0 113.118 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.32 -41.31 18.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.903 0.851 . . . . 0.0 109.688 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.97 80.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.574 1.15 . . . . 0.0 112.384 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -105.64 10.79 32.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.812 1.245 . . . . 0.0 110.968 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.24 -3.3 2.46 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.068 -1.407 . . . . 0.0 115.578 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.79 -9.65 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.392 2.096 . . . . 0.0 113.836 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -75.11 120.77 21.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.992 1.269 . . . . 0.0 108.404 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.3 mt -93.7 110.69 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -54.36 -40.84 68.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.871 1.668 . . . . 0.0 111.837 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.24 -6.69 59.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.16 0.584 . . . . 0.0 112.45 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -126.03 -18.54 5.02 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.26 33.41 22.15 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -168.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.6 tp -128.0 171.23 12.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.318 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.3 141.19 47.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.158 0.983 . . . . 0.0 108.748 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 175.89 2.78 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.609 1.164 . . . . 0.0 111.066 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -113.65 18.36 17.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.1 m -63.19 162.35 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 111.727 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.86 147.86 28.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.726 0.81 . . . . 0.0 109.843 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -142.79 155.38 44.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.714 0.805 . . . . 0.0 108.923 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.01 135.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.9 mt -127.93 121.11 29.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.485 1.514 . . . . 0.0 107.276 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.48 160.65 18.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.061 0.945 . . . . 0.0 108.951 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.82 -19.09 15.46 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.772 1.229 . . . . 0.0 113.164 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -73.59 -11.96 60.6 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.534 -1.354 . . . . 0.0 112.465 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.55 43.92 8.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -127.7 131.42 49.75 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.0 109.25 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.974 1.31 . . . . 0.0 108.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.5 -39.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 125.432 1.493 . . . . 0.0 109.331 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -153.76 142.64 21.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.112 1.365 . . . . 0.0 107.504 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.89 139.12 27.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.4 145.26 27.97 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -120.19 131.62 55.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.192 1.397 . . . . 0.0 107.474 -172.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.4 -15.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.3 m 62.55 -12.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.723 2.009 . . . . 0.0 114.658 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -139.74 116.44 10.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.67 1.588 . . . . 0.0 107.029 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.16 66.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.962 1.305 . . . . 0.0 112.676 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 p -91.05 15.34 11.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.347 1.459 . . . . 0.0 111.545 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -138.52 123.1 18.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.366 1.466 . . . . 0.0 109.201 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 155.34 90.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.997 0.919 . . . . 0.0 112.034 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.65 -167.47 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.421 3.414 . . . . 0.0 109.547 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -124.78 116.65 22.63 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -53.38 -27.36 23.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 112.551 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.88 -34.06 71.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.454 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.19 -57.02 19.55 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.233 0.924 . . . . 0.0 111.761 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.34 -29.27 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.398 1.399 . . . . 0.0 111.873 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 mm -56.11 -48.46 79.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 119.878 1.217 . . . . 0.0 109.668 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -65.5 -28.79 69.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.891 0.769 . . . . 0.0 111.423 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.42 -49.83 57.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.394 0.543 . . . . 0.0 111.348 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.8 74.81 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.486 0.714 . . . . 0.0 111.566 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -20.3 63.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.407 0.683 . . . . 0.0 112.175 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.68 -26.65 67.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.72 0.691 . . . . 0.0 111.393 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.6 mt -107.1 -21.97 12.8 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.866 1.266 . . . . 0.0 113.362 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 m -65.96 -18.8 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 119.123 0.874 . . . . 0.0 112.483 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.406 1.082 . . . . 0.0 110.126 -178.227 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 122.18 0.991 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.46 140.72 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.287 1.035 . . . . 0.0 108.472 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 p -102.1 156.97 17.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.988 0.915 . . . . 0.0 109.777 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -104.43 41.83 1.27 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 63.26 -39.8 0.18 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.606 2.762 . . . . 0.0 114.551 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.03 -36.03 33.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.95 0.786 . . . . 0.0 112.015 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.79 177.31 48.06 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.08 153.1 27.51 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.914 3.076 . . . . 0.0 112.797 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.27 131.63 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.62 1.168 . . . . 0.0 108.752 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -63.03 151.28 40.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.446 1.499 . . . . 0.0 111.105 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 mt -122.65 139.63 53.73 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.981 2.112 . . . . 0.0 106.97 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.91 -16.8 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.93 169.1 28.73 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -71.8 159.4 34.38 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.002 0.906 . . . . 0.0 112.057 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -73.37 149.87 42.22 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.51 148.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -131.85 160.35 35.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 111.142 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 141.85 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.028 1.331 . . . . 0.0 109.646 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -22.51 26.35 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.051 1.31 . . . . 0.0 112.027 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -74.95 151.16 38.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.514 1.157 . . . . 0.0 109.91 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -71.29 123.63 22.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.46 152.03 75.21 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.36 -26.53 44.29 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.797 2.998 . . . . 0.0 116.065 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t0 51.38 86.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.282 1.833 . . . . 0.0 114.303 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -127.14 -176.02 3.6 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.798 1.639 . . . . 0.0 108.814 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 m -124.37 154.2 40.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.198 0.999 . . . . 0.0 111.014 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.65 166.33 26.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.883 2.073 . . . . 0.0 107.811 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 tp -84.89 143.92 28.72 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.4 p -71.22 166.86 20.64 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -67.31 -3.42 7.99 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.024 -1.672 . . . . 0.0 112.156 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 m -110.56 17.1 21.08 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.367 1.867 . . . . 0.0 111.323 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.4 mt 66.51 28.1 9.53 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.347 1.459 . . . . 0.0 112.829 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.76 174.34 5.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.03 146.61 43.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.178 -1.576 . . . . 0.0 109.992 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -141.37 136.28 31.3 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 p -124.01 164.11 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.243 1.017 . . . . 0.0 109.247 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.68 -36.69 69.89 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.08 -0.388 . . . . 0.0 110.254 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.53 54.27 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.48 -39.75 52.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 mtt -64.27 -24.81 67.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.632 1.173 . . . . 0.0 111.323 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -55.85 -14.06 2.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.464 1.106 . . . . 0.0 113.401 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.23 -24.36 44.2 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.424 1.011 . . . . 0.0 113.423 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -151.36 169.01 23.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.908 1.354 . . . . 0.0 108.832 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.5 t -62.71 122.43 13.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.0 m -129.39 135.28 48.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.521 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.42 141.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -127.76 120.21 53.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 125.372 1.469 . . . . 0.0 107.42 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.4 m -116.94 100.32 7.68 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.269 1.028 . . . . 0.0 108.395 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.6 136.66 22.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.74 157.69 74.49 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.81 -60.44 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.833 2.355 . . . . 0.0 110.578 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 m -148.49 152.37 36.77 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.295 1.438 . . . . 0.0 107.958 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.75 -18.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.688 1.195 . . . . 0.0 113.284 -173.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.8 19.17 18.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.893 0.877 . . . . 0.0 111.753 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.421 ' HB ' HH12 ' A' ' 129' ' ' ARG . 16.8 p -68.84 -6.37 26.6 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.22 4.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.505 1.526 . . . . 0.0 110.71 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.03 -11.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 122.001 -0.706 . . . . 0.0 111.985 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.14 -21.61 13.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.067 0.947 . . . . 0.0 111.384 169.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -47.77 -47.78 30.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.96 1.304 . . . . 0.0 111.674 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.0 91.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.882 0.473 . . . . 0.0 110.762 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -82.72 -6.58 59.47 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.629 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -136.25 -62.8 0.66 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.676 1.125 . . . . 0.0 111.304 -169.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -83.27 -45.26 14.03 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.798 -1.189 . . . . 0.0 110.998 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -62.97 -32.6 73.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.697 0.68 . . . . 0.0 109.974 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.1 -43.58 87.2 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.327 0.512 . . . . 0.0 111.687 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.15 -45.06 96.2 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.992 0.517 . . . . 0.0 111.342 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.43 -51.03 71.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.46 -38.07 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.627 1.103 . . . . 0.0 110.529 -173.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.05 78.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.46 76.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.04 0.836 . . . . 0.0 110.65 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -70.74 -37.36 73.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.817 0.735 . . . . 0.0 109.77 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.57 -45.07 92.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.627 0.771 . . . . 0.0 109.857 170.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.09 -47.65 1.19 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.191 1.377 . . . . 0.0 110.859 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -140.36 109.52 6.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.301 1.041 . . . . 0.0 109.775 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 p -158.75 -175.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.981 2.512 . . . . 0.0 104.97 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -137.62 138.18 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.84 142.58 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.01 154.74 51.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.697 0.799 . . . . 0.0 109.055 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.5 m -117.67 142.33 47.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.0 mt -131.31 136.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.92 158.69 42.82 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.199 0.999 . . . . 0.0 110.15 -170.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.65 3.16 56.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.669 0.788 . . . . 0.0 111.794 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -101.52 -174.9 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.118 0.967 . . . . 0.0 109.978 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 133.58 90.31 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.79 -37.42 54.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.393 2.729 . . . . 0.0 113.964 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -72.41 -28.64 63.1 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.503 -0.748 . . . . 0.0 111.782 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.59 74.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.13 0.877 . . . . 0.0 109.42 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.36 -49.18 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.262 0.625 . . . . 0.0 110.384 169.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.74 75.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.281 0.491 . . . . 0.0 111.73 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -67.08 -40.5 87.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.356 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.07 -49.29 78.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.99 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.4 m -58.86 -48.25 82.04 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.38 0.536 . . . . 0.0 111.343 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.32 86.1 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.528 -0.596 . . . . 0.0 112.284 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.06 -41.71 70.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.013 0.906 . . . . 0.0 110.567 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -85.98 -22.15 27.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 119.088 -0.482 . . . . 0.0 112.179 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.42 24.17 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.51 143.35 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -146.92 -36.66 0.23 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.642 0.777 . . . . 0.0 112.999 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.45 -21.56 59.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.406 0.548 . . . . 0.0 111.201 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.77 165.2 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.937 1.295 . . . . 0.0 108.247 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -142.7 137.62 30.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 p -85.24 145.99 27.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt -135.12 169.33 17.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.625 1.97 . . . . 0.0 107.276 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -135.66 105.01 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.605 0.762 . . . . 0.0 109.481 -169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.64 -15.46 62.79 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.408 0.683 . . . . 0.0 110.927 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -46.11 -20.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.008 2.523 . . . . 0.0 113.45 169.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -40.8 -60.6 1.13 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.904 1.682 . . . . 0.0 111.497 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.29 15.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.126 0.97 . . . . 0.0 111.071 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.07 18.35 1.7 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.225 1.81 . . . . 0.0 113.325 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -49.68 76.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.928 1.291 . . . . 0.0 112.035 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -77.72 -40.64 40.51 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.931 -0.481 . . . . 0.0 109.843 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.71 -36.79 91.77 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.86 -51.24 69.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 117.544 0.672 . . . . 0.0 109.594 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.9 92.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.75 4.38 44.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.06 0.944 . . . . 0.0 112.423 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.93 39.68 96.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.091 0.853 . . . . 0.0 113.449 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.76 -12.91 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.52 1.128 . . . . 0.0 111.522 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.37 108.75 8.37 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mt -80.1 108.35 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -53.61 -45.75 70.19 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.702 1.201 . . . . 0.0 110.893 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.32 -2.39 24.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.029 0.932 . . . . 0.0 113.236 -173.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -125.92 -18.39 5.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.382 1.073 . . . . 0.0 112.346 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 52.94 39.04 28.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.644 1.178 . . . . 0.0 109.645 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -138.16 150.58 46.93 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.24 1.016 . . . . 0.0 108.31 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.36 145.24 49.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.449 0.643 . . . . 0.0 110.745 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.26 177.11 1.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.007 2.123 . . . . 0.0 111.014 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.421 HH12 ' HB ' ' A' ' 57' ' ' THR . 6.3 mtp180 -115.31 106.39 13.97 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 m -152.76 169.28 23.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.53 146.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -138.85 158.81 43.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.265 1.026 . . . . 0.0 109.073 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.82 143.08 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 170.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 mt -129.31 126.37 38.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.915 1.686 . . . . 0.0 107.078 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.52 165.07 21.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.388 0.675 . . . . 0.0 109.454 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.04 -23.56 47.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.975 0.91 . . . . 0.0 112.385 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -76.43 -3.67 38.33 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.966 -1.084 . . . . 0.0 112.126 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.39 24.61 76.02 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.077 0.846 . . . . 0.0 112.045 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.32 142.25 28.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.32 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.8 -15.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.735 0.814 . . . . 0.0 111.556 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -152.38 145.28 24.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.47 141.79 25.18 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -148.68 140.78 23.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -122.41 123.09 40.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.77 133.24 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -68.06 -7.7 31.54 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.066 0.947 . . . . 0.0 113.309 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.03 122.35 13.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.474 1.11 . . . . 0.0 108.303 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.27 -22.71 64.73 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.905 0.882 . . . . 0.0 113.26 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.1 p -76.21 1.44 15.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.013 0.824 . . . . 0.0 111.91 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.48 156.79 44.19 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.917 2.087 . . . . 0.0 107.531 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.5 157.54 74.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.726 0.81 . . . . 0.0 111.951 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.1 168.88 22.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.798 2.332 . . . . 0.0 110.447 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -108.95 118.0 35.66 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -48.99 -28.13 3.68 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.317 2.247 . . . . 0.0 113.381 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.28 -38.51 83.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.575 0.625 . . . . 0.0 111.17 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.51 -53.18 54.08 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.712 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.72 -25.92 33.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.621 1.548 . . . . 0.0 112.063 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -44.59 95.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 120.255 1.389 . . . . 0.0 109.104 171.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.27 -33.04 74.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.197 0.908 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.31 -53.15 39.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.513 0.325 . . . . 0.0 110.986 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.24 76.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.565 0.746 . . . . 0.0 112.08 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.27 67.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.753 0.706 . . . . 0.0 111.649 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.14 71.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.183 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.02 -31.39 8.77 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.83 -30.32 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.905 0.775 . . . . 0.0 112.249 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.2 pttp . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.495 0.718 . . . . 0.0 110.457 177.527 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.0 mt -140.63 171.26 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.281 2.632 . . . . 0.0 103.98 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 p -117.64 148.25 42.12 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 120.989 -1.069 . . . . 0.0 109.826 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -75.58 -18.34 59.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.875 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt 138.55 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 132.089 4.156 . . . . 0.0 109.586 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.17 -5.6 26.58 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.053 0.835 . . . . 0.0 113.586 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.6 47.16 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.2 164.58 35.22 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.609 2.873 . . . . 0.0 112.439 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.73 139.38 46.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.532 1.533 . . . . 0.0 108.266 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -74.52 148.55 40.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.545 0.738 . . . . 0.0 109.502 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.74 146.85 42.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.743 2.417 . . . . 0.0 105.984 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -74.12 -14.16 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 179.86 21.44 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 119.319 0.963 . . . . 0.0 112.888 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -90.89 148.67 22.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.689 0.796 . . . . 0.0 110.043 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.09 141.52 58.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.45 147.39 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -128.44 165.82 19.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.577 0.703 . . . . 0.0 112.12 -168.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -52.63 140.17 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.799 1.64 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.32 63.44 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.655 -1.08 . . . . 0.0 112.955 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.13 157.31 16.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.133 1.467 . . . . 0.0 109.873 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -66.1 134.92 53.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.15 155.47 84.17 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.24 -25.77 73.61 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.21 2.607 . . . . 0.0 115.841 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.9 t70 51.0 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.586 1.954 . . . . 0.0 114.866 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -129.23 -175.19 3.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.516 1.526 . . . . 0.0 109.225 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.1 m -121.41 151.63 39.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 109.957 -169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.68 163.65 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.764 2.426 . . . . 0.0 106.688 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tp -87.35 147.4 25.5 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 169.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.4 p -72.02 166.85 21.39 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -65.41 -4.44 5.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.689 -1.257 . . . . 0.0 111.571 168.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.9 m -114.66 17.04 17.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.157 2.183 . . . . 0.0 111.322 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.5 mt 66.19 41.13 3.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 112.98 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.63 154.77 41.81 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.83 141.0 40.85 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.76 -1.213 . . . . 0.0 108.798 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.06 144.42 33.58 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.074 1.349 . . . . 0.0 107.499 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 p -139.1 166.21 25.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.54 -35.85 70.85 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.471 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.62 -30.7 43.95 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 113.593 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.81 -40.34 33.18 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.647 0.779 . . . . 0.0 110.67 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.8 mtt -63.36 -24.49 67.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.791 1.237 . . . . 0.0 111.31 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.79 -14.59 2.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.49 1.116 . . . . 0.0 113.319 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.55 56.39 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.519 1.054 . . . . 0.0 114.013 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.68 162.48 41.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.256 1.528 . . . . 0.0 108.212 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.07 119.59 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -124.53 131.02 53.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.481 0.313 . . . . 0.0 111.129 -168.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.49 143.83 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -126.68 132.91 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.5 m -128.72 88.26 2.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.94 0.896 . . . . 0.0 108.602 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.45 133.95 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.27 73.34 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.56 -60.04 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.028 2.486 . . . . 0.0 113.333 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 m -152.04 164.26 37.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.458 1.903 . . . . 0.0 106.969 -170.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 tp -79.6 -17.87 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.77 -0.582 . . . . 0.0 112.23 -169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.79 -21.72 54.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.086 -1.008 . . . . 0.0 112.858 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 t -70.6 112.22 6.69 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 0.0 111.191 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.49 -31.32 80.37 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.566 -0.709 . . . . 0.0 112.843 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.23 -15.77 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.464 1.132 . . . . 0.0 112.419 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -105.93 -14.25 15.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.769 0.827 . . . . 0.0 112.336 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.59 -44.03 93.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.736 0.698 . . . . 0.0 109.545 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.41 93.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.424 0.69 . . . . 0.0 111.367 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -58.94 -56.15 25.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.59 0.632 . . . . 0.0 109.483 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -65.88 -35.59 81.06 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.169 0.895 . . . . 0.0 111.404 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -60.61 -49.65 76.68 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.523 1.056 . . . . 0.0 110.686 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.18 -34.44 76.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.911 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.17 -43.31 74.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.146 1.339 . . . . 0.0 110.915 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.51 -47.75 84.17 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.171 0.441 . . . . 0.0 111.606 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -63.45 -49.23 74.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.915 0.886 . . . . 0.0 109.085 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.04 -38.68 91.67 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.006 0.821 . . . . 0.0 110.591 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.99 97.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.974 0.806 . . . . 0.0 111.26 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.82 88.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.138 0.426 . . . . 0.0 111.103 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.07 -39.69 82.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.795 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.83 -40.69 96.16 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.203 0.911 . . . . 0.0 110.292 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.79 -24.44 12.69 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.624 1.107 . . . . 0.0 112.912 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -148.95 102.91 3.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.341 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.47 171.64 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.262 2.225 . . . . 0.0 105.069 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -128.68 143.04 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.14 144.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -135.92 158.43 44.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.028 1.331 . . . . 0.0 109.392 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -119.27 148.51 43.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mt -134.31 134.49 54.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.84 158.97 42.04 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.766 0.827 . . . . 0.0 109.881 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.36 41.79 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -129.46 165.75 20.98 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 111.271 -168.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.99 127.38 90.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 126.874 2.069 . . . . 0.0 108.621 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.05 -38.6 32.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.458 2.772 . . . . 0.0 113.94 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.45 -27.96 41.61 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.791 -0.568 . . . . 0.0 112.24 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.72 -42.37 67.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.374 0.988 . . . . 0.0 109.525 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -55.42 -42.92 74.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.176 0.99 . . . . 0.0 111.531 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.62 91.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.015 0.526 . . . . 0.0 111.414 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -66.42 -44.28 83.39 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.709 -0.62 . . . . 0.0 109.546 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -43.13 79.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.708 0.803 . . . . 0.0 111.165 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.46 -35.84 34.32 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.823 0.738 . . . . 0.0 111.048 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.72 98.77 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.61 82.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.498 0.719 . . . . 0.0 111.085 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.57 -10.69 59.79 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.47 30.7 59.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 119.399 0.999 . . . . 0.0 111.008 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.0 mm -67.37 148.65 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.525 1.13 . . . . 0.0 108.117 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -137.69 -38.65 0.58 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 111.585 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -87.69 -22.72 24.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.239 1.016 . . . . 0.0 112.621 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.91 162.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -141.16 143.75 34.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 149.41 21.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 mt -135.48 156.23 49.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.916 1.287 . . . . 0.0 109.15 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -120.94 97.91 5.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.836 1.255 . . . . 0.0 109.181 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.23 -7.25 56.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.04 0.536 . . . . 0.0 110.839 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -43.46 -28.0 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.08 2.552 . . . . 0.0 114.018 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -57.42 -46.07 83.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.938 0.895 . . . . 0.0 111.731 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.98 11.47 0.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.5 mmm 53.55 20.45 2.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.205 . . . . 0.0 114.967 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.4 m -58.36 -44.07 88.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.22 0.918 . . . . 0.0 112.364 -171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -70.64 -46.57 63.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.89 -38.13 84.61 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.55 -50.69 72.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.023 0.911 . . . . 0.0 109.509 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.89 -8.2 57.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.384 0.674 . . . . 0.0 112.449 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.8 45.56 57.49 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.459 1.027 . . . . 0.0 112.029 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.1 25.29 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 110.764 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -116.8 119.18 34.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.36 102.21 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.06 -35.81 36.68 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.936 1.694 . . . . 0.0 111.317 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.01 -14.54 61.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.5 mt -130.83 -21.0 2.77 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 59.79 34.94 22.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.828 0.851 . . . . 0.0 110.028 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.62 154.07 45.68 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.647 1.179 . . . . 0.0 108.361 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.69 157.36 36.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.233 0.54 . . . . 0.0 110.163 172.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.04 -178.69 2.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.41 1.484 . . . . 0.0 110.551 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -106.06 13.39 29.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.793 0.837 . . . . 0.0 111.671 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.7 m -63.05 159.19 17.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.337 1.855 . . . . 0.0 112.886 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.79 149.12 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.631 0.773 . . . . 0.0 109.346 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -137.37 163.0 32.07 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.344 1.058 . . . . 0.0 109.774 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.82 140.94 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.9 mt -131.4 128.07 38.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.62 167.16 17.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.968 0.907 . . . . 0.0 109.86 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.89 -23.93 63.86 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.406 -0.809 . . . . 0.0 112.284 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -75.78 -11.44 59.99 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.731 -1.231 . . . . 0.0 111.827 172.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.93 22.44 71.69 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.146 0.879 . . . . 0.0 112.465 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -82.5 145.58 29.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.39 126.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -101.96 -34.84 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.727 1.611 . . . . 0.0 109.394 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -151.6 143.96 24.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 138.45 22.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.89 143.82 33.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.86 100.63 6.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.328 1.851 . . . . 0.0 106.43 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.55 119.42 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 m -71.06 -8.83 56.11 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -139.85 125.9 19.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.613 1.097 . . . . 0.0 108.311 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.19 70.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.785 0.834 . . . . 0.0 112.406 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 p -82.42 6.22 17.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.221 1.008 . . . . 0.0 112.892 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -120.16 162.32 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.251 1.42 . . . . 0.0 109.197 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -117.56 162.78 26.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.445 1.498 . . . . 0.0 110.106 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.17 -171.46 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.137 2.558 . . . . 0.0 109.918 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -128.68 112.4 14.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -56.58 -28.27 59.85 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.913 1.685 . . . . 0.0 112.897 -169.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.39 -31.87 73.2 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.889 -0.507 . . . . 0.0 111.754 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -61.8 -54.61 49.59 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.843 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.09 -26.95 49.94 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 CA-C-N 120.842 1.336 . . . . 0.0 111.822 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -44.05 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 120.218 1.372 . . . . 0.0 109.948 171.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.78 -32.29 73.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.137 0.88 . . . . 0.0 110.45 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.72 -49.64 57.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.3 0.24 . . . . 0.0 111.586 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.14 72.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.076 0.55 . . . . 0.0 112.018 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.49 64.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.496 0.718 . . . . 0.0 112.657 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.6 mt -111.35 -28.68 8.12 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.96 -11.94 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.3 pttt . . . . . 0 C--O 1.249 1.039 0 C-N-CA 125.864 1.665 . . . . 0.0 108.272 -176.474 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 122.427 1.108 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.02 145.94 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.026 1.33 . . . . 0.0 108.269 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -115.33 153.41 31.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.309 1.444 . . . . 0.0 109.396 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -110.91 42.6 1.58 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.822 1.249 . . . . 0.0 108.99 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm 42.0 64.65 1.04 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.738 2.015 . . . . 0.0 111.755 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.17 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.658 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 172.11 44.17 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.465 1.031 . . . . 0.0 110.573 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.76 159.75 51.64 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.403 2.735 . . . . 0.0 110.995 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.77 129.61 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.415 1.086 . . . . 0.0 108.386 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -61.74 156.36 20.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.492 1.517 . . . . 0.0 111.131 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.82 133.65 41.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.74 1.616 . . . . 0.0 109.284 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.29 161.52 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.75 -159.01 52.74 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.109 -0.994 . . . . 0.0 111.346 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.05 147.65 52.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.175 1.39 . . . . 0.0 109.205 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -66.13 115.42 6.12 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.3 158.37 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.969 1.307 . . . . 0.0 107.617 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -134.49 159.51 40.91 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 111.048 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.28 142.88 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.124 0.97 . . . . 0.0 108.999 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -22.28 24.43 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.03 1.3 . . . . 0.0 112.367 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -74.5 154.41 38.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.64 1.22 . . . . 0.0 109.839 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -70.14 132.69 46.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.71 158.82 48.74 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.74 -3.84 3.99 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.154 3.236 . . . . 0.0 117.548 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t0 53.64 57.76 5.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.978 1.371 . . . . 0.0 111.791 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -79.47 167.03 21.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.361 1.865 . . . . 0.0 110.26 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -135.03 148.29 49.89 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.33 170.74 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.981 2.112 . . . . 0.0 108.251 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -102.08 143.27 32.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.269 1.028 . . . . 0.0 108.808 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -74.05 -15.75 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 102.84 -14.92 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 130.264 3.426 . . . . 0.0 108.129 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -119.07 22.08 12.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.145 1.778 . . . . 0.0 111.052 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp 61.66 40.31 13.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.882 1.673 . . . . 0.0 111.656 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.88 156.05 43.2 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.42 152.37 19.15 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.381 0.61 . . . . 0.0 109.735 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.91 148.7 32.05 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.427 1.891 . . . . 0.0 106.139 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 p -149.97 171.66 16.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.531 0.605 . . . . 0.0 109.821 -169.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -43.47 -45.81 6.55 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 111.552 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.01 -29.01 66.93 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.963 0.905 . . . . 0.0 112.866 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -39.99 21.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.771 0.828 . . . . 0.0 110.717 174.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt -71.36 -34.87 70.86 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.154 0.582 . . . . 0.0 111.008 -170.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -63.85 -3.48 2.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.67 -21.84 23.31 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.146 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.44 168.26 20.97 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.26 1.53 . . . . 0.0 108.631 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.99 124.42 17.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.9 m -131.68 134.05 45.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.141 0.275 . . . . 0.0 111.11 -168.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.0 mt -93.21 141.1 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -123.48 133.54 68.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -129.34 106.05 8.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.4 127.93 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 pt -137.79 137.49 21.74 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.11 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.967 2.444 . . . . 0.0 114.185 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.3 m -159.45 158.25 31.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.882 1.673 . . . . 0.0 106.92 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -90.1 12.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 122.198 -0.314 . . . . 0.0 111.649 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -118.77 15.69 13.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.109 1.364 . . . . 0.0 110.338 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.42 -11.5 60.87 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.303 1.441 . . . . 0.0 113.395 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 -51.8 4.59 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.57 -22.44 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 118.028 0.914 . . . . 0.0 111.878 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.0 p -49.64 -36.21 23.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.272 1.029 . . . . 0.0 112.278 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.93 -38.32 90.53 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.928 0.891 . . . . 0.0 110.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.52 17.38 3.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.395 1.478 . . . . 0.0 112.003 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -132.16 -79.03 0.5 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.206 1.003 . . . . 0.0 108.338 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -52.9 -53.63 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.903 1.281 . . . . 0.0 112.991 -168.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -79.31 -27.9 42.16 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.172 -0.955 . . . . 0.0 112.126 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -62.51 -43.73 98.1 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.767 1.167 . . . . 0.0 109.689 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -58.43 -37.51 75.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.473 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -59.19 -49.57 77.33 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.566 1.076 . . . . 0.0 111.311 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.68 -47.43 66.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -64.0 -36.14 83.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.346 0.975 . . . . 0.0 111.034 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.13 86.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.868 0.758 . . . . 0.0 111.379 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.94 93.96 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.638 0.654 . . . . 0.0 110.273 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -34.4 78.19 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.609 0.641 . . . . 0.0 111.496 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.29 -22.23 65.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.062 0.846 . . . . 0.0 112.074 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 -43.42 3.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.947 1.26 . . . . 0.0 112.075 174.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.64 117.62 5.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.03 1.332 . . . . 0.0 108.928 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -158.89 -175.6 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.086 2.154 . . . . 0.0 105.484 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -139.66 138.22 35.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.36 138.87 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -128.81 159.39 35.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 m -126.7 145.92 50.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.95 138.04 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -140.94 152.57 45.1 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 123.51 0.506 . . . . 0.0 111.408 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.99 43.79 0.72 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.679 1.192 . . . . 0.0 108.663 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -131.05 158.7 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.589 1.556 . . . . 0.0 108.925 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.85 134.9 96.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.846 1.258 . . . . 0.0 111.08 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.85 -42.18 6.48 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 124.994 3.796 . . . . 0.0 115.554 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.66 -28.56 60.9 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.11 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.29 70.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.379 0.991 . . . . 0.0 109.419 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.9 -47.31 64.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.919 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.23 70.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.359 0.264 . . . . 0.0 111.364 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -61.76 -45.58 93.27 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.286 0.634 . . . . 0.0 110.789 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.0 -37.88 88.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.896 0.316 . . . . 0.0 110.476 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.2 m -66.84 -41.51 87.3 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.798 -0.564 . . . . 0.0 111.737 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -35.52 92.15 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.34 70.86 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.772 0.786 . . . . 0.0 110.243 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -78.92 -21.52 47.19 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.71 15.42 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.31 144.21 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -145.75 -37.43 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.614 1.166 . . . . 0.0 112.698 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -84.88 -13.37 51.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.559 0.743 . . . . 0.0 112.258 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.03 155.99 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -133.85 124.82 27.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 p -79.47 157.2 27.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.676 0.791 . . . . 0.0 109.339 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.4 mt -144.18 164.57 30.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.785 1.634 . . . . 0.0 108.102 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -118.21 140.98 48.98 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.544 -0.723 . . . . 0.0 109.389 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.54 5.59 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.18 1.792 . . . . 0.0 109.952 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -59.59 -26.72 65.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 111.841 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -60.17 -46.05 91.01 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.961 0.904 . . . . 0.0 111.87 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -156.01 14.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 95.0 mmm 48.12 26.51 1.04 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.849 2.06 . . . . 0.0 113.968 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.39 -50.14 73.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.643 1.177 . . . . 0.0 111.711 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.98 -48.66 75.56 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.145 0.884 . . . . 0.0 109.405 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.34 -47.67 80.88 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.29 -50.15 64.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.255 1.022 . . . . 0.0 109.832 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 7.58 43.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 112.154 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.94 36.57 86.65 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.735 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.7 -13.41 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.553 1.177 . . . . 0.0 111.636 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 104.94 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.78 98.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.36 -34.74 49.0 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.793 1.637 . . . . 0.0 111.108 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.62 -17.08 62.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.7 pp -146.78 16.47 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.962 1.256 . . . . 0.0 114.327 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 48.39 51.13 15.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.197 1.799 . . . . 0.0 111.685 169.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -152.28 150.44 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.45 156.02 25.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.688 0.676 . . . . 0.0 110.569 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.48 -155.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.856 2.062 . . . . 0.0 112.538 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.42 118.3 22.89 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 m -162.06 163.16 28.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -170.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.13 147.79 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.013 0.925 . . . . 0.0 108.685 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -138.68 156.83 47.08 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.064 0.945 . . . . 0.0 108.649 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.0 t -135.2 143.73 36.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.8 mt -128.27 126.21 40.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.939 1.695 . . . . 0.0 108.227 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.59 163.62 25.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.607 1.163 . . . . 0.0 110.154 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.25 -15.52 25.51 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.1 10.57 41.18 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.687 1.131 . . . . 0.0 112.225 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.43 76.99 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.978 . . . . 0.0 112.88 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.91 144.25 25.45 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.294 1.047 . . . . 0.0 108.442 173.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.39 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.65 -16.4 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.728 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -151.68 144.38 24.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.77 139.15 23.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -151.66 137.16 17.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -122.31 122.18 38.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.3 t -72.67 123.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.3 m -61.81 -40.67 96.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.584 0.353 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -83.6 109.55 17.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.943 0.897 . . . . 0.0 109.232 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.98 62.7 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.694 -0.629 . . . . 0.0 111.676 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -71.82 -1.08 12.84 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.084 1.354 . . . . 0.0 113.124 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.78 171.22 13.78 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.58 1.552 . . . . 0.0 110.067 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -128.55 156.84 76.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.518 1.527 . . . . 0.0 109.302 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.64 154.18 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.964 1.776 . . . . 0.0 109.391 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -79.61 116.01 19.56 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -52.43 -24.91 8.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.011 1.725 . . . . 0.0 113.459 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -62.34 -35.48 79.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.807 0.73 . . . . 0.0 111.467 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -64.58 -50.8 63.38 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 121.172 -0.955 . . . . 0.0 112.335 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.29 -25.95 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.075 1.42 . . . . 0.0 111.53 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -44.29 97.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 109.597 171.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.62 -33.28 75.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.325 0.966 . . . . 0.0 111.088 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.85 38.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.338 0.255 . . . . 0.0 110.915 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.29 78.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.232 0.613 . . . . 0.0 112.419 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -29.45 67.61 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.665 0.666 . . . . 0.0 111.709 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.1 68.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.219 0.607 . . . . 0.0 112.256 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.94 -28.66 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.38 -12.41 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.059 0.944 . . . . 0.0 110.087 178.041 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 122.852 1.311 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.84 153.45 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.804 2.042 . . . . 0.0 109.095 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -94.45 155.3 17.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.504 1.122 . . . . 0.0 108.407 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -132.59 108.26 8.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt 27.14 56.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.668 2.387 . . . . 0.0 115.253 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.73 -2.2 27.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 117.801 -1.555 . . . . 0.0 115.652 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.51 147.18 18.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 120.578 2.189 . . . . 0.0 111.988 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.78 154.32 67.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.056 2.504 . . . . 0.0 110.651 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.0 145.4 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.553 0.692 . . . . 0.0 110.11 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -79.52 156.88 27.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.919 1.288 . . . . 0.0 111.286 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.62 142.13 51.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.099 1.76 . . . . 0.0 108.843 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.17 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.44 -160.96 22.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.12 146.99 52.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.851 0.86 . . . . 0.0 109.266 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -65.56 113.76 4.42 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -73.06 169.53 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.401 0.546 . . . . 0.0 109.708 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.93 160.85 37.33 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.148 0.979 . . . . 0.0 109.065 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.58 137.8 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.32 -16.14 60.54 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.538 -1.146 . . . . 0.0 112.614 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.36 160.32 24.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.318 1.559 . . . . 0.0 109.941 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -99.92 121.84 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.05 136.95 67.07 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.595 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.76 0.51 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.657 1 C-N-CA 126.112 4.541 . . . . 0.0 119.263 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.29 64.88 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.812 1.291 . . . . 0.0 111.447 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -73.62 165.45 25.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.698 1.599 . . . . 0.0 109.929 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.6 m -133.16 149.34 52.07 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.69 162.38 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.759 2.023 . . . . 0.0 106.734 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 tp -88.63 135.86 33.29 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -65.12 162.91 16.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -64.88 -8.52 15.74 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.663 -1.273 . . . . 0.0 111.004 168.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 m -95.27 6.41 49.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.874 2.07 . . . . 0.0 111.696 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.7 mt 70.84 35.88 1.65 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.32 1.448 . . . . 0.0 112.319 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.09 152.34 44.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.52 139.88 40.94 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.763 -1.211 . . . . 0.0 108.968 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -136.95 145.54 44.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.4 p -144.38 170.81 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.165 0.586 . . . . 0.0 109.701 -170.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -46.77 -44.75 19.31 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.374 0.67 . . . . 0.0 110.796 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.19 63.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.817 0.847 . . . . 0.0 113.022 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.31 -41.04 42.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.515 0.726 . . . . 0.0 110.542 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.7 mtt -69.05 -22.73 64.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.214 1.005 . . . . 0.0 111.877 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.08 -16.56 3.04 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.664 1.186 . . . . 0.0 113.291 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.55 53.25 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.763 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -153.13 160.09 42.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.456 1.628 . . . . 0.0 109.15 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.63 120.09 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.1 m -123.56 131.03 53.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.027 0.441 . . . . 0.0 110.639 -168.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.0 mt -89.37 141.58 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.64 137.81 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.7 m -131.31 94.53 3.58 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.86 143.43 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.48 150.02 59.33 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.656 0.783 . . . . 0.0 111.373 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.92 123.35 9.25 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.679 2.253 . . . . 0.0 110.047 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m 48.08 -162.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.471 1.509 . . . . 0.0 113.224 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 tt -148.04 -22.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 120.882 -1.136 . . . . 0.0 111.51 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.92 -24.8 67.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.972 -1.08 . . . . 0.0 112.807 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.6 p -73.0 -17.77 61.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.137 1.375 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.04 -53.15 3.75 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.021 1.296 . . . . 0.0 112.805 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.55 -14.5 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.102 0.951 . . . . 0.0 110.457 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 14.3 p -49.56 -31.31 10.15 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.846 1.658 . . . . 0.0 113.449 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.66 130.57 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.578 1.081 . . . . 0.0 113.49 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.85 -6.43 8.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.498 1.919 . . . . 0.0 108.821 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -33.07 23.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.155 0.982 . . . . 0.0 110.803 -170.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 p -53.55 -48.31 69.22 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.071 1.305 . . . . 0.0 112.327 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -39.15 91.88 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.91 0.777 . . . . 0.0 110.959 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -66.76 -45.34 78.87 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.956 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -57.56 -41.34 80.84 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.88 0.764 . . . . 0.0 111.31 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -60.35 -50.87 71.9 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.653 0.781 . . . . 0.0 110.471 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.02 -41.63 77.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -67.86 -36.19 79.85 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.86 96.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.956 0.798 . . . . 0.0 110.884 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.07 93.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.925 0.33 . . . . 0.0 111.125 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -65.91 -40.98 91.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.43 -40.2 95.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.51 1.05 . . . . 0.0 110.25 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.3 10.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.818 1.199 . . . . 0.0 112.002 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -152.68 112.0 3.86 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.557 1.143 . . . . 0.0 109.121 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.86 176.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.405 2.282 . . . . 0.0 105.275 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -134.5 141.07 46.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.07 141.46 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -134.08 153.24 51.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.817 0.847 . . . . 0.0 109.917 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -108.58 146.67 32.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.23 135.0 57.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 m -131.36 152.51 50.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.307 1.043 . . . . 0.0 109.652 -170.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.37 52.24 1.02 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -140.08 165.06 28.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.98 145.96 96.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 123.268 0.627 . . . . 0.0 110.249 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.27 -32.07 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.623 2.215 . . . . 0.0 112.766 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -79.28 -22.13 45.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.199 0.909 . . . . 0.0 112.212 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.61 53.44 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.173 -0.955 . . . . 0.0 108.718 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -51.36 -56.42 13.24 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.31 1.044 . . . . 0.0 110.492 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.15 -42.32 80.78 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.787 0.835 . . . . 0.0 111.843 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.0 -44.81 62.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -63.97 -39.62 94.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.976 0.511 . . . . 0.0 111.134 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.49 -36.29 57.89 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.212 -1.555 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.19 93.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.85 -45.37 82.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.646 0.778 . . . . 0.0 110.537 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -68.4 -24.09 64.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.521 0.728 . . . . 0.0 111.683 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.24 25.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.527 1.06 . . . . 0.0 111.837 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.18 142.87 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.152 0.981 . . . . 0.0 108.435 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -143.6 -44.31 0.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.485 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.67 -11.81 59.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.027 0.931 . . . . 0.0 111.941 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.49 160.94 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -140.6 145.8 37.16 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 p -89.68 139.49 30.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.905 1.682 . . . . 0.0 109.799 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 mt -131.14 168.91 16.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.615 1.966 . . . . 0.0 109.354 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.38 105.95 11.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.686 1.194 . . . . 0.0 111.683 -168.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -72.71 -21.94 60.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -52.57 -14.3 0.49 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.839 2.056 . . . . 0.0 113.121 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -45.91 -57.33 4.45 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.944 1.297 . . . . 0.0 110.821 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -164.59 16.49 0.05 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.2 mmm 55.86 26.35 9.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.761 1.624 . . . . 0.0 111.039 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -38.12 82.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.116 0.966 . . . . 0.0 113.018 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -74.06 -42.47 60.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.106 1.321 . . . . 0.0 108.907 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.64 -60.13 2.56 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.396 1.95 . . . . 0.0 111.884 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.8 -39.66 69.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.242 1.017 . . . . 0.0 110.473 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.63 95.42 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.23 0.612 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.43 9.25 37.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 113.208 -169.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.3 37.69 86.6 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.118 0.872 . . . . 0.0 111.972 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.54 3.92 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.56 1.144 . . . . 0.0 112.588 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -83.19 108.45 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.532 1.515 . . . . 0.0 107.183 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.91 111.56 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -55.4 -53.55 54.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.176 1.79 . . . . 0.0 111.406 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.79 -29.05 55.87 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.499 0.32 . . . . 0.0 111.255 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -79.5 -22.18 44.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.974 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 56.44 36.28 27.29 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -168.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -135.22 154.73 51.49 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.934 0.894 . . . . 0.0 109.745 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.36 142.69 52.11 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.458 0.703 . . . . 0.0 109.382 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.39 -168.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.801 1.64 . . . . 0.0 111.387 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -127.3 127.8 44.92 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -170.18 170.98 7.07 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.763 1.625 . . . . 0.0 106.968 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.6 145.12 30.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -137.46 156.79 47.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.328 1.051 . . . . 0.0 108.635 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 t -134.74 140.36 45.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.2 mt -129.07 126.39 39.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.434 1.494 . . . . 0.0 107.448 -169.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.94 167.73 9.23 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 109.147 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.12 -21.88 35.64 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.178 -0.951 . . . . 0.0 112.587 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -81.73 -7.5 59.6 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.594 -1.316 . . . . 0.0 112.543 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.03 16.77 80.46 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 120.872 -1.142 . . . . 0.0 112.133 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -77.79 133.66 38.18 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.12 110.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.55 -36.2 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.058 1.343 . . . . 0.0 109.687 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -151.47 145.22 25.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.05 133.6 18.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.99 137.07 22.07 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -104.8 117.21 33.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.9 127.96 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -69.76 -6.21 30.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -140.94 115.9 9.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 120.299 1.409 . . . . 0.0 107.475 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.61 69.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 -24.21 66.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.394 0.678 . . . . 0.0 111.113 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -100.82 126.31 47.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.169 1.388 . . . . 0.0 108.047 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -72.64 149.51 90.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.09 162.12 43.03 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.547 3.498 . . . . 0.0 109.596 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -96.36 120.38 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -55.98 -28.07 55.52 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.337 1.455 . . . . 0.0 112.703 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.16 -34.17 74.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.441 0.564 . . . . 0.0 111.426 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -65.06 -54.46 33.7 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 118.875 0.762 . . . . 0.0 111.692 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -30.44 24.05 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.486 1.458 . . . . 0.0 111.894 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 mm -54.43 -50.14 59.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 119.599 1.091 . . . . 0.0 109.523 169.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.32 -30.5 71.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.672 0.669 . . . . 0.0 111.494 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.09 71.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.164 0.438 . . . . 0.0 111.72 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.8 -45.55 57.91 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.452 0.701 . . . . 0.0 111.824 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -28.79 64.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.45 0.7 . . . . 0.0 111.56 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 -29.33 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 112.534 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 mt -103.63 -29.12 11.3 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.55 -10.64 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.094 0.957 . . . . 0.0 110.144 177.34 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 122.679 1.228 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 99.2 mt -54.85 156.73 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.733 1.613 . . . . 0.0 108.817 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.17 128.32 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.907 1.283 . . . . 0.0 108.177 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -84.68 42.58 0.92 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 110.268 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt 38.23 60.29 1.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.885 2.074 . . . . 0.0 112.337 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.75 -24.63 0.14 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.761 0.696 . . . . 0.0 111.646 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.35 169.05 40.58 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.94 155.3 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.144 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 m -136.54 166.37 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 107.949 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.9 m -117.18 161.05 20.08 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.033 0.933 . . . . 0.0 108.971 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 mt -125.54 141.98 51.75 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.852 1.661 . . . . 0.0 106.986 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.43 -65.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.25 165.72 54.77 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.49 165.29 24.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.708 0.766 . . . . 0.0 110.658 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.19 117.52 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.5 t -76.54 154.53 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -130.49 163.85 26.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 121.453 -0.779 . . . . 0.0 110.007 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.51 144.89 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.81 78.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.864 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -118.5 154.84 31.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.911 1.355 . . . . 0.0 108.814 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -65.87 134.86 53.93 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.51 159.24 61.74 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.732 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.23 -29.81 58.72 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.71 2.94 . . . . 0.0 115.845 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t0 46.72 86.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.258 1.823 . . . . 0.0 114.117 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -127.36 -172.79 2.74 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.284 1.433 . . . . 0.0 108.843 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.0 m -120.58 151.65 39.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.679 1.192 . . . . 0.0 110.461 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.61 165.06 27.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.723 2.409 . . . . 0.0 106.85 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.07 135.78 33.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -67.09 162.94 21.15 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.14 -10.41 49.94 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.488 -1.383 . . . . 0.0 110.816 168.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -82.1 3.38 27.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.578 1.951 . . . . 0.0 111.43 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.3 mt 68.44 30.93 5.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.897 2.079 . . . . 0.0 112.211 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.58 140.39 48.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.01 140.41 49.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.325 1.05 . . . . 0.0 111.456 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -141.68 143.48 33.61 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 126.094 1.757 . . . . 0.0 106.823 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -130.99 160.05 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tt -56.88 -33.92 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.257 0.481 . . . . 0.0 110.927 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.45 -29.62 50.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.092 0.957 . . . . 0.0 113.393 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -78.39 -40.34 36.45 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.125 0.97 . . . . 0.0 110.444 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.1 mtt -63.03 -27.29 69.31 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.953 1.301 . . . . 0.0 111.49 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -55.28 -15.46 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.058 . . . . 0.0 113.071 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.77 46.01 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.654 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 46' ' ' VAL . 9.8 tppt? -149.78 155.99 41.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.688 1.744 . . . . 0.0 110.299 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.419 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 99.2 t -56.2 118.18 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.6 m -119.8 148.76 43.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.018 0.527 . . . . 0.0 110.029 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.22 146.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.12 138.57 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -113.17 99.63 7.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.518 1.527 . . . . 0.0 108.088 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.85 125.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 pt -133.55 155.3 80.73 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.281 1.032 . . . . 0.0 109.004 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.57 -58.1 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.95 2.433 . . . . 0.0 111.858 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.3 m -153.04 157.8 41.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.454 1.901 . . . . 0.0 106.732 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.07 -5.7 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.303 0.956 . . . . 0.0 111.52 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.9 -3.24 43.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.417 1.087 . . . . 0.0 112.623 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.3 p -64.29 -16.9 63.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -49.91 3.88 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.398 0.999 . . . . 0.0 111.089 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.72 -8.91 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.328 1.064 . . . . 0.0 112.239 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.3 p -55.21 -36.95 66.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.269 1.027 . . . . 0.0 108.953 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.56 -45.66 91.93 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.506 1.123 . . . . 0.0 111.177 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.61 -0.27 3.77 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 112.489 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -122.84 -87.74 0.63 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -48.89 -49.48 39.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.359 1.864 . . . . 0.0 113.532 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -72.44 -40.83 66.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.66 -1.275 . . . . 0.0 110.723 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.83 -38.48 91.12 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.061 -0.399 . . . . 0.0 110.342 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -60.22 -34.75 74.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.576 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -60.77 -50.29 74.07 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 120.094 1.315 . . . . 0.0 111.114 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.91 -42.59 76.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.302 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.35 -36.56 84.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.904 1.229 . . . . 0.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.56 -21.81 65.43 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.652 -0.655 . . . . 0.0 112.223 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.05 44.48 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.939 0.79 . . . . 0.0 111.194 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -72.19 -41.95 66.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.266 0.626 . . . . 0.0 110.143 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.19 137.22 58.15 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -36.27 80.19 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.765 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.75 79.08 0.86 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.49 1.145 . . . . 0.0 110.162 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.52 171.34 18.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.077 0.951 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -136.68 145.55 44.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.188 1.795 . . . . 0.0 106.802 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.26 151.67 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.306 -0.871 . . . . 0.0 109.749 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -135.42 170.72 15.51 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.513 1.525 . . . . 0.0 109.736 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.8 m -134.85 148.71 50.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.63 137.89 54.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -136.77 153.77 50.74 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.792 0.837 . . . . 0.0 111.427 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.8 46.15 1.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.413 1.485 . . . . 0.0 107.842 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -140.07 170.33 16.04 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.352 1.461 . . . . 0.0 107.863 -168.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.07 144.32 62.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 123.677 0.791 . . . . 0.0 111.181 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.04 -31.13 76.5 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.402 2.068 . . . . 0.0 112.896 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -71.55 -28.94 64.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.727 1.149 . . . . 0.0 111.387 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.09 74.54 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.043 0.838 . . . . 0.0 108.877 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.35 -46.51 69.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.513 0.725 . . . . 0.0 110.93 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.62 51.09 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.23 0.612 . . . . 0.0 111.211 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.12 -34.19 75.9 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.933 -0.479 . . . . 0.0 111.068 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -63.4 -42.5 98.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.124 0.42 . . . . 0.0 110.126 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.1 m -65.12 -42.9 93.47 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 121.77 -0.581 . . . . 0.0 111.37 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.31 98.85 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.33 86.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.571 0.748 . . . . 0.0 110.599 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.06 -24.86 51.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.127 0.571 . . . . 0.0 112.376 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 32.46 22.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.845 0.735 . . . . 0.0 111.432 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.08 144.64 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.8 -34.8 0.23 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.393 1.077 . . . . 0.0 112.677 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -79.21 -16.35 56.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.685 0.794 . . . . 0.0 111.952 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.19 159.1 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.05 134.74 40.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -92.84 145.59 24.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.632 0.773 . . . . 0.0 109.433 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 mt -136.66 166.04 24.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.936 1.695 . . . . 0.0 107.815 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 m -136.91 133.03 35.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.037 0.935 . . . . 0.0 109.352 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.23 -3.95 8.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.499 0.72 . . . . 0.0 112.14 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -57.22 -25.01 58.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.682 -1.261 . . . . 0.0 112.262 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -69.39 -25.11 63.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.272 1.029 . . . . 0.0 112.9 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.71 -19.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mmt 54.15 -0.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.144 2.978 . . . . 0.0 117.582 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 p -59.0 -36.78 75.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.501 1.501 . . . . 0.0 112.614 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.61 -56.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.022 0.529 . . . . 0.0 109.579 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.88 65.65 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.44 -53.65 55.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.467 0.707 . . . . 0.0 109.145 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.37 -31.0 57.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.154 -0.451 . . . . 0.0 112.17 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -4.0 27.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.567 0.621 . . . . 0.0 112.256 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 48.04 52.79 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 119.084 0.856 . . . . 0.0 111.283 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.89 -14.46 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.828 0.851 . . . . 0.0 111.383 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -72.93 111.86 8.43 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.54 112.13 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -54.26 -38.02 65.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.554 1.542 . . . . 0.0 111.425 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.62 -6.28 58.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.583 0.753 . . . . 0.0 112.638 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.7 mt -131.94 -21.24 2.43 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.038 0.935 . . . . 0.0 112.779 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 52.7 42.41 31.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.395 1.078 . . . . 0.0 109.313 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -135.19 153.22 52.03 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.218 1.407 . . . . 0.0 107.714 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.2 mt -84.06 141.94 30.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.327 0.512 . . . . 0.0 110.712 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.59 141.03 57.97 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.702 1.201 . . . . 0.0 109.806 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -68.36 109.09 3.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 p -154.77 165.06 37.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.878 0.763 . . . . 0.0 110.977 -169.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.27 153.52 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.79 156.45 46.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.359 1.063 . . . . 0.0 109.222 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.4 t -131.32 143.25 41.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 38.4 mt -135.2 126.4 28.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.736 1.615 . . . . 0.0 107.697 -169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.78 165.63 23.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.641 0.776 . . . . 0.0 109.085 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.14 -17.16 57.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.261 -0.899 . . . . 0.0 112.764 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -78.04 -11.45 59.91 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.537 -1.352 . . . . 0.0 112.236 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.03 75.87 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.009 -1.057 . . . . 0.0 112.645 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.93 139.28 37.14 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.89 134.26 30.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.48 -29.03 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.632 1.573 . . . . 0.0 109.254 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -155.08 146.28 22.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.61 1.564 . . . . 0.0 106.842 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.61 143.31 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.403 1.081 . . . . 0.0 108.463 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -149.93 146.5 27.09 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.848 1.659 . . . . 0.0 107.099 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -128.71 -15.34 4.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.561 1.545 . . . . 0.0 112.392 -169.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t 50.25 106.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 129.078 2.951 . . . . 0.0 113.093 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -59.14 -28.66 66.77 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.136 0.974 . . . . 0.0 112.797 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.67 105.94 17.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.1 62.4 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.9 p -73.68 -13.29 60.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.433 1.893 . . . . 0.0 112.904 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -109.87 156.45 20.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.557 1.543 . . . . 0.0 109.397 -169.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -106.8 153.46 40.76 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.373 0.669 . . . . 0.0 110.109 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.84 151.47 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.354 2.036 . . . . 0.0 109.488 171.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -82.04 119.39 23.94 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -54.05 -25.61 22.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.783 1.633 . . . . 0.0 112.878 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -60.59 -35.64 76.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.681 0.673 . . . . 0.0 111.138 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.82 -53.32 50.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.529 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.9 -27.8 43.09 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.951 1.375 . . . . 0.0 112.214 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.22 -46.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 120.695 1.588 . . . . 0.0 109.82 172.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.43 -33.77 76.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.907 0.776 . . . . 0.0 110.679 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.66 68.32 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.675 0.274 . . . . 0.0 111.149 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.38 -48.7 66.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.982 0.513 . . . . 0.0 110.795 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -29.05 69.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.746 0.703 . . . . 0.0 111.643 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.88 -31.7 71.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.579 0.627 . . . . 0.0 111.568 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.8 mt -88.29 -24.6 23.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.89 0.876 . . . . 0.0 112.054 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.4 -27.93 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.966 171.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.034 0.934 . . . . 0.0 110.746 176.548 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.32 148.64 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 p -92.87 153.11 19.01 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.601 1.091 . . . . 0.0 110.307 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -112.46 41.31 2.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.091 1.356 . . . . 0.0 108.622 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 44.11 62.99 1.77 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.769 2.028 . . . . 0.0 112.3 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.04 -25.63 0.16 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.55 1.071 . . . . 0.0 110.922 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.49 173.89 45.71 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.979 1.276 . . . . 0.0 110.108 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.56 157.61 58.34 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.157 2.572 . . . . 0.0 111.004 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.47 136.99 48.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.644 1.578 . . . . 0.0 107.471 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -74.32 154.78 38.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.763 1.225 . . . . 0.0 109.878 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.72 138.68 54.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.055 1.742 . . . . 0.0 106.549 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.71 -173.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.9 -152.83 51.73 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 123.266 0.46 . . . . 0.0 112.967 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -132.23 155.42 48.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.479 1.111 . . . . 0.0 109.697 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.12 154.41 37.8 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 168.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.13 152.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -126.37 157.31 38.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.62 1.168 . . . . 0.0 110.264 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.24 142.71 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.609 1.163 . . . . 0.0 109.377 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.17 -19.44 46.53 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.811 1.196 . . . . 0.0 111.878 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -74.94 149.26 39.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.396 1.098 . . . . 0.0 109.599 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -73.08 120.29 18.51 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 155.26 73.71 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.306 0.242 . . . . 0.0 110.768 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.17 -19.02 15.18 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 125.295 3.997 . . . . 0.0 118.501 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 55.03 65.24 1.55 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.924 1.345 . . . . 0.0 110.692 -168.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -71.58 168.33 17.85 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 110.071 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -131.06 149.21 52.71 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.48 167.43 14.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 125.825 1.65 . . . . 0.0 106.696 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 tp -86.05 147.28 26.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.1 p -72.57 172.0 11.39 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.684 -1.26 . . . . 0.0 107.701 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -67.26 -3.31 7.57 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.835 -1.166 . . . . 0.0 111.498 168.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.1 m -118.58 17.63 13.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.968 2.107 . . . . 0.0 111.276 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 63.86 43.73 5.24 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.402 1.481 . . . . 0.0 112.449 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.87 154.22 45.73 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 142.97 39.04 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.749 -1.219 . . . . 0.0 109.21 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.77 147.47 35.58 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.601 1.56 . . . . 0.0 107.05 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 p -143.06 165.9 26.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.997 0.919 . . . . 0.0 109.175 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.8 -34.49 67.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.354 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.58 -31.24 56.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.021 0.828 . . . . 0.0 112.975 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.87 -35.98 37.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.958 0.903 . . . . 0.0 111.426 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.8 mtt -78.9 -34.97 44.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.936 0.895 . . . . 0.0 112.111 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.77 -3.48 3.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -18.14 23.65 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 118.916 -0.936 . . . . 0.0 112.03 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -139.57 164.61 29.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.109 1.455 . . . . 0.0 109.138 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.51 128.29 20.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.1 m -130.45 136.77 49.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.3 mt -100.29 142.21 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.8 mm -120.33 129.01 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.9 m -124.97 98.59 5.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.418 1.087 . . . . 0.0 108.455 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.14 135.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.58 155.5 75.24 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.476 1.51 . . . . 0.0 107.929 172.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.99 -51.97 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.673 1.582 . . . . 0.0 110.76 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.25 158.88 42.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.258 1.423 . . . . 0.0 107.869 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 tt -106.79 29.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.114 0.966 . . . . 0.0 112.317 -168.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -134.79 16.44 3.58 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.814 0.845 . . . . 0.0 110.422 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.8 p -81.91 -9.43 59.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.225 1.01 . . . . 0.0 112.544 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.14 -50.08 3.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -25.64 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.165 0.982 . . . . 0.0 110.853 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -49.48 -33.83 15.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.449 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.87 -43.61 94.61 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.116 0.967 . . . . 0.0 111.497 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.25 6.29 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.736 1.214 . . . . 0.0 113.023 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.84 -77.82 0.58 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -54.2 -46.61 72.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -65.55 -41.97 92.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.213 0.915 . . . . 0.0 110.13 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -81.1 -25.71 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.999 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -63.36 -38.1 89.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.263 0.938 . . . . 0.0 109.726 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -61.35 -43.16 99.34 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.943 0.792 . . . . 0.0 111.147 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.83 -56.35 16.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.77 -30.69 70.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.297 -0.877 . . . . 0.0 111.87 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.24 89.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.15 0.886 . . . . 0.0 111.088 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.76 80.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.555 0.616 . . . . 0.0 110.664 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -41.25 90.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.091 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.97 -39.63 90.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.571 0.748 . . . . 0.0 110.2 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.95 -27.73 8.7 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.628 1.108 . . . . 0.0 112.048 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -151.62 118.4 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.49 172.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.1 -176.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.622 1.969 . . . . 0.0 105.749 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -138.81 136.03 35.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.59 145.63 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 152.19 51.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.586 0.754 . . . . 0.0 109.977 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.4 m -104.53 146.0 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.3 mt -129.28 132.95 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 m -134.57 149.63 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.577 1.151 . . . . 0.0 109.768 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.66 55.31 2.94 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.03 160.39 40.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.056 1.342 . . . . 0.0 108.098 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.29 146.51 92.2 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.262 -169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.8 -44.04 43.34 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.269 2.646 . . . . 0.0 112.858 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -77.23 -28.26 53.65 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.754 -0.591 . . . . 0.0 111.855 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.27 83.31 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.128 0.876 . . . . 0.0 109.996 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.83 -46.43 65.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.252 0.621 . . . . 0.0 111.507 173.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.94 77.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.439 0.563 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -50.22 74.53 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.703 1.201 . . . . 0.0 108.769 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -45.51 81.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.505 0.322 . . . . 0.0 110.159 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.0 m -64.28 -44.72 90.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.219 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.28 -37.02 90.54 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.15 80.56 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.842 0.821 . . . . 0.0 110.635 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -79.35 -33.08 43.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.162 0.585 . . . . 0.0 111.985 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 37.81 8.86 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.02 144.59 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.77 -37.58 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.694 1.197 . . . . 0.0 112.486 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.71 -16.2 42.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.558 0.743 . . . . 0.0 112.318 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.61 159.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -134.05 140.14 46.46 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 p -96.63 145.55 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.0 mt -134.9 158.28 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.29 113.65 22.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.914 1.686 . . . . 0.0 108.346 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.32 10.8 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.839 0.828 . . . . 0.0 111.651 170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.21 -16.25 5.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.327 1.451 . . . . 0.0 111.214 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.4 ttt-85 -68.43 69.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.945 1.698 . . . . 0.0 109.508 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 46.17 41.15 8.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.284 1.834 . . . . 0.0 113.85 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.9 mmm 50.04 32.02 5.4 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.231 1.812 . . . . 0.0 113.601 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.7 m -53.71 -49.72 67.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.975 0.91 . . . . 0.0 111.751 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -72.03 -43.72 64.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.893 0.77 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.46 92.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.101 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.37 -47.46 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.013 0.907 . . . . 0.0 109.9 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.18 75.58 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.66 4.65 38.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.264 1.026 . . . . 0.0 112.265 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.05 49.5 77.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.482 1.039 . . . . 0.0 113.616 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.16 -12.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.58 1.552 . . . . 0.0 111.251 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.73 113.63 5.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.4 mt -75.36 109.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.68 -41.53 55.81 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.658 1.983 . . . . 0.0 111.28 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.8 2.45 53.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.489 -171.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.54 -25.13 3.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.088 0.858 . . . . 0.0 113.311 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 56.06 33.89 22.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.592 0.633 . . . . 0.0 109.884 -168.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.38 164.6 20.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.651 1.58 . . . . 0.0 107.107 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.73 147.58 24.73 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.156 0.503 . . . . 0.0 110.127 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.88 145.26 46.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.411 1.484 . . . . 0.0 110.637 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -79.19 102.57 8.58 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 71.1 m -149.77 168.47 23.59 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.751 1.22 . . . . 0.0 108.46 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.39 149.81 17.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.982 -0.449 . . . . 0.0 109.798 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.6 157.17 45.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.283 1.033 . . . . 0.0 108.692 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -137.93 138.64 43.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.52 133.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.504 1.522 . . . . 0.0 107.408 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.1 176.69 3.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.872 0.869 . . . . 0.0 110.591 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.24 9.57 0.31 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.783 1.233 . . . . 0.0 114.243 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -127.6 4.77 6.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.875 1.67 . . . . 0.0 110.219 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.86 77.98 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.973 0.806 . . . . 0.0 112.553 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -87.4 136.84 32.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 119.452 1.626 . . . . 0.0 107.274 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.74 126.94 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.57 -19.84 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.464 0.705 . . . . 0.0 110.46 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -154.33 144.89 22.3 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.84 140.07 24.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.828 1.651 . . . . 0.0 107.168 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -152.23 147.33 26.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.306 0.503 . . . . 0.0 109.658 171.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.58 104.83 7.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.848 2.059 . . . . 0.0 105.633 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.22 133.61 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -73.39 -13.66 61.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -138.11 113.85 9.78 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.03 68.11 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 p -74.28 -0.66 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.31 0.959 . . . . 0.0 113.155 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.09 167.21 17.87 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.454 1.101 . . . . 0.0 108.957 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -117.88 157.14 49.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.472 0.709 . . . . 0.0 112.263 -168.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.67 152.27 78.13 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.618 2.212 . . . . 0.0 108.783 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -78.79 117.39 19.87 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -56.36 -20.97 21.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.499 1.519 . . . . 0.0 113.279 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.08 -36.62 82.25 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.054 0.843 . . . . 0.0 111.424 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -61.33 -52.62 69.41 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 119.327 0.967 . . . . 0.0 111.945 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.78 -27.86 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 120.797 1.32 . . . . 0.0 111.766 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -45.04 93.78 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 120.11 1.323 . . . . 0.0 109.731 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.19 -35.71 81.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.872 0.76 . . . . 0.0 110.652 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.38 79.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.401 0.143 . . . . 0.0 111.053 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.72 -50.12 46.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.736 0.415 . . . . 0.0 111.2 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -34.11 70.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.679 0.672 . . . . 0.0 111.157 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.33 67.19 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.361 0.528 . . . . 0.0 112.018 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.34 -23.74 16.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 50.2 t -57.13 -36.17 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.583 0.629 . . . . 0.0 110.495 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.717 1.207 . . . . 0.0 110.88 175.654 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.8 mt -132.73 168.99 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 p -115.93 148.17 40.33 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.88 -1.138 . . . . 0.0 109.011 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -91.69 37.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 63.25 -41.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.876 2.871 . . . . 0.0 114.204 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.79 -31.12 41.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.319 0.961 . . . . 0.0 112.477 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 173.73 46.46 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.234 1.017 . . . . 0.0 111.245 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.6 152.13 50.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 124.0 3.133 . . . . 0.0 113.718 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.51 127.58 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.507 1.923 . . . . 0.0 107.133 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -70.08 153.71 42.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.516 1.526 . . . . 0.0 110.634 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.07 140.42 44.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.42 1.488 . . . . 0.0 108.459 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.13 -16.82 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.42 162.15 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.89 160.04 33.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.74 0.781 . . . . 0.0 110.442 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 pm0 -74.17 136.96 42.87 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 168.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.53 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -133.66 161.62 34.15 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.271 -0.893 . . . . 0.0 110.427 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.14 140.93 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.87 32.78 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.797 -1.001 . . . . 0.0 112.862 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -70.51 155.54 40.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.179 1.49 . . . . 0.0 109.235 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -76.34 127.55 33.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 158.84 57.92 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.563 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -54.86 -14.95 8.85 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.432 3.421 . . . . 0.0 117.867 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 52.78 56.94 6.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 123.103 1.43 . . . . 0.0 110.169 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -83.26 170.95 14.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.928 2.091 . . . . 0.0 111.32 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 m -131.8 149.22 52.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.823 1.249 . . . . 0.0 107.653 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.89 170.87 10.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.703 2.001 . . . . 0.0 106.956 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tp -87.13 142.6 27.8 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -69.58 166.6 18.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.14 -6.64 18.56 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.634 -1.291 . . . . 0.0 110.897 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -100.24 8.64 43.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.055 2.142 . . . . 0.0 111.688 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.0 mt 68.15 39.52 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.404 1.482 . . . . 0.0 112.688 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -127.48 157.76 39.22 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.31 142.76 48.84 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 120.896 -1.127 . . . . 0.0 108.962 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.9 142.63 33.08 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -135.45 165.18 26.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.902 0.881 . . . . 0.0 108.656 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -53.97 -33.16 56.18 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.38 -0.343 . . . . 0.0 111.465 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.71 -33.56 61.2 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.42 -35.46 70.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.4 mtt -78.81 -29.69 44.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.386 1.474 . . . . 0.0 111.882 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -55.8 -14.86 2.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.635 1.574 . . . . 0.0 114.619 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.39 -17.41 32.24 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.604 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -151.17 157.54 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.26 1.53 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.66 126.51 13.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.8 m -118.89 151.66 37.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.424 0.69 . . . . 0.0 109.832 -169.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.7 mt -123.86 146.67 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 mm -130.18 110.66 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.631 1.572 . . . . 0.0 107.398 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 140.32 45.37 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.97 122.15 64.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.65 153.63 68.23 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.56 -57.09 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 111.301 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -146.28 142.5 28.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.556 1.942 . . . . 0.0 105.991 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.6 tt -77.33 -22.79 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -168.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.92 -18.67 62.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.8 p -66.54 149.78 49.95 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.861 0.755 . . . . 0.0 109.643 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.44 -37.41 92.01 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.901 -0.5 . . . . 0.0 111.898 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.46 -43.09 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 117.9 0.85 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -62.42 -42.71 99.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.891 0.769 . . . . 0.0 110.671 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.94 -56.23 24.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.664 1.186 . . . . 0.0 110.84 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.85 79.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.92 0.488 . . . . 0.0 112.248 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -57.17 10.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 173.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -62.46 -44.67 95.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.846 0.748 . . . . 0.0 111.948 -170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -76.66 -37.57 56.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.194 1.361 . . . . 0.0 112.859 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -62.3 -43.18 99.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.045 0.839 . . . . 0.0 108.878 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.21 -35.36 76.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.944 -0.551 . . . . 0.0 112.003 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.38 -42.91 96.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.575 1.08 . . . . 0.0 112.263 173.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.76 -42.97 99.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 64.6 mm-40 -61.46 -39.08 89.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.864 1.211 . . . . 0.0 111.448 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.63 78.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.444 0.566 . . . . 0.0 111.092 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.37 83.07 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.941 0.791 . . . . 0.0 111.478 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -65.13 -39.46 93.07 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.459 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.7 -49.72 69.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 109.785 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 -61.91 2.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.967 1.746 . . . . 0.0 112.032 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -83.79 55.28 3.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.547 1.539 . . . . 0.0 110.72 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.14 169.91 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.191 1.396 . . . . 0.0 107.778 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -130.15 137.82 50.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.1 t -144.86 145.29 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.177 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -138.16 171.72 13.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.918 1.287 . . . . 0.0 109.689 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 m -132.8 144.42 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.42 1.888 . . . . 0.0 105.905 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -131.47 133.32 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -135.19 152.79 51.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.331 1.052 . . . . 0.0 109.539 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.46 45.12 1.16 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -129.62 164.94 22.78 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 -168.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.9 137.38 96.0 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.49 -42.71 48.0 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.091 2.528 . . . . 0.0 112.196 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -73.31 -32.24 64.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.621 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.39 -43.55 90.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.409 1.004 . . . . 0.0 109.802 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.05 -48.55 79.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.013 1.325 . . . . 0.0 111.908 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.8 86.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.751 0.705 . . . . 0.0 111.158 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -45.64 93.72 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.318 1.047 . . . . 0.0 108.953 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -64.69 -40.71 95.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.336 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 m -61.14 -43.66 98.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.606 0.639 . . . . 0.0 110.885 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.15 86.47 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.358 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.21 92.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.061 0.931 . . . . 0.0 110.629 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.96 -13.32 19.16 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.24 37.61 41.78 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.62 143.14 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.952 1.301 . . . . 0.0 108.207 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -139.35 -25.87 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -117.74 -5.04 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.431 1.092 . . . . 0.0 111.984 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.23 158.5 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -143.59 135.6 26.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 p -96.67 142.75 28.33 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.278 1.031 . . . . 0.0 108.358 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.97 150.21 45.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.528 1.531 . . . . 0.0 108.471 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -107.62 106.79 17.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 111.025 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.35 -11.34 59.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 109.843 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -48.64 -28.22 3.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.633 1.173 . . . . 0.0 111.58 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.98 88.11 1.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.075 1.35 . . . . 0.0 110.787 170.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.5 t70 65.03 14.48 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.059 1.744 . . . . 0.0 115.433 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp 44.34 30.7 0.49 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.016 2.527 . . . . 0.0 115.064 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.24 -46.86 88.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.439 0.696 . . . . 0.0 111.38 -173.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -66.32 -50.38 63.81 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -39.18 96.18 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 123.059 0.361 . . . . 0.0 112.202 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.47 -53.6 27.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.711 0.804 . . . . 0.0 109.978 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.08 67.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.93 56.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.597 1.159 . . . . 0.0 111.851 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.06 49.68 65.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.826 0.727 . . . . 0.0 113.296 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -123.4 -11.17 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.867 1.267 . . . . 0.0 111.012 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 108.05 3.72 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 98.4 mt -74.7 115.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.1 -47.54 82.38 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.448 1.099 . . . . 0.0 111.229 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.65 13.93 2.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.122 0.874 . . . . 0.0 113.237 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 40.14 53.82 2.77 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.204 2.201 . . . . 0.0 113.689 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 tp -145.96 169.55 18.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.113 0.965 . . . . 0.0 108.681 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.07 137.25 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.087 0.555 . . . . 0.0 109.984 -173.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.49 149.22 49.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.987 1.315 . . . . 0.0 111.156 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -81.05 115.9 20.73 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 70.8 m -162.18 171.19 17.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.747 1.219 . . . . 0.0 108.825 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.19 144.4 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.501 -0.749 . . . . 0.0 109.622 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -132.66 153.16 51.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.811 0.695 . . . . 0.0 110.479 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.63 134.27 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -125.39 132.57 52.76 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.108 1.363 . . . . 0.0 107.979 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.0 166.0 22.26 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.371 1.068 . . . . 0.0 109.747 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.36 -26.89 43.84 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.382 1.073 . . . . 0.0 112.394 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.61 -0.43 23.35 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.042 -1.036 . . . . 0.0 112.115 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 28.19 73.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.036 0.827 . . . . 0.0 111.887 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.33 147.33 26.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.321 1.06 . . . . 0.0 108.28 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.1 t -71.72 138.15 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.73 -35.66 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.909 1.684 . . . . 0.0 109.419 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -150.18 142.94 24.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 144.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.78 148.51 27.31 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 17' ' ' GLU . 63.8 m-85 -132.0 98.61 4.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.468 2.307 . . . . 0.0 105.982 -169.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.42 131.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -67.79 -15.64 63.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.992 0.917 . . . . 0.0 113.183 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -126.28 118.14 24.49 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.44 69.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.22 0.608 . . . . 0.0 111.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.6 p -68.93 -12.71 61.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.568 1.547 . . . . 0.0 112.679 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -116.64 161.26 19.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.866 1.666 . . . . 0.0 108.674 -170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -121.94 153.15 60.5 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.776 0.83 . . . . 0.0 110.297 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.85 150.68 55.94 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.666 1.577 . . . . 0.0 108.301 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.19 115.98 20.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -66.7 -8.77 30.2 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.93 -32.05 71.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.997 0.817 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.18 -53.15 34.23 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.306 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.01 -30.43 25.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.494 1.569 . . . . 0.0 111.564 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.94 -51.47 53.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 119.191 0.905 . . . . 0.0 109.44 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.98 -28.97 70.17 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 111.545 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.88 -49.37 46.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.113 0.565 . . . . 0.0 111.427 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.62 65.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.236 0.614 . . . . 0.0 111.192 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -32.54 65.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.49 0.716 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.73 76.52 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.359 0.664 . . . . 0.0 111.316 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.6 mt -79.57 -44.75 20.5 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.216 0.462 . . . . 0.0 110.96 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -84.48 14.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.249 1.069 0 O-C-N 121.53 -0.731 . . . . 0.0 109.583 169.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 122.032 0.92 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.85 147.27 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.768 0.827 . . . . 0.0 109.085 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.3 p -116.08 167.4 11.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.945 1.698 . . . . 0.0 109.135 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -135.8 95.08 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 40.76 33.42 0.2 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.584 2.354 . . . . 0.0 115.921 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.31 -23.96 0.27 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.418 -1.212 . . . . 0.0 114.777 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.78 169.49 40.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.778 1.789 . . . . 0.0 113.006 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.31 154.01 65.91 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.898 3.065 . . . . 0.0 111.831 -173.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.11 128.06 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.274 1.03 . . . . 0.0 108.835 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -61.7 156.31 20.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.48 1.512 . . . . 0.0 111.275 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.7 mt -125.68 141.4 52.03 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.586 1.954 . . . . 0.0 106.942 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.27 -65.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.3 -170.25 46.93 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.269 0.937 . . . . 0.0 112.276 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -108.96 150.19 28.09 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.1 0.96 . . . . 0.0 110.796 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.61 121.22 12.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.96 167.71 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.5 155.93 49.52 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.477 -0.764 . . . . 0.0 109.558 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.44 136.18 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 170.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.95 -18.5 57.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.013 1.292 . . . . 0.0 111.943 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -76.99 157.02 31.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.73 1.265 . . . . 0.0 109.537 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -81.26 126.67 31.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.85 93.67 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.262 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -55.16 -30.27 70.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.36 2.707 . . . . 0.0 116.031 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 50.71 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.391 1.877 . . . . 0.0 113.728 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.35 178.1 6.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.907 1.283 . . . . 0.0 109.616 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -108.1 152.42 24.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.25 1.02 . . . . 0.0 109.564 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -141.61 171.33 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.583 2.353 . . . . 0.0 107.315 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.95 155.68 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.0 p -71.16 -158.35 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.653 1.181 . . . . 0.0 109.366 169.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -72.33 0.14 10.81 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.353 -1.467 . . . . 0.0 113.054 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -126.54 -88.72 0.57 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.508 1.049 . . . . 0.0 108.627 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -157.56 -3.88 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.346 1.858 . . . . 0.0 112.405 -169.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.38 138.35 32.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -72.9 138.88 46.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -137.27 149.26 46.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.999 1.72 . . . . 0.0 106.534 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -137.67 160.2 39.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.97 -30.39 67.89 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.967 -0.458 . . . . 0.0 111.861 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -28.04 68.4 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.832 0.853 . . . . 0.0 112.816 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -75.72 -36.31 59.99 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.487 0.715 . . . . 0.0 110.425 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.8 mtt -73.96 -36.48 64.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -65.67 0.83 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.35 -16.38 20.5 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.005 -1.059 . . . . 0.0 112.73 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -141.02 167.63 21.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.112 1.456 . . . . 0.0 108.263 169.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.47 128.97 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.9 m -131.68 151.36 51.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.409 0.284 . . . . 0.0 110.888 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.4 mt -113.82 139.02 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.45 126.02 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -118.96 98.34 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 0.0 108.745 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 m -74.89 136.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 155.9 80.42 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 169.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.04 -54.92 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.676 2.251 . . . . 0.0 111.775 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -157.37 149.45 22.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.45 -15.72 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.43 -0.793 . . . . 0.0 111.266 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.64 -16.46 61.01 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.166 -0.959 . . . . 0.0 113.289 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.6 p -61.37 -23.8 66.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.716 1.144 . . . . 0.0 114.024 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -42.47 2.16 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.315 0.96 . . . . 0.0 111.436 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.04 -24.54 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.884 1.273 . . . . 0.0 110.421 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 24.1 p -47.48 -32.27 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.257 1.423 . . . . 0.0 113.009 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.6 -33.49 70.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 125.353 1.461 . . . . 0.0 112.253 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.03 -17.4 57.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.271 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -108.57 -80.12 0.58 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.1 m -54.15 -43.39 70.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.529 1.132 . . . . 0.0 113.624 -168.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -63.06 -53.33 55.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.514 0.597 . . . . 0.0 109.596 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -69.54 -36.16 76.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.78 -172.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -59.22 -36.91 76.26 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.88 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -60.18 -46.06 91.0 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.863 1.21 . . . . 0.0 110.477 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.68 -51.34 57.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.56 -38.54 87.86 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 121.285 -0.884 . . . . 0.0 110.94 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.97 -37.37 86.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.888 0.767 . . . . 0.0 111.309 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.83 95.62 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.685 0.675 . . . . 0.0 110.643 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -38.75 83.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.586 0.63 . . . . 0.0 111.367 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.48 -33.33 73.59 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.862 0.865 . . . . 0.0 110.538 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.28 -35.06 3.5 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.81 1.195 . . . . 0.0 111.859 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.48 116.76 5.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.666 1.187 . . . . 0.0 109.207 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.0 p -159.19 -174.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 127.476 2.31 . . . . 0.0 105.409 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -138.85 134.2 33.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -141.39 140.43 31.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 108.7 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.18 159.8 37.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.279 1.032 . . . . 0.0 109.899 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.0 m -122.12 142.8 50.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.52 141.13 46.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.0 t -143.71 155.18 44.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 110.499 -169.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 9.78 41.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.26 177.91 8.31 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -84.82 147.1 47.71 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 123.968 0.907 . . . . 0.0 110.201 -169.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.63 -45.36 27.87 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.858 3.038 . . . . 0.0 113.698 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -67.0 -29.72 69.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.518 -0.739 . . . . 0.0 112.311 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.98 72.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.312 0.96 . . . . 0.0 109.657 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -52.88 -51.36 61.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.559 0.743 . . . . 0.0 109.658 170.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.93 74.81 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 111.164 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -62.75 -45.94 90.35 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.566 0.747 . . . . 0.0 110.25 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -63.48 -43.95 95.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.655 0.382 . . . . 0.0 110.854 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -70.16 -37.87 75.3 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.744 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.52 -38.08 94.38 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.3 79.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.627 0.771 . . . . 0.0 110.216 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -70.74 -31.8 68.75 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.657 0.783 . . . . 0.0 112.694 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.14 35.78 23.06 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.25 144.18 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.53 -35.26 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.699 1.199 . . . . 0.0 112.602 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.66 -10.41 51.39 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.605 0.762 . . . . 0.0 112.471 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.9 159.83 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.72 149.94 52.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 140.09 48.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.797 0.839 . . . . 0.0 110.228 -169.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.3 mt -138.74 163.81 31.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.468 1.507 . . . . 0.0 109.07 -169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.34 136.15 36.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.099 0.56 . . . . 0.0 109.516 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -122.67 -5.46 8.65 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.603 0.761 . . . . 0.0 111.679 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -57.68 -19.5 27.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -54.46 -43.02 71.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 111.23 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.84 -1.79 0.3 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.394 0.678 . . . . 0.0 112.664 -171.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 64.1 mmm 47.04 28.44 0.9 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.771 2.428 . . . . 0.0 113.601 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -44.81 92.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 111.149 -171.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.84 -46.59 57.51 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -37.19 87.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -46.26 90.69 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.769 -0.842 . . . . 0.0 109.245 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.56 79.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.89 1.71 16.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.643 0.777 . . . . 0.0 112.481 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.79 90.23 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.982 1.265 . . . . 0.0 112.553 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 m -124.91 -2.16 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.116 1.366 . . . . 0.0 111.397 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -79.56 105.99 11.27 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.26 101.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -51.69 -42.23 62.03 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.333 1.453 . . . . 0.0 111.441 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.6 -10.81 60.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -122.61 -17.73 6.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.187 0.995 . . . . 0.0 112.069 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.19 38.13 26.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.048 -168.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 157.27 43.95 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.471 1.108 . . . . 0.0 108.592 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.4 tp -77.79 148.65 34.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.122 0.969 . . . . 0.0 109.279 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.2 -175.06 4.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.492 . . . . 0.0 111.458 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.7 ttm105 -121.73 111.93 17.77 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 m -157.69 169.55 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.483 1.913 . . . . 0.0 106.94 -170.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.35 144.57 18.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -134.18 157.64 45.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.715 1.206 . . . . 0.0 108.542 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.75 134.63 53.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.76 132.16 53.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.941 1.296 . . . . 0.0 108.07 -173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.45 167.52 10.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.601 1.561 . . . . 0.0 109.592 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -58.54 -21.17 51.65 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.449 -0.782 . . . . 0.0 113.024 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -86.9 -0.17 56.05 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.297 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.56 23.29 78.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.04 -1.037 . . . . 0.0 112.299 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -88.14 141.28 28.69 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.826 1.313 . . . . 0.0 107.518 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.3 t -68.57 116.86 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.74 -33.97 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.827 1.251 . . . . 0.0 109.275 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -158.96 146.35 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.32 144.15 27.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -145.52 136.99 25.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -128.6 121.28 28.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.53 135.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -67.79 -5.89 18.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.778 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -147.41 118.8 7.87 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.49 63.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.111 0.964 . . . . 0.0 113.549 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 10.12 20.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.881 1.272 . . . . 0.0 110.414 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -127.77 178.3 6.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.55 2.34 . . . . 0.0 108.132 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -138.3 152.15 70.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 120.623 -1.298 . . . . 0.0 112.147 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.63 149.55 18.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.687 2.258 . . . . 0.0 108.951 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -74.71 115.84 14.73 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -51.73 -26.53 9.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.032 1.733 . . . . 0.0 112.922 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -61.7 -31.31 71.45 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.646 -0.659 . . . . 0.0 111.882 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -48.04 10.63 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.741 1.155 . . . . 0.0 112.07 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.01 -30.65 32.07 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 121.315 1.505 . . . . 0.0 111.646 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.3 mm -55.36 -50.17 67.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.313 0.961 . . . . 0.0 109.42 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.12 -32.73 73.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.39 0.541 . . . . 0.0 111.364 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.01 69.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.097 0.559 . . . . 0.0 111.512 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.13 -46.52 56.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.522 0.729 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -26.22 62.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.783 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.07 65.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.287 1.035 . . . . 0.0 113.175 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.27 -26.96 6.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.15 -13.41 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.184 1.794 . . . . 0.0 108.123 -175.934 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 CA--C 1.545 0.783 0 CA-C-O 122.047 0.927 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.0 126.1 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 109.131 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.0 p -76.99 161.87 28.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.444 0.64 . . . . 0.0 110.105 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -116.97 38.93 3.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.153 0.981 . . . . 0.0 109.552 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm 41.83 63.91 1.2 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.596 1.959 . . . . 0.0 111.571 -171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.1 -28.18 0.11 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.239 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.54 170.46 42.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.618 1.104 . . . . 0.0 110.534 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.9 158.52 55.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.739 2.959 . . . . 0.0 110.761 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.47 142.28 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -67.51 157.08 35.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.513 1.525 . . . . 0.0 110.359 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' ' H ' ' A' ' 122' ' ' LYS . 4.6 mp -135.18 144.94 47.28 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.911 1.284 . . . . 0.0 107.771 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -82.44 147.91 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.44 -157.15 19.45 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -132.62 161.3 34.26 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.93 115.24 5.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 168.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -83.4 151.44 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -132.67 155.05 49.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.883 0.873 . . . . 0.0 109.888 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.43 141.02 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.049 0.94 . . . . 0.0 109.289 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.55 -21.64 31.54 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.943 1.259 . . . . 0.0 112.175 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.67 152.79 40.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.73 1.265 . . . . 0.0 109.771 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -70.81 126.79 30.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 152.41 73.79 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.152 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.77 -29.0 60.26 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.224 2.616 . . . . 0.0 115.482 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.6 t0 51.9 85.91 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.913 2.085 . . . . 0.0 113.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.37 172.34 12.83 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 110.642 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -87.04 158.99 19.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.771 1.628 . . . . 0.0 110.366 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 p -151.87 159.31 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.043 2.537 . . . . 0.0 105.639 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tp -90.54 145.99 24.44 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.548 -1.345 . . . . 0.0 108.018 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -74.35 165.66 24.81 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.056 -1.028 . . . . 0.0 108.395 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -66.67 -6.61 16.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.871 -1.143 . . . . 0.0 111.368 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -93.54 3.7 55.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.39 1.876 . . . . 0.0 111.893 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp 62.81 44.74 6.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.195 1.398 . . . . 0.0 111.817 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.49 160.76 29.64 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.68 1.192 . . . . 0.0 107.785 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -78.31 142.08 38.01 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.844 -1.16 . . . . 0.0 109.753 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -139.15 163.52 32.22 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.161 1.784 . . . . 0.0 106.55 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 p -151.68 169.22 22.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.969 -1.082 . . . . 0.0 108.51 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.73 -27.6 59.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.512 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -28.64 62.32 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.01 -41.42 35.9 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.361 0.664 . . . . 0.0 109.834 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.4 mtt -65.45 -40.63 93.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.966 0.906 . . . . 0.0 109.105 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -71.1 -0.89 10.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.67 . . . . 0.0 112.381 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.16 -15.72 59.02 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.837 -1.165 . . . . 0.0 111.97 169.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -147.94 168.96 20.93 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.899 1.349 . . . . 0.0 108.428 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.97 120.9 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 168.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -130.14 153.89 48.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 123.156 0.285 . . . . 0.0 110.763 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.03 142.18 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.1 mm -127.85 113.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -112.94 98.44 7.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.141 0.976 . . . . 0.0 109.007 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.41 140.71 15.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.33 -0.857 . . . . 0.0 108.872 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.85 156.03 72.88 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.839 1.256 . . . . 0.0 108.491 169.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.81 -50.03 12.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.644 2.229 . . . . 0.0 112.498 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -160.44 164.62 32.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.936 2.494 . . . . 0.0 106.295 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 tt -98.3 -23.79 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.56 0.618 . . . . 0.0 111.564 -169.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -82.91 54.44 2.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.862 1.265 . . . . 0.0 110.387 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -154.99 -178.15 7.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.184 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.95 179.5 31.24 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.38 0.991 . . . . 0.0 112.271 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.285 19.5 m 53.25 -6.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 129.339 3.055 . . . . 0.0 116.832 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.8 m -65.27 -22.7 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.59 -1.319 . . . . 0.0 110.896 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.27 -31.76 67.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.666 -0.647 . . . . 0.0 111.233 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.46 -58.2 2.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.892 0.769 . . . . 0.0 109.778 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.29 -15.78 63.7 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -128.89 -54.17 1.22 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.79 1.177 . . . . 0.0 110.074 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.97 -52.31 13.24 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.771 1.169 . . . . 0.0 111.556 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.55 79.41 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.388 0.995 . . . . 0.0 109.605 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -44.21 71.9 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.336 0.516 . . . . 0.0 111.67 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.02 -44.08 93.67 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.619 0.767 . . . . 0.0 111.836 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.35 -49.48 77.42 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -64.27 -39.47 94.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.094 0.861 . . . . 0.0 110.863 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.974 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.25 -33.55 69.92 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.427 1.012 . . . . 0.0 110.775 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -68.84 -40.08 79.59 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 109.346 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.24 -50.43 74.03 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.25 -0.21 60.02 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.769 1.176 . . . . 0.0 114.286 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.92 65.51 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.133 1.373 . . . . 0.0 108.668 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.96 167.7 4.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.024 1.33 . . . . 0.0 107.593 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -120.49 144.44 48.01 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.4 147.08 14.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.954 -1.091 . . . . 0.0 109.748 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -134.13 162.81 31.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.703 1.601 . . . . 0.0 109.417 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -127.84 149.26 50.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.89 136.5 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 m -139.37 158.64 43.8 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.47 48.99 1.43 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -132.4 165.33 24.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.55 1.54 . . . . 0.0 108.889 -169.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.96 136.18 96.69 Favored Pre-proline 0 C--O 1.236 0.387 0 C-N-CA 123.826 0.851 . . . . 0.0 109.826 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.37 -42.8 46.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.352 2.702 . . . . 0.0 112.277 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -73.68 -31.58 63.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.523 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.9 75.05 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.358 0.981 . . . . 0.0 108.993 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -57.7 -42.89 84.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.125 0.97 . . . . 0.0 112.572 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.48 85.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.031 0.832 . . . . 0.0 111.264 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.26 -42.33 93.37 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.306 0.643 . . . . 0.0 109.725 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -60.4 -40.23 90.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.24 0.616 . . . . 0.0 110.527 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -65.23 -47.09 78.02 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.007 -0.433 . . . . 0.0 111.173 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.08 96.84 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.21 97.25 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.744 0.818 . . . . 0.0 110.702 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -85.39 -19.75 30.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 112.702 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.86 38.18 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 mm -64.33 142.81 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -144.91 -37.83 0.28 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.05 0.94 . . . . 0.0 112.652 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -80.81 -25.85 37.54 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.393 0.677 . . . . 0.0 111.226 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.8 157.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.827 1.251 . . . . 0.0 107.668 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -138.06 138.82 39.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 p -95.65 148.19 22.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.5 1.12 . . . . 0.0 108.205 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -137.93 140.19 40.17 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.655 1.182 . . . . 0.0 108.648 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -102.29 105.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.6 1.16 . . . . 0.0 110.06 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.34 -4.47 55.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.754 169.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -51.56 -41.36 61.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.737 1.215 . . . . 0.0 111.589 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.2 -44.76 44.64 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.645 0.778 . . . . 0.0 111.424 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.59 -36.15 11.36 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 55.12 -19.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.719 3.208 . . . . 0.0 115.759 -169.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -59.46 -33.0 70.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.371 1.441 . . . . 0.0 112.678 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -67.54 -54.65 18.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.989 0.813 . . . . 0.0 108.942 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -36.71 73.03 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -32.05 71.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.332 1.053 . . . . 0.0 110.822 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.93 -44.11 10.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.615 0.643 . . . . 0.0 112.319 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.17 13.49 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.57 93.22 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.563 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.77 -10.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.47 1.135 . . . . 0.0 112.149 -168.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -82.11 116.37 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.8 mt -79.6 97.47 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.466 ' H ' ' HA ' ' A' ' 13' ' ' LEU . 57.6 tttm -44.68 -55.64 5.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 126.615 1.966 . . . . 0.0 111.869 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -86.11 -11.54 52.4 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 mt -83.54 -21.74 32.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.943 0.792 . . . . 0.0 109.525 168.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 58.36 32.06 21.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.915 1.286 . . . . 0.0 109.354 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.79 154.17 51.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 108.516 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.37 152.17 34.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.168 0.987 . . . . 0.0 109.778 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 -174.44 5.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.31 1.044 . . . . 0.0 111.258 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -116.43 127.04 54.25 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -167.43 175.15 7.39 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.51 1.924 . . . . 0.0 107.128 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.15 145.92 14.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -137.7 158.41 44.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.859 1.264 . . . . 0.0 109.345 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.26 144.71 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -131.54 128.75 39.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.634 1.573 . . . . 0.0 108.149 -169.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.25 163.43 27.84 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 109.011 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.21 -17.53 42.1 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -81.42 -4.96 57.33 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.296 -1.502 . . . . 0.0 112.378 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.93 27.64 66.3 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.317 -0.865 . . . . 0.0 111.698 -172.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.36 144.11 27.44 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.33 135.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.2 -32.92 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.416 1.486 . . . . 0.0 109.614 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -150.12 144.85 25.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 139.84 24.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -148.22 149.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -125.85 142.83 51.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.348 1.859 . . . . 0.0 106.214 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.96 -10.51 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m 62.99 -21.99 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.241 2.216 . . . . 0.0 115.626 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -143.63 123.97 13.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.218 1.372 . . . . 0.0 107.505 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.05 -18.38 46.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.9 p -77.63 -3.96 43.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.227 0.921 . . . . 0.0 112.905 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 163.11 25.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.402 1.001 . . . . 0.0 110.048 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -118.54 155.97 51.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.632 -170.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.15 155.04 47.19 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 108.2 -1.5 . . . . 0.0 108.2 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -84.65 114.0 21.69 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -49.1 -26.07 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.009 2.124 . . . . 0.0 113.508 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.8 -37.57 82.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.877 0.762 . . . . 0.0 111.242 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -63.98 -51.92 60.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.617 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.59 -27.3 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.806 1.67 . . . . 0.0 112.233 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -59.82 -45.63 94.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-N 120.22 1.373 . . . . 0.0 109.246 171.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.91 -32.85 74.52 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.885 0.766 . . . . 0.0 111.021 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.25 56.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.611 0.364 . . . . 0.0 111.103 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.61 -46.87 71.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.135 0.574 . . . . 0.0 111.639 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -29.1 67.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.72 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.28 77.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.317 0.508 . . . . 0.0 111.696 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.72 -35.65 19.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.439 0.563 . . . . 0.0 112.401 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.91 -9.32 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.736 0.814 . . . . 0.0 110.18 176.257 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -137.59 169.66 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 150.49 31.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -143.08 121.84 12.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.61 37.61 3.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.344 1.458 . . . . 0.0 113.166 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.28 12.05 60.39 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.196 -1.336 . . . . 0.0 114.628 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.06 154.43 23.9 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.954 1.877 . . . . 0.0 110.955 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.0 153.93 63.02 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.653 2.236 . . . . 0.0 111.344 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -139.04 129.2 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.526 1.53 . . . . 0.0 108.286 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -74.54 160.39 30.97 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.197 1.399 . . . . 0.0 109.244 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.54 148.91 51.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 108.944 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 t -82.36 135.26 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.0 -158.28 14.44 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 118.38 0.536 . . . . 0.0 112.785 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -131.62 143.88 50.65 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.316 1.447 . . . . 0.0 108.666 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.86 103.0 7.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.84 157.09 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 108.832 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -127.71 156.5 42.29 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.991 1.316 . . . . 0.0 109.357 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.72 140.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.13 59.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.6 1.095 . . . . 0.0 112.756 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.78 156.8 37.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.32 1.56 . . . . 0.0 109.582 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.37 139.65 32.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.63 159.34 74.82 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -60.4 -7.06 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.449 3.432 . . . . 0.0 117.8 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 52.4 58.58 5.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.833 1.302 . . . . 0.0 110.823 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -85.69 165.78 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.034 1.734 . . . . 0.0 109.712 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -130.9 146.12 52.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.988 1.315 . . . . 0.0 107.514 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.87 168.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.581 1.952 . . . . 0.0 107.235 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.68 146.67 26.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.0 p -74.42 167.11 22.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -63.89 -8.02 9.91 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.062 -1.023 . . . . 0.0 111.656 168.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -109.72 13.9 23.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.836 2.054 . . . . 0.0 111.251 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 64.59 44.99 3.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.167 1.387 . . . . 0.0 111.978 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.14 161.53 29.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.58 144.13 35.82 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.62 -1.3 . . . . 0.0 108.895 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -142.67 145.83 33.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 m -140.37 167.28 22.51 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.671 0.788 . . . . 0.0 109.556 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 tp -47.22 -40.53 16.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.193 0.997 . . . . 0.0 111.958 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.97 -30.95 62.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.72 0.808 . . . . 0.0 113.084 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.55 -40.59 42.02 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.464 0.65 . . . . 0.0 110.577 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.8 mtt -65.34 -27.04 68.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.706 1.202 . . . . 0.0 111.346 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -55.42 -16.08 3.3 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 113.414 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.8 -20.37 56.91 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.845 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -154.47 156.45 36.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.443 1.621 . . . . 0.0 109.0 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.24 122.04 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.7 m -117.2 150.81 38.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 109.975 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.8 mt -121.89 145.64 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.2 mt -126.54 138.94 53.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.23 93.83 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.242 1.817 . . . . 0.0 106.823 -171.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.45 128.32 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 pt -139.27 154.45 72.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.11 -46.49 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 CA-C-N 121.098 1.428 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 p -158.73 173.98 15.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.614 1.966 . . . . 0.0 107.762 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tt -113.58 -177.67 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.802 0.841 . . . . 0.0 110.635 -169.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 56.3 43.81 25.78 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.24 1.416 . . . . 0.0 112.894 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -147.27 138.43 23.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -45.55 -46.34 12.37 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.191 1.376 . . . . 0.0 114.56 -169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.21 -25.59 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.434 1.094 . . . . 0.0 112.598 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.46 -40.59 7.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.925 1.69 . . . . 0.0 110.099 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.92 -49.76 74.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 127.15 2.18 . . . . 0.0 110.693 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.31 88.31 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.948 0.499 . . . . 0.0 111.348 -174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -61.36 2.63 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.7 m -64.33 -39.07 93.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.337 0.517 . . . . 0.0 111.163 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.89 -50.37 69.02 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.219 -0.926 . . . . 0.0 110.253 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.86 -33.59 75.05 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.602 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.31 -39.68 73.12 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 120.142 1.337 . . . . 0.0 112.16 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.94 -48.91 79.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.601 1.091 . . . . 0.0 110.874 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -67.6 -44.09 78.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -63.3 -37.82 88.73 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.03 -1.044 . . . . 0.0 110.819 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.6 92.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.622 -0.674 . . . . 0.0 111.041 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.06 88.6 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.788 0.722 . . . . 0.0 111.227 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -67.66 -40.09 84.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.694 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.7 mp -60.9 -45.41 94.73 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.852 0.751 . . . . 0.0 109.842 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.59 -9.83 61.04 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.961 1.267 . . . . 0.0 114.842 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -153.62 58.66 0.75 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.042 1.421 . . . . 0.0 109.492 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.43 171.9 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.783 1.233 . . . . 0.0 107.789 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.97 141.61 50.74 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 t -138.05 151.95 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.188 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.28 169.69 16.83 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.984 1.314 . . . . 0.0 109.703 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -132.75 143.85 49.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.98 133.88 60.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 m -139.48 158.57 43.91 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.57 1.169 . . . . 0.0 110.879 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.5 54.22 2.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 168.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.43 163.95 31.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 108.244 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.65 135.86 85.89 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -169.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.16 -36.68 79.7 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.986 1.791 . . . . 0.0 110.714 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -75.2 -27.71 59.71 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.776 -0.63 . . . . 0.0 112.101 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.72 71.29 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.52 1.055 . . . . 0.0 108.964 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -60.18 -41.61 93.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.826 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.97 92.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.63 0.65 . . . . 0.0 111.007 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -67.55 -39.25 84.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.174 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 74.9 t90 -69.25 -45.13 70.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.207 0.603 . . . . 0.0 110.934 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -69.76 -33.73 72.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.824 -1.173 . . . . 0.0 110.353 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -33.69 87.92 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.037 -0.868 . . . . 0.0 112.402 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.74 93.41 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.705 1.253 . . . . 0.0 110.206 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -72.83 -27.71 62.11 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.123 0.569 . . . . 0.0 111.968 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.14 53.41 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mt -68.37 145.8 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.263 1.025 . . . . 0.0 108.499 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.89 -34.93 0.42 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.069 1.348 . . . . 0.0 111.976 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.33 -13.62 59.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.645 0.778 . . . . 0.0 111.927 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.16 155.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -134.21 130.81 37.76 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -84.46 151.55 24.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.101 0.56 . . . . 0.0 109.62 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 mt -143.09 150.27 39.29 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.505 1.522 . . . . 0.0 107.255 -173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.4 m -116.01 115.39 26.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.652 1.181 . . . . 0.0 108.505 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.26 -9.7 55.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.581 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.39 -36.42 6.44 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.049 2.139 . . . . 0.0 114.259 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -78.57 -13.39 59.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.891 -173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -147.64 -16.19 0.37 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -169.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.1 mmm 51.93 9.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.462 2.705 . . . . 0.0 117.213 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.7 m -63.15 -38.25 90.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.751 1.614 . . . . 0.0 112.525 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -64.71 -50.53 66.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.128 1.331 . . . . 0.0 108.952 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.48 97.73 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 -172.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.464 0.706 . . . . 0.0 109.814 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.581 -0.7 . . . . 0.0 111.847 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.57 1.02 40.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.691 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.1 90.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.873 1.215 . . . . 0.0 112.862 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.9 -7.37 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.743 1.217 . . . . 0.0 111.352 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.75 108.3 5.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.058 1.299 . . . . 0.0 107.942 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.86 112.71 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -57.32 -38.09 73.51 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.519 1.527 . . . . 0.0 110.887 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.58 8.51 40.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.965 0.906 . . . . 0.0 112.149 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.66 -23.87 2.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 55.58 37.35 28.76 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 110.037 -168.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.9 mt -130.72 161.15 32.31 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.125 1.37 . . . . 0.0 108.092 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.6 mt -83.27 143.35 30.46 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.14 152.01 41.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 111.01 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -80.7 100.61 8.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 62.0 m -147.97 167.25 25.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.328 1.451 . . . . 0.0 109.417 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 m -141.0 153.41 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.469 -0.769 . . . . 0.0 110.515 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.69 157.12 44.99 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.539 1.136 . . . . 0.0 109.619 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.49 139.51 48.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -133.24 119.49 19.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 107.618 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.01 163.85 21.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.56 0.744 . . . . 0.0 109.528 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.2 -23.33 21.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.078 1.351 . . . . 0.0 112.811 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -76.06 -6.49 51.33 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.805 -1.184 . . . . 0.0 112.377 175.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.17 42.61 35.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -121.46 132.09 54.53 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.81 112.78 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -171.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.28 -33.76 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.692 1.197 . . . . 0.0 109.355 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -154.99 147.04 23.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.839 1.256 . . . . 0.0 108.363 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.33 31.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.776 1.23 . . . . 0.0 107.837 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.1 137.59 21.0 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.886 0.874 . . . . 0.0 108.794 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -131.33 93.97 3.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 105.355 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.54 132.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 m -67.79 -9.67 46.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 113.074 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.15 110.51 11.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.74 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.885 0.874 . . . . 0.0 110.925 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.46 6.02 6.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 112.627 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -122.88 173.24 7.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.196 2.199 . . . . 0.0 107.033 170.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.57 157.44 73.08 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 120.936 -1.103 . . . . 0.0 111.543 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.17 -179.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.742 3.628 . . . . 0.0 113.594 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -124.77 111.7 15.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -52.25 -25.07 8.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.69 1.996 . . . . 0.0 112.948 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.67 -38.04 80.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.995 0.816 . . . . 0.0 111.383 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -60.28 -56.09 38.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.892 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.9 -26.96 31.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.49 1.46 . . . . 0.0 112.059 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -44.38 94.89 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.654 1.57 . . . . 0.0 109.638 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.53 -34.52 78.43 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.16 0.891 . . . . 0.0 110.713 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.57 -49.06 70.23 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.5 0.19 . . . . 0.0 111.258 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.14 -49.4 61.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.026 0.53 . . . . 0.0 111.128 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -33.82 69.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.759 0.708 . . . . 0.0 111.355 -176.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.35 -31.37 69.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.446 0.566 . . . . 0.0 111.784 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.7 mt -89.61 -24.41 21.68 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.698 0.799 . . . . 0.0 112.155 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.91 -32.73 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.483 0.583 . . . . 0.0 110.519 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.183 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.94 170.8 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.16 151.31 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -133.73 113.33 12.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.74 -50.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.877 2.871 . . . . 0.0 115.529 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 17.35 0.06 OUTLIER Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.818 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.75 27.48 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.577 1.689 . . . . 0.0 110.979 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.63 157.69 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.048 2.499 . . . . 0.0 111.874 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.55 124.97 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.144 1.778 . . . . 0.0 107.479 171.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -73.98 158.09 35.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.476 1.51 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.47 136.81 46.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 123.987 0.915 . . . . 0.0 108.889 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.35 127.31 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.55 -167.56 18.94 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 121.415 0.453 . . . . 0.0 112.697 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -109.0 141.6 40.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 108.264 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.25 107.96 10.02 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.08 152.96 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.2 157.49 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 109.881 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -57.4 141.07 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.715 0.806 . . . . 0.0 108.923 175.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -24.23 17.6 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.748 1.166 . . . . 0.0 112.257 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.82 158.85 34.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.295 1.547 . . . . 0.0 110.299 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -76.25 136.49 39.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 153.98 89.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.789 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.28 -28.12 70.09 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.86 3.04 . . . . 0.0 115.907 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.05 80.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.775 1.63 . . . . 0.0 113.756 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -126.09 -172.31 2.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.514 1.526 . . . . 0.0 109.806 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 m -125.17 156.04 39.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.107 . . . . 0.0 110.527 -168.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -141.62 178.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 129.193 2.997 . . . . 0.0 106.604 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.87 149.17 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.0 p -69.29 170.23 10.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.177 -0.952 . . . . 0.0 108.636 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.25 -10.61 33.46 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.777 -1.202 . . . . 0.0 110.767 168.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -97.29 10.51 39.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.976 2.11 . . . . 0.0 111.74 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.8 mt 60.76 42.99 12.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.872 1.669 . . . . 0.0 113.573 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.74 141.56 51.28 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.92 141.15 57.73 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.892 -1.13 . . . . 0.0 110.89 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -142.36 151.36 41.82 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 125.643 1.577 . . . . 0.0 108.034 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 p -138.42 170.52 15.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.602 0.637 . . . . 0.0 110.358 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.65 48.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.284 0.634 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -31.89 66.33 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.28 -37.51 80.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.172 0.987 . . . . 0.0 109.956 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.0 mtt -74.7 5.22 5.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.429 2.292 . . . . 0.0 111.45 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -99.65 -7.95 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.017 1.327 . . . . 0.0 111.234 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.66 68.3 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.09 0.859 . . . . 0.0 112.729 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -153.13 168.07 27.17 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.994 2.118 . . . . 0.0 106.436 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.78 118.7 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.4 m -122.82 135.69 54.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.092 0.557 . . . . 0.0 109.503 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.69 139.64 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.0 131.01 73.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -120.19 97.35 5.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -83.56 119.02 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.75 145.5 53.27 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -62.25 -58.92 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.256 2.637 . . . . 0.0 113.639 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.7 m -158.12 143.95 17.08 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.62 -15.94 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.26 -14.93 62.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.03 1.332 . . . . 0.0 114.439 -172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -65.37 -22.01 66.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.471 1.032 . . . . 0.0 113.741 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.19 -36.58 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.221 0.915 . . . . 0.0 111.39 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.64 -40.03 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.568 1.184 . . . . 0.0 108.633 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.9 m -61.04 -37.9 84.25 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.925 0.89 . . . . 0.0 111.994 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -61.61 -51.76 67.19 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.442 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -49.48 77.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.975 0.352 . . . . 0.0 110.773 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.41 -54.27 47.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.46 1.104 . . . . 0.0 109.75 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -70.63 -38.89 73.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.646 -0.659 . . . . 0.0 110.949 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -63.21 -43.62 97.62 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 120.894 -1.129 . . . . 0.0 110.944 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -66.72 -42.39 86.39 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.921 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -54.53 -38.05 66.1 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.973 1.26 . . . . 0.0 112.286 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -60.26 -51.36 69.88 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.077 0.853 . . . . 0.0 111.099 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.62 -34.09 69.54 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 118.989 -1.084 . . . . 0.0 111.709 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.24 -37.4 87.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 120.209 1.368 . . . . 0.0 109.922 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.42 92.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.839 0.455 . . . . 0.0 111.074 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.47 94.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.75 0.705 . . . . 0.0 111.368 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -65.36 -41.07 94.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.619 0.768 . . . . 0.0 110.103 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -45.7 86.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.18 0.992 . . . . 0.0 110.812 173.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -23.79 4.19 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.993 1.282 . . . . 0.0 113.773 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -147.97 66.14 1.1 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.166 1.386 . . . . 0.0 109.506 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.69 172.65 9.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -130.26 139.85 50.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.04 133.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -130.71 161.34 31.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.664 1.186 . . . . 0.0 109.645 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -128.27 143.43 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.91 135.93 57.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m -142.2 158.81 43.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.906 0.882 . . . . 0.0 111.675 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.76 40.06 0.92 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -126.15 163.84 22.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.259 1.423 . . . . 0.0 109.027 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.89 128.41 93.86 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -169.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.11 -33.78 94.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.742 1.628 . . . . 0.0 111.163 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -73.31 -27.09 61.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.223 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -48.64 63.8 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.834 1.197 . . . . 0.0 109.144 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -57.04 -42.41 80.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.307 0.243 . . . . 0.0 111.578 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.31 -42.26 96.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.662 0.665 . . . . 0.0 111.571 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -65.24 -42.31 93.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -59.69 -39.8 85.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.086 0.554 . . . . 0.0 111.22 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.3 m -60.76 -42.25 97.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.518 1.054 . . . . 0.0 110.505 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.29 -31.86 82.26 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.532 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.82 78.52 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.261 1.03 . . . . 0.0 111.368 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -106.6 -16.03 14.62 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.81 0.844 . . . . 0.0 112.277 -171.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.2 38.34 34.75 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.29 144.97 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.674 1.19 . . . . 0.0 108.207 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -143.83 -35.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.229 1.012 . . . . 0.0 112.405 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -87.13 -14.82 40.23 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.406 0.683 . . . . 0.0 112.313 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.57 154.44 14.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.33 128.48 33.8 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -86.92 151.01 23.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.427 1.091 . . . . 0.0 109.251 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.1 mt -144.19 152.49 40.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.216 1.807 . . . . 0.0 106.507 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.1 m -121.03 125.97 48.69 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.172 -0.955 . . . . 0.0 109.45 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.59 3.94 48.02 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.031 1.332 . . . . 0.0 110.149 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -48.18 135.42 13.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.716 2.007 . . . . 0.0 111.573 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 63.44 -38.93 0.18 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.805 2.842 . . . . 0.0 114.392 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.36 -39.02 68.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.14 0.882 . . . . 0.0 111.56 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 53.93 9.7 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.712 2.805 . . . . 0.0 116.586 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.7 m -60.93 -43.76 98.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.364 1.893 . . . . 0.0 111.813 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.26 -44.28 68.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.068 0.849 . . . . 0.0 109.824 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.04 -47.07 91.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 123.96 0.79 . . . . 0.0 111.319 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.44 -37.58 87.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.505 0.722 . . . . 0.0 110.639 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -35.55 63.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.336 -0.852 . . . . 0.0 112.37 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.18 1.37 41.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.337 1.055 . . . . 0.0 112.168 -174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.79 35.58 50.32 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.342 0.974 . . . . 0.0 113.003 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.38 21.38 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.658 1.183 . . . . 0.0 111.548 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -107.89 110.66 22.48 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.5 110.99 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.13 -38.35 73.32 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 126.113 1.765 . . . . 0.0 111.083 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -91.29 4.57 52.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.893 0.877 . . . . 0.0 112.109 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -130.87 -21.81 2.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.361 1.064 . . . . 0.0 112.747 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 53.77 38.99 29.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.67 -168.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -131.4 152.62 50.48 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.075 1.35 . . . . 0.0 107.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.87 155.19 31.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 110.695 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.44 175.48 6.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.328 1.061 . . . . 0.0 111.679 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -113.57 85.31 2.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -141.48 164.57 29.86 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 110.519 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.14 152.43 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 121.636 -0.665 . . . . 0.0 109.424 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.5 159.63 41.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.572 1.149 . . . . 0.0 108.665 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.52 141.65 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -129.9 123.17 30.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.087 1.755 . . . . 0.0 106.854 -169.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.63 164.35 26.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.03 -20.89 26.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.445 1.098 . . . . 0.0 112.785 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -81.4 0.08 39.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.835 -1.166 . . . . 0.0 112.394 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.71 28.3 73.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.367 0.985 . . . . 0.0 111.701 -171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.03 133.06 43.85 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -75.66 127.26 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.8 t -102.15 -30.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.477 1.511 . . . . 0.0 109.636 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -153.41 147.95 26.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.04 140.39 24.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.2 144.12 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.56 79.68 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.1 123.81 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -63.83 -14.59 54.33 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -122.77 116.42 23.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.06 65.78 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.19 10.81 2.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.959 1.304 . . . . 0.0 112.0 170.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -139.07 170.92 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.989 2.516 . . . . 0.0 107.319 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.92 154.36 79.2 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.145 -0.972 . . . . 0.0 111.085 -173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.47 149.81 37.06 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.915 3.077 . . . . 0.0 112.73 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -91.82 118.55 30.81 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -54.16 -25.4 22.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.046 1.338 . . . . 0.0 113.227 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.35 -37.42 83.26 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.765 0.712 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -60.92 -54.64 52.39 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.115 -172.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.11 -26.64 30.44 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.834 1.334 . . . . 0.0 111.433 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -44.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 120.191 1.36 . . . . 0.0 109.604 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.2 -38.29 90.54 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.27 0.941 . . . . 0.0 110.315 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.8 85.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.366 -0.209 . . . . 0.0 111.393 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.59 -51.38 51.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.447 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.444 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.39 -31.24 69.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.276 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.7 mt -88.8 -34.06 17.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.601 0.761 . . . . 0.0 111.924 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 82.1 t -63.4 -41.82 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.98 0.512 . . . . 0.0 111.063 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 19.0 pttp . . . . . 0 C--O 1.249 1.057 0 CA-C-N 118.292 0.496 . . . . 0.0 111.143 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 122.071 0.938 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.71 146.28 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 p -112.71 160.43 17.93 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.294 1.038 . . . . 0.0 109.74 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -111.83 45.0 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.495 1.118 . . . . 0.0 108.743 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt 42.66 61.71 1.98 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.647 1.979 . . . . 0.0 112.346 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 -26.12 0.11 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.568 1.08 . . . . 0.0 111.019 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.19 176.04 47.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.242 1.401 . . . . 0.0 109.872 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.31 158.62 47.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.158 2.572 . . . . 0.0 110.552 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.42 134.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -66.16 151.26 47.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.263 1.025 . . . . 0.0 111.163 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.03 141.46 49.24 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.144 2.178 . . . . 0.0 105.886 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.66 -70.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.65 0.659 . . . . 0.0 110.013 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.54 54.74 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.516 0.579 . . . . 0.0 112.405 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.11 166.75 22.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.734 0.778 . . . . 0.0 110.967 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -70.23 115.6 9.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 168.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.96 153.66 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -124.83 156.29 38.05 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.804 0.841 . . . . 0.0 109.796 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.29 140.1 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.414 0.686 . . . . 0.0 109.308 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.47 -20.05 48.89 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.431 1.491 . . . . 0.0 112.244 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.39 155.12 39.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.791 1.295 . . . . 0.0 110.038 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -72.9 132.91 44.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.06 160.51 29.71 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.274 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.29 -4.04 2.11 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.499 3.466 . . . . 0.0 117.85 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.91 55.38 9.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.755 1.265 . . . . 0.0 111.375 -174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -89.37 170.52 10.48 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.487 1.515 . . . . 0.0 110.859 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -131.02 151.51 51.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.659 1.184 . . . . 0.0 108.341 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.34 163.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 0.0 107.312 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -86.69 138.69 31.44 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -71.16 166.09 22.2 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.11 -13.88 62.37 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.529 -1.357 . . . . 0.0 110.904 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.46 0.94 40.0 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.909 1.683 . . . . 0.0 111.497 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt 69.1 37.23 2.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.687 1.595 . . . . 0.0 111.687 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.41 164.17 21.02 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.991 1.316 . . . . 0.0 107.897 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.86 141.19 37.89 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.013 -1.054 . . . . 0.0 109.493 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -138.02 143.96 40.82 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -146.44 172.03 14.15 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.25 0.62 . . . . 0.0 109.934 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.4 tp -44.21 -45.96 8.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 111.582 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.13 67.55 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.783 0.833 . . . . 0.0 112.465 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.45 -40.22 21.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.84 0.856 . . . . 0.0 110.795 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.04 -39.04 83.16 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.207 0.603 . . . . 0.0 110.011 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -65.17 -4.63 5.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -19.57 41.47 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 113.025 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.82 158.56 43.6 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.369 1.468 . . . . 0.0 107.074 173.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.9 t -60.88 119.76 5.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.0 m -127.64 128.76 46.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 109.98 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.3 mt -89.84 140.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.15 133.34 68.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -128.57 95.74 4.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.38 134.24 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.26 157.6 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 107.25 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.39 -54.15 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.721 1.614 . . . . 0.0 111.671 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 p -155.5 154.5 31.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.316 1.846 . . . . 0.0 107.187 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.3 tt -78.8 -14.73 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -169.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.52 -34.59 78.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.87 155.31 40.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.465 0.575 . . . . 0.0 111.201 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.13 -39.06 93.95 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.858 -0.526 . . . . 0.0 112.534 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 m -70.04 -40.54 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.174 0.987 . . . . 0.0 110.971 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.07 -43.88 97.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.589 0.755 . . . . 0.0 110.799 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -58.93 -56.16 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.512 1.525 . . . . 0.0 109.929 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.92 88.78 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.159 0.584 . . . . 0.0 111.156 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -56.05 -54.16 48.25 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.321 1.048 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -64.95 -40.91 95.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.193 0.452 . . . . 0.0 110.441 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.3 tpt85 -67.96 -43.08 79.87 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.104 -0.997 . . . . 0.0 111.26 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -70.74 -35.13 72.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.083 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.79 -41.44 74.11 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.263 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.81 -49.39 76.51 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.331 0.969 . . . . 0.0 111.31 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.91 -38.9 83.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -67.29 -38.25 84.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.99 86.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.425 0.69 . . . . 0.0 111.326 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.58 88.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 111.282 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.43 -41.09 93.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.267 0.627 . . . . 0.0 110.079 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.29 -43.01 92.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.015 0.526 . . . . 0.0 110.444 173.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 -69.5 2.54 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.133 1.825 . . . . 0.0 110.685 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -85.3 67.76 10.26 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.078 1.351 . . . . 0.0 110.142 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.22 162.53 6.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -123.14 141.21 52.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.62 138.53 42.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -131.41 154.46 48.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.819 0.848 . . . . 0.0 109.664 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.5 m -116.05 148.44 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.91 135.67 63.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.1 m -136.57 150.64 48.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.69 49.78 1.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -137.44 162.56 33.33 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.208 2.203 . . . . 0.0 107.537 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.12 138.12 92.13 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-O 119.013 -0.517 . . . . 0.0 111.226 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.67 -37.13 81.57 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.103 1.869 . . . . 0.0 111.654 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -69.35 -33.64 73.4 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.5 -50.81 49.42 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.069 0.849 . . . . 0.0 109.647 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -55.94 -49.12 74.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.147 0.579 . . . . 0.0 110.919 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.06 -45.11 93.73 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.436 0.695 . . . . 0.0 111.873 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 tpt85 -66.4 -36.99 84.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.49 0.586 . . . . 0.0 110.412 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.53 -41.61 92.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.036 0.534 . . . . 0.0 110.177 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 92.9 m -61.7 -41.67 97.9 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.999 -1.063 . . . . 0.0 110.633 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.03 -32.21 83.42 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.24 0.924 . . . . 0.0 112.378 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.63 95.06 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.437 1.118 . . . . 0.0 110.388 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.11 -20.87 29.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.746 0.818 . . . . 0.0 112.36 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.63 61.2 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.613 0.642 . . . . 0.0 111.724 -172.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mt -69.56 141.84 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.844 1.258 . . . . 0.0 108.095 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -147.97 -32.86 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -75.25 -16.37 60.46 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.728 0.694 . . . . 0.0 111.977 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.4 t -111.58 150.08 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 169.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.39 148.01 49.23 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.2 151.73 23.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.3 mt -136.38 152.79 51.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.6 m -124.27 168.61 12.74 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.873 -0.517 . . . . 0.0 112.367 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -47.47 114.34 0.86 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 109.339 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -39.63 75.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.759 -175.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 157.18 -38.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.556 2.343 . . . . 0.0 105.652 -169.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.41 141.97 45.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.162 1.385 . . . . 0.0 107.353 170.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 97.2 mmm -55.85 19.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 130.059 3.344 . . . . 0.0 115.698 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -52.63 -42.11 64.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.863 1.665 . . . . 0.0 112.404 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -56.03 -25.62 45.51 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.662 1.985 . . . . 0.0 114.344 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.6 -35.89 2.95 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 118.565 0.621 . . . . 0.0 111.675 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.32 -49.12 78.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.154 1.382 . . . . 0.0 109.97 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.96 -5.85 59.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.89 0.876 . . . . 0.0 112.415 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.2 10.76 14.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.911 1.284 . . . . 0.0 110.22 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.63 74.36 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.599 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.94 -5.2 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.007 1.404 . . . . 0.0 112.522 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -78.4 105.96 10.01 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.06 97.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -50.15 -41.56 49.25 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.87 1.668 . . . . 0.0 111.998 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.38 -10.18 59.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.863 0.865 . . . . 0.0 113.118 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.63 -20.78 5.4 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.555 1.142 . . . . 0.0 112.074 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 54.42 36.91 26.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.148 1.379 . . . . 0.0 109.944 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.5 mt -117.04 160.01 21.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.466 1.106 . . . . 0.0 108.351 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.45 137.26 32.48 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.76 163.63 25.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.749 0.819 . . . . 0.0 111.216 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.18 110.91 22.61 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 169.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.2 m -166.42 173.05 10.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.437 1.495 . . . . 0.0 108.144 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.12 152.17 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.257 -0.902 . . . . 0.0 110.691 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -136.45 161.31 36.2 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.126 1.37 . . . . 0.0 108.003 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 139.49 46.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.06 116.66 24.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.49 1.516 . . . . 0.0 107.72 -169.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.49 160.32 19.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.868 1.267 . . . . 0.0 108.83 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -64.25 -8.5 12.88 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.86 5.03 53.07 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.652 -1.28 . . . . 0.0 111.827 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.65 26.97 68.23 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.362 0.982 . . . . 0.0 112.086 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -91.67 139.42 30.7 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 108.46 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.37 -22.94 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.544 0.611 . . . . 0.0 110.615 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -153.92 143.71 21.81 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.82 145.02 31.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.59 142.81 29.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -132.53 106.04 7.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.503 1.921 . . . . 0.0 106.178 -170.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.52 131.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -68.59 0.53 4.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 113.058 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -139.16 110.12 6.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.781 2.032 . . . . 0.0 106.042 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.28 -28.55 68.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.146 0.43 . . . . 0.0 111.471 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.0 p -70.43 -9.94 57.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.265 1.826 . . . . 0.0 113.197 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.15 167.65 12.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.82 1.648 . . . . 0.0 108.905 -169.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -128.52 153.21 79.33 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.252 0.933 . . . . 0.0 109.715 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.07 152.07 45.31 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.844 1.696 . . . . 0.0 108.242 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -69.65 119.35 13.75 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -50.61 -27.36 6.71 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.143 1.777 . . . . 0.0 113.331 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -61.14 -34.44 75.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.753 -0.592 . . . . 0.0 111.447 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -66.28 -49.92 51.88 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 117.944 -1.026 . . . . 0.0 112.542 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.05 -27.77 49.71 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 121.403 1.537 . . . . 0.0 111.896 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -44.13 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.93 1.241 . . . . 0.0 109.545 171.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.12 -31.79 73.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.13 0.877 . . . . 0.0 111.179 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.76 -49.6 61.65 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.972 0.351 . . . . 0.0 111.014 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.49 75.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.8 0.44 . . . . 0.0 111.673 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -28.59 68.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.673 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.84 80.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.583 0.629 . . . . 0.0 111.416 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.0 mt -76.69 -43.21 38.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.411 0.551 . . . . 0.0 111.672 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.81 -4.49 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.07 0.85 . . . . 0.0 110.011 174.686 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 119.279 -0.391 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.273 18.1 mt 69.29 171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 126.665 1.986 . . . . 0.0 111.886 169.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -141.4 156.89 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.428 2.691 . . . . 0.0 105.903 -174.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -135.93 119.54 17.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HE2' HG22 ' A' ' 150' ' ' THR . 13.1 tppt? 42.14 43.45 2.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.213 1.805 . . . . 0.0 111.591 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.31 85.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.539 -1.145 . . . . 0.0 114.165 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.6 139.54 15.73 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.21 155.37 69.63 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.193 1.929 . . . . 0.0 111.381 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.07 -167.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.473 1.509 . . . . 0.0 108.082 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.3 m -138.68 160.01 40.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.77 128.26 46.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.93 1.292 . . . . 0.0 109.686 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.4 157.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.43 -154.5 40.47 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 123.617 0.627 . . . . 0.0 112.168 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.95 155.59 47.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.65 1.18 . . . . 0.0 109.064 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.29 152.25 45.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.72 154.38 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.751 1.62 . . . . 0.0 106.96 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.57 157.86 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.006 0.922 . . . . 0.0 111.764 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.26 144.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.899 1.28 . . . . 0.0 109.332 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 -23.61 18.66 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.685 1.136 . . . . 0.0 111.952 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.49 153.63 40.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.421 1.11 . . . . 0.0 109.519 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -70.28 128.23 35.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.93 153.99 78.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.466 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.68 -31.14 59.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.263 2.642 . . . . 0.0 115.315 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 47.76 84.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.343 1.857 . . . . 0.0 113.357 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.6 177.88 6.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.596 1.158 . . . . 0.0 109.228 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.7 m -109.59 151.05 27.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.651 1.181 . . . . 0.0 109.542 -169.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.21 173.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 128.208 2.603 . . . . 0.0 106.098 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.99 156.85 16.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.2 p -71.82 174.03 7.45 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.088 -1.008 . . . . 0.0 108.847 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -67.2 -11.14 56.58 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.26 -0.9 . . . . 0.0 110.842 168.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m -73.22 -65.82 0.76 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 pp 154.49 12.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 130.581 3.552 . . . . 0.0 112.168 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.82 144.53 30.37 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.732 -1.23 . . . . 0.0 109.181 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.51 133.19 55.86 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.657 -0.652 . . . . 0.0 111.227 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -140.48 147.1 39.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.209 1.804 . . . . 0.0 107.503 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -131.63 159.1 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.03 -31.17 68.59 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.08 66.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.788 0.835 . . . . 0.0 113.191 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.25 -35.66 68.86 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.8 mtt -75.78 -35.85 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.201 1.0 . . . . 0.0 111.177 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -63.97 -3.82 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.05 13.6 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 119.485 1.038 . . . . 0.0 113.009 169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.49 157.23 45.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.864 1.666 . . . . 0.0 107.113 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.3 t -54.85 124.97 8.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.2 m -120.46 149.31 42.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.18 141.42 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.5 mm -123.24 140.15 47.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 84.17 2.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 m -71.93 135.66 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.78 157.05 58.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.709 1.604 . . . . 0.0 108.955 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.56 -61.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.305 2.003 . . . . 0.0 110.641 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -144.25 147.77 34.01 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.39 1.476 . . . . 0.0 107.172 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.8 tt -98.82 -31.38 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.815 0.446 . . . . 0.0 111.438 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.5 -24.91 67.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 t -64.43 -21.25 66.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.218 1.007 . . . . 0.0 112.01 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.54 -11.95 64.56 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.029 -1.044 . . . . 0.0 114.094 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.37 -30.29 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.198 1.499 . . . . 0.0 110.542 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.14 -6.12 1.85 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.337 1.455 . . . . 0.0 113.365 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.38 -43.63 64.84 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.481 1.491 . . . . 0.0 110.15 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.17 4.42 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.153 0.981 . . . . 0.0 112.92 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -129.57 -83.36 0.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -55.59 -51.68 66.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.025 1.33 . . . . 0.0 111.814 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -70.72 -46.31 63.31 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.518 -0.739 . . . . 0.0 110.014 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -41.21 93.95 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.259 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -59.98 -31.19 69.67 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 120.455 1.48 . . . . 0.0 112.354 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.98 -43.66 98.51 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.252 0.933 . . . . 0.0 110.678 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -65.6 -51.4 59.94 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -63.1 -35.17 79.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.768 . . . . 0.0 111.303 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.87 95.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.529 0.604 . . . . 0.0 110.783 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.3 81.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.644 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -66.02 -41.53 90.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 110.702 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.04 -46.62 86.69 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.964 0.906 . . . . 0.0 109.808 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.53 -33.93 5.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.296 1.426 . . . . 0.0 111.071 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.95 120.9 4.28 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.98 1.312 . . . . 0.0 108.827 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -159.59 171.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.837 2.055 . . . . 0.0 105.715 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -119.04 138.72 52.66 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.3 146.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 120.809 -1.182 . . . . 0.0 110.305 -174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.55 170.2 16.17 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.781 1.232 . . . . 0.0 110.199 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.4 m -126.51 146.7 50.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.34 131.1 70.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -131.37 144.27 51.1 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.942 0.497 . . . . 0.0 110.978 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.72 48.87 1.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.82 161.67 35.97 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.14 1.776 . . . . 0.0 106.864 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.48 140.46 84.65 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.84 -47.59 20.73 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.045 2.497 . . . . 0.0 112.365 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -72.95 -30.11 63.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.76 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.85 85.66 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.855 0.752 . . . . 0.0 110.166 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.56 -48.87 63.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.975 0.91 . . . . 0.0 110.161 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.66 77.89 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 117.943 0.338 . . . . 0.0 110.508 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -45.06 93.5 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.345 1.058 . . . . 0.0 109.769 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -63.33 -43.46 97.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.94 -44.02 81.69 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.804 -0.56 . . . . 0.0 111.23 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -38.97 96.3 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.628 0.632 . . . . 0.0 111.987 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.62 98.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.788 0.835 . . . . 0.0 110.314 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -78.85 -17.77 55.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.69 0.796 . . . . 0.0 112.429 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.63 62.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.095 0.855 . . . . 0.0 111.733 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.84 141.94 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.789 1.236 . . . . 0.0 108.244 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.73 -28.72 0.43 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.574 1.15 . . . . 0.0 112.542 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -76.82 -24.4 52.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.015 0.825 . . . . 0.0 111.264 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 t -105.63 154.8 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.79 127.56 38.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.44 153.54 31.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.384 0.611 . . . . 0.0 109.797 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.7 mt -142.62 159.92 41.31 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.609 1.964 . . . . 0.0 107.546 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -124.0 130.2 52.18 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.844 1.258 . . . . 0.0 109.485 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.73 26.18 4.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.653 1.181 . . . . 0.0 109.449 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -68.11 -20.54 64.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.805 1.642 . . . . 0.0 113.23 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -146.29 153.28 40.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 46.32 56.07 6.69 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -168.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp -64.63 28.23 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.974 2.909 . . . . 0.0 114.071 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -55.21 -36.25 65.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.935 1.694 . . . . 0.0 112.737 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -70.6 -52.31 22.35 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.876 0.762 . . . . 0.0 110.081 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.12 85.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.17 -56.79 17.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.43 1.092 . . . . 0.0 109.38 170.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.29 73.9 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -2.49 37.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.246 0.618 . . . . 0.0 111.954 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.47 47.99 53.87 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.008 1.289 . . . . 0.0 113.034 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.84 -10.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 117.956 0.878 . . . . 0.0 112.272 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 107.67 0.96 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.1 mt -74.8 110.39 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -52.26 -44.21 64.78 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 110.896 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -3.15 47.33 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.393 0.677 . . . . 0.0 112.457 -171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.76 -25.58 4.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.011 0.924 . . . . 0.0 112.381 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 58.37 35.19 24.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.79 0.836 . . . . 0.0 109.845 -168.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.17 157.5 40.65 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.18 146.09 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.06 30.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.533 0.733 . . . . 0.0 111.361 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -81.2 103.29 10.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -149.45 168.88 22.23 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.221 1.409 . . . . 0.0 107.669 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.94 151.75 20.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 121.564 -0.71 . . . . 0.0 110.059 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -135.96 157.16 47.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.607 1.163 . . . . 0.0 108.722 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.98 139.29 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -125.5 132.69 52.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 108.058 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.31 165.93 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 169.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.69 -20.27 47.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.4 -2.56 57.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.601 -1.312 . . . . 0.0 112.271 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.19 23.24 77.95 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 121.078 -1.014 . . . . 0.0 112.42 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.22 145.36 25.45 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.799 1.3 . . . . 0.0 107.556 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.99 134.21 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.6 t -110.42 -30.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.777 1.631 . . . . 0.0 109.405 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -152.14 145.52 24.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.01 141.31 25.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.44 145.34 27.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -132.08 96.9 4.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.818 2.047 . . . . 0.0 106.109 -169.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.59 140.52 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 p -68.0 -12.78 61.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.778 1.231 . . . . 0.0 113.274 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.97 126.06 15.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.88 -21.06 34.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.463 HG22 ' HE2' ' A' ' 7' ' ' LYS . 78.8 p -75.04 -25.54 58.78 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 171.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -80.03 172.6 13.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.462 1.505 . . . . 0.0 107.683 169.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -140.74 157.37 67.89 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 120.702 -1.249 . . . . 0.0 110.109 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 165.8 30.89 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.841 2.361 . . . . 0.0 110.083 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -90.82 118.27 30.1 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -49.72 -28.75 6.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.983 1.713 . . . . 0.0 113.169 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -59.9 -36.09 76.24 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.516 0.598 . . . . 0.0 110.801 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -65.03 -52.94 45.4 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.274 -0.869 . . . . 0.0 112.261 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 -24.97 41.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 121.083 1.423 . . . . 0.0 111.795 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.71 -45.89 97.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 109.869 170.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.94 -32.8 72.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.213 0.915 . . . . 0.0 110.345 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.63 -55.27 12.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.922 0.489 . . . . 0.0 111.614 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.63 83.2 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.161 0.584 . . . . 0.0 112.027 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.81 65.55 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.612 0.765 . . . . 0.0 111.826 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.95 -30.74 70.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.063 0.545 . . . . 0.0 111.914 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.3 mt -98.35 -29.19 13.3 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.23 -8.91 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 123.915 0.886 . . . . 0.0 110.024 176.686 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 121.803 0.811 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.91 144.9 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -111.5 161.11 16.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 109.753 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -128.06 54.36 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.704 1.202 . . . . 0.0 108.437 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 41.11 62.33 1.49 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.941 2.096 . . . . 0.0 113.115 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.74 0.18 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.591 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.95 46.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.271 0.939 . . . . 0.0 110.767 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.3 164.36 6.97 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.97 3.113 . . . . 0.0 113.188 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.91 139.78 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.916 1.286 . . . . 0.0 108.632 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 m -65.48 149.95 49.17 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.466 0.651 . . . . 0.0 109.347 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -129.41 134.66 47.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.65 1.98 . . . . 0.0 107.941 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.66 140.65 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 -166.68 42.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.75 48.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.155 1.382 . . . . 0.0 109.224 -176.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.16 112.34 2.61 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 m -73.17 169.0 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.49 158.27 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.636 -0.665 . . . . 0.0 109.506 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 133.52 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.98 -18.88 56.48 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.933 1.254 . . . . 0.0 112.257 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -70.96 153.38 42.71 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.065 1.432 . . . . 0.0 109.843 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -80.42 130.0 34.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.59 157.38 27.22 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.169 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.54 -7.0 4.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.458 3.438 . . . . 0.0 118.44 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t0 53.5 56.17 7.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.939 1.352 . . . . 0.0 110.894 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -86.01 169.78 12.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.667 1.987 . . . . 0.0 110.192 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -130.78 147.81 52.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.442 1.097 . . . . 0.0 108.189 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.37 162.38 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.297 1.839 . . . . 0.0 107.034 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.03 141.65 29.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -69.66 162.78 26.99 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -64.57 -17.5 64.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.051 -1.656 . . . . 0.0 111.399 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -85.1 3.18 40.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.539 1.936 . . . . 0.0 112.129 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt 73.62 33.47 1.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.398 1.879 . . . . 0.0 113.032 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -115.45 164.54 14.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.085 1.354 . . . . 0.0 108.021 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.22 143.42 35.36 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 120.445 -1.409 . . . . 0.0 109.12 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -141.14 146.08 36.56 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 p -147.66 169.68 19.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -47.69 -41.88 23.63 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.38 0.672 . . . . 0.0 111.651 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.44 64.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 112.751 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -77.96 -40.45 39.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.827 0.851 . . . . 0.0 110.607 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -66.8 -24.59 66.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.179 0.991 . . . . 0.0 111.583 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -55.95 -14.02 2.24 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.541 1.137 . . . . 0.0 113.631 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -27.42 50.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.312 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -155.01 169.47 24.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.959 1.379 . . . . 0.0 109.516 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.21 125.25 17.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 168.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.3 m -129.69 131.93 46.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.887 0.475 . . . . 0.0 111.038 -168.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 mt -89.68 141.96 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -118.83 136.33 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 172.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -128.11 90.33 3.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 108.037 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.79 139.05 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.63 144.69 45.79 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.97 -45.03 34.88 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.292 2.661 . . . . 0.0 112.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -160.04 168.15 26.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 106.542 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 tt -107.61 172.48 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.375 0.67 . . . . 0.0 110.14 -170.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.3 25.52 11.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.499 1.52 . . . . 0.0 113.396 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -75.23 -15.36 60.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.079 . . . . 0.0 112.253 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.79 0.1 86.13 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.226 0.917 . . . . 0.0 112.406 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.16 -46.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.748 1.274 . . . . 0.0 109.076 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.07 -28.57 69.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.281 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.96 -32.71 54.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.423 1.489 . . . . 0.0 111.982 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.55 60.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.601 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -55.69 -59.08 5.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.803 0.841 . . . . 0.0 110.424 -169.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -64.38 -40.78 96.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.021 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -74.71 -30.84 61.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.432 1.469 . . . . 0.0 111.45 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -63.52 -42.44 98.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.191 170.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.83 -37.63 79.76 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 120.069 1.304 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -60.41 -48.65 80.84 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.776 0.716 . . . . 0.0 111.036 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.57 -53.48 54.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.02 0.928 . . . . 0.0 109.51 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.7 -39.11 83.48 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.553 0.741 . . . . 0.0 111.363 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.05 87.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.265 0.484 . . . . 0.0 111.104 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.26 -33.82 73.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -69.73 -41.34 75.41 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.007 0.821 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -43.54 98.55 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.496 0.589 . . . . 0.0 110.268 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.44 -21.23 39.31 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.676 1.132 . . . . 0.0 112.686 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -153.04 100.74 2.51 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.735 1.214 . . . . 0.0 109.111 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.9 174.35 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 126.913 2.085 . . . . 0.0 105.433 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -129.65 142.73 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.98 144.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.85 166.17 23.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 0.0 108.974 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -126.3 142.01 51.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mt -128.59 137.92 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -147.36 165.41 30.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 111.76 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.09 -6.93 59.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.67 164.02 25.88 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.523 1.129 . . . . 0.0 110.462 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.5 135.04 96.08 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.25 -34.03 88.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.893 1.728 . . . . 0.0 111.522 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -70.08 -31.12 68.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.505 0.593 . . . . 0.0 111.697 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.82 75.23 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.069 0.85 . . . . 0.0 109.273 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.66 -43.37 93.98 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.582 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.86 -41.94 88.21 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.704 0.684 . . . . 0.0 111.153 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -69.37 -39.18 78.2 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 121.828 -0.545 . . . . 0.0 110.235 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -64.32 -40.25 95.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.795 0.438 . . . . 0.0 110.298 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.16 -38.47 83.25 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.122 -0.986 . . . . 0.0 110.828 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.98 -29.09 74.46 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.764 175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.8 71.6 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.712 1.256 . . . . 0.0 110.21 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -89.06 -17.88 28.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.05 39.27 24.19 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.74 143.99 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.362 1.065 . . . . 0.0 108.152 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -144.12 -38.07 0.31 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.577 1.151 . . . . 0.0 112.405 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -83.9 -18.72 36.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.428 0.691 . . . . 0.0 112.179 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.55 161.72 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -136.01 128.0 29.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p -80.85 149.11 29.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.609 0.764 . . . . 0.0 109.278 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.0 mt -142.67 148.73 37.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.137 1.775 . . . . 0.0 106.239 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.2 m -119.04 126.47 51.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.541 1.064 . . . . 0.0 110.182 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -82.99 -21.23 34.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.764 1.626 . . . . 0.0 109.779 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.7 t60 31.68 -73.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 1 C-N-CA 132.221 4.208 . . . . 0.0 117.413 173.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -139.99 -0.44 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.169 1.387 . . . . 0.0 111.65 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.31 -38.72 63.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.281 0.946 . . . . 0.0 109.882 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 34.0 mmm 53.29 8.73 0.12 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.904 2.882 . . . . 0.0 116.595 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 p -59.79 -41.33 90.92 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 122.407 2.367 . . . . 0.0 111.693 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -60.57 -59.71 4.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.45 -41.59 99.58 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-O 119.994 -0.337 . . . . 0.0 112.61 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.36 -41.96 85.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.439 1.496 . . . . 0.0 110.521 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.24 -23.22 15.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -169.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.33 1.41 45.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.818 1.19 . . . . 0.0 112.749 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.18 28.03 62.93 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.106 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.4 -8.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 119.629 1.715 . . . . 0.0 113.493 -171.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.67 102.69 6.28 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.19 104.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.0 -38.35 67.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.45 1.1 . . . . 0.0 110.796 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -65.63 -16.08 63.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.135 0.974 . . . . 0.0 112.869 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.2 mt -127.3 -18.76 4.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.691 1.196 . . . . 0.0 112.502 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.51 40.08 30.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.523 1.129 . . . . 0.0 109.23 -168.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -136.44 153.71 50.99 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.623 1.169 . . . . 0.0 107.953 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.63 156.43 34.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.592 0.633 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.73 -172.39 1.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.435 1.494 . . . . 0.0 110.513 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -117.95 17.63 14.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.903 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -64.71 170.24 4.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.733 2.013 . . . . 0.0 113.417 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.08 151.66 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.332 1.053 . . . . 0.0 109.816 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -141.72 162.28 35.88 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.26 145.6 31.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 171.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.72 128.11 43.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.982 1.713 . . . . 0.0 107.191 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.42 167.12 15.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.842 0.857 . . . . 0.0 109.815 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.18 -24.15 52.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.128 0.971 . . . . 0.0 112.609 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.41 -4.13 46.77 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.796 -1.19 . . . . 0.0 112.189 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.52 24.5 76.77 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.184 -0.948 . . . . 0.0 112.246 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -91.78 142.69 27.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.17 129.71 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.26 -15.71 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.685 0.794 . . . . 0.0 111.636 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -153.05 144.36 23.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.46 137.51 28.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.77 130.07 13.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -106.8 144.38 33.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.32 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 61.72 -15.27 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.299 2.24 . . . . 0.0 115.204 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -149.4 113.96 5.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.06 -31.53 67.16 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.145 0.578 . . . . 0.0 111.872 -174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 p -73.46 7.23 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.744 1.218 . . . . 0.0 113.718 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.83 176.64 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.786 1.176 . . . . 0.0 110.516 172.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.77 150.6 70.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.494 1.118 . . . . 0.0 110.282 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.09 154.51 42.13 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.472 2.781 . . . . 0.0 110.388 -169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -79.2 115.25 18.74 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -52.78 -26.44 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.852 1.661 . . . . 0.0 113.198 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -61.57 -36.08 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.049 0.84 . . . . 0.0 111.404 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -58.49 -57.84 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.596 0.634 . . . . 0.0 112.033 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.24 -24.34 32.17 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.118 1.212 . . . . 0.0 111.684 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 120.139 1.336 . . . . 0.0 109.605 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.27 -33.36 75.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.084 0.856 . . . . 0.0 110.494 -177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.63 -56.9 10.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.373 0.269 . . . . 0.0 111.361 172.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.37 88.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.422 0.689 . . . . 0.0 112.307 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -26.43 67.67 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.53 0.605 . . . . 0.0 111.986 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.63 65.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.089 0.556 . . . . 0.0 112.228 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.5 mt -102.46 -28.2 12.34 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.67 -18.47 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.386 1.075 . . . . 0.0 109.938 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.237 0.429 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.5 mt -140.98 143.8 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p -82.49 158.81 23.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.839 1.2 . . . . 0.0 110.621 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -132.12 85.85 2.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt 43.03 37.59 1.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.297 2.239 . . . . 0.0 115.441 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.96 -26.61 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.665 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.09 171.03 44.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.773 1.287 . . . . 0.0 112.054 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.83 151.82 51.71 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.842 3.028 . . . . 0.0 111.696 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.37 145.75 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.852 1.661 . . . . 0.0 108.519 171.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -76.45 141.67 41.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.928 1.691 . . . . 0.0 111.103 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.94 137.82 32.46 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -75.67 -21.0 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.54 -177.38 19.34 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.418 0.532 . . . . 0.0 112.243 -169.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -64.23 138.22 58.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.804 1.242 . . . . 0.0 111.142 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -78.82 143.07 36.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.3 153.94 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.94 157.12 43.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.358 1.063 . . . . 0.0 110.731 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.3 t -58.75 143.0 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.001 0.92 . . . . 0.0 109.034 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.57 -24.0 13.94 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.872 1.225 . . . . 0.0 112.42 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -73.79 155.21 39.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.718 1.259 . . . . 0.0 109.848 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -70.77 128.86 37.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.85 153.74 78.56 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.247 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.23 -32.03 69.07 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.65 2.9 . . . . 0.0 114.655 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.16 81.4 0.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.486 1.915 . . . . 0.0 113.138 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -127.59 -174.77 3.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.738 1.615 . . . . 0.0 109.564 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -115.64 155.91 26.82 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.856 1.262 . . . . 0.0 110.251 -168.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.12 159.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.836 2.454 . . . . 0.0 106.555 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.18 140.65 29.26 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.958 -1.089 . . . . 0.0 109.323 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.5 p -73.33 170.0 15.94 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -68.08 -13.95 62.6 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.516 -1.365 . . . . 0.0 111.45 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.05 0.4 40.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.254 1.421 . . . . 0.0 111.622 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp 58.03 47.1 15.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.039 1.336 . . . . 0.0 111.346 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.22 166.56 16.86 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.192 1.397 . . . . 0.0 107.528 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.02 141.98 29.91 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -138.93 150.88 46.42 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 126.257 1.823 . . . . 0.0 106.155 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 p -146.07 168.52 20.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.297 -0.877 . . . . 0.0 109.304 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.64 -31.53 68.22 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.864 -0.522 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.4 -28.62 8.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 113.828 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.73 -38.7 13.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.91 1.284 . . . . 0.0 110.804 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.0 mtt -68.66 -36.77 79.0 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.652 0.781 . . . . 0.0 110.614 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -62.8 -3.57 1.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.77 30.46 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.659 1.118 . . . . 0.0 113.107 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -148.2 166.01 29.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.49 1.645 . . . . 0.0 109.118 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.49 117.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.0 m -127.41 129.63 47.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.314 0.384 . . . . 0.0 111.37 -168.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.18 137.91 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.02 100.5 9.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.94 140.9 45.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 t -126.42 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 118.493 0.588 . . . . 0.0 109.493 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 159.64 67.45 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.495 1.518 . . . . 0.0 108.263 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.72 -53.67 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.618 1.545 . . . . 0.0 111.373 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -147.29 154.14 40.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.752 2.021 . . . . 0.0 106.566 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.0 tt -98.7 -6.5 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -168.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.1 -28.06 68.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.529 -0.732 . . . . 0.0 112.425 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -73.28 142.08 47.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.394 0.678 . . . . 0.0 110.581 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.6 -16.25 65.23 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.137 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.88 -29.28 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.996 1.398 . . . . 0.0 111.125 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.8 m -63.76 -12.82 38.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.537 0.735 . . . . 0.0 112.843 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.72 -45.3 77.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.668 1.122 . . . . 0.0 110.828 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.43 7.24 2.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.315 1.046 . . . . 0.0 112.612 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -129.06 -87.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -53.08 -54.18 39.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.808 1.643 . . . . 0.0 112.967 -169.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.69 -42.21 67.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.978 -1.077 . . . . 0.0 110.569 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpp85 -60.23 -38.19 82.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.648 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -64.99 -32.41 74.13 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.209 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.43 -48.19 81.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.674 1.579 . . . . 0.0 110.216 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.27 -57.14 9.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.325 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -61.58 -40.53 95.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.434 0.561 . . . . 0.0 111.028 -172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.17 78.26 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.848 0.749 . . . . 0.0 111.482 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.07 79.4 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.112 0.869 . . . . 0.0 110.803 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -70.18 -39.88 74.98 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.505 0.593 . . . . 0.0 109.552 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.4 -47.24 82.81 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.195 0.598 . . . . 0.0 110.141 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.51 9.08 84.59 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.864 1.221 . . . . 0.0 113.949 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -151.99 35.61 0.54 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.391 1.595 . . . . 0.0 112.322 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.88 173.48 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -123.62 151.0 43.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.8 149.71 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.691 -1.256 . . . . 0.0 110.171 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -135.23 172.52 12.9 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.746 1.619 . . . . 0.0 108.982 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.6 m -132.5 144.04 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.64 137.71 56.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.59 147.87 36.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.14 0.976 . . . . 0.0 109.826 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.26 56.03 2.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -144.9 170.06 16.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.606 1.562 . . . . 0.0 107.143 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.04 142.11 63.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.132 -0.98 . . . . 0.0 112.468 -168.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -47.64 -41.03 30.9 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.34 3.36 . . . . 0.0 115.028 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -73.43 -29.4 62.54 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.95 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.39 82.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.525 1.057 . . . . 0.0 109.334 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -47.8 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.125 172.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.37 80.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.417 0.553 . . . . 0.0 111.09 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -59.75 -43.83 94.11 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.59 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -58.95 -52.05 67.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.533 0.606 . . . . 0.0 110.171 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.6 m -65.13 -44.96 86.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.95 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.59 -41.66 83.38 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.342 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.13 -39.78 82.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.12 0.96 . . . . 0.0 110.538 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -79.69 -19.17 49.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.957 0.503 . . . . 0.0 112.274 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.74 64.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 118.831 0.741 . . . . 0.0 111.425 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.03 146.78 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.587 1.155 . . . . 0.0 108.179 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -139.02 -35.8 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 112.172 -173.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -81.43 -18.74 44.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.025 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.21 158.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -139.76 130.1 25.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 168.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 p -84.26 155.94 22.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 mt -143.44 162.98 34.37 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.893 1.277 . . . . 0.0 108.406 -170.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.3 m -129.82 107.67 9.57 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.503 0.721 . . . . 0.0 109.586 -169.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -95.28 56.19 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -136.62 33.44 2.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.324 1.05 . . . . 0.0 112.693 -168.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -122.86 -48.33 2.02 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -144.65 121.12 11.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 101.871 -3.381 . . . . 0.0 101.871 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.1 mtp -73.69 36.87 0.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.734 1.613 . . . . 0.0 112.801 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -57.87 -41.71 83.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.859 1.264 . . . . 0.0 111.782 -169.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.13 -46.22 62.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.767 0.712 . . . . 0.0 109.581 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.82 -33.58 62.97 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.534 0.588 . . . . 0.0 111.868 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.96 -48.85 72.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.806 0.803 . . . . 0.0 109.367 171.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.55 72.69 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.3 3.52 53.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.597 1.159 . . . . 0.0 111.527 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.86 -13.8 8.27 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.081 1.801 . . . . 0.0 115.351 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.68 -23.39 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.559 1.544 . . . . 0.0 112.741 -173.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 110.57 1.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.28 113.43 17.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -53.29 -45.21 68.85 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.585 1.554 . . . . 0.0 111.331 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.72 0.14 51.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.361 0.665 . . . . 0.0 112.567 -169.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.24 -22.64 3.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.871 0.759 . . . . 0.0 112.976 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.36 37.15 28.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.195 0.998 . . . . 0.0 111.943 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.68 162.83 24.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.173 -0.954 . . . . 0.0 108.814 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -88.47 134.18 33.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.63 141.32 32.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.74 1.216 . . . . 0.0 110.471 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -73.32 112.63 9.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 168.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -154.65 170.06 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.447 1.499 . . . . 0.0 107.098 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.99 146.83 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -134.71 162.72 31.53 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 124.022 0.826 . . . . 0.0 110.139 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.5 t -134.8 145.81 31.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.16 130.55 41.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.452 1.501 . . . . 0.0 107.477 -169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.67 165.09 25.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.007 1.323 . . . . 0.0 109.54 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.65 -6.49 3.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.09 12.31 23.57 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.952 -1.092 . . . . 0.0 112.448 169.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.68 78.75 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.029 0.823 . . . . 0.0 112.849 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -88.99 145.82 25.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.34 139.75 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.45 -26.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.564 1.546 . . . . 0.0 109.397 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -147.77 147.07 29.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -150.96 133.87 15.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 169.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.78 147.37 29.79 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -127.66 102.4 6.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.81 136.21 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -66.3 -13.52 60.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -134.93 125.58 26.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.991 1.716 . . . . 0.0 106.833 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.87 66.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.141 0.577 . . . . 0.0 111.827 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -79.5 12.96 2.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.146 1.378 . . . . 0.0 111.366 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -134.69 167.02 21.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.952 2.101 . . . . 0.0 107.857 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -128.31 154.73 79.06 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 110.923 -170.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.17 160.61 48.53 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.622 2.215 . . . . 0.0 109.65 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -87.06 117.44 25.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -51.51 -28.32 13.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.128 1.771 . . . . 0.0 112.857 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -60.14 -32.11 70.71 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.567 0.621 . . . . 0.0 111.695 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.73 -51.85 11.24 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.443 -171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.68 -30.56 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.452 1.434 . . . . 0.0 111.729 174.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.44 -49.01 79.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 119.838 1.199 . . . . 0.0 109.904 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.75 -32.17 73.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.514 0.597 . . . . 0.0 110.771 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.66 71.51 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.209 0.459 . . . . 0.0 111.437 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.92 64.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.857 0.463 . . . . 0.0 110.01 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -26.76 68.88 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.442 -0.786 . . . . 0.0 111.797 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.64 71.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.988 0.813 . . . . 0.0 111.626 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.59 -29.13 28.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.15 0.58 . . . . 0.0 111.512 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.04 -51.97 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.368 0.531 . . . . 0.0 110.371 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.1 pttp . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.052 -175.692 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 mt -146.13 155.37 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -169.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -117.51 168.51 10.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.852 1.261 . . . . 0.0 110.753 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -141.05 56.95 1.55 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.93 1.292 . . . . 0.0 108.619 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 37.74 71.21 0.16 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.082 2.153 . . . . 0.0 113.782 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -16.98 0.59 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.098 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.93 174.76 41.06 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.01 162.91 41.08 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.391 2.728 . . . . 0.0 111.151 178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.96 135.16 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.283 1.433 . . . . 0.0 107.395 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.2 m -67.12 152.0 46.57 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 110.385 -176.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.59 135.3 50.1 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.641 1.576 . . . . 0.0 108.661 -175.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.44 136.71 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 -163.68 13.51 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.424 0.556 . . . . 0.0 113.33 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -123.24 138.85 54.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.294 1.437 . . . . 0.0 110.385 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.7 114.67 14.55 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.43 170.38 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.936 0.789 . . . . 0.0 109.887 174.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 161.33 35.74 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.191 0.997 . . . . 0.0 109.094 174.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 129.93 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 174.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.15 -13.08 60.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.797 1.189 . . . . 0.0 112.383 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.62 140.03 58.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.629 1.715 . . . . 0.0 110.214 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -89.88 108.15 19.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 172.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.34 148.72 92.93 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.149 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -57.95 -8.92 5.16 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 125.245 3.963 . . . . 0.0 118.536 -178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 52.79 70.61 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.872 1.32 . . . . 0.0 111.74 -169.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -73.3 166.68 22.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.22 1.408 . . . . 0.0 109.827 177.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 m -127.97 144.92 51.11 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.33 163.12 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.208 2.203 . . . . 0.0 106.69 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.35 137.52 32.25 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -63.67 165.18 8.61 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -64.88 -3.48 3.46 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.699 -1.251 . . . . 0.0 111.864 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 m -114.48 17.97 17.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.127 2.171 . . . . 0.0 111.239 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 mt 65.93 39.85 4.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.133 1.373 . . . . 0.0 112.884 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.58 148.87 49.7 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.62 141.04 44.71 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.904 1.229 . . . . 0.0 109.128 172.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -138.33 144.99 40.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -134.02 165.96 23.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -53.49 -34.7 59.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.972 0.509 . . . . 0.0 110.442 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.97 46.09 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.12 -42.62 59.76 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.584 0.707 . . . . 0.0 110.441 173.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.6 mtt -64.7 -25.8 68.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.074 1.35 . . . . 0.0 111.643 -177.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -54.69 -16.75 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.592 1.157 . . . . 0.0 113.258 174.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.65 47.06 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.677 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -151.97 159.18 43.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.752 1.776 . . . . 0.0 109.695 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.49 119.46 6.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.8 m -124.95 134.23 52.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.446 0.299 . . . . 0.0 110.883 -168.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.11 142.59 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mm -120.89 138.08 52.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -126.92 102.37 6.98 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.109 0.964 . . . . 0.0 108.601 -169.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.04 134.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.81 157.31 61.76 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 107.984 169.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.39 -55.64 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.28 1.987 . . . . 0.0 111.59 -172.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -161.27 150.07 16.15 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 127.962 2.505 . . . . 0.0 104.833 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 tt -73.17 -10.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 118.92 0.782 . . . . 0.0 112.517 -169.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -32.35 73.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.868 1.267 . . . . 0.0 113.013 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.27 114.29 10.23 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.58 -17.99 43.02 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.408 1.004 . . . . 0.0 113.61 -174.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.33 -21.79 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 118.511 1.156 . . . . 0.0 111.311 174.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 64.3 m -58.75 -19.86 44.27 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.788 1.176 . . . . 0.0 112.8 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.7 -29.35 69.29 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.142 0.977 . . . . 0.0 111.828 173.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.58 5.94 22.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.622 1.169 . . . . 0.0 112.441 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -124.82 -83.83 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -57.68 -45.85 85.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.561 1.144 . . . . 0.0 111.885 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -68.6 -45.5 71.81 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.552 -0.717 . . . . 0.0 111.02 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.02 -37.43 87.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -57.98 -37.47 74.28 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.232 0.923 . . . . 0.0 112.207 171.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.53 -48.41 81.77 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.485 1.039 . . . . 0.0 110.825 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.48 -47.3 70.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.72 -40.07 96.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.378 0.99 . . . . 0.0 110.713 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.7 78.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.919 0.781 . . . . 0.0 111.627 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.16 87.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.701 0.682 . . . . 0.0 111.725 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -70.48 -40.05 73.85 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.443 0.697 . . . . 0.0 111.067 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.38 149.45 33.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.894 1.278 . . . . 0.0 108.805 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.53 -44.42 97.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.132 -178.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.23 137.24 7.04 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.677 1.591 . . . . 0.0 107.57 174.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -162.73 175.31 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.654 1.582 . . . . 0.0 106.956 174.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -136.54 140.62 43.09 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.51 146.52 23.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.05 163.37 29.71 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.962 1.305 . . . . 0.0 109.209 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.4 m -121.29 146.18 47.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 169.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.57 140.68 47.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 m -140.27 149.13 42.44 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.665 1.186 . . . . 0.0 109.939 -169.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.89 45.75 1.24 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.21 -176.63 3.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.136 1.375 . . . . 0.0 110.87 -168.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.43 140.52 26.92 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.275 -174.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.14 -41.48 57.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.874 3.049 . . . . 0.0 113.97 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -78.62 -29.44 45.94 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.509 -0.745 . . . . 0.0 112.083 -174.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.39 73.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.281 0.946 . . . . 0.0 109.102 175.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -51.05 -50.49 58.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.538 1.535 . . . . 0.0 111.11 171.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.683 0.393 . . . . 0.0 111.518 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -63.84 -44.41 93.28 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.033 0.533 . . . . 0.0 110.044 -174.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -61.69 -39.86 92.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.556 0.342 . . . . 0.0 110.565 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.4 m -65.35 -44.05 88.92 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.92 -0.487 . . . . 0.0 111.224 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.66 94.87 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.56 -44.3 87.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.696 0.748 . . . . 0.0 110.463 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -77.31 -23.49 51.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.281 0.632 . . . . 0.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.59 22.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.807 0.718 . . . . 0.0 111.325 -178.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.46 144.1 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.45 -37.9 0.23 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.176 1.391 . . . . 0.0 111.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -80.44 -16.49 54.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.08 0.952 . . . . 0.0 111.919 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.4 160.79 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.93 146.1 40.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 p -99.25 142.62 30.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.391 1.076 . . . . 0.0 108.63 -177.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 mt -129.02 155.66 45.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.051 1.34 . . . . 0.0 107.984 -174.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.66 125.6 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.258 1.423 . . . . 0.0 109.441 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -118.66 -2.54 10.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 111.966 -176.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -55.59 -23.29 26.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.518 1.527 . . . . 0.0 113.006 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -59.08 -45.48 90.72 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.119 0.968 . . . . 0.0 111.864 -176.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -154.95 7.37 0.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -171.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 mmm 51.77 28.47 4.95 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.128 1.771 . . . . 0.0 113.873 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -51.72 -51.33 56.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 111.928 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.66 -44.8 69.8 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.513 0.597 . . . . 0.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.22 -43.56 64.02 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.795 1.188 . . . . 0.0 112.672 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -74.35 -42.23 59.73 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.986 0.915 . . . . 0.0 110.213 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.79 86.5 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 0.0 112.034 -173.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -109.95 6.3 23.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.474 1.51 . . . . 0.0 112.581 -176.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.9 78.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.563 1.074 . . . . 0.0 113.109 171.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.95 1.59 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.282 . . . . 0.0 112.679 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -82.67 108.48 16.07 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 120.534 1.515 . . . . 0.0 107.48 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.64 105.0 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -51.48 -49.51 61.68 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 126.337 1.855 . . . . 0.0 110.981 -171.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -74.28 -35.61 63.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.407 0.683 . . . . 0.0 111.711 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.74 -23.69 42.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.765 0.711 . . . . 0.0 112.148 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? 57.99 34.57 24.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.132 0.973 . . . . 0.0 109.075 -168.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.4 mt -130.16 160.96 32.22 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.794 1.238 . . . . 0.0 108.688 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -75.32 158.25 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.09 -167.55 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.167 1.387 . . . . 0.0 111.307 175.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -124.66 123.57 40.33 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 169.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -166.55 169.12 14.04 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.924 1.69 . . . . 0.0 106.908 -169.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.46 143.23 23.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.22 156.9 47.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.016 0.926 . . . . 0.0 108.693 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 t -136.54 138.91 46.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.3 mt -130.84 124.51 31.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.401 1.481 . . . . 0.0 107.838 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.81 164.64 14.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.75 -21.13 10.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.655 1.182 . . . . 0.0 112.822 174.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -76.18 -2.85 33.17 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.586 -1.321 . . . . 0.0 112.502 174.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.35 76.53 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -171.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -116.68 129.7 56.3 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.73 129.27 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -173.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.94 -18.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.799 0.84 . . . . 0.0 111.406 177.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -153.61 143.13 21.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 144.91 27.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.22 144.9 23.43 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.218 1.007 . . . . 0.0 108.87 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -132.86 126.0 31.23 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.742 1.617 . . . . 0.0 106.82 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.82 137.12 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -70.76 -3.69 20.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.444 0.698 . . . . 0.0 112.88 177.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.92 125.38 21.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.94 1.696 . . . . 0.0 107.252 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.32 -23.48 62.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 169.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.02 3.79 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.222 2.609 . . . . 0.0 112.986 173.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -140.91 171.14 14.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.534 1.934 . . . . 0.0 108.191 -176.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -131.51 155.98 80.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.357 1.063 . . . . 0.0 110.791 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.07 170.41 19.77 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.792 2.328 . . . . 0.0 109.9 176.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -97.9 118.74 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -55.75 -24.22 34.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.909 1.684 . . . . 0.0 112.922 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -61.64 -35.24 77.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.254 0.933 . . . . 0.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -62.07 -54.06 53.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.171 -174.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -31.36 16.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.957 1.771 . . . . 0.0 112.279 177.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mm -53.62 -50.28 51.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 119.67 1.123 . . . . 0.0 109.623 172.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.844 0.293 . . . . 0.0 110.688 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.39 91.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.916 0.325 . . . . 0.0 111.568 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.71 -53.81 24.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.208 0.603 . . . . 0.0 110.921 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -24.46 67.91 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.437 1.017 . . . . 0.0 112.186 -177.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.35 66.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.024 0.829 . . . . 0.0 111.565 170.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.78 -24.25 12.93 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.506 1.122 . . . . 0.0 112.545 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . 0.258 7.1 p -126.36 74.71 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 122.695 1.236 . . . . 0.0 108.351 177.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.997 172.29 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tpp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.11 134.75 39.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 158.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -127.84 98.85 5.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.69 150.52 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -97.91 155.54 17.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 123.038 1.399 . . . . 0.0 108.748 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -120.87 66.49 0.85 Allowed 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HE3' HG23 ' A' ' 150' ' ' THR . 2.0 ttmt 57.35 36.75 27.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.55 -21.27 0.27 Allowed Glycine 0 CA--C 1.497 -1.088 0 O-C-N 118.751 -2.468 . . . . 0.0 111.116 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.33 163.61 34.02 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.64 157.46 55.48 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.986 3.124 . . . . 0.0 110.118 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.42 137.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.248 1.419 . . . . 0.0 107.317 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.601 ' H ' ' HG3' ' A' ' 123' ' ' GLU . 27.1 m -74.99 151.18 38.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.605 1.162 . . . . 0.0 109.138 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.2 mt -113.09 143.92 43.52 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.4 165.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 158.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.73 -172.41 14.51 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.449 1.027 . . . . 0.0 113.3 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -116.63 158.52 23.6 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.304 1.441 . . . . 0.0 107.659 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.45 127.27 32.05 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.8 t -89.76 163.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 127.441 2.297 . . . . 0.0 107.505 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -137.04 169.29 18.03 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.339 -0.851 . . . . 0.0 111.487 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.97 137.09 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.397 165.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.37 -23.25 30.83 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.312 1.91 . . . . 0.0 112.387 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -71.84 151.09 43.7 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.648 0.779 . . . . 0.0 109.856 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -73.86 126.97 31.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 146.93 93.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 118.023 -0.989 . . . . 0.0 108.371 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.592 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 31.4 Cg_exo -52.81 -25.77 28.31 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 121.943 1.762 . . . . 0.0 115.528 -172.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' CE1' ' A' ' 27' ' ' PHE . 26.1 t0 61.26 89.47 0.08 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 129.375 3.07 . . . . 0.0 118.232 -170.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.622 ' CD2' ' HA ' ' A' ' 113' ' ' PHE . 0.6 OUTLIER -131.19 -166.76 1.75 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.437 -2.04 . . . . 0.0 107.175 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.436 ' H ' ' HB3' ' A' ' 27' ' ' PHE . 5.4 m -125.08 143.57 50.85 Favored 'General case' 0 N--CA 1.406 -2.651 1 C-N-CA 134.53 5.132 . . . . 0.0 107.21 -170.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.58 171.07 18.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 129.253 3.021 . . . . 0.0 103.768 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.33 146.34 25.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -67.17 162.36 22.66 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 119.822 1.192 . . . . 0.0 108.106 162.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.38 -11.63 4.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.67 165.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 m -98.06 4.8 49.19 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.951 2.1 . . . . 0.0 112.795 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 75.42 33.89 0.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.852 1.661 . . . . 0.0 112.094 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.18 153.8 35.72 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.51 141.74 48.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.092 -1.005 . . . . 0.0 108.921 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -139.64 145.1 38.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 168.42 18.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.251 0.621 . . . . 0.0 111.247 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -37.13 65.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.343 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.27 -35.07 49.14 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.7 -42.51 61.15 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.318 1.056 . . . . 0.0 109.845 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.87 -30.09 71.07 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 112.05 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -10.73 19.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.563 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -11.99 6.22 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.041 1.292 . . . . 0.0 112.878 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.68 164.79 34.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.661 1.73 . . . . 0.0 107.073 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.06 120.42 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -126.72 138.9 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.5 mt -100.88 144.82 12.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.27 132.16 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -121.32 100.09 6.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.08 134.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 60' ' ' CYS . 0.4 OUTLIER -137.6 161.54 59.83 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.66 -57.38 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.151 1.901 . . . . 0.0 111.594 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 164.4 33.08 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.844 2.058 . . . . 0.0 106.38 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.418 ' HA ' ' HG ' ' A' ' 60' ' ' CYS . 10.3 tt -94.93 -15.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.656 1.571 . . . . 0.0 112.985 -168.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.97 -1.75 53.33 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.555 ' HG1' ' NH2' ' A' ' 129' ' ' ARG . 3.2 p -78.99 3.41 17.27 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 118.815 -2.428 . . . . 0.0 115.318 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.36 -52.37 0.83 Allowed Glycine 0 CA--C 1.54 1.61 0 CA-C-O 117.771 -1.571 . . . . 0.0 113.194 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -30.29 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 122.282 3.041 . . . . 0.0 111.34 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . 0.418 ' HG ' ' HA ' ' A' ' 55' ' ' ILE . 1.9 m -58.65 -31.89 68.58 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.673 -0.642 . . . . 0.0 112.035 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.633 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 15.1 t70 -55.54 -50.3 70.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.885 0.874 . . . . 0.0 108.753 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.93 -13.79 5.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.622 0.576 . . . . 0.0 112.306 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.516 HE22 ' HG2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -99.28 -75.81 0.56 Allowed 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.012 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -59.43 -40.2 86.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 123.597 1.665 . . . . 0.0 111.489 -159.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.262 1.7 tpt180 -76.1 -49.89 16.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.176 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' HG2' ' CZ ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -57.34 -38.72 74.54 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -58.45 -41.1 84.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.763 0.825 . . . . 0.0 109.945 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -57.5 -45.26 85.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.326 0.966 . . . . 0.0 111.556 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -70.98 -48.63 52.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.026 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.35 -38.21 86.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.572 0.349 . . . . 0.0 110.671 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.04 86.05 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.507 -0.745 . . . . 0.0 111.402 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.69 88.49 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.762 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -70.75 -36.4 73.11 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.587 0.755 . . . . 0.0 111.396 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mp -62.4 -41.48 98.7 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 123.192 0.597 . . . . 0.0 109.97 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 -37.36 3.4 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.491 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -140.23 85.32 2.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.34 1.07 . . . . 0.0 109.575 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.29 172.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -127.93 144.2 51.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.4 t -144.41 139.22 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.51 161.26 35.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.464 0.65 . . . . 0.0 109.312 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.6 m -122.01 148.5 44.74 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.8 mt -132.9 134.74 57.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 m -132.13 159.9 37.57 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.438 0.695 . . . . 0.0 110.671 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.49 39.62 0.92 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 109.18 167.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -133.66 168.69 18.23 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.107 1.363 . . . . 0.0 108.804 -166.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 136.04 96.45 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.073 0.949 . . . . 0.0 110.536 -171.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.97 -42.39 64.71 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.365 2.043 . . . . 0.0 111.903 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -72.84 -30.07 63.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.059 -1.026 . . . . 0.0 112.672 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.87 98.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.503 1.047 . . . . 0.0 108.627 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.1 -46.23 78.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.09 75.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.79 0.805 . . . . 0.0 108.982 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.9 ttp85 -70.3 -44.95 67.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.775 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 61' ' ' ASP . 69.3 t90 -53.98 -41.44 67.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.1 -46.98 84.83 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.265 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.25 -38.89 97.19 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.839 0.712 . . . . 0.0 111.753 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.13 93.4 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.738 0.815 . . . . 0.0 110.751 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -87.7 -17.15 32.39 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.84 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.72 56.08 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 119.29 0.95 . . . . 0.0 112.132 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mm -71.35 142.76 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.279 1.432 . . . . 0.0 107.443 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.66 -36.59 0.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.09 1.356 . . . . 0.0 110.637 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -79.86 -18.62 50.28 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.838 -1.164 . . . . 0.0 112.988 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -117.13 150.29 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.38 138.97 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 p -93.88 150.62 20.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.713 1.205 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.6 mt -141.65 157.51 44.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.339 1.456 . . . . 0.0 107.406 -170.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -121.64 109.72 15.1 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.518 -1.364 . . . . 0.0 109.09 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 109' ' ' ARG . 25.0 t0 -84.06 -10.1 58.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.927 1.291 . . . . 0.0 110.333 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -32.55 -25.34 0.0 OUTLIER 'General case' 0 C--N 1.347 0.458 1 C-N-CA 132.148 4.179 . . . . 0.0 115.246 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -97.82 -38.12 9.57 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -151.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.21 -7.72 0.62 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 125.82 1.95 . . . . 0.0 107.859 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.414 ' HE1' ' CD2' ' A' ' 120' ' ' TYR . 7.5 mmm 59.09 12.67 2.55 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 125.494 1.518 . . . . 0.0 109.561 172.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.1 -42.74 77.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.622 ' HA ' ' CD2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -64.79 -57.63 8.4 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 125.052 1.341 . . . . 0.0 110.573 177.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.43 -37.9 93.94 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 118.9 -1.619 . . . . 0.0 111.474 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.2 -53.28 51.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.666 1.186 . . . . 0.0 109.778 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.37 77.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -83.7 0.66 46.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.026 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.19 44.62 95.37 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.55 1.068 . . . . 0.0 111.712 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.92 -6.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.882 0.873 . . . . 0.0 112.168 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.414 ' CD2' ' HE1' ' A' ' 111' ' ' MET . 0.3 OUTLIER -70.84 118.82 14.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 165.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 51.2 mt -82.06 105.94 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -53.14 -41.34 65.02 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 112.037 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.601 ' HG3' ' H ' ' A' ' 12' ' ' THR . 1.5 mm-40 -80.1 -11.77 59.73 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.727 1.211 . . . . 0.0 111.632 -171.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.08 -23.06 6.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.886 0.766 . . . . 0.0 112.54 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 61.15 38.9 16.56 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.935 1.35 . . . . 0.0 114.332 -168.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.76 145.35 48.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -168.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.08 142.57 52.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.1 17.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.624 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.555 ' NH2' ' HG1' ' A' ' 57' ' ' THR . 72.5 mtt85 -95.98 111.69 23.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 m -150.78 168.13 25.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.79 156.87 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.153 0.888 . . . . 0.0 109.316 171.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -141.41 159.73 41.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.57 1.148 . . . . 0.0 108.015 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.02 143.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.5 mt -134.65 125.28 26.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -165.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.69 164.57 23.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.614 1.165 . . . . 0.0 109.087 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.32 -14.13 16.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.481 1.912 . . . . 0.0 112.988 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.96 -9.69 59.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.499 -1.376 . . . . 0.0 111.977 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.14 25.95 65.25 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.453 -1.405 . . . . 0.0 111.476 -168.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -89.71 142.51 27.62 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 118.821 1.311 . . . . 0.0 108.973 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.2 t -72.56 122.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 t -94.77 -31.59 4.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 126.27 1.828 . . . . 0.0 108.845 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -152.99 149.22 27.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.31 144.65 28.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 168.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.28 142.29 23.95 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.353 1.061 . . . . 0.0 108.525 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.46 108.17 10.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.401 HG23 ' HD3' ' A' ' 153' ' ' PRO . 17.5 t -62.8 123.94 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -60.82 -12.6 11.37 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.264 -1.35 . . . . 0.0 112.646 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -134.74 115.18 13.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.54 1.536 . . . . 0.0 107.381 -172.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.16 -25.88 68.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.212 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.422 HG23 ' HE3' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -80.69 1.72 28.95 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.616 1.566 . . . . 0.0 113.95 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.36 164.26 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.94 2.496 . . . . 0.0 106.429 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -129.95 155.06 81.18 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 121.4 -0.812 . . . . 0.0 109.187 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.516 ' HG2' HE22 ' A' ' 63' ' ' GLN . 37.9 Cg_endo -66.86 168.89 15.87 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.536 2.157 . . . . 0.0 110.24 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.82 122.08 38.23 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.162 -1.586 . . . . 0.0 107.098 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.546 ' CZ ' ' HG2' ' A' ' 66' ' ' ARG . 19.7 p90 -59.3 -23.2 62.24 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.226 1.81 . . . . 0.0 112.824 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.43 -36.15 71.0 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.699 1.136 . . . . 0.0 109.842 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -60.22 -57.69 24.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.023 0.929 . . . . 0.0 113.16 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.59 -26.77 28.04 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 120.663 0.909 . . . . 0.0 111.224 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -49.42 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 108.493 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -63.96 -34.14 77.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.006 0.821 . . . . 0.0 111.204 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.31 66.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.59 0.756 . . . . 0.0 110.934 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.18 -44.99 67.61 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.444 -0.785 . . . . 0.0 110.421 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.427 ' O ' ' HE2' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -62.13 -23.61 66.66 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.67 -28.03 65.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.477 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.0 -25.79 13.94 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.002 -1.475 . . . . 0.0 113.702 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -73.53 -13.37 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.113 1.324 . . . . 0.0 113.031 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 163' ' ' LYS . 7.1 mmtt . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.659 -2.115 . . . . 0.0 110.624 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.37 0.128 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.24 -24.51 67.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.576 0.751 . . . . 0.0 112.914 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 56.06 55.74 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.603 1.561 . . . . 0.0 110.798 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.92 151.63 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.659 169.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -113.84 160.78 18.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.337 1.055 . . . . 0.0 109.687 173.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.87 46.84 1.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.493 1.117 . . . . 0.0 108.673 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 42.33 63.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.608 1.963 . . . . 0.0 111.94 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.1 -25.58 0.18 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.571 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 171.81 43.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.271 0.938 . . . . 0.0 110.822 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.09 159.71 52.2 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.567 2.844 . . . . 0.0 111.076 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.54 133.61 45.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 124.125 0.97 . . . . 0.0 109.119 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -68.83 134.64 49.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.695 0.798 . . . . 0.0 110.481 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.23 146.59 23.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.398 1.479 . . . . 0.0 108.496 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -74.33 -65.02 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.25 169.52 54.65 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.509 0.576 . . . . 0.0 112.047 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.61 166.3 22.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.759 0.79 . . . . 0.0 110.611 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.48 120.09 18.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.75 152.5 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -128.15 158.06 39.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.251 1.02 . . . . 0.0 110.642 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.38 144.51 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.962 0.905 . . . . 0.0 108.813 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.38 19.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.646 1.117 . . . . 0.0 112.451 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.15 155.97 39.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.62 1.21 . . . . 0.0 109.872 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -74.02 136.19 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 157.92 30.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 122.987 0.515 . . . . 0.0 111.21 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -53.52 -27.42 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.969 3.113 . . . . 0.0 116.985 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 t0 51.91 78.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.255 1.422 . . . . 0.0 113.548 -169.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -139.15 -176.9 4.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.771 1.228 . . . . 0.0 110.636 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -125.64 152.31 45.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 110.994 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 m -140.39 170.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.791 2.436 . . . . 0.0 106.909 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.26 147.67 22.71 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.971 -1.08 . . . . 0.0 108.184 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.9 p -70.81 170.58 12.22 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -61.79 -9.25 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.633 -1.292 . . . . 0.0 112.524 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 m -105.83 12.09 31.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.476 1.91 . . . . 0.0 111.204 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.41 47.4 8.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.172 1.789 . . . . 0.0 111.209 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.9 140.44 51.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.99 135.09 56.25 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.537 -0.727 . . . . 0.0 111.153 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -137.29 141.57 41.93 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -126.65 157.21 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -169.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -54.48 -34.44 61.59 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.48 1.112 . . . . 0.0 111.132 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.56 67.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.51 -38.11 62.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.68 0.792 . . . . 0.0 110.331 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 mtt -66.43 -27.05 67.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.62 1.168 . . . . 0.0 111.013 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.19 -15.48 3.87 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.776 0.83 . . . . 0.0 113.142 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.54 -18.79 56.91 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.4 1.0 . . . . 0.0 113.849 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -152.48 160.56 43.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.347 1.573 . . . . 0.0 108.758 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.92 118.87 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.9 m -126.64 132.52 51.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.492 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.2 mt -93.05 142.51 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -126.89 128.62 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 125.553 1.541 . . . . 0.0 106.944 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 m -126.32 98.53 5.49 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.292 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.16 131.33 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.7 147.17 47.65 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.929 0.786 . . . . 0.0 111.827 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -65.21 133.54 35.68 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.3 2.0 . . . . 0.0 108.545 168.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m 44.44 -133.4 0.71 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.349 1.06 . . . . 0.0 111.073 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.5 tt -163.46 178.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.208 2.203 . . . . 0.0 106.15 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t0 56.09 38.98 30.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.072 1.749 . . . . 0.0 112.245 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.1 p -81.8 11.94 4.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.468 1.107 . . . . 0.0 111.646 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 -59.68 4.78 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 125.408 1.48 . . . . 0.0 109.761 -169.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.38 -8.7 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.55 -23.9 63.27 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.551 1.069 . . . . 0.0 111.274 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.19 -33.61 76.14 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.852 -1.155 . . . . 0.0 111.444 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.25 11.9 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.043 0.937 . . . . 0.0 111.899 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -134.92 -91.51 0.32 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.429 1.092 . . . . 0.0 108.481 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -54.59 -44.25 72.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.41 1.484 . . . . 0.0 112.297 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -67.61 -52.04 43.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -42.6 85.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.663 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.48 -37.87 79.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.378 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -59.58 -46.16 89.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.897 1.226 . . . . 0.0 111.609 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.74 -51.77 31.26 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.56 -36.52 84.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.502 -0.749 . . . . 0.0 111.078 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.655 -0.653 . . . . 0.0 111.668 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.16 66.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.486 1.039 . . . . 0.0 110.761 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -69.63 -41.49 75.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 0.0 110.058 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.2 -39.77 93.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.627 0.771 . . . . 0.0 110.144 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -73.49 2.67 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 125.821 1.677 . . . . 0.0 110.33 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -88.42 41.31 1.0 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.559 1.143 . . . . 0.0 112.088 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 164.7 15.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.467 1.107 . . . . 0.0 108.109 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.51 145.25 50.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.53 145.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.474 -0.766 . . . . 0.0 108.941 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -131.54 158.39 41.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.607 1.163 . . . . 0.0 108.544 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.1 m -127.59 144.84 51.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.44 113.68 23.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 p -76.15 162.31 28.1 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.87 0.843 . . . . 0.0 110.123 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 -9.96 59.72 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -154.03 -31.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -169.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.83 111.26 10.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 120.412 1.46 . . . . 0.0 111.835 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.41 -31.65 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.903 1.735 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -71.26 -38.52 71.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.01 74.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.006 1.275 . . . . 0.0 110.844 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.13 -27.04 68.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.535 . . . . 0.0 111.438 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.19 82.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.465 0.575 . . . . 0.0 110.391 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -74.33 -39.96 62.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.549 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -52.66 -45.94 66.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.443 0.565 . . . . 0.0 109.81 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.78 -45.75 73.94 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.212 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.2 94.05 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.68 76.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.695 0.747 . . . . 0.0 110.406 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -73.77 -33.69 64.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.312 0.645 . . . . 0.0 112.34 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.24 37.71 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.72 145.02 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.11 -38.63 0.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.214 1.005 . . . . 0.0 112.789 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -74.74 -24.45 58.72 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.809 0.732 . . . . 0.0 112.408 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.1 158.94 10.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.25 134.45 34.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.0 p -87.56 154.37 20.67 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 mt -146.84 171.62 14.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 128.523 2.729 . . . . 0.0 106.076 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -150.97 142.33 23.36 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 119.656 -1.902 . . . . 0.0 109.06 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.63 -33.38 73.84 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 168.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.5 t60 55.79 -67.1 0.02 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 129.734 3.214 . . . . 0.0 113.981 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -149.44 0.11 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.302 1.441 . . . . 0.0 112.15 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.15 -39.9 90.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.253 0.933 . . . . 0.0 110.515 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 62.42 -23.55 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 129.523 3.129 . . . . 0.0 114.72 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.84 -43.96 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 121.05 1.75 . . . . 0.0 111.203 -170.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -64.65 -55.31 20.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.48 93.07 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 122.951 0.31 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.04 -47.59 73.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.615 -0.932 . . . . 0.0 110.273 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.06 -31.03 58.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.894 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.88 9.99 3.14 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.26 0.482 . . . . 0.0 112.071 172.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.91 -15.41 5.11 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 120.8 -1.187 . . . . 0.0 114.363 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.94 -25.49 30.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.053 1.427 . . . . 0.0 112.051 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.98 109.04 1.98 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.45 1.477 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.81 107.33 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -49.98 -45.66 51.84 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.75 1.22 . . . . 0.0 110.139 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.57 -16.27 62.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.519 1.128 . . . . 0.0 113.107 -171.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 mt -128.27 -16.82 4.38 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.517 1.127 . . . . 0.0 112.393 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.14 36.77 27.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.425 1.09 . . . . 0.0 109.417 -168.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.3 tp -126.08 147.06 49.67 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.159 1.383 . . . . 0.0 107.714 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.27 134.27 35.57 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.73 156.31 17.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.908 1.683 . . . . 0.0 111.955 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -83.22 116.66 22.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -162.14 168.44 22.54 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.935 0.894 . . . . 0.0 109.092 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.71 145.99 18.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 O-C-N 121.791 -0.568 . . . . 0.0 109.917 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -140.82 161.31 38.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.307 1.043 . . . . 0.0 109.581 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t -136.06 140.75 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.15 136.07 52.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.785 1.634 . . . . 0.0 108.122 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -75.77 166.76 23.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.213 1.005 . . . . 0.0 108.886 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.61 -23.01 57.91 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.254 -0.904 . . . . 0.0 112.588 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -76.06 -3.47 36.08 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.822 -1.174 . . . . 0.0 112.124 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.47 75.34 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.125 0.869 . . . . 0.0 112.096 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -92.56 143.94 25.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.45 130.86 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.4 t -104.93 -31.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.917 1.687 . . . . 0.0 109.409 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -152.28 149.12 28.34 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.82 139.23 24.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -149.08 134.13 18.13 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -114.29 126.05 54.59 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.5 t -70.0 136.69 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -67.48 -9.97 47.21 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.12 117.36 18.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.49 67.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 111.838 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.3 p -72.03 -10.59 59.99 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.88 1.672 . . . . 0.0 112.726 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -120.06 158.46 26.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 109.617 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -106.49 152.73 40.74 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.857 0.863 . . . . 0.0 111.082 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.08 154.58 57.43 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.592 2.194 . . . . 0.0 109.373 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.27 121.39 25.02 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -53.84 -26.56 25.02 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.262 1.425 . . . . 0.0 113.262 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -62.17 -33.61 74.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.778 0.717 . . . . 0.0 111.16 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -59.32 -56.79 32.36 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.178 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.57 -28.52 31.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 121.046 1.409 . . . . 0.0 111.851 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -48.45 88.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.529 1.059 . . . . 0.0 108.81 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.01 -31.06 72.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.888 0.767 . . . . 0.0 111.12 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -51.09 35.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.646 0.378 . . . . 0.0 111.36 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.47 -44.5 71.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -29.31 65.16 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.485 0.714 . . . . 0.0 111.67 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.58 71.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.498 0.719 . . . . 0.0 112.019 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.4 mt -99.16 -36.05 9.8 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.63 0.91 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.703 0.801 . . . . 0.0 109.897 173.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.318 0.104 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 167.44 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.181 0.515 . . . . 0.0 110.366 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -149.12 142.5 25.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 87.0 mt -137.69 166.48 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -115.37 155.25 27.71 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.068 1.304 . . . . 0.0 110.195 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -124.88 65.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.789 1.236 . . . . 0.0 108.175 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 pttt 39.09 50.44 1.81 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.813 2.045 . . . . 0.0 113.972 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.92 -27.3 0.13 Allowed Glycine 0 CA--C 1.523 0.594 0 CA-C-O 119.523 -0.598 . . . . 0.0 112.669 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.71 45.71 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 117.998 0.899 . . . . 0.0 111.294 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.09 157.8 28.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.599 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.37 131.8 40.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 126.553 1.941 . . . . 0.0 106.378 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -76.0 160.6 29.67 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.13 0.972 . . . . 0.0 109.858 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 138.04 54.25 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.23 128.42 38.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.69 -159.73 18.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 123.555 0.598 . . . . 0.0 112.201 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -126.03 155.09 42.03 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.289 1.036 . . . . 0.0 109.045 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.54 152.76 43.62 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 168.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.64 146.33 31.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.19 158.94 34.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.44 0.696 . . . . 0.0 110.837 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.37 139.54 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.077 0.951 . . . . 0.0 108.856 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -18.15 53.33 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.792 1.187 . . . . 0.0 112.346 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -77.21 153.95 33.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.013 1.406 . . . . 0.0 109.98 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -75.29 127.61 33.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 169.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.29 150.78 78.73 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.653 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.17 -30.3 49.98 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.816 3.01 . . . . 0.0 115.625 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 51.63 88.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.557 1.943 . . . . 0.0 113.965 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.02 168.27 19.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.376 1.07 . . . . 0.0 110.405 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.2 157.34 19.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.321 1.448 . . . . 0.0 112.375 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.85 157.69 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.942 2.497 . . . . 0.0 106.279 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tp -86.22 138.08 32.14 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.954 -1.091 . . . . 0.0 108.972 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.8 p -71.18 167.44 19.37 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -65.44 -17.03 64.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.476 -1.39 . . . . 0.0 110.887 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -81.08 0.78 34.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.805 1.642 . . . . 0.0 111.374 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 mt 69.26 34.06 3.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.54 1.536 . . . . 0.0 111.404 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.77 163.06 20.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.668 1.187 . . . . 0.0 108.264 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.3 137.21 37.26 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -134.03 149.94 51.2 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -143.04 165.47 27.28 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.91 -35.57 64.28 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 111.939 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.1 -29.11 56.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.204 1.002 . . . . 0.0 113.146 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -81.14 -40.45 23.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.395 1.078 . . . . 0.0 110.762 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.69 -42.3 91.37 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -66.19 -0.79 2.71 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.67 -16.5 30.45 Favored Glycine 0 CA--C 1.54 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 112.488 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -140.25 158.54 43.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.534 1.533 . . . . 0.0 107.366 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.73 120.28 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -125.46 136.31 53.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.881 -169.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.21 139.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mm -120.55 133.76 66.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -125.99 94.43 4.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.333 1.053 . . . . 0.0 108.696 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.06 124.08 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.82 162.42 55.36 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.41 1.484 . . . . 0.0 107.799 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.02 -59.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.955 1.77 . . . . 0.0 110.315 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.8 m -152.41 160.32 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.581 2.353 . . . . 0.0 106.887 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.29 17.16 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -126.95 14.38 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.891 1.276 . . . . 0.0 110.42 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -73.51 -12.41 60.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.899 1.28 . . . . 0.0 112.713 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.15 -50.77 4.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.808 1.194 . . . . 0.0 110.213 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.68 -25.77 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 118.173 0.987 . . . . 0.0 112.073 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.7 p -53.42 -37.99 63.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.309 1.044 . . . . 0.0 112.257 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.98 -43.75 67.38 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.138 0.975 . . . . 0.0 110.787 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.98 43.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.155 0.982 . . . . 0.0 112.441 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -106.67 -55.01 2.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.189 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -64.78 -40.04 94.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.864 1.211 . . . . 0.0 112.348 -169.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -63.06 -49.3 75.09 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.029 -1.044 . . . . 0.0 109.335 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -67.01 -36.04 81.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.165 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -59.5 -43.86 93.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.75 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -58.08 -46.79 84.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.495 1.043 . . . . 0.0 111.343 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.58 -46.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -69.16 -33.31 73.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.296 -0.878 . . . . 0.0 110.721 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.92 96.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.526 0.603 . . . . 0.0 110.892 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.863 0.756 . . . . 0.0 111.144 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -65.48 -39.76 92.32 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.092 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.02 -45.75 84.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.598 1.09 . . . . 0.0 110.114 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 -4.93 75.22 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.796 1.189 . . . . 0.0 114.433 170.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -153.8 55.1 0.73 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.473 . . . . 0.0 109.831 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.33 168.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -127.76 140.81 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.6 t -137.34 139.79 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -128.71 162.84 26.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.886 0.851 . . . . 0.0 109.502 170.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.5 m -129.11 143.99 51.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 mt -130.87 134.95 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.4 m -138.95 157.0 46.81 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.414 1.086 . . . . 0.0 110.436 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.99 54.32 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -140.41 162.93 34.15 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.651 1.581 . . . . 0.0 107.891 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.34 137.08 95.32 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.46 -32.08 80.56 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.015 1.81 . . . . 0.0 111.269 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -29.44 62.3 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.275 -0.891 . . . . 0.0 111.461 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -45.23 67.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.96 1.255 . . . . 0.0 109.709 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.26 -44.07 79.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.305 1.042 . . . . 0.0 111.714 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.27 -39.96 95.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.387 -0.821 . . . . 0.0 111.894 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -67.16 -39.06 86.44 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -53.95 -51.81 62.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.433 0.693 . . . . 0.0 109.428 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.0 m -60.11 -36.45 77.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.852 0.751 . . . . 0.0 111.231 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.06 -19.56 72.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.954 -0.914 . . . . 0.0 113.548 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.25 -25.17 24.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.168 1.484 . . . . 0.0 111.571 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -124.13 -16.28 6.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.64 1.176 . . . . 0.0 113.08 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.44 22.24 77.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.242 -0.755 . . . . 0.0 112.198 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mt -55.99 140.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -143.33 -35.89 0.38 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.65 1.18 . . . . 0.0 111.807 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -76.48 -17.14 59.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 111.448 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.26 153.98 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.65 150.64 50.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.1 p -111.77 148.02 34.42 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -171.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.1 mt -138.72 145.25 40.05 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.215 1.006 . . . . 0.0 109.192 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.3 m -107.82 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.516 0.674 . . . . 0.0 109.827 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -81.36 -14.55 57.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.512 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -42.43 -39.92 2.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.761 2.424 . . . . 0.0 114.192 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -119.74 24.05 10.79 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.251 1.021 . . . . 0.0 110.266 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -136.26 -45.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.787 0.835 . . . . 0.0 110.461 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.1 -15.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.15 2.98 . . . . 0.0 114.898 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 m -62.86 -50.57 70.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.329 1.422 . . . . 0.0 111.871 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.92 -46.84 85.9 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.214 0.916 . . . . 0.0 110.162 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.36 99.08 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.89 -42.97 80.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.295 -0.532 . . . . 0.0 109.955 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.56 92.06 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.37 -0.831 . . . . 0.0 112.035 -169.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.11 -1.35 52.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.687 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.63 54.06 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 119.385 0.993 . . . . 0.0 112.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.4 28.87 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.993 1.317 . . . . 0.0 110.46 -170.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -119.84 117.41 28.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.85 112.54 19.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.36 -43.53 83.59 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.595 1.958 . . . . 0.0 111.234 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.4 -43.61 66.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.388 0.275 . . . . 0.0 110.476 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.09 -22.09 31.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 56.59 37.62 28.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.889 0.876 . . . . 0.0 108.697 -168.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.162 1.385 . . . . 0.0 108.056 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.9 150.67 42.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.398 0.618 . . . . 0.0 110.75 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -177.21 2.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.554 1.169 . . . . 0.0 112.232 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.45 101.21 7.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 102.034 -3.321 . . . . 0.0 102.034 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -156.51 167.88 29.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -169.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.13 144.93 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -141.04 159.91 41.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.706 0.802 . . . . 0.0 109.825 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.5 t -135.56 144.45 33.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.3 mt -130.24 123.11 29.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.536 1.534 . . . . 0.0 107.961 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.97 166.23 11.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.158 0.983 . . . . 0.0 108.714 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.51 -20.99 59.45 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.153 -0.967 . . . . 0.0 113.397 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -80.45 -10.68 59.74 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.593 -1.317 . . . . 0.0 112.247 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.58 18.05 69.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.399 -0.813 . . . . 0.0 111.179 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -75.66 132.21 40.42 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.34 125.7 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.97 -10.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -153.55 144.06 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.85 138.69 22.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.08 149.94 29.38 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 109.201 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -129.57 108.19 10.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.72 123.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -68.43 -11.29 59.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -135.28 124.87 25.09 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 108.375 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.87 66.09 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 p -84.52 16.6 3.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 112.017 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -137.23 170.32 16.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.161 2.185 . . . . 0.0 107.954 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.25 164.11 42.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.706 1.203 . . . . 0.0 110.617 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.52 173.64 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.305 2.67 . . . . 0.0 112.258 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -113.91 120.11 39.57 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -53.08 -28.48 25.27 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.526 1.53 . . . . 0.0 112.845 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -58.85 -36.18 74.14 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.496 0.589 . . . . 0.0 111.12 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -67.59 -52.95 24.56 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.677 -170.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.98 -32.94 27.31 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.842 1.336 . . . . 0.0 111.846 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.16 -48.3 79.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-N 119.25 0.932 . . . . 0.0 109.54 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.08 -39.55 92.81 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.508 0.594 . . . . 0.0 110.545 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.216 -0.303 . . . . 0.0 111.603 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.57 -52.2 41.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.532 0.733 . . . . 0.0 110.168 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.13 69.58 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.133 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.454 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.55 -32.02 69.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.374 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.57 -35.85 19.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.796 0.838 . . . . 0.0 111.556 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.4 -40.43 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.451 0.701 . . . . 0.0 111.302 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 18.7 pttp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.336 0.516 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.95 -179.76 1.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.724 0.693 . . . . 0.0 109.135 169.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -144.47 140.09 28.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.68 150.86 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -77.56 161.33 27.95 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.905 -1.122 . . . . 0.0 108.797 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -138.15 109.38 6.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 39.03 51.3 1.89 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 111.583 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.22 5.47 79.88 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.519 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.08 142.33 13.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 120.299 2.05 . . . . 0.0 109.966 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 149.41 63.27 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 CA-C-N 120.61 2.205 . . . . 0.0 112.006 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.91 141.37 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.095 1.358 . . . . 0.0 109.432 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -78.07 147.79 34.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.391 1.476 . . . . 0.0 110.115 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -116.04 147.32 41.38 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.871 1.668 . . . . 0.0 106.842 175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -67.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.572 0.624 . . . . 0.0 111.222 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 173.02 36.24 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.561 0.534 . . . . 0.0 112.331 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.9 152.3 37.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.78 114.29 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.818 1.19 . . . . 0.0 108.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.5 160.52 20.49 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.98 135.06 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -15.29 60.26 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.736 1.16 . . . . 0.0 112.704 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -70.59 147.23 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.619 1.71 . . . . 0.0 109.137 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -87.03 117.8 25.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 152.1 40.57 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -169.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.42 -24.66 36.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.373 3.382 . . . . 0.0 116.542 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 52.74 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.633 1.973 . . . . 0.0 114.324 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.12 -172.98 2.82 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.411 1.484 . . . . 0.0 108.872 172.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 m -122.92 154.76 37.92 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.946 0.899 . . . . 0.0 110.082 -168.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.02 165.02 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.096 2.158 . . . . 0.0 106.796 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tp -89.59 142.54 27.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -69.16 166.91 17.28 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -65.24 -4.13 4.83 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.71 -1.243 . . . . 0.0 111.941 168.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.3 m -115.01 17.68 16.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.102 2.161 . . . . 0.0 111.332 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.1 mt 65.59 37.77 5.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 113.021 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -122.83 157.09 33.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.03 143.24 35.84 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.739 -1.226 . . . . 0.0 109.167 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.04 142.98 32.91 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -138.51 167.03 22.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.516 -171.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tt -57.78 -35.97 71.53 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.96 -0.463 . . . . 0.0 111.188 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.93 54.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.896 . . . . 0.0 113.073 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.46 -37.87 19.26 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.402 1.081 . . . . 0.0 110.718 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.46 -39.37 91.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.96 0.904 . . . . 0.0 110.244 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -67.5 -0.25 3.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.65 -17.07 40.08 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 120.751 -1.218 . . . . 0.0 113.003 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -144.92 166.63 24.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.299 1.84 . . . . 0.0 106.678 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.18 116.68 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 m -125.51 139.35 53.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.809 0.338 . . . . 0.0 110.635 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 mt -103.13 141.77 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.67 95.81 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 125.92 1.688 . . . . 0.0 107.21 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -73.38 145.51 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.82 137.85 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 pt -141.56 150.12 56.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -48.83 10.15 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.986 1.79 . . . . 0.0 111.951 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -156.07 149.11 24.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 tt -79.33 3.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -89.13 -3.9 58.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.28 1.032 . . . . 0.0 111.964 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -65.5 -10.38 34.0 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.922 -1.111 . . . . 0.0 113.399 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.7 -50.1 4.35 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.323 1.44 . . . . 0.0 111.994 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.7 -2.83 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.919 0.888 . . . . 0.0 112.349 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -49.85 -31.5 12.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.369 1.468 . . . . 0.0 110.058 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.48 -50.74 51.81 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.853 1.261 . . . . 0.0 111.92 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.52 79.71 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.612 0.365 . . . . 0.0 110.921 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -85.43 -8.51 58.35 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.648 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -141.01 -60.91 0.49 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.861 1.21 . . . . 0.0 112.47 -169.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -71.87 -43.72 64.97 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.483 -1.386 . . . . 0.0 110.064 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.56 -35.98 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.998 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -62.46 -36.88 83.85 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.555 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -57.37 -45.98 83.87 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.752 1.16 . . . . 0.0 110.323 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.75 -50.18 65.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.831 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -32.18 72.78 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.134 -0.979 . . . . 0.0 110.929 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.98 93.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.911 0.884 . . . . 0.0 111.166 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.26 99.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.202 0.455 . . . . 0.0 109.947 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -65.13 -35.73 82.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.28 0.632 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -62.42 -19.4 63.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.168 0.987 . . . . 0.0 113.225 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.3 -43.27 3.11 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.497 1.046 . . . . 0.0 112.054 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -149.95 126.3 10.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.851 1.261 . . . . 0.0 108.563 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -165.52 174.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.354 2.262 . . . . 0.0 105.379 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -129.41 138.57 51.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -140.54 140.4 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -134.33 167.35 20.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.493 1.117 . . . . 0.0 109.493 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.4 m -131.63 144.15 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.82 141.85 43.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -142.5 156.78 45.18 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.021 0.528 . . . . 0.0 111.452 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.88 50.95 1.87 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.663 1.185 . . . . 0.0 108.047 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -142.71 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.328 1.451 . . . . 0.0 107.787 -169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.41 140.6 72.47 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 111.882 -168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.49 -39.72 45.25 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.93 3.087 . . . . 0.0 114.498 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -74.42 -28.04 60.89 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.74 0.7 . . . . 0.0 111.604 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.27 -44.2 84.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.447 1.021 . . . . 0.0 108.941 172.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -48.26 74.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.663 0.785 . . . . 0.0 111.095 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -41.21 97.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.416 0.553 . . . . 0.0 111.451 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -63.77 -41.48 97.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.103 0.561 . . . . 0.0 109.787 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -56.21 -48.48 76.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.416 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 66.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.882 0.764 . . . . 0.0 110.865 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.19 98.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.38 85.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.857 0.829 . . . . 0.0 110.758 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -86.69 -11.07 52.28 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.539 0.736 . . . . 0.0 112.672 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.48 27.85 68.79 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.182 0.901 . . . . 0.0 111.903 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.4 mt -76.54 147.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.188 0.995 . . . . 0.0 108.943 -174.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.65 -39.08 0.47 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 111.849 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -11.18 59.86 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.335 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.32 155.44 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -135.27 134.41 39.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -89.14 151.08 22.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.181 0.992 . . . . 0.0 108.777 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 mt -141.59 166.18 25.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.78 2.032 . . . . 0.0 107.388 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.93 123.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -80.4 36.23 0.36 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.561 1.172 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -66.04 -10.43 39.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.738 1.615 . . . . 0.0 111.671 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -79.1 63.29 3.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.456 1.503 . . . . 0.0 108.743 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t0 47.05 44.83 15.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.818 2.047 . . . . 0.0 112.691 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 83.1 mmm 48.73 23.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.192 2.197 . . . . 0.0 114.127 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -63.64 -37.14 86.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.075 -1.016 . . . . 0.0 112.977 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.65 -48.86 62.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 109.65 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.3 61.63 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.33 -49.51 77.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.891 0.845 . . . . 0.0 109.24 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.7 -39.1 80.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.41 -3.08 21.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 113.2 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.26 62.75 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.322 0.965 . . . . 0.0 112.61 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.52 1.08 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.64 1.22 . . . . 0.0 112.449 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -90.89 120.28 31.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.9 mt -82.25 108.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -54.96 -38.53 67.86 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.159 1.383 . . . . 0.0 110.908 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -75.47 -10.85 59.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 112.628 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 mt -134.29 -19.77 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 53.42 42.17 32.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 109.17 -167.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -119.6 148.08 43.75 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.39 1.476 . . . . 0.0 107.249 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 tp -91.9 139.04 31.05 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.04 172.37 10.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.085 0.954 . . . . 0.0 111.13 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ttm105 -101.67 21.17 14.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.922 0.889 . . . . 0.0 111.475 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 m -58.66 176.31 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.285 2.234 . . . . 0.0 113.89 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.47 147.62 16.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.542 -1.349 . . . . 0.0 108.568 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.83 165.18 26.21 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 109.884 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.29 145.02 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.4 mt -131.0 130.21 43.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.431 -168.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.19 168.23 10.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 109.365 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.79 -14.61 22.67 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.207 -0.933 . . . . 0.0 113.511 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -93.8 6.82 47.15 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.539 -1.351 . . . . 0.0 111.743 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.61 22.28 73.29 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.865 -1.147 . . . . 0.0 111.978 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.78 135.53 34.5 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.695 1.248 . . . . 0.0 107.78 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.72 115.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.89 -34.25 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -162.05 144.72 11.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.219 1.808 . . . . 0.0 107.105 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.84 147.94 34.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.895 0.878 . . . . 0.0 108.725 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.26 135.16 26.76 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.053 1.341 . . . . 0.0 107.704 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -106.81 18.7 21.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.051 1.74 . . . . 0.0 112.951 -168.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.1 m 49.21 -16.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 130.193 3.397 . . . . 0.0 118.376 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 m 55.02 -7.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.048 2.939 . . . . 0.0 116.05 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.51 126.15 11.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.056 1.342 . . . . 0.0 112.649 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 80.9 p -93.43 12.8 23.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.148 1.34 . . . . 0.0 112.211 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.17 163.93 15.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.592 1.557 . . . . 0.0 109.765 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -124.65 157.43 65.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.224 1.41 . . . . 0.0 108.714 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.89 -167.49 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.346 2.697 . . . . 0.0 108.646 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -124.2 116.45 22.71 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -47.46 -29.0 2.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.954 2.101 . . . . 0.0 113.897 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.21 -36.49 77.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.15 0.432 . . . . 0.0 110.969 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -58.52 -58.21 20.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.801 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -24.15 23.1 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-O 116.814 -1.411 . . . . 0.0 112.553 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -47.22 94.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 121.332 1.878 . . . . 0.0 109.066 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.53 -34.84 79.17 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 110.855 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.5 62.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.672 0.389 . . . . 0.0 111.625 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.23 -48.44 70.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.631 0.772 . . . . 0.0 111.171 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -31.45 68.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.962 0.505 . . . . 0.0 111.515 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.28 -30.76 71.8 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.054 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.73 -39.29 7.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.682 0.674 . . . . 0.0 112.548 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.22 -23.49 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.161 0.585 . . . . 0.0 111.208 178.535 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.14 153.76 14.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.946 1.298 . . . . 0.0 112.072 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -144.77 -32.7 0.4 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.085 2.154 . . . . 0.0 109.944 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.286 16.2 mt 73.65 162.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.699 2.4 . . . . 0.0 111.068 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 p -125.02 165.87 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.812 2.045 . . . . 0.0 108.767 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -136.5 105.37 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt 31.4 56.81 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.115 2.166 . . . . 0.0 114.545 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.52 13.06 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.608 169.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.78 159.87 29.89 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.327 1.564 . . . . 0.0 110.501 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.16 156.73 37.99 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.108 2.539 . . . . 0.0 112.164 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.18 -161.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.926 1.691 . . . . 0.0 106.862 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.0 m -149.13 152.31 35.9 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.284 -1.51 . . . . 0.0 108.219 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.45 138.06 47.33 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.191 1.397 . . . . 0.0 108.406 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.65 -17.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.1 175.88 24.44 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.41 150.61 44.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.096 0.951 . . . . 0.0 111.794 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.37 123.37 26.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 168.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.75 162.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.892 1.224 . . . . 0.0 110.123 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -123.26 156.39 35.31 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.475 1.51 . . . . 0.0 107.72 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.07 135.1 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.34 68.52 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.473 -1.182 . . . . 0.0 112.998 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.02 149.73 49.78 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 108.976 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.35 128.23 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 169.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.98 142.38 92.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.353 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.42 0.41 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.703 1 C-N-CA 126.102 4.535 . . . . 0.0 119.204 -178.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.28 65.24 1.31 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.816 1.293 . . . . 0.0 111.902 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -74.67 164.54 26.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.568 1.547 . . . . 0.0 109.805 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.0 m -130.58 136.57 49.02 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.93 155.11 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.013 1.725 . . . . 0.0 106.618 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -85.39 139.11 31.81 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -70.99 164.87 24.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -67.08 -3.4 7.3 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.852 -1.155 . . . . 0.0 111.594 168.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -97.87 5.24 49.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.415 1.886 . . . . 0.0 111.836 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 63.31 42.72 6.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.82 1.248 . . . . 0.0 111.294 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.97 164.46 20.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -84.14 144.94 28.68 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 120.729 -1.232 . . . . 0.0 109.872 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -138.23 156.32 47.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.95 2.1 . . . . 0.0 106.092 171.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 p -149.48 169.8 20.06 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.293 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -47.02 -43.89 19.99 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.776 0.83 . . . . 0.0 111.347 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -30.57 66.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.949 0.9 . . . . 0.0 112.8 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.91 -40.27 60.97 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.382 0.673 . . . . 0.0 110.426 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.5 mtt -67.74 -25.08 65.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.283 1.033 . . . . 0.0 111.62 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -55.77 -14.84 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.225 1.01 . . . . 0.0 113.622 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.29 -23.27 57.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.754 -1.026 . . . . 0.0 113.672 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -151.77 156.86 41.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.677 1.739 . . . . 0.0 109.517 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.1 122.21 8.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 168.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.5 m -125.96 130.47 51.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.63 0.372 . . . . 0.0 110.923 -168.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.4 mt -89.71 141.43 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 mm -118.74 131.61 71.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -127.42 84.45 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.418 1.087 . . . . 0.0 108.16 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.9 143.65 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.73 169.95 9.77 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 106.989 169.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.27 -54.88 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.82 1.68 . . . . 0.0 110.812 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 m -151.37 170.37 19.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.409 2.284 . . . . 0.0 107.563 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -149.3 81.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.954 0.883 . . . . 0.0 109.206 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.68 6.42 1.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 t -152.64 -170.03 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.941 1.297 . . . . 0.0 107.782 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.28 -52.44 3.78 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.75 -29.68 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 117.897 0.849 . . . . 0.0 112.316 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.4 -24.7 64.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.688 0.676 . . . . 0.0 112.485 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -139.53 -95.68 0.16 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.191 0.997 . . . . 0.0 108.718 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.54 6.34 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.597 1.959 . . . . 0.0 114.581 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -87.7 -44.43 11.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.463 1.105 . . . . 0.0 108.353 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.0 m -51.31 -41.74 60.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.43 1.092 . . . . 0.0 112.393 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -65.28 -45.27 85.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -69.15 -39.23 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -56.73 -40.86 76.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.221 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -59.59 -46.09 89.95 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-N 119.348 0.977 . . . . 0.0 111.416 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.45 -55.72 16.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.392 0.677 . . . . 0.0 109.354 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.4 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 27.2 mm-40 -60.08 -40.97 91.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.859 0.754 . . . . 0.0 110.778 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.17 69.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.203 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.67 70.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.572 1.078 . . . . 0.0 110.299 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.93 -41.65 86.66 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.726 174.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.85 -40.78 92.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 110.551 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 -66.62 2.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.951 1.739 . . . . 0.0 110.939 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.69 45.36 1.19 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.725 1.61 . . . . 0.0 111.782 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.65 166.4 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.152 1.381 . . . . 0.0 107.734 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -132.24 146.08 51.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.28 145.32 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.31 155.37 47.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 108.706 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.4 m -117.23 145.81 43.67 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.29 138.05 53.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -140.48 159.18 42.76 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.973 0.909 . . . . 0.0 110.23 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.01 54.66 1.72 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -143.11 161.54 37.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.887 1.275 . . . . 0.0 108.757 -169.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.86 138.43 85.35 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.015 0.926 . . . . 0.0 108.93 -169.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.25 -34.27 88.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.619 2.213 . . . . 0.0 112.129 -170.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -73.86 -29.05 61.9 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.361 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.97 86.3 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.955 0.798 . . . . 0.0 109.381 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -62.89 -42.64 99.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.328 -0.232 . . . . 0.0 111.123 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.87 84.57 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.696 0.398 . . . . 0.0 111.25 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -63.5 -45.72 89.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -60.66 -40.32 91.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.503 0.321 . . . . 0.0 110.436 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.1 m -63.97 -46.1 86.14 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.005 -0.434 . . . . 0.0 111.315 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.38 94.63 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.65 67.67 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.871 0.868 . . . . 0.0 111.999 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -108.25 -4.89 17.15 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.897 0.879 . . . . 0.0 112.345 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.21 30.65 56.76 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.725 0.679 . . . . 0.0 111.528 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -72.19 143.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.412 1.085 . . . . 0.0 108.675 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.67 -38.38 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.619 1.168 . . . . 0.0 112.87 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -73.35 -21.13 60.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 112.342 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.48 157.79 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.22 143.77 36.18 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.9 p -96.86 149.96 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.79 0.836 . . . . 0.0 109.521 -177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.5 mt -137.7 139.4 40.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.592 1.157 . . . . 0.0 108.664 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.7 m -102.06 122.23 43.71 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.427 1.091 . . . . 0.0 108.874 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -104.23 -7.36 20.14 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.669 0.787 . . . . 0.0 111.825 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.51 -27.16 47.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.855 1.262 . . . . 0.0 112.817 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -62.33 -32.04 72.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -146.2 -8.24 0.53 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 50.63 31.02 5.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.421 1.488 . . . . 0.0 112.629 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 m -58.22 -55.47 34.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.296 -0.877 . . . . 0.0 111.136 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -67.26 -40.21 86.19 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.92 -45.09 32.19 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 126.337 1.922 . . . . 0.0 113.118 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.32 -41.31 18.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.903 0.851 . . . . 0.0 109.688 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.97 80.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.574 1.15 . . . . 0.0 112.384 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -105.64 10.79 32.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.812 1.245 . . . . 0.0 110.968 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.24 -3.3 2.46 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.068 -1.407 . . . . 0.0 115.578 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.79 -9.65 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.392 2.096 . . . . 0.0 113.836 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -75.11 120.77 21.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.992 1.269 . . . . 0.0 108.404 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.3 mt -93.7 110.69 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -54.36 -40.84 68.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.871 1.668 . . . . 0.0 111.837 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.24 -6.69 59.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.16 0.584 . . . . 0.0 112.45 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -126.03 -18.54 5.02 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.26 33.41 22.15 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -168.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.6 tp -128.0 171.23 12.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.318 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.3 141.19 47.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.158 0.983 . . . . 0.0 108.748 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 175.89 2.78 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.609 1.164 . . . . 0.0 111.066 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -113.65 18.36 17.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.1 m -63.19 162.35 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 111.727 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.86 147.86 28.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.726 0.81 . . . . 0.0 109.843 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -142.79 155.38 44.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.714 0.805 . . . . 0.0 108.923 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.01 135.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.9 mt -127.93 121.11 29.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.485 1.514 . . . . 0.0 107.276 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.48 160.65 18.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.061 0.945 . . . . 0.0 108.951 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.82 -19.09 15.46 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.772 1.229 . . . . 0.0 113.164 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -73.59 -11.96 60.6 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.534 -1.354 . . . . 0.0 112.465 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.55 43.92 8.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -127.7 131.42 49.75 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.0 109.25 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.974 1.31 . . . . 0.0 108.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.5 -39.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 125.432 1.493 . . . . 0.0 109.331 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -153.76 142.64 21.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.112 1.365 . . . . 0.0 107.504 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.89 139.12 27.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.4 145.26 27.97 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -120.19 131.62 55.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.192 1.397 . . . . 0.0 107.474 -172.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.4 -15.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.3 m 62.55 -12.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.723 2.009 . . . . 0.0 114.658 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -139.74 116.44 10.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.67 1.588 . . . . 0.0 107.029 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.16 66.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.962 1.305 . . . . 0.0 112.676 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 p -91.05 15.34 11.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.347 1.459 . . . . 0.0 111.545 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -138.52 123.1 18.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.366 1.466 . . . . 0.0 109.201 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 155.34 90.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.997 0.919 . . . . 0.0 112.034 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.65 -167.47 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.421 3.414 . . . . 0.0 109.547 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -124.78 116.65 22.63 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -53.38 -27.36 23.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 112.551 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.88 -34.06 71.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.454 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.19 -57.02 19.55 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.233 0.924 . . . . 0.0 111.761 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.34 -29.27 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.398 1.399 . . . . 0.0 111.873 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 mm -56.11 -48.46 79.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 119.878 1.217 . . . . 0.0 109.668 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -65.5 -28.79 69.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.891 0.769 . . . . 0.0 111.423 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.42 -49.83 57.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.394 0.543 . . . . 0.0 111.348 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.8 74.81 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.486 0.714 . . . . 0.0 111.566 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -20.3 63.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.407 0.683 . . . . 0.0 112.175 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.68 -26.65 67.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.72 0.691 . . . . 0.0 111.393 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.6 mt -107.1 -21.97 12.8 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.866 1.266 . . . . 0.0 113.362 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 m -65.96 -18.8 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 119.123 0.874 . . . . 0.0 112.483 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.406 1.082 . . . . 0.0 110.126 -178.227 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.48 81.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.821 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 45.1 49.08 9.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.96 1.704 . . . . 0.0 111.633 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.46 140.72 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.287 1.035 . . . . 0.0 108.472 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 p -102.1 156.97 17.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.988 0.915 . . . . 0.0 109.777 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -104.43 41.83 1.27 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 63.26 -39.8 0.18 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.606 2.762 . . . . 0.0 114.551 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.03 -36.03 33.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.95 0.786 . . . . 0.0 112.015 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.79 177.31 48.06 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.08 153.1 27.51 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.914 3.076 . . . . 0.0 112.797 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.27 131.63 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.62 1.168 . . . . 0.0 108.752 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -63.03 151.28 40.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.446 1.499 . . . . 0.0 111.105 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 mt -122.65 139.63 53.73 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.981 2.112 . . . . 0.0 106.97 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.91 -16.8 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.93 169.1 28.73 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -71.8 159.4 34.38 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.002 0.906 . . . . 0.0 112.057 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -73.37 149.87 42.22 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.51 148.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -131.85 160.35 35.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 111.142 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 141.85 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.028 1.331 . . . . 0.0 109.646 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -22.51 26.35 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.051 1.31 . . . . 0.0 112.027 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -74.95 151.16 38.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.514 1.157 . . . . 0.0 109.91 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -71.29 123.63 22.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.46 152.03 75.21 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.36 -26.53 44.29 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.797 2.998 . . . . 0.0 116.065 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t0 51.38 86.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.282 1.833 . . . . 0.0 114.303 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -127.14 -176.02 3.6 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.798 1.639 . . . . 0.0 108.814 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 m -124.37 154.2 40.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.198 0.999 . . . . 0.0 111.014 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.65 166.33 26.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.883 2.073 . . . . 0.0 107.811 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 tp -84.89 143.92 28.72 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.4 p -71.22 166.86 20.64 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -67.31 -3.42 7.99 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.024 -1.672 . . . . 0.0 112.156 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 m -110.56 17.1 21.08 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.367 1.867 . . . . 0.0 111.323 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.4 mt 66.51 28.1 9.53 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.347 1.459 . . . . 0.0 112.829 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.76 174.34 5.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.03 146.61 43.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.178 -1.576 . . . . 0.0 109.992 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -141.37 136.28 31.3 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 p -124.01 164.11 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.243 1.017 . . . . 0.0 109.247 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.68 -36.69 69.89 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.08 -0.388 . . . . 0.0 110.254 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.53 54.27 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.48 -39.75 52.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 mtt -64.27 -24.81 67.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.632 1.173 . . . . 0.0 111.323 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -55.85 -14.06 2.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.464 1.106 . . . . 0.0 113.401 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.23 -24.36 44.2 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.424 1.011 . . . . 0.0 113.423 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -151.36 169.01 23.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.908 1.354 . . . . 0.0 108.832 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.5 t -62.71 122.43 13.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.0 m -129.39 135.28 48.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.521 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.42 141.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -127.76 120.21 53.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 125.372 1.469 . . . . 0.0 107.42 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.4 m -116.94 100.32 7.68 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.269 1.028 . . . . 0.0 108.395 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.6 136.66 22.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.74 157.69 74.49 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.81 -60.44 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.833 2.355 . . . . 0.0 110.578 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 m -148.49 152.37 36.77 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.295 1.438 . . . . 0.0 107.958 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.75 -18.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.688 1.195 . . . . 0.0 113.284 -173.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.8 19.17 18.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.893 0.877 . . . . 0.0 111.753 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.421 ' HB ' HH12 ' A' ' 129' ' ' ARG . 16.8 p -68.84 -6.37 26.6 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.22 4.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.505 1.526 . . . . 0.0 110.71 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.03 -11.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 122.001 -0.706 . . . . 0.0 111.985 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.14 -21.61 13.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.067 0.947 . . . . 0.0 111.384 169.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -47.77 -47.78 30.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.96 1.304 . . . . 0.0 111.674 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.0 91.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.882 0.473 . . . . 0.0 110.762 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -82.72 -6.58 59.47 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.629 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -136.25 -62.8 0.66 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.676 1.125 . . . . 0.0 111.304 -169.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -83.27 -45.26 14.03 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.798 -1.189 . . . . 0.0 110.998 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -62.97 -32.6 73.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.697 0.68 . . . . 0.0 109.974 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.1 -43.58 87.2 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.327 0.512 . . . . 0.0 111.687 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.15 -45.06 96.2 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.992 0.517 . . . . 0.0 111.342 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.43 -51.03 71.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.46 -38.07 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.627 1.103 . . . . 0.0 110.529 -173.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.05 78.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.46 76.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.04 0.836 . . . . 0.0 110.65 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -70.74 -37.36 73.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.817 0.735 . . . . 0.0 109.77 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.57 -45.07 92.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.627 0.771 . . . . 0.0 109.857 170.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.09 -47.65 1.19 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.191 1.377 . . . . 0.0 110.859 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -140.36 109.52 6.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.301 1.041 . . . . 0.0 109.775 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 p -158.75 -175.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.981 2.512 . . . . 0.0 104.97 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -137.62 138.18 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.84 142.58 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.01 154.74 51.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.697 0.799 . . . . 0.0 109.055 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.5 m -117.67 142.33 47.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.0 mt -131.31 136.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.92 158.69 42.82 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.199 0.999 . . . . 0.0 110.15 -170.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.65 3.16 56.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.669 0.788 . . . . 0.0 111.794 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -101.52 -174.9 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.118 0.967 . . . . 0.0 109.978 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 133.58 90.31 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.79 -37.42 54.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.393 2.729 . . . . 0.0 113.964 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -72.41 -28.64 63.1 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.503 -0.748 . . . . 0.0 111.782 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.59 74.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.13 0.877 . . . . 0.0 109.42 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.36 -49.18 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.262 0.625 . . . . 0.0 110.384 169.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.74 75.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.281 0.491 . . . . 0.0 111.73 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -67.08 -40.5 87.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.356 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.07 -49.29 78.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.99 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.4 m -58.86 -48.25 82.04 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.38 0.536 . . . . 0.0 111.343 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.32 86.1 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.528 -0.596 . . . . 0.0 112.284 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.06 -41.71 70.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.013 0.906 . . . . 0.0 110.567 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -85.98 -22.15 27.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 119.088 -0.482 . . . . 0.0 112.179 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.42 24.17 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.51 143.35 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -146.92 -36.66 0.23 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.642 0.777 . . . . 0.0 112.999 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.45 -21.56 59.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.406 0.548 . . . . 0.0 111.201 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.77 165.2 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.937 1.295 . . . . 0.0 108.247 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -142.7 137.62 30.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 p -85.24 145.99 27.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt -135.12 169.33 17.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.625 1.97 . . . . 0.0 107.276 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -135.66 105.01 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.605 0.762 . . . . 0.0 109.481 -169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.64 -15.46 62.79 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.408 0.683 . . . . 0.0 110.927 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -46.11 -20.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.008 2.523 . . . . 0.0 113.45 169.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -40.8 -60.6 1.13 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.904 1.682 . . . . 0.0 111.497 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.29 15.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.126 0.97 . . . . 0.0 111.071 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.07 18.35 1.7 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.225 1.81 . . . . 0.0 113.325 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -49.68 76.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.928 1.291 . . . . 0.0 112.035 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -77.72 -40.64 40.51 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.931 -0.481 . . . . 0.0 109.843 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.71 -36.79 91.77 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.86 -51.24 69.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 117.544 0.672 . . . . 0.0 109.594 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.9 92.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.75 4.38 44.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.06 0.944 . . . . 0.0 112.423 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.93 39.68 96.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.091 0.853 . . . . 0.0 113.449 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.76 -12.91 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.52 1.128 . . . . 0.0 111.522 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.37 108.75 8.37 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mt -80.1 108.35 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -53.61 -45.75 70.19 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.702 1.201 . . . . 0.0 110.893 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.32 -2.39 24.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.029 0.932 . . . . 0.0 113.236 -173.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -125.92 -18.39 5.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.382 1.073 . . . . 0.0 112.346 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 52.94 39.04 28.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.644 1.178 . . . . 0.0 109.645 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -138.16 150.58 46.93 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.24 1.016 . . . . 0.0 108.31 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.36 145.24 49.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.449 0.643 . . . . 0.0 110.745 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.26 177.11 1.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.007 2.123 . . . . 0.0 111.014 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.421 HH12 ' HB ' ' A' ' 57' ' ' THR . 6.3 mtp180 -115.31 106.39 13.97 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 169.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 m -152.76 169.28 23.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.53 146.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -138.85 158.81 43.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.265 1.026 . . . . 0.0 109.073 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.82 143.08 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 170.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 mt -129.31 126.37 38.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.915 1.686 . . . . 0.0 107.078 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.52 165.07 21.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.388 0.675 . . . . 0.0 109.454 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.04 -23.56 47.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.975 0.91 . . . . 0.0 112.385 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -76.43 -3.67 38.33 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.966 -1.084 . . . . 0.0 112.126 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.39 24.61 76.02 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.077 0.846 . . . . 0.0 112.045 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.32 142.25 28.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.32 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.8 -15.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.735 0.814 . . . . 0.0 111.556 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -152.38 145.28 24.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.47 141.79 25.18 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -148.68 140.78 23.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -122.41 123.09 40.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.77 133.24 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -68.06 -7.7 31.54 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.066 0.947 . . . . 0.0 113.309 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.03 122.35 13.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.474 1.11 . . . . 0.0 108.303 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.27 -22.71 64.73 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.905 0.882 . . . . 0.0 113.26 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.1 p -76.21 1.44 15.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.013 0.824 . . . . 0.0 111.91 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.48 156.79 44.19 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.917 2.087 . . . . 0.0 107.531 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.5 157.54 74.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.726 0.81 . . . . 0.0 111.951 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.1 168.88 22.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.798 2.332 . . . . 0.0 110.447 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -108.95 118.0 35.66 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -48.99 -28.13 3.68 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.317 2.247 . . . . 0.0 113.381 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.28 -38.51 83.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.575 0.625 . . . . 0.0 111.17 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.51 -53.18 54.08 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.712 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.72 -25.92 33.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.621 1.548 . . . . 0.0 112.063 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -44.59 95.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 120.255 1.389 . . . . 0.0 109.104 171.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.27 -33.04 74.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.197 0.908 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.31 -53.15 39.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.513 0.325 . . . . 0.0 110.986 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.24 76.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.565 0.746 . . . . 0.0 112.08 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.27 67.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.753 0.706 . . . . 0.0 111.649 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.14 71.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.183 175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.02 -31.39 8.77 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.83 -30.32 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.905 0.775 . . . . 0.0 112.249 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 21.2 pttp . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.495 0.718 . . . . 0.0 110.457 177.527 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.75 169.29 4.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.999 0.428 . . . . 0.0 109.866 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 142.37 29.36 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.155 0.982 . . . . 0.0 108.386 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.0 mt -140.63 171.26 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.281 2.632 . . . . 0.0 103.98 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 p -117.64 148.25 42.12 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 120.989 -1.069 . . . . 0.0 109.826 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -75.58 -18.34 59.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.875 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt 138.55 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 132.089 4.156 . . . . 0.0 109.586 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.17 -5.6 26.58 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.053 0.835 . . . . 0.0 113.586 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.6 47.16 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.2 164.58 35.22 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.609 2.873 . . . . 0.0 112.439 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.73 139.38 46.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.532 1.533 . . . . 0.0 108.266 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -74.52 148.55 40.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.545 0.738 . . . . 0.0 109.502 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.74 146.85 42.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.743 2.417 . . . . 0.0 105.984 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -74.12 -14.16 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 179.86 21.44 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 119.319 0.963 . . . . 0.0 112.888 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -90.89 148.67 22.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.689 0.796 . . . . 0.0 110.043 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.09 141.52 58.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.45 147.39 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -128.44 165.82 19.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.577 0.703 . . . . 0.0 112.12 -168.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -52.63 140.17 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.799 1.64 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.32 63.44 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.655 -1.08 . . . . 0.0 112.955 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.13 157.31 16.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.133 1.467 . . . . 0.0 109.873 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -66.1 134.92 53.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.15 155.47 84.17 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.24 -25.77 73.61 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.21 2.607 . . . . 0.0 115.841 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.9 t70 51.0 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.586 1.954 . . . . 0.0 114.866 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -129.23 -175.19 3.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.516 1.526 . . . . 0.0 109.225 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.1 m -121.41 151.63 39.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 109.957 -169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.68 163.65 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.764 2.426 . . . . 0.0 106.688 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tp -87.35 147.4 25.5 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 169.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.4 p -72.02 166.85 21.39 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -65.41 -4.44 5.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.689 -1.257 . . . . 0.0 111.571 168.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.9 m -114.66 17.04 17.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.157 2.183 . . . . 0.0 111.322 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.5 mt 66.19 41.13 3.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 112.98 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.63 154.77 41.81 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.83 141.0 40.85 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.76 -1.213 . . . . 0.0 108.798 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.06 144.42 33.58 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.074 1.349 . . . . 0.0 107.499 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 p -139.1 166.21 25.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.54 -35.85 70.85 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.471 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.62 -30.7 43.95 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 113.593 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.81 -40.34 33.18 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.647 0.779 . . . . 0.0 110.67 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.8 mtt -63.36 -24.49 67.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.791 1.237 . . . . 0.0 111.31 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.79 -14.59 2.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.49 1.116 . . . . 0.0 113.319 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.55 56.39 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.519 1.054 . . . . 0.0 114.013 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.68 162.48 41.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.256 1.528 . . . . 0.0 108.212 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.07 119.59 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -124.53 131.02 53.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.481 0.313 . . . . 0.0 111.129 -168.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 mt -89.49 143.83 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -126.68 132.91 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.5 m -128.72 88.26 2.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.94 0.896 . . . . 0.0 108.602 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.45 133.95 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.27 73.34 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.56 -60.04 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.028 2.486 . . . . 0.0 113.333 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 m -152.04 164.26 37.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.458 1.903 . . . . 0.0 106.969 -170.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 tp -79.6 -17.87 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.77 -0.582 . . . . 0.0 112.23 -169.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.79 -21.72 54.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.086 -1.008 . . . . 0.0 112.858 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 t -70.6 112.22 6.69 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 0.0 111.191 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.49 -31.32 80.37 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.566 -0.709 . . . . 0.0 112.843 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.23 -15.77 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.464 1.132 . . . . 0.0 112.419 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -105.93 -14.25 15.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.769 0.827 . . . . 0.0 112.336 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.59 -44.03 93.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.736 0.698 . . . . 0.0 109.545 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.41 93.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.424 0.69 . . . . 0.0 111.367 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -58.94 -56.15 25.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.59 0.632 . . . . 0.0 109.483 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.5 m -65.88 -35.59 81.06 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.169 0.895 . . . . 0.0 111.404 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -60.61 -49.65 76.68 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.523 1.056 . . . . 0.0 110.686 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.18 -34.44 76.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.911 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.17 -43.31 74.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.146 1.339 . . . . 0.0 110.915 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.51 -47.75 84.17 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.171 0.441 . . . . 0.0 111.606 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -63.45 -49.23 74.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.915 0.886 . . . . 0.0 109.085 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.04 -38.68 91.67 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.006 0.821 . . . . 0.0 110.591 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.99 97.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.974 0.806 . . . . 0.0 111.26 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.82 88.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.138 0.426 . . . . 0.0 111.103 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.07 -39.69 82.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.795 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.83 -40.69 96.16 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.203 0.911 . . . . 0.0 110.292 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.79 -24.44 12.69 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.624 1.107 . . . . 0.0 112.912 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -148.95 102.91 3.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.341 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.47 171.64 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.262 2.225 . . . . 0.0 105.069 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -128.68 143.04 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 p -153.14 144.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -135.92 158.43 44.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.028 1.331 . . . . 0.0 109.392 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -119.27 148.51 43.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mt -134.31 134.49 54.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.84 158.97 42.04 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.766 0.827 . . . . 0.0 109.881 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.36 41.79 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -129.46 165.75 20.98 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 111.271 -168.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.99 127.38 90.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 126.874 2.069 . . . . 0.0 108.621 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.05 -38.6 32.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.458 2.772 . . . . 0.0 113.94 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.45 -27.96 41.61 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.791 -0.568 . . . . 0.0 112.24 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.72 -42.37 67.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.374 0.988 . . . . 0.0 109.525 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -55.42 -42.92 74.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.176 0.99 . . . . 0.0 111.531 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.62 91.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.015 0.526 . . . . 0.0 111.414 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -66.42 -44.28 83.39 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.709 -0.62 . . . . 0.0 109.546 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -43.13 79.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.708 0.803 . . . . 0.0 111.165 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.46 -35.84 34.32 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.823 0.738 . . . . 0.0 111.048 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.72 98.77 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.61 82.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.498 0.719 . . . . 0.0 111.085 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.57 -10.69 59.79 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.47 30.7 59.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 119.399 0.999 . . . . 0.0 111.008 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.0 mm -67.37 148.65 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.525 1.13 . . . . 0.0 108.117 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -137.69 -38.65 0.58 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 111.585 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -87.69 -22.72 24.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.239 1.016 . . . . 0.0 112.621 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.91 162.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -141.16 143.75 34.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 149.41 21.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 mt -135.48 156.23 49.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.916 1.287 . . . . 0.0 109.15 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -120.94 97.91 5.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.836 1.255 . . . . 0.0 109.181 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.23 -7.25 56.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.04 0.536 . . . . 0.0 110.839 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -43.46 -28.0 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.08 2.552 . . . . 0.0 114.018 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -57.42 -46.07 83.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.938 0.895 . . . . 0.0 111.731 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.98 11.47 0.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.5 mmm 53.55 20.45 2.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.205 . . . . 0.0 114.967 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.4 m -58.36 -44.07 88.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.22 0.918 . . . . 0.0 112.364 -171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -70.64 -46.57 63.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.89 -38.13 84.61 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.55 -50.69 72.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.023 0.911 . . . . 0.0 109.509 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.89 -8.2 57.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.384 0.674 . . . . 0.0 112.449 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.8 45.56 57.49 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.459 1.027 . . . . 0.0 112.029 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.1 25.29 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 110.764 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -116.8 119.18 34.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.36 102.21 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.06 -35.81 36.68 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.936 1.694 . . . . 0.0 111.317 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.01 -14.54 61.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.5 mt -130.83 -21.0 2.77 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 59.79 34.94 22.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.828 0.851 . . . . 0.0 110.028 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.62 154.07 45.68 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.647 1.179 . . . . 0.0 108.361 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.69 157.36 36.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.233 0.54 . . . . 0.0 110.163 172.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.04 -178.69 2.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.41 1.484 . . . . 0.0 110.551 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -106.06 13.39 29.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.793 0.837 . . . . 0.0 111.671 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.7 m -63.05 159.19 17.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.337 1.855 . . . . 0.0 112.886 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.79 149.12 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.631 0.773 . . . . 0.0 109.346 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -137.37 163.0 32.07 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.344 1.058 . . . . 0.0 109.774 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.82 140.94 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.9 mt -131.4 128.07 38.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.62 167.16 17.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.968 0.907 . . . . 0.0 109.86 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.89 -23.93 63.86 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.406 -0.809 . . . . 0.0 112.284 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -75.78 -11.44 59.99 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.731 -1.231 . . . . 0.0 111.827 172.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.93 22.44 71.69 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.146 0.879 . . . . 0.0 112.465 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -82.5 145.58 29.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.39 126.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -101.96 -34.84 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.727 1.611 . . . . 0.0 109.394 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -151.6 143.96 24.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 138.45 22.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.89 143.82 33.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.86 100.63 6.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.328 1.851 . . . . 0.0 106.43 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.55 119.42 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 m -71.06 -8.83 56.11 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -139.85 125.9 19.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.613 1.097 . . . . 0.0 108.311 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.19 70.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.785 0.834 . . . . 0.0 112.406 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 p -82.42 6.22 17.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.221 1.008 . . . . 0.0 112.892 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -120.16 162.32 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.251 1.42 . . . . 0.0 109.197 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -117.56 162.78 26.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.445 1.498 . . . . 0.0 110.106 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.17 -171.46 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.137 2.558 . . . . 0.0 109.918 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -128.68 112.4 14.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -56.58 -28.27 59.85 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.913 1.685 . . . . 0.0 112.897 -169.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.39 -31.87 73.2 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.889 -0.507 . . . . 0.0 111.754 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -61.8 -54.61 49.59 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.843 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.09 -26.95 49.94 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 CA-C-N 120.842 1.336 . . . . 0.0 111.822 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -44.05 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 120.218 1.372 . . . . 0.0 109.948 171.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.78 -32.29 73.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.137 0.88 . . . . 0.0 110.45 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.72 -49.64 57.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.3 0.24 . . . . 0.0 111.586 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.14 72.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.076 0.55 . . . . 0.0 112.018 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.49 64.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.496 0.718 . . . . 0.0 112.657 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.6 mt -111.35 -28.68 8.12 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.96 -11.94 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.3 pttt . . . . . 0 C--O 1.249 1.039 0 C-N-CA 125.864 1.665 . . . . 0.0 108.272 -176.474 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.97 -29.43 70.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 45.59 51.78 9.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.025 1.73 . . . . 0.0 111.456 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.02 145.94 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.026 1.33 . . . . 0.0 108.269 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -115.33 153.41 31.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.309 1.444 . . . . 0.0 109.396 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -110.91 42.6 1.58 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.822 1.249 . . . . 0.0 108.99 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm 42.0 64.65 1.04 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.738 2.015 . . . . 0.0 111.755 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.17 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.658 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 172.11 44.17 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.465 1.031 . . . . 0.0 110.573 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.76 159.75 51.64 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.403 2.735 . . . . 0.0 110.995 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.77 129.61 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.415 1.086 . . . . 0.0 108.386 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -61.74 156.36 20.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.492 1.517 . . . . 0.0 111.131 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.82 133.65 41.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.74 1.616 . . . . 0.0 109.284 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.29 161.52 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.75 -159.01 52.74 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.109 -0.994 . . . . 0.0 111.346 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.05 147.65 52.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.175 1.39 . . . . 0.0 109.205 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -66.13 115.42 6.12 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.3 158.37 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.969 1.307 . . . . 0.0 107.617 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -134.49 159.51 40.91 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 111.048 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.28 142.88 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.124 0.97 . . . . 0.0 108.999 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -22.28 24.43 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.03 1.3 . . . . 0.0 112.367 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -74.5 154.41 38.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.64 1.22 . . . . 0.0 109.839 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -70.14 132.69 46.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.71 158.82 48.74 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.74 -3.84 3.99 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.154 3.236 . . . . 0.0 117.548 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t0 53.64 57.76 5.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.978 1.371 . . . . 0.0 111.791 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -79.47 167.03 21.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.361 1.865 . . . . 0.0 110.26 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -135.03 148.29 49.89 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.33 170.74 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.981 2.112 . . . . 0.0 108.251 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -102.08 143.27 32.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.269 1.028 . . . . 0.0 108.808 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -74.05 -15.75 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 102.84 -14.92 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 130.264 3.426 . . . . 0.0 108.129 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -119.07 22.08 12.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.145 1.778 . . . . 0.0 111.052 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp 61.66 40.31 13.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.882 1.673 . . . . 0.0 111.656 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.88 156.05 43.2 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.42 152.37 19.15 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.381 0.61 . . . . 0.0 109.735 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.91 148.7 32.05 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.427 1.891 . . . . 0.0 106.139 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 p -149.97 171.66 16.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.531 0.605 . . . . 0.0 109.821 -169.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -43.47 -45.81 6.55 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 111.552 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.01 -29.01 66.93 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.963 0.905 . . . . 0.0 112.866 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -39.99 21.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.771 0.828 . . . . 0.0 110.717 174.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt -71.36 -34.87 70.86 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.154 0.582 . . . . 0.0 111.008 -170.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -63.85 -3.48 2.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.67 -21.84 23.31 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.146 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.44 168.26 20.97 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.26 1.53 . . . . 0.0 108.631 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.99 124.42 17.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.9 m -131.68 134.05 45.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.141 0.275 . . . . 0.0 111.11 -168.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.0 mt -93.21 141.1 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -123.48 133.54 68.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -129.34 106.05 8.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.4 127.93 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 pt -137.79 137.49 21.74 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.11 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.967 2.444 . . . . 0.0 114.185 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.3 m -159.45 158.25 31.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.882 1.673 . . . . 0.0 106.92 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -90.1 12.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 122.198 -0.314 . . . . 0.0 111.649 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -118.77 15.69 13.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.109 1.364 . . . . 0.0 110.338 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.42 -11.5 60.87 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.303 1.441 . . . . 0.0 113.395 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 -51.8 4.59 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.57 -22.44 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 118.028 0.914 . . . . 0.0 111.878 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.0 p -49.64 -36.21 23.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.272 1.029 . . . . 0.0 112.278 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.93 -38.32 90.53 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.928 0.891 . . . . 0.0 110.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.52 17.38 3.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.395 1.478 . . . . 0.0 112.003 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -132.16 -79.03 0.5 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.206 1.003 . . . . 0.0 108.338 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -52.9 -53.63 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.903 1.281 . . . . 0.0 112.991 -168.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -79.31 -27.9 42.16 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.172 -0.955 . . . . 0.0 112.126 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -62.51 -43.73 98.1 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.767 1.167 . . . . 0.0 109.689 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -58.43 -37.51 75.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.473 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -59.19 -49.57 77.33 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.566 1.076 . . . . 0.0 111.311 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.68 -47.43 66.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -64.0 -36.14 83.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.346 0.975 . . . . 0.0 111.034 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.13 86.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.868 0.758 . . . . 0.0 111.379 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.94 93.96 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.638 0.654 . . . . 0.0 110.273 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -34.4 78.19 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.609 0.641 . . . . 0.0 111.496 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.29 -22.23 65.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.062 0.846 . . . . 0.0 112.074 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 -43.42 3.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.947 1.26 . . . . 0.0 112.075 174.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.64 117.62 5.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.03 1.332 . . . . 0.0 108.928 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.3 p -158.89 -175.6 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.086 2.154 . . . . 0.0 105.484 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -139.66 138.22 35.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.36 138.87 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -128.81 159.39 35.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 m -126.7 145.92 50.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.95 138.04 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -140.94 152.57 45.1 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 123.51 0.506 . . . . 0.0 111.408 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.99 43.79 0.72 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.679 1.192 . . . . 0.0 108.663 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -131.05 158.7 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.589 1.556 . . . . 0.0 108.925 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.85 134.9 96.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.846 1.258 . . . . 0.0 111.08 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.85 -42.18 6.48 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 124.994 3.796 . . . . 0.0 115.554 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.66 -28.56 60.9 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.11 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.29 70.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.379 0.991 . . . . 0.0 109.419 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.9 -47.31 64.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.919 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.23 70.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.359 0.264 . . . . 0.0 111.364 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -61.76 -45.58 93.27 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.286 0.634 . . . . 0.0 110.789 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.0 -37.88 88.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.896 0.316 . . . . 0.0 110.476 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.2 m -66.84 -41.51 87.3 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.798 -0.564 . . . . 0.0 111.737 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -35.52 92.15 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.34 70.86 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.772 0.786 . . . . 0.0 110.243 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -78.92 -21.52 47.19 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.71 15.42 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.31 144.21 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -145.75 -37.43 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.614 1.166 . . . . 0.0 112.698 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -84.88 -13.37 51.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.559 0.743 . . . . 0.0 112.258 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.03 155.99 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -133.85 124.82 27.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 p -79.47 157.2 27.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.676 0.791 . . . . 0.0 109.339 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.4 mt -144.18 164.57 30.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.785 1.634 . . . . 0.0 108.102 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -118.21 140.98 48.98 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.544 -0.723 . . . . 0.0 109.389 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.54 5.59 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.18 1.792 . . . . 0.0 109.952 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -59.59 -26.72 65.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 111.841 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -60.17 -46.05 91.01 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.961 0.904 . . . . 0.0 111.87 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -156.01 14.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 95.0 mmm 48.12 26.51 1.04 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.849 2.06 . . . . 0.0 113.968 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.39 -50.14 73.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.643 1.177 . . . . 0.0 111.711 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.98 -48.66 75.56 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.145 0.884 . . . . 0.0 109.405 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.34 -47.67 80.88 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.29 -50.15 64.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.255 1.022 . . . . 0.0 109.832 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 7.58 43.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 112.154 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.94 36.57 86.65 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.735 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.7 -13.41 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.553 1.177 . . . . 0.0 111.636 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 104.94 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.78 98.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.36 -34.74 49.0 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.793 1.637 . . . . 0.0 111.108 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.62 -17.08 62.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.7 pp -146.78 16.47 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.962 1.256 . . . . 0.0 114.327 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 48.39 51.13 15.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.197 1.799 . . . . 0.0 111.685 169.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -152.28 150.44 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.1 pp -81.45 156.02 25.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.688 0.676 . . . . 0.0 110.569 175.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.48 -155.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.856 2.062 . . . . 0.0 112.538 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.42 118.3 22.89 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 m -162.06 163.16 28.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -170.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.13 147.79 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.013 0.925 . . . . 0.0 108.685 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -138.68 156.83 47.08 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.064 0.945 . . . . 0.0 108.649 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.0 t -135.2 143.73 36.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.8 mt -128.27 126.21 40.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.939 1.695 . . . . 0.0 108.227 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.59 163.62 25.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.607 1.163 . . . . 0.0 110.154 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.25 -15.52 25.51 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.1 10.57 41.18 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.687 1.131 . . . . 0.0 112.225 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.43 76.99 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.978 . . . . 0.0 112.88 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.91 144.25 25.45 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.294 1.047 . . . . 0.0 108.442 173.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.39 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.65 -16.4 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.728 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -151.68 144.38 24.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.77 139.15 23.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -151.66 137.16 17.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -122.31 122.18 38.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.3 t -72.67 123.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.3 m -61.81 -40.67 96.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.584 0.353 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -83.6 109.55 17.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.943 0.897 . . . . 0.0 109.232 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.98 62.7 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.694 -0.629 . . . . 0.0 111.676 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -71.82 -1.08 12.84 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.084 1.354 . . . . 0.0 113.124 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.78 171.22 13.78 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.58 1.552 . . . . 0.0 110.067 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -128.55 156.84 76.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.518 1.527 . . . . 0.0 109.302 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.64 154.18 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.964 1.776 . . . . 0.0 109.391 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -79.61 116.01 19.56 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -52.43 -24.91 8.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.011 1.725 . . . . 0.0 113.459 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -62.34 -35.48 79.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.807 0.73 . . . . 0.0 111.467 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -64.58 -50.8 63.38 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 121.172 -0.955 . . . . 0.0 112.335 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.29 -25.95 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.075 1.42 . . . . 0.0 111.53 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -44.29 97.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 109.597 171.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.62 -33.28 75.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.325 0.966 . . . . 0.0 111.088 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.85 38.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.338 0.255 . . . . 0.0 110.915 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.29 78.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.232 0.613 . . . . 0.0 112.419 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -29.45 67.61 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.665 0.666 . . . . 0.0 111.709 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.1 68.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.219 0.607 . . . . 0.0 112.256 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.94 -28.66 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.38 -12.41 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.059 0.944 . . . . 0.0 110.087 178.041 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.74 95.18 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.504 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 39.45 55.08 2.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.119 1.768 . . . . 0.0 111.418 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.84 153.45 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.804 2.042 . . . . 0.0 109.095 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -94.45 155.3 17.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.504 1.122 . . . . 0.0 108.407 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -132.59 108.26 8.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt 27.14 56.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.668 2.387 . . . . 0.0 115.253 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.73 -2.2 27.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 117.801 -1.555 . . . . 0.0 115.652 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.51 147.18 18.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 120.578 2.189 . . . . 0.0 111.988 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.78 154.32 67.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.056 2.504 . . . . 0.0 110.651 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.0 145.4 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.553 0.692 . . . . 0.0 110.11 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -79.52 156.88 27.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.919 1.288 . . . . 0.0 111.286 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.62 142.13 51.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.099 1.76 . . . . 0.0 108.843 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.17 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.44 -160.96 22.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.12 146.99 52.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.851 0.86 . . . . 0.0 109.266 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -65.56 113.76 4.42 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -73.06 169.53 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.401 0.546 . . . . 0.0 109.708 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.93 160.85 37.33 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.148 0.979 . . . . 0.0 109.065 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.58 137.8 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.32 -16.14 60.54 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.538 -1.146 . . . . 0.0 112.614 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.36 160.32 24.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.318 1.559 . . . . 0.0 109.941 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -99.92 121.84 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.05 136.95 67.07 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.595 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -58.76 0.51 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.657 1 C-N-CA 126.112 4.541 . . . . 0.0 119.263 -176.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.29 64.88 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.812 1.291 . . . . 0.0 111.447 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -73.62 165.45 25.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.698 1.599 . . . . 0.0 109.929 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.6 m -133.16 149.34 52.07 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.69 162.38 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.759 2.023 . . . . 0.0 106.734 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 tp -88.63 135.86 33.29 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -65.12 162.91 16.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -64.88 -8.52 15.74 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.663 -1.273 . . . . 0.0 111.004 168.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 m -95.27 6.41 49.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.874 2.07 . . . . 0.0 111.696 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.7 mt 70.84 35.88 1.65 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.32 1.448 . . . . 0.0 112.319 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.09 152.34 44.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.52 139.88 40.94 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.763 -1.211 . . . . 0.0 108.968 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -136.95 145.54 44.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.4 p -144.38 170.81 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.165 0.586 . . . . 0.0 109.701 -170.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -46.77 -44.75 19.31 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.374 0.67 . . . . 0.0 110.796 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.19 63.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.817 0.847 . . . . 0.0 113.022 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.31 -41.04 42.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.515 0.726 . . . . 0.0 110.542 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.7 mtt -69.05 -22.73 64.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.214 1.005 . . . . 0.0 111.877 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.08 -16.56 3.04 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.664 1.186 . . . . 0.0 113.291 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.55 53.25 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.763 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -153.13 160.09 42.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.456 1.628 . . . . 0.0 109.15 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.63 120.09 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.1 m -123.56 131.03 53.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.027 0.441 . . . . 0.0 110.639 -168.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.0 mt -89.37 141.58 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.64 137.81 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.7 m -131.31 94.53 3.58 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.86 143.43 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.48 150.02 59.33 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.656 0.783 . . . . 0.0 111.373 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.92 123.35 9.25 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.679 2.253 . . . . 0.0 110.047 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m 48.08 -162.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.471 1.509 . . . . 0.0 113.224 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 tt -148.04 -22.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 120.882 -1.136 . . . . 0.0 111.51 169.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.92 -24.8 67.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.972 -1.08 . . . . 0.0 112.807 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.6 p -73.0 -17.77 61.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.137 1.375 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.04 -53.15 3.75 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.021 1.296 . . . . 0.0 112.805 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.55 -14.5 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.102 0.951 . . . . 0.0 110.457 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 14.3 p -49.56 -31.31 10.15 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.846 1.658 . . . . 0.0 113.449 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.66 130.57 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.578 1.081 . . . . 0.0 113.49 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.85 -6.43 8.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.498 1.919 . . . . 0.0 108.821 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -33.07 23.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.155 0.982 . . . . 0.0 110.803 -170.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 p -53.55 -48.31 69.22 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.071 1.305 . . . . 0.0 112.327 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -39.15 91.88 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.91 0.777 . . . . 0.0 110.959 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -66.76 -45.34 78.87 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.956 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -57.56 -41.34 80.84 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.88 0.764 . . . . 0.0 111.31 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -60.35 -50.87 71.9 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.653 0.781 . . . . 0.0 110.471 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.02 -41.63 77.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -67.86 -36.19 79.85 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.86 96.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.956 0.798 . . . . 0.0 110.884 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.07 93.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.925 0.33 . . . . 0.0 111.125 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -65.91 -40.98 91.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.43 -40.2 95.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.51 1.05 . . . . 0.0 110.25 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.3 10.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.818 1.199 . . . . 0.0 112.002 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -152.68 112.0 3.86 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.557 1.143 . . . . 0.0 109.121 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.86 176.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.405 2.282 . . . . 0.0 105.275 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -134.5 141.07 46.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.07 141.46 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -134.08 153.24 51.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.817 0.847 . . . . 0.0 109.917 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -108.58 146.67 32.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.23 135.0 57.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 m -131.36 152.51 50.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.307 1.043 . . . . 0.0 109.652 -170.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.37 52.24 1.02 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -140.08 165.06 28.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.98 145.96 96.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 123.268 0.627 . . . . 0.0 110.249 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.27 -32.07 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.623 2.215 . . . . 0.0 112.766 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -79.28 -22.13 45.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.199 0.909 . . . . 0.0 112.212 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.61 53.44 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.173 -0.955 . . . . 0.0 108.718 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -51.36 -56.42 13.24 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.31 1.044 . . . . 0.0 110.492 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.15 -42.32 80.78 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.787 0.835 . . . . 0.0 111.843 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.0 -44.81 62.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -63.97 -39.62 94.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.976 0.511 . . . . 0.0 111.134 -176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.49 -36.29 57.89 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.212 -1.555 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.19 93.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.85 -45.37 82.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.646 0.778 . . . . 0.0 110.537 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -68.4 -24.09 64.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.521 0.728 . . . . 0.0 111.683 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.24 25.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.527 1.06 . . . . 0.0 111.837 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.18 142.87 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.152 0.981 . . . . 0.0 108.435 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -143.6 -44.31 0.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.485 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.67 -11.81 59.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.027 0.931 . . . . 0.0 111.941 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.49 160.94 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -140.6 145.8 37.16 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 p -89.68 139.49 30.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.905 1.682 . . . . 0.0 109.799 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 mt -131.14 168.91 16.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.615 1.966 . . . . 0.0 109.354 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.38 105.95 11.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.686 1.194 . . . . 0.0 111.683 -168.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -72.71 -21.94 60.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -52.57 -14.3 0.49 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.839 2.056 . . . . 0.0 113.121 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -45.91 -57.33 4.45 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.944 1.297 . . . . 0.0 110.821 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -164.59 16.49 0.05 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.2 mmm 55.86 26.35 9.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.761 1.624 . . . . 0.0 111.039 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -38.12 82.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.116 0.966 . . . . 0.0 113.018 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -74.06 -42.47 60.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.106 1.321 . . . . 0.0 108.907 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -41.64 -60.13 2.56 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.396 1.95 . . . . 0.0 111.884 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.8 -39.66 69.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.242 1.017 . . . . 0.0 110.473 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.63 95.42 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.23 0.612 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.43 9.25 37.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 113.208 -169.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.3 37.69 86.6 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.118 0.872 . . . . 0.0 111.972 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.54 3.92 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.56 1.144 . . . . 0.0 112.588 -173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -83.19 108.45 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.532 1.515 . . . . 0.0 107.183 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.91 111.56 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -55.4 -53.55 54.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.176 1.79 . . . . 0.0 111.406 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.79 -29.05 55.87 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.499 0.32 . . . . 0.0 111.255 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -79.5 -22.18 44.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.974 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 56.44 36.28 27.29 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -168.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -135.22 154.73 51.49 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.934 0.894 . . . . 0.0 109.745 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.36 142.69 52.11 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.458 0.703 . . . . 0.0 109.382 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.39 -168.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.801 1.64 . . . . 0.0 111.387 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -127.3 127.8 44.92 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -170.18 170.98 7.07 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.763 1.625 . . . . 0.0 106.968 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.6 145.12 30.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -137.46 156.79 47.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.328 1.051 . . . . 0.0 108.635 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 t -134.74 140.36 45.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.2 mt -129.07 126.39 39.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.434 1.494 . . . . 0.0 107.448 -169.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.94 167.73 9.23 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 109.147 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.12 -21.88 35.64 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.178 -0.951 . . . . 0.0 112.587 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -81.73 -7.5 59.6 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.594 -1.316 . . . . 0.0 112.543 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.03 16.77 80.46 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 120.872 -1.142 . . . . 0.0 112.133 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -77.79 133.66 38.18 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.12 110.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.55 -36.2 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.058 1.343 . . . . 0.0 109.687 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -151.47 145.22 25.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.05 133.6 18.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.99 137.07 22.07 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -104.8 117.21 33.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.9 127.96 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -69.76 -6.21 30.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -140.94 115.9 9.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 120.299 1.409 . . . . 0.0 107.475 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.61 69.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 -24.21 66.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.394 0.678 . . . . 0.0 111.113 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -100.82 126.31 47.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.169 1.388 . . . . 0.0 108.047 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -72.64 149.51 90.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.09 162.12 43.03 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.547 3.498 . . . . 0.0 109.596 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -96.36 120.38 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -55.98 -28.07 55.52 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.337 1.455 . . . . 0.0 112.703 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.16 -34.17 74.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.441 0.564 . . . . 0.0 111.426 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -65.06 -54.46 33.7 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 118.875 0.762 . . . . 0.0 111.692 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -30.44 24.05 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.486 1.458 . . . . 0.0 111.894 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 mm -54.43 -50.14 59.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 119.599 1.091 . . . . 0.0 109.523 169.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.32 -30.5 71.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.672 0.669 . . . . 0.0 111.494 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.09 71.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.164 0.438 . . . . 0.0 111.72 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.8 -45.55 57.91 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.452 0.701 . . . . 0.0 111.824 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -28.79 64.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.45 0.7 . . . . 0.0 111.56 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 -29.33 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 112.534 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 mt -103.63 -29.12 11.3 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.55 -10.64 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.094 0.957 . . . . 0.0 110.144 177.34 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.24 68.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.331 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 45.78 65.34 1.17 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.355 1.862 . . . . 0.0 111.346 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 99.2 mt -54.85 156.73 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.733 1.613 . . . . 0.0 108.817 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.17 128.32 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.907 1.283 . . . . 0.0 108.177 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -84.68 42.58 0.92 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 110.268 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt 38.23 60.29 1.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.885 2.074 . . . . 0.0 112.337 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.75 -24.63 0.14 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.761 0.696 . . . . 0.0 111.646 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.35 169.05 40.58 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.94 155.3 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.144 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 m -136.54 166.37 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 107.949 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.9 m -117.18 161.05 20.08 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.033 0.933 . . . . 0.0 108.971 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 mt -125.54 141.98 51.75 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.852 1.661 . . . . 0.0 106.986 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.43 -65.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.25 165.72 54.77 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.49 165.29 24.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.708 0.766 . . . . 0.0 110.658 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.19 117.52 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.5 t -76.54 154.53 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -130.49 163.85 26.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 121.453 -0.779 . . . . 0.0 110.007 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.51 144.89 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.81 78.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.864 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -118.5 154.84 31.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.911 1.355 . . . . 0.0 108.814 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -65.87 134.86 53.93 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.51 159.24 61.74 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.732 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.23 -29.81 58.72 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.71 2.94 . . . . 0.0 115.845 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t0 46.72 86.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.258 1.823 . . . . 0.0 114.117 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -127.36 -172.79 2.74 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.284 1.433 . . . . 0.0 108.843 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.0 m -120.58 151.65 39.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.679 1.192 . . . . 0.0 110.461 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.61 165.06 27.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.723 2.409 . . . . 0.0 106.85 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.07 135.78 33.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -67.09 162.94 21.15 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.14 -10.41 49.94 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.488 -1.383 . . . . 0.0 110.816 168.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -82.1 3.38 27.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.578 1.951 . . . . 0.0 111.43 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.3 mt 68.44 30.93 5.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.897 2.079 . . . . 0.0 112.211 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.58 140.39 48.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.01 140.41 49.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.325 1.05 . . . . 0.0 111.456 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -141.68 143.48 33.61 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 126.094 1.757 . . . . 0.0 106.823 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -130.99 160.05 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tt -56.88 -33.92 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.257 0.481 . . . . 0.0 110.927 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.45 -29.62 50.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.092 0.957 . . . . 0.0 113.393 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -78.39 -40.34 36.45 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.125 0.97 . . . . 0.0 110.444 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.1 mtt -63.03 -27.29 69.31 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.953 1.301 . . . . 0.0 111.49 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -55.28 -15.46 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.058 . . . . 0.0 113.071 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.77 46.01 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.654 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 46' ' ' VAL . 9.8 tppt? -149.78 155.99 41.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.688 1.744 . . . . 0.0 110.299 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.419 ' H ' ' HD3' ' A' ' 45' ' ' LYS . 99.2 t -56.2 118.18 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.6 m -119.8 148.76 43.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.018 0.527 . . . . 0.0 110.029 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.22 146.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.12 138.57 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -113.17 99.63 7.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.518 1.527 . . . . 0.0 108.088 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.85 125.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 pt -133.55 155.3 80.73 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.281 1.032 . . . . 0.0 109.004 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.57 -58.1 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.95 2.433 . . . . 0.0 111.858 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.3 m -153.04 157.8 41.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.454 1.901 . . . . 0.0 106.732 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.07 -5.7 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.303 0.956 . . . . 0.0 111.52 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.9 -3.24 43.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.417 1.087 . . . . 0.0 112.623 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.3 p -64.29 -16.9 63.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -49.91 3.88 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.398 0.999 . . . . 0.0 111.089 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.72 -8.91 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.328 1.064 . . . . 0.0 112.239 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.3 p -55.21 -36.95 66.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.269 1.027 . . . . 0.0 108.953 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.56 -45.66 91.93 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.506 1.123 . . . . 0.0 111.177 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.61 -0.27 3.77 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 112.489 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -122.84 -87.74 0.63 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -48.89 -49.48 39.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.359 1.864 . . . . 0.0 113.532 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -72.44 -40.83 66.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.66 -1.275 . . . . 0.0 110.723 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.83 -38.48 91.12 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.061 -0.399 . . . . 0.0 110.342 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -60.22 -34.75 74.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.576 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -60.77 -50.29 74.07 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 120.094 1.315 . . . . 0.0 111.114 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.91 -42.59 76.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.302 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.35 -36.56 84.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.904 1.229 . . . . 0.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.56 -21.81 65.43 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.652 -0.655 . . . . 0.0 112.223 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.05 44.48 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.939 0.79 . . . . 0.0 111.194 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -72.19 -41.95 66.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.266 0.626 . . . . 0.0 110.143 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.19 137.22 58.15 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -36.27 80.19 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.765 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.75 79.08 0.86 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.49 1.145 . . . . 0.0 110.162 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.52 171.34 18.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.077 0.951 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -136.68 145.55 44.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.188 1.795 . . . . 0.0 106.802 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.26 151.67 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.306 -0.871 . . . . 0.0 109.749 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -135.42 170.72 15.51 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.513 1.525 . . . . 0.0 109.736 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.8 m -134.85 148.71 50.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.63 137.89 54.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -136.77 153.77 50.74 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.792 0.837 . . . . 0.0 111.427 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.8 46.15 1.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.413 1.485 . . . . 0.0 107.842 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -140.07 170.33 16.04 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.352 1.461 . . . . 0.0 107.863 -168.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.07 144.32 62.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 123.677 0.791 . . . . 0.0 111.181 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.04 -31.13 76.5 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.402 2.068 . . . . 0.0 112.896 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -71.55 -28.94 64.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.727 1.149 . . . . 0.0 111.387 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.09 74.54 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.043 0.838 . . . . 0.0 108.877 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.35 -46.51 69.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.513 0.725 . . . . 0.0 110.93 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.62 51.09 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.23 0.612 . . . . 0.0 111.211 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.12 -34.19 75.9 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.933 -0.479 . . . . 0.0 111.068 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -63.4 -42.5 98.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.124 0.42 . . . . 0.0 110.126 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.1 m -65.12 -42.9 93.47 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 121.77 -0.581 . . . . 0.0 111.37 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.31 98.85 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.33 86.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.571 0.748 . . . . 0.0 110.599 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.06 -24.86 51.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.127 0.571 . . . . 0.0 112.376 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 32.46 22.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.845 0.735 . . . . 0.0 111.432 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.08 144.64 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.8 -34.8 0.23 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.393 1.077 . . . . 0.0 112.677 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -79.21 -16.35 56.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.685 0.794 . . . . 0.0 111.952 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.19 159.1 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.05 134.74 40.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -92.84 145.59 24.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.632 0.773 . . . . 0.0 109.433 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 mt -136.66 166.04 24.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.936 1.695 . . . . 0.0 107.815 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 m -136.91 133.03 35.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.037 0.935 . . . . 0.0 109.352 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.23 -3.95 8.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.499 0.72 . . . . 0.0 112.14 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -57.22 -25.01 58.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.682 -1.261 . . . . 0.0 112.262 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -69.39 -25.11 63.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.272 1.029 . . . . 0.0 112.9 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.71 -19.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mmt 54.15 -0.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.144 2.978 . . . . 0.0 117.582 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 p -59.0 -36.78 75.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.501 1.501 . . . . 0.0 112.614 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.61 -56.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.022 0.529 . . . . 0.0 109.579 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.88 65.65 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.44 -53.65 55.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.467 0.707 . . . . 0.0 109.145 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.37 -31.0 57.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.154 -0.451 . . . . 0.0 112.17 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -4.0 27.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.567 0.621 . . . . 0.0 112.256 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 48.04 52.79 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 119.084 0.856 . . . . 0.0 111.283 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.89 -14.46 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.828 0.851 . . . . 0.0 111.383 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -72.93 111.86 8.43 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.54 112.13 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -54.26 -38.02 65.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.554 1.542 . . . . 0.0 111.425 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.62 -6.28 58.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.583 0.753 . . . . 0.0 112.638 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.7 mt -131.94 -21.24 2.43 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.038 0.935 . . . . 0.0 112.779 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 52.7 42.41 31.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.395 1.078 . . . . 0.0 109.313 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -135.19 153.22 52.03 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.218 1.407 . . . . 0.0 107.714 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.2 mt -84.06 141.94 30.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.327 0.512 . . . . 0.0 110.712 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.59 141.03 57.97 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.702 1.201 . . . . 0.0 109.806 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -68.36 109.09 3.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 p -154.77 165.06 37.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.878 0.763 . . . . 0.0 110.977 -169.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.27 153.52 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.79 156.45 46.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.359 1.063 . . . . 0.0 109.222 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.4 t -131.32 143.25 41.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 38.4 mt -135.2 126.4 28.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.736 1.615 . . . . 0.0 107.697 -169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.78 165.63 23.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.641 0.776 . . . . 0.0 109.085 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.14 -17.16 57.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.261 -0.899 . . . . 0.0 112.764 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -78.04 -11.45 59.91 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.537 -1.352 . . . . 0.0 112.236 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.03 75.87 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.009 -1.057 . . . . 0.0 112.645 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.93 139.28 37.14 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.89 134.26 30.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.48 -29.03 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.632 1.573 . . . . 0.0 109.254 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -155.08 146.28 22.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.61 1.564 . . . . 0.0 106.842 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.61 143.31 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.403 1.081 . . . . 0.0 108.463 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -149.93 146.5 27.09 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.848 1.659 . . . . 0.0 107.099 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -128.71 -15.34 4.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.561 1.545 . . . . 0.0 112.392 -169.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t 50.25 106.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 129.078 2.951 . . . . 0.0 113.093 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -59.14 -28.66 66.77 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.136 0.974 . . . . 0.0 112.797 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.67 105.94 17.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.1 62.4 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.9 p -73.68 -13.29 60.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.433 1.893 . . . . 0.0 112.904 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -109.87 156.45 20.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.557 1.543 . . . . 0.0 109.397 -169.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -106.8 153.46 40.76 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.373 0.669 . . . . 0.0 110.109 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.84 151.47 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.354 2.036 . . . . 0.0 109.488 171.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -82.04 119.39 23.94 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -54.05 -25.61 22.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.783 1.633 . . . . 0.0 112.878 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -60.59 -35.64 76.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.681 0.673 . . . . 0.0 111.138 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.82 -53.32 50.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.529 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.9 -27.8 43.09 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.951 1.375 . . . . 0.0 112.214 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.22 -46.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 120.695 1.588 . . . . 0.0 109.82 172.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.43 -33.77 76.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.907 0.776 . . . . 0.0 110.679 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.66 68.32 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.675 0.274 . . . . 0.0 111.149 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.38 -48.7 66.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.982 0.513 . . . . 0.0 110.795 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -29.05 69.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.746 0.703 . . . . 0.0 111.643 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.88 -31.7 71.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.579 0.627 . . . . 0.0 111.568 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.8 mt -88.29 -24.6 23.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.89 0.876 . . . . 0.0 112.054 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.4 -27.93 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.966 171.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.034 0.934 . . . . 0.0 110.746 176.548 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 118.923 -0.561 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.94 156.65 44.5 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 108.044 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.9 144.6 22.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.32 148.64 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 p -92.87 153.11 19.01 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.601 1.091 . . . . 0.0 110.307 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -112.46 41.31 2.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.091 1.356 . . . . 0.0 108.622 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 44.11 62.99 1.77 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.769 2.028 . . . . 0.0 112.3 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.04 -25.63 0.16 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.55 1.071 . . . . 0.0 110.922 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.49 173.89 45.71 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.979 1.276 . . . . 0.0 110.108 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.56 157.61 58.34 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.157 2.572 . . . . 0.0 111.004 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.47 136.99 48.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.644 1.578 . . . . 0.0 107.471 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -74.32 154.78 38.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.763 1.225 . . . . 0.0 109.878 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.72 138.68 54.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.055 1.742 . . . . 0.0 106.549 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.71 -173.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.9 -152.83 51.73 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 123.266 0.46 . . . . 0.0 112.967 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -132.23 155.42 48.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.479 1.111 . . . . 0.0 109.697 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.12 154.41 37.8 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 168.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.13 152.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -126.37 157.31 38.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.62 1.168 . . . . 0.0 110.264 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.24 142.71 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.609 1.163 . . . . 0.0 109.377 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.17 -19.44 46.53 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.811 1.196 . . . . 0.0 111.878 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -74.94 149.26 39.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.396 1.098 . . . . 0.0 109.599 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -73.08 120.29 18.51 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 155.26 73.71 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.306 0.242 . . . . 0.0 110.768 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.17 -19.02 15.18 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 125.295 3.997 . . . . 0.0 118.501 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 55.03 65.24 1.55 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.924 1.345 . . . . 0.0 110.692 -168.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -71.58 168.33 17.85 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 110.071 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -131.06 149.21 52.71 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.48 167.43 14.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 125.825 1.65 . . . . 0.0 106.696 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 tp -86.05 147.28 26.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.1 p -72.57 172.0 11.39 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.684 -1.26 . . . . 0.0 107.701 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -67.26 -3.31 7.57 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.835 -1.166 . . . . 0.0 111.498 168.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.1 m -118.58 17.63 13.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.968 2.107 . . . . 0.0 111.276 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 63.86 43.73 5.24 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.402 1.481 . . . . 0.0 112.449 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.87 154.22 45.73 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 142.97 39.04 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.749 -1.219 . . . . 0.0 109.21 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.77 147.47 35.58 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.601 1.56 . . . . 0.0 107.05 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 p -143.06 165.9 26.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.997 0.919 . . . . 0.0 109.175 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.8 -34.49 67.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.354 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.58 -31.24 56.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.021 0.828 . . . . 0.0 112.975 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.87 -35.98 37.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.958 0.903 . . . . 0.0 111.426 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.8 mtt -78.9 -34.97 44.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.936 0.895 . . . . 0.0 112.111 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.77 -3.48 3.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -18.14 23.65 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 118.916 -0.936 . . . . 0.0 112.03 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -139.57 164.61 29.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.109 1.455 . . . . 0.0 109.138 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.51 128.29 20.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.1 m -130.45 136.77 49.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.3 mt -100.29 142.21 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.8 mm -120.33 129.01 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.9 m -124.97 98.59 5.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.418 1.087 . . . . 0.0 108.455 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.14 135.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.58 155.5 75.24 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.476 1.51 . . . . 0.0 107.929 172.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.99 -51.97 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.673 1.582 . . . . 0.0 110.76 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.25 158.88 42.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.258 1.423 . . . . 0.0 107.869 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.7 tt -106.79 29.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.114 0.966 . . . . 0.0 112.317 -168.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -134.79 16.44 3.58 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.814 0.845 . . . . 0.0 110.422 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.8 p -81.91 -9.43 59.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.225 1.01 . . . . 0.0 112.544 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.14 -50.08 3.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -25.64 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.165 0.982 . . . . 0.0 110.853 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -49.48 -33.83 15.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.449 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.87 -43.61 94.61 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.116 0.967 . . . . 0.0 111.497 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.25 6.29 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.736 1.214 . . . . 0.0 113.023 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.84 -77.82 0.58 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -54.2 -46.61 72.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -65.55 -41.97 92.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.213 0.915 . . . . 0.0 110.13 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -81.1 -25.71 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.999 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -63.36 -38.1 89.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.263 0.938 . . . . 0.0 109.726 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -61.35 -43.16 99.34 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.943 0.792 . . . . 0.0 111.147 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.83 -56.35 16.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.77 -30.69 70.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.297 -0.877 . . . . 0.0 111.87 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.24 89.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.15 0.886 . . . . 0.0 111.088 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.76 80.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.555 0.616 . . . . 0.0 110.664 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -41.25 90.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.091 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.97 -39.63 90.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.571 0.748 . . . . 0.0 110.2 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.95 -27.73 8.7 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.628 1.108 . . . . 0.0 112.048 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -151.62 118.4 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.49 172.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.1 -176.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.622 1.969 . . . . 0.0 105.749 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -138.81 136.03 35.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.59 145.63 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 152.19 51.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.586 0.754 . . . . 0.0 109.977 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.4 m -104.53 146.0 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.3 mt -129.28 132.95 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 m -134.57 149.63 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.577 1.151 . . . . 0.0 109.768 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.66 55.31 2.94 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.03 160.39 40.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.056 1.342 . . . . 0.0 108.098 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.29 146.51 92.2 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.262 -169.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.8 -44.04 43.34 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.269 2.646 . . . . 0.0 112.858 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -77.23 -28.26 53.65 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.754 -0.591 . . . . 0.0 111.855 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.27 83.31 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.128 0.876 . . . . 0.0 109.996 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -69.83 -46.43 65.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.252 0.621 . . . . 0.0 111.507 173.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.94 77.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.439 0.563 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -50.22 74.53 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.703 1.201 . . . . 0.0 108.769 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -45.51 81.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.505 0.322 . . . . 0.0 110.159 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.0 m -64.28 -44.72 90.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.219 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.28 -37.02 90.54 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.15 80.56 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.842 0.821 . . . . 0.0 110.635 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -79.35 -33.08 43.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.162 0.585 . . . . 0.0 111.985 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 37.81 8.86 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.02 144.59 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.77 -37.58 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.694 1.197 . . . . 0.0 112.486 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.71 -16.2 42.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.558 0.743 . . . . 0.0 112.318 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.61 159.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -134.05 140.14 46.46 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.9 p -96.63 145.55 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.0 mt -134.9 158.28 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.29 113.65 22.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.914 1.686 . . . . 0.0 108.346 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.32 10.8 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.839 0.828 . . . . 0.0 111.651 170.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.21 -16.25 5.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.327 1.451 . . . . 0.0 111.214 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.4 ttt-85 -68.43 69.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.945 1.698 . . . . 0.0 109.508 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 46.17 41.15 8.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.284 1.834 . . . . 0.0 113.85 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.9 mmm 50.04 32.02 5.4 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.231 1.812 . . . . 0.0 113.601 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.7 m -53.71 -49.72 67.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.975 0.91 . . . . 0.0 111.751 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -72.03 -43.72 64.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.893 0.77 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.46 92.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.101 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.37 -47.46 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.013 0.907 . . . . 0.0 109.9 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.18 75.58 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.66 4.65 38.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.264 1.026 . . . . 0.0 112.265 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.05 49.5 77.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.482 1.039 . . . . 0.0 113.616 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.16 -12.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.58 1.552 . . . . 0.0 111.251 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.73 113.63 5.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 169.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.4 mt -75.36 109.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.68 -41.53 55.81 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.658 1.983 . . . . 0.0 111.28 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.8 2.45 53.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.489 -171.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.54 -25.13 3.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.088 0.858 . . . . 0.0 113.311 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 56.06 33.89 22.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.592 0.633 . . . . 0.0 109.884 -168.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.38 164.6 20.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.651 1.58 . . . . 0.0 107.107 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.73 147.58 24.73 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.156 0.503 . . . . 0.0 110.127 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.88 145.26 46.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.411 1.484 . . . . 0.0 110.637 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -79.19 102.57 8.58 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 71.1 m -149.77 168.47 23.59 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.751 1.22 . . . . 0.0 108.46 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.39 149.81 17.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.982 -0.449 . . . . 0.0 109.798 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.6 157.17 45.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.283 1.033 . . . . 0.0 108.692 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -137.93 138.64 43.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.52 133.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.504 1.522 . . . . 0.0 107.408 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.1 176.69 3.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.872 0.869 . . . . 0.0 110.591 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.24 9.57 0.31 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.783 1.233 . . . . 0.0 114.243 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -127.6 4.77 6.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.875 1.67 . . . . 0.0 110.219 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.86 77.98 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.973 0.806 . . . . 0.0 112.553 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -87.4 136.84 32.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 119.452 1.626 . . . . 0.0 107.274 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.74 126.94 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.57 -19.84 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.464 0.705 . . . . 0.0 110.46 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -154.33 144.89 22.3 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.84 140.07 24.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.828 1.651 . . . . 0.0 107.168 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -152.23 147.33 26.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.306 0.503 . . . . 0.0 109.658 171.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.58 104.83 7.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.848 2.059 . . . . 0.0 105.633 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.22 133.61 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -73.39 -13.66 61.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -138.11 113.85 9.78 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.03 68.11 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 p -74.28 -0.66 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.31 0.959 . . . . 0.0 113.155 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.09 167.21 17.87 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.454 1.101 . . . . 0.0 108.957 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -117.88 157.14 49.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.472 0.709 . . . . 0.0 112.263 -168.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.67 152.27 78.13 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.618 2.212 . . . . 0.0 108.783 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -78.79 117.39 19.87 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -56.36 -20.97 21.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.499 1.519 . . . . 0.0 113.279 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.08 -36.62 82.25 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.054 0.843 . . . . 0.0 111.424 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -61.33 -52.62 69.41 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 119.327 0.967 . . . . 0.0 111.945 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.78 -27.86 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 120.797 1.32 . . . . 0.0 111.766 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -45.04 93.78 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 120.11 1.323 . . . . 0.0 109.731 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.19 -35.71 81.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.872 0.76 . . . . 0.0 110.652 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.38 79.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.401 0.143 . . . . 0.0 111.053 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.72 -50.12 46.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.736 0.415 . . . . 0.0 111.2 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -34.11 70.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.679 0.672 . . . . 0.0 111.157 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.33 67.19 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.361 0.528 . . . . 0.0 112.018 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.34 -23.74 16.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 50.2 t -57.13 -36.17 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.583 0.629 . . . . 0.0 110.495 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.717 1.207 . . . . 0.0 110.88 175.654 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.79 160.35 30.04 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.541 1.137 . . . . 0.0 109.674 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -147.04 164.9 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.912 2.885 . . . . 0.0 104.575 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.8 mt -132.73 168.99 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 p -115.93 148.17 40.33 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.88 -1.138 . . . . 0.0 109.011 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -91.69 37.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 63.25 -41.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.876 2.871 . . . . 0.0 114.204 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.79 -31.12 41.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.319 0.961 . . . . 0.0 112.477 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 173.73 46.46 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.234 1.017 . . . . 0.0 111.245 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.6 152.13 50.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 124.0 3.133 . . . . 0.0 113.718 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.51 127.58 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.507 1.923 . . . . 0.0 107.133 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -70.08 153.71 42.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.516 1.526 . . . . 0.0 110.634 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.07 140.42 44.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.42 1.488 . . . . 0.0 108.459 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.13 -16.82 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.42 162.15 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -173.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.89 160.04 33.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.74 0.781 . . . . 0.0 110.442 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 pm0 -74.17 136.96 42.87 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 168.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.53 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -133.66 161.62 34.15 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.271 -0.893 . . . . 0.0 110.427 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.14 140.93 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.87 32.78 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.797 -1.001 . . . . 0.0 112.862 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -70.51 155.54 40.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.179 1.49 . . . . 0.0 109.235 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -76.34 127.55 33.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 158.84 57.92 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.563 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -54.86 -14.95 8.85 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.432 3.421 . . . . 0.0 117.867 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 52.78 56.94 6.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 123.103 1.43 . . . . 0.0 110.169 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -83.26 170.95 14.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.928 2.091 . . . . 0.0 111.32 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 m -131.8 149.22 52.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.823 1.249 . . . . 0.0 107.653 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.89 170.87 10.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.703 2.001 . . . . 0.0 106.956 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tp -87.13 142.6 27.8 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -69.58 166.6 18.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.14 -6.64 18.56 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.634 -1.291 . . . . 0.0 110.897 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -100.24 8.64 43.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.055 2.142 . . . . 0.0 111.688 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.0 mt 68.15 39.52 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.404 1.482 . . . . 0.0 112.688 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -127.48 157.76 39.22 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.31 142.76 48.84 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 120.896 -1.127 . . . . 0.0 108.962 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.9 142.63 33.08 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -135.45 165.18 26.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.902 0.881 . . . . 0.0 108.656 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -53.97 -33.16 56.18 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.38 -0.343 . . . . 0.0 111.465 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.71 -33.56 61.2 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.42 -35.46 70.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.4 mtt -78.81 -29.69 44.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.386 1.474 . . . . 0.0 111.882 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -55.8 -14.86 2.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.635 1.574 . . . . 0.0 114.619 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.39 -17.41 32.24 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.604 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -151.17 157.54 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.26 1.53 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.66 126.51 13.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 46.8 m -118.89 151.66 37.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.424 0.69 . . . . 0.0 109.832 -169.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.7 mt -123.86 146.67 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 mm -130.18 110.66 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.631 1.572 . . . . 0.0 107.398 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 140.32 45.37 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.97 122.15 64.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.65 153.63 68.23 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.56 -57.09 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 111.301 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -146.28 142.5 28.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.556 1.942 . . . . 0.0 105.991 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.6 tt -77.33 -22.79 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -168.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.92 -18.67 62.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.8 p -66.54 149.78 49.95 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.861 0.755 . . . . 0.0 109.643 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.44 -37.41 92.01 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.901 -0.5 . . . . 0.0 111.898 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.46 -43.09 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 117.9 0.85 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -62.42 -42.71 99.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.891 0.769 . . . . 0.0 110.671 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.94 -56.23 24.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.664 1.186 . . . . 0.0 110.84 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.85 79.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.92 0.488 . . . . 0.0 112.248 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -57.17 10.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 173.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -62.46 -44.67 95.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.846 0.748 . . . . 0.0 111.948 -170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -76.66 -37.57 56.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.194 1.361 . . . . 0.0 112.859 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -62.3 -43.18 99.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.045 0.839 . . . . 0.0 108.878 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.21 -35.36 76.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.944 -0.551 . . . . 0.0 112.003 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.38 -42.91 96.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.575 1.08 . . . . 0.0 112.263 173.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.76 -42.97 99.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 64.6 mm-40 -61.46 -39.08 89.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.864 1.211 . . . . 0.0 111.448 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.63 78.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.444 0.566 . . . . 0.0 111.092 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.37 83.07 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.941 0.791 . . . . 0.0 111.478 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -65.13 -39.46 93.07 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.459 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.7 -49.72 69.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 109.785 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 -61.91 2.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.967 1.746 . . . . 0.0 112.032 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -83.79 55.28 3.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.547 1.539 . . . . 0.0 110.72 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.14 169.91 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.191 1.396 . . . . 0.0 107.778 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -130.15 137.82 50.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.1 t -144.86 145.29 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.177 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -138.16 171.72 13.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.918 1.287 . . . . 0.0 109.689 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 m -132.8 144.42 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.42 1.888 . . . . 0.0 105.905 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -131.47 133.32 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -135.19 152.79 51.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.331 1.052 . . . . 0.0 109.539 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.46 45.12 1.16 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -129.62 164.94 22.78 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 -168.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.9 137.38 96.0 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.49 -42.71 48.0 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.091 2.528 . . . . 0.0 112.196 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -73.31 -32.24 64.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.621 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.39 -43.55 90.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.409 1.004 . . . . 0.0 109.802 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.05 -48.55 79.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.013 1.325 . . . . 0.0 111.908 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.8 86.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.751 0.705 . . . . 0.0 111.158 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -45.64 93.72 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.318 1.047 . . . . 0.0 108.953 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 85.8 t90 -64.69 -40.71 95.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.336 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 m -61.14 -43.66 98.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.606 0.639 . . . . 0.0 110.885 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.15 86.47 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.358 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.21 92.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.061 0.931 . . . . 0.0 110.629 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.96 -13.32 19.16 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.24 37.61 41.78 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.62 143.14 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.952 1.301 . . . . 0.0 108.207 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -139.35 -25.87 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -117.74 -5.04 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.431 1.092 . . . . 0.0 111.984 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.23 158.5 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -143.59 135.6 26.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 p -96.67 142.75 28.33 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.278 1.031 . . . . 0.0 108.358 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.97 150.21 45.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.528 1.531 . . . . 0.0 108.471 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -107.62 106.79 17.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 111.025 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.35 -11.34 59.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 109.843 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -48.64 -28.22 3.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.633 1.173 . . . . 0.0 111.58 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.98 88.11 1.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.075 1.35 . . . . 0.0 110.787 170.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.5 t70 65.03 14.48 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.059 1.744 . . . . 0.0 115.433 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp 44.34 30.7 0.49 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.016 2.527 . . . . 0.0 115.064 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.24 -46.86 88.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.439 0.696 . . . . 0.0 111.38 -173.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -66.32 -50.38 63.81 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -39.18 96.18 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 123.059 0.361 . . . . 0.0 112.202 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.47 -53.6 27.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.711 0.804 . . . . 0.0 109.978 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.08 67.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.93 56.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.597 1.159 . . . . 0.0 111.851 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.06 49.68 65.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.826 0.727 . . . . 0.0 113.296 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -123.4 -11.17 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.867 1.267 . . . . 0.0 111.012 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 108.05 3.72 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 98.4 mt -74.7 115.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.1 -47.54 82.38 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.448 1.099 . . . . 0.0 111.229 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.65 13.93 2.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.122 0.874 . . . . 0.0 113.237 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 40.14 53.82 2.77 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.204 2.201 . . . . 0.0 113.689 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 tp -145.96 169.55 18.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.113 0.965 . . . . 0.0 108.681 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.07 137.25 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.087 0.555 . . . . 0.0 109.984 -173.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.49 149.22 49.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.987 1.315 . . . . 0.0 111.156 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -81.05 115.9 20.73 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 70.8 m -162.18 171.19 17.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.747 1.219 . . . . 0.0 108.825 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.19 144.4 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.501 -0.749 . . . . 0.0 109.622 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -132.66 153.16 51.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.811 0.695 . . . . 0.0 110.479 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.63 134.27 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -125.39 132.57 52.76 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.108 1.363 . . . . 0.0 107.979 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.0 166.0 22.26 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.371 1.068 . . . . 0.0 109.747 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.36 -26.89 43.84 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.382 1.073 . . . . 0.0 112.394 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.61 -0.43 23.35 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.042 -1.036 . . . . 0.0 112.115 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 28.19 73.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.036 0.827 . . . . 0.0 111.887 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.33 147.33 26.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.321 1.06 . . . . 0.0 108.28 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.1 t -71.72 138.15 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.73 -35.66 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.909 1.684 . . . . 0.0 109.419 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -150.18 142.94 24.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 144.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.78 148.51 27.31 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.422 ' CE1' ' HB2' ' A' ' 17' ' ' GLU . 63.8 m-85 -132.0 98.61 4.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.468 2.307 . . . . 0.0 105.982 -169.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.42 131.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -67.79 -15.64 63.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.992 0.917 . . . . 0.0 113.183 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -126.28 118.14 24.49 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.44 69.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.22 0.608 . . . . 0.0 111.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.6 p -68.93 -12.71 61.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.568 1.547 . . . . 0.0 112.679 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -116.64 161.26 19.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.866 1.666 . . . . 0.0 108.674 -170.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -121.94 153.15 60.5 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.776 0.83 . . . . 0.0 110.297 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.85 150.68 55.94 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.666 1.577 . . . . 0.0 108.301 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.19 115.98 20.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -66.7 -8.77 30.2 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.93 -32.05 71.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.997 0.817 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.18 -53.15 34.23 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.306 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.01 -30.43 25.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.494 1.569 . . . . 0.0 111.564 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.94 -51.47 53.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 119.191 0.905 . . . . 0.0 109.44 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.98 -28.97 70.17 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 111.545 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.88 -49.37 46.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.113 0.565 . . . . 0.0 111.427 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.62 65.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.236 0.614 . . . . 0.0 111.192 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -32.54 65.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.49 0.716 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.73 76.52 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.359 0.664 . . . . 0.0 111.316 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.6 mt -79.57 -44.75 20.5 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.216 0.462 . . . . 0.0 110.96 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -84.48 14.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.249 1.069 0 O-C-N 121.53 -0.731 . . . . 0.0 109.583 169.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.79 71.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.109 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.95 48.44 15.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.39 1.876 . . . . 0.0 111.815 171.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.85 147.27 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.768 0.827 . . . . 0.0 109.085 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.3 p -116.08 167.4 11.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.945 1.698 . . . . 0.0 109.135 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -135.8 95.08 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 40.76 33.42 0.2 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.584 2.354 . . . . 0.0 115.921 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.31 -23.96 0.27 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.418 -1.212 . . . . 0.0 114.777 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.78 169.49 40.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.778 1.789 . . . . 0.0 113.006 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.31 154.01 65.91 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.898 3.065 . . . . 0.0 111.831 -173.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.11 128.06 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.274 1.03 . . . . 0.0 108.835 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -61.7 156.31 20.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.48 1.512 . . . . 0.0 111.275 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.7 mt -125.68 141.4 52.03 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.586 1.954 . . . . 0.0 106.942 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.27 -65.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.3 -170.25 46.93 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.269 0.937 . . . . 0.0 112.276 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -108.96 150.19 28.09 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.1 0.96 . . . . 0.0 110.796 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.61 121.22 12.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.96 167.71 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.5 155.93 49.52 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.477 -0.764 . . . . 0.0 109.558 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.44 136.18 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 170.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.95 -18.5 57.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.013 1.292 . . . . 0.0 111.943 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -76.99 157.02 31.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.73 1.265 . . . . 0.0 109.537 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -81.26 126.67 31.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.85 93.67 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.262 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -55.16 -30.27 70.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.36 2.707 . . . . 0.0 116.031 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 50.71 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.391 1.877 . . . . 0.0 113.728 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.35 178.1 6.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.907 1.283 . . . . 0.0 109.616 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -108.1 152.42 24.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.25 1.02 . . . . 0.0 109.564 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -141.61 171.33 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.583 2.353 . . . . 0.0 107.315 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.95 155.68 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.0 p -71.16 -158.35 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.653 1.181 . . . . 0.0 109.366 169.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -72.33 0.14 10.81 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.353 -1.467 . . . . 0.0 113.054 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -126.54 -88.72 0.57 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.508 1.049 . . . . 0.0 108.627 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -157.56 -3.88 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.346 1.858 . . . . 0.0 112.405 -169.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.38 138.35 32.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -72.9 138.88 46.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -137.27 149.26 46.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.999 1.72 . . . . 0.0 106.534 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -137.67 160.2 39.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.97 -30.39 67.89 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.967 -0.458 . . . . 0.0 111.861 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -28.04 68.4 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.832 0.853 . . . . 0.0 112.816 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -75.72 -36.31 59.99 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.487 0.715 . . . . 0.0 110.425 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.8 mtt -73.96 -36.48 64.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -65.67 0.83 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.35 -16.38 20.5 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.005 -1.059 . . . . 0.0 112.73 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -141.02 167.63 21.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.112 1.456 . . . . 0.0 108.263 169.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.47 128.97 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.9 m -131.68 151.36 51.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.409 0.284 . . . . 0.0 110.888 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.4 mt -113.82 139.02 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.45 126.02 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -118.96 98.34 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 0.0 108.745 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 m -74.89 136.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 155.9 80.42 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 169.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.04 -54.92 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.676 2.251 . . . . 0.0 111.775 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -157.37 149.45 22.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.45 -15.72 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.43 -0.793 . . . . 0.0 111.266 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.64 -16.46 61.01 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.166 -0.959 . . . . 0.0 113.289 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.6 p -61.37 -23.8 66.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.716 1.144 . . . . 0.0 114.024 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -42.47 2.16 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.315 0.96 . . . . 0.0 111.436 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.04 -24.54 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.884 1.273 . . . . 0.0 110.421 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 24.1 p -47.48 -32.27 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.257 1.423 . . . . 0.0 113.009 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.6 -33.49 70.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 125.353 1.461 . . . . 0.0 112.253 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.03 -17.4 57.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.271 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -108.57 -80.12 0.58 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.1 m -54.15 -43.39 70.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.529 1.132 . . . . 0.0 113.624 -168.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -63.06 -53.33 55.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.514 0.597 . . . . 0.0 109.596 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -69.54 -36.16 76.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.78 -172.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -59.22 -36.91 76.26 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.88 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -60.18 -46.06 91.0 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.863 1.21 . . . . 0.0 110.477 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.68 -51.34 57.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.56 -38.54 87.86 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 121.285 -0.884 . . . . 0.0 110.94 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.97 -37.37 86.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.888 0.767 . . . . 0.0 111.309 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.83 95.62 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.685 0.675 . . . . 0.0 110.643 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -38.75 83.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.586 0.63 . . . . 0.0 111.367 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.48 -33.33 73.59 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.862 0.865 . . . . 0.0 110.538 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.28 -35.06 3.5 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.81 1.195 . . . . 0.0 111.859 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.48 116.76 5.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.666 1.187 . . . . 0.0 109.207 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.0 p -159.19 -174.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 127.476 2.31 . . . . 0.0 105.409 173.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -138.85 134.2 33.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -141.39 140.43 31.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 108.7 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.18 159.8 37.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.279 1.032 . . . . 0.0 109.899 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.0 m -122.12 142.8 50.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.52 141.13 46.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.0 t -143.71 155.18 44.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 110.499 -169.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 9.78 41.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.26 177.91 8.31 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -84.82 147.1 47.71 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 123.968 0.907 . . . . 0.0 110.201 -169.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.63 -45.36 27.87 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.858 3.038 . . . . 0.0 113.698 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -67.0 -29.72 69.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.518 -0.739 . . . . 0.0 112.311 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.98 72.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.312 0.96 . . . . 0.0 109.657 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -52.88 -51.36 61.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.559 0.743 . . . . 0.0 109.658 170.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.93 74.81 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 111.164 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -62.75 -45.94 90.35 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.566 0.747 . . . . 0.0 110.25 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -63.48 -43.95 95.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.655 0.382 . . . . 0.0 110.854 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -70.16 -37.87 75.3 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.744 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.52 -38.08 94.38 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.3 79.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.627 0.771 . . . . 0.0 110.216 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -70.74 -31.8 68.75 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.657 0.783 . . . . 0.0 112.694 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.14 35.78 23.06 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.25 144.18 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.53 -35.26 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.699 1.199 . . . . 0.0 112.602 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.66 -10.41 51.39 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.605 0.762 . . . . 0.0 112.471 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.9 159.83 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.72 149.94 52.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 140.09 48.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.797 0.839 . . . . 0.0 110.228 -169.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.3 mt -138.74 163.81 31.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.468 1.507 . . . . 0.0 109.07 -169.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.34 136.15 36.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.099 0.56 . . . . 0.0 109.516 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -122.67 -5.46 8.65 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.603 0.761 . . . . 0.0 111.679 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -57.68 -19.5 27.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -54.46 -43.02 71.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 111.23 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.84 -1.79 0.3 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.394 0.678 . . . . 0.0 112.664 -171.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 64.1 mmm 47.04 28.44 0.9 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.771 2.428 . . . . 0.0 113.601 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -44.81 92.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 111.149 -171.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.84 -46.59 57.51 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -37.19 87.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -46.26 90.69 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.769 -0.842 . . . . 0.0 109.245 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.56 79.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.89 1.71 16.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.643 0.777 . . . . 0.0 112.481 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.79 90.23 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.982 1.265 . . . . 0.0 112.553 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 m -124.91 -2.16 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.116 1.366 . . . . 0.0 111.397 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -79.56 105.99 11.27 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.26 101.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -51.69 -42.23 62.03 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.333 1.453 . . . . 0.0 111.441 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.6 -10.81 60.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -122.61 -17.73 6.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.187 0.995 . . . . 0.0 112.069 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.19 38.13 26.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.048 -168.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 157.27 43.95 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.471 1.108 . . . . 0.0 108.592 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.4 tp -77.79 148.65 34.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.122 0.969 . . . . 0.0 109.279 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.2 -175.06 4.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.492 . . . . 0.0 111.458 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.7 ttm105 -121.73 111.93 17.77 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 m -157.69 169.55 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.483 1.913 . . . . 0.0 106.94 -170.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.35 144.57 18.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -134.18 157.64 45.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.715 1.206 . . . . 0.0 108.542 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.75 134.63 53.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.76 132.16 53.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.941 1.296 . . . . 0.0 108.07 -173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.45 167.52 10.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.601 1.561 . . . . 0.0 109.592 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -58.54 -21.17 51.65 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.449 -0.782 . . . . 0.0 113.024 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -86.9 -0.17 56.05 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.297 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.56 23.29 78.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.04 -1.037 . . . . 0.0 112.299 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -88.14 141.28 28.69 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.826 1.313 . . . . 0.0 107.518 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.3 t -68.57 116.86 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.74 -33.97 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.827 1.251 . . . . 0.0 109.275 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -158.96 146.35 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.32 144.15 27.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -145.52 136.99 25.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -128.6 121.28 28.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.53 135.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -67.79 -5.89 18.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.778 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -147.41 118.8 7.87 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.49 63.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.111 0.964 . . . . 0.0 113.549 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 10.12 20.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.881 1.272 . . . . 0.0 110.414 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -127.77 178.3 6.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.55 2.34 . . . . 0.0 108.132 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -138.3 152.15 70.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 120.623 -1.298 . . . . 0.0 112.147 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.63 149.55 18.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.687 2.258 . . . . 0.0 108.951 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -74.71 115.84 14.73 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -51.73 -26.53 9.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.032 1.733 . . . . 0.0 112.922 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -61.7 -31.31 71.45 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.646 -0.659 . . . . 0.0 111.882 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -48.04 10.63 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.741 1.155 . . . . 0.0 112.07 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.01 -30.65 32.07 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 121.315 1.505 . . . . 0.0 111.646 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.3 mm -55.36 -50.17 67.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.313 0.961 . . . . 0.0 109.42 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.12 -32.73 73.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.39 0.541 . . . . 0.0 111.364 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.01 69.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.097 0.559 . . . . 0.0 111.512 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.13 -46.52 56.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.522 0.729 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -26.22 62.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.783 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.07 65.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.287 1.035 . . . . 0.0 113.175 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.27 -26.96 6.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.15 -13.41 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.184 1.794 . . . . 0.0 108.123 -175.934 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.09 86.03 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 119.089 -0.481 . . . . 0.0 112.282 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 41.84 47.0 3.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.4 1.88 . . . . 0.0 112.049 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.0 126.1 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 109.131 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.0 p -76.99 161.87 28.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.444 0.64 . . . . 0.0 110.105 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -116.97 38.93 3.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.153 0.981 . . . . 0.0 109.552 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm 41.83 63.91 1.2 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.596 1.959 . . . . 0.0 111.571 -171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.1 -28.18 0.11 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.239 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.54 170.46 42.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.618 1.104 . . . . 0.0 110.534 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.9 158.52 55.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.739 2.959 . . . . 0.0 110.761 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.47 142.28 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -67.51 157.08 35.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.513 1.525 . . . . 0.0 110.359 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.466 ' HA ' ' H ' ' A' ' 122' ' ' LYS . 4.6 mp -135.18 144.94 47.28 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.911 1.284 . . . . 0.0 107.771 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -82.44 147.91 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.44 -157.15 19.45 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -132.62 161.3 34.26 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.93 115.24 5.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 168.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -83.4 151.44 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -132.67 155.05 49.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.883 0.873 . . . . 0.0 109.888 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.43 141.02 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.049 0.94 . . . . 0.0 109.289 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.55 -21.64 31.54 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.943 1.259 . . . . 0.0 112.175 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.67 152.79 40.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.73 1.265 . . . . 0.0 109.771 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -70.81 126.79 30.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 152.41 73.79 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.152 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.77 -29.0 60.26 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.224 2.616 . . . . 0.0 115.482 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.6 t0 51.9 85.91 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.913 2.085 . . . . 0.0 113.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.37 172.34 12.83 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 110.642 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -87.04 158.99 19.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.771 1.628 . . . . 0.0 110.366 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 p -151.87 159.31 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.043 2.537 . . . . 0.0 105.639 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tp -90.54 145.99 24.44 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.548 -1.345 . . . . 0.0 108.018 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -74.35 165.66 24.81 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.056 -1.028 . . . . 0.0 108.395 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -66.67 -6.61 16.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.871 -1.143 . . . . 0.0 111.368 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -93.54 3.7 55.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.39 1.876 . . . . 0.0 111.893 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp 62.81 44.74 6.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.195 1.398 . . . . 0.0 111.817 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.49 160.76 29.64 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.68 1.192 . . . . 0.0 107.785 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -78.31 142.08 38.01 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.844 -1.16 . . . . 0.0 109.753 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -139.15 163.52 32.22 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.161 1.784 . . . . 0.0 106.55 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 p -151.68 169.22 22.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.969 -1.082 . . . . 0.0 108.51 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.73 -27.6 59.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.512 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -28.64 62.32 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.01 -41.42 35.9 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.361 0.664 . . . . 0.0 109.834 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.4 mtt -65.45 -40.63 93.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.966 0.906 . . . . 0.0 109.105 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -71.1 -0.89 10.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.67 . . . . 0.0 112.381 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.16 -15.72 59.02 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.837 -1.165 . . . . 0.0 111.97 169.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -147.94 168.96 20.93 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.899 1.349 . . . . 0.0 108.428 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.97 120.9 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 168.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -130.14 153.89 48.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 123.156 0.285 . . . . 0.0 110.763 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.03 142.18 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.1 mm -127.85 113.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -112.94 98.44 7.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.141 0.976 . . . . 0.0 109.007 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.41 140.71 15.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.33 -0.857 . . . . 0.0 108.872 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.85 156.03 72.88 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.839 1.256 . . . . 0.0 108.491 169.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.81 -50.03 12.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.644 2.229 . . . . 0.0 112.498 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -160.44 164.62 32.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.936 2.494 . . . . 0.0 106.295 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 tt -98.3 -23.79 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.56 0.618 . . . . 0.0 111.564 -169.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -82.91 54.44 2.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.862 1.265 . . . . 0.0 110.387 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -154.99 -178.15 7.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.184 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.95 179.5 31.24 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.38 0.991 . . . . 0.0 112.271 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.285 19.5 m 53.25 -6.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 129.339 3.055 . . . . 0.0 116.832 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.8 m -65.27 -22.7 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.59 -1.319 . . . . 0.0 110.896 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.27 -31.76 67.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.666 -0.647 . . . . 0.0 111.233 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.46 -58.2 2.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.892 0.769 . . . . 0.0 109.778 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.29 -15.78 63.7 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -128.89 -54.17 1.22 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.79 1.177 . . . . 0.0 110.074 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.97 -52.31 13.24 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.771 1.169 . . . . 0.0 111.556 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.55 79.41 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.388 0.995 . . . . 0.0 109.605 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -44.21 71.9 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.336 0.516 . . . . 0.0 111.67 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.02 -44.08 93.67 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.619 0.767 . . . . 0.0 111.836 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.35 -49.48 77.42 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -64.27 -39.47 94.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.094 0.861 . . . . 0.0 110.863 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.974 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.25 -33.55 69.92 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.427 1.012 . . . . 0.0 110.775 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -68.84 -40.08 79.59 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 109.346 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.24 -50.43 74.03 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.25 -0.21 60.02 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.769 1.176 . . . . 0.0 114.286 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.92 65.51 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.133 1.373 . . . . 0.0 108.668 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.96 167.7 4.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.024 1.33 . . . . 0.0 107.593 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -120.49 144.44 48.01 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.4 147.08 14.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.954 -1.091 . . . . 0.0 109.748 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -134.13 162.81 31.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.703 1.601 . . . . 0.0 109.417 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -127.84 149.26 50.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.89 136.5 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 m -139.37 158.64 43.8 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.47 48.99 1.43 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -132.4 165.33 24.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.55 1.54 . . . . 0.0 108.889 -169.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.96 136.18 96.69 Favored Pre-proline 0 C--O 1.236 0.387 0 C-N-CA 123.826 0.851 . . . . 0.0 109.826 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.37 -42.8 46.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.352 2.702 . . . . 0.0 112.277 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -73.68 -31.58 63.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.523 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.9 75.05 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.358 0.981 . . . . 0.0 108.993 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -57.7 -42.89 84.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.125 0.97 . . . . 0.0 112.572 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.48 85.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.031 0.832 . . . . 0.0 111.264 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.26 -42.33 93.37 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.306 0.643 . . . . 0.0 109.725 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -60.4 -40.23 90.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.24 0.616 . . . . 0.0 110.527 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -65.23 -47.09 78.02 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.007 -0.433 . . . . 0.0 111.173 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.08 96.84 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.21 97.25 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.744 0.818 . . . . 0.0 110.702 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -85.39 -19.75 30.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 112.702 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.86 38.18 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 mm -64.33 142.81 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -144.91 -37.83 0.28 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.05 0.94 . . . . 0.0 112.652 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -80.81 -25.85 37.54 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.393 0.677 . . . . 0.0 111.226 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.8 157.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.827 1.251 . . . . 0.0 107.668 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -138.06 138.82 39.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 p -95.65 148.19 22.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.5 1.12 . . . . 0.0 108.205 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -137.93 140.19 40.17 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.655 1.182 . . . . 0.0 108.648 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -102.29 105.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.6 1.16 . . . . 0.0 110.06 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.34 -4.47 55.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.754 169.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -51.56 -41.36 61.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.737 1.215 . . . . 0.0 111.589 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.2 -44.76 44.64 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.645 0.778 . . . . 0.0 111.424 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.59 -36.15 11.36 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 55.12 -19.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.719 3.208 . . . . 0.0 115.759 -169.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -59.46 -33.0 70.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.371 1.441 . . . . 0.0 112.678 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -67.54 -54.65 18.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.989 0.813 . . . . 0.0 108.942 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -36.71 73.03 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -32.05 71.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.332 1.053 . . . . 0.0 110.822 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.93 -44.11 10.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.615 0.643 . . . . 0.0 112.319 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.17 13.49 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.57 93.22 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.563 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.77 -10.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.47 1.135 . . . . 0.0 112.149 -168.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -82.11 116.37 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.8 mt -79.6 97.47 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.466 ' H ' ' HA ' ' A' ' 13' ' ' LEU . 57.6 tttm -44.68 -55.64 5.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 126.615 1.966 . . . . 0.0 111.869 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -86.11 -11.54 52.4 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 mt -83.54 -21.74 32.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.943 0.792 . . . . 0.0 109.525 168.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 58.36 32.06 21.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.915 1.286 . . . . 0.0 109.354 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.79 154.17 51.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 108.516 -177.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.3 tp -77.37 152.17 34.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.168 0.987 . . . . 0.0 109.778 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 -174.44 5.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.31 1.044 . . . . 0.0 111.258 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -116.43 127.04 54.25 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -167.43 175.15 7.39 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.51 1.924 . . . . 0.0 107.128 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.15 145.92 14.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -137.7 158.41 44.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.859 1.264 . . . . 0.0 109.345 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.26 144.71 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -131.54 128.75 39.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.634 1.573 . . . . 0.0 108.149 -169.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.25 163.43 27.84 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 109.011 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.21 -17.53 42.1 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -81.42 -4.96 57.33 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.296 -1.502 . . . . 0.0 112.378 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.93 27.64 66.3 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.317 -0.865 . . . . 0.0 111.698 -172.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.36 144.11 27.44 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.33 135.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.2 -32.92 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.416 1.486 . . . . 0.0 109.614 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -150.12 144.85 25.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 139.84 24.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -148.22 149.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -125.85 142.83 51.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.348 1.859 . . . . 0.0 106.214 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.96 -10.51 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m 62.99 -21.99 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.241 2.216 . . . . 0.0 115.626 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -143.63 123.97 13.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.218 1.372 . . . . 0.0 107.505 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.05 -18.38 46.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.9 p -77.63 -3.96 43.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.227 0.921 . . . . 0.0 112.905 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 163.11 25.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.402 1.001 . . . . 0.0 110.048 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -118.54 155.97 51.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.632 -170.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.15 155.04 47.19 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 108.2 -1.5 . . . . 0.0 108.2 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -84.65 114.0 21.69 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -49.1 -26.07 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.009 2.124 . . . . 0.0 113.508 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.8 -37.57 82.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.877 0.762 . . . . 0.0 111.242 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -63.98 -51.92 60.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.617 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.59 -27.3 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.806 1.67 . . . . 0.0 112.233 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -59.82 -45.63 94.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-N 120.22 1.373 . . . . 0.0 109.246 171.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.91 -32.85 74.52 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.885 0.766 . . . . 0.0 111.021 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.25 56.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.611 0.364 . . . . 0.0 111.103 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.61 -46.87 71.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.135 0.574 . . . . 0.0 111.639 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -29.1 67.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.72 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.28 77.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.317 0.508 . . . . 0.0 111.696 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.72 -35.65 19.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.439 0.563 . . . . 0.0 112.401 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.91 -9.32 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.736 0.814 . . . . 0.0 110.18 176.257 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.943 -0.021 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.27 158.45 26.25 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.39 141.09 35.61 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 85.1 mt -137.59 169.66 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 150.49 31.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -143.08 121.84 12.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.61 37.61 3.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.344 1.458 . . . . 0.0 113.166 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.28 12.05 60.39 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.196 -1.336 . . . . 0.0 114.628 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.06 154.43 23.9 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.954 1.877 . . . . 0.0 110.955 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.0 153.93 63.02 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.653 2.236 . . . . 0.0 111.344 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -139.04 129.2 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.526 1.53 . . . . 0.0 108.286 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -74.54 160.39 30.97 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.197 1.399 . . . . 0.0 109.244 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.54 148.91 51.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 108.944 175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 t -82.36 135.26 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.0 -158.28 14.44 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 118.38 0.536 . . . . 0.0 112.785 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -131.62 143.88 50.65 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.316 1.447 . . . . 0.0 108.666 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.86 103.0 7.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.84 157.09 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 108.832 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -127.71 156.5 42.29 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.991 1.316 . . . . 0.0 109.357 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.72 140.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.13 59.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.6 1.095 . . . . 0.0 112.756 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.78 156.8 37.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.32 1.56 . . . . 0.0 109.582 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.37 139.65 32.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.63 159.34 74.82 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -60.4 -7.06 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.449 3.432 . . . . 0.0 117.8 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 52.4 58.58 5.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.833 1.302 . . . . 0.0 110.823 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -85.69 165.78 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.034 1.734 . . . . 0.0 109.712 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -130.9 146.12 52.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.988 1.315 . . . . 0.0 107.514 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.87 168.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.581 1.952 . . . . 0.0 107.235 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.68 146.67 26.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.0 p -74.42 167.11 22.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -63.89 -8.02 9.91 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.062 -1.023 . . . . 0.0 111.656 168.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -109.72 13.9 23.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.836 2.054 . . . . 0.0 111.251 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 64.59 44.99 3.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.167 1.387 . . . . 0.0 111.978 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.14 161.53 29.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.58 144.13 35.82 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.62 -1.3 . . . . 0.0 108.895 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -142.67 145.83 33.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 m -140.37 167.28 22.51 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.671 0.788 . . . . 0.0 109.556 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 tp -47.22 -40.53 16.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.193 0.997 . . . . 0.0 111.958 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.97 -30.95 62.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.72 0.808 . . . . 0.0 113.084 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.55 -40.59 42.02 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.464 0.65 . . . . 0.0 110.577 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.8 mtt -65.34 -27.04 68.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.706 1.202 . . . . 0.0 111.346 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -55.42 -16.08 3.3 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 113.414 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.8 -20.37 56.91 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.845 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -154.47 156.45 36.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.443 1.621 . . . . 0.0 109.0 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.24 122.04 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.7 m -117.2 150.81 38.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 109.975 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.8 mt -121.89 145.64 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.2 mt -126.54 138.94 53.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.23 93.83 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.242 1.817 . . . . 0.0 106.823 -171.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.45 128.32 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 pt -139.27 154.45 72.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.11 -46.49 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 CA-C-N 121.098 1.428 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 p -158.73 173.98 15.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.614 1.966 . . . . 0.0 107.762 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tt -113.58 -177.67 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.802 0.841 . . . . 0.0 110.635 -169.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 56.3 43.81 25.78 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.24 1.416 . . . . 0.0 112.894 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -147.27 138.43 23.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -45.55 -46.34 12.37 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.191 1.376 . . . . 0.0 114.56 -169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.21 -25.59 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.434 1.094 . . . . 0.0 112.598 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.46 -40.59 7.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.925 1.69 . . . . 0.0 110.099 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.92 -49.76 74.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 127.15 2.18 . . . . 0.0 110.693 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.31 88.31 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.948 0.499 . . . . 0.0 111.348 -174.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -61.36 2.63 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.7 m -64.33 -39.07 93.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.337 0.517 . . . . 0.0 111.163 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.89 -50.37 69.02 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.219 -0.926 . . . . 0.0 110.253 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.86 -33.59 75.05 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.602 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.31 -39.68 73.12 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 120.142 1.337 . . . . 0.0 112.16 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.94 -48.91 79.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.601 1.091 . . . . 0.0 110.874 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -67.6 -44.09 78.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -63.3 -37.82 88.73 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.03 -1.044 . . . . 0.0 110.819 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.6 92.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.622 -0.674 . . . . 0.0 111.041 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.06 88.6 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.788 0.722 . . . . 0.0 111.227 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -67.66 -40.09 84.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.694 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.7 mp -60.9 -45.41 94.73 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.852 0.751 . . . . 0.0 109.842 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.59 -9.83 61.04 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.961 1.267 . . . . 0.0 114.842 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -153.62 58.66 0.75 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.042 1.421 . . . . 0.0 109.492 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.43 171.9 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.783 1.233 . . . . 0.0 107.789 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.97 141.61 50.74 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 t -138.05 151.95 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.188 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.28 169.69 16.83 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.984 1.314 . . . . 0.0 109.703 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -132.75 143.85 49.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.98 133.88 60.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 m -139.48 158.57 43.91 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.57 1.169 . . . . 0.0 110.879 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.5 54.22 2.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 168.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.43 163.95 31.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 108.244 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.65 135.86 85.89 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -169.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.16 -36.68 79.7 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.986 1.791 . . . . 0.0 110.714 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -75.2 -27.71 59.71 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.776 -0.63 . . . . 0.0 112.101 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.72 71.29 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.52 1.055 . . . . 0.0 108.964 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -60.18 -41.61 93.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.826 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.97 92.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.63 0.65 . . . . 0.0 111.007 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -67.55 -39.25 84.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.174 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 74.9 t90 -69.25 -45.13 70.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.207 0.603 . . . . 0.0 110.934 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -69.76 -33.73 72.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.824 -1.173 . . . . 0.0 110.353 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -33.69 87.92 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.037 -0.868 . . . . 0.0 112.402 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.74 93.41 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.705 1.253 . . . . 0.0 110.206 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -72.83 -27.71 62.11 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.123 0.569 . . . . 0.0 111.968 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.14 53.41 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mt -68.37 145.8 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.263 1.025 . . . . 0.0 108.499 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.89 -34.93 0.42 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.069 1.348 . . . . 0.0 111.976 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.33 -13.62 59.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.645 0.778 . . . . 0.0 111.927 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.16 155.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -134.21 130.81 37.76 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -84.46 151.55 24.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.101 0.56 . . . . 0.0 109.62 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 mt -143.09 150.27 39.29 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.505 1.522 . . . . 0.0 107.255 -173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.4 m -116.01 115.39 26.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.652 1.181 . . . . 0.0 108.505 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.26 -9.7 55.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.581 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.39 -36.42 6.44 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.049 2.139 . . . . 0.0 114.259 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -78.57 -13.39 59.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.891 -173.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -147.64 -16.19 0.37 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -169.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.1 mmm 51.93 9.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.462 2.705 . . . . 0.0 117.213 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.7 m -63.15 -38.25 90.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.751 1.614 . . . . 0.0 112.525 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -64.71 -50.53 66.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.128 1.331 . . . . 0.0 108.952 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.48 97.73 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 -172.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.464 0.706 . . . . 0.0 109.814 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.581 -0.7 . . . . 0.0 111.847 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.57 1.02 40.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.691 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.1 90.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.873 1.215 . . . . 0.0 112.862 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.9 -7.37 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.743 1.217 . . . . 0.0 111.352 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.75 108.3 5.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.058 1.299 . . . . 0.0 107.942 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.86 112.71 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -57.32 -38.09 73.51 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.519 1.527 . . . . 0.0 110.887 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.58 8.51 40.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.965 0.906 . . . . 0.0 112.149 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.66 -23.87 2.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 55.58 37.35 28.76 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 110.037 -168.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.9 mt -130.72 161.15 32.31 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.125 1.37 . . . . 0.0 108.092 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.6 mt -83.27 143.35 30.46 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.14 152.01 41.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 111.01 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -80.7 100.61 8.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 62.0 m -147.97 167.25 25.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.328 1.451 . . . . 0.0 109.417 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 m -141.0 153.41 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.469 -0.769 . . . . 0.0 110.515 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.69 157.12 44.99 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.539 1.136 . . . . 0.0 109.619 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.49 139.51 48.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -133.24 119.49 19.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 107.618 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.01 163.85 21.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.56 0.744 . . . . 0.0 109.528 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.2 -23.33 21.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.078 1.351 . . . . 0.0 112.811 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -76.06 -6.49 51.33 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.805 -1.184 . . . . 0.0 112.377 175.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.17 42.61 35.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -121.46 132.09 54.53 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.81 112.78 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -171.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.28 -33.76 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.692 1.197 . . . . 0.0 109.355 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -154.99 147.04 23.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.839 1.256 . . . . 0.0 108.363 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.33 31.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.776 1.23 . . . . 0.0 107.837 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.1 137.59 21.0 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.886 0.874 . . . . 0.0 108.794 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -131.33 93.97 3.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 105.355 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.54 132.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 m -67.79 -9.67 46.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 113.074 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.15 110.51 11.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.74 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.885 0.874 . . . . 0.0 110.925 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.46 6.02 6.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 112.627 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -122.88 173.24 7.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.196 2.199 . . . . 0.0 107.033 170.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.57 157.44 73.08 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 120.936 -1.103 . . . . 0.0 111.543 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.17 -179.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.742 3.628 . . . . 0.0 113.594 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -124.77 111.7 15.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -52.25 -25.07 8.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.69 1.996 . . . . 0.0 112.948 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.67 -38.04 80.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.995 0.816 . . . . 0.0 111.383 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -60.28 -56.09 38.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.892 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.9 -26.96 31.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.49 1.46 . . . . 0.0 112.059 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -44.38 94.89 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.654 1.57 . . . . 0.0 109.638 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.53 -34.52 78.43 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.16 0.891 . . . . 0.0 110.713 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.57 -49.06 70.23 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.5 0.19 . . . . 0.0 111.258 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.14 -49.4 61.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.026 0.53 . . . . 0.0 111.128 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -33.82 69.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.759 0.708 . . . . 0.0 111.355 -176.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.35 -31.37 69.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.446 0.566 . . . . 0.0 111.784 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.7 mt -89.61 -24.41 21.68 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.698 0.799 . . . . 0.0 112.155 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.91 -32.73 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.483 0.583 . . . . 0.0 110.519 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.183 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.18 171.61 10.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.06 140.21 30.83 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 95.5 mt -133.94 170.8 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.16 151.31 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -133.73 113.33 12.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.74 -50.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.877 2.871 . . . . 0.0 115.529 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 17.35 0.06 OUTLIER Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.818 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.75 27.48 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.577 1.689 . . . . 0.0 110.979 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.63 157.69 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.048 2.499 . . . . 0.0 111.874 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.55 124.97 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.144 1.778 . . . . 0.0 107.479 171.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -73.98 158.09 35.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.476 1.51 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -132.47 136.81 46.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 123.987 0.915 . . . . 0.0 108.889 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.35 127.31 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.55 -167.56 18.94 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 121.415 0.453 . . . . 0.0 112.697 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -109.0 141.6 40.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 108.264 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.25 107.96 10.02 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.08 152.96 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.2 157.49 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 109.881 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -57.4 141.07 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.715 0.806 . . . . 0.0 108.923 175.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -24.23 17.6 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.748 1.166 . . . . 0.0 112.257 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.82 158.85 34.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.295 1.547 . . . . 0.0 110.299 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -76.25 136.49 39.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 153.98 89.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.789 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.28 -28.12 70.09 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.86 3.04 . . . . 0.0 115.907 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.05 80.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.775 1.63 . . . . 0.0 113.756 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -126.09 -172.31 2.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.514 1.526 . . . . 0.0 109.806 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 m -125.17 156.04 39.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.107 . . . . 0.0 110.527 -168.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -141.62 178.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 129.193 2.997 . . . . 0.0 106.604 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.87 149.17 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.0 p -69.29 170.23 10.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.177 -0.952 . . . . 0.0 108.636 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.25 -10.61 33.46 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.777 -1.202 . . . . 0.0 110.767 168.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -97.29 10.51 39.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.976 2.11 . . . . 0.0 111.74 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.8 mt 60.76 42.99 12.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.872 1.669 . . . . 0.0 113.573 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.74 141.56 51.28 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.92 141.15 57.73 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.892 -1.13 . . . . 0.0 110.89 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -142.36 151.36 41.82 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 125.643 1.577 . . . . 0.0 108.034 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 p -138.42 170.52 15.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.602 0.637 . . . . 0.0 110.358 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.65 48.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.284 0.634 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -31.89 66.33 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.28 -37.51 80.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.172 0.987 . . . . 0.0 109.956 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.0 mtt -74.7 5.22 5.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.429 2.292 . . . . 0.0 111.45 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -99.65 -7.95 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.017 1.327 . . . . 0.0 111.234 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.66 68.3 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.09 0.859 . . . . 0.0 112.729 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -153.13 168.07 27.17 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.994 2.118 . . . . 0.0 106.436 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.78 118.7 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.4 m -122.82 135.69 54.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.092 0.557 . . . . 0.0 109.503 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.69 139.64 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.0 131.01 73.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -120.19 97.35 5.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -83.56 119.02 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.75 145.5 53.27 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -62.25 -58.92 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.256 2.637 . . . . 0.0 113.639 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.7 m -158.12 143.95 17.08 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.62 -15.94 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.26 -14.93 62.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.03 1.332 . . . . 0.0 114.439 -172.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -65.37 -22.01 66.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.471 1.032 . . . . 0.0 113.741 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.19 -36.58 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.221 0.915 . . . . 0.0 111.39 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.64 -40.03 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.568 1.184 . . . . 0.0 108.633 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.9 m -61.04 -37.9 84.25 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.925 0.89 . . . . 0.0 111.994 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -61.61 -51.76 67.19 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.442 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -49.48 77.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.975 0.352 . . . . 0.0 110.773 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.41 -54.27 47.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.46 1.104 . . . . 0.0 109.75 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -70.63 -38.89 73.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.646 -0.659 . . . . 0.0 110.949 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -63.21 -43.62 97.62 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 120.894 -1.129 . . . . 0.0 110.944 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -66.72 -42.39 86.39 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.921 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -54.53 -38.05 66.1 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.973 1.26 . . . . 0.0 112.286 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -60.26 -51.36 69.88 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.077 0.853 . . . . 0.0 111.099 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.62 -34.09 69.54 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 118.989 -1.084 . . . . 0.0 111.709 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.24 -37.4 87.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 120.209 1.368 . . . . 0.0 109.922 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.42 92.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.839 0.455 . . . . 0.0 111.074 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.47 94.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.75 0.705 . . . . 0.0 111.368 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -65.36 -41.07 94.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.619 0.768 . . . . 0.0 110.103 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -45.7 86.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.18 0.992 . . . . 0.0 110.812 173.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -23.79 4.19 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.993 1.282 . . . . 0.0 113.773 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -147.97 66.14 1.1 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.166 1.386 . . . . 0.0 109.506 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.69 172.65 9.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -130.26 139.85 50.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.04 133.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -130.71 161.34 31.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.664 1.186 . . . . 0.0 109.645 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -128.27 143.43 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.91 135.93 57.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m -142.2 158.81 43.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.906 0.882 . . . . 0.0 111.675 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.76 40.06 0.92 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -126.15 163.84 22.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.259 1.423 . . . . 0.0 109.027 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.89 128.41 93.86 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -169.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.11 -33.78 94.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.742 1.628 . . . . 0.0 111.163 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -73.31 -27.09 61.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.223 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -48.64 63.8 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.834 1.197 . . . . 0.0 109.144 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -57.04 -42.41 80.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.307 0.243 . . . . 0.0 111.578 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.31 -42.26 96.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.662 0.665 . . . . 0.0 111.571 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -65.24 -42.31 93.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -59.69 -39.8 85.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.086 0.554 . . . . 0.0 111.22 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.3 m -60.76 -42.25 97.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.518 1.054 . . . . 0.0 110.505 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.29 -31.86 82.26 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.532 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.82 78.52 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.261 1.03 . . . . 0.0 111.368 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -106.6 -16.03 14.62 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.81 0.844 . . . . 0.0 112.277 -171.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.2 38.34 34.75 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.29 144.97 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.674 1.19 . . . . 0.0 108.207 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -143.83 -35.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.229 1.012 . . . . 0.0 112.405 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -87.13 -14.82 40.23 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.406 0.683 . . . . 0.0 112.313 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.57 154.44 14.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.33 128.48 33.8 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -86.92 151.01 23.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.427 1.091 . . . . 0.0 109.251 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.1 mt -144.19 152.49 40.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.216 1.807 . . . . 0.0 106.507 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.1 m -121.03 125.97 48.69 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.172 -0.955 . . . . 0.0 109.45 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.59 3.94 48.02 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.031 1.332 . . . . 0.0 110.149 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -48.18 135.42 13.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.716 2.007 . . . . 0.0 111.573 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 63.44 -38.93 0.18 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.805 2.842 . . . . 0.0 114.392 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.36 -39.02 68.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.14 0.882 . . . . 0.0 111.56 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 53.93 9.7 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.712 2.805 . . . . 0.0 116.586 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.7 m -60.93 -43.76 98.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.364 1.893 . . . . 0.0 111.813 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.26 -44.28 68.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.068 0.849 . . . . 0.0 109.824 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -58.04 -47.07 91.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 123.96 0.79 . . . . 0.0 111.319 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.44 -37.58 87.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.505 0.722 . . . . 0.0 110.639 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -35.55 63.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.336 -0.852 . . . . 0.0 112.37 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.18 1.37 41.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.337 1.055 . . . . 0.0 112.168 -174.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.79 35.58 50.32 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.342 0.974 . . . . 0.0 113.003 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.38 21.38 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.658 1.183 . . . . 0.0 111.548 -169.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -107.89 110.66 22.48 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.5 110.99 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.13 -38.35 73.32 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 126.113 1.765 . . . . 0.0 111.083 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -91.29 4.57 52.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.893 0.877 . . . . 0.0 112.109 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -130.87 -21.81 2.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.361 1.064 . . . . 0.0 112.747 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 53.77 38.99 29.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.67 -168.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -131.4 152.62 50.48 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.075 1.35 . . . . 0.0 107.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.87 155.19 31.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 110.695 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.44 175.48 6.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.328 1.061 . . . . 0.0 111.679 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -113.57 85.31 2.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -141.48 164.57 29.86 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 110.519 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.14 152.43 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 121.636 -0.665 . . . . 0.0 109.424 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.5 159.63 41.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.572 1.149 . . . . 0.0 108.665 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.52 141.65 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -129.9 123.17 30.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.087 1.755 . . . . 0.0 106.854 -169.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.63 164.35 26.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.03 -20.89 26.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.445 1.098 . . . . 0.0 112.785 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -81.4 0.08 39.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.835 -1.166 . . . . 0.0 112.394 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.71 28.3 73.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.367 0.985 . . . . 0.0 111.701 -171.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.03 133.06 43.85 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -75.66 127.26 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.8 t -102.15 -30.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.477 1.511 . . . . 0.0 109.636 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -153.41 147.95 26.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.04 140.39 24.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.2 144.12 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.56 79.68 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.1 123.81 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -63.83 -14.59 54.33 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -122.77 116.42 23.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.06 65.78 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.19 10.81 2.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.959 1.304 . . . . 0.0 112.0 170.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -139.07 170.92 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.989 2.516 . . . . 0.0 107.319 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.92 154.36 79.2 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.145 -0.972 . . . . 0.0 111.085 -173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.47 149.81 37.06 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.915 3.077 . . . . 0.0 112.73 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -91.82 118.55 30.81 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -54.16 -25.4 22.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.046 1.338 . . . . 0.0 113.227 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.35 -37.42 83.26 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.765 0.712 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -60.92 -54.64 52.39 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.115 -172.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.11 -26.64 30.44 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.834 1.334 . . . . 0.0 111.433 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -44.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 120.191 1.36 . . . . 0.0 109.604 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.2 -38.29 90.54 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.27 0.941 . . . . 0.0 110.315 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.8 85.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.366 -0.209 . . . . 0.0 111.393 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.59 -51.38 51.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.447 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.444 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.39 -31.24 69.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.276 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.7 mt -88.8 -34.06 17.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.601 0.761 . . . . 0.0 111.924 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 82.1 t -63.4 -41.82 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.98 0.512 . . . . 0.0 111.063 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 19.0 pttp . . . . . 0 C--O 1.249 1.057 0 CA-C-N 118.292 0.496 . . . . 0.0 111.143 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.58 94.05 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.554 0.342 . . . . 0.0 111.752 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 40.4 51.57 2.85 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.769 2.028 . . . . 0.0 112.684 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.71 146.28 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 p -112.71 160.43 17.93 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.294 1.038 . . . . 0.0 109.74 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -111.83 45.0 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.495 1.118 . . . . 0.0 108.743 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt 42.66 61.71 1.98 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.647 1.979 . . . . 0.0 112.346 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 -26.12 0.11 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.568 1.08 . . . . 0.0 111.019 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.19 176.04 47.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.242 1.401 . . . . 0.0 109.872 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.31 158.62 47.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.158 2.572 . . . . 0.0 110.552 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.42 134.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -66.16 151.26 47.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.263 1.025 . . . . 0.0 111.163 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.03 141.46 49.24 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.144 2.178 . . . . 0.0 105.886 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.66 -70.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.65 0.659 . . . . 0.0 110.013 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.54 54.74 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.516 0.579 . . . . 0.0 112.405 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.11 166.75 22.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.734 0.778 . . . . 0.0 110.967 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -70.23 115.6 9.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 168.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.96 153.66 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -124.83 156.29 38.05 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.804 0.841 . . . . 0.0 109.796 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.29 140.1 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.414 0.686 . . . . 0.0 109.308 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.47 -20.05 48.89 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.431 1.491 . . . . 0.0 112.244 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.39 155.12 39.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.791 1.295 . . . . 0.0 110.038 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -72.9 132.91 44.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.06 160.51 29.71 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.274 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.29 -4.04 2.11 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.499 3.466 . . . . 0.0 117.85 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.91 55.38 9.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.755 1.265 . . . . 0.0 111.375 -174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -89.37 170.52 10.48 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.487 1.515 . . . . 0.0 110.859 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -131.02 151.51 51.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.659 1.184 . . . . 0.0 108.341 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.34 163.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 0.0 107.312 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -86.69 138.69 31.44 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -71.16 166.09 22.2 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.11 -13.88 62.37 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.529 -1.357 . . . . 0.0 110.904 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.46 0.94 40.0 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.909 1.683 . . . . 0.0 111.497 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt 69.1 37.23 2.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.687 1.595 . . . . 0.0 111.687 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.41 164.17 21.02 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.991 1.316 . . . . 0.0 107.897 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.86 141.19 37.89 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.013 -1.054 . . . . 0.0 109.493 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -138.02 143.96 40.82 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -146.44 172.03 14.15 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.25 0.62 . . . . 0.0 109.934 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.4 tp -44.21 -45.96 8.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 111.582 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.13 67.55 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.783 0.833 . . . . 0.0 112.465 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.45 -40.22 21.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.84 0.856 . . . . 0.0 110.795 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.04 -39.04 83.16 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.207 0.603 . . . . 0.0 110.011 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -65.17 -4.63 5.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -19.57 41.47 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 113.025 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.82 158.56 43.6 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.369 1.468 . . . . 0.0 107.074 173.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.9 t -60.88 119.76 5.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.0 m -127.64 128.76 46.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 109.98 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.3 mt -89.84 140.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.15 133.34 68.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -128.57 95.74 4.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.38 134.24 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.26 157.6 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 107.25 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.39 -54.15 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.721 1.614 . . . . 0.0 111.671 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 p -155.5 154.5 31.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.316 1.846 . . . . 0.0 107.187 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.3 tt -78.8 -14.73 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -169.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.52 -34.59 78.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.87 155.31 40.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.465 0.575 . . . . 0.0 111.201 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.13 -39.06 93.95 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.858 -0.526 . . . . 0.0 112.534 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 m -70.04 -40.54 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.174 0.987 . . . . 0.0 110.971 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.07 -43.88 97.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.589 0.755 . . . . 0.0 110.799 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -58.93 -56.16 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.512 1.525 . . . . 0.0 109.929 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.92 88.78 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.159 0.584 . . . . 0.0 111.156 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -56.05 -54.16 48.25 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.321 1.048 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -64.95 -40.91 95.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.193 0.452 . . . . 0.0 110.441 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.3 tpt85 -67.96 -43.08 79.87 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.104 -0.997 . . . . 0.0 111.26 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -70.74 -35.13 72.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.083 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.79 -41.44 74.11 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.263 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.81 -49.39 76.51 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.331 0.969 . . . . 0.0 111.31 -178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.91 -38.9 83.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -67.29 -38.25 84.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.99 86.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.425 0.69 . . . . 0.0 111.326 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.58 88.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 111.282 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.43 -41.09 93.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.267 0.627 . . . . 0.0 110.079 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.29 -43.01 92.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.015 0.526 . . . . 0.0 110.444 173.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 -69.5 2.54 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.133 1.825 . . . . 0.0 110.685 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -85.3 67.76 10.26 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.078 1.351 . . . . 0.0 110.142 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.22 162.53 6.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -123.14 141.21 52.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.62 138.53 42.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -131.41 154.46 48.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.819 0.848 . . . . 0.0 109.664 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.5 m -116.05 148.44 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.91 135.67 63.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.1 m -136.57 150.64 48.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.69 49.78 1.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -137.44 162.56 33.33 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.208 2.203 . . . . 0.0 107.537 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.12 138.12 92.13 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-O 119.013 -0.517 . . . . 0.0 111.226 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.67 -37.13 81.57 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.103 1.869 . . . . 0.0 111.654 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -69.35 -33.64 73.4 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.5 -50.81 49.42 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.069 0.849 . . . . 0.0 109.647 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -55.94 -49.12 74.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.147 0.579 . . . . 0.0 110.919 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.06 -45.11 93.73 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.436 0.695 . . . . 0.0 111.873 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 tpt85 -66.4 -36.99 84.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.49 0.586 . . . . 0.0 110.412 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -65.53 -41.61 92.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.036 0.534 . . . . 0.0 110.177 173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 92.9 m -61.7 -41.67 97.9 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.999 -1.063 . . . . 0.0 110.633 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.03 -32.21 83.42 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.24 0.924 . . . . 0.0 112.378 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.63 95.06 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.437 1.118 . . . . 0.0 110.388 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.11 -20.87 29.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.746 0.818 . . . . 0.0 112.36 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.63 61.2 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.613 0.642 . . . . 0.0 111.724 -172.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mt -69.56 141.84 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.844 1.258 . . . . 0.0 108.095 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -147.97 -32.86 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -75.25 -16.37 60.46 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.728 0.694 . . . . 0.0 111.977 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.4 t -111.58 150.08 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 169.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.39 148.01 49.23 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.2 151.73 23.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -175.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.3 mt -136.38 152.79 51.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.6 m -124.27 168.61 12.74 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.873 -0.517 . . . . 0.0 112.367 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -47.47 114.34 0.86 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 109.339 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -39.63 75.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.759 -175.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 157.18 -38.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.556 2.343 . . . . 0.0 105.652 -169.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.41 141.97 45.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.162 1.385 . . . . 0.0 107.353 170.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 97.2 mmm -55.85 19.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 130.059 3.344 . . . . 0.0 115.698 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -52.63 -42.11 64.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.863 1.665 . . . . 0.0 112.404 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -56.03 -25.62 45.51 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.662 1.985 . . . . 0.0 114.344 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.6 -35.89 2.95 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 118.565 0.621 . . . . 0.0 111.675 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.32 -49.12 78.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.154 1.382 . . . . 0.0 109.97 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.96 -5.85 59.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.89 0.876 . . . . 0.0 112.415 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.2 10.76 14.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.911 1.284 . . . . 0.0 110.22 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.63 74.36 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.599 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.94 -5.2 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.007 1.404 . . . . 0.0 112.522 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -78.4 105.96 10.01 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.06 97.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -50.15 -41.56 49.25 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.87 1.668 . . . . 0.0 111.998 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.38 -10.18 59.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.863 0.865 . . . . 0.0 113.118 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.63 -20.78 5.4 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.555 1.142 . . . . 0.0 112.074 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 54.42 36.91 26.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.148 1.379 . . . . 0.0 109.944 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.5 mt -117.04 160.01 21.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.466 1.106 . . . . 0.0 108.351 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.45 137.26 32.48 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.76 163.63 25.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.749 0.819 . . . . 0.0 111.216 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.18 110.91 22.61 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 169.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.2 m -166.42 173.05 10.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.437 1.495 . . . . 0.0 108.144 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.12 152.17 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.257 -0.902 . . . . 0.0 110.691 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -136.45 161.31 36.2 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.126 1.37 . . . . 0.0 108.003 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 139.49 46.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.06 116.66 24.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.49 1.516 . . . . 0.0 107.72 -169.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.49 160.32 19.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.868 1.267 . . . . 0.0 108.83 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -64.25 -8.5 12.88 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.86 5.03 53.07 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.652 -1.28 . . . . 0.0 111.827 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.65 26.97 68.23 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.362 0.982 . . . . 0.0 112.086 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -91.67 139.42 30.7 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 108.46 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.37 -22.94 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.544 0.611 . . . . 0.0 110.615 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -153.92 143.71 21.81 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.82 145.02 31.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.59 142.81 29.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -132.53 106.04 7.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.503 1.921 . . . . 0.0 106.178 -170.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.52 131.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -68.59 0.53 4.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 113.058 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -139.16 110.12 6.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.781 2.032 . . . . 0.0 106.042 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.28 -28.55 68.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.146 0.43 . . . . 0.0 111.471 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.0 p -70.43 -9.94 57.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.265 1.826 . . . . 0.0 113.197 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.15 167.65 12.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.82 1.648 . . . . 0.0 108.905 -169.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -128.52 153.21 79.33 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.252 0.933 . . . . 0.0 109.715 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.07 152.07 45.31 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.844 1.696 . . . . 0.0 108.242 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -69.65 119.35 13.75 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -50.61 -27.36 6.71 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.143 1.777 . . . . 0.0 113.331 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -61.14 -34.44 75.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.753 -0.592 . . . . 0.0 111.447 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -66.28 -49.92 51.88 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 117.944 -1.026 . . . . 0.0 112.542 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.05 -27.77 49.71 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 121.403 1.537 . . . . 0.0 111.896 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -44.13 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.93 1.241 . . . . 0.0 109.545 171.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.12 -31.79 73.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.13 0.877 . . . . 0.0 111.179 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.76 -49.6 61.65 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.972 0.351 . . . . 0.0 111.014 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.49 75.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.8 0.44 . . . . 0.0 111.673 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -28.59 68.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.673 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.84 80.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.583 0.629 . . . . 0.0 111.416 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.0 mt -76.69 -43.21 38.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.411 0.551 . . . . 0.0 111.672 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.81 -4.49 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.07 0.85 . . . . 0.0 110.011 174.686 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttm . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.91 146.55 5.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.86 1.264 . . . . 0.0 112.148 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.81 -29.38 0.51 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.344 1.458 . . . . 0.0 110.824 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.273 18.1 mt 69.29 171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 126.665 1.986 . . . . 0.0 111.886 169.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -141.4 156.89 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.428 2.691 . . . . 0.0 105.903 -174.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -135.93 119.54 17.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' HE2' HG22 ' A' ' 150' ' ' THR . 13.1 tppt? 42.14 43.45 2.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.213 1.805 . . . . 0.0 111.591 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.31 85.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.539 -1.145 . . . . 0.0 114.165 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.6 139.54 15.73 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.21 155.37 69.63 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.193 1.929 . . . . 0.0 111.381 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.07 -167.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.473 1.509 . . . . 0.0 108.082 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.3 m -138.68 160.01 40.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tp -126.77 128.26 46.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.93 1.292 . . . . 0.0 109.686 -170.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.4 157.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.43 -154.5 40.47 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 123.617 0.627 . . . . 0.0 112.168 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.95 155.59 47.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.65 1.18 . . . . 0.0 109.064 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.29 152.25 45.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.72 154.38 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.751 1.62 . . . . 0.0 106.96 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.57 157.86 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.006 0.922 . . . . 0.0 111.764 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.26 144.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.899 1.28 . . . . 0.0 109.332 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 -23.61 18.66 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.685 1.136 . . . . 0.0 111.952 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.49 153.63 40.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.421 1.11 . . . . 0.0 109.519 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -70.28 128.23 35.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.93 153.99 78.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.466 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.68 -31.14 59.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.263 2.642 . . . . 0.0 115.315 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 47.76 84.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.343 1.857 . . . . 0.0 113.357 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.6 177.88 6.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.596 1.158 . . . . 0.0 109.228 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.7 m -109.59 151.05 27.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.651 1.181 . . . . 0.0 109.542 -169.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.21 173.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 128.208 2.603 . . . . 0.0 106.098 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.99 156.85 16.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.2 p -71.82 174.03 7.45 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.088 -1.008 . . . . 0.0 108.847 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -67.2 -11.14 56.58 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.26 -0.9 . . . . 0.0 110.842 168.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m -73.22 -65.82 0.76 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 pp 154.49 12.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 130.581 3.552 . . . . 0.0 112.168 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.82 144.53 30.37 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.732 -1.23 . . . . 0.0 109.181 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.51 133.19 55.86 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.657 -0.652 . . . . 0.0 111.227 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -140.48 147.1 39.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.209 1.804 . . . . 0.0 107.503 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -131.63 159.1 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.03 -31.17 68.59 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.08 66.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.788 0.835 . . . . 0.0 113.191 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.25 -35.66 68.86 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.8 mtt -75.78 -35.85 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.201 1.0 . . . . 0.0 111.177 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -63.97 -3.82 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.05 13.6 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 119.485 1.038 . . . . 0.0 113.009 169.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.49 157.23 45.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.864 1.666 . . . . 0.0 107.113 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.3 t -54.85 124.97 8.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.2 m -120.46 149.31 42.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 mt -116.18 141.42 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.5 mm -123.24 140.15 47.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 84.17 2.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 m -71.93 135.66 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.78 157.05 58.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.709 1.604 . . . . 0.0 108.955 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.56 -61.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.305 2.003 . . . . 0.0 110.641 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -144.25 147.77 34.01 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.39 1.476 . . . . 0.0 107.172 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.8 tt -98.82 -31.38 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.815 0.446 . . . . 0.0 111.438 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.5 -24.91 67.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 t -64.43 -21.25 66.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.218 1.007 . . . . 0.0 112.01 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.54 -11.95 64.56 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.029 -1.044 . . . . 0.0 114.094 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.37 -30.29 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.198 1.499 . . . . 0.0 110.542 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.14 -6.12 1.85 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.337 1.455 . . . . 0.0 113.365 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.38 -43.63 64.84 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.481 1.491 . . . . 0.0 110.15 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.17 4.42 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.153 0.981 . . . . 0.0 112.92 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -129.57 -83.36 0.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -55.59 -51.68 66.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.025 1.33 . . . . 0.0 111.814 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -70.72 -46.31 63.31 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.518 -0.739 . . . . 0.0 110.014 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -41.21 93.95 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.259 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -59.98 -31.19 69.67 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 120.455 1.48 . . . . 0.0 112.354 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.98 -43.66 98.51 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.252 0.933 . . . . 0.0 110.678 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -65.6 -51.4 59.94 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -63.1 -35.17 79.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.768 . . . . 0.0 111.303 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.87 95.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.529 0.604 . . . . 0.0 110.783 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.3 81.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.644 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -66.02 -41.53 90.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 110.702 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.04 -46.62 86.69 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.964 0.906 . . . . 0.0 109.808 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.53 -33.93 5.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.296 1.426 . . . . 0.0 111.071 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.95 120.9 4.28 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.98 1.312 . . . . 0.0 108.827 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -159.59 171.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.837 2.055 . . . . 0.0 105.715 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -119.04 138.72 52.66 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 p -154.3 146.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 120.809 -1.182 . . . . 0.0 110.305 -174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.55 170.2 16.17 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.781 1.232 . . . . 0.0 110.199 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.4 m -126.51 146.7 50.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.34 131.1 70.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -131.37 144.27 51.1 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.942 0.497 . . . . 0.0 110.978 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.72 48.87 1.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.82 161.67 35.97 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.14 1.776 . . . . 0.0 106.864 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.48 140.46 84.65 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.84 -47.59 20.73 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.045 2.497 . . . . 0.0 112.365 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -72.95 -30.11 63.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.76 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.85 85.66 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.855 0.752 . . . . 0.0 110.166 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.56 -48.87 63.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.975 0.91 . . . . 0.0 110.161 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.66 77.89 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 117.943 0.338 . . . . 0.0 110.508 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -45.06 93.5 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.345 1.058 . . . . 0.0 109.769 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -63.33 -43.46 97.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.94 -44.02 81.69 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.804 -0.56 . . . . 0.0 111.23 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -38.97 96.3 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.628 0.632 . . . . 0.0 111.987 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.62 98.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.788 0.835 . . . . 0.0 110.314 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -78.85 -17.77 55.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.69 0.796 . . . . 0.0 112.429 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.63 62.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.095 0.855 . . . . 0.0 111.733 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.84 141.94 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.789 1.236 . . . . 0.0 108.244 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.73 -28.72 0.43 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.574 1.15 . . . . 0.0 112.542 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -76.82 -24.4 52.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.015 0.825 . . . . 0.0 111.264 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 t -105.63 154.8 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.79 127.56 38.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.44 153.54 31.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.384 0.611 . . . . 0.0 109.797 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.7 mt -142.62 159.92 41.31 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.609 1.964 . . . . 0.0 107.546 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -124.0 130.2 52.18 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.844 1.258 . . . . 0.0 109.485 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.73 26.18 4.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.653 1.181 . . . . 0.0 109.449 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -68.11 -20.54 64.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.805 1.642 . . . . 0.0 113.23 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -146.29 153.28 40.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 46.32 56.07 6.69 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -168.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp -64.63 28.23 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.974 2.909 . . . . 0.0 114.071 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -55.21 -36.25 65.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.935 1.694 . . . . 0.0 112.737 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -70.6 -52.31 22.35 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.876 0.762 . . . . 0.0 110.081 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.12 85.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.17 -56.79 17.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.43 1.092 . . . . 0.0 109.38 170.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.29 73.9 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -2.49 37.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.246 0.618 . . . . 0.0 111.954 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.47 47.99 53.87 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.008 1.289 . . . . 0.0 113.034 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.84 -10.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 117.956 0.878 . . . . 0.0 112.272 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 107.67 0.96 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.1 mt -74.8 110.39 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -52.26 -44.21 64.78 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 110.896 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -3.15 47.33 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.393 0.677 . . . . 0.0 112.457 -171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.76 -25.58 4.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.011 0.924 . . . . 0.0 112.381 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 58.37 35.19 24.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.79 0.836 . . . . 0.0 109.845 -168.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.17 157.5 40.65 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.18 146.09 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.06 30.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.533 0.733 . . . . 0.0 111.361 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -81.2 103.29 10.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -149.45 168.88 22.23 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.221 1.409 . . . . 0.0 107.669 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.94 151.75 20.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 121.564 -0.71 . . . . 0.0 110.059 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -135.96 157.16 47.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.607 1.163 . . . . 0.0 108.722 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.98 139.29 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -125.5 132.69 52.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 108.058 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.31 165.93 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 169.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.69 -20.27 47.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.4 -2.56 57.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.601 -1.312 . . . . 0.0 112.271 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.19 23.24 77.95 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 121.078 -1.014 . . . . 0.0 112.42 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.22 145.36 25.45 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.799 1.3 . . . . 0.0 107.556 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.99 134.21 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.6 t -110.42 -30.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.777 1.631 . . . . 0.0 109.405 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -152.14 145.52 24.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.01 141.31 25.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.44 145.34 27.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -132.08 96.9 4.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.818 2.047 . . . . 0.0 106.109 -169.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.59 140.52 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 p -68.0 -12.78 61.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.778 1.231 . . . . 0.0 113.274 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.97 126.06 15.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.88 -21.06 34.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.463 HG22 ' HE2' ' A' ' 7' ' ' LYS . 78.8 p -75.04 -25.54 58.78 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 171.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -80.03 172.6 13.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.462 1.505 . . . . 0.0 107.683 169.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -140.74 157.37 67.89 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 120.702 -1.249 . . . . 0.0 110.109 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 165.8 30.89 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.841 2.361 . . . . 0.0 110.083 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -90.82 118.27 30.1 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -49.72 -28.75 6.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.983 1.713 . . . . 0.0 113.169 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -59.9 -36.09 76.24 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.516 0.598 . . . . 0.0 110.801 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -65.03 -52.94 45.4 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.274 -0.869 . . . . 0.0 112.261 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 -24.97 41.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 121.083 1.423 . . . . 0.0 111.795 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.71 -45.89 97.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 109.869 170.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.94 -32.8 72.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.213 0.915 . . . . 0.0 110.345 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.63 -55.27 12.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.922 0.489 . . . . 0.0 111.614 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.63 83.2 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.161 0.584 . . . . 0.0 112.027 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.81 65.55 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.612 0.765 . . . . 0.0 111.826 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.95 -30.74 70.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.063 0.545 . . . . 0.0 111.914 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.3 mt -98.35 -29.19 13.3 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.23 -8.91 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 123.915 0.886 . . . . 0.0 110.024 176.686 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.22 76.29 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.949 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 42.59 53.55 4.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.21 1.804 . . . . 0.0 111.812 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.91 144.9 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -111.5 161.11 16.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 109.753 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -128.06 54.36 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.704 1.202 . . . . 0.0 108.437 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 41.11 62.33 1.49 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.941 2.096 . . . . 0.0 113.115 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.74 0.18 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.591 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.95 46.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.271 0.939 . . . . 0.0 110.767 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.3 164.36 6.97 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.97 3.113 . . . . 0.0 113.188 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.91 139.78 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.916 1.286 . . . . 0.0 108.632 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 m -65.48 149.95 49.17 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.466 0.651 . . . . 0.0 109.347 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -129.41 134.66 47.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.65 1.98 . . . . 0.0 107.941 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.66 140.65 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 -166.68 42.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.75 48.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.155 1.382 . . . . 0.0 109.224 -176.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.16 112.34 2.61 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 m -73.17 169.0 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.49 158.27 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.636 -0.665 . . . . 0.0 109.506 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 133.52 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.98 -18.88 56.48 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.933 1.254 . . . . 0.0 112.257 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -70.96 153.38 42.71 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.065 1.432 . . . . 0.0 109.843 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -80.42 130.0 34.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.59 157.38 27.22 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.169 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.54 -7.0 4.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.458 3.438 . . . . 0.0 118.44 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t0 53.5 56.17 7.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.939 1.352 . . . . 0.0 110.894 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -86.01 169.78 12.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.667 1.987 . . . . 0.0 110.192 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -130.78 147.81 52.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.442 1.097 . . . . 0.0 108.189 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.37 162.38 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.297 1.839 . . . . 0.0 107.034 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.03 141.65 29.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -69.66 162.78 26.99 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -64.57 -17.5 64.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.051 -1.656 . . . . 0.0 111.399 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -85.1 3.18 40.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.539 1.936 . . . . 0.0 112.129 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt 73.62 33.47 1.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.398 1.879 . . . . 0.0 113.032 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -115.45 164.54 14.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.085 1.354 . . . . 0.0 108.021 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.22 143.42 35.36 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 120.445 -1.409 . . . . 0.0 109.12 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -141.14 146.08 36.56 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 p -147.66 169.68 19.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -47.69 -41.88 23.63 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.38 0.672 . . . . 0.0 111.651 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.44 64.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 112.751 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -77.96 -40.45 39.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.827 0.851 . . . . 0.0 110.607 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -66.8 -24.59 66.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.179 0.991 . . . . 0.0 111.583 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -55.95 -14.02 2.24 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.541 1.137 . . . . 0.0 113.631 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -27.42 50.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.312 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -155.01 169.47 24.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.959 1.379 . . . . 0.0 109.516 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.21 125.25 17.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 168.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.3 m -129.69 131.93 46.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.887 0.475 . . . . 0.0 111.038 -168.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 mt -89.68 141.96 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -118.83 136.33 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 172.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -128.11 90.33 3.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 108.037 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.79 139.05 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.63 144.69 45.79 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.97 -45.03 34.88 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.292 2.661 . . . . 0.0 112.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -160.04 168.15 26.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 106.542 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 tt -107.61 172.48 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.375 0.67 . . . . 0.0 110.14 -170.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.3 25.52 11.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.499 1.52 . . . . 0.0 113.396 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -75.23 -15.36 60.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.079 . . . . 0.0 112.253 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.79 0.1 86.13 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.226 0.917 . . . . 0.0 112.406 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.16 -46.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.748 1.274 . . . . 0.0 109.076 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.07 -28.57 69.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.281 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.96 -32.71 54.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.423 1.489 . . . . 0.0 111.982 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.55 60.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.601 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -55.69 -59.08 5.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.803 0.841 . . . . 0.0 110.424 -169.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -64.38 -40.78 96.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.021 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -74.71 -30.84 61.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.432 1.469 . . . . 0.0 111.45 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -63.52 -42.44 98.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.191 170.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.83 -37.63 79.76 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 120.069 1.304 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -60.41 -48.65 80.84 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.776 0.716 . . . . 0.0 111.036 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.57 -53.48 54.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.02 0.928 . . . . 0.0 109.51 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.7 -39.11 83.48 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.553 0.741 . . . . 0.0 111.363 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.05 87.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.265 0.484 . . . . 0.0 111.104 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.26 -33.82 73.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -69.73 -41.34 75.41 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.007 0.821 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -43.54 98.55 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.496 0.589 . . . . 0.0 110.268 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.44 -21.23 39.31 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.676 1.132 . . . . 0.0 112.686 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -153.04 100.74 2.51 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.735 1.214 . . . . 0.0 109.111 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.9 174.35 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 126.913 2.085 . . . . 0.0 105.433 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -129.65 142.73 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.6 p -151.98 144.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.85 166.17 23.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 0.0 108.974 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -126.3 142.01 51.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mt -128.59 137.92 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -147.36 165.41 30.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 111.76 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.09 -6.93 59.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.67 164.02 25.88 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.523 1.129 . . . . 0.0 110.462 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.5 135.04 96.08 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.25 -34.03 88.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.893 1.728 . . . . 0.0 111.522 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -70.08 -31.12 68.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.505 0.593 . . . . 0.0 111.697 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.82 75.23 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.069 0.85 . . . . 0.0 109.273 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.66 -43.37 93.98 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.582 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.86 -41.94 88.21 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.704 0.684 . . . . 0.0 111.153 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -69.37 -39.18 78.2 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 121.828 -0.545 . . . . 0.0 110.235 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -64.32 -40.25 95.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.795 0.438 . . . . 0.0 110.298 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.16 -38.47 83.25 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.122 -0.986 . . . . 0.0 110.828 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.98 -29.09 74.46 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.764 175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.8 71.6 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.712 1.256 . . . . 0.0 110.21 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -89.06 -17.88 28.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.05 39.27 24.19 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.74 143.99 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.362 1.065 . . . . 0.0 108.152 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -144.12 -38.07 0.31 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.577 1.151 . . . . 0.0 112.405 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -83.9 -18.72 36.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.428 0.691 . . . . 0.0 112.179 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.55 161.72 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -136.01 128.0 29.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p -80.85 149.11 29.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.609 0.764 . . . . 0.0 109.278 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.0 mt -142.67 148.73 37.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.137 1.775 . . . . 0.0 106.239 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.2 m -119.04 126.47 51.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.541 1.064 . . . . 0.0 110.182 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -82.99 -21.23 34.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.764 1.626 . . . . 0.0 109.779 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.7 t60 31.68 -73.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 1 C-N-CA 132.221 4.208 . . . . 0.0 117.413 173.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -139.99 -0.44 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.169 1.387 . . . . 0.0 111.65 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.31 -38.72 63.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.281 0.946 . . . . 0.0 109.882 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 34.0 mmm 53.29 8.73 0.12 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.904 2.882 . . . . 0.0 116.595 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 p -59.79 -41.33 90.92 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 122.407 2.367 . . . . 0.0 111.693 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -60.57 -59.71 4.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.45 -41.59 99.58 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-O 119.994 -0.337 . . . . 0.0 112.61 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.36 -41.96 85.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.439 1.496 . . . . 0.0 110.521 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.24 -23.22 15.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -169.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.33 1.41 45.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.818 1.19 . . . . 0.0 112.749 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.18 28.03 62.93 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.106 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.4 -8.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 119.629 1.715 . . . . 0.0 113.493 -171.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.67 102.69 6.28 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.19 104.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.0 -38.35 67.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.45 1.1 . . . . 0.0 110.796 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -65.63 -16.08 63.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.135 0.974 . . . . 0.0 112.869 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.2 mt -127.3 -18.76 4.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.691 1.196 . . . . 0.0 112.502 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.51 40.08 30.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.523 1.129 . . . . 0.0 109.23 -168.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -136.44 153.71 50.99 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.623 1.169 . . . . 0.0 107.953 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.63 156.43 34.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.592 0.633 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.73 -172.39 1.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.435 1.494 . . . . 0.0 110.513 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -117.95 17.63 14.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.903 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -64.71 170.24 4.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.733 2.013 . . . . 0.0 113.417 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.08 151.66 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.332 1.053 . . . . 0.0 109.816 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -141.72 162.28 35.88 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.26 145.6 31.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 171.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.72 128.11 43.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.982 1.713 . . . . 0.0 107.191 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.42 167.12 15.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.842 0.857 . . . . 0.0 109.815 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.18 -24.15 52.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.128 0.971 . . . . 0.0 112.609 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.41 -4.13 46.77 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.796 -1.19 . . . . 0.0 112.189 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.52 24.5 76.77 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.184 -0.948 . . . . 0.0 112.246 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -91.78 142.69 27.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.17 129.71 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.26 -15.71 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.685 0.794 . . . . 0.0 111.636 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -153.05 144.36 23.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.46 137.51 28.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.77 130.07 13.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -106.8 144.38 33.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.32 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 61.72 -15.27 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.299 2.24 . . . . 0.0 115.204 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -149.4 113.96 5.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.06 -31.53 67.16 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.145 0.578 . . . . 0.0 111.872 -174.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 p -73.46 7.23 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.744 1.218 . . . . 0.0 113.718 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.83 176.64 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.786 1.176 . . . . 0.0 110.516 172.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.77 150.6 70.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.494 1.118 . . . . 0.0 110.282 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.09 154.51 42.13 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.472 2.781 . . . . 0.0 110.388 -169.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -79.2 115.25 18.74 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -52.78 -26.44 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.852 1.661 . . . . 0.0 113.198 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -61.57 -36.08 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.049 0.84 . . . . 0.0 111.404 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -58.49 -57.84 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.596 0.634 . . . . 0.0 112.033 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.24 -24.34 32.17 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.118 1.212 . . . . 0.0 111.684 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 120.139 1.336 . . . . 0.0 109.605 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.27 -33.36 75.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.084 0.856 . . . . 0.0 110.494 -177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.63 -56.9 10.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.373 0.269 . . . . 0.0 111.361 172.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.37 88.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.422 0.689 . . . . 0.0 112.307 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -26.43 67.67 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.53 0.605 . . . . 0.0 111.986 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.63 65.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.089 0.556 . . . . 0.0 112.228 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.5 mt -102.46 -28.2 12.34 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.67 -18.47 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.386 1.075 . . . . 0.0 109.938 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.66 173.26 7.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.066 0.936 . . . . 0.0 110.78 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.39 157.62 43.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.323 3.449 . . . . 0.0 104.451 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 51.5 mt -140.98 143.8 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -169.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p -82.49 158.81 23.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.839 1.2 . . . . 0.0 110.621 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -132.12 85.85 2.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt 43.03 37.59 1.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.297 2.239 . . . . 0.0 115.441 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.96 -26.61 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.665 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.09 171.03 44.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.773 1.287 . . . . 0.0 112.054 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.83 151.82 51.71 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.842 3.028 . . . . 0.0 111.696 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.37 145.75 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.852 1.661 . . . . 0.0 108.519 171.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -76.45 141.67 41.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.928 1.691 . . . . 0.0 111.103 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.94 137.82 32.46 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -75.67 -21.0 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.54 -177.38 19.34 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.418 0.532 . . . . 0.0 112.243 -169.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -64.23 138.22 58.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.804 1.242 . . . . 0.0 111.142 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -78.82 143.07 36.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.3 153.94 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.94 157.12 43.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.358 1.063 . . . . 0.0 110.731 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.3 t -58.75 143.0 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.001 0.92 . . . . 0.0 109.034 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.57 -24.0 13.94 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.872 1.225 . . . . 0.0 112.42 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -73.79 155.21 39.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.718 1.259 . . . . 0.0 109.848 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -70.77 128.86 37.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.85 153.74 78.56 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.247 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.23 -32.03 69.07 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.65 2.9 . . . . 0.0 114.655 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.16 81.4 0.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.486 1.915 . . . . 0.0 113.138 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -127.59 -174.77 3.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.738 1.615 . . . . 0.0 109.564 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -115.64 155.91 26.82 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.856 1.262 . . . . 0.0 110.251 -168.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.12 159.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.836 2.454 . . . . 0.0 106.555 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.18 140.65 29.26 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.958 -1.089 . . . . 0.0 109.323 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.5 p -73.33 170.0 15.94 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -68.08 -13.95 62.6 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.516 -1.365 . . . . 0.0 111.45 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.05 0.4 40.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.254 1.421 . . . . 0.0 111.622 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp 58.03 47.1 15.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.039 1.336 . . . . 0.0 111.346 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.22 166.56 16.86 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.192 1.397 . . . . 0.0 107.528 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.02 141.98 29.91 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -138.93 150.88 46.42 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 126.257 1.823 . . . . 0.0 106.155 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 p -146.07 168.52 20.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.297 -0.877 . . . . 0.0 109.304 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.64 -31.53 68.22 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.864 -0.522 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.4 -28.62 8.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 113.828 170.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.73 -38.7 13.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.91 1.284 . . . . 0.0 110.804 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.0 mtt -68.66 -36.77 79.0 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.652 0.781 . . . . 0.0 110.614 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -62.8 -3.57 1.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.77 30.46 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.659 1.118 . . . . 0.0 113.107 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -148.2 166.01 29.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.49 1.645 . . . . 0.0 109.118 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.49 117.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.0 m -127.41 129.63 47.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.314 0.384 . . . . 0.0 111.37 -168.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.18 137.91 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.02 100.5 9.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.94 140.9 45.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 t -126.42 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 118.493 0.588 . . . . 0.0 109.493 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 159.64 67.45 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.495 1.518 . . . . 0.0 108.263 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.72 -53.67 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.618 1.545 . . . . 0.0 111.373 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -147.29 154.14 40.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.752 2.021 . . . . 0.0 106.566 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.0 tt -98.7 -6.5 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -168.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.1 -28.06 68.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.529 -0.732 . . . . 0.0 112.425 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -73.28 142.08 47.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.394 0.678 . . . . 0.0 110.581 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.6 -16.25 65.23 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.137 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.88 -29.28 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.996 1.398 . . . . 0.0 111.125 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.8 m -63.76 -12.82 38.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.537 0.735 . . . . 0.0 112.843 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.72 -45.3 77.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.668 1.122 . . . . 0.0 110.828 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.43 7.24 2.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.315 1.046 . . . . 0.0 112.612 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -129.06 -87.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -53.08 -54.18 39.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.808 1.643 . . . . 0.0 112.967 -169.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.69 -42.21 67.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.978 -1.077 . . . . 0.0 110.569 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpp85 -60.23 -38.19 82.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.648 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -64.99 -32.41 74.13 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.209 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.43 -48.19 81.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.674 1.579 . . . . 0.0 110.216 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.27 -57.14 9.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.325 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -61.58 -40.53 95.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.434 0.561 . . . . 0.0 111.028 -172.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.17 78.26 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.848 0.749 . . . . 0.0 111.482 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.07 79.4 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.112 0.869 . . . . 0.0 110.803 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -70.18 -39.88 74.98 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.505 0.593 . . . . 0.0 109.552 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.4 -47.24 82.81 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.195 0.598 . . . . 0.0 110.141 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.51 9.08 84.59 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.864 1.221 . . . . 0.0 113.949 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -151.99 35.61 0.54 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.391 1.595 . . . . 0.0 112.322 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.88 173.48 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -123.62 151.0 43.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.8 149.71 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.691 -1.256 . . . . 0.0 110.171 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -135.23 172.52 12.9 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.746 1.619 . . . . 0.0 108.982 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.6 m -132.5 144.04 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 169.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.64 137.71 56.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.59 147.87 36.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.14 0.976 . . . . 0.0 109.826 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.26 56.03 2.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -144.9 170.06 16.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.606 1.562 . . . . 0.0 107.143 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.04 142.11 63.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.132 -0.98 . . . . 0.0 112.468 -168.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -47.64 -41.03 30.9 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.34 3.36 . . . . 0.0 115.028 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -73.43 -29.4 62.54 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.95 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.39 82.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.525 1.057 . . . . 0.0 109.334 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -47.8 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.125 172.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.37 80.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.417 0.553 . . . . 0.0 111.09 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -59.75 -43.83 94.11 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.59 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -58.95 -52.05 67.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.533 0.606 . . . . 0.0 110.171 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.6 m -65.13 -44.96 86.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.95 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.59 -41.66 83.38 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.342 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.13 -39.78 82.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.12 0.96 . . . . 0.0 110.538 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -79.69 -19.17 49.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.957 0.503 . . . . 0.0 112.274 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.74 64.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 118.831 0.741 . . . . 0.0 111.425 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.03 146.78 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.587 1.155 . . . . 0.0 108.179 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -139.02 -35.8 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 112.172 -173.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -81.43 -18.74 44.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.025 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.21 158.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -139.76 130.1 25.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 168.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.2 p -84.26 155.94 22.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 mt -143.44 162.98 34.37 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.893 1.277 . . . . 0.0 108.406 -170.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.3 m -129.82 107.67 9.57 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.503 0.721 . . . . 0.0 109.586 -169.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -95.28 56.19 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -136.62 33.44 2.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.324 1.05 . . . . 0.0 112.693 -168.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -122.86 -48.33 2.02 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -144.65 121.12 11.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 101.871 -3.381 . . . . 0.0 101.871 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.1 mtp -73.69 36.87 0.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.734 1.613 . . . . 0.0 112.801 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -57.87 -41.71 83.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.859 1.264 . . . . 0.0 111.782 -169.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.13 -46.22 62.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.767 0.712 . . . . 0.0 109.581 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.82 -33.58 62.97 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.534 0.588 . . . . 0.0 111.868 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.96 -48.85 72.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.806 0.803 . . . . 0.0 109.367 171.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.55 72.69 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.3 3.52 53.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.597 1.159 . . . . 0.0 111.527 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.86 -13.8 8.27 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.081 1.801 . . . . 0.0 115.351 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.68 -23.39 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.559 1.544 . . . . 0.0 112.741 -173.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 110.57 1.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.28 113.43 17.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -53.29 -45.21 68.85 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.585 1.554 . . . . 0.0 111.331 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.72 0.14 51.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.361 0.665 . . . . 0.0 112.567 -169.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.24 -22.64 3.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.871 0.759 . . . . 0.0 112.976 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.36 37.15 28.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.195 0.998 . . . . 0.0 111.943 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.68 162.83 24.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.173 -0.954 . . . . 0.0 108.814 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -88.47 134.18 33.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.63 141.32 32.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.74 1.216 . . . . 0.0 110.471 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -73.32 112.63 9.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 168.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -154.65 170.06 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.447 1.499 . . . . 0.0 107.098 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 p -153.99 146.83 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -134.71 162.72 31.53 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 124.022 0.826 . . . . 0.0 110.139 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.5 t -134.8 145.81 31.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.16 130.55 41.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.452 1.501 . . . . 0.0 107.477 -169.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.67 165.09 25.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.007 1.323 . . . . 0.0 109.54 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.65 -6.49 3.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.09 12.31 23.57 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.952 -1.092 . . . . 0.0 112.448 169.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.68 78.75 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.029 0.823 . . . . 0.0 112.849 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -88.99 145.82 25.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.34 139.75 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.45 -26.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.564 1.546 . . . . 0.0 109.397 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -147.77 147.07 29.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -150.96 133.87 15.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 169.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.78 147.37 29.79 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -127.66 102.4 6.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.81 136.21 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -66.3 -13.52 60.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -134.93 125.58 26.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.991 1.716 . . . . 0.0 106.833 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.87 66.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.141 0.577 . . . . 0.0 111.827 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -79.5 12.96 2.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.146 1.378 . . . . 0.0 111.366 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -134.69 167.02 21.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.952 2.101 . . . . 0.0 107.857 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -128.31 154.73 79.06 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 110.923 -170.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.17 160.61 48.53 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.622 2.215 . . . . 0.0 109.65 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -87.06 117.44 25.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -51.51 -28.32 13.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.128 1.771 . . . . 0.0 112.857 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -60.14 -32.11 70.71 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.567 0.621 . . . . 0.0 111.695 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.73 -51.85 11.24 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.443 -171.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.68 -30.56 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.452 1.434 . . . . 0.0 111.729 174.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.44 -49.01 79.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 119.838 1.199 . . . . 0.0 109.904 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.75 -32.17 73.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.514 0.597 . . . . 0.0 110.771 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.66 71.51 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.209 0.459 . . . . 0.0 111.437 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.92 64.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.857 0.463 . . . . 0.0 110.01 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -26.76 68.88 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.442 -0.786 . . . . 0.0 111.797 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.64 71.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.988 0.813 . . . . 0.0 111.626 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.59 -29.13 28.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.15 0.58 . . . . 0.0 111.512 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.04 -51.97 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.368 0.531 . . . . 0.0 110.371 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.1 pttp . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.052 -175.692 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptt? . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 111.11 0.041 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.3 169.42 12.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.97 135.73 36.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 mt -146.13 155.37 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -169.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -117.51 168.51 10.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.852 1.261 . . . . 0.0 110.753 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -141.05 56.95 1.55 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.93 1.292 . . . . 0.0 108.619 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 37.74 71.21 0.16 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.082 2.153 . . . . 0.0 113.782 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -16.98 0.59 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.098 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.93 174.76 41.06 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.01 162.91 41.08 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.391 2.728 . . . . 0.0 111.151 178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.96 135.16 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.283 1.433 . . . . 0.0 107.395 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.2 m -67.12 152.0 46.57 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 110.385 -176.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.59 135.3 50.1 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.641 1.576 . . . . 0.0 108.661 -175.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.44 136.71 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 -163.68 13.51 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.424 0.556 . . . . 0.0 113.33 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -123.24 138.85 54.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.294 1.437 . . . . 0.0 110.385 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.7 114.67 14.55 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.43 170.38 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.936 0.789 . . . . 0.0 109.887 174.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 161.33 35.74 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.191 0.997 . . . . 0.0 109.094 174.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 129.93 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 174.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.15 -13.08 60.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.797 1.189 . . . . 0.0 112.383 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.62 140.03 58.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.629 1.715 . . . . 0.0 110.214 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -89.88 108.15 19.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 172.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.34 148.72 92.93 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.149 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -57.95 -8.92 5.16 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 125.245 3.963 . . . . 0.0 118.536 -178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 52.79 70.61 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.872 1.32 . . . . 0.0 111.74 -169.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -73.3 166.68 22.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.22 1.408 . . . . 0.0 109.827 177.198 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 m -127.97 144.92 51.11 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.33 163.12 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.208 2.203 . . . . 0.0 106.69 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.35 137.52 32.25 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -63.67 165.18 8.61 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -64.88 -3.48 3.46 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.699 -1.251 . . . . 0.0 111.864 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 m -114.48 17.97 17.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.127 2.171 . . . . 0.0 111.239 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 mt 65.93 39.85 4.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.133 1.373 . . . . 0.0 112.884 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.58 148.87 49.7 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.62 141.04 44.71 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.904 1.229 . . . . 0.0 109.128 172.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -138.33 144.99 40.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -134.02 165.96 23.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -53.49 -34.7 59.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.972 0.509 . . . . 0.0 110.442 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.97 46.09 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.12 -42.62 59.76 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.584 0.707 . . . . 0.0 110.441 173.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.6 mtt -64.7 -25.8 68.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.074 1.35 . . . . 0.0 111.643 -177.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -54.69 -16.75 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.592 1.157 . . . . 0.0 113.258 174.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.65 47.06 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.677 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -151.97 159.18 43.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.752 1.776 . . . . 0.0 109.695 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.49 119.46 6.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.8 m -124.95 134.23 52.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.446 0.299 . . . . 0.0 110.883 -168.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.11 142.59 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mm -120.89 138.08 52.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -126.92 102.37 6.98 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.109 0.964 . . . . 0.0 108.601 -169.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.04 134.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.81 157.31 61.76 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 107.984 169.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.39 -55.64 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.28 1.987 . . . . 0.0 111.59 -172.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -161.27 150.07 16.15 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 127.962 2.505 . . . . 0.0 104.833 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 tt -73.17 -10.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 118.92 0.782 . . . . 0.0 112.517 -169.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -32.35 73.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.868 1.267 . . . . 0.0 113.013 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.27 114.29 10.23 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.58 -17.99 43.02 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.408 1.004 . . . . 0.0 113.61 -174.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.33 -21.79 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 118.511 1.156 . . . . 0.0 111.311 174.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 64.3 m -58.75 -19.86 44.27 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.788 1.176 . . . . 0.0 112.8 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.7 -29.35 69.29 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.142 0.977 . . . . 0.0 111.828 173.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.58 5.94 22.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.622 1.169 . . . . 0.0 112.441 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -124.82 -83.83 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -57.68 -45.85 85.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.561 1.144 . . . . 0.0 111.885 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -68.6 -45.5 71.81 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.552 -0.717 . . . . 0.0 111.02 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.02 -37.43 87.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -57.98 -37.47 74.28 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.232 0.923 . . . . 0.0 112.207 171.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.53 -48.41 81.77 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.485 1.039 . . . . 0.0 110.825 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.48 -47.3 70.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.72 -40.07 96.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.378 0.99 . . . . 0.0 110.713 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.7 78.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.919 0.781 . . . . 0.0 111.627 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.16 87.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.701 0.682 . . . . 0.0 111.725 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -70.48 -40.05 73.85 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.443 0.697 . . . . 0.0 111.067 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.38 149.45 33.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.894 1.278 . . . . 0.0 108.805 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.53 -44.42 97.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.132 -178.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.23 137.24 7.04 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.677 1.591 . . . . 0.0 107.57 174.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -162.73 175.31 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.654 1.582 . . . . 0.0 106.956 174.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -136.54 140.62 43.09 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.51 146.52 23.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.05 163.37 29.71 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.962 1.305 . . . . 0.0 109.209 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.4 m -121.29 146.18 47.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 169.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.57 140.68 47.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 m -140.27 149.13 42.44 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.665 1.186 . . . . 0.0 109.939 -169.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.89 45.75 1.24 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.21 -176.63 3.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.136 1.375 . . . . 0.0 110.87 -168.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.43 140.52 26.92 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.275 -174.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.14 -41.48 57.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.874 3.049 . . . . 0.0 113.97 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -78.62 -29.44 45.94 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.509 -0.745 . . . . 0.0 112.083 -174.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.39 73.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.281 0.946 . . . . 0.0 109.102 175.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -51.05 -50.49 58.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.538 1.535 . . . . 0.0 111.11 171.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.683 0.393 . . . . 0.0 111.518 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -63.84 -44.41 93.28 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.033 0.533 . . . . 0.0 110.044 -174.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -61.69 -39.86 92.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.556 0.342 . . . . 0.0 110.565 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.4 m -65.35 -44.05 88.92 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.92 -0.487 . . . . 0.0 111.224 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.66 94.87 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.56 -44.3 87.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.696 0.748 . . . . 0.0 110.463 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -77.31 -23.49 51.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.281 0.632 . . . . 0.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.59 22.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.807 0.718 . . . . 0.0 111.325 -178.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.46 144.1 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.45 -37.9 0.23 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.176 1.391 . . . . 0.0 111.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -80.44 -16.49 54.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.08 0.952 . . . . 0.0 111.919 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.4 160.79 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.93 146.1 40.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 p -99.25 142.62 30.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.391 1.076 . . . . 0.0 108.63 -177.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 mt -129.02 155.66 45.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.051 1.34 . . . . 0.0 107.984 -174.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.66 125.6 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.258 1.423 . . . . 0.0 109.441 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -118.66 -2.54 10.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 111.966 -176.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -55.59 -23.29 26.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.518 1.527 . . . . 0.0 113.006 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -59.08 -45.48 90.72 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.119 0.968 . . . . 0.0 111.864 -176.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -154.95 7.37 0.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -171.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 mmm 51.77 28.47 4.95 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.128 1.771 . . . . 0.0 113.873 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -51.72 -51.33 56.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 111.928 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.66 -44.8 69.8 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.513 0.597 . . . . 0.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.22 -43.56 64.02 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.795 1.188 . . . . 0.0 112.672 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -74.35 -42.23 59.73 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.986 0.915 . . . . 0.0 110.213 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.79 86.5 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 0.0 112.034 -173.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -109.95 6.3 23.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.474 1.51 . . . . 0.0 112.581 -176.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.9 78.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.563 1.074 . . . . 0.0 113.109 171.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.95 1.59 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.282 . . . . 0.0 112.679 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -82.67 108.48 16.07 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 120.534 1.515 . . . . 0.0 107.48 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.64 105.0 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -51.48 -49.51 61.68 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 126.337 1.855 . . . . 0.0 110.981 -171.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -74.28 -35.61 63.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.407 0.683 . . . . 0.0 111.711 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.74 -23.69 42.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.765 0.711 . . . . 0.0 112.148 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? 57.99 34.57 24.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.132 0.973 . . . . 0.0 109.075 -168.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.4 mt -130.16 160.96 32.22 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.794 1.238 . . . . 0.0 108.688 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -75.32 158.25 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.09 -167.55 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.167 1.387 . . . . 0.0 111.307 175.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -124.66 123.57 40.33 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 169.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -166.55 169.12 14.04 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.924 1.69 . . . . 0.0 106.908 -169.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.46 143.23 23.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.22 156.9 47.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.016 0.926 . . . . 0.0 108.693 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 t -136.54 138.91 46.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.3 mt -130.84 124.51 31.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.401 1.481 . . . . 0.0 107.838 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.81 164.64 14.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.282 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.75 -21.13 10.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.655 1.182 . . . . 0.0 112.822 174.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -76.18 -2.85 33.17 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.586 -1.321 . . . . 0.0 112.502 174.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.35 76.53 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -171.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -116.68 129.7 56.3 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.73 129.27 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -173.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.94 -18.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.799 0.84 . . . . 0.0 111.406 177.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -153.61 143.13 21.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 144.91 27.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.22 144.9 23.43 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.218 1.007 . . . . 0.0 108.87 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -132.86 126.0 31.23 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.742 1.617 . . . . 0.0 106.82 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.82 137.12 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -70.76 -3.69 20.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.444 0.698 . . . . 0.0 112.88 177.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.92 125.38 21.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.94 1.696 . . . . 0.0 107.252 -178.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.32 -23.48 62.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 169.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.02 3.79 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.222 2.609 . . . . 0.0 112.986 173.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -140.91 171.14 14.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.534 1.934 . . . . 0.0 108.191 -176.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -131.51 155.98 80.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.357 1.063 . . . . 0.0 110.791 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.07 170.41 19.77 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.792 2.328 . . . . 0.0 109.9 176.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -97.9 118.74 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -55.75 -24.22 34.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.909 1.684 . . . . 0.0 112.922 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -61.64 -35.24 77.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.254 0.933 . . . . 0.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -62.07 -54.06 53.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.171 -174.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -31.36 16.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.957 1.771 . . . . 0.0 112.279 177.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mm -53.62 -50.28 51.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 119.67 1.123 . . . . 0.0 109.623 172.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.844 0.293 . . . . 0.0 110.688 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.39 91.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.916 0.325 . . . . 0.0 111.568 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.71 -53.81 24.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.208 0.603 . . . . 0.0 110.921 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -24.46 67.91 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.437 1.017 . . . . 0.0 112.186 -177.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.35 66.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.024 0.829 . . . . 0.0 111.565 170.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.78 -24.25 12.93 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.506 1.122 . . . . 0.0 112.545 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . 0.258 7.1 p -126.36 74.71 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 122.695 1.236 . . . . 0.0 108.351 177.031 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.997 172.29 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.69 150.52 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -97.91 155.54 17.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 123.038 1.399 . . . . 0.0 108.748 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -120.87 66.49 0.85 Allowed 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HE3' HG21 ' A' ' 150' ' ' THR . 2.0 ttmt 57.35 36.75 27.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.55 -21.27 0.27 Allowed Glycine 0 CA--C 1.497 -1.088 0 O-C-N 118.751 -2.468 . . . . 0.0 111.116 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.33 163.61 34.02 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.64 157.46 55.48 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.986 3.124 . . . . 0.0 110.118 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.42 137.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.248 1.419 . . . . 0.0 107.317 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.656 ' H ' ' HG3' ' A' ' 123' ' ' GLU . 27.1 m -74.99 151.18 38.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.605 1.162 . . . . 0.0 109.138 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 121' ' ' ILE . 22.2 mt -113.09 143.92 43.52 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.4 165.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 158.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.73 -172.41 14.51 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.449 1.027 . . . . 0.0 113.3 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -116.63 158.52 23.6 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.304 1.441 . . . . 0.0 107.659 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.45 127.27 32.05 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 117' ' ' PHE . 1.8 t -89.76 163.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 127.441 2.297 . . . . 0.0 107.505 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -137.04 169.29 18.03 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.339 -0.851 . . . . 0.0 111.487 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.97 137.09 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.397 165.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.37 -23.25 30.83 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.312 1.91 . . . . 0.0 112.387 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -71.84 151.09 43.7 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.648 0.779 . . . . 0.0 109.856 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -73.86 126.97 31.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 146.93 93.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 118.023 -0.989 . . . . 0.0 108.371 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 31.4 Cg_exo -52.81 -25.77 28.31 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 121.943 1.762 . . . . 0.0 115.528 -172.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' CE1' ' A' ' 27' ' ' PHE . 26.1 t0 61.26 89.47 0.08 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 129.375 3.07 . . . . 0.0 118.232 -170.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.727 ' CE1' ' HB2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -131.19 -166.76 1.75 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.437 -2.04 . . . . 0.0 107.175 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 5.4 m -125.08 143.57 50.85 Favored 'General case' 0 N--CA 1.406 -2.651 1 C-N-CA 134.53 5.132 . . . . 0.0 107.21 -170.133 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.58 171.07 18.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 129.253 3.021 . . . . 0.0 103.768 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.33 146.34 25.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -67.17 162.36 22.66 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 119.822 1.192 . . . . 0.0 108.106 162.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.38 -11.63 4.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.67 165.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 m -98.06 4.8 49.19 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.951 2.1 . . . . 0.0 112.795 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 75.42 33.89 0.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.852 1.661 . . . . 0.0 112.094 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.18 153.8 35.72 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.51 141.74 48.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.092 -1.005 . . . . 0.0 108.921 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' THR . 13.5 ttmm -139.64 145.1 38.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 168.42 18.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.251 0.621 . . . . 0.0 111.247 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 134' ' ' LEU . 0.9 OUTLIER -54.89 -37.13 65.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.343 177.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.27 -35.07 49.14 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.7 -42.51 61.15 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.318 1.056 . . . . 0.0 109.845 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.87 -30.09 71.07 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 112.05 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -10.73 19.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.563 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -11.99 6.22 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.041 1.292 . . . . 0.0 112.878 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.68 164.79 34.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.661 1.73 . . . . 0.0 107.073 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.06 120.42 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -126.72 138.9 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.5 mt -100.88 144.82 12.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.27 132.16 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -121.32 100.09 6.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.08 134.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 60' ' ' CYS . 0.4 OUTLIER -137.6 161.54 59.83 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.66 -57.38 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.151 1.901 . . . . 0.0 111.594 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 164.4 33.08 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.844 2.058 . . . . 0.0 106.38 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.4 HG12 ' CG ' ' A' ' 93' ' ' TRP . 10.3 tt -94.93 -15.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.656 1.571 . . . . 0.0 112.985 -168.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.97 -1.75 53.33 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -78.99 3.41 17.27 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 118.815 -2.428 . . . . 0.0 115.318 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.36 -52.37 0.83 Allowed Glycine 0 CA--C 1.54 1.61 0 CA-C-O 117.771 -1.571 . . . . 0.0 113.194 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -30.29 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 122.282 3.041 . . . . 0.0 111.34 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 52' ' ' ILE . 1.9 m -58.65 -31.89 68.58 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.673 -0.642 . . . . 0.0 112.035 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.706 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 15.1 t70 -55.54 -50.3 70.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.885 0.874 . . . . 0.0 108.753 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.93 -13.79 5.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.622 0.576 . . . . 0.0 112.306 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.554 HE22 ' HG2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -99.28 -75.81 0.56 Allowed 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.012 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -59.43 -40.2 86.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 123.597 1.665 . . . . 0.0 111.489 -159.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.262 1.7 tpt180 -76.1 -49.89 16.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.176 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -57.34 -38.72 74.54 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -58.45 -41.1 84.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.763 0.825 . . . . 0.0 109.945 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -57.5 -45.26 85.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.326 0.966 . . . . 0.0 111.556 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -70.98 -48.63 52.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.026 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.35 -38.21 86.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.572 0.349 . . . . 0.0 110.671 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.04 86.05 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.507 -0.745 . . . . 0.0 111.402 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.69 88.49 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.762 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -70.75 -36.4 73.11 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.587 0.755 . . . . 0.0 111.396 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mp -62.4 -41.48 98.7 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 123.192 0.597 . . . . 0.0 109.97 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 -37.36 3.4 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.491 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG11 ' A' ' 166' ' ' VAL . 43.6 t0 -140.23 85.32 2.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.34 1.07 . . . . 0.0 109.575 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.29 172.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -127.93 144.2 51.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.4 t -144.41 139.22 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.51 161.26 35.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.464 0.65 . . . . 0.0 109.312 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.6 m -122.01 148.5 44.74 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.8 mt -132.9 134.74 57.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 m -132.13 159.9 37.57 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.438 0.695 . . . . 0.0 110.671 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.49 39.62 0.92 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 109.18 167.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -133.66 168.69 18.23 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.107 1.363 . . . . 0.0 108.804 -166.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 136.04 96.45 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.073 0.949 . . . . 0.0 110.536 -171.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.97 -42.39 64.71 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.365 2.043 . . . . 0.0 111.903 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -72.84 -30.07 63.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.059 -1.026 . . . . 0.0 112.672 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.87 98.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.503 1.047 . . . . 0.0 108.627 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.1 -46.23 78.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.09 75.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.79 0.805 . . . . 0.0 108.982 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 92' ' ' ARG . 18.9 ttp85 -70.3 -44.95 67.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.775 -172.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 61' ' ' ASP . 69.3 t90 -53.98 -41.44 67.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.1 -46.98 84.83 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.265 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.25 -38.89 97.19 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.839 0.712 . . . . 0.0 111.753 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.13 93.4 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.738 0.815 . . . . 0.0 110.751 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -87.7 -17.15 32.39 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.84 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.72 56.08 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 119.29 0.95 . . . . 0.0 112.132 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mm -71.35 142.76 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.279 1.432 . . . . 0.0 107.443 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.66 -36.59 0.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.09 1.356 . . . . 0.0 110.637 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -79.86 -18.62 50.28 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.838 -1.164 . . . . 0.0 112.988 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -117.13 150.29 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.38 138.97 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 p -93.88 150.62 20.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.713 1.205 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.6 mt -141.65 157.51 44.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.339 1.456 . . . . 0.0 107.406 -170.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -121.64 109.72 15.1 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.518 -1.364 . . . . 0.0 109.09 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 109' ' ' ARG . 25.0 t0 -84.06 -10.1 58.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.927 1.291 . . . . 0.0 110.333 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -32.55 -25.34 0.0 OUTLIER 'General case' 0 C--N 1.347 0.458 1 C-N-CA 132.148 4.179 . . . . 0.0 115.246 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -97.82 -38.12 9.57 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -151.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.21 -7.72 0.62 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 125.82 1.95 . . . . 0.0 107.859 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mmm 59.09 12.67 2.55 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 125.494 1.518 . . . . 0.0 109.561 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.1 -42.74 77.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.692 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -64.79 -57.63 8.4 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 125.052 1.341 . . . . 0.0 110.573 177.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -60.43 -37.9 93.94 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 118.9 -1.619 . . . . 0.0 111.474 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.2 -53.28 51.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.666 1.186 . . . . 0.0 109.778 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.37 77.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -83.7 0.66 46.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.026 177.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.19 44.62 95.37 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.55 1.068 . . . . 0.0 111.712 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.417 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.2 m -125.92 -6.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.882 0.873 . . . . 0.0 112.168 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.84 118.82 14.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 165.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 13' ' ' LEU . 51.2 mt -82.06 105.94 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -53.14 -41.34 65.02 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 112.037 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.656 ' HG3' ' H ' ' A' ' 12' ' ' THR . 1.5 mm-40 -80.1 -11.77 59.73 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.727 1.211 . . . . 0.0 111.632 -171.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.08 -23.06 6.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.886 0.766 . . . . 0.0 112.54 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 61.15 38.9 16.56 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.935 1.35 . . . . 0.0 114.332 -168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.76 145.35 48.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -168.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.08 142.57 52.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.1 17.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.624 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -95.98 111.69 23.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 m -150.78 168.13 25.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.445 HG13 ' CG ' ' A' ' 153' ' ' PRO . 3.0 m -138.79 156.87 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.153 0.888 . . . . 0.0 109.316 171.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -141.41 159.73 41.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.57 1.148 . . . . 0.0 108.015 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.02 143.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 39' ' ' LEU . 69.5 mt -134.65 125.28 26.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -165.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.69 164.57 23.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.614 1.165 . . . . 0.0 109.087 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.32 -14.13 16.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.481 1.912 . . . . 0.0 112.988 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.96 -9.69 59.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.499 -1.376 . . . . 0.0 111.977 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.14 25.95 65.25 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.453 -1.405 . . . . 0.0 111.476 -168.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -89.71 142.51 27.62 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 118.821 1.311 . . . . 0.0 108.973 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.2 t -72.56 122.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 t -94.77 -31.59 4.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 126.27 1.828 . . . . 0.0 108.845 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -152.99 149.22 27.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.31 144.65 28.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 168.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.28 142.29 23.95 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.353 1.061 . . . . 0.0 108.525 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.46 108.17 10.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 153' ' ' PRO . 17.5 t -62.8 123.94 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -60.82 -12.6 11.37 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.264 -1.35 . . . . 0.0 112.646 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -134.74 115.18 13.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.54 1.536 . . . . 0.0 107.381 -172.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.16 -25.88 68.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.212 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -80.69 1.72 28.95 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.616 1.566 . . . . 0.0 113.95 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.36 164.26 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.94 2.496 . . . . 0.0 106.429 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -129.95 155.06 81.18 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 121.4 -0.812 . . . . 0.0 109.187 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.554 ' HG2' HE22 ' A' ' 63' ' ' GLN . 37.9 Cg_endo -66.86 168.89 15.87 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.536 2.157 . . . . 0.0 110.24 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.82 122.08 38.23 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.162 -1.586 . . . . 0.0 107.098 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 66' ' ' ARG . 19.7 p90 -59.3 -23.2 62.24 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.226 1.81 . . . . 0.0 112.824 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.43 -36.15 71.0 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.699 1.136 . . . . 0.0 109.842 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -60.22 -57.69 24.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.023 0.929 . . . . 0.0 113.16 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.59 -26.77 28.04 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 120.663 0.909 . . . . 0.0 111.224 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -49.42 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 108.493 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -63.96 -34.14 77.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.006 0.821 . . . . 0.0 111.204 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.31 66.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.59 0.756 . . . . 0.0 110.934 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.18 -44.99 67.61 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.444 -0.785 . . . . 0.0 110.421 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.428 ' HA ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -62.13 -23.61 66.66 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.67 -28.03 65.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.477 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.0 -25.79 13.94 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.002 -1.475 . . . . 0.0 113.702 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 163' ' ' LYS . 35.5 m -73.53 -13.37 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.113 1.324 . . . . 0.0 113.031 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 163' ' ' LYS . 7.1 mmtt . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.659 -2.115 . . . . 0.0 110.624 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 122.766 1.269 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.92 151.63 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.659 169.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -113.84 160.78 18.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.337 1.055 . . . . 0.0 109.687 173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.87 46.84 1.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.493 1.117 . . . . 0.0 108.673 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 42.33 63.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.608 1.963 . . . . 0.0 111.94 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.1 -25.58 0.18 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.571 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 171.81 43.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.271 0.938 . . . . 0.0 110.822 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.09 159.71 52.2 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.567 2.844 . . . . 0.0 111.076 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.54 133.61 45.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 124.125 0.97 . . . . 0.0 109.119 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -68.83 134.64 49.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.695 0.798 . . . . 0.0 110.481 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.23 146.59 23.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.398 1.479 . . . . 0.0 108.496 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -74.33 -65.02 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.25 169.52 54.65 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.509 0.576 . . . . 0.0 112.047 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.61 166.3 22.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.759 0.79 . . . . 0.0 110.611 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.48 120.09 18.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.75 152.5 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -128.15 158.06 39.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.251 1.02 . . . . 0.0 110.642 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.38 144.51 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.962 0.905 . . . . 0.0 108.813 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.38 19.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.646 1.117 . . . . 0.0 112.451 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.15 155.97 39.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.62 1.21 . . . . 0.0 109.872 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -74.02 136.19 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 157.92 30.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 122.987 0.515 . . . . 0.0 111.21 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -53.52 -27.42 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.969 3.113 . . . . 0.0 116.985 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 t0 51.91 78.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.255 1.422 . . . . 0.0 113.548 -169.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -139.15 -176.9 4.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.771 1.228 . . . . 0.0 110.636 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -125.64 152.31 45.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 110.994 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 m -140.39 170.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.791 2.436 . . . . 0.0 106.909 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.26 147.67 22.71 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.971 -1.08 . . . . 0.0 108.184 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.9 p -70.81 170.58 12.22 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -61.79 -9.25 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.633 -1.292 . . . . 0.0 112.524 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 m -105.83 12.09 31.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.476 1.91 . . . . 0.0 111.204 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.41 47.4 8.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.172 1.789 . . . . 0.0 111.209 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.9 140.44 51.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.99 135.09 56.25 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.537 -0.727 . . . . 0.0 111.153 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -137.29 141.57 41.93 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -126.65 157.21 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -169.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -54.48 -34.44 61.59 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.48 1.112 . . . . 0.0 111.132 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.56 67.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.51 -38.11 62.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.68 0.792 . . . . 0.0 110.331 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 mtt -66.43 -27.05 67.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.62 1.168 . . . . 0.0 111.013 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.19 -15.48 3.87 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.776 0.83 . . . . 0.0 113.142 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.54 -18.79 56.91 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.4 1.0 . . . . 0.0 113.849 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -152.48 160.56 43.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.347 1.573 . . . . 0.0 108.758 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.92 118.87 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.9 m -126.64 132.52 51.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.492 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.2 mt -93.05 142.51 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -126.89 128.62 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 125.553 1.541 . . . . 0.0 106.944 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 m -126.32 98.53 5.49 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.292 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.16 131.33 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.7 147.17 47.65 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.929 0.786 . . . . 0.0 111.827 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -65.21 133.54 35.68 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.3 2.0 . . . . 0.0 108.545 168.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m 44.44 -133.4 0.71 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.349 1.06 . . . . 0.0 111.073 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.5 tt -163.46 178.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.208 2.203 . . . . 0.0 106.15 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t0 56.09 38.98 30.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.072 1.749 . . . . 0.0 112.245 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.1 p -81.8 11.94 4.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.468 1.107 . . . . 0.0 111.646 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 -59.68 4.78 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 125.408 1.48 . . . . 0.0 109.761 -169.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.38 -8.7 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.55 -23.9 63.27 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.551 1.069 . . . . 0.0 111.274 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.19 -33.61 76.14 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.852 -1.155 . . . . 0.0 111.444 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.25 11.9 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.043 0.937 . . . . 0.0 111.899 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -134.92 -91.51 0.32 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.429 1.092 . . . . 0.0 108.481 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -54.59 -44.25 72.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.41 1.484 . . . . 0.0 112.297 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -67.61 -52.04 43.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -42.6 85.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.663 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.48 -37.87 79.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.378 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -59.58 -46.16 89.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.897 1.226 . . . . 0.0 111.609 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.74 -51.77 31.26 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.56 -36.52 84.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.502 -0.749 . . . . 0.0 111.078 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.655 -0.653 . . . . 0.0 111.668 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.16 66.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.486 1.039 . . . . 0.0 110.761 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -69.63 -41.49 75.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 0.0 110.058 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.2 -39.77 93.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.627 0.771 . . . . 0.0 110.144 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -73.49 2.67 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 125.821 1.677 . . . . 0.0 110.33 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -88.42 41.31 1.0 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.559 1.143 . . . . 0.0 112.088 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 164.7 15.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.467 1.107 . . . . 0.0 108.109 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.51 145.25 50.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.53 145.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.474 -0.766 . . . . 0.0 108.941 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -131.54 158.39 41.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.607 1.163 . . . . 0.0 108.544 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' HG22 ' A' ' 104' ' ' THR . 55.1 m -127.59 144.84 51.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.44 113.68 23.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 p -76.15 162.31 28.1 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.87 0.843 . . . . 0.0 110.123 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 -9.96 59.72 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -154.03 -31.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -169.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.83 111.26 10.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 120.412 1.46 . . . . 0.0 111.835 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.41 -31.65 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.903 1.735 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -71.26 -38.52 71.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.01 74.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.006 1.275 . . . . 0.0 110.844 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.13 -27.04 68.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.535 . . . . 0.0 111.438 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.19 82.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.465 0.575 . . . . 0.0 110.391 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -74.33 -39.96 62.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.549 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -52.66 -45.94 66.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.443 0.565 . . . . 0.0 109.81 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.78 -45.75 73.94 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.212 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.2 94.05 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.68 76.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.695 0.747 . . . . 0.0 110.406 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -73.77 -33.69 64.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.312 0.645 . . . . 0.0 112.34 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.24 37.71 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.72 145.02 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.11 -38.63 0.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.214 1.005 . . . . 0.0 112.789 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -74.74 -24.45 58.72 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.809 0.732 . . . . 0.0 112.408 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.1 158.94 10.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.25 134.45 34.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 81' ' ' THR . 7.0 p -87.56 154.37 20.67 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 mt -146.84 171.62 14.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 128.523 2.729 . . . . 0.0 106.076 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -150.97 142.33 23.36 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 119.656 -1.902 . . . . 0.0 109.06 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.63 -33.38 73.84 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 168.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.5 t60 55.79 -67.1 0.02 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 129.734 3.214 . . . . 0.0 113.981 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -149.44 0.11 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.302 1.441 . . . . 0.0 112.15 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.15 -39.9 90.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.253 0.933 . . . . 0.0 110.515 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 62.42 -23.55 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 129.523 3.129 . . . . 0.0 114.72 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.84 -43.96 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 121.05 1.75 . . . . 0.0 111.203 -170.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -64.65 -55.31 20.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.48 93.07 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 122.951 0.31 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.04 -47.59 73.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.615 -0.932 . . . . 0.0 110.273 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.06 -31.03 58.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.894 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.88 9.99 3.14 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.26 0.482 . . . . 0.0 112.071 172.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.91 -15.41 5.11 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 120.8 -1.187 . . . . 0.0 114.363 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.94 -25.49 30.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.053 1.427 . . . . 0.0 112.051 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.98 109.04 1.98 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.45 1.477 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.81 107.33 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -49.98 -45.66 51.84 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.75 1.22 . . . . 0.0 110.139 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.57 -16.27 62.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.519 1.128 . . . . 0.0 113.107 -171.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 mt -128.27 -16.82 4.38 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.517 1.127 . . . . 0.0 112.393 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.14 36.77 27.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.425 1.09 . . . . 0.0 109.417 -168.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.3 tp -126.08 147.06 49.67 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.159 1.383 . . . . 0.0 107.714 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.27 134.27 35.57 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.73 156.31 17.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.908 1.683 . . . . 0.0 111.955 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -83.22 116.66 22.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -162.14 168.44 22.54 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.935 0.894 . . . . 0.0 109.092 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.71 145.99 18.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 O-C-N 121.791 -0.568 . . . . 0.0 109.917 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -140.82 161.31 38.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.307 1.043 . . . . 0.0 109.581 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t -136.06 140.75 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.15 136.07 52.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.785 1.634 . . . . 0.0 108.122 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -75.77 166.76 23.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.213 1.005 . . . . 0.0 108.886 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.61 -23.01 57.91 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.254 -0.904 . . . . 0.0 112.588 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -76.06 -3.47 36.08 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.822 -1.174 . . . . 0.0 112.124 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.47 75.34 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.125 0.869 . . . . 0.0 112.096 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -92.56 143.94 25.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.45 130.86 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.4 t -104.93 -31.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.917 1.687 . . . . 0.0 109.409 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -152.28 149.12 28.34 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.82 139.23 24.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -149.08 134.13 18.13 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -114.29 126.05 54.59 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.5 t -70.0 136.69 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -67.48 -9.97 47.21 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.12 117.36 18.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.49 67.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 111.838 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.3 p -72.03 -10.59 59.99 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.88 1.672 . . . . 0.0 112.726 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -120.06 158.46 26.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 109.617 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -106.49 152.73 40.74 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.857 0.863 . . . . 0.0 111.082 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.08 154.58 57.43 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.592 2.194 . . . . 0.0 109.373 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.27 121.39 25.02 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -53.84 -26.56 25.02 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.262 1.425 . . . . 0.0 113.262 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -62.17 -33.61 74.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.778 0.717 . . . . 0.0 111.16 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -59.32 -56.79 32.36 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.178 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.57 -28.52 31.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 121.046 1.409 . . . . 0.0 111.851 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -48.45 88.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.529 1.059 . . . . 0.0 108.81 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.01 -31.06 72.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.888 0.767 . . . . 0.0 111.12 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -51.09 35.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.646 0.378 . . . . 0.0 111.36 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.47 -44.5 71.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -29.31 65.16 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.485 0.714 . . . . 0.0 111.67 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.58 71.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.498 0.719 . . . . 0.0 112.019 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.4 mt -99.16 -36.05 9.8 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.63 0.91 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.703 0.801 . . . . 0.0 109.897 173.781 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 87.0 mt -137.69 166.48 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -115.37 155.25 27.71 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.068 1.304 . . . . 0.0 110.195 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -124.88 65.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.789 1.236 . . . . 0.0 108.175 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 pttt 39.09 50.44 1.81 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.813 2.045 . . . . 0.0 113.972 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.92 -27.3 0.13 Allowed Glycine 0 CA--C 1.523 0.594 0 CA-C-O 119.523 -0.598 . . . . 0.0 112.669 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.71 45.71 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 117.998 0.899 . . . . 0.0 111.294 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.09 157.8 28.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.599 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.37 131.8 40.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 126.553 1.941 . . . . 0.0 106.378 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -76.0 160.6 29.67 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.13 0.972 . . . . 0.0 109.858 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 138.04 54.25 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.23 128.42 38.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.69 -159.73 18.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 123.555 0.598 . . . . 0.0 112.201 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -126.03 155.09 42.03 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.289 1.036 . . . . 0.0 109.045 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.54 152.76 43.62 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 168.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.64 146.33 31.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.19 158.94 34.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.44 0.696 . . . . 0.0 110.837 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.37 139.54 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.077 0.951 . . . . 0.0 108.856 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -18.15 53.33 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.792 1.187 . . . . 0.0 112.346 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -77.21 153.95 33.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.013 1.406 . . . . 0.0 109.98 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -75.29 127.61 33.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 169.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.29 150.78 78.73 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.653 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.17 -30.3 49.98 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.816 3.01 . . . . 0.0 115.625 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 51.63 88.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.557 1.943 . . . . 0.0 113.965 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.02 168.27 19.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.376 1.07 . . . . 0.0 110.405 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.2 157.34 19.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.321 1.448 . . . . 0.0 112.375 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.85 157.69 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.942 2.497 . . . . 0.0 106.279 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tp -86.22 138.08 32.14 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.954 -1.091 . . . . 0.0 108.972 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.8 p -71.18 167.44 19.37 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -65.44 -17.03 64.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.476 -1.39 . . . . 0.0 110.887 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -81.08 0.78 34.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.805 1.642 . . . . 0.0 111.374 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 mt 69.26 34.06 3.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.54 1.536 . . . . 0.0 111.404 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.77 163.06 20.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.668 1.187 . . . . 0.0 108.264 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.3 137.21 37.26 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -134.03 149.94 51.2 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -143.04 165.47 27.28 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.91 -35.57 64.28 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 111.939 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.1 -29.11 56.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.204 1.002 . . . . 0.0 113.146 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -81.14 -40.45 23.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.395 1.078 . . . . 0.0 110.762 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.69 -42.3 91.37 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -66.19 -0.79 2.71 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.67 -16.5 30.45 Favored Glycine 0 CA--C 1.54 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 112.488 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -140.25 158.54 43.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.534 1.533 . . . . 0.0 107.366 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.73 120.28 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -125.46 136.31 53.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.881 -169.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.21 139.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mm -120.55 133.76 66.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -125.99 94.43 4.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.333 1.053 . . . . 0.0 108.696 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.06 124.08 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.82 162.42 55.36 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.41 1.484 . . . . 0.0 107.799 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.02 -59.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.955 1.77 . . . . 0.0 110.315 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.8 m -152.41 160.32 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.581 2.353 . . . . 0.0 106.887 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.29 17.16 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -126.95 14.38 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.891 1.276 . . . . 0.0 110.42 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -73.51 -12.41 60.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.899 1.28 . . . . 0.0 112.713 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.15 -50.77 4.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.808 1.194 . . . . 0.0 110.213 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.68 -25.77 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 118.173 0.987 . . . . 0.0 112.073 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.7 p -53.42 -37.99 63.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.309 1.044 . . . . 0.0 112.257 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.98 -43.75 67.38 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.138 0.975 . . . . 0.0 110.787 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.98 43.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.155 0.982 . . . . 0.0 112.441 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -106.67 -55.01 2.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.189 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -64.78 -40.04 94.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.864 1.211 . . . . 0.0 112.348 -169.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -63.06 -49.3 75.09 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.029 -1.044 . . . . 0.0 109.335 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -67.01 -36.04 81.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.165 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -59.5 -43.86 93.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.75 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -58.08 -46.79 84.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.495 1.043 . . . . 0.0 111.343 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.58 -46.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -69.16 -33.31 73.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.296 -0.878 . . . . 0.0 110.721 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.92 96.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.526 0.603 . . . . 0.0 110.892 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.863 0.756 . . . . 0.0 111.144 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -65.48 -39.76 92.32 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.092 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.02 -45.75 84.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.598 1.09 . . . . 0.0 110.114 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 -4.93 75.22 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.796 1.189 . . . . 0.0 114.433 170.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -153.8 55.1 0.73 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.473 . . . . 0.0 109.831 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.33 168.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -127.76 140.81 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.6 t -137.34 139.79 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -128.71 162.84 26.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.886 0.851 . . . . 0.0 109.502 170.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.63 ' HB ' HG22 ' A' ' 104' ' ' THR . 21.5 m -129.11 143.99 51.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 mt -130.87 134.95 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.4 m -138.95 157.0 46.81 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.414 1.086 . . . . 0.0 110.436 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.99 54.32 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -140.41 162.93 34.15 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.651 1.581 . . . . 0.0 107.891 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.34 137.08 95.32 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.46 -32.08 80.56 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.015 1.81 . . . . 0.0 111.269 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -29.44 62.3 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.275 -0.891 . . . . 0.0 111.461 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -45.23 67.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.96 1.255 . . . . 0.0 109.709 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.26 -44.07 79.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.305 1.042 . . . . 0.0 111.714 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.27 -39.96 95.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.387 -0.821 . . . . 0.0 111.894 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -67.16 -39.06 86.44 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -53.95 -51.81 62.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.433 0.693 . . . . 0.0 109.428 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.0 m -60.11 -36.45 77.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.852 0.751 . . . . 0.0 111.231 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.06 -19.56 72.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.954 -0.914 . . . . 0.0 113.548 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.25 -25.17 24.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.168 1.484 . . . . 0.0 111.571 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -124.13 -16.28 6.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.64 1.176 . . . . 0.0 113.08 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.44 22.24 77.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.242 -0.755 . . . . 0.0 112.198 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mt -55.99 140.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -143.33 -35.89 0.38 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.65 1.18 . . . . 0.0 111.807 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -76.48 -17.14 59.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 111.448 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.26 153.98 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.65 150.64 50.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.1 p -111.77 148.02 34.42 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.1 mt -138.72 145.25 40.05 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.215 1.006 . . . . 0.0 109.192 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.3 m -107.82 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.516 0.674 . . . . 0.0 109.827 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -81.36 -14.55 57.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.512 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -42.43 -39.92 2.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.761 2.424 . . . . 0.0 114.192 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -119.74 24.05 10.79 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.251 1.021 . . . . 0.0 110.266 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -136.26 -45.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.787 0.835 . . . . 0.0 110.461 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.1 -15.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.15 2.98 . . . . 0.0 114.898 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 m -62.86 -50.57 70.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.329 1.422 . . . . 0.0 111.871 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.92 -46.84 85.9 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.214 0.916 . . . . 0.0 110.162 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.36 99.08 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.89 -42.97 80.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.295 -0.532 . . . . 0.0 109.955 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.56 92.06 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.37 -0.831 . . . . 0.0 112.035 -169.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.11 -1.35 52.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.687 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.63 54.06 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 119.385 0.993 . . . . 0.0 112.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.4 28.87 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.993 1.317 . . . . 0.0 110.46 -170.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -119.84 117.41 28.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.85 112.54 19.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.36 -43.53 83.59 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.595 1.958 . . . . 0.0 111.234 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.4 -43.61 66.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.388 0.275 . . . . 0.0 110.476 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.09 -22.09 31.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 56.59 37.62 28.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.889 0.876 . . . . 0.0 108.697 -168.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.162 1.385 . . . . 0.0 108.056 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.9 150.67 42.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.398 0.618 . . . . 0.0 110.75 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -177.21 2.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.554 1.169 . . . . 0.0 112.232 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.45 101.21 7.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 102.034 -3.321 . . . . 0.0 102.034 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -156.51 167.88 29.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -169.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.13 144.93 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -141.04 159.91 41.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.706 0.802 . . . . 0.0 109.825 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.5 t -135.56 144.45 33.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.3 mt -130.24 123.11 29.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.536 1.534 . . . . 0.0 107.961 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.97 166.23 11.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.158 0.983 . . . . 0.0 108.714 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.51 -20.99 59.45 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.153 -0.967 . . . . 0.0 113.397 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -80.45 -10.68 59.74 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.593 -1.317 . . . . 0.0 112.247 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.58 18.05 69.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.399 -0.813 . . . . 0.0 111.179 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -75.66 132.21 40.42 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.34 125.7 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.97 -10.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -153.55 144.06 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.85 138.69 22.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.08 149.94 29.38 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 109.201 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -129.57 108.19 10.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.72 123.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -68.43 -11.29 59.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -135.28 124.87 25.09 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 108.375 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.87 66.09 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 p -84.52 16.6 3.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 112.017 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -137.23 170.32 16.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.161 2.185 . . . . 0.0 107.954 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.25 164.11 42.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.706 1.203 . . . . 0.0 110.617 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.52 173.64 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.305 2.67 . . . . 0.0 112.258 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -113.91 120.11 39.57 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -53.08 -28.48 25.27 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.526 1.53 . . . . 0.0 112.845 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -58.85 -36.18 74.14 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.496 0.589 . . . . 0.0 111.12 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -67.59 -52.95 24.56 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.677 -170.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.98 -32.94 27.31 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.842 1.336 . . . . 0.0 111.846 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.16 -48.3 79.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-N 119.25 0.932 . . . . 0.0 109.54 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.08 -39.55 92.81 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.508 0.594 . . . . 0.0 110.545 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.216 -0.303 . . . . 0.0 111.603 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.57 -52.2 41.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.532 0.733 . . . . 0.0 110.168 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.13 69.58 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.133 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.55 -32.02 69.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.374 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.57 -35.85 19.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.796 0.838 . . . . 0.0 111.556 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.4 -40.43 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.451 0.701 . . . . 0.0 111.302 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 18.7 pttp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.336 0.516 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.68 150.86 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -77.56 161.33 27.95 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.905 -1.122 . . . . 0.0 108.797 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -138.15 109.38 6.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 39.03 51.3 1.89 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 111.583 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.22 5.47 79.88 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.519 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.08 142.33 13.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 120.299 2.05 . . . . 0.0 109.966 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 149.41 63.27 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 CA-C-N 120.61 2.205 . . . . 0.0 112.006 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.91 141.37 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.095 1.358 . . . . 0.0 109.432 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -78.07 147.79 34.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.391 1.476 . . . . 0.0 110.115 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 119' ' ' VAL . 2.0 mm? -116.04 147.32 41.38 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.871 1.668 . . . . 0.0 106.842 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -67.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.572 0.624 . . . . 0.0 111.222 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 173.02 36.24 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.561 0.534 . . . . 0.0 112.331 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.9 152.3 37.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.78 114.29 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.818 1.19 . . . . 0.0 108.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.5 160.52 20.49 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.98 135.06 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -15.29 60.26 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.736 1.16 . . . . 0.0 112.704 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -70.59 147.23 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.619 1.71 . . . . 0.0 109.137 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -87.03 117.8 25.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 152.1 40.57 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -169.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.42 -24.66 36.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.373 3.382 . . . . 0.0 116.542 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 52.74 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.633 1.973 . . . . 0.0 114.324 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.12 -172.98 2.82 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.411 1.484 . . . . 0.0 108.872 172.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 m -122.92 154.76 37.92 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.946 0.899 . . . . 0.0 110.082 -168.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.02 165.02 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.096 2.158 . . . . 0.0 106.796 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tp -89.59 142.54 27.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -69.16 166.91 17.28 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -65.24 -4.13 4.83 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.71 -1.243 . . . . 0.0 111.941 168.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.3 m -115.01 17.68 16.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.102 2.161 . . . . 0.0 111.332 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.1 mt 65.59 37.77 5.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 113.021 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -122.83 157.09 33.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.03 143.24 35.84 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.739 -1.226 . . . . 0.0 109.167 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.04 142.98 32.91 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -138.51 167.03 22.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.516 -171.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tt -57.78 -35.97 71.53 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.96 -0.463 . . . . 0.0 111.188 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.93 54.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.896 . . . . 0.0 113.073 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.46 -37.87 19.26 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.402 1.081 . . . . 0.0 110.718 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.46 -39.37 91.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.96 0.904 . . . . 0.0 110.244 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -67.5 -0.25 3.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.65 -17.07 40.08 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 120.751 -1.218 . . . . 0.0 113.003 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -144.92 166.63 24.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.299 1.84 . . . . 0.0 106.678 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.18 116.68 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 m -125.51 139.35 53.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.809 0.338 . . . . 0.0 110.635 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 mt -103.13 141.77 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.67 95.81 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 125.92 1.688 . . . . 0.0 107.21 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -73.38 145.51 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.82 137.85 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 pt -141.56 150.12 56.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -48.83 10.15 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.986 1.79 . . . . 0.0 111.951 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -156.07 149.11 24.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 tt -79.33 3.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -89.13 -3.9 58.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.28 1.032 . . . . 0.0 111.964 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -65.5 -10.38 34.0 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.922 -1.111 . . . . 0.0 113.399 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.7 -50.1 4.35 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.323 1.44 . . . . 0.0 111.994 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.7 -2.83 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.919 0.888 . . . . 0.0 112.349 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -49.85 -31.5 12.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.369 1.468 . . . . 0.0 110.058 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.48 -50.74 51.81 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.853 1.261 . . . . 0.0 111.92 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.52 79.71 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.612 0.365 . . . . 0.0 110.921 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -85.43 -8.51 58.35 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.648 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -141.01 -60.91 0.49 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.861 1.21 . . . . 0.0 112.47 -169.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -71.87 -43.72 64.97 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.483 -1.386 . . . . 0.0 110.064 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.56 -35.98 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.998 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -62.46 -36.88 83.85 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.555 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -57.37 -45.98 83.87 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.752 1.16 . . . . 0.0 110.323 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.75 -50.18 65.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.831 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -32.18 72.78 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.134 -0.979 . . . . 0.0 110.929 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.98 93.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.911 0.884 . . . . 0.0 111.166 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.26 99.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.202 0.455 . . . . 0.0 109.947 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -65.13 -35.73 82.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.28 0.632 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -62.42 -19.4 63.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.168 0.987 . . . . 0.0 113.225 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.3 -43.27 3.11 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.497 1.046 . . . . 0.0 112.054 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -149.95 126.3 10.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.851 1.261 . . . . 0.0 108.563 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -165.52 174.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.354 2.262 . . . . 0.0 105.379 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -129.41 138.57 51.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -140.54 140.4 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -134.33 167.35 20.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.493 1.117 . . . . 0.0 109.493 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.4 m -131.63 144.15 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.82 141.85 43.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -142.5 156.78 45.18 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.021 0.528 . . . . 0.0 111.452 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.88 50.95 1.87 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.663 1.185 . . . . 0.0 108.047 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -142.71 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.328 1.451 . . . . 0.0 107.787 -169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.41 140.6 72.47 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 111.882 -168.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.49 -39.72 45.25 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.93 3.087 . . . . 0.0 114.498 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -74.42 -28.04 60.89 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.74 0.7 . . . . 0.0 111.604 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.27 -44.2 84.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.447 1.021 . . . . 0.0 108.941 172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -48.26 74.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.663 0.785 . . . . 0.0 111.095 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -41.21 97.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.416 0.553 . . . . 0.0 111.451 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -63.77 -41.48 97.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.103 0.561 . . . . 0.0 109.787 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -56.21 -48.48 76.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.416 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 66.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.882 0.764 . . . . 0.0 110.865 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.19 98.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.38 85.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.857 0.829 . . . . 0.0 110.758 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -86.69 -11.07 52.28 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.539 0.736 . . . . 0.0 112.672 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.48 27.85 68.79 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.182 0.901 . . . . 0.0 111.903 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.4 mt -76.54 147.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.188 0.995 . . . . 0.0 108.943 -174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.65 -39.08 0.47 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 111.849 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -11.18 59.86 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.335 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.32 155.44 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -135.27 134.41 39.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -89.14 151.08 22.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.181 0.992 . . . . 0.0 108.777 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 mt -141.59 166.18 25.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.78 2.032 . . . . 0.0 107.388 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.93 123.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -80.4 36.23 0.36 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.561 1.172 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -66.04 -10.43 39.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.738 1.615 . . . . 0.0 111.671 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -79.1 63.29 3.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.456 1.503 . . . . 0.0 108.743 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t0 47.05 44.83 15.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.818 2.047 . . . . 0.0 112.691 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 83.1 mmm 48.73 23.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.192 2.197 . . . . 0.0 114.127 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -63.64 -37.14 86.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.075 -1.016 . . . . 0.0 112.977 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.65 -48.86 62.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 109.65 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.3 61.63 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.33 -49.51 77.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.891 0.845 . . . . 0.0 109.24 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.7 -39.1 80.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.41 -3.08 21.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 113.2 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.26 62.75 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.322 0.965 . . . . 0.0 112.61 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.436 ' HA ' HD12 ' A' ' 13' ' ' LEU . 26.9 m -121.52 1.08 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.64 1.22 . . . . 0.0 112.449 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -90.89 120.28 31.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.9 mt -82.25 108.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -54.96 -38.53 67.86 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.159 1.383 . . . . 0.0 110.908 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -75.47 -10.85 59.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 112.628 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 mt -134.29 -19.77 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 53.42 42.17 32.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 109.17 -167.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -119.6 148.08 43.75 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.39 1.476 . . . . 0.0 107.249 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 tp -91.9 139.04 31.05 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.04 172.37 10.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.085 0.954 . . . . 0.0 111.13 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ttm105 -101.67 21.17 14.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.922 0.889 . . . . 0.0 111.475 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 m -58.66 176.31 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.285 2.234 . . . . 0.0 113.89 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.47 147.62 16.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.542 -1.349 . . . . 0.0 108.568 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.83 165.18 26.21 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 109.884 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.29 145.02 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.4 mt -131.0 130.21 43.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.431 -168.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.19 168.23 10.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 109.365 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.79 -14.61 22.67 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.207 -0.933 . . . . 0.0 113.511 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -93.8 6.82 47.15 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.539 -1.351 . . . . 0.0 111.743 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.61 22.28 73.29 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.865 -1.147 . . . . 0.0 111.978 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.78 135.53 34.5 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.695 1.248 . . . . 0.0 107.78 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.72 115.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.89 -34.25 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -162.05 144.72 11.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.219 1.808 . . . . 0.0 107.105 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.84 147.94 34.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.895 0.878 . . . . 0.0 108.725 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.26 135.16 26.76 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.053 1.341 . . . . 0.0 107.704 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -106.81 18.7 21.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.051 1.74 . . . . 0.0 112.951 -168.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.1 m 49.21 -16.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 130.193 3.397 . . . . 0.0 118.376 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 m 55.02 -7.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.048 2.939 . . . . 0.0 116.05 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.51 126.15 11.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.056 1.342 . . . . 0.0 112.649 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 80.9 p -93.43 12.8 23.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.148 1.34 . . . . 0.0 112.211 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.17 163.93 15.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.592 1.557 . . . . 0.0 109.765 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -124.65 157.43 65.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.224 1.41 . . . . 0.0 108.714 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.89 -167.49 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.346 2.697 . . . . 0.0 108.646 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -124.2 116.45 22.71 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -47.46 -29.0 2.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.954 2.101 . . . . 0.0 113.897 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.21 -36.49 77.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.15 0.432 . . . . 0.0 110.969 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -58.52 -58.21 20.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.801 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -24.15 23.1 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-O 116.814 -1.411 . . . . 0.0 112.553 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -47.22 94.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 121.332 1.878 . . . . 0.0 109.066 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.53 -34.84 79.17 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 110.855 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.5 62.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.672 0.389 . . . . 0.0 111.625 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.23 -48.44 70.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.631 0.772 . . . . 0.0 111.171 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -31.45 68.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.962 0.505 . . . . 0.0 111.515 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.28 -30.76 71.8 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.054 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.73 -39.29 7.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.682 0.674 . . . . 0.0 112.548 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.22 -23.49 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.161 0.585 . . . . 0.0 111.208 178.535 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.286 16.2 mt 73.65 162.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.699 2.4 . . . . 0.0 111.068 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 p -125.02 165.87 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.812 2.045 . . . . 0.0 108.767 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -136.5 105.37 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 150' ' ' THR . 16.3 ptpt 31.4 56.81 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.115 2.166 . . . . 0.0 114.545 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.52 13.06 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.608 169.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.78 159.87 29.89 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.327 1.564 . . . . 0.0 110.501 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.16 156.73 37.99 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.108 2.539 . . . . 0.0 112.164 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.18 -161.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.926 1.691 . . . . 0.0 106.862 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.0 m -149.13 152.31 35.9 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.284 -1.51 . . . . 0.0 108.219 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.45 138.06 47.33 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.191 1.397 . . . . 0.0 108.406 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.65 -17.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.1 175.88 24.44 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.41 150.61 44.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.096 0.951 . . . . 0.0 111.794 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.37 123.37 26.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 168.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.75 162.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.892 1.224 . . . . 0.0 110.123 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -123.26 156.39 35.31 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.475 1.51 . . . . 0.0 107.72 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.07 135.1 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.34 68.52 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.473 -1.182 . . . . 0.0 112.998 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.02 149.73 49.78 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 108.976 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.35 128.23 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 169.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -60.98 142.38 92.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.353 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 36.1 Cg_exo -57.42 0.41 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.703 1 C-N-CA 126.102 4.535 . . . . 0.0 119.204 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.28 65.24 1.31 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.816 1.293 . . . . 0.0 111.902 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -74.67 164.54 26.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.568 1.547 . . . . 0.0 109.805 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.0 m -130.58 136.57 49.02 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.93 155.11 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.013 1.725 . . . . 0.0 106.618 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -85.39 139.11 31.81 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -70.99 164.87 24.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -67.08 -3.4 7.3 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.852 -1.155 . . . . 0.0 111.594 168.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -97.87 5.24 49.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.415 1.886 . . . . 0.0 111.836 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 63.31 42.72 6.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.82 1.248 . . . . 0.0 111.294 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.97 164.46 20.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -84.14 144.94 28.68 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 120.729 -1.232 . . . . 0.0 109.872 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -138.23 156.32 47.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.95 2.1 . . . . 0.0 106.092 171.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 p -149.48 169.8 20.06 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.293 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -47.02 -43.89 19.99 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.776 0.83 . . . . 0.0 111.347 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -30.57 66.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.949 0.9 . . . . 0.0 112.8 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.91 -40.27 60.97 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.382 0.673 . . . . 0.0 110.426 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.5 mtt -67.74 -25.08 65.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.283 1.033 . . . . 0.0 111.62 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -55.77 -14.84 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.225 1.01 . . . . 0.0 113.622 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.29 -23.27 57.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.754 -1.026 . . . . 0.0 113.672 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -151.77 156.86 41.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.677 1.739 . . . . 0.0 109.517 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.1 122.21 8.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 168.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.5 m -125.96 130.47 51.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.63 0.372 . . . . 0.0 110.923 -168.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.4 mt -89.71 141.43 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 mm -118.74 131.61 71.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -127.42 84.45 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.418 1.087 . . . . 0.0 108.16 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.9 143.65 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.73 169.95 9.77 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 106.989 169.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.27 -54.88 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.82 1.68 . . . . 0.0 110.812 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 m -151.37 170.37 19.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.409 2.284 . . . . 0.0 107.563 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -149.3 81.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.954 0.883 . . . . 0.0 109.206 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.68 6.42 1.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 t -152.64 -170.03 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.941 1.297 . . . . 0.0 107.782 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.28 -52.44 3.78 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.75 -29.68 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 117.897 0.849 . . . . 0.0 112.316 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.4 -24.7 64.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.688 0.676 . . . . 0.0 112.485 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -139.53 -95.68 0.16 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.191 0.997 . . . . 0.0 108.718 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.54 6.34 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.597 1.959 . . . . 0.0 114.581 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -87.7 -44.43 11.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.463 1.105 . . . . 0.0 108.353 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.0 m -51.31 -41.74 60.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.43 1.092 . . . . 0.0 112.393 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -65.28 -45.27 85.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -69.15 -39.23 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -56.73 -40.86 76.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.221 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -59.59 -46.09 89.95 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-N 119.348 0.977 . . . . 0.0 111.416 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.45 -55.72 16.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.392 0.677 . . . . 0.0 109.354 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 27.2 mm-40 -60.08 -40.97 91.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.859 0.754 . . . . 0.0 110.778 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.17 69.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.203 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.67 70.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.572 1.078 . . . . 0.0 110.299 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.93 -41.65 86.66 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.726 174.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.85 -40.78 92.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 110.551 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 -66.62 2.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.951 1.739 . . . . 0.0 110.939 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.69 45.36 1.19 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.725 1.61 . . . . 0.0 111.782 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.65 166.4 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.152 1.381 . . . . 0.0 107.734 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -132.24 146.08 51.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.28 145.32 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.31 155.37 47.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 108.706 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 104' ' ' THR . 54.4 m -117.23 145.81 43.67 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.29 138.05 53.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -140.48 159.18 42.76 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.973 0.909 . . . . 0.0 110.23 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.01 54.66 1.72 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -143.11 161.54 37.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.887 1.275 . . . . 0.0 108.757 -169.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.86 138.43 85.35 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.015 0.926 . . . . 0.0 108.93 -169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.25 -34.27 88.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.619 2.213 . . . . 0.0 112.129 -170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -73.86 -29.05 61.9 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.361 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.97 86.3 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.955 0.798 . . . . 0.0 109.381 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -62.89 -42.64 99.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.328 -0.232 . . . . 0.0 111.123 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.87 84.57 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.696 0.398 . . . . 0.0 111.25 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -63.5 -45.72 89.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -60.66 -40.32 91.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.503 0.321 . . . . 0.0 110.436 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.1 m -63.97 -46.1 86.14 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.005 -0.434 . . . . 0.0 111.315 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.38 94.63 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.65 67.67 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.871 0.868 . . . . 0.0 111.999 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -108.25 -4.89 17.15 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.897 0.879 . . . . 0.0 112.345 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.21 30.65 56.76 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.725 0.679 . . . . 0.0 111.528 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -72.19 143.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.412 1.085 . . . . 0.0 108.675 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.67 -38.38 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.619 1.168 . . . . 0.0 112.87 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -73.35 -21.13 60.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 112.342 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.48 157.79 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.22 143.77 36.18 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.429 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.9 p -96.86 149.96 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.79 0.836 . . . . 0.0 109.521 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.5 mt -137.7 139.4 40.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.592 1.157 . . . . 0.0 108.664 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.7 m -102.06 122.23 43.71 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.427 1.091 . . . . 0.0 108.874 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -104.23 -7.36 20.14 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.669 0.787 . . . . 0.0 111.825 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.51 -27.16 47.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.855 1.262 . . . . 0.0 112.817 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -62.33 -32.04 72.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -146.2 -8.24 0.53 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 50.63 31.02 5.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.421 1.488 . . . . 0.0 112.629 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 m -58.22 -55.47 34.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.296 -0.877 . . . . 0.0 111.136 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -67.26 -40.21 86.19 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.92 -45.09 32.19 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 126.337 1.922 . . . . 0.0 113.118 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.32 -41.31 18.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.903 0.851 . . . . 0.0 109.688 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.97 80.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.574 1.15 . . . . 0.0 112.384 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -105.64 10.79 32.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.812 1.245 . . . . 0.0 110.968 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.24 -3.3 2.46 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.068 -1.407 . . . . 0.0 115.578 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.79 -9.65 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.392 2.096 . . . . 0.0 113.836 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -75.11 120.77 21.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.992 1.269 . . . . 0.0 108.404 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.3 mt -93.7 110.69 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -54.36 -40.84 68.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.871 1.668 . . . . 0.0 111.837 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.24 -6.69 59.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.16 0.584 . . . . 0.0 112.45 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -126.03 -18.54 5.02 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.26 33.41 22.15 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -168.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.6 tp -128.0 171.23 12.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.318 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.3 141.19 47.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.158 0.983 . . . . 0.0 108.748 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 175.89 2.78 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.609 1.164 . . . . 0.0 111.066 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -113.65 18.36 17.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.1 m -63.19 162.35 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 111.727 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.86 147.86 28.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.726 0.81 . . . . 0.0 109.843 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -142.79 155.38 44.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.714 0.805 . . . . 0.0 108.923 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.01 135.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.9 mt -127.93 121.11 29.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.485 1.514 . . . . 0.0 107.276 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.48 160.65 18.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.061 0.945 . . . . 0.0 108.951 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.82 -19.09 15.46 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.772 1.229 . . . . 0.0 113.164 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -73.59 -11.96 60.6 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.534 -1.354 . . . . 0.0 112.465 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.55 43.92 8.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -127.7 131.42 49.75 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.0 109.25 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.974 1.31 . . . . 0.0 108.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.5 -39.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 125.432 1.493 . . . . 0.0 109.331 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -153.76 142.64 21.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.112 1.365 . . . . 0.0 107.504 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.89 139.12 27.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.4 145.26 27.97 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -120.19 131.62 55.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.192 1.397 . . . . 0.0 107.474 -172.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.4 -15.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.3 m 62.55 -12.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.723 2.009 . . . . 0.0 114.658 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -139.74 116.44 10.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.67 1.588 . . . . 0.0 107.029 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.16 66.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.962 1.305 . . . . 0.0 112.676 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.454 HG21 ' HE3' ' A' ' 7' ' ' LYS . 5.6 p -91.05 15.34 11.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.347 1.459 . . . . 0.0 111.545 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -138.52 123.1 18.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.366 1.466 . . . . 0.0 109.201 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 155.34 90.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.997 0.919 . . . . 0.0 112.034 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.65 -167.47 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.421 3.414 . . . . 0.0 109.547 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -124.78 116.65 22.63 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -53.38 -27.36 23.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 112.551 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.88 -34.06 71.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.454 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.19 -57.02 19.55 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.233 0.924 . . . . 0.0 111.761 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.34 -29.27 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.398 1.399 . . . . 0.0 111.873 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 mm -56.11 -48.46 79.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 119.878 1.217 . . . . 0.0 109.668 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -65.5 -28.79 69.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.891 0.769 . . . . 0.0 111.423 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.42 -49.83 57.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.394 0.543 . . . . 0.0 111.348 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.8 74.81 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.486 0.714 . . . . 0.0 111.566 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -20.3 63.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.407 0.683 . . . . 0.0 112.175 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.68 -26.65 67.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.72 0.691 . . . . 0.0 111.393 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.6 mt -107.1 -21.97 12.8 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.866 1.266 . . . . 0.0 113.362 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 m -65.96 -18.8 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 119.123 0.874 . . . . 0.0 112.483 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.406 1.082 . . . . 0.0 110.126 -178.227 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 122.18 0.991 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.46 140.72 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.287 1.035 . . . . 0.0 108.472 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 p -102.1 156.97 17.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.988 0.915 . . . . 0.0 109.777 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -104.43 41.83 1.27 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 63.26 -39.8 0.18 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.606 2.762 . . . . 0.0 114.551 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.03 -36.03 33.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.95 0.786 . . . . 0.0 112.015 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.79 177.31 48.06 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.08 153.1 27.51 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.914 3.076 . . . . 0.0 112.797 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.27 131.63 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.62 1.168 . . . . 0.0 108.752 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -63.03 151.28 40.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.446 1.499 . . . . 0.0 111.105 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 mt -122.65 139.63 53.73 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.981 2.112 . . . . 0.0 106.97 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.91 -16.8 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.93 169.1 28.73 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -71.8 159.4 34.38 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.002 0.906 . . . . 0.0 112.057 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -73.37 149.87 42.22 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.51 148.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -131.85 160.35 35.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 111.142 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 141.85 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.028 1.331 . . . . 0.0 109.646 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -22.51 26.35 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.051 1.31 . . . . 0.0 112.027 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -74.95 151.16 38.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.514 1.157 . . . . 0.0 109.91 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -71.29 123.63 22.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.46 152.03 75.21 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.36 -26.53 44.29 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.797 2.998 . . . . 0.0 116.065 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t0 51.38 86.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.282 1.833 . . . . 0.0 114.303 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -127.14 -176.02 3.6 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.798 1.639 . . . . 0.0 108.814 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 m -124.37 154.2 40.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.198 0.999 . . . . 0.0 111.014 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.65 166.33 26.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.883 2.073 . . . . 0.0 107.811 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 tp -84.89 143.92 28.72 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.4 p -71.22 166.86 20.64 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -67.31 -3.42 7.99 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.024 -1.672 . . . . 0.0 112.156 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 m -110.56 17.1 21.08 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.367 1.867 . . . . 0.0 111.323 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.4 mt 66.51 28.1 9.53 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.347 1.459 . . . . 0.0 112.829 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.76 174.34 5.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.03 146.61 43.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.178 -1.576 . . . . 0.0 109.992 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -141.37 136.28 31.3 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 p -124.01 164.11 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.243 1.017 . . . . 0.0 109.247 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.68 -36.69 69.89 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.08 -0.388 . . . . 0.0 110.254 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.53 54.27 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.48 -39.75 52.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 mtt -64.27 -24.81 67.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.632 1.173 . . . . 0.0 111.323 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -55.85 -14.06 2.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.464 1.106 . . . . 0.0 113.401 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.23 -24.36 44.2 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.424 1.011 . . . . 0.0 113.423 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -151.36 169.01 23.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.908 1.354 . . . . 0.0 108.832 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.5 t -62.71 122.43 13.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.0 m -129.39 135.28 48.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.521 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.42 141.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -127.76 120.21 53.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 125.372 1.469 . . . . 0.0 107.42 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.4 m -116.94 100.32 7.68 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.269 1.028 . . . . 0.0 108.395 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.6 136.66 22.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.74 157.69 74.49 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.81 -60.44 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.833 2.355 . . . . 0.0 110.578 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 m -148.49 152.37 36.77 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.295 1.438 . . . . 0.0 107.958 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.75 -18.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.688 1.195 . . . . 0.0 113.284 -173.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.8 19.17 18.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.893 0.877 . . . . 0.0 111.753 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 p -68.84 -6.37 26.6 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.22 4.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.505 1.526 . . . . 0.0 110.71 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.03 -11.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 122.001 -0.706 . . . . 0.0 111.985 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.14 -21.61 13.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.067 0.947 . . . . 0.0 111.384 169.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -47.77 -47.78 30.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.96 1.304 . . . . 0.0 111.674 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.0 91.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.882 0.473 . . . . 0.0 110.762 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -82.72 -6.58 59.47 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.629 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -136.25 -62.8 0.66 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.676 1.125 . . . . 0.0 111.304 -169.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -83.27 -45.26 14.03 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.798 -1.189 . . . . 0.0 110.998 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -62.97 -32.6 73.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.697 0.68 . . . . 0.0 109.974 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.1 -43.58 87.2 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.327 0.512 . . . . 0.0 111.687 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.15 -45.06 96.2 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.992 0.517 . . . . 0.0 111.342 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.43 -51.03 71.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.46 -38.07 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.627 1.103 . . . . 0.0 110.529 -173.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.05 78.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.46 76.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.04 0.836 . . . . 0.0 110.65 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -70.74 -37.36 73.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.817 0.735 . . . . 0.0 109.77 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.57 -45.07 92.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.627 0.771 . . . . 0.0 109.857 170.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.09 -47.65 1.19 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.191 1.377 . . . . 0.0 110.859 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -140.36 109.52 6.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.301 1.041 . . . . 0.0 109.775 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.1 p -158.75 -175.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.981 2.512 . . . . 0.0 104.97 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.406 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -137.62 138.18 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.84 142.58 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.01 154.74 51.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.697 0.799 . . . . 0.0 109.055 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.5 m -117.67 142.33 47.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.0 mt -131.31 136.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.92 158.69 42.82 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.199 0.999 . . . . 0.0 110.15 -170.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.65 3.16 56.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.669 0.788 . . . . 0.0 111.794 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -101.52 -174.9 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.118 0.967 . . . . 0.0 109.978 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 133.58 90.31 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.79 -37.42 54.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.393 2.729 . . . . 0.0 113.964 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -72.41 -28.64 63.1 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.503 -0.748 . . . . 0.0 111.782 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.59 74.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.13 0.877 . . . . 0.0 109.42 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.36 -49.18 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.262 0.625 . . . . 0.0 110.384 169.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.74 75.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.281 0.491 . . . . 0.0 111.73 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -67.08 -40.5 87.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.356 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.07 -49.29 78.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.99 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.4 m -58.86 -48.25 82.04 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.38 0.536 . . . . 0.0 111.343 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.32 86.1 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.528 -0.596 . . . . 0.0 112.284 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.06 -41.71 70.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.013 0.906 . . . . 0.0 110.567 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -85.98 -22.15 27.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 119.088 -0.482 . . . . 0.0 112.179 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.42 24.17 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.51 143.35 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -146.92 -36.66 0.23 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.642 0.777 . . . . 0.0 112.999 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.45 -21.56 59.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.406 0.548 . . . . 0.0 111.201 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.77 165.2 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.937 1.295 . . . . 0.0 108.247 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -142.7 137.62 30.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 p -85.24 145.99 27.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt -135.12 169.33 17.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.625 1.97 . . . . 0.0 107.276 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -135.66 105.01 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.605 0.762 . . . . 0.0 109.481 -169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.64 -15.46 62.79 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.408 0.683 . . . . 0.0 110.927 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -46.11 -20.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.008 2.523 . . . . 0.0 113.45 169.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -40.8 -60.6 1.13 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.904 1.682 . . . . 0.0 111.497 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.29 15.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.126 0.97 . . . . 0.0 111.071 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.07 18.35 1.7 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.225 1.81 . . . . 0.0 113.325 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -49.68 76.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.928 1.291 . . . . 0.0 112.035 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -77.72 -40.64 40.51 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.931 -0.481 . . . . 0.0 109.843 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.71 -36.79 91.77 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.86 -51.24 69.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 117.544 0.672 . . . . 0.0 109.594 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.9 92.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.75 4.38 44.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.06 0.944 . . . . 0.0 112.423 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.93 39.68 96.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.091 0.853 . . . . 0.0 113.449 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.76 -12.91 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.52 1.128 . . . . 0.0 111.522 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.37 108.75 8.37 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mt -80.1 108.35 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -53.61 -45.75 70.19 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.702 1.201 . . . . 0.0 110.893 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.32 -2.39 24.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.029 0.932 . . . . 0.0 113.236 -173.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -125.92 -18.39 5.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.382 1.073 . . . . 0.0 112.346 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 52.94 39.04 28.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.644 1.178 . . . . 0.0 109.645 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -138.16 150.58 46.93 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.24 1.016 . . . . 0.0 108.31 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.36 145.24 49.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.449 0.643 . . . . 0.0 110.745 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.26 177.11 1.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.007 2.123 . . . . 0.0 111.014 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -115.31 106.39 13.97 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 169.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 m -152.76 169.28 23.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 158' ' ' PRO . 11.8 p -152.53 146.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -138.85 158.81 43.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.265 1.026 . . . . 0.0 109.073 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.82 143.08 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 170.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 mt -129.31 126.37 38.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.915 1.686 . . . . 0.0 107.078 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.52 165.07 21.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.388 0.675 . . . . 0.0 109.454 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.04 -23.56 47.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.975 0.91 . . . . 0.0 112.385 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -76.43 -3.67 38.33 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.966 -1.084 . . . . 0.0 112.126 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.39 24.61 76.02 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.077 0.846 . . . . 0.0 112.045 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.32 142.25 28.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.32 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.8 -15.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.735 0.814 . . . . 0.0 111.556 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -152.38 145.28 24.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.47 141.79 25.18 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -148.68 140.78 23.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -122.41 123.09 40.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.77 133.24 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -68.06 -7.7 31.54 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.066 0.947 . . . . 0.0 113.309 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.03 122.35 13.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.474 1.11 . . . . 0.0 108.303 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.27 -22.71 64.73 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.905 0.882 . . . . 0.0 113.26 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.1 p -76.21 1.44 15.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.013 0.824 . . . . 0.0 111.91 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.48 156.79 44.19 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.917 2.087 . . . . 0.0 107.531 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.5 157.54 74.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.726 0.81 . . . . 0.0 111.951 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.1 168.88 22.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.798 2.332 . . . . 0.0 110.447 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -108.95 118.0 35.66 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -48.99 -28.13 3.68 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.317 2.247 . . . . 0.0 113.381 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.28 -38.51 83.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.575 0.625 . . . . 0.0 111.17 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.51 -53.18 54.08 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.712 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 131' ' ' VAL . 62.1 Cg_endo -68.72 -25.92 33.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.621 1.548 . . . . 0.0 112.063 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -44.59 95.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 120.255 1.389 . . . . 0.0 109.104 171.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.27 -33.04 74.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.197 0.908 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.31 -53.15 39.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.513 0.325 . . . . 0.0 110.986 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.24 76.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.565 0.746 . . . . 0.0 112.08 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.27 67.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.753 0.706 . . . . 0.0 111.649 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -64.78 -30.14 71.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.183 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.02 -31.39 8.77 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.83 -30.32 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.905 0.775 . . . . 0.0 112.249 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 21.2 pttp . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.495 0.718 . . . . 0.0 110.457 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.0 mt -140.63 171.26 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.281 2.632 . . . . 0.0 103.98 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 p -117.64 148.25 42.12 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 120.989 -1.069 . . . . 0.0 109.826 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -75.58 -18.34 59.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.875 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt 138.55 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 132.089 4.156 . . . . 0.0 109.586 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.17 -5.6 26.58 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.053 0.835 . . . . 0.0 113.586 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.6 47.16 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.2 164.58 35.22 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.609 2.873 . . . . 0.0 112.439 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.73 139.38 46.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.532 1.533 . . . . 0.0 108.266 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -74.52 148.55 40.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.545 0.738 . . . . 0.0 109.502 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.74 146.85 42.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.743 2.417 . . . . 0.0 105.984 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -74.12 -14.16 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 179.86 21.44 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 119.319 0.963 . . . . 0.0 112.888 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -90.89 148.67 22.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.689 0.796 . . . . 0.0 110.043 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.09 141.52 58.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.45 147.39 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -128.44 165.82 19.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.577 0.703 . . . . 0.0 112.12 -168.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -52.63 140.17 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.799 1.64 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.32 63.44 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.655 -1.08 . . . . 0.0 112.955 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.13 157.31 16.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.133 1.467 . . . . 0.0 109.873 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -66.1 134.92 53.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.15 155.47 84.17 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.24 -25.77 73.61 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.21 2.607 . . . . 0.0 115.841 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.9 t70 51.0 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.586 1.954 . . . . 0.0 114.866 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -129.23 -175.19 3.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.516 1.526 . . . . 0.0 109.225 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.1 m -121.41 151.63 39.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 109.957 -169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.68 163.65 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.764 2.426 . . . . 0.0 106.688 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tp -87.35 147.4 25.5 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 169.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.4 p -72.02 166.85 21.39 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -65.41 -4.44 5.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.689 -1.257 . . . . 0.0 111.571 168.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.9 m -114.66 17.04 17.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.157 2.183 . . . . 0.0 111.322 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.5 mt 66.19 41.13 3.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 112.98 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.63 154.77 41.81 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.83 141.0 40.85 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.76 -1.213 . . . . 0.0 108.798 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.06 144.42 33.58 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.074 1.349 . . . . 0.0 107.499 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 p -139.1 166.21 25.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.54 -35.85 70.85 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.471 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.62 -30.7 43.95 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 113.593 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.81 -40.34 33.18 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.647 0.779 . . . . 0.0 110.67 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.8 mtt -63.36 -24.49 67.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.791 1.237 . . . . 0.0 111.31 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.79 -14.59 2.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.49 1.116 . . . . 0.0 113.319 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.55 56.39 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.519 1.054 . . . . 0.0 114.013 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.68 162.48 41.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.256 1.528 . . . . 0.0 108.212 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.07 119.59 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -124.53 131.02 53.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.481 0.313 . . . . 0.0 111.129 -168.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.6 mt -89.49 143.83 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -126.68 132.91 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.5 m -128.72 88.26 2.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.94 0.896 . . . . 0.0 108.602 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.45 133.95 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.27 73.34 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.56 -60.04 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.028 2.486 . . . . 0.0 113.333 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 m -152.04 164.26 37.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.458 1.903 . . . . 0.0 106.969 -170.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 tp -79.6 -17.87 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.77 -0.582 . . . . 0.0 112.23 -169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.79 -21.72 54.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.086 -1.008 . . . . 0.0 112.858 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 t -70.6 112.22 6.69 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 0.0 111.191 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.49 -31.32 80.37 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.566 -0.709 . . . . 0.0 112.843 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.23 -15.77 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.464 1.132 . . . . 0.0 112.419 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -105.93 -14.25 15.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.769 0.827 . . . . 0.0 112.336 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.59 -44.03 93.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.736 0.698 . . . . 0.0 109.545 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.41 93.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.424 0.69 . . . . 0.0 111.367 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -58.94 -56.15 25.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.59 0.632 . . . . 0.0 109.483 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.434 HG21 ' HE1' ' A' ' 93' ' ' TRP . 30.5 m -65.88 -35.59 81.06 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.169 0.895 . . . . 0.0 111.404 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -60.61 -49.65 76.68 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.523 1.056 . . . . 0.0 110.686 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.18 -34.44 76.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.911 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.17 -43.31 74.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.146 1.339 . . . . 0.0 110.915 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.51 -47.75 84.17 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.171 0.441 . . . . 0.0 111.606 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -63.45 -49.23 74.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.915 0.886 . . . . 0.0 109.085 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.04 -38.68 91.67 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.006 0.821 . . . . 0.0 110.591 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.99 97.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.974 0.806 . . . . 0.0 111.26 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.82 88.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.138 0.426 . . . . 0.0 111.103 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.07 -39.69 82.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.795 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.83 -40.69 96.16 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.203 0.911 . . . . 0.0 110.292 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.79 -24.44 12.69 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.624 1.107 . . . . 0.0 112.912 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -148.95 102.91 3.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.341 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.47 171.64 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.262 2.225 . . . . 0.0 105.069 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -128.68 143.04 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -153.14 144.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -135.92 158.43 44.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.028 1.331 . . . . 0.0 109.392 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -119.27 148.51 43.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mt -134.31 134.49 54.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.84 158.97 42.04 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.766 0.827 . . . . 0.0 109.881 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.36 41.79 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -129.46 165.75 20.98 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 111.271 -168.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.99 127.38 90.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 126.874 2.069 . . . . 0.0 108.621 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.05 -38.6 32.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.458 2.772 . . . . 0.0 113.94 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.45 -27.96 41.61 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.791 -0.568 . . . . 0.0 112.24 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.72 -42.37 67.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.374 0.988 . . . . 0.0 109.525 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -55.42 -42.92 74.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.176 0.99 . . . . 0.0 111.531 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.62 91.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.015 0.526 . . . . 0.0 111.414 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -66.42 -44.28 83.39 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.709 -0.62 . . . . 0.0 109.546 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' HE1' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -56.6 -43.13 79.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.708 0.803 . . . . 0.0 111.165 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.46 -35.84 34.32 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.823 0.738 . . . . 0.0 111.048 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.72 98.77 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.61 82.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.498 0.719 . . . . 0.0 111.085 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.57 -10.69 59.79 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.47 30.7 59.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 119.399 0.999 . . . . 0.0 111.008 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.0 mm -67.37 148.65 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.525 1.13 . . . . 0.0 108.117 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -137.69 -38.65 0.58 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 111.585 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -87.69 -22.72 24.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.239 1.016 . . . . 0.0 112.621 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.91 162.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -141.16 143.75 34.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 149.41 21.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 mt -135.48 156.23 49.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.916 1.287 . . . . 0.0 109.15 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -120.94 97.91 5.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.836 1.255 . . . . 0.0 109.181 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.23 -7.25 56.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.04 0.536 . . . . 0.0 110.839 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -43.46 -28.0 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.08 2.552 . . . . 0.0 114.018 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -57.42 -46.07 83.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.938 0.895 . . . . 0.0 111.731 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.98 11.47 0.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.5 mmm 53.55 20.45 2.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.205 . . . . 0.0 114.967 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.4 m -58.36 -44.07 88.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.22 0.918 . . . . 0.0 112.364 -171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -70.64 -46.57 63.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.89 -38.13 84.61 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.55 -50.69 72.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.023 0.911 . . . . 0.0 109.509 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.89 -8.2 57.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.384 0.674 . . . . 0.0 112.449 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.8 45.56 57.49 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.459 1.027 . . . . 0.0 112.029 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.1 25.29 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 110.764 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -116.8 119.18 34.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.36 102.21 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.06 -35.81 36.68 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.936 1.694 . . . . 0.0 111.317 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.01 -14.54 61.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.5 mt -130.83 -21.0 2.77 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 59.79 34.94 22.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.828 0.851 . . . . 0.0 110.028 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.62 154.07 45.68 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.647 1.179 . . . . 0.0 108.361 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.69 157.36 36.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.233 0.54 . . . . 0.0 110.163 172.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.04 -178.69 2.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.41 1.484 . . . . 0.0 110.551 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -106.06 13.39 29.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.793 0.837 . . . . 0.0 111.671 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.7 m -63.05 159.19 17.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.337 1.855 . . . . 0.0 112.886 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.79 149.12 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.631 0.773 . . . . 0.0 109.346 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -137.37 163.0 32.07 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.344 1.058 . . . . 0.0 109.774 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.82 140.94 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.9 mt -131.4 128.07 38.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.62 167.16 17.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.968 0.907 . . . . 0.0 109.86 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.89 -23.93 63.86 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.406 -0.809 . . . . 0.0 112.284 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -75.78 -11.44 59.99 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.731 -1.231 . . . . 0.0 111.827 172.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.93 22.44 71.69 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.146 0.879 . . . . 0.0 112.465 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -82.5 145.58 29.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.39 126.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -101.96 -34.84 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.727 1.611 . . . . 0.0 109.394 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -151.6 143.96 24.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 138.45 22.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.89 143.82 33.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.86 100.63 6.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.328 1.851 . . . . 0.0 106.43 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.55 119.42 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 m -71.06 -8.83 56.11 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -139.85 125.9 19.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.613 1.097 . . . . 0.0 108.311 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.19 70.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.785 0.834 . . . . 0.0 112.406 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 p -82.42 6.22 17.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.221 1.008 . . . . 0.0 112.892 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -120.16 162.32 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.251 1.42 . . . . 0.0 109.197 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -117.56 162.78 26.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.445 1.498 . . . . 0.0 110.106 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.17 -171.46 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.137 2.558 . . . . 0.0 109.918 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -128.68 112.4 14.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -56.58 -28.27 59.85 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.913 1.685 . . . . 0.0 112.897 -169.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.39 -31.87 73.2 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.889 -0.507 . . . . 0.0 111.754 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -61.8 -54.61 49.59 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.843 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.09 -26.95 49.94 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 CA-C-N 120.842 1.336 . . . . 0.0 111.822 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -44.05 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 120.218 1.372 . . . . 0.0 109.948 171.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.78 -32.29 73.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.137 0.88 . . . . 0.0 110.45 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.72 -49.64 57.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.3 0.24 . . . . 0.0 111.586 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.14 72.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.076 0.55 . . . . 0.0 112.018 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.49 64.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.496 0.718 . . . . 0.0 112.657 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.6 mt -111.35 -28.68 8.12 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.96 -11.94 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.3 pttt . . . . . 0 C--O 1.249 1.039 0 C-N-CA 125.864 1.665 . . . . 0.0 108.272 -176.474 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 122.427 1.108 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.02 145.94 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.026 1.33 . . . . 0.0 108.269 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -115.33 153.41 31.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.309 1.444 . . . . 0.0 109.396 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -110.91 42.6 1.58 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.822 1.249 . . . . 0.0 108.99 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm 42.0 64.65 1.04 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.738 2.015 . . . . 0.0 111.755 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.17 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.658 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 172.11 44.17 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.465 1.031 . . . . 0.0 110.573 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.76 159.75 51.64 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.403 2.735 . . . . 0.0 110.995 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.77 129.61 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.415 1.086 . . . . 0.0 108.386 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -61.74 156.36 20.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.492 1.517 . . . . 0.0 111.131 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.82 133.65 41.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.74 1.616 . . . . 0.0 109.284 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.29 161.52 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.75 -159.01 52.74 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.109 -0.994 . . . . 0.0 111.346 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.05 147.65 52.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.175 1.39 . . . . 0.0 109.205 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -66.13 115.42 6.12 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.3 158.37 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.969 1.307 . . . . 0.0 107.617 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -134.49 159.51 40.91 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 111.048 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.28 142.88 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.124 0.97 . . . . 0.0 108.999 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -22.28 24.43 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.03 1.3 . . . . 0.0 112.367 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -74.5 154.41 38.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.64 1.22 . . . . 0.0 109.839 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -70.14 132.69 46.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.71 158.82 48.74 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.74 -3.84 3.99 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.154 3.236 . . . . 0.0 117.548 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t0 53.64 57.76 5.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.978 1.371 . . . . 0.0 111.791 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -79.47 167.03 21.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.361 1.865 . . . . 0.0 110.26 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -135.03 148.29 49.89 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.33 170.74 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.981 2.112 . . . . 0.0 108.251 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -102.08 143.27 32.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.269 1.028 . . . . 0.0 108.808 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -74.05 -15.75 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 102.84 -14.92 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 130.264 3.426 . . . . 0.0 108.129 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -119.07 22.08 12.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.145 1.778 . . . . 0.0 111.052 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp 61.66 40.31 13.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.882 1.673 . . . . 0.0 111.656 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.88 156.05 43.2 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.42 152.37 19.15 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.381 0.61 . . . . 0.0 109.735 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.91 148.7 32.05 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.427 1.891 . . . . 0.0 106.139 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 p -149.97 171.66 16.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.531 0.605 . . . . 0.0 109.821 -169.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -43.47 -45.81 6.55 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 111.552 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.01 -29.01 66.93 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.963 0.905 . . . . 0.0 112.866 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -39.99 21.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.771 0.828 . . . . 0.0 110.717 174.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt -71.36 -34.87 70.86 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.154 0.582 . . . . 0.0 111.008 -170.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -63.85 -3.48 2.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.67 -21.84 23.31 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.146 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.44 168.26 20.97 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.26 1.53 . . . . 0.0 108.631 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.99 124.42 17.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.9 m -131.68 134.05 45.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.141 0.275 . . . . 0.0 111.11 -168.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.0 mt -93.21 141.1 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -123.48 133.54 68.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -129.34 106.05 8.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.4 127.93 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 pt -137.79 137.49 21.74 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.11 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.967 2.444 . . . . 0.0 114.185 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.3 m -159.45 158.25 31.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.882 1.673 . . . . 0.0 106.92 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -90.1 12.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 122.198 -0.314 . . . . 0.0 111.649 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -118.77 15.69 13.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.109 1.364 . . . . 0.0 110.338 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.42 -11.5 60.87 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.303 1.441 . . . . 0.0 113.395 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 -51.8 4.59 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.57 -22.44 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 118.028 0.914 . . . . 0.0 111.878 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.0 p -49.64 -36.21 23.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.272 1.029 . . . . 0.0 112.278 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.93 -38.32 90.53 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.928 0.891 . . . . 0.0 110.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.52 17.38 3.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.395 1.478 . . . . 0.0 112.003 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -132.16 -79.03 0.5 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.206 1.003 . . . . 0.0 108.338 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -52.9 -53.63 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.903 1.281 . . . . 0.0 112.991 -168.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -79.31 -27.9 42.16 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.172 -0.955 . . . . 0.0 112.126 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -62.51 -43.73 98.1 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.767 1.167 . . . . 0.0 109.689 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -58.43 -37.51 75.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.473 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -59.19 -49.57 77.33 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.566 1.076 . . . . 0.0 111.311 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.68 -47.43 66.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -64.0 -36.14 83.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.346 0.975 . . . . 0.0 111.034 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.13 86.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.868 0.758 . . . . 0.0 111.379 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.94 93.96 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.638 0.654 . . . . 0.0 110.273 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -34.4 78.19 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.609 0.641 . . . . 0.0 111.496 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.29 -22.23 65.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.062 0.846 . . . . 0.0 112.074 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 -43.42 3.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.947 1.26 . . . . 0.0 112.075 174.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.64 117.62 5.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.03 1.332 . . . . 0.0 108.928 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 78' ' ' ASN . 12.3 p -158.89 -175.6 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.086 2.154 . . . . 0.0 105.484 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' H ' HG22 ' A' ' 77' ' ' VAL . 48.6 t30 -139.66 138.22 35.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.36 138.87 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -128.81 159.39 35.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 m -126.7 145.92 50.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.95 138.04 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -140.94 152.57 45.1 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 123.51 0.506 . . . . 0.0 111.408 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.99 43.79 0.72 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.679 1.192 . . . . 0.0 108.663 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -131.05 158.7 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.589 1.556 . . . . 0.0 108.925 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.85 134.9 96.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.846 1.258 . . . . 0.0 111.08 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.85 -42.18 6.48 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 124.994 3.796 . . . . 0.0 115.554 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.66 -28.56 60.9 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.11 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.29 70.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.379 0.991 . . . . 0.0 109.419 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.9 -47.31 64.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.919 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.23 70.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.359 0.264 . . . . 0.0 111.364 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -61.76 -45.58 93.27 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.286 0.634 . . . . 0.0 110.789 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.0 -37.88 88.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.896 0.316 . . . . 0.0 110.476 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.2 m -66.84 -41.51 87.3 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.798 -0.564 . . . . 0.0 111.737 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -35.52 92.15 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.34 70.86 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.772 0.786 . . . . 0.0 110.243 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -78.92 -21.52 47.19 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.71 15.42 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.31 144.21 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -145.75 -37.43 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.614 1.166 . . . . 0.0 112.698 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -84.88 -13.37 51.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.559 0.743 . . . . 0.0 112.258 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.03 155.99 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -133.85 124.82 27.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 p -79.47 157.2 27.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.676 0.791 . . . . 0.0 109.339 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.4 mt -144.18 164.57 30.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.785 1.634 . . . . 0.0 108.102 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -118.21 140.98 48.98 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.544 -0.723 . . . . 0.0 109.389 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.54 5.59 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.18 1.792 . . . . 0.0 109.952 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -59.59 -26.72 65.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 111.841 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -60.17 -46.05 91.01 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.961 0.904 . . . . 0.0 111.87 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -156.01 14.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 95.0 mmm 48.12 26.51 1.04 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.849 2.06 . . . . 0.0 113.968 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.39 -50.14 73.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.643 1.177 . . . . 0.0 111.711 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.98 -48.66 75.56 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.145 0.884 . . . . 0.0 109.405 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.34 -47.67 80.88 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.29 -50.15 64.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.255 1.022 . . . . 0.0 109.832 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 7.58 43.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 112.154 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.94 36.57 86.65 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.735 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.7 -13.41 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.553 1.177 . . . . 0.0 111.636 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 104.94 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.78 98.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.36 -34.74 49.0 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.793 1.637 . . . . 0.0 111.108 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.62 -17.08 62.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.7 pp -146.78 16.47 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.962 1.256 . . . . 0.0 114.327 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 48.39 51.13 15.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.197 1.799 . . . . 0.0 111.685 169.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -152.28 150.44 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 51' ' ' VAL . 4.1 pp -81.45 156.02 25.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.688 0.676 . . . . 0.0 110.569 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.48 -155.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.856 2.062 . . . . 0.0 112.538 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.42 118.3 22.89 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 m -162.06 163.16 28.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -170.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.13 147.79 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.013 0.925 . . . . 0.0 108.685 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -138.68 156.83 47.08 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.064 0.945 . . . . 0.0 108.649 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.0 t -135.2 143.73 36.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.8 mt -128.27 126.21 40.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.939 1.695 . . . . 0.0 108.227 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.59 163.62 25.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.607 1.163 . . . . 0.0 110.154 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.25 -15.52 25.51 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.1 10.57 41.18 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.687 1.131 . . . . 0.0 112.225 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.43 76.99 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.978 . . . . 0.0 112.88 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.91 144.25 25.45 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.294 1.047 . . . . 0.0 108.442 173.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.39 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.65 -16.4 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.728 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -151.68 144.38 24.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.77 139.15 23.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -151.66 137.16 17.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -122.31 122.18 38.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.3 t -72.67 123.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.3 m -61.81 -40.67 96.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.584 0.353 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -83.6 109.55 17.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.943 0.897 . . . . 0.0 109.232 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.98 62.7 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.694 -0.629 . . . . 0.0 111.676 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -71.82 -1.08 12.84 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.084 1.354 . . . . 0.0 113.124 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.78 171.22 13.78 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.58 1.552 . . . . 0.0 110.067 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -128.55 156.84 76.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.518 1.527 . . . . 0.0 109.302 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.64 154.18 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.964 1.776 . . . . 0.0 109.391 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -79.61 116.01 19.56 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -52.43 -24.91 8.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.011 1.725 . . . . 0.0 113.459 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -62.34 -35.48 79.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.807 0.73 . . . . 0.0 111.467 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -64.58 -50.8 63.38 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 121.172 -0.955 . . . . 0.0 112.335 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.29 -25.95 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.075 1.42 . . . . 0.0 111.53 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -44.29 97.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 109.597 171.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.62 -33.28 75.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.325 0.966 . . . . 0.0 111.088 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.85 38.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.338 0.255 . . . . 0.0 110.915 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.29 78.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.232 0.613 . . . . 0.0 112.419 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -29.45 67.61 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.665 0.666 . . . . 0.0 111.709 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.1 68.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.219 0.607 . . . . 0.0 112.256 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.94 -28.66 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.38 -12.41 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.059 0.944 . . . . 0.0 110.087 178.041 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 122.852 1.311 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.84 153.45 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.804 2.042 . . . . 0.0 109.095 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -94.45 155.3 17.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.504 1.122 . . . . 0.0 108.407 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -132.59 108.26 8.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt 27.14 56.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.668 2.387 . . . . 0.0 115.253 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.73 -2.2 27.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 117.801 -1.555 . . . . 0.0 115.652 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.51 147.18 18.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 120.578 2.189 . . . . 0.0 111.988 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.78 154.32 67.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.056 2.504 . . . . 0.0 110.651 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.0 145.4 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.553 0.692 . . . . 0.0 110.11 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -79.52 156.88 27.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.919 1.288 . . . . 0.0 111.286 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.62 142.13 51.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.099 1.76 . . . . 0.0 108.843 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.17 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.44 -160.96 22.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.12 146.99 52.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.851 0.86 . . . . 0.0 109.266 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -65.56 113.76 4.42 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -73.06 169.53 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.401 0.546 . . . . 0.0 109.708 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.93 160.85 37.33 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.148 0.979 . . . . 0.0 109.065 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.58 137.8 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.32 -16.14 60.54 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.538 -1.146 . . . . 0.0 112.614 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.36 160.32 24.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.318 1.559 . . . . 0.0 109.941 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -99.92 121.84 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -55.05 136.95 67.07 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.595 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 49.9 Cg_exo -58.76 0.51 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.657 1 C-N-CA 126.112 4.541 . . . . 0.0 119.263 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.29 64.88 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.812 1.291 . . . . 0.0 111.447 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -73.62 165.45 25.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.698 1.599 . . . . 0.0 109.929 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.6 m -133.16 149.34 52.07 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.69 162.38 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.759 2.023 . . . . 0.0 106.734 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 tp -88.63 135.86 33.29 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -65.12 162.91 16.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -64.88 -8.52 15.74 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.663 -1.273 . . . . 0.0 111.004 168.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 m -95.27 6.41 49.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.874 2.07 . . . . 0.0 111.696 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.7 mt 70.84 35.88 1.65 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.32 1.448 . . . . 0.0 112.319 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.09 152.34 44.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.52 139.88 40.94 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.763 -1.211 . . . . 0.0 108.968 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -136.95 145.54 44.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.4 p -144.38 170.81 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.165 0.586 . . . . 0.0 109.701 -170.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -46.77 -44.75 19.31 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.374 0.67 . . . . 0.0 110.796 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.19 63.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.817 0.847 . . . . 0.0 113.022 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.31 -41.04 42.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.515 0.726 . . . . 0.0 110.542 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.7 mtt -69.05 -22.73 64.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.214 1.005 . . . . 0.0 111.877 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.08 -16.56 3.04 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.664 1.186 . . . . 0.0 113.291 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.55 53.25 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.763 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -153.13 160.09 42.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.456 1.628 . . . . 0.0 109.15 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.63 120.09 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.1 m -123.56 131.03 53.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.027 0.441 . . . . 0.0 110.639 -168.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.0 mt -89.37 141.58 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.64 137.81 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.7 m -131.31 94.53 3.58 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.86 143.43 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.48 150.02 59.33 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.656 0.783 . . . . 0.0 111.373 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.92 123.35 9.25 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.679 2.253 . . . . 0.0 110.047 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m 48.08 -162.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.471 1.509 . . . . 0.0 113.224 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 90' ' ' GLN . 3.7 tt -148.04 -22.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 120.882 -1.136 . . . . 0.0 111.51 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.92 -24.8 67.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.972 -1.08 . . . . 0.0 112.807 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.6 p -73.0 -17.77 61.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.137 1.375 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.04 -53.15 3.75 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.021 1.296 . . . . 0.0 112.805 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.55 -14.5 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.102 0.951 . . . . 0.0 110.457 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 14.3 p -49.56 -31.31 10.15 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.846 1.658 . . . . 0.0 113.449 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.66 130.57 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.578 1.081 . . . . 0.0 113.49 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.85 -6.43 8.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.498 1.919 . . . . 0.0 108.821 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -33.07 23.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.155 0.982 . . . . 0.0 110.803 -170.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 p -53.55 -48.31 69.22 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.071 1.305 . . . . 0.0 112.327 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -39.15 91.88 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.91 0.777 . . . . 0.0 110.959 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -66.76 -45.34 78.87 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.956 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -57.56 -41.34 80.84 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.88 0.764 . . . . 0.0 111.31 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -60.35 -50.87 71.9 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.653 0.781 . . . . 0.0 110.471 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.02 -41.63 77.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -67.86 -36.19 79.85 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.86 96.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.956 0.798 . . . . 0.0 110.884 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.07 93.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.925 0.33 . . . . 0.0 111.125 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -65.91 -40.98 91.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.43 -40.2 95.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.51 1.05 . . . . 0.0 110.25 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.3 10.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.818 1.199 . . . . 0.0 112.002 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -152.68 112.0 3.86 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.557 1.143 . . . . 0.0 109.121 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.86 176.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.405 2.282 . . . . 0.0 105.275 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -134.5 141.07 46.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.07 141.46 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -134.08 153.24 51.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.817 0.847 . . . . 0.0 109.917 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -108.58 146.67 32.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.23 135.0 57.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 m -131.36 152.51 50.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.307 1.043 . . . . 0.0 109.652 -170.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.37 52.24 1.02 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -140.08 165.06 28.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.98 145.96 96.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 123.268 0.627 . . . . 0.0 110.249 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.27 -32.07 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.623 2.215 . . . . 0.0 112.766 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -79.28 -22.13 45.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.199 0.909 . . . . 0.0 112.212 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.61 53.44 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.173 -0.955 . . . . 0.0 108.718 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' ILE . 66.4 mt-30 -51.36 -56.42 13.24 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.31 1.044 . . . . 0.0 110.492 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.15 -42.32 80.78 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.787 0.835 . . . . 0.0 111.843 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.0 -44.81 62.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.459 ' CE3' HD11 ' A' ' 55' ' ' ILE . 44.7 t90 -63.97 -39.62 94.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.976 0.511 . . . . 0.0 111.134 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.49 -36.29 57.89 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.212 -1.555 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.19 93.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.85 -45.37 82.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.646 0.778 . . . . 0.0 110.537 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -68.4 -24.09 64.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.521 0.728 . . . . 0.0 111.683 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.24 25.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.527 1.06 . . . . 0.0 111.837 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.18 142.87 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.152 0.981 . . . . 0.0 108.435 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -143.6 -44.31 0.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.485 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.67 -11.81 59.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.027 0.931 . . . . 0.0 111.941 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.49 160.94 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -140.6 145.8 37.16 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 p -89.68 139.49 30.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.905 1.682 . . . . 0.0 109.799 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 mt -131.14 168.91 16.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.615 1.966 . . . . 0.0 109.354 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.38 105.95 11.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.686 1.194 . . . . 0.0 111.683 -168.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -72.71 -21.94 60.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -52.57 -14.3 0.49 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.839 2.056 . . . . 0.0 113.121 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -45.91 -57.33 4.45 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.944 1.297 . . . . 0.0 110.821 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -164.59 16.49 0.05 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.2 mmm 55.86 26.35 9.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.761 1.624 . . . . 0.0 111.039 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -38.12 82.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.116 0.966 . . . . 0.0 113.018 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -74.06 -42.47 60.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.106 1.321 . . . . 0.0 108.907 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -41.64 -60.13 2.56 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.396 1.95 . . . . 0.0 111.884 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.8 -39.66 69.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.242 1.017 . . . . 0.0 110.473 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.63 95.42 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.23 0.612 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.43 9.25 37.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 113.208 -169.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.3 37.69 86.6 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.118 0.872 . . . . 0.0 111.972 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.452 HG23 ' HA2' ' A' ' 114' ' ' GLY . 8.1 m -126.54 3.92 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.56 1.144 . . . . 0.0 112.588 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -83.19 108.45 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.532 1.515 . . . . 0.0 107.183 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.91 111.56 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -55.4 -53.55 54.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.176 1.79 . . . . 0.0 111.406 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.79 -29.05 55.87 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.499 0.32 . . . . 0.0 111.255 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -79.5 -22.18 44.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.974 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 56.44 36.28 27.29 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -168.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -135.22 154.73 51.49 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.934 0.894 . . . . 0.0 109.745 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.36 142.69 52.11 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.458 0.703 . . . . 0.0 109.382 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.39 -168.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.801 1.64 . . . . 0.0 111.387 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -127.3 127.8 44.92 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -170.18 170.98 7.07 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.763 1.625 . . . . 0.0 106.968 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.6 145.12 30.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -137.46 156.79 47.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.328 1.051 . . . . 0.0 108.635 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 t -134.74 140.36 45.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.2 mt -129.07 126.39 39.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.434 1.494 . . . . 0.0 107.448 -169.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.94 167.73 9.23 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 109.147 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.12 -21.88 35.64 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.178 -0.951 . . . . 0.0 112.587 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -81.73 -7.5 59.6 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.594 -1.316 . . . . 0.0 112.543 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.03 16.77 80.46 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 120.872 -1.142 . . . . 0.0 112.133 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -77.79 133.66 38.18 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.12 110.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.55 -36.2 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.058 1.343 . . . . 0.0 109.687 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -151.47 145.22 25.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.05 133.6 18.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.99 137.07 22.07 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -104.8 117.21 33.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.9 127.96 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -69.76 -6.21 30.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -140.94 115.9 9.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 120.299 1.409 . . . . 0.0 107.475 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.61 69.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 -24.21 66.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.394 0.678 . . . . 0.0 111.113 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -100.82 126.31 47.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.169 1.388 . . . . 0.0 108.047 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -72.64 149.51 90.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.09 162.12 43.03 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.547 3.498 . . . . 0.0 109.596 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -96.36 120.38 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -55.98 -28.07 55.52 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.337 1.455 . . . . 0.0 112.703 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.16 -34.17 74.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.441 0.564 . . . . 0.0 111.426 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -65.06 -54.46 33.7 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 118.875 0.762 . . . . 0.0 111.692 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -30.44 24.05 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.486 1.458 . . . . 0.0 111.894 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 mm -54.43 -50.14 59.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 119.599 1.091 . . . . 0.0 109.523 169.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.32 -30.5 71.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.672 0.669 . . . . 0.0 111.494 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.09 71.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.164 0.438 . . . . 0.0 111.72 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.8 -45.55 57.91 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.452 0.701 . . . . 0.0 111.824 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -28.79 64.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.45 0.7 . . . . 0.0 111.56 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 -29.33 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 112.534 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 mt -103.63 -29.12 11.3 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.55 -10.64 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.094 0.957 . . . . 0.0 110.144 177.34 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 122.679 1.228 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 99.2 mt -54.85 156.73 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.733 1.613 . . . . 0.0 108.817 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.17 128.32 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.907 1.283 . . . . 0.0 108.177 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -84.68 42.58 0.92 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 110.268 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt 38.23 60.29 1.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.885 2.074 . . . . 0.0 112.337 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.75 -24.63 0.14 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.761 0.696 . . . . 0.0 111.646 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.35 169.05 40.58 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.94 155.3 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.144 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 m -136.54 166.37 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 107.949 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.9 m -117.18 161.05 20.08 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.033 0.933 . . . . 0.0 108.971 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 mt -125.54 141.98 51.75 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.852 1.661 . . . . 0.0 106.986 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.43 -65.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.25 165.72 54.77 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.49 165.29 24.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.708 0.766 . . . . 0.0 110.658 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.19 117.52 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.5 t -76.54 154.53 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -130.49 163.85 26.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 121.453 -0.779 . . . . 0.0 110.007 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.51 144.89 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.81 78.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.864 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -118.5 154.84 31.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.911 1.355 . . . . 0.0 108.814 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -65.87 134.86 53.93 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.51 159.24 61.74 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.732 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.23 -29.81 58.72 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.71 2.94 . . . . 0.0 115.845 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t0 46.72 86.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.258 1.823 . . . . 0.0 114.117 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -127.36 -172.79 2.74 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.284 1.433 . . . . 0.0 108.843 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.0 m -120.58 151.65 39.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.679 1.192 . . . . 0.0 110.461 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.61 165.06 27.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.723 2.409 . . . . 0.0 106.85 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.07 135.78 33.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -67.09 162.94 21.15 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.14 -10.41 49.94 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.488 -1.383 . . . . 0.0 110.816 168.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -82.1 3.38 27.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.578 1.951 . . . . 0.0 111.43 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.3 mt 68.44 30.93 5.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.897 2.079 . . . . 0.0 112.211 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.58 140.39 48.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.01 140.41 49.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.325 1.05 . . . . 0.0 111.456 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -141.68 143.48 33.61 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 126.094 1.757 . . . . 0.0 106.823 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -130.99 160.05 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tt -56.88 -33.92 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.257 0.481 . . . . 0.0 110.927 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.45 -29.62 50.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.092 0.957 . . . . 0.0 113.393 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -78.39 -40.34 36.45 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.125 0.97 . . . . 0.0 110.444 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.1 mtt -63.03 -27.29 69.31 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.953 1.301 . . . . 0.0 111.49 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -55.28 -15.46 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.058 . . . . 0.0 113.071 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.77 46.01 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.654 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -149.78 155.99 41.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.688 1.744 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.2 118.18 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.6 m -119.8 148.76 43.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.018 0.527 . . . . 0.0 110.029 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.22 146.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.12 138.57 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -113.17 99.63 7.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.518 1.527 . . . . 0.0 108.088 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.85 125.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 pt -133.55 155.3 80.73 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.281 1.032 . . . . 0.0 109.004 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.57 -58.1 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.95 2.433 . . . . 0.0 111.858 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.3 m -153.04 157.8 41.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.454 1.901 . . . . 0.0 106.732 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.07 -5.7 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.303 0.956 . . . . 0.0 111.52 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.9 -3.24 43.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.417 1.087 . . . . 0.0 112.623 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.3 p -64.29 -16.9 63.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -49.91 3.88 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.398 0.999 . . . . 0.0 111.089 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.72 -8.91 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.328 1.064 . . . . 0.0 112.239 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.3 p -55.21 -36.95 66.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.269 1.027 . . . . 0.0 108.953 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.56 -45.66 91.93 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.506 1.123 . . . . 0.0 111.177 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.61 -0.27 3.77 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 112.489 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -122.84 -87.74 0.63 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -48.89 -49.48 39.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.359 1.864 . . . . 0.0 113.532 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -72.44 -40.83 66.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.66 -1.275 . . . . 0.0 110.723 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.83 -38.48 91.12 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.061 -0.399 . . . . 0.0 110.342 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -60.22 -34.75 74.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.576 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -60.77 -50.29 74.07 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 120.094 1.315 . . . . 0.0 111.114 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.91 -42.59 76.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.302 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.35 -36.56 84.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.904 1.229 . . . . 0.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.56 -21.81 65.43 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.652 -0.655 . . . . 0.0 112.223 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.05 44.48 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.939 0.79 . . . . 0.0 111.194 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -72.19 -41.95 66.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.266 0.626 . . . . 0.0 110.143 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.19 137.22 58.15 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -36.27 80.19 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.765 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.75 79.08 0.86 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.49 1.145 . . . . 0.0 110.162 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.52 171.34 18.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.077 0.951 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -136.68 145.55 44.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.188 1.795 . . . . 0.0 106.802 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.26 151.67 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.306 -0.871 . . . . 0.0 109.749 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -135.42 170.72 15.51 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.513 1.525 . . . . 0.0 109.736 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.8 m -134.85 148.71 50.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.63 137.89 54.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -136.77 153.77 50.74 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.792 0.837 . . . . 0.0 111.427 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.8 46.15 1.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.413 1.485 . . . . 0.0 107.842 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -140.07 170.33 16.04 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.352 1.461 . . . . 0.0 107.863 -168.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.07 144.32 62.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 123.677 0.791 . . . . 0.0 111.181 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.04 -31.13 76.5 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.402 2.068 . . . . 0.0 112.896 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -71.55 -28.94 64.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.727 1.149 . . . . 0.0 111.387 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.09 74.54 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.043 0.838 . . . . 0.0 108.877 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.35 -46.51 69.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.513 0.725 . . . . 0.0 110.93 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.62 51.09 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.23 0.612 . . . . 0.0 111.211 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.12 -34.19 75.9 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.933 -0.479 . . . . 0.0 111.068 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -63.4 -42.5 98.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.124 0.42 . . . . 0.0 110.126 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.1 m -65.12 -42.9 93.47 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 121.77 -0.581 . . . . 0.0 111.37 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.31 98.85 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.33 86.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.571 0.748 . . . . 0.0 110.599 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.06 -24.86 51.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.127 0.571 . . . . 0.0 112.376 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 32.46 22.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.845 0.735 . . . . 0.0 111.432 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.08 144.64 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.8 -34.8 0.23 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.393 1.077 . . . . 0.0 112.677 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -79.21 -16.35 56.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.685 0.794 . . . . 0.0 111.952 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.19 159.1 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.05 134.74 40.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -92.84 145.59 24.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.632 0.773 . . . . 0.0 109.433 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 mt -136.66 166.04 24.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.936 1.695 . . . . 0.0 107.815 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 m -136.91 133.03 35.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.037 0.935 . . . . 0.0 109.352 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.23 -3.95 8.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.499 0.72 . . . . 0.0 112.14 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -57.22 -25.01 58.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.682 -1.261 . . . . 0.0 112.262 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -69.39 -25.11 63.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.272 1.029 . . . . 0.0 112.9 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.71 -19.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mmt 54.15 -0.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.144 2.978 . . . . 0.0 117.582 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 p -59.0 -36.78 75.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.501 1.501 . . . . 0.0 112.614 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.61 -56.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.022 0.529 . . . . 0.0 109.579 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.88 65.65 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.44 -53.65 55.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.467 0.707 . . . . 0.0 109.145 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.37 -31.0 57.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.154 -0.451 . . . . 0.0 112.17 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -4.0 27.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.567 0.621 . . . . 0.0 112.256 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 48.04 52.79 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 119.084 0.856 . . . . 0.0 111.283 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.89 -14.46 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.828 0.851 . . . . 0.0 111.383 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -72.93 111.86 8.43 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.54 112.13 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -54.26 -38.02 65.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.554 1.542 . . . . 0.0 111.425 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.62 -6.28 58.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.583 0.753 . . . . 0.0 112.638 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.7 mt -131.94 -21.24 2.43 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.038 0.935 . . . . 0.0 112.779 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 52.7 42.41 31.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.395 1.078 . . . . 0.0 109.313 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -135.19 153.22 52.03 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.218 1.407 . . . . 0.0 107.714 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.2 mt -84.06 141.94 30.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.327 0.512 . . . . 0.0 110.712 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.59 141.03 57.97 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.702 1.201 . . . . 0.0 109.806 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -68.36 109.09 3.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 p -154.77 165.06 37.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.878 0.763 . . . . 0.0 110.977 -169.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.27 153.52 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.79 156.45 46.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.359 1.063 . . . . 0.0 109.222 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.4 t -131.32 143.25 41.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 38.4 mt -135.2 126.4 28.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.736 1.615 . . . . 0.0 107.697 -169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.78 165.63 23.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.641 0.776 . . . . 0.0 109.085 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.14 -17.16 57.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.261 -0.899 . . . . 0.0 112.764 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -78.04 -11.45 59.91 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.537 -1.352 . . . . 0.0 112.236 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.03 75.87 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.009 -1.057 . . . . 0.0 112.645 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.93 139.28 37.14 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.89 134.26 30.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.48 -29.03 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.632 1.573 . . . . 0.0 109.254 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -155.08 146.28 22.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.61 1.564 . . . . 0.0 106.842 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.61 143.31 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.403 1.081 . . . . 0.0 108.463 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -149.93 146.5 27.09 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.848 1.659 . . . . 0.0 107.099 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -128.71 -15.34 4.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.561 1.545 . . . . 0.0 112.392 -169.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t 50.25 106.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 129.078 2.951 . . . . 0.0 113.093 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -59.14 -28.66 66.77 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.136 0.974 . . . . 0.0 112.797 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.67 105.94 17.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.1 62.4 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.9 p -73.68 -13.29 60.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.433 1.893 . . . . 0.0 112.904 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -109.87 156.45 20.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.557 1.543 . . . . 0.0 109.397 -169.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -106.8 153.46 40.76 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.373 0.669 . . . . 0.0 110.109 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.84 151.47 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.354 2.036 . . . . 0.0 109.488 171.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -82.04 119.39 23.94 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -54.05 -25.61 22.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.783 1.633 . . . . 0.0 112.878 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -60.59 -35.64 76.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.681 0.673 . . . . 0.0 111.138 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.82 -53.32 50.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.529 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.9 -27.8 43.09 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.951 1.375 . . . . 0.0 112.214 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.22 -46.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 120.695 1.588 . . . . 0.0 109.82 172.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.43 -33.77 76.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.907 0.776 . . . . 0.0 110.679 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.66 68.32 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.675 0.274 . . . . 0.0 111.149 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.38 -48.7 66.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.982 0.513 . . . . 0.0 110.795 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -29.05 69.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.746 0.703 . . . . 0.0 111.643 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.88 -31.7 71.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.579 0.627 . . . . 0.0 111.568 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.8 mt -88.29 -24.6 23.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.89 0.876 . . . . 0.0 112.054 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.4 -27.93 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.966 171.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.034 0.934 . . . . 0.0 110.746 176.548 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.32 148.64 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 p -92.87 153.11 19.01 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.601 1.091 . . . . 0.0 110.307 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -112.46 41.31 2.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.091 1.356 . . . . 0.0 108.622 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 44.11 62.99 1.77 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.769 2.028 . . . . 0.0 112.3 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.04 -25.63 0.16 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.55 1.071 . . . . 0.0 110.922 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.49 173.89 45.71 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.979 1.276 . . . . 0.0 110.108 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.56 157.61 58.34 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.157 2.572 . . . . 0.0 111.004 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.47 136.99 48.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.644 1.578 . . . . 0.0 107.471 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -74.32 154.78 38.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.763 1.225 . . . . 0.0 109.878 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.72 138.68 54.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.055 1.742 . . . . 0.0 106.549 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 120' ' ' TYR . 22.3 m -78.71 -173.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.9 -152.83 51.73 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 123.266 0.46 . . . . 0.0 112.967 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -132.23 155.42 48.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.479 1.111 . . . . 0.0 109.697 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.12 154.41 37.8 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 168.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.13 152.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -126.37 157.31 38.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.62 1.168 . . . . 0.0 110.264 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.24 142.71 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.609 1.163 . . . . 0.0 109.377 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.17 -19.44 46.53 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.811 1.196 . . . . 0.0 111.878 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -74.94 149.26 39.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.396 1.098 . . . . 0.0 109.599 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -73.08 120.29 18.51 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 155.26 73.71 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.306 0.242 . . . . 0.0 110.768 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.17 -19.02 15.18 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 125.295 3.997 . . . . 0.0 118.501 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 55.03 65.24 1.55 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.924 1.345 . . . . 0.0 110.692 -168.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -71.58 168.33 17.85 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 110.071 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -131.06 149.21 52.71 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.48 167.43 14.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 125.825 1.65 . . . . 0.0 106.696 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 tp -86.05 147.28 26.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.1 p -72.57 172.0 11.39 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.684 -1.26 . . . . 0.0 107.701 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -67.26 -3.31 7.57 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.835 -1.166 . . . . 0.0 111.498 168.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.1 m -118.58 17.63 13.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.968 2.107 . . . . 0.0 111.276 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 63.86 43.73 5.24 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.402 1.481 . . . . 0.0 112.449 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.87 154.22 45.73 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 142.97 39.04 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.749 -1.219 . . . . 0.0 109.21 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.77 147.47 35.58 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.601 1.56 . . . . 0.0 107.05 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 p -143.06 165.9 26.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.997 0.919 . . . . 0.0 109.175 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.8 -34.49 67.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.354 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.58 -31.24 56.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.021 0.828 . . . . 0.0 112.975 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.87 -35.98 37.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.958 0.903 . . . . 0.0 111.426 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.8 mtt -78.9 -34.97 44.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.936 0.895 . . . . 0.0 112.111 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.77 -3.48 3.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -18.14 23.65 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 118.916 -0.936 . . . . 0.0 112.03 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -139.57 164.61 29.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.109 1.455 . . . . 0.0 109.138 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.51 128.29 20.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.1 m -130.45 136.77 49.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.3 mt -100.29 142.21 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.8 mm -120.33 129.01 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.9 m -124.97 98.59 5.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.418 1.087 . . . . 0.0 108.455 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.14 135.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.58 155.5 75.24 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.476 1.51 . . . . 0.0 107.929 172.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.99 -51.97 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.673 1.582 . . . . 0.0 110.76 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.25 158.88 42.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.258 1.423 . . . . 0.0 107.869 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 90' ' ' GLN . 9.7 tt -106.79 29.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.114 0.966 . . . . 0.0 112.317 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -134.79 16.44 3.58 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.814 0.845 . . . . 0.0 110.422 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.8 p -81.91 -9.43 59.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.225 1.01 . . . . 0.0 112.544 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.14 -50.08 3.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -25.64 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.165 0.982 . . . . 0.0 110.853 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -49.48 -33.83 15.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.449 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.87 -43.61 94.61 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.116 0.967 . . . . 0.0 111.497 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.25 6.29 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.736 1.214 . . . . 0.0 113.023 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.84 -77.82 0.58 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -54.2 -46.61 72.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -65.55 -41.97 92.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.213 0.915 . . . . 0.0 110.13 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -81.1 -25.71 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.999 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -63.36 -38.1 89.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.263 0.938 . . . . 0.0 109.726 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -61.35 -43.16 99.34 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.943 0.792 . . . . 0.0 111.147 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.83 -56.35 16.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.77 -30.69 70.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.297 -0.877 . . . . 0.0 111.87 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.24 89.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.15 0.886 . . . . 0.0 111.088 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.76 80.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.555 0.616 . . . . 0.0 110.664 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -41.25 90.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.091 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.97 -39.63 90.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.571 0.748 . . . . 0.0 110.2 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.95 -27.73 8.7 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.628 1.108 . . . . 0.0 112.048 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -151.62 118.4 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.49 172.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 78' ' ' ASN . 10.5 p -163.1 -176.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.622 1.969 . . . . 0.0 105.749 172.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -138.81 136.03 35.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.59 145.63 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 152.19 51.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.586 0.754 . . . . 0.0 109.977 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 104' ' ' THR . 19.4 m -104.53 146.0 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.3 mt -129.28 132.95 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 m -134.57 149.63 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.577 1.151 . . . . 0.0 109.768 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.66 55.31 2.94 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.03 160.39 40.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.056 1.342 . . . . 0.0 108.098 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.29 146.51 92.2 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.262 -169.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.8 -44.04 43.34 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.269 2.646 . . . . 0.0 112.858 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -77.23 -28.26 53.65 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.754 -0.591 . . . . 0.0 111.855 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.27 83.31 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.128 0.876 . . . . 0.0 109.996 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HA ' HG21 ' A' ' 55' ' ' ILE . 41.8 mt-30 -69.83 -46.43 65.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.252 0.621 . . . . 0.0 111.507 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.94 77.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.439 0.563 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -50.22 74.53 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.703 1.201 . . . . 0.0 108.769 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.44 ' CD1' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -56.62 -45.51 81.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.505 0.322 . . . . 0.0 110.159 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.0 m -64.28 -44.72 90.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.219 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.28 -37.02 90.54 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.15 80.56 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.842 0.821 . . . . 0.0 110.635 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -79.35 -33.08 43.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.162 0.585 . . . . 0.0 111.985 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 37.81 8.86 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.02 144.59 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.77 -37.58 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.694 1.197 . . . . 0.0 112.486 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.71 -16.2 42.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.558 0.743 . . . . 0.0 112.318 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.61 159.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -134.05 140.14 46.46 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.9 p -96.63 145.55 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.0 mt -134.9 158.28 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.29 113.65 22.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.914 1.686 . . . . 0.0 108.346 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.32 10.8 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.839 0.828 . . . . 0.0 111.651 170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.21 -16.25 5.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.327 1.451 . . . . 0.0 111.214 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.4 ttt-85 -68.43 69.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.945 1.698 . . . . 0.0 109.508 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 46.17 41.15 8.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.284 1.834 . . . . 0.0 113.85 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.9 mmm 50.04 32.02 5.4 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.231 1.812 . . . . 0.0 113.601 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.7 m -53.71 -49.72 67.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.975 0.91 . . . . 0.0 111.751 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -72.03 -43.72 64.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.893 0.77 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.46 92.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.101 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.37 -47.46 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.013 0.907 . . . . 0.0 109.9 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.18 75.58 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.66 4.65 38.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.264 1.026 . . . . 0.0 112.265 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.05 49.5 77.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.482 1.039 . . . . 0.0 113.616 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.16 -12.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.58 1.552 . . . . 0.0 111.251 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CD2' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -67.73 113.63 5.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 169.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.4 mt -75.36 109.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.68 -41.53 55.81 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.658 1.983 . . . . 0.0 111.28 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.8 2.45 53.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.489 -171.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.54 -25.13 3.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.088 0.858 . . . . 0.0 113.311 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 56.06 33.89 22.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.592 0.633 . . . . 0.0 109.884 -168.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.38 164.6 20.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.651 1.58 . . . . 0.0 107.107 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.73 147.58 24.73 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.156 0.503 . . . . 0.0 110.127 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.88 145.26 46.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.411 1.484 . . . . 0.0 110.637 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -79.19 102.57 8.58 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 71.1 m -149.77 168.47 23.59 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.751 1.22 . . . . 0.0 108.46 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.39 149.81 17.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.982 -0.449 . . . . 0.0 109.798 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.6 157.17 45.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.283 1.033 . . . . 0.0 108.692 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -137.93 138.64 43.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.52 133.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.504 1.522 . . . . 0.0 107.408 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.1 176.69 3.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.872 0.869 . . . . 0.0 110.591 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.24 9.57 0.31 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.783 1.233 . . . . 0.0 114.243 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -127.6 4.77 6.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.875 1.67 . . . . 0.0 110.219 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.86 77.98 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.973 0.806 . . . . 0.0 112.553 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -87.4 136.84 32.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 119.452 1.626 . . . . 0.0 107.274 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.74 126.94 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.57 -19.84 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.464 0.705 . . . . 0.0 110.46 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -154.33 144.89 22.3 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.84 140.07 24.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.828 1.651 . . . . 0.0 107.168 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -152.23 147.33 26.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.306 0.503 . . . . 0.0 109.658 171.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.58 104.83 7.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.848 2.059 . . . . 0.0 105.633 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.22 133.61 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -73.39 -13.66 61.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -138.11 113.85 9.78 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.03 68.11 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 p -74.28 -0.66 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.31 0.959 . . . . 0.0 113.155 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.09 167.21 17.87 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.454 1.101 . . . . 0.0 108.957 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -117.88 157.14 49.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.472 0.709 . . . . 0.0 112.263 -168.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.67 152.27 78.13 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.618 2.212 . . . . 0.0 108.783 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -78.79 117.39 19.87 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -56.36 -20.97 21.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.499 1.519 . . . . 0.0 113.279 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.08 -36.62 82.25 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.054 0.843 . . . . 0.0 111.424 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -61.33 -52.62 69.41 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 119.327 0.967 . . . . 0.0 111.945 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.78 -27.86 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 120.797 1.32 . . . . 0.0 111.766 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -45.04 93.78 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 120.11 1.323 . . . . 0.0 109.731 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.19 -35.71 81.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.872 0.76 . . . . 0.0 110.652 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.38 79.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.401 0.143 . . . . 0.0 111.053 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.72 -50.12 46.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.736 0.415 . . . . 0.0 111.2 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -34.11 70.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.679 0.672 . . . . 0.0 111.157 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.33 67.19 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.361 0.528 . . . . 0.0 112.018 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.34 -23.74 16.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 50.2 t -57.13 -36.17 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.583 0.629 . . . . 0.0 110.495 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.717 1.207 . . . . 0.0 110.88 175.654 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.8 mt -132.73 168.99 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 p -115.93 148.17 40.33 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.88 -1.138 . . . . 0.0 109.011 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -91.69 37.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 63.25 -41.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.876 2.871 . . . . 0.0 114.204 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.79 -31.12 41.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.319 0.961 . . . . 0.0 112.477 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 173.73 46.46 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.234 1.017 . . . . 0.0 111.245 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.6 152.13 50.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 124.0 3.133 . . . . 0.0 113.718 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.51 127.58 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.507 1.923 . . . . 0.0 107.133 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -70.08 153.71 42.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.516 1.526 . . . . 0.0 110.634 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.07 140.42 44.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.42 1.488 . . . . 0.0 108.459 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.13 -16.82 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.42 162.15 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.89 160.04 33.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.74 0.781 . . . . 0.0 110.442 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 pm0 -74.17 136.96 42.87 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 168.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.53 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -133.66 161.62 34.15 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.271 -0.893 . . . . 0.0 110.427 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.14 140.93 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.87 32.78 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.797 -1.001 . . . . 0.0 112.862 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -70.51 155.54 40.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.179 1.49 . . . . 0.0 109.235 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -76.34 127.55 33.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 158.84 57.92 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.563 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -54.86 -14.95 8.85 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.432 3.421 . . . . 0.0 117.867 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 52.78 56.94 6.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 123.103 1.43 . . . . 0.0 110.169 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -83.26 170.95 14.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.928 2.091 . . . . 0.0 111.32 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 m -131.8 149.22 52.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.823 1.249 . . . . 0.0 107.653 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.89 170.87 10.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.703 2.001 . . . . 0.0 106.956 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tp -87.13 142.6 27.8 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -69.58 166.6 18.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.14 -6.64 18.56 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.634 -1.291 . . . . 0.0 110.897 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -100.24 8.64 43.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.055 2.142 . . . . 0.0 111.688 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.0 mt 68.15 39.52 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.404 1.482 . . . . 0.0 112.688 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -127.48 157.76 39.22 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.31 142.76 48.84 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 120.896 -1.127 . . . . 0.0 108.962 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.9 142.63 33.08 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -135.45 165.18 26.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.902 0.881 . . . . 0.0 108.656 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -53.97 -33.16 56.18 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.38 -0.343 . . . . 0.0 111.465 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.71 -33.56 61.2 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.42 -35.46 70.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.4 mtt -78.81 -29.69 44.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.386 1.474 . . . . 0.0 111.882 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -55.8 -14.86 2.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.635 1.574 . . . . 0.0 114.619 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.39 -17.41 32.24 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.604 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -151.17 157.54 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.26 1.53 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.66 126.51 13.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 46.8 m -118.89 151.66 37.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.424 0.69 . . . . 0.0 109.832 -169.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.7 mt -123.86 146.67 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 mm -130.18 110.66 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.631 1.572 . . . . 0.0 107.398 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 140.32 45.37 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.97 122.15 64.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.65 153.63 68.23 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.56 -57.09 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 111.301 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -146.28 142.5 28.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.556 1.942 . . . . 0.0 105.991 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' CE3' ' A' ' 93' ' ' TRP . 11.6 tt -77.33 -22.79 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -168.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.92 -18.67 62.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.8 p -66.54 149.78 49.95 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.861 0.755 . . . . 0.0 109.643 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.44 -37.41 92.01 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.901 -0.5 . . . . 0.0 111.898 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.46 -43.09 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 117.9 0.85 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -62.42 -42.71 99.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.891 0.769 . . . . 0.0 110.671 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.94 -56.23 24.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.664 1.186 . . . . 0.0 110.84 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.85 79.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.92 0.488 . . . . 0.0 112.248 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -57.17 10.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 173.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -62.46 -44.67 95.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.846 0.748 . . . . 0.0 111.948 -170.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -76.66 -37.57 56.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.194 1.361 . . . . 0.0 112.859 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -62.3 -43.18 99.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.045 0.839 . . . . 0.0 108.878 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.21 -35.36 76.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.944 -0.551 . . . . 0.0 112.003 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.38 -42.91 96.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.575 1.08 . . . . 0.0 112.263 173.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.76 -42.97 99.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 64.6 mm-40 -61.46 -39.08 89.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.864 1.211 . . . . 0.0 111.448 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.63 78.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.444 0.566 . . . . 0.0 111.092 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.37 83.07 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.941 0.791 . . . . 0.0 111.478 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -65.13 -39.46 93.07 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.459 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.7 -49.72 69.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 109.785 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 -61.91 2.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.967 1.746 . . . . 0.0 112.032 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -83.79 55.28 3.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.547 1.539 . . . . 0.0 110.72 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.14 169.91 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.191 1.396 . . . . 0.0 107.778 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 47' ' ' THR . 42.5 t30 -130.15 137.82 50.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.1 t -144.86 145.29 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.177 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -138.16 171.72 13.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.918 1.287 . . . . 0.0 109.689 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 m -132.8 144.42 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.42 1.888 . . . . 0.0 105.905 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -131.47 133.32 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -135.19 152.79 51.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.331 1.052 . . . . 0.0 109.539 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.46 45.12 1.16 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -129.62 164.94 22.78 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 -168.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.9 137.38 96.0 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.49 -42.71 48.0 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.091 2.528 . . . . 0.0 112.196 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -73.31 -32.24 64.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.621 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.39 -43.55 90.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.409 1.004 . . . . 0.0 109.802 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.05 -48.55 79.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.013 1.325 . . . . 0.0 111.908 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.8 86.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.751 0.705 . . . . 0.0 111.158 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -45.64 93.72 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.318 1.047 . . . . 0.0 108.953 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.409 ' CE3' HD11 ' A' ' 55' ' ' ILE . 85.8 t90 -64.69 -40.71 95.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.336 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 m -61.14 -43.66 98.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.606 0.639 . . . . 0.0 110.885 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.15 86.47 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.358 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.21 92.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.061 0.931 . . . . 0.0 110.629 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.96 -13.32 19.16 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.24 37.61 41.78 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.62 143.14 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.952 1.301 . . . . 0.0 108.207 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -139.35 -25.87 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -117.74 -5.04 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.431 1.092 . . . . 0.0 111.984 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.23 158.5 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -143.59 135.6 26.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 p -96.67 142.75 28.33 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.278 1.031 . . . . 0.0 108.358 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.97 150.21 45.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.528 1.531 . . . . 0.0 108.471 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -107.62 106.79 17.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 111.025 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.35 -11.34 59.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 109.843 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -48.64 -28.22 3.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.633 1.173 . . . . 0.0 111.58 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.98 88.11 1.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.075 1.35 . . . . 0.0 110.787 170.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.5 t70 65.03 14.48 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.059 1.744 . . . . 0.0 115.433 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp 44.34 30.7 0.49 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.016 2.527 . . . . 0.0 115.064 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.24 -46.86 88.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.439 0.696 . . . . 0.0 111.38 -173.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -66.32 -50.38 63.81 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -39.18 96.18 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 123.059 0.361 . . . . 0.0 112.202 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.47 -53.6 27.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.711 0.804 . . . . 0.0 109.978 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.08 67.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.93 56.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.597 1.159 . . . . 0.0 111.851 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.06 49.68 65.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.826 0.727 . . . . 0.0 113.296 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -123.4 -11.17 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.867 1.267 . . . . 0.0 111.012 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 108.05 3.72 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 98.4 mt -74.7 115.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.1 -47.54 82.38 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.448 1.099 . . . . 0.0 111.229 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.65 13.93 2.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.122 0.874 . . . . 0.0 113.237 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 40.14 53.82 2.77 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.204 2.201 . . . . 0.0 113.689 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 tp -145.96 169.55 18.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.113 0.965 . . . . 0.0 108.681 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.07 137.25 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.087 0.555 . . . . 0.0 109.984 -173.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.49 149.22 49.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.987 1.315 . . . . 0.0 111.156 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -81.05 115.9 20.73 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 70.8 m -162.18 171.19 17.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.747 1.219 . . . . 0.0 108.825 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.19 144.4 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.501 -0.749 . . . . 0.0 109.622 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -132.66 153.16 51.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.811 0.695 . . . . 0.0 110.479 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.63 134.27 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -125.39 132.57 52.76 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.108 1.363 . . . . 0.0 107.979 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.0 166.0 22.26 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.371 1.068 . . . . 0.0 109.747 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.36 -26.89 43.84 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.382 1.073 . . . . 0.0 112.394 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.61 -0.43 23.35 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.042 -1.036 . . . . 0.0 112.115 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 28.19 73.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.036 0.827 . . . . 0.0 111.887 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.33 147.33 26.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.321 1.06 . . . . 0.0 108.28 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.1 t -71.72 138.15 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.73 -35.66 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.909 1.684 . . . . 0.0 109.419 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -150.18 142.94 24.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 144.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.78 148.51 27.31 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 17' ' ' GLU . 63.8 m-85 -132.0 98.61 4.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.468 2.307 . . . . 0.0 105.982 -169.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.42 131.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -67.79 -15.64 63.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.992 0.917 . . . . 0.0 113.183 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -126.28 118.14 24.49 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.44 69.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.22 0.608 . . . . 0.0 111.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.6 p -68.93 -12.71 61.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.568 1.547 . . . . 0.0 112.679 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -116.64 161.26 19.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.866 1.666 . . . . 0.0 108.674 -170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -121.94 153.15 60.5 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.776 0.83 . . . . 0.0 110.297 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.85 150.68 55.94 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.666 1.577 . . . . 0.0 108.301 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.19 115.98 20.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -66.7 -8.77 30.2 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.93 -32.05 71.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.997 0.817 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.18 -53.15 34.23 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.306 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.01 -30.43 25.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.494 1.569 . . . . 0.0 111.564 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.94 -51.47 53.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 119.191 0.905 . . . . 0.0 109.44 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.98 -28.97 70.17 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 111.545 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.88 -49.37 46.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.113 0.565 . . . . 0.0 111.427 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.62 65.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.236 0.614 . . . . 0.0 111.192 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -32.54 65.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.49 0.716 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.73 76.52 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.359 0.664 . . . . 0.0 111.316 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.6 mt -79.57 -44.75 20.5 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.216 0.462 . . . . 0.0 110.96 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -84.48 14.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.249 1.069 0 O-C-N 121.53 -0.731 . . . . 0.0 109.583 169.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 122.032 0.92 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.85 147.27 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.768 0.827 . . . . 0.0 109.085 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.3 p -116.08 167.4 11.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.945 1.698 . . . . 0.0 109.135 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -135.8 95.08 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 40.76 33.42 0.2 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.584 2.354 . . . . 0.0 115.921 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.31 -23.96 0.27 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.418 -1.212 . . . . 0.0 114.777 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.78 169.49 40.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.778 1.789 . . . . 0.0 113.006 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.31 154.01 65.91 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.898 3.065 . . . . 0.0 111.831 -173.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.11 128.06 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.274 1.03 . . . . 0.0 108.835 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -61.7 156.31 20.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.48 1.512 . . . . 0.0 111.275 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.7 mt -125.68 141.4 52.03 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.586 1.954 . . . . 0.0 106.942 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.27 -65.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.3 -170.25 46.93 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.269 0.937 . . . . 0.0 112.276 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -108.96 150.19 28.09 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.1 0.96 . . . . 0.0 110.796 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.61 121.22 12.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.96 167.71 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.5 155.93 49.52 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.477 -0.764 . . . . 0.0 109.558 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.44 136.18 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 170.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.95 -18.5 57.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.013 1.292 . . . . 0.0 111.943 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -76.99 157.02 31.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.73 1.265 . . . . 0.0 109.537 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -81.26 126.67 31.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.85 93.67 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.262 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -55.16 -30.27 70.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.36 2.707 . . . . 0.0 116.031 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 50.71 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.391 1.877 . . . . 0.0 113.728 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.35 178.1 6.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.907 1.283 . . . . 0.0 109.616 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -108.1 152.42 24.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.25 1.02 . . . . 0.0 109.564 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -141.61 171.33 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.583 2.353 . . . . 0.0 107.315 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.95 155.68 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.0 p -71.16 -158.35 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.653 1.181 . . . . 0.0 109.366 169.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -72.33 0.14 10.81 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.353 -1.467 . . . . 0.0 113.054 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -126.54 -88.72 0.57 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.508 1.049 . . . . 0.0 108.627 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -157.56 -3.88 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.346 1.858 . . . . 0.0 112.405 -169.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.38 138.35 32.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -72.9 138.88 46.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -137.27 149.26 46.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.999 1.72 . . . . 0.0 106.534 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -137.67 160.2 39.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.97 -30.39 67.89 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.967 -0.458 . . . . 0.0 111.861 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -28.04 68.4 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.832 0.853 . . . . 0.0 112.816 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -75.72 -36.31 59.99 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.487 0.715 . . . . 0.0 110.425 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.8 mtt -73.96 -36.48 64.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -65.67 0.83 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.35 -16.38 20.5 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.005 -1.059 . . . . 0.0 112.73 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -141.02 167.63 21.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.112 1.456 . . . . 0.0 108.263 169.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.47 128.97 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.9 m -131.68 151.36 51.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.409 0.284 . . . . 0.0 110.888 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.4 mt -113.82 139.02 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.45 126.02 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -118.96 98.34 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 0.0 108.745 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 m -74.89 136.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 155.9 80.42 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 169.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.04 -54.92 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.676 2.251 . . . . 0.0 111.775 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -157.37 149.45 22.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.45 -15.72 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.43 -0.793 . . . . 0.0 111.266 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.64 -16.46 61.01 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.166 -0.959 . . . . 0.0 113.289 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.6 p -61.37 -23.8 66.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.716 1.144 . . . . 0.0 114.024 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -42.47 2.16 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.315 0.96 . . . . 0.0 111.436 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.04 -24.54 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.884 1.273 . . . . 0.0 110.421 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 24.1 p -47.48 -32.27 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.257 1.423 . . . . 0.0 113.009 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.6 -33.49 70.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 125.353 1.461 . . . . 0.0 112.253 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.03 -17.4 57.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.271 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -108.57 -80.12 0.58 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.1 m -54.15 -43.39 70.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.529 1.132 . . . . 0.0 113.624 -168.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -63.06 -53.33 55.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.514 0.597 . . . . 0.0 109.596 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -69.54 -36.16 76.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.78 -172.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -59.22 -36.91 76.26 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.88 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -60.18 -46.06 91.0 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.863 1.21 . . . . 0.0 110.477 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.68 -51.34 57.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.56 -38.54 87.86 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 121.285 -0.884 . . . . 0.0 110.94 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.97 -37.37 86.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.888 0.767 . . . . 0.0 111.309 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.83 95.62 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.685 0.675 . . . . 0.0 110.643 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -38.75 83.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.586 0.63 . . . . 0.0 111.367 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.48 -33.33 73.59 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.862 0.865 . . . . 0.0 110.538 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.28 -35.06 3.5 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.81 1.195 . . . . 0.0 111.859 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.48 116.76 5.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.666 1.187 . . . . 0.0 109.207 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.0 p -159.19 -174.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 127.476 2.31 . . . . 0.0 105.409 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.2 t30 -138.85 134.2 33.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -141.39 140.43 31.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 108.7 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.18 159.8 37.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.279 1.032 . . . . 0.0 109.899 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.0 m -122.12 142.8 50.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.52 141.13 46.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.0 t -143.71 155.18 44.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 110.499 -169.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 9.78 41.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.26 177.91 8.31 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -84.82 147.1 47.71 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 123.968 0.907 . . . . 0.0 110.201 -169.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.63 -45.36 27.87 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.858 3.038 . . . . 0.0 113.698 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -67.0 -29.72 69.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.518 -0.739 . . . . 0.0 112.311 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.98 72.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.312 0.96 . . . . 0.0 109.657 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -52.88 -51.36 61.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.559 0.743 . . . . 0.0 109.658 170.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.93 74.81 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 111.164 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -62.75 -45.94 90.35 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.566 0.747 . . . . 0.0 110.25 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -63.48 -43.95 95.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.655 0.382 . . . . 0.0 110.854 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -70.16 -37.87 75.3 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.744 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.52 -38.08 94.38 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.3 79.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.627 0.771 . . . . 0.0 110.216 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -70.74 -31.8 68.75 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.657 0.783 . . . . 0.0 112.694 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.14 35.78 23.06 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.25 144.18 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.53 -35.26 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.699 1.199 . . . . 0.0 112.602 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.66 -10.41 51.39 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.605 0.762 . . . . 0.0 112.471 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.9 159.83 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.72 149.94 52.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 140.09 48.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.797 0.839 . . . . 0.0 110.228 -169.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.3 mt -138.74 163.81 31.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.468 1.507 . . . . 0.0 109.07 -169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.34 136.15 36.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.099 0.56 . . . . 0.0 109.516 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -122.67 -5.46 8.65 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.603 0.761 . . . . 0.0 111.679 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -57.68 -19.5 27.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -54.46 -43.02 71.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 111.23 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.84 -1.79 0.3 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.394 0.678 . . . . 0.0 112.664 -171.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 64.1 mmm 47.04 28.44 0.9 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.771 2.428 . . . . 0.0 113.601 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -44.81 92.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 111.149 -171.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.84 -46.59 57.51 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -37.19 87.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -46.26 90.69 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.769 -0.842 . . . . 0.0 109.245 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.56 79.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.89 1.71 16.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.643 0.777 . . . . 0.0 112.481 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.79 90.23 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.982 1.265 . . . . 0.0 112.553 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 m -124.91 -2.16 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.116 1.366 . . . . 0.0 111.397 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -79.56 105.99 11.27 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.26 101.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -51.69 -42.23 62.03 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.333 1.453 . . . . 0.0 111.441 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.6 -10.81 60.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -122.61 -17.73 6.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.187 0.995 . . . . 0.0 112.069 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.19 38.13 26.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.048 -168.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 157.27 43.95 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.471 1.108 . . . . 0.0 108.592 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.4 tp -77.79 148.65 34.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.122 0.969 . . . . 0.0 109.279 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.2 -175.06 4.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.492 . . . . 0.0 111.458 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.7 ttm105 -121.73 111.93 17.77 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 m -157.69 169.55 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.483 1.913 . . . . 0.0 106.94 -170.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.35 144.57 18.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -134.18 157.64 45.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.715 1.206 . . . . 0.0 108.542 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.75 134.63 53.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.76 132.16 53.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.941 1.296 . . . . 0.0 108.07 -173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.45 167.52 10.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.601 1.561 . . . . 0.0 109.592 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -58.54 -21.17 51.65 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.449 -0.782 . . . . 0.0 113.024 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -86.9 -0.17 56.05 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.297 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.56 23.29 78.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.04 -1.037 . . . . 0.0 112.299 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -88.14 141.28 28.69 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.826 1.313 . . . . 0.0 107.518 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.3 t -68.57 116.86 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.74 -33.97 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.827 1.251 . . . . 0.0 109.275 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -158.96 146.35 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.32 144.15 27.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -145.52 136.99 25.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -128.6 121.28 28.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.53 135.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -67.79 -5.89 18.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.778 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -147.41 118.8 7.87 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.49 63.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.111 0.964 . . . . 0.0 113.549 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 10.12 20.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.881 1.272 . . . . 0.0 110.414 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -127.77 178.3 6.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.55 2.34 . . . . 0.0 108.132 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -138.3 152.15 70.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 120.623 -1.298 . . . . 0.0 112.147 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.63 149.55 18.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.687 2.258 . . . . 0.0 108.951 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -74.71 115.84 14.73 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -51.73 -26.53 9.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.032 1.733 . . . . 0.0 112.922 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -61.7 -31.31 71.45 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.646 -0.659 . . . . 0.0 111.882 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -48.04 10.63 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.741 1.155 . . . . 0.0 112.07 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.01 -30.65 32.07 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 121.315 1.505 . . . . 0.0 111.646 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.3 mm -55.36 -50.17 67.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.313 0.961 . . . . 0.0 109.42 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.12 -32.73 73.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.39 0.541 . . . . 0.0 111.364 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.01 69.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.097 0.559 . . . . 0.0 111.512 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.13 -46.52 56.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.522 0.729 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -26.22 62.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.783 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.07 65.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.287 1.035 . . . . 0.0 113.175 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.27 -26.96 6.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.15 -13.41 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.184 1.794 . . . . 0.0 108.123 -175.934 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 CA--C 1.545 0.783 0 CA-C-O 122.047 0.927 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 13' ' ' LEU . 40.6 mt -54.0 126.1 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 109.131 -170.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.0 p -76.99 161.87 28.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.444 0.64 . . . . 0.0 110.105 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -116.97 38.93 3.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.153 0.981 . . . . 0.0 109.552 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm 41.83 63.91 1.2 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.596 1.959 . . . . 0.0 111.571 -171.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.1 -28.18 0.11 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.239 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.54 170.46 42.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.618 1.104 . . . . 0.0 110.534 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.9 158.52 55.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.739 2.959 . . . . 0.0 110.761 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.47 142.28 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -67.51 157.08 35.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.513 1.525 . . . . 0.0 110.359 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' HA ' ' H ' ' A' ' 122' ' ' LYS . 4.6 mp -135.18 144.94 47.28 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.911 1.284 . . . . 0.0 107.771 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -82.44 147.91 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.44 -157.15 19.45 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -132.62 161.3 34.26 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.93 115.24 5.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 168.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -83.4 151.44 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -132.67 155.05 49.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.883 0.873 . . . . 0.0 109.888 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.43 141.02 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.049 0.94 . . . . 0.0 109.289 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.55 -21.64 31.54 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.943 1.259 . . . . 0.0 112.175 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.67 152.79 40.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.73 1.265 . . . . 0.0 109.771 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -70.81 126.79 30.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 152.41 73.79 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.152 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.77 -29.0 60.26 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.224 2.616 . . . . 0.0 115.482 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.6 t0 51.9 85.91 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.913 2.085 . . . . 0.0 113.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.37 172.34 12.83 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 110.642 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -87.04 158.99 19.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.771 1.628 . . . . 0.0 110.366 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 p -151.87 159.31 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.043 2.537 . . . . 0.0 105.639 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tp -90.54 145.99 24.44 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.548 -1.345 . . . . 0.0 108.018 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -74.35 165.66 24.81 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.056 -1.028 . . . . 0.0 108.395 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -66.67 -6.61 16.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.871 -1.143 . . . . 0.0 111.368 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -93.54 3.7 55.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.39 1.876 . . . . 0.0 111.893 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp 62.81 44.74 6.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.195 1.398 . . . . 0.0 111.817 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.49 160.76 29.64 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.68 1.192 . . . . 0.0 107.785 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -78.31 142.08 38.01 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.844 -1.16 . . . . 0.0 109.753 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -139.15 163.52 32.22 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.161 1.784 . . . . 0.0 106.55 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 p -151.68 169.22 22.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.969 -1.082 . . . . 0.0 108.51 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.73 -27.6 59.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.512 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -28.64 62.32 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.01 -41.42 35.9 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.361 0.664 . . . . 0.0 109.834 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.4 mtt -65.45 -40.63 93.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.966 0.906 . . . . 0.0 109.105 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -71.1 -0.89 10.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.67 . . . . 0.0 112.381 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.16 -15.72 59.02 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.837 -1.165 . . . . 0.0 111.97 169.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -147.94 168.96 20.93 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.899 1.349 . . . . 0.0 108.428 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.97 120.9 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 168.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -130.14 153.89 48.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 123.156 0.285 . . . . 0.0 110.763 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.03 142.18 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.1 mm -127.85 113.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -112.94 98.44 7.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.141 0.976 . . . . 0.0 109.007 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.41 140.71 15.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.33 -0.857 . . . . 0.0 108.872 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.85 156.03 72.88 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.839 1.256 . . . . 0.0 108.491 169.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.81 -50.03 12.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.644 2.229 . . . . 0.0 112.498 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -160.44 164.62 32.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.936 2.494 . . . . 0.0 106.295 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 tt -98.3 -23.79 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.56 0.618 . . . . 0.0 111.564 -169.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -82.91 54.44 2.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.862 1.265 . . . . 0.0 110.387 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -154.99 -178.15 7.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.184 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.95 179.5 31.24 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.38 0.991 . . . . 0.0 112.271 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.285 19.5 m 53.25 -6.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 129.339 3.055 . . . . 0.0 116.832 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.8 m -65.27 -22.7 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.59 -1.319 . . . . 0.0 110.896 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.27 -31.76 67.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.666 -0.647 . . . . 0.0 111.233 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.46 -58.2 2.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.892 0.769 . . . . 0.0 109.778 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.29 -15.78 63.7 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -128.89 -54.17 1.22 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.79 1.177 . . . . 0.0 110.074 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.97 -52.31 13.24 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.771 1.169 . . . . 0.0 111.556 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.55 79.41 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.388 0.995 . . . . 0.0 109.605 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -44.21 71.9 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.336 0.516 . . . . 0.0 111.67 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.02 -44.08 93.67 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.619 0.767 . . . . 0.0 111.836 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.35 -49.48 77.42 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 73' ' ' LYS . 21.8 mm-40 -64.27 -39.47 94.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.094 0.861 . . . . 0.0 110.863 -176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.974 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.25 -33.55 69.92 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.427 1.012 . . . . 0.0 110.775 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 70' ' ' GLU . 17.3 mmtp -68.84 -40.08 79.59 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 109.346 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.24 -50.43 74.03 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.25 -0.21 60.02 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.769 1.176 . . . . 0.0 114.286 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.92 65.51 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.133 1.373 . . . . 0.0 108.668 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.96 167.7 4.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.024 1.33 . . . . 0.0 107.593 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -120.49 144.44 48.01 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.4 147.08 14.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.954 -1.091 . . . . 0.0 109.748 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -134.13 162.81 31.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.703 1.601 . . . . 0.0 109.417 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -127.84 149.26 50.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.89 136.5 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 m -139.37 158.64 43.8 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.47 48.99 1.43 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -132.4 165.33 24.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.55 1.54 . . . . 0.0 108.889 -169.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.96 136.18 96.69 Favored Pre-proline 0 C--O 1.236 0.387 0 C-N-CA 123.826 0.851 . . . . 0.0 109.826 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.37 -42.8 46.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.352 2.702 . . . . 0.0 112.277 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -73.68 -31.58 63.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.523 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.9 75.05 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.358 0.981 . . . . 0.0 108.993 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -57.7 -42.89 84.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.125 0.97 . . . . 0.0 112.572 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.48 85.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.031 0.832 . . . . 0.0 111.264 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.26 -42.33 93.37 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.306 0.643 . . . . 0.0 109.725 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -60.4 -40.23 90.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.24 0.616 . . . . 0.0 110.527 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -65.23 -47.09 78.02 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.007 -0.433 . . . . 0.0 111.173 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.08 96.84 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.21 97.25 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.744 0.818 . . . . 0.0 110.702 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -85.39 -19.75 30.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 112.702 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.86 38.18 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 mm -64.33 142.81 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -144.91 -37.83 0.28 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.05 0.94 . . . . 0.0 112.652 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -80.81 -25.85 37.54 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.393 0.677 . . . . 0.0 111.226 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.8 157.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.827 1.251 . . . . 0.0 107.668 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -138.06 138.82 39.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 p -95.65 148.19 22.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.5 1.12 . . . . 0.0 108.205 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -137.93 140.19 40.17 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.655 1.182 . . . . 0.0 108.648 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -102.29 105.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.6 1.16 . . . . 0.0 110.06 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.34 -4.47 55.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.754 169.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -51.56 -41.36 61.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.737 1.215 . . . . 0.0 111.589 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.2 -44.76 44.64 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.645 0.778 . . . . 0.0 111.424 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.59 -36.15 11.36 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 55.12 -19.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.719 3.208 . . . . 0.0 115.759 -169.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -59.46 -33.0 70.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.371 1.441 . . . . 0.0 112.678 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -67.54 -54.65 18.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.989 0.813 . . . . 0.0 108.942 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -36.71 73.03 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -32.05 71.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.332 1.053 . . . . 0.0 110.822 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.93 -44.11 10.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.615 0.643 . . . . 0.0 112.319 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.17 13.49 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.57 93.22 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.563 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.77 -10.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.47 1.135 . . . . 0.0 112.149 -168.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -82.11 116.37 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.8 mt -79.6 97.47 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' ' HA ' ' A' ' 13' ' ' LEU . 57.6 tttm -44.68 -55.64 5.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 126.615 1.966 . . . . 0.0 111.869 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -86.11 -11.54 52.4 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 mt -83.54 -21.74 32.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.943 0.792 . . . . 0.0 109.525 168.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 58.36 32.06 21.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.915 1.286 . . . . 0.0 109.354 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -135.79 154.17 51.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 108.516 -177.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.421 ' H ' HD13 ' A' ' 126' ' ' LEU . 14.3 tp -77.37 152.17 34.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.168 0.987 . . . . 0.0 109.778 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 -174.44 5.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.31 1.044 . . . . 0.0 111.258 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -116.43 127.04 54.25 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -167.43 175.15 7.39 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.51 1.924 . . . . 0.0 107.128 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.15 145.92 14.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -137.7 158.41 44.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.859 1.264 . . . . 0.0 109.345 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.26 144.71 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -131.54 128.75 39.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.634 1.573 . . . . 0.0 108.149 -169.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.25 163.43 27.84 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 109.011 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.21 -17.53 42.1 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -81.42 -4.96 57.33 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.296 -1.502 . . . . 0.0 112.378 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.93 27.64 66.3 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.317 -0.865 . . . . 0.0 111.698 -172.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.36 144.11 27.44 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.33 135.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.2 -32.92 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.416 1.486 . . . . 0.0 109.614 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -150.12 144.85 25.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 139.84 24.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -148.22 149.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -125.85 142.83 51.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.348 1.859 . . . . 0.0 106.214 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.96 -10.51 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m 62.99 -21.99 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.241 2.216 . . . . 0.0 115.626 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -143.63 123.97 13.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.218 1.372 . . . . 0.0 107.505 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.05 -18.38 46.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.9 p -77.63 -3.96 43.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.227 0.921 . . . . 0.0 112.905 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 163.11 25.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.402 1.001 . . . . 0.0 110.048 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -118.54 155.97 51.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.632 -170.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.15 155.04 47.19 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 108.2 -1.5 . . . . 0.0 108.2 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -84.65 114.0 21.69 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -49.1 -26.07 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.009 2.124 . . . . 0.0 113.508 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.8 -37.57 82.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.877 0.762 . . . . 0.0 111.242 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -63.98 -51.92 60.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.617 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.59 -27.3 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.806 1.67 . . . . 0.0 112.233 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -59.82 -45.63 94.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-N 120.22 1.373 . . . . 0.0 109.246 171.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.91 -32.85 74.52 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.885 0.766 . . . . 0.0 111.021 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.25 56.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.611 0.364 . . . . 0.0 111.103 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.61 -46.87 71.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.135 0.574 . . . . 0.0 111.639 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -29.1 67.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.72 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.28 77.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.317 0.508 . . . . 0.0 111.696 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.72 -35.65 19.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.439 0.563 . . . . 0.0 112.401 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.91 -9.32 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.736 0.814 . . . . 0.0 110.18 176.257 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.514 HD12 HD21 ' A' ' 13' ' ' LEU . 85.1 mt -137.59 169.66 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 150.49 31.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -143.08 121.84 12.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.61 37.61 3.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.344 1.458 . . . . 0.0 113.166 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.28 12.05 60.39 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.196 -1.336 . . . . 0.0 114.628 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.06 154.43 23.9 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.954 1.877 . . . . 0.0 110.955 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.0 153.93 63.02 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.653 2.236 . . . . 0.0 111.344 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -139.04 129.2 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.526 1.53 . . . . 0.0 108.286 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -74.54 160.39 30.97 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.197 1.399 . . . . 0.0 109.244 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.514 HD21 HD12 ' A' ' 4' ' ' ILE . 4.9 mp -129.54 148.91 51.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 108.944 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 t -82.36 135.26 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.0 -158.28 14.44 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 118.38 0.536 . . . . 0.0 112.785 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -131.62 143.88 50.65 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.316 1.447 . . . . 0.0 108.666 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.86 103.0 7.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.84 157.09 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 108.832 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -127.71 156.5 42.29 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.991 1.316 . . . . 0.0 109.357 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.72 140.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.13 59.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.6 1.095 . . . . 0.0 112.756 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.78 156.8 37.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.32 1.56 . . . . 0.0 109.582 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.37 139.65 32.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.63 159.34 74.82 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -60.4 -7.06 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.449 3.432 . . . . 0.0 117.8 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 52.4 58.58 5.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.833 1.302 . . . . 0.0 110.823 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -85.69 165.78 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.034 1.734 . . . . 0.0 109.712 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -130.9 146.12 52.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.988 1.315 . . . . 0.0 107.514 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.87 168.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.581 1.952 . . . . 0.0 107.235 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.68 146.67 26.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.0 p -74.42 167.11 22.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -63.89 -8.02 9.91 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.062 -1.023 . . . . 0.0 111.656 168.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -109.72 13.9 23.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.836 2.054 . . . . 0.0 111.251 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 64.59 44.99 3.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.167 1.387 . . . . 0.0 111.978 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.14 161.53 29.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.58 144.13 35.82 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.62 -1.3 . . . . 0.0 108.895 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -142.67 145.83 33.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 m -140.37 167.28 22.51 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.671 0.788 . . . . 0.0 109.556 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 tp -47.22 -40.53 16.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.193 0.997 . . . . 0.0 111.958 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.97 -30.95 62.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.72 0.808 . . . . 0.0 113.084 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.55 -40.59 42.02 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.464 0.65 . . . . 0.0 110.577 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.8 mtt -65.34 -27.04 68.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.706 1.202 . . . . 0.0 111.346 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -55.42 -16.08 3.3 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 113.414 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.8 -20.37 56.91 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.845 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -154.47 156.45 36.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.443 1.621 . . . . 0.0 109.0 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.24 122.04 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.7 m -117.2 150.81 38.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 109.975 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.8 mt -121.89 145.64 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.2 mt -126.54 138.94 53.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.23 93.83 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.242 1.817 . . . . 0.0 106.823 -171.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.45 128.32 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 pt -139.27 154.45 72.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.11 -46.49 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 CA-C-N 121.098 1.428 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 p -158.73 173.98 15.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.614 1.966 . . . . 0.0 107.762 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.437 HD11 ' CE3' ' A' ' 93' ' ' TRP . 3.8 tt -113.58 -177.67 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.802 0.841 . . . . 0.0 110.635 -169.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 56.3 43.81 25.78 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.24 1.416 . . . . 0.0 112.894 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -147.27 138.43 23.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -45.55 -46.34 12.37 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.191 1.376 . . . . 0.0 114.56 -169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.21 -25.59 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.434 1.094 . . . . 0.0 112.598 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.46 -40.59 7.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.925 1.69 . . . . 0.0 110.099 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.92 -49.76 74.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 127.15 2.18 . . . . 0.0 110.693 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.31 88.31 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.948 0.499 . . . . 0.0 111.348 -174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -61.36 2.63 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.7 m -64.33 -39.07 93.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.337 0.517 . . . . 0.0 111.163 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.89 -50.37 69.02 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.219 -0.926 . . . . 0.0 110.253 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.86 -33.59 75.05 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.602 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.31 -39.68 73.12 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 120.142 1.337 . . . . 0.0 112.16 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.94 -48.91 79.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.601 1.091 . . . . 0.0 110.874 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -67.6 -44.09 78.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -63.3 -37.82 88.73 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.03 -1.044 . . . . 0.0 110.819 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.6 92.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.622 -0.674 . . . . 0.0 111.041 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.06 88.6 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.788 0.722 . . . . 0.0 111.227 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -67.66 -40.09 84.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.694 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.7 mp -60.9 -45.41 94.73 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.852 0.751 . . . . 0.0 109.842 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.59 -9.83 61.04 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.961 1.267 . . . . 0.0 114.842 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -153.62 58.66 0.75 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.042 1.421 . . . . 0.0 109.492 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.43 171.9 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.783 1.233 . . . . 0.0 107.789 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.97 141.61 50.74 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 t -138.05 151.95 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.188 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.28 169.69 16.83 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.984 1.314 . . . . 0.0 109.703 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -132.75 143.85 49.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.98 133.88 60.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 m -139.48 158.57 43.91 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.57 1.169 . . . . 0.0 110.879 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.5 54.22 2.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 168.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.43 163.95 31.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 108.244 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.65 135.86 85.89 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -169.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.16 -36.68 79.7 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.986 1.791 . . . . 0.0 110.714 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -75.2 -27.71 59.71 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.776 -0.63 . . . . 0.0 112.101 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.72 71.29 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.52 1.055 . . . . 0.0 108.964 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -60.18 -41.61 93.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.826 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.97 92.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.63 0.65 . . . . 0.0 111.007 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -67.55 -39.25 84.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.174 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.437 ' CE3' HD11 ' A' ' 55' ' ' ILE . 74.9 t90 -69.25 -45.13 70.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.207 0.603 . . . . 0.0 110.934 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -69.76 -33.73 72.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.824 -1.173 . . . . 0.0 110.353 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -33.69 87.92 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.037 -0.868 . . . . 0.0 112.402 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.74 93.41 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.705 1.253 . . . . 0.0 110.206 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -72.83 -27.71 62.11 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.123 0.569 . . . . 0.0 111.968 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.14 53.41 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mt -68.37 145.8 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.263 1.025 . . . . 0.0 108.499 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.89 -34.93 0.42 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.069 1.348 . . . . 0.0 111.976 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.33 -13.62 59.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.645 0.778 . . . . 0.0 111.927 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.16 155.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -134.21 130.81 37.76 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -84.46 151.55 24.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.101 0.56 . . . . 0.0 109.62 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 mt -143.09 150.27 39.29 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.505 1.522 . . . . 0.0 107.255 -173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.4 m -116.01 115.39 26.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.652 1.181 . . . . 0.0 108.505 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.26 -9.7 55.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.581 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.39 -36.42 6.44 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.049 2.139 . . . . 0.0 114.259 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -78.57 -13.39 59.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.891 -173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -147.64 -16.19 0.37 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -169.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.1 mmm 51.93 9.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.462 2.705 . . . . 0.0 117.213 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.7 m -63.15 -38.25 90.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.751 1.614 . . . . 0.0 112.525 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -64.71 -50.53 66.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.128 1.331 . . . . 0.0 108.952 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.48 97.73 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 -172.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.464 0.706 . . . . 0.0 109.814 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.581 -0.7 . . . . 0.0 111.847 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.57 1.02 40.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.691 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.1 90.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.873 1.215 . . . . 0.0 112.862 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.9 -7.37 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.743 1.217 . . . . 0.0 111.352 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.75 108.3 5.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.058 1.299 . . . . 0.0 107.942 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.86 112.71 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -57.32 -38.09 73.51 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.519 1.527 . . . . 0.0 110.887 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.58 8.51 40.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.965 0.906 . . . . 0.0 112.149 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.66 -23.87 2.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 55.58 37.35 28.76 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 110.037 -168.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.9 mt -130.72 161.15 32.31 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.125 1.37 . . . . 0.0 108.092 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.6 mt -83.27 143.35 30.46 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.14 152.01 41.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 111.01 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -80.7 100.61 8.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 62.0 m -147.97 167.25 25.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.328 1.451 . . . . 0.0 109.417 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 m -141.0 153.41 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.469 -0.769 . . . . 0.0 110.515 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.69 157.12 44.99 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.539 1.136 . . . . 0.0 109.619 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.49 139.51 48.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -133.24 119.49 19.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 107.618 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.01 163.85 21.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.56 0.744 . . . . 0.0 109.528 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.2 -23.33 21.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.078 1.351 . . . . 0.0 112.811 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -76.06 -6.49 51.33 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.805 -1.184 . . . . 0.0 112.377 175.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.17 42.61 35.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -121.46 132.09 54.53 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.81 112.78 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -171.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.28 -33.76 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.692 1.197 . . . . 0.0 109.355 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -154.99 147.04 23.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.839 1.256 . . . . 0.0 108.363 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.33 31.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.776 1.23 . . . . 0.0 107.837 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.1 137.59 21.0 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.886 0.874 . . . . 0.0 108.794 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -131.33 93.97 3.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 105.355 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.54 132.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 m -67.79 -9.67 46.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 113.074 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.15 110.51 11.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.74 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.885 0.874 . . . . 0.0 110.925 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.46 6.02 6.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 112.627 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -122.88 173.24 7.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.196 2.199 . . . . 0.0 107.033 170.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.57 157.44 73.08 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 120.936 -1.103 . . . . 0.0 111.543 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.17 -179.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.742 3.628 . . . . 0.0 113.594 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -124.77 111.7 15.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -52.25 -25.07 8.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.69 1.996 . . . . 0.0 112.948 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.67 -38.04 80.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.995 0.816 . . . . 0.0 111.383 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -60.28 -56.09 38.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.892 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.9 -26.96 31.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.49 1.46 . . . . 0.0 112.059 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -44.38 94.89 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.654 1.57 . . . . 0.0 109.638 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.53 -34.52 78.43 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.16 0.891 . . . . 0.0 110.713 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.57 -49.06 70.23 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.5 0.19 . . . . 0.0 111.258 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.14 -49.4 61.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.026 0.53 . . . . 0.0 111.128 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -33.82 69.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.759 0.708 . . . . 0.0 111.355 -176.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.35 -31.37 69.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.446 0.566 . . . . 0.0 111.784 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.7 mt -89.61 -24.41 21.68 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.698 0.799 . . . . 0.0 112.155 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.91 -32.73 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.483 0.583 . . . . 0.0 110.519 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.183 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 13' ' ' LEU . 95.5 mt -133.94 170.8 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.16 151.31 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -133.73 113.33 12.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.74 -50.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.877 2.871 . . . . 0.0 115.529 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 17.35 0.06 OUTLIER Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.818 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.75 27.48 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.577 1.689 . . . . 0.0 110.979 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.63 157.69 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.048 2.499 . . . . 0.0 111.874 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.55 124.97 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.144 1.778 . . . . 0.0 107.479 171.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -73.98 158.09 35.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.476 1.51 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD21 HD12 ' A' ' 4' ' ' ILE . 4.8 mp -132.47 136.81 46.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 123.987 0.915 . . . . 0.0 108.889 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.35 127.31 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.55 -167.56 18.94 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 121.415 0.453 . . . . 0.0 112.697 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -109.0 141.6 40.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 108.264 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.25 107.96 10.02 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.08 152.96 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.2 157.49 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 109.881 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -57.4 141.07 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.715 0.806 . . . . 0.0 108.923 175.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -24.23 17.6 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.748 1.166 . . . . 0.0 112.257 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.82 158.85 34.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.295 1.547 . . . . 0.0 110.299 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -76.25 136.49 39.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 153.98 89.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.789 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.28 -28.12 70.09 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.86 3.04 . . . . 0.0 115.907 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.05 80.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.775 1.63 . . . . 0.0 113.756 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -126.09 -172.31 2.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.514 1.526 . . . . 0.0 109.806 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 m -125.17 156.04 39.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.107 . . . . 0.0 110.527 -168.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -141.62 178.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 129.193 2.997 . . . . 0.0 106.604 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.87 149.17 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.0 p -69.29 170.23 10.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.177 -0.952 . . . . 0.0 108.636 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.25 -10.61 33.46 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.777 -1.202 . . . . 0.0 110.767 168.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -97.29 10.51 39.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.976 2.11 . . . . 0.0 111.74 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.8 mt 60.76 42.99 12.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.872 1.669 . . . . 0.0 113.573 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.74 141.56 51.28 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.92 141.15 57.73 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.892 -1.13 . . . . 0.0 110.89 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -142.36 151.36 41.82 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 125.643 1.577 . . . . 0.0 108.034 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 p -138.42 170.52 15.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.602 0.637 . . . . 0.0 110.358 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.65 48.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.284 0.634 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -31.89 66.33 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.28 -37.51 80.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.172 0.987 . . . . 0.0 109.956 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.0 mtt -74.7 5.22 5.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.429 2.292 . . . . 0.0 111.45 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -99.65 -7.95 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.017 1.327 . . . . 0.0 111.234 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.66 68.3 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.09 0.859 . . . . 0.0 112.729 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -153.13 168.07 27.17 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.994 2.118 . . . . 0.0 106.436 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.78 118.7 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.4 m -122.82 135.69 54.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.092 0.557 . . . . 0.0 109.503 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.69 139.64 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.0 131.01 73.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -120.19 97.35 5.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -83.56 119.02 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.75 145.5 53.27 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -62.25 -58.92 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.256 2.637 . . . . 0.0 113.639 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.7 m -158.12 143.95 17.08 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.62 -15.94 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.26 -14.93 62.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.03 1.332 . . . . 0.0 114.439 -172.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -65.37 -22.01 66.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.471 1.032 . . . . 0.0 113.741 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.19 -36.58 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.221 0.915 . . . . 0.0 111.39 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.64 -40.03 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.568 1.184 . . . . 0.0 108.633 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.9 m -61.04 -37.9 84.25 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.925 0.89 . . . . 0.0 111.994 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -61.61 -51.76 67.19 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.442 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -49.48 77.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.975 0.352 . . . . 0.0 110.773 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.41 -54.27 47.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.46 1.104 . . . . 0.0 109.75 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -70.63 -38.89 73.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.646 -0.659 . . . . 0.0 110.949 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -63.21 -43.62 97.62 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 120.894 -1.129 . . . . 0.0 110.944 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -66.72 -42.39 86.39 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.921 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -54.53 -38.05 66.1 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.973 1.26 . . . . 0.0 112.286 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.412 ' HA ' HG23 ' A' ' 102' ' ' VAL . 17.6 t30 -60.26 -51.36 69.88 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.077 0.853 . . . . 0.0 111.099 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.62 -34.09 69.54 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 118.989 -1.084 . . . . 0.0 111.709 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.24 -37.4 87.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 120.209 1.368 . . . . 0.0 109.922 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.42 92.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.839 0.455 . . . . 0.0 111.074 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.47 94.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.75 0.705 . . . . 0.0 111.368 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -65.36 -41.07 94.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.619 0.768 . . . . 0.0 110.103 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -45.7 86.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.18 0.992 . . . . 0.0 110.812 173.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -23.79 4.19 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.993 1.282 . . . . 0.0 113.773 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -147.97 66.14 1.1 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.166 1.386 . . . . 0.0 109.506 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.69 172.65 9.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -130.26 139.85 50.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.04 133.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -130.71 161.34 31.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.664 1.186 . . . . 0.0 109.645 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -128.27 143.43 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.91 135.93 57.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m -142.2 158.81 43.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.906 0.882 . . . . 0.0 111.675 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.76 40.06 0.92 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -126.15 163.84 22.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.259 1.423 . . . . 0.0 109.027 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.89 128.41 93.86 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -169.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.11 -33.78 94.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.742 1.628 . . . . 0.0 111.163 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -73.31 -27.09 61.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.223 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -48.64 63.8 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.834 1.197 . . . . 0.0 109.144 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -57.04 -42.41 80.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.307 0.243 . . . . 0.0 111.578 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.31 -42.26 96.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.662 0.665 . . . . 0.0 111.571 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -65.24 -42.31 93.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -59.69 -39.8 85.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.086 0.554 . . . . 0.0 111.22 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.3 m -60.76 -42.25 97.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.518 1.054 . . . . 0.0 110.505 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.29 -31.86 82.26 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.532 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.82 78.52 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.261 1.03 . . . . 0.0 111.368 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -106.6 -16.03 14.62 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.81 0.844 . . . . 0.0 112.277 -171.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.2 38.34 34.75 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.29 144.97 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.674 1.19 . . . . 0.0 108.207 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -143.83 -35.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.229 1.012 . . . . 0.0 112.405 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -87.13 -14.82 40.23 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.406 0.683 . . . . 0.0 112.313 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 68' ' ' ASN . 69.8 t -113.57 154.44 14.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.33 128.48 33.8 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -86.92 151.01 23.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.427 1.091 . . . . 0.0 109.251 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.1 mt -144.19 152.49 40.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.216 1.807 . . . . 0.0 106.507 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.1 m -121.03 125.97 48.69 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.172 -0.955 . . . . 0.0 109.45 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.59 3.94 48.02 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.031 1.332 . . . . 0.0 110.149 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -48.18 135.42 13.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.716 2.007 . . . . 0.0 111.573 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 63.44 -38.93 0.18 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.805 2.842 . . . . 0.0 114.392 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.36 -39.02 68.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.14 0.882 . . . . 0.0 111.56 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 53.93 9.7 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.712 2.805 . . . . 0.0 116.586 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.7 m -60.93 -43.76 98.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.364 1.893 . . . . 0.0 111.813 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.26 -44.28 68.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.068 0.849 . . . . 0.0 109.824 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -58.04 -47.07 91.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 123.96 0.79 . . . . 0.0 111.319 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.44 -37.58 87.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.505 0.722 . . . . 0.0 110.639 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -35.55 63.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.336 -0.852 . . . . 0.0 112.37 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.18 1.37 41.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.337 1.055 . . . . 0.0 112.168 -174.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.79 35.58 50.32 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.342 0.974 . . . . 0.0 113.003 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG23 ' HA2' ' A' ' 114' ' ' GLY . 21.1 m -131.38 21.38 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.658 1.183 . . . . 0.0 111.548 -169.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -107.89 110.66 22.48 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.5 110.99 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.13 -38.35 73.32 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 126.113 1.765 . . . . 0.0 111.083 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -91.29 4.57 52.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.893 0.877 . . . . 0.0 112.109 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -130.87 -21.81 2.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.361 1.064 . . . . 0.0 112.747 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 53.77 38.99 29.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.67 -168.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -131.4 152.62 50.48 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.075 1.35 . . . . 0.0 107.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.87 155.19 31.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 110.695 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.44 175.48 6.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.328 1.061 . . . . 0.0 111.679 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -113.57 85.31 2.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -141.48 164.57 29.86 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 110.519 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.14 152.43 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 121.636 -0.665 . . . . 0.0 109.424 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.5 159.63 41.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.572 1.149 . . . . 0.0 108.665 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.52 141.65 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -129.9 123.17 30.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.087 1.755 . . . . 0.0 106.854 -169.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.63 164.35 26.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.03 -20.89 26.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.445 1.098 . . . . 0.0 112.785 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -81.4 0.08 39.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.835 -1.166 . . . . 0.0 112.394 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.71 28.3 73.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.367 0.985 . . . . 0.0 111.701 -171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.03 133.06 43.85 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -75.66 127.26 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.8 t -102.15 -30.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.477 1.511 . . . . 0.0 109.636 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -153.41 147.95 26.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.04 140.39 24.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.2 144.12 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.56 79.68 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.1 123.81 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -63.83 -14.59 54.33 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -122.77 116.42 23.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.06 65.78 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.19 10.81 2.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.959 1.304 . . . . 0.0 112.0 170.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -139.07 170.92 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.989 2.516 . . . . 0.0 107.319 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.92 154.36 79.2 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.145 -0.972 . . . . 0.0 111.085 -173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.47 149.81 37.06 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.915 3.077 . . . . 0.0 112.73 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -91.82 118.55 30.81 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -54.16 -25.4 22.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.046 1.338 . . . . 0.0 113.227 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.35 -37.42 83.26 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.765 0.712 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -60.92 -54.64 52.39 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.115 -172.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.11 -26.64 30.44 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.834 1.334 . . . . 0.0 111.433 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -44.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 120.191 1.36 . . . . 0.0 109.604 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.2 -38.29 90.54 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.27 0.941 . . . . 0.0 110.315 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.8 85.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.366 -0.209 . . . . 0.0 111.393 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.59 -51.38 51.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.447 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.46 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.39 -31.24 69.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.276 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.7 mt -88.8 -34.06 17.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.601 0.761 . . . . 0.0 111.924 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 82.1 t -63.4 -41.82 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.98 0.512 . . . . 0.0 111.063 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 19.0 pttp . . . . . 0 C--O 1.249 1.057 0 CA-C-N 118.292 0.496 . . . . 0.0 111.143 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 122.071 0.938 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.71 146.28 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 p -112.71 160.43 17.93 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.294 1.038 . . . . 0.0 109.74 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -111.83 45.0 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.495 1.118 . . . . 0.0 108.743 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt 42.66 61.71 1.98 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.647 1.979 . . . . 0.0 112.346 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 -26.12 0.11 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.568 1.08 . . . . 0.0 111.019 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.19 176.04 47.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.242 1.401 . . . . 0.0 109.872 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.31 158.62 47.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.158 2.572 . . . . 0.0 110.552 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.42 134.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -66.16 151.26 47.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.263 1.025 . . . . 0.0 111.163 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.03 141.46 49.24 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.144 2.178 . . . . 0.0 105.886 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.66 -70.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.65 0.659 . . . . 0.0 110.013 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.54 54.74 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.516 0.579 . . . . 0.0 112.405 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.11 166.75 22.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.734 0.778 . . . . 0.0 110.967 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -70.23 115.6 9.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 168.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.96 153.66 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -124.83 156.29 38.05 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.804 0.841 . . . . 0.0 109.796 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.29 140.1 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.414 0.686 . . . . 0.0 109.308 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.47 -20.05 48.89 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.431 1.491 . . . . 0.0 112.244 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.39 155.12 39.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.791 1.295 . . . . 0.0 110.038 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -72.9 132.91 44.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.06 160.51 29.71 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.274 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.29 -4.04 2.11 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.499 3.466 . . . . 0.0 117.85 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.91 55.38 9.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.755 1.265 . . . . 0.0 111.375 -174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -89.37 170.52 10.48 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.487 1.515 . . . . 0.0 110.859 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -131.02 151.51 51.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.659 1.184 . . . . 0.0 108.341 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.34 163.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 0.0 107.312 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -86.69 138.69 31.44 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -71.16 166.09 22.2 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.11 -13.88 62.37 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.529 -1.357 . . . . 0.0 110.904 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.46 0.94 40.0 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.909 1.683 . . . . 0.0 111.497 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt 69.1 37.23 2.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.687 1.595 . . . . 0.0 111.687 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.41 164.17 21.02 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.991 1.316 . . . . 0.0 107.897 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.86 141.19 37.89 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.013 -1.054 . . . . 0.0 109.493 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -138.02 143.96 40.82 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -146.44 172.03 14.15 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.25 0.62 . . . . 0.0 109.934 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.4 tp -44.21 -45.96 8.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 111.582 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.13 67.55 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.783 0.833 . . . . 0.0 112.465 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.45 -40.22 21.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.84 0.856 . . . . 0.0 110.795 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.04 -39.04 83.16 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.207 0.603 . . . . 0.0 110.011 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -65.17 -4.63 5.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -19.57 41.47 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 113.025 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.82 158.56 43.6 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.369 1.468 . . . . 0.0 107.074 173.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.9 t -60.88 119.76 5.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.0 m -127.64 128.76 46.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 109.98 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.3 mt -89.84 140.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.15 133.34 68.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -128.57 95.74 4.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.38 134.24 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.26 157.6 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 107.25 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.39 -54.15 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.721 1.614 . . . . 0.0 111.671 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 p -155.5 154.5 31.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.316 1.846 . . . . 0.0 107.187 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' CE3' ' A' ' 93' ' ' TRP . 9.3 tt -78.8 -14.73 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -169.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.52 -34.59 78.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.87 155.31 40.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.465 0.575 . . . . 0.0 111.201 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.13 -39.06 93.95 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.858 -0.526 . . . . 0.0 112.534 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 m -70.04 -40.54 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.174 0.987 . . . . 0.0 110.971 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.07 -43.88 97.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.589 0.755 . . . . 0.0 110.799 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -58.93 -56.16 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.512 1.525 . . . . 0.0 109.929 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.92 88.78 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.159 0.584 . . . . 0.0 111.156 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -56.05 -54.16 48.25 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.321 1.048 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -64.95 -40.91 95.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.193 0.452 . . . . 0.0 110.441 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.3 tpt85 -67.96 -43.08 79.87 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.104 -0.997 . . . . 0.0 111.26 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -70.74 -35.13 72.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.083 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.79 -41.44 74.11 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.263 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.417 ' HA ' HG23 ' A' ' 102' ' ' VAL . 22.3 t30 -61.81 -49.39 76.51 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.331 0.969 . . . . 0.0 111.31 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.91 -38.9 83.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -67.29 -38.25 84.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.99 86.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.425 0.69 . . . . 0.0 111.326 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.58 88.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 111.282 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.43 -41.09 93.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.267 0.627 . . . . 0.0 110.079 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.29 -43.01 92.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.015 0.526 . . . . 0.0 110.444 173.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 -69.5 2.54 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.133 1.825 . . . . 0.0 110.685 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -85.3 67.76 10.26 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.078 1.351 . . . . 0.0 110.142 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.22 162.53 6.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -123.14 141.21 52.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.62 138.53 42.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -131.41 154.46 48.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.819 0.848 . . . . 0.0 109.664 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 104' ' ' THR . 51.5 m -116.05 148.44 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.91 135.67 63.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.1 m -136.57 150.64 48.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.69 49.78 1.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -137.44 162.56 33.33 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.208 2.203 . . . . 0.0 107.537 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.12 138.12 92.13 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-O 119.013 -0.517 . . . . 0.0 111.226 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.67 -37.13 81.57 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.103 1.869 . . . . 0.0 111.654 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -69.35 -33.64 73.4 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.5 -50.81 49.42 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.069 0.849 . . . . 0.0 109.647 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -55.94 -49.12 74.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.147 0.579 . . . . 0.0 110.919 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.06 -45.11 93.73 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.436 0.695 . . . . 0.0 111.873 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 tpt85 -66.4 -36.99 84.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.49 0.586 . . . . 0.0 110.412 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.408 ' CE3' HD11 ' A' ' 55' ' ' ILE . 65.7 t90 -65.53 -41.61 92.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.036 0.534 . . . . 0.0 110.177 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 92.9 m -61.7 -41.67 97.9 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.999 -1.063 . . . . 0.0 110.633 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.03 -32.21 83.42 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.24 0.924 . . . . 0.0 112.378 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.63 95.06 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.437 1.118 . . . . 0.0 110.388 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.11 -20.87 29.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.746 0.818 . . . . 0.0 112.36 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.63 61.2 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.613 0.642 . . . . 0.0 111.724 -172.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mt -69.56 141.84 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.844 1.258 . . . . 0.0 108.095 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -147.97 -32.86 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -75.25 -16.37 60.46 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.728 0.694 . . . . 0.0 111.977 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 68' ' ' ASN . 96.4 t -111.58 150.08 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.39 148.01 49.23 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -105.2 151.73 23.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.3 mt -136.38 152.79 51.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.6 m -124.27 168.61 12.74 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.873 -0.517 . . . . 0.0 112.367 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -47.47 114.34 0.86 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 109.339 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -39.63 75.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.759 -175.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 157.18 -38.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.556 2.343 . . . . 0.0 105.652 -169.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.41 141.97 45.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.162 1.385 . . . . 0.0 107.353 170.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . 97.2 mmm -55.85 19.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 130.059 3.344 . . . . 0.0 115.698 177.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -52.63 -42.11 64.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.863 1.665 . . . . 0.0 112.404 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 111' ' ' MET . 40.6 p90 -56.03 -25.62 45.51 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.662 1.985 . . . . 0.0 114.344 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.6 -35.89 2.95 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 118.565 0.621 . . . . 0.0 111.675 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.32 -49.12 78.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.154 1.382 . . . . 0.0 109.97 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.96 -5.85 59.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.89 0.876 . . . . 0.0 112.415 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.2 10.76 14.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.911 1.284 . . . . 0.0 110.22 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.63 74.36 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.599 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.94 -5.2 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.007 1.404 . . . . 0.0 112.522 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -78.4 105.96 10.01 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.06 97.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -50.15 -41.56 49.25 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.87 1.668 . . . . 0.0 111.998 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.38 -10.18 59.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.863 0.865 . . . . 0.0 113.118 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.63 -20.78 5.4 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.555 1.142 . . . . 0.0 112.074 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 54.42 36.91 26.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.148 1.379 . . . . 0.0 109.944 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.5 mt -117.04 160.01 21.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.466 1.106 . . . . 0.0 108.351 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.45 137.26 32.48 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.76 163.63 25.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.749 0.819 . . . . 0.0 111.216 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.18 110.91 22.61 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 169.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.2 m -166.42 173.05 10.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.437 1.495 . . . . 0.0 108.144 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.12 152.17 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.257 -0.902 . . . . 0.0 110.691 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -136.45 161.31 36.2 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.126 1.37 . . . . 0.0 108.003 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 139.49 46.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.06 116.66 24.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.49 1.516 . . . . 0.0 107.72 -169.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.49 160.32 19.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.868 1.267 . . . . 0.0 108.83 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -64.25 -8.5 12.88 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.86 5.03 53.07 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.652 -1.28 . . . . 0.0 111.827 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.65 26.97 68.23 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.362 0.982 . . . . 0.0 112.086 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -91.67 139.42 30.7 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 108.46 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.37 -22.94 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.544 0.611 . . . . 0.0 110.615 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -153.92 143.71 21.81 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.82 145.02 31.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.59 142.81 29.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -132.53 106.04 7.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.503 1.921 . . . . 0.0 106.178 -170.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.52 131.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -68.59 0.53 4.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 113.058 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -139.16 110.12 6.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.781 2.032 . . . . 0.0 106.042 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.28 -28.55 68.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.146 0.43 . . . . 0.0 111.471 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.0 p -70.43 -9.94 57.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.265 1.826 . . . . 0.0 113.197 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.15 167.65 12.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.82 1.648 . . . . 0.0 108.905 -169.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -128.52 153.21 79.33 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.252 0.933 . . . . 0.0 109.715 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.07 152.07 45.31 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.844 1.696 . . . . 0.0 108.242 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -69.65 119.35 13.75 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -50.61 -27.36 6.71 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.143 1.777 . . . . 0.0 113.331 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -61.14 -34.44 75.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.753 -0.592 . . . . 0.0 111.447 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -66.28 -49.92 51.88 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 117.944 -1.026 . . . . 0.0 112.542 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.05 -27.77 49.71 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 121.403 1.537 . . . . 0.0 111.896 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -44.13 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.93 1.241 . . . . 0.0 109.545 171.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.12 -31.79 73.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.13 0.877 . . . . 0.0 111.179 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.76 -49.6 61.65 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.972 0.351 . . . . 0.0 111.014 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.49 75.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.8 0.44 . . . . 0.0 111.673 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -28.59 68.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.673 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.84 80.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.583 0.629 . . . . 0.0 111.416 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.0 mt -76.69 -43.21 38.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.411 0.551 . . . . 0.0 111.672 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.81 -4.49 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.07 0.85 . . . . 0.0 110.011 174.686 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 119.279 -0.391 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 5' ' ' THR 0.273 18.1 mt 69.29 171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 126.665 1.986 . . . . 0.0 111.886 169.12 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -141.4 156.89 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.428 2.691 . . . . 0.0 105.903 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -135.93 119.54 17.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HE2' HG21 ' A' ' 150' ' ' THR . 13.1 tppt? 42.14 43.45 2.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.213 1.805 . . . . 0.0 111.591 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.31 85.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.539 -1.145 . . . . 0.0 114.165 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.6 139.54 15.73 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.21 155.37 69.63 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.193 1.929 . . . . 0.0 111.381 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.07 -167.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.473 1.509 . . . . 0.0 108.082 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.3 m -138.68 160.01 40.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 4' ' ' ILE . 1.2 tp -126.77 128.26 46.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.93 1.292 . . . . 0.0 109.686 -170.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.4 157.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.43 -154.5 40.47 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 123.617 0.627 . . . . 0.0 112.168 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.95 155.59 47.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.65 1.18 . . . . 0.0 109.064 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.29 152.25 45.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.72 154.38 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.751 1.62 . . . . 0.0 106.96 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.57 157.86 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.006 0.922 . . . . 0.0 111.764 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.26 144.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.899 1.28 . . . . 0.0 109.332 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 -23.61 18.66 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.685 1.136 . . . . 0.0 111.952 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.49 153.63 40.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.421 1.11 . . . . 0.0 109.519 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -70.28 128.23 35.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.93 153.99 78.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.466 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.68 -31.14 59.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.263 2.642 . . . . 0.0 115.315 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 47.76 84.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.343 1.857 . . . . 0.0 113.357 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.6 177.88 6.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.596 1.158 . . . . 0.0 109.228 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.7 m -109.59 151.05 27.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.651 1.181 . . . . 0.0 109.542 -169.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.21 173.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 128.208 2.603 . . . . 0.0 106.098 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.99 156.85 16.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.2 p -71.82 174.03 7.45 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.088 -1.008 . . . . 0.0 108.847 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -67.2 -11.14 56.58 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.26 -0.9 . . . . 0.0 110.842 168.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m -73.22 -65.82 0.76 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 pp 154.49 12.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 130.581 3.552 . . . . 0.0 112.168 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.82 144.53 30.37 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.732 -1.23 . . . . 0.0 109.181 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.51 133.19 55.86 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.657 -0.652 . . . . 0.0 111.227 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -140.48 147.1 39.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.209 1.804 . . . . 0.0 107.503 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -131.63 159.1 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.03 -31.17 68.59 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.08 66.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.788 0.835 . . . . 0.0 113.191 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.25 -35.66 68.86 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.8 mtt -75.78 -35.85 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.201 1.0 . . . . 0.0 111.177 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -63.97 -3.82 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.05 13.6 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 119.485 1.038 . . . . 0.0 113.009 169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.49 157.23 45.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.864 1.666 . . . . 0.0 107.113 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.3 t -54.85 124.97 8.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.2 m -120.46 149.31 42.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.463 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.2 mt -116.18 141.42 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.5 mm -123.24 140.15 47.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 84.17 2.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 m -71.93 135.66 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.78 157.05 58.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.709 1.604 . . . . 0.0 108.955 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.56 -61.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.305 2.003 . . . . 0.0 110.641 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -144.25 147.77 34.01 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.39 1.476 . . . . 0.0 107.172 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.8 tt -98.82 -31.38 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.815 0.446 . . . . 0.0 111.438 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.5 -24.91 67.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 t -64.43 -21.25 66.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.218 1.007 . . . . 0.0 112.01 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.54 -11.95 64.56 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.029 -1.044 . . . . 0.0 114.094 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.37 -30.29 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.198 1.499 . . . . 0.0 110.542 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.14 -6.12 1.85 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.337 1.455 . . . . 0.0 113.365 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.38 -43.63 64.84 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.481 1.491 . . . . 0.0 110.15 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.17 4.42 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.153 0.981 . . . . 0.0 112.92 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -129.57 -83.36 0.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -55.59 -51.68 66.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.025 1.33 . . . . 0.0 111.814 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -70.72 -46.31 63.31 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.518 -0.739 . . . . 0.0 110.014 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -41.21 93.95 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.259 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -59.98 -31.19 69.67 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 120.455 1.48 . . . . 0.0 112.354 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.98 -43.66 98.51 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.252 0.933 . . . . 0.0 110.678 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 73' ' ' LYS . 28.3 mt-10 -65.6 -51.4 59.94 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -63.1 -35.17 79.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.768 . . . . 0.0 111.303 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.87 95.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.529 0.604 . . . . 0.0 110.783 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.3 81.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.644 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 69' ' ' GLU . 56.0 mttt -66.02 -41.53 90.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 110.702 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.04 -46.62 86.69 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.964 0.906 . . . . 0.0 109.808 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.53 -33.93 5.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.296 1.426 . . . . 0.0 111.071 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.95 120.9 4.28 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.98 1.312 . . . . 0.0 108.827 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -159.59 171.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.837 2.055 . . . . 0.0 105.715 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -119.04 138.72 52.66 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.4 p -154.3 146.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 120.809 -1.182 . . . . 0.0 110.305 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.55 170.2 16.17 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.781 1.232 . . . . 0.0 110.199 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.4 m -126.51 146.7 50.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.34 131.1 70.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -131.37 144.27 51.1 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.942 0.497 . . . . 0.0 110.978 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.72 48.87 1.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.82 161.67 35.97 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.14 1.776 . . . . 0.0 106.864 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.48 140.46 84.65 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.84 -47.59 20.73 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.045 2.497 . . . . 0.0 112.365 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -72.95 -30.11 63.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.76 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.85 85.66 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.855 0.752 . . . . 0.0 110.166 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.56 -48.87 63.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.975 0.91 . . . . 0.0 110.161 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.66 77.89 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 117.943 0.338 . . . . 0.0 110.508 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -45.06 93.5 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.345 1.058 . . . . 0.0 109.769 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -63.33 -43.46 97.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.94 -44.02 81.69 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.804 -0.56 . . . . 0.0 111.23 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -38.97 96.3 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.628 0.632 . . . . 0.0 111.987 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.62 98.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.788 0.835 . . . . 0.0 110.314 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -78.85 -17.77 55.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.69 0.796 . . . . 0.0 112.429 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.63 62.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.095 0.855 . . . . 0.0 111.733 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.84 141.94 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.789 1.236 . . . . 0.0 108.244 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.73 -28.72 0.43 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.574 1.15 . . . . 0.0 112.542 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -76.82 -24.4 52.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.015 0.825 . . . . 0.0 111.264 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 t -105.63 154.8 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.79 127.56 38.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.44 153.54 31.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.384 0.611 . . . . 0.0 109.797 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.7 mt -142.62 159.92 41.31 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.609 1.964 . . . . 0.0 107.546 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -124.0 130.2 52.18 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.844 1.258 . . . . 0.0 109.485 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.73 26.18 4.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.653 1.181 . . . . 0.0 109.449 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -68.11 -20.54 64.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.805 1.642 . . . . 0.0 113.23 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -146.29 153.28 40.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 46.32 56.07 6.69 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -168.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp -64.63 28.23 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.974 2.909 . . . . 0.0 114.071 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -55.21 -36.25 65.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.935 1.694 . . . . 0.0 112.737 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -70.6 -52.31 22.35 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.876 0.762 . . . . 0.0 110.081 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.12 85.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.17 -56.79 17.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.43 1.092 . . . . 0.0 109.38 170.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.29 73.9 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -2.49 37.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.246 0.618 . . . . 0.0 111.954 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.47 47.99 53.87 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.008 1.289 . . . . 0.0 113.034 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.84 -10.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 117.956 0.878 . . . . 0.0 112.272 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 107.67 0.96 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.1 mt -74.8 110.39 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -52.26 -44.21 64.78 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 110.896 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -3.15 47.33 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.393 0.677 . . . . 0.0 112.457 -171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.76 -25.58 4.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.011 0.924 . . . . 0.0 112.381 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 58.37 35.19 24.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.79 0.836 . . . . 0.0 109.845 -168.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.17 157.5 40.65 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.18 146.09 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.06 30.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.533 0.733 . . . . 0.0 111.361 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -81.2 103.29 10.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -149.45 168.88 22.23 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.221 1.409 . . . . 0.0 107.669 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.94 151.75 20.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 121.564 -0.71 . . . . 0.0 110.059 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -135.96 157.16 47.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.607 1.163 . . . . 0.0 108.722 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.98 139.29 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -125.5 132.69 52.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 108.058 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.31 165.93 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 169.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.69 -20.27 47.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.4 -2.56 57.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.601 -1.312 . . . . 0.0 112.271 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.19 23.24 77.95 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 121.078 -1.014 . . . . 0.0 112.42 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.22 145.36 25.45 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.799 1.3 . . . . 0.0 107.556 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.99 134.21 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.6 t -110.42 -30.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.777 1.631 . . . . 0.0 109.405 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -152.14 145.52 24.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.01 141.31 25.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.44 145.34 27.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -132.08 96.9 4.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.818 2.047 . . . . 0.0 106.109 -169.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.59 140.52 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 p -68.0 -12.78 61.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.778 1.231 . . . . 0.0 113.274 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.97 126.06 15.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.88 -21.06 34.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 7' ' ' LYS . 78.8 p -75.04 -25.54 58.78 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 171.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -80.03 172.6 13.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.462 1.505 . . . . 0.0 107.683 169.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -140.74 157.37 67.89 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 120.702 -1.249 . . . . 0.0 110.109 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 165.8 30.89 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.841 2.361 . . . . 0.0 110.083 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -90.82 118.27 30.1 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -49.72 -28.75 6.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.983 1.713 . . . . 0.0 113.169 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -59.9 -36.09 76.24 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.516 0.598 . . . . 0.0 110.801 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -65.03 -52.94 45.4 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.274 -0.869 . . . . 0.0 112.261 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 -24.97 41.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 121.083 1.423 . . . . 0.0 111.795 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.71 -45.89 97.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 109.869 170.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.94 -32.8 72.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.213 0.915 . . . . 0.0 110.345 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.63 -55.27 12.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.922 0.489 . . . . 0.0 111.614 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.63 83.2 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.161 0.584 . . . . 0.0 112.027 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.81 65.55 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.612 0.765 . . . . 0.0 111.826 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.95 -30.74 70.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.063 0.545 . . . . 0.0 111.914 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.3 mt -98.35 -29.19 13.3 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.23 -8.91 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 123.915 0.886 . . . . 0.0 110.024 176.686 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 121.803 0.811 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.91 144.9 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -111.5 161.11 16.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 109.753 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -128.06 54.36 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.704 1.202 . . . . 0.0 108.437 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 41.11 62.33 1.49 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.941 2.096 . . . . 0.0 113.115 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.74 0.18 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.591 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.95 46.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.271 0.939 . . . . 0.0 110.767 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.3 164.36 6.97 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.97 3.113 . . . . 0.0 113.188 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.91 139.78 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.916 1.286 . . . . 0.0 108.632 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 m -65.48 149.95 49.17 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.466 0.651 . . . . 0.0 109.347 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -129.41 134.66 47.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.65 1.98 . . . . 0.0 107.941 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.66 140.65 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 -166.68 42.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.75 48.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.155 1.382 . . . . 0.0 109.224 -176.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.16 112.34 2.61 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 m -73.17 169.0 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.49 158.27 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.636 -0.665 . . . . 0.0 109.506 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 133.52 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.98 -18.88 56.48 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.933 1.254 . . . . 0.0 112.257 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -70.96 153.38 42.71 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.065 1.432 . . . . 0.0 109.843 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -80.42 130.0 34.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.59 157.38 27.22 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.169 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.54 -7.0 4.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.458 3.438 . . . . 0.0 118.44 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t0 53.5 56.17 7.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.939 1.352 . . . . 0.0 110.894 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -86.01 169.78 12.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.667 1.987 . . . . 0.0 110.192 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -130.78 147.81 52.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.442 1.097 . . . . 0.0 108.189 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.37 162.38 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.297 1.839 . . . . 0.0 107.034 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.03 141.65 29.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -69.66 162.78 26.99 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -64.57 -17.5 64.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.051 -1.656 . . . . 0.0 111.399 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -85.1 3.18 40.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.539 1.936 . . . . 0.0 112.129 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt 73.62 33.47 1.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.398 1.879 . . . . 0.0 113.032 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -115.45 164.54 14.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.085 1.354 . . . . 0.0 108.021 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.22 143.42 35.36 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 120.445 -1.409 . . . . 0.0 109.12 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -141.14 146.08 36.56 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 p -147.66 169.68 19.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -47.69 -41.88 23.63 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.38 0.672 . . . . 0.0 111.651 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.44 64.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 112.751 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -77.96 -40.45 39.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.827 0.851 . . . . 0.0 110.607 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -66.8 -24.59 66.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.179 0.991 . . . . 0.0 111.583 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -55.95 -14.02 2.24 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.541 1.137 . . . . 0.0 113.631 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -27.42 50.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.312 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -155.01 169.47 24.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.959 1.379 . . . . 0.0 109.516 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.21 125.25 17.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 168.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.3 m -129.69 131.93 46.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.887 0.475 . . . . 0.0 111.038 -168.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.4 mt -89.68 141.96 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -118.83 136.33 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 172.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -128.11 90.33 3.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 108.037 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.79 139.05 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.63 144.69 45.79 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.97 -45.03 34.88 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.292 2.661 . . . . 0.0 112.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -160.04 168.15 26.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 106.542 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 tt -107.61 172.48 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.375 0.67 . . . . 0.0 110.14 -170.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.3 25.52 11.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.499 1.52 . . . . 0.0 113.396 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -75.23 -15.36 60.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.079 . . . . 0.0 112.253 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.79 0.1 86.13 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.226 0.917 . . . . 0.0 112.406 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.16 -46.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.748 1.274 . . . . 0.0 109.076 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.07 -28.57 69.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.281 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.96 -32.71 54.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.423 1.489 . . . . 0.0 111.982 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.55 60.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.601 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -55.69 -59.08 5.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.803 0.841 . . . . 0.0 110.424 -169.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -64.38 -40.78 96.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.021 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -74.71 -30.84 61.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.432 1.469 . . . . 0.0 111.45 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -63.52 -42.44 98.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.191 170.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.83 -37.63 79.76 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 120.069 1.304 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -60.41 -48.65 80.84 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.776 0.716 . . . . 0.0 111.036 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.57 -53.48 54.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.02 0.928 . . . . 0.0 109.51 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.7 -39.11 83.48 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.553 0.741 . . . . 0.0 111.363 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.05 87.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.265 0.484 . . . . 0.0 111.104 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.26 -33.82 73.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -69.73 -41.34 75.41 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.007 0.821 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -43.54 98.55 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.496 0.589 . . . . 0.0 110.268 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.44 -21.23 39.31 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.676 1.132 . . . . 0.0 112.686 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -153.04 100.74 2.51 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.735 1.214 . . . . 0.0 109.111 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.9 174.35 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 126.913 2.085 . . . . 0.0 105.433 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -129.65 142.73 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.6 p -151.98 144.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.85 166.17 23.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 0.0 108.974 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -126.3 142.01 51.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mt -128.59 137.92 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -147.36 165.41 30.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 111.76 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.09 -6.93 59.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.67 164.02 25.88 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.523 1.129 . . . . 0.0 110.462 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.5 135.04 96.08 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.25 -34.03 88.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.893 1.728 . . . . 0.0 111.522 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -70.08 -31.12 68.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.505 0.593 . . . . 0.0 111.697 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.82 75.23 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.069 0.85 . . . . 0.0 109.273 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.66 -43.37 93.98 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.582 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.86 -41.94 88.21 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.704 0.684 . . . . 0.0 111.153 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -69.37 -39.18 78.2 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 121.828 -0.545 . . . . 0.0 110.235 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -64.32 -40.25 95.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.795 0.438 . . . . 0.0 110.298 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.16 -38.47 83.25 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.122 -0.986 . . . . 0.0 110.828 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.98 -29.09 74.46 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.764 175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.8 71.6 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.712 1.256 . . . . 0.0 110.21 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -89.06 -17.88 28.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.05 39.27 24.19 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.74 143.99 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.362 1.065 . . . . 0.0 108.152 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -144.12 -38.07 0.31 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.577 1.151 . . . . 0.0 112.405 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -83.9 -18.72 36.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.428 0.691 . . . . 0.0 112.179 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.55 161.72 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -136.01 128.0 29.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p -80.85 149.11 29.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.609 0.764 . . . . 0.0 109.278 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.0 mt -142.67 148.73 37.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.137 1.775 . . . . 0.0 106.239 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.2 m -119.04 126.47 51.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.541 1.064 . . . . 0.0 110.182 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -82.99 -21.23 34.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.764 1.626 . . . . 0.0 109.779 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.7 t60 31.68 -73.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 1 C-N-CA 132.221 4.208 . . . . 0.0 117.413 173.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -139.99 -0.44 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.169 1.387 . . . . 0.0 111.65 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.31 -38.72 63.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.281 0.946 . . . . 0.0 109.882 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 34.0 mmm 53.29 8.73 0.12 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.904 2.882 . . . . 0.0 116.595 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 p -59.79 -41.33 90.92 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 122.407 2.367 . . . . 0.0 111.693 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -60.57 -59.71 4.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.45 -41.59 99.58 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-O 119.994 -0.337 . . . . 0.0 112.61 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.36 -41.96 85.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.439 1.496 . . . . 0.0 110.521 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.24 -23.22 15.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -169.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.33 1.41 45.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.818 1.19 . . . . 0.0 112.749 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.18 28.03 62.93 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.106 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.4 -8.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 119.629 1.715 . . . . 0.0 113.493 -171.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.67 102.69 6.28 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.19 104.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.0 -38.35 67.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.45 1.1 . . . . 0.0 110.796 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -65.63 -16.08 63.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.135 0.974 . . . . 0.0 112.869 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.2 mt -127.3 -18.76 4.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.691 1.196 . . . . 0.0 112.502 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.51 40.08 30.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.523 1.129 . . . . 0.0 109.23 -168.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -136.44 153.71 50.99 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.623 1.169 . . . . 0.0 107.953 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.63 156.43 34.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.592 0.633 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.73 -172.39 1.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.435 1.494 . . . . 0.0 110.513 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -117.95 17.63 14.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.903 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -64.71 170.24 4.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.733 2.013 . . . . 0.0 113.417 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.08 151.66 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.332 1.053 . . . . 0.0 109.816 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -141.72 162.28 35.88 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.26 145.6 31.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 171.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.72 128.11 43.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.982 1.713 . . . . 0.0 107.191 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.42 167.12 15.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.842 0.857 . . . . 0.0 109.815 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.18 -24.15 52.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.128 0.971 . . . . 0.0 112.609 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.41 -4.13 46.77 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.796 -1.19 . . . . 0.0 112.189 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.52 24.5 76.77 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.184 -0.948 . . . . 0.0 112.246 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -91.78 142.69 27.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.17 129.71 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.26 -15.71 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.685 0.794 . . . . 0.0 111.636 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -153.05 144.36 23.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.46 137.51 28.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.77 130.07 13.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -106.8 144.38 33.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.32 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 61.72 -15.27 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.299 2.24 . . . . 0.0 115.204 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -149.4 113.96 5.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.06 -31.53 67.16 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.145 0.578 . . . . 0.0 111.872 -174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 p -73.46 7.23 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.744 1.218 . . . . 0.0 113.718 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.83 176.64 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.786 1.176 . . . . 0.0 110.516 172.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.77 150.6 70.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.494 1.118 . . . . 0.0 110.282 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.09 154.51 42.13 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.472 2.781 . . . . 0.0 110.388 -169.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -79.2 115.25 18.74 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -52.78 -26.44 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.852 1.661 . . . . 0.0 113.198 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -61.57 -36.08 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.049 0.84 . . . . 0.0 111.404 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -58.49 -57.84 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.596 0.634 . . . . 0.0 112.033 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.24 -24.34 32.17 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.118 1.212 . . . . 0.0 111.684 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 120.139 1.336 . . . . 0.0 109.605 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.27 -33.36 75.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.084 0.856 . . . . 0.0 110.494 -177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.63 -56.9 10.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.373 0.269 . . . . 0.0 111.361 172.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.37 88.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.422 0.689 . . . . 0.0 112.307 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -26.43 67.67 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.53 0.605 . . . . 0.0 111.986 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.63 65.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.089 0.556 . . . . 0.0 112.228 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.5 mt -102.46 -28.2 12.34 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.67 -18.47 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.386 1.075 . . . . 0.0 109.938 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.237 0.429 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 13' ' ' LEU . 51.5 mt -140.98 143.8 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -169.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p -82.49 158.81 23.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.839 1.2 . . . . 0.0 110.621 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -132.12 85.85 2.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt 43.03 37.59 1.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.297 2.239 . . . . 0.0 115.441 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.96 -26.61 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.665 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.09 171.03 44.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.773 1.287 . . . . 0.0 112.054 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.83 151.82 51.71 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.842 3.028 . . . . 0.0 111.696 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.37 145.75 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.852 1.661 . . . . 0.0 108.519 171.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -76.45 141.67 41.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.928 1.691 . . . . 0.0 111.103 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 4' ' ' ILE . 12.2 mt -85.94 137.82 32.46 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 169.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -75.67 -21.0 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.54 -177.38 19.34 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.418 0.532 . . . . 0.0 112.243 -169.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -64.23 138.22 58.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.804 1.242 . . . . 0.0 111.142 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -78.82 143.07 36.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.3 153.94 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.94 157.12 43.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.358 1.063 . . . . 0.0 110.731 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.3 t -58.75 143.0 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.001 0.92 . . . . 0.0 109.034 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.57 -24.0 13.94 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.872 1.225 . . . . 0.0 112.42 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -73.79 155.21 39.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.718 1.259 . . . . 0.0 109.848 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -70.77 128.86 37.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.85 153.74 78.56 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.247 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.23 -32.03 69.07 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.65 2.9 . . . . 0.0 114.655 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.16 81.4 0.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.486 1.915 . . . . 0.0 113.138 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -127.59 -174.77 3.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.738 1.615 . . . . 0.0 109.564 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -115.64 155.91 26.82 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.856 1.262 . . . . 0.0 110.251 -168.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.12 159.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.836 2.454 . . . . 0.0 106.555 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.18 140.65 29.26 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.958 -1.089 . . . . 0.0 109.323 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.5 p -73.33 170.0 15.94 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -68.08 -13.95 62.6 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.516 -1.365 . . . . 0.0 111.45 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.05 0.4 40.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.254 1.421 . . . . 0.0 111.622 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp 58.03 47.1 15.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.039 1.336 . . . . 0.0 111.346 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.22 166.56 16.86 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.192 1.397 . . . . 0.0 107.528 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.02 141.98 29.91 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -138.93 150.88 46.42 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 126.257 1.823 . . . . 0.0 106.155 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 p -146.07 168.52 20.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.297 -0.877 . . . . 0.0 109.304 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.64 -31.53 68.22 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.864 -0.522 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . . . -50.4 -28.62 8.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 113.828 170.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.73 -38.7 13.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.91 1.284 . . . . 0.0 110.804 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.0 mtt -68.66 -36.77 79.0 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.652 0.781 . . . . 0.0 110.614 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 40' ' ' ALA . 15.6 ptpt -62.8 -3.57 1.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.77 30.46 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.659 1.118 . . . . 0.0 113.107 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -148.2 166.01 29.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.49 1.645 . . . . 0.0 109.118 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.49 117.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.0 m -127.41 129.63 47.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.314 0.384 . . . . 0.0 111.37 -168.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.8 mt -89.18 137.91 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.02 100.5 9.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.94 140.9 45.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 t -126.42 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 118.493 0.588 . . . . 0.0 109.493 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 159.64 67.45 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.495 1.518 . . . . 0.0 108.263 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.72 -53.67 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.618 1.545 . . . . 0.0 111.373 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -147.29 154.14 40.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.752 2.021 . . . . 0.0 106.566 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.0 tt -98.7 -6.5 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -168.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.1 -28.06 68.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.529 -0.732 . . . . 0.0 112.425 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -73.28 142.08 47.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.394 0.678 . . . . 0.0 110.581 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.6 -16.25 65.23 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.137 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.88 -29.28 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.996 1.398 . . . . 0.0 111.125 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.8 m -63.76 -12.82 38.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.537 0.735 . . . . 0.0 112.843 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.72 -45.3 77.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.668 1.122 . . . . 0.0 110.828 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.43 7.24 2.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.315 1.046 . . . . 0.0 112.612 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -129.06 -87.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -53.08 -54.18 39.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.808 1.643 . . . . 0.0 112.967 -169.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.69 -42.21 67.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.978 -1.077 . . . . 0.0 110.569 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpp85 -60.23 -38.19 82.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.648 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -64.99 -32.41 74.13 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.209 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.43 -48.19 81.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.674 1.579 . . . . 0.0 110.216 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.27 -57.14 9.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.325 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -61.58 -40.53 95.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.434 0.561 . . . . 0.0 111.028 -172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.17 78.26 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.848 0.749 . . . . 0.0 111.482 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.07 79.4 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.112 0.869 . . . . 0.0 110.803 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -70.18 -39.88 74.98 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.505 0.593 . . . . 0.0 109.552 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.4 -47.24 82.81 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.195 0.598 . . . . 0.0 110.141 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.51 9.08 84.59 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.864 1.221 . . . . 0.0 113.949 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -151.99 35.61 0.54 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.391 1.595 . . . . 0.0 112.322 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.88 173.48 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -123.62 151.0 43.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.476 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -149.8 149.71 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.691 -1.256 . . . . 0.0 110.171 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -135.23 172.52 12.9 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.746 1.619 . . . . 0.0 108.982 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.412 ' HB ' HG22 ' A' ' 104' ' ' THR . 23.6 m -132.5 144.04 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.64 137.71 56.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.59 147.87 36.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.14 0.976 . . . . 0.0 109.826 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.26 56.03 2.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -144.9 170.06 16.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.606 1.562 . . . . 0.0 107.143 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.04 142.11 63.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.132 -0.98 . . . . 0.0 112.468 -168.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -47.64 -41.03 30.9 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.34 3.36 . . . . 0.0 115.028 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -73.43 -29.4 62.54 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.95 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.39 82.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.525 1.057 . . . . 0.0 109.334 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -47.8 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.125 172.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.37 80.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.417 0.553 . . . . 0.0 111.09 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -59.75 -43.83 94.11 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.59 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -58.95 -52.05 67.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.533 0.606 . . . . 0.0 110.171 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.6 m -65.13 -44.96 86.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.95 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.59 -41.66 83.38 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.342 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.13 -39.78 82.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.12 0.96 . . . . 0.0 110.538 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -79.69 -19.17 49.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.957 0.503 . . . . 0.0 112.274 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.74 64.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 118.831 0.741 . . . . 0.0 111.425 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.03 146.78 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.587 1.155 . . . . 0.0 108.179 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -139.02 -35.8 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 112.172 -173.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -81.43 -18.74 44.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.025 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.21 158.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -139.76 130.1 25.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 168.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 81' ' ' THR . 3.2 p -84.26 155.94 22.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 mt -143.44 162.98 34.37 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.893 1.277 . . . . 0.0 108.406 -170.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.3 m -129.82 107.67 9.57 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.503 0.721 . . . . 0.0 109.586 -169.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -95.28 56.19 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -136.62 33.44 2.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.324 1.05 . . . . 0.0 112.693 -168.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -122.86 -48.33 2.02 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -144.65 121.12 11.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 101.871 -3.381 . . . . 0.0 101.871 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.1 mtp -73.69 36.87 0.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.734 1.613 . . . . 0.0 112.801 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -57.87 -41.71 83.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.859 1.264 . . . . 0.0 111.782 -169.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.13 -46.22 62.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.767 0.712 . . . . 0.0 109.581 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.82 -33.58 62.97 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.534 0.588 . . . . 0.0 111.868 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.96 -48.85 72.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.806 0.803 . . . . 0.0 109.367 171.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.55 72.69 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.3 3.52 53.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.597 1.159 . . . . 0.0 111.527 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.86 -13.8 8.27 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.081 1.801 . . . . 0.0 115.351 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.68 -23.39 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.559 1.544 . . . . 0.0 112.741 -173.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 110.57 1.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.28 113.43 17.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -53.29 -45.21 68.85 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.585 1.554 . . . . 0.0 111.331 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.72 0.14 51.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.361 0.665 . . . . 0.0 112.567 -169.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.24 -22.64 3.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.871 0.759 . . . . 0.0 112.976 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.36 37.15 28.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.195 0.998 . . . . 0.0 111.943 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.68 162.83 24.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.173 -0.954 . . . . 0.0 108.814 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -88.47 134.18 33.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.63 141.32 32.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.74 1.216 . . . . 0.0 110.471 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -73.32 112.63 9.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 168.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -154.65 170.06 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.447 1.499 . . . . 0.0 107.098 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG21 ' HG3' ' A' ' 158' ' ' PRO . 14.8 p -153.99 146.83 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -134.71 162.72 31.53 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 124.022 0.826 . . . . 0.0 110.139 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.5 t -134.8 145.81 31.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.16 130.55 41.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.452 1.501 . . . . 0.0 107.477 -169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.67 165.09 25.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.007 1.323 . . . . 0.0 109.54 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.65 -6.49 3.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.09 12.31 23.57 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.952 -1.092 . . . . 0.0 112.448 169.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.68 78.75 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.029 0.823 . . . . 0.0 112.849 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -88.99 145.82 25.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.34 139.75 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.45 -26.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.564 1.546 . . . . 0.0 109.397 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -147.77 147.07 29.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -150.96 133.87 15.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 169.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.78 147.37 29.79 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -127.66 102.4 6.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.81 136.21 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -66.3 -13.52 60.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -134.93 125.58 26.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.991 1.716 . . . . 0.0 106.833 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.87 66.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.141 0.577 . . . . 0.0 111.827 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -79.5 12.96 2.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.146 1.378 . . . . 0.0 111.366 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -134.69 167.02 21.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.952 2.101 . . . . 0.0 107.857 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -128.31 154.73 79.06 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 110.923 -170.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.17 160.61 48.53 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.622 2.215 . . . . 0.0 109.65 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -87.06 117.44 25.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -51.51 -28.32 13.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.128 1.771 . . . . 0.0 112.857 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -60.14 -32.11 70.71 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.567 0.621 . . . . 0.0 111.695 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.73 -51.85 11.24 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.443 -171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.416 ' HG3' HG21 ' A' ' 131' ' ' VAL . 55.9 Cg_endo -67.68 -30.56 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.452 1.434 . . . . 0.0 111.729 174.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.44 -49.01 79.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 119.838 1.199 . . . . 0.0 109.904 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.75 -32.17 73.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.514 0.597 . . . . 0.0 110.771 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.66 71.51 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.209 0.459 . . . . 0.0 111.437 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.92 64.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.857 0.463 . . . . 0.0 110.01 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -26.76 68.88 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.442 -0.786 . . . . 0.0 111.797 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.64 71.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.988 0.813 . . . . 0.0 111.626 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.59 -29.13 28.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.15 0.58 . . . . 0.0 111.512 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.04 -51.97 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.368 0.531 . . . . 0.0 110.371 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.1 pttp . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.052 -175.692 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 mt -146.13 155.37 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -169.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -117.51 168.51 10.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.852 1.261 . . . . 0.0 110.753 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -141.05 56.95 1.55 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.93 1.292 . . . . 0.0 108.619 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 37.74 71.21 0.16 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.082 2.153 . . . . 0.0 113.782 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -16.98 0.59 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.098 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.93 174.76 41.06 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.01 162.91 41.08 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.391 2.728 . . . . 0.0 111.151 178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.96 135.16 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.283 1.433 . . . . 0.0 107.395 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.2 m -67.12 152.0 46.57 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 110.385 -176.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.59 135.3 50.1 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.641 1.576 . . . . 0.0 108.661 -175.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.44 136.71 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 -163.68 13.51 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.424 0.556 . . . . 0.0 113.33 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -123.24 138.85 54.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.294 1.437 . . . . 0.0 110.385 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.7 114.67 14.55 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.43 170.38 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.936 0.789 . . . . 0.0 109.887 174.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 161.33 35.74 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.191 0.997 . . . . 0.0 109.094 174.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 129.93 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 174.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.15 -13.08 60.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.797 1.189 . . . . 0.0 112.383 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.62 140.03 58.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.629 1.715 . . . . 0.0 110.214 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -89.88 108.15 19.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 172.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.34 148.72 92.93 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.149 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -57.95 -8.92 5.16 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 125.245 3.963 . . . . 0.0 118.536 -178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 52.79 70.61 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.872 1.32 . . . . 0.0 111.74 -169.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -73.3 166.68 22.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.22 1.408 . . . . 0.0 109.827 177.198 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 m -127.97 144.92 51.11 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.33 163.12 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.208 2.203 . . . . 0.0 106.69 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.35 137.52 32.25 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -63.67 165.18 8.61 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -64.88 -3.48 3.46 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.699 -1.251 . . . . 0.0 111.864 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 m -114.48 17.97 17.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.127 2.171 . . . . 0.0 111.239 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 mt 65.93 39.85 4.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.133 1.373 . . . . 0.0 112.884 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.58 148.87 49.7 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.62 141.04 44.71 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.904 1.229 . . . . 0.0 109.128 172.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -138.33 144.99 40.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -134.02 165.96 23.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -53.49 -34.7 59.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.972 0.509 . . . . 0.0 110.442 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.97 46.09 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.12 -42.62 59.76 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.584 0.707 . . . . 0.0 110.441 173.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.6 mtt -64.7 -25.8 68.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.074 1.35 . . . . 0.0 111.643 -177.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -54.69 -16.75 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.592 1.157 . . . . 0.0 113.258 174.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.65 47.06 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.677 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -151.97 159.18 43.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.752 1.776 . . . . 0.0 109.695 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.49 119.46 6.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.8 m -124.95 134.23 52.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.446 0.299 . . . . 0.0 110.883 -168.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.11 142.59 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mm -120.89 138.08 52.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -126.92 102.37 6.98 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.109 0.964 . . . . 0.0 108.601 -169.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.04 134.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.81 157.31 61.76 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 107.984 169.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.39 -55.64 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.28 1.987 . . . . 0.0 111.59 -172.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -161.27 150.07 16.15 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 127.962 2.505 . . . . 0.0 104.833 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 tt -73.17 -10.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 118.92 0.782 . . . . 0.0 112.517 -169.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -32.35 73.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.868 1.267 . . . . 0.0 113.013 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.27 114.29 10.23 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.58 -17.99 43.02 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.408 1.004 . . . . 0.0 113.61 -174.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.33 -21.79 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 118.511 1.156 . . . . 0.0 111.311 174.391 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 64.3 m -58.75 -19.86 44.27 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.788 1.176 . . . . 0.0 112.8 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.7 -29.35 69.29 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.142 0.977 . . . . 0.0 111.828 173.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.58 5.94 22.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.622 1.169 . . . . 0.0 112.441 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -124.82 -83.83 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -57.68 -45.85 85.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.561 1.144 . . . . 0.0 111.885 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -68.6 -45.5 71.81 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.552 -0.717 . . . . 0.0 111.02 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.02 -37.43 87.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -57.98 -37.47 74.28 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.232 0.923 . . . . 0.0 112.207 171.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.53 -48.41 81.77 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.485 1.039 . . . . 0.0 110.825 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.48 -47.3 70.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.72 -40.07 96.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.378 0.99 . . . . 0.0 110.713 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.7 78.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.919 0.781 . . . . 0.0 111.627 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.16 87.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.701 0.682 . . . . 0.0 111.725 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -70.48 -40.05 73.85 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.443 0.697 . . . . 0.0 111.067 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.38 149.45 33.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.894 1.278 . . . . 0.0 108.805 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.53 -44.42 97.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.132 -178.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.23 137.24 7.04 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.677 1.591 . . . . 0.0 107.57 174.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -162.73 175.31 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.654 1.582 . . . . 0.0 106.956 174.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -136.54 140.62 43.09 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.51 146.52 23.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.05 163.37 29.71 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.962 1.305 . . . . 0.0 109.209 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.4 m -121.29 146.18 47.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 169.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.57 140.68 47.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 m -140.27 149.13 42.44 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.665 1.186 . . . . 0.0 109.939 -169.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.89 45.75 1.24 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.373 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.21 -176.63 3.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.136 1.375 . . . . 0.0 110.87 -168.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.43 140.52 26.92 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.275 -174.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.14 -41.48 57.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.874 3.049 . . . . 0.0 113.97 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -78.62 -29.44 45.94 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.509 -0.745 . . . . 0.0 112.083 -174.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.39 73.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.281 0.946 . . . . 0.0 109.102 175.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -51.05 -50.49 58.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.538 1.535 . . . . 0.0 111.11 171.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.683 0.393 . . . . 0.0 111.518 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -63.84 -44.41 93.28 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.033 0.533 . . . . 0.0 110.044 -174.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -61.69 -39.86 92.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.556 0.342 . . . . 0.0 110.565 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.4 m -65.35 -44.05 88.92 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.92 -0.487 . . . . 0.0 111.224 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.66 94.87 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.56 -44.3 87.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.696 0.748 . . . . 0.0 110.463 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -77.31 -23.49 51.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.281 0.632 . . . . 0.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.59 22.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.807 0.718 . . . . 0.0 111.325 -178.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.46 144.1 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.45 -37.9 0.23 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.176 1.391 . . . . 0.0 111.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -80.44 -16.49 54.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.08 0.952 . . . . 0.0 111.919 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.4 160.79 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.93 146.1 40.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 p -99.25 142.62 30.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.391 1.076 . . . . 0.0 108.63 -177.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 mt -129.02 155.66 45.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.051 1.34 . . . . 0.0 107.984 -174.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.66 125.6 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.258 1.423 . . . . 0.0 109.441 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -118.66 -2.54 10.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 111.966 -176.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -55.59 -23.29 26.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.518 1.527 . . . . 0.0 113.006 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -59.08 -45.48 90.72 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.119 0.968 . . . . 0.0 111.864 -176.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -154.95 7.37 0.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -171.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 mmm 51.77 28.47 4.95 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.128 1.771 . . . . 0.0 113.873 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -51.72 -51.33 56.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 111.928 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.66 -44.8 69.8 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.513 0.597 . . . . 0.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.22 -43.56 64.02 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.795 1.188 . . . . 0.0 112.672 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -74.35 -42.23 59.73 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.986 0.915 . . . . 0.0 110.213 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.79 86.5 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 0.0 112.034 -173.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -109.95 6.3 23.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.474 1.51 . . . . 0.0 112.581 -176.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.9 78.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.563 1.074 . . . . 0.0 113.109 171.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.95 1.59 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.282 . . . . 0.0 112.679 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -82.67 108.48 16.07 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 120.534 1.515 . . . . 0.0 107.48 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.64 105.0 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -51.48 -49.51 61.68 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 126.337 1.855 . . . . 0.0 110.981 -171.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -74.28 -35.61 63.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.407 0.683 . . . . 0.0 111.711 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.74 -23.69 42.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.765 0.711 . . . . 0.0 112.148 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? 57.99 34.57 24.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.132 0.973 . . . . 0.0 109.075 -168.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.4 mt -130.16 160.96 32.22 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.794 1.238 . . . . 0.0 108.688 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -75.32 158.25 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.09 -167.55 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.167 1.387 . . . . 0.0 111.307 175.078 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -124.66 123.57 40.33 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 169.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -166.55 169.12 14.04 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.924 1.69 . . . . 0.0 106.908 -169.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.46 143.23 23.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.22 156.9 47.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.016 0.926 . . . . 0.0 108.693 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 t -136.54 138.91 46.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.3 mt -130.84 124.51 31.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.401 1.481 . . . . 0.0 107.838 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.81 164.64 14.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.282 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.75 -21.13 10.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.655 1.182 . . . . 0.0 112.822 174.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -76.18 -2.85 33.17 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.586 -1.321 . . . . 0.0 112.502 174.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.35 76.53 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -171.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -116.68 129.7 56.3 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.73 129.27 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -173.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.94 -18.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.799 0.84 . . . . 0.0 111.406 177.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -153.61 143.13 21.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 144.91 27.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.22 144.9 23.43 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.218 1.007 . . . . 0.0 108.87 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -132.86 126.0 31.23 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.742 1.617 . . . . 0.0 106.82 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 148' ' ' GLU . 13.5 t -75.82 137.12 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.381 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -70.76 -3.69 20.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.444 0.698 . . . . 0.0 112.88 177.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.419 ' H ' HG12 ' A' ' 146' ' ' VAL . 6.7 mt-10 -137.92 125.38 21.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.94 1.696 . . . . 0.0 107.252 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.32 -23.48 62.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 169.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.02 3.79 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.222 2.609 . . . . 0.0 112.986 173.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -140.91 171.14 14.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.534 1.934 . . . . 0.0 108.191 -176.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -131.51 155.98 80.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.357 1.063 . . . . 0.0 110.791 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.07 170.41 19.77 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.792 2.328 . . . . 0.0 109.9 176.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -97.9 118.74 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -55.75 -24.22 34.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.909 1.684 . . . . 0.0 112.922 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -61.64 -35.24 77.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.254 0.933 . . . . 0.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -62.07 -54.06 53.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.171 -174.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -31.36 16.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.957 1.771 . . . . 0.0 112.279 177.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mm -53.62 -50.28 51.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 119.67 1.123 . . . . 0.0 109.623 172.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.844 0.293 . . . . 0.0 110.688 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.39 91.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.916 0.325 . . . . 0.0 111.568 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.71 -53.81 24.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.208 0.603 . . . . 0.0 110.921 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -24.46 67.91 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.437 1.017 . . . . 0.0 112.186 -177.215 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.35 66.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.024 0.829 . . . . 0.0 111.565 170.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.78 -24.25 12.93 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.506 1.122 . . . . 0.0 112.545 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . 0.258 7.1 p -126.36 74.71 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 122.695 1.236 . . . . 0.0 108.351 177.031 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.997 172.29 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tpp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.11 134.75 39.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 158.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -127.84 98.85 5.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.69 150.52 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -97.91 155.54 17.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 123.038 1.399 . . . . 0.0 108.748 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -120.87 66.49 0.85 Allowed 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HE3' HG21 ' A' ' 150' ' ' THR . 2.0 ttmt 57.35 36.75 27.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.55 -21.27 0.27 Allowed Glycine 0 CA--C 1.497 -1.088 0 O-C-N 118.751 -2.468 . . . . 0.0 111.116 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.33 163.61 34.02 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.64 157.46 55.48 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.986 3.124 . . . . 0.0 110.118 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.42 137.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.248 1.419 . . . . 0.0 107.317 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.656 ' H ' ' HG3' ' A' ' 123' ' ' GLU . 27.1 m -74.99 151.18 38.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.605 1.162 . . . . 0.0 109.138 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 121' ' ' ILE . 22.2 mt -113.09 143.92 43.52 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.4 165.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 158.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.73 -172.41 14.51 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.449 1.027 . . . . 0.0 113.3 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -116.63 158.52 23.6 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.304 1.441 . . . . 0.0 107.659 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.45 127.27 32.05 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 117' ' ' PHE . 1.8 t -89.76 163.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 127.441 2.297 . . . . 0.0 107.505 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -137.04 169.29 18.03 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.339 -0.851 . . . . 0.0 111.487 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.97 137.09 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.397 165.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.37 -23.25 30.83 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.312 1.91 . . . . 0.0 112.387 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -71.84 151.09 43.7 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.648 0.779 . . . . 0.0 109.856 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -73.86 126.97 31.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 146.93 93.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 118.023 -0.989 . . . . 0.0 108.371 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 31.4 Cg_exo -52.81 -25.77 28.31 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 121.943 1.762 . . . . 0.0 115.528 -172.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' CE1' ' A' ' 27' ' ' PHE . 26.1 t0 61.26 89.47 0.08 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 129.375 3.07 . . . . 0.0 118.232 -170.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.727 ' CE1' ' HB2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -131.19 -166.76 1.75 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.437 -2.04 . . . . 0.0 107.175 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 5.4 m -125.08 143.57 50.85 Favored 'General case' 0 N--CA 1.406 -2.651 1 C-N-CA 134.53 5.132 . . . . 0.0 107.21 -170.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.58 171.07 18.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 129.253 3.021 . . . . 0.0 103.768 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.33 146.34 25.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -67.17 162.36 22.66 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 119.822 1.192 . . . . 0.0 108.106 162.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.38 -11.63 4.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.67 165.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 m -98.06 4.8 49.19 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.951 2.1 . . . . 0.0 112.795 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 75.42 33.89 0.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.852 1.661 . . . . 0.0 112.094 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.18 153.8 35.72 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.51 141.74 48.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.092 -1.005 . . . . 0.0 108.921 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' THR . 13.5 ttmm -139.64 145.1 38.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 168.42 18.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.251 0.621 . . . . 0.0 111.247 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 134' ' ' LEU . 0.9 OUTLIER -54.89 -37.13 65.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.343 177.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.27 -35.07 49.14 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.7 -42.51 61.15 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.318 1.056 . . . . 0.0 109.845 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.87 -30.09 71.07 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 112.05 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -10.73 19.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.563 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -11.99 6.22 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.041 1.292 . . . . 0.0 112.878 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.68 164.79 34.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.661 1.73 . . . . 0.0 107.073 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.06 120.42 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -126.72 138.9 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.5 mt -100.88 144.82 12.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.27 132.16 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -121.32 100.09 6.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.08 134.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 60' ' ' CYS . 0.4 OUTLIER -137.6 161.54 59.83 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.66 -57.38 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.151 1.901 . . . . 0.0 111.594 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 164.4 33.08 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.844 2.058 . . . . 0.0 106.38 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.4 HG12 ' CG ' ' A' ' 93' ' ' TRP . 10.3 tt -94.93 -15.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.656 1.571 . . . . 0.0 112.985 -168.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.97 -1.75 53.33 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -78.99 3.41 17.27 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 118.815 -2.428 . . . . 0.0 115.318 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.36 -52.37 0.83 Allowed Glycine 0 CA--C 1.54 1.61 0 CA-C-O 117.771 -1.571 . . . . 0.0 113.194 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -30.29 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 122.282 3.041 . . . . 0.0 111.34 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 52' ' ' ILE . 1.9 m -58.65 -31.89 68.58 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.673 -0.642 . . . . 0.0 112.035 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.706 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 15.1 t70 -55.54 -50.3 70.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.885 0.874 . . . . 0.0 108.753 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.93 -13.79 5.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.622 0.576 . . . . 0.0 112.306 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.554 HE22 ' HG2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -99.28 -75.81 0.56 Allowed 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.012 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -59.43 -40.2 86.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 123.597 1.665 . . . . 0.0 111.489 -159.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.262 1.7 tpt180 -76.1 -49.89 16.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.176 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -57.34 -38.72 74.54 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -58.45 -41.1 84.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.763 0.825 . . . . 0.0 109.945 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -57.5 -45.26 85.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.326 0.966 . . . . 0.0 111.556 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -70.98 -48.63 52.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.026 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.35 -38.21 86.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.572 0.349 . . . . 0.0 110.671 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.04 86.05 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.507 -0.745 . . . . 0.0 111.402 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.69 88.49 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.762 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -70.75 -36.4 73.11 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.587 0.755 . . . . 0.0 111.396 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mp -62.4 -41.48 98.7 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 123.192 0.597 . . . . 0.0 109.97 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 -37.36 3.4 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.491 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG11 ' A' ' 166' ' ' VAL . 43.6 t0 -140.23 85.32 2.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.34 1.07 . . . . 0.0 109.575 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.29 172.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -127.93 144.2 51.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.4 t -144.41 139.22 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.51 161.26 35.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.464 0.65 . . . . 0.0 109.312 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.6 m -122.01 148.5 44.74 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.8 mt -132.9 134.74 57.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 m -132.13 159.9 37.57 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.438 0.695 . . . . 0.0 110.671 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.49 39.62 0.92 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 109.18 167.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -133.66 168.69 18.23 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.107 1.363 . . . . 0.0 108.804 -166.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 136.04 96.45 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.073 0.949 . . . . 0.0 110.536 -171.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.97 -42.39 64.71 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.365 2.043 . . . . 0.0 111.903 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -72.84 -30.07 63.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.059 -1.026 . . . . 0.0 112.672 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.87 98.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.503 1.047 . . . . 0.0 108.627 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.1 -46.23 78.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.09 75.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.79 0.805 . . . . 0.0 108.982 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 92' ' ' ARG . 18.9 ttp85 -70.3 -44.95 67.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.775 -172.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 61' ' ' ASP . 69.3 t90 -53.98 -41.44 67.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.1 -46.98 84.83 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.265 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.25 -38.89 97.19 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.839 0.712 . . . . 0.0 111.753 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.13 93.4 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.738 0.815 . . . . 0.0 110.751 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -87.7 -17.15 32.39 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.84 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.72 56.08 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 119.29 0.95 . . . . 0.0 112.132 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mm -71.35 142.76 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.279 1.432 . . . . 0.0 107.443 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.66 -36.59 0.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.09 1.356 . . . . 0.0 110.637 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -79.86 -18.62 50.28 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.838 -1.164 . . . . 0.0 112.988 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -117.13 150.29 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.38 138.97 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 p -93.88 150.62 20.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.713 1.205 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.6 mt -141.65 157.51 44.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.339 1.456 . . . . 0.0 107.406 -170.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -121.64 109.72 15.1 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.518 -1.364 . . . . 0.0 109.09 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 109' ' ' ARG . 25.0 t0 -84.06 -10.1 58.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.927 1.291 . . . . 0.0 110.333 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -32.55 -25.34 0.0 OUTLIER 'General case' 0 C--N 1.347 0.458 1 C-N-CA 132.148 4.179 . . . . 0.0 115.246 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -97.82 -38.12 9.57 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -151.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.21 -7.72 0.62 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 125.82 1.95 . . . . 0.0 107.859 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mmm 59.09 12.67 2.55 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 125.494 1.518 . . . . 0.0 109.561 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.1 -42.74 77.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.692 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -64.79 -57.63 8.4 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 125.052 1.341 . . . . 0.0 110.573 177.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -60.43 -37.9 93.94 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 118.9 -1.619 . . . . 0.0 111.474 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.2 -53.28 51.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.666 1.186 . . . . 0.0 109.778 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.37 77.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -83.7 0.66 46.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.026 177.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.19 44.62 95.37 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.55 1.068 . . . . 0.0 111.712 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.417 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.2 m -125.92 -6.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.882 0.873 . . . . 0.0 112.168 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.84 118.82 14.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 165.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 13' ' ' LEU . 51.2 mt -82.06 105.94 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -53.14 -41.34 65.02 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 112.037 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.656 ' HG3' ' H ' ' A' ' 12' ' ' THR . 1.5 mm-40 -80.1 -11.77 59.73 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.727 1.211 . . . . 0.0 111.632 -171.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.08 -23.06 6.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.886 0.766 . . . . 0.0 112.54 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 61.15 38.9 16.56 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.935 1.35 . . . . 0.0 114.332 -168.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.76 145.35 48.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -168.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.08 142.57 52.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.1 17.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.624 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -95.98 111.69 23.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 m -150.78 168.13 25.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.445 HG13 ' CG ' ' A' ' 153' ' ' PRO . 3.0 m -138.79 156.87 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.153 0.888 . . . . 0.0 109.316 171.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -141.41 159.73 41.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.57 1.148 . . . . 0.0 108.015 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.02 143.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 39' ' ' LEU . 69.5 mt -134.65 125.28 26.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -165.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.69 164.57 23.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.614 1.165 . . . . 0.0 109.087 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.32 -14.13 16.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.481 1.912 . . . . 0.0 112.988 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.96 -9.69 59.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.499 -1.376 . . . . 0.0 111.977 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.14 25.95 65.25 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.453 -1.405 . . . . 0.0 111.476 -168.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -89.71 142.51 27.62 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 118.821 1.311 . . . . 0.0 108.973 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.2 t -72.56 122.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 t -94.77 -31.59 4.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 126.27 1.828 . . . . 0.0 108.845 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -152.99 149.22 27.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.31 144.65 28.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 168.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.28 142.29 23.95 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.353 1.061 . . . . 0.0 108.525 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.46 108.17 10.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 153' ' ' PRO . 17.5 t -62.8 123.94 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -60.82 -12.6 11.37 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.264 -1.35 . . . . 0.0 112.646 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -134.74 115.18 13.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.54 1.536 . . . . 0.0 107.381 -172.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.16 -25.88 68.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.212 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -80.69 1.72 28.95 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.616 1.566 . . . . 0.0 113.95 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.36 164.26 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.94 2.496 . . . . 0.0 106.429 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -129.95 155.06 81.18 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 121.4 -0.812 . . . . 0.0 109.187 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.554 ' HG2' HE22 ' A' ' 63' ' ' GLN . 37.9 Cg_endo -66.86 168.89 15.87 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.536 2.157 . . . . 0.0 110.24 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.82 122.08 38.23 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.162 -1.586 . . . . 0.0 107.098 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 66' ' ' ARG . 19.7 p90 -59.3 -23.2 62.24 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.226 1.81 . . . . 0.0 112.824 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.43 -36.15 71.0 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.699 1.136 . . . . 0.0 109.842 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -60.22 -57.69 24.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.023 0.929 . . . . 0.0 113.16 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.59 -26.77 28.04 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 120.663 0.909 . . . . 0.0 111.224 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -49.42 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 108.493 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -63.96 -34.14 77.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.006 0.821 . . . . 0.0 111.204 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.31 66.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.59 0.756 . . . . 0.0 110.934 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.18 -44.99 67.61 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.444 -0.785 . . . . 0.0 110.421 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.428 ' HA ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -62.13 -23.61 66.66 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.67 -28.03 65.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.477 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.0 -25.79 13.94 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.002 -1.475 . . . . 0.0 113.702 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 163' ' ' LYS . 35.5 m -73.53 -13.37 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.113 1.324 . . . . 0.0 113.031 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 163' ' ' LYS . 7.1 mmtt . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.659 -2.115 . . . . 0.0 110.624 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.37 0.128 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.24 -24.51 67.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.576 0.751 . . . . 0.0 112.914 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 56.06 55.74 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.603 1.561 . . . . 0.0 110.798 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.92 151.63 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.659 169.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -113.84 160.78 18.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.337 1.055 . . . . 0.0 109.687 173.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.87 46.84 1.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.493 1.117 . . . . 0.0 108.673 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 42.33 63.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.608 1.963 . . . . 0.0 111.94 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.1 -25.58 0.18 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.571 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 171.81 43.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.271 0.938 . . . . 0.0 110.822 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.09 159.71 52.2 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.567 2.844 . . . . 0.0 111.076 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.54 133.61 45.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 124.125 0.97 . . . . 0.0 109.119 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -68.83 134.64 49.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.695 0.798 . . . . 0.0 110.481 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.23 146.59 23.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.398 1.479 . . . . 0.0 108.496 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -74.33 -65.02 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.25 169.52 54.65 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.509 0.576 . . . . 0.0 112.047 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.61 166.3 22.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.759 0.79 . . . . 0.0 110.611 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.48 120.09 18.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.75 152.5 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -128.15 158.06 39.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.251 1.02 . . . . 0.0 110.642 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.38 144.51 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.962 0.905 . . . . 0.0 108.813 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.38 19.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.646 1.117 . . . . 0.0 112.451 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.15 155.97 39.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.62 1.21 . . . . 0.0 109.872 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -74.02 136.19 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 157.92 30.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 122.987 0.515 . . . . 0.0 111.21 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -53.52 -27.42 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.969 3.113 . . . . 0.0 116.985 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 t0 51.91 78.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.255 1.422 . . . . 0.0 113.548 -169.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -139.15 -176.9 4.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.771 1.228 . . . . 0.0 110.636 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -125.64 152.31 45.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 110.994 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 m -140.39 170.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.791 2.436 . . . . 0.0 106.909 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.26 147.67 22.71 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.971 -1.08 . . . . 0.0 108.184 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.9 p -70.81 170.58 12.22 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -61.79 -9.25 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.633 -1.292 . . . . 0.0 112.524 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 m -105.83 12.09 31.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.476 1.91 . . . . 0.0 111.204 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.41 47.4 8.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.172 1.789 . . . . 0.0 111.209 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.9 140.44 51.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.99 135.09 56.25 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.537 -0.727 . . . . 0.0 111.153 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -137.29 141.57 41.93 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -126.65 157.21 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -169.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -54.48 -34.44 61.59 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.48 1.112 . . . . 0.0 111.132 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.56 67.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.51 -38.11 62.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.68 0.792 . . . . 0.0 110.331 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 mtt -66.43 -27.05 67.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.62 1.168 . . . . 0.0 111.013 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.19 -15.48 3.87 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.776 0.83 . . . . 0.0 113.142 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.54 -18.79 56.91 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.4 1.0 . . . . 0.0 113.849 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -152.48 160.56 43.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.347 1.573 . . . . 0.0 108.758 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.92 118.87 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.9 m -126.64 132.52 51.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.492 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.2 mt -93.05 142.51 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -126.89 128.62 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 125.553 1.541 . . . . 0.0 106.944 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 m -126.32 98.53 5.49 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.292 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.16 131.33 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.7 147.17 47.65 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.929 0.786 . . . . 0.0 111.827 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -65.21 133.54 35.68 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.3 2.0 . . . . 0.0 108.545 168.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m 44.44 -133.4 0.71 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.349 1.06 . . . . 0.0 111.073 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.5 tt -163.46 178.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.208 2.203 . . . . 0.0 106.15 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t0 56.09 38.98 30.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.072 1.749 . . . . 0.0 112.245 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.1 p -81.8 11.94 4.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.468 1.107 . . . . 0.0 111.646 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 -59.68 4.78 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 125.408 1.48 . . . . 0.0 109.761 -169.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.38 -8.7 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.55 -23.9 63.27 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.551 1.069 . . . . 0.0 111.274 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.19 -33.61 76.14 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.852 -1.155 . . . . 0.0 111.444 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.25 11.9 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.043 0.937 . . . . 0.0 111.899 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -134.92 -91.51 0.32 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.429 1.092 . . . . 0.0 108.481 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -54.59 -44.25 72.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.41 1.484 . . . . 0.0 112.297 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -67.61 -52.04 43.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -42.6 85.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.663 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.48 -37.87 79.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.378 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -59.58 -46.16 89.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.897 1.226 . . . . 0.0 111.609 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.74 -51.77 31.26 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.56 -36.52 84.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.502 -0.749 . . . . 0.0 111.078 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.655 -0.653 . . . . 0.0 111.668 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.16 66.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.486 1.039 . . . . 0.0 110.761 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -69.63 -41.49 75.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 0.0 110.058 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.2 -39.77 93.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.627 0.771 . . . . 0.0 110.144 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -73.49 2.67 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 125.821 1.677 . . . . 0.0 110.33 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -88.42 41.31 1.0 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.559 1.143 . . . . 0.0 112.088 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 164.7 15.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.467 1.107 . . . . 0.0 108.109 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.51 145.25 50.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.53 145.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.474 -0.766 . . . . 0.0 108.941 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -131.54 158.39 41.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.607 1.163 . . . . 0.0 108.544 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' HG22 ' A' ' 104' ' ' THR . 55.1 m -127.59 144.84 51.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.44 113.68 23.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 p -76.15 162.31 28.1 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.87 0.843 . . . . 0.0 110.123 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 -9.96 59.72 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -154.03 -31.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -169.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.83 111.26 10.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 120.412 1.46 . . . . 0.0 111.835 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.41 -31.65 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.903 1.735 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -71.26 -38.52 71.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.01 74.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.006 1.275 . . . . 0.0 110.844 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.13 -27.04 68.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.535 . . . . 0.0 111.438 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.19 82.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.465 0.575 . . . . 0.0 110.391 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -74.33 -39.96 62.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.549 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -52.66 -45.94 66.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.443 0.565 . . . . 0.0 109.81 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.78 -45.75 73.94 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.212 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.2 94.05 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.68 76.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.695 0.747 . . . . 0.0 110.406 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -73.77 -33.69 64.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.312 0.645 . . . . 0.0 112.34 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.24 37.71 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.72 145.02 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.11 -38.63 0.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.214 1.005 . . . . 0.0 112.789 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -74.74 -24.45 58.72 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.809 0.732 . . . . 0.0 112.408 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.1 158.94 10.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.25 134.45 34.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 81' ' ' THR . 7.0 p -87.56 154.37 20.67 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 mt -146.84 171.62 14.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 128.523 2.729 . . . . 0.0 106.076 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -150.97 142.33 23.36 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 119.656 -1.902 . . . . 0.0 109.06 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.63 -33.38 73.84 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 168.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.5 t60 55.79 -67.1 0.02 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 129.734 3.214 . . . . 0.0 113.981 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -149.44 0.11 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.302 1.441 . . . . 0.0 112.15 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.15 -39.9 90.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.253 0.933 . . . . 0.0 110.515 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 62.42 -23.55 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 129.523 3.129 . . . . 0.0 114.72 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.84 -43.96 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 121.05 1.75 . . . . 0.0 111.203 -170.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -64.65 -55.31 20.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.48 93.07 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 122.951 0.31 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.04 -47.59 73.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.615 -0.932 . . . . 0.0 110.273 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.06 -31.03 58.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.894 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.88 9.99 3.14 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.26 0.482 . . . . 0.0 112.071 172.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.91 -15.41 5.11 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 120.8 -1.187 . . . . 0.0 114.363 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.94 -25.49 30.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.053 1.427 . . . . 0.0 112.051 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.98 109.04 1.98 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.45 1.477 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.81 107.33 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -49.98 -45.66 51.84 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.75 1.22 . . . . 0.0 110.139 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.57 -16.27 62.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.519 1.128 . . . . 0.0 113.107 -171.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 mt -128.27 -16.82 4.38 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.517 1.127 . . . . 0.0 112.393 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.14 36.77 27.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.425 1.09 . . . . 0.0 109.417 -168.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.3 tp -126.08 147.06 49.67 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.159 1.383 . . . . 0.0 107.714 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.27 134.27 35.57 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.73 156.31 17.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.908 1.683 . . . . 0.0 111.955 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -83.22 116.66 22.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -162.14 168.44 22.54 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.935 0.894 . . . . 0.0 109.092 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.71 145.99 18.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 O-C-N 121.791 -0.568 . . . . 0.0 109.917 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -140.82 161.31 38.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.307 1.043 . . . . 0.0 109.581 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t -136.06 140.75 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.15 136.07 52.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.785 1.634 . . . . 0.0 108.122 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -75.77 166.76 23.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.213 1.005 . . . . 0.0 108.886 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.61 -23.01 57.91 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.254 -0.904 . . . . 0.0 112.588 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -76.06 -3.47 36.08 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.822 -1.174 . . . . 0.0 112.124 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.47 75.34 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.125 0.869 . . . . 0.0 112.096 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -92.56 143.94 25.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.45 130.86 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.4 t -104.93 -31.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.917 1.687 . . . . 0.0 109.409 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -152.28 149.12 28.34 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.82 139.23 24.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -149.08 134.13 18.13 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -114.29 126.05 54.59 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.5 t -70.0 136.69 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -67.48 -9.97 47.21 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.12 117.36 18.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.49 67.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 111.838 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.3 p -72.03 -10.59 59.99 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.88 1.672 . . . . 0.0 112.726 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -120.06 158.46 26.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 109.617 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -106.49 152.73 40.74 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.857 0.863 . . . . 0.0 111.082 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.08 154.58 57.43 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.592 2.194 . . . . 0.0 109.373 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.27 121.39 25.02 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -53.84 -26.56 25.02 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.262 1.425 . . . . 0.0 113.262 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -62.17 -33.61 74.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.778 0.717 . . . . 0.0 111.16 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -59.32 -56.79 32.36 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.178 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.57 -28.52 31.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 121.046 1.409 . . . . 0.0 111.851 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -48.45 88.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.529 1.059 . . . . 0.0 108.81 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.01 -31.06 72.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.888 0.767 . . . . 0.0 111.12 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -51.09 35.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.646 0.378 . . . . 0.0 111.36 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.47 -44.5 71.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -29.31 65.16 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.485 0.714 . . . . 0.0 111.67 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.58 71.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.498 0.719 . . . . 0.0 112.019 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.4 mt -99.16 -36.05 9.8 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.63 0.91 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.703 0.801 . . . . 0.0 109.897 173.781 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.318 0.104 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 167.44 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.181 0.515 . . . . 0.0 110.366 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -149.12 142.5 25.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 87.0 mt -137.69 166.48 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -115.37 155.25 27.71 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.068 1.304 . . . . 0.0 110.195 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -124.88 65.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.789 1.236 . . . . 0.0 108.175 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 pttt 39.09 50.44 1.81 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.813 2.045 . . . . 0.0 113.972 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.92 -27.3 0.13 Allowed Glycine 0 CA--C 1.523 0.594 0 CA-C-O 119.523 -0.598 . . . . 0.0 112.669 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.71 45.71 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 117.998 0.899 . . . . 0.0 111.294 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.09 157.8 28.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.599 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.37 131.8 40.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 126.553 1.941 . . . . 0.0 106.378 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -76.0 160.6 29.67 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.13 0.972 . . . . 0.0 109.858 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 138.04 54.25 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.23 128.42 38.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.69 -159.73 18.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 123.555 0.598 . . . . 0.0 112.201 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -126.03 155.09 42.03 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.289 1.036 . . . . 0.0 109.045 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.54 152.76 43.62 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 168.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.64 146.33 31.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.19 158.94 34.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.44 0.696 . . . . 0.0 110.837 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.37 139.54 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.077 0.951 . . . . 0.0 108.856 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -18.15 53.33 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.792 1.187 . . . . 0.0 112.346 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -77.21 153.95 33.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.013 1.406 . . . . 0.0 109.98 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -75.29 127.61 33.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 169.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.29 150.78 78.73 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.653 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.17 -30.3 49.98 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.816 3.01 . . . . 0.0 115.625 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 51.63 88.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.557 1.943 . . . . 0.0 113.965 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.02 168.27 19.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.376 1.07 . . . . 0.0 110.405 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.2 157.34 19.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.321 1.448 . . . . 0.0 112.375 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.85 157.69 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.942 2.497 . . . . 0.0 106.279 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tp -86.22 138.08 32.14 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.954 -1.091 . . . . 0.0 108.972 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.8 p -71.18 167.44 19.37 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -65.44 -17.03 64.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.476 -1.39 . . . . 0.0 110.887 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -81.08 0.78 34.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.805 1.642 . . . . 0.0 111.374 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 mt 69.26 34.06 3.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.54 1.536 . . . . 0.0 111.404 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.77 163.06 20.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.668 1.187 . . . . 0.0 108.264 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.3 137.21 37.26 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -134.03 149.94 51.2 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -143.04 165.47 27.28 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.91 -35.57 64.28 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 111.939 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.1 -29.11 56.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.204 1.002 . . . . 0.0 113.146 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -81.14 -40.45 23.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.395 1.078 . . . . 0.0 110.762 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.69 -42.3 91.37 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -66.19 -0.79 2.71 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.67 -16.5 30.45 Favored Glycine 0 CA--C 1.54 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 112.488 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -140.25 158.54 43.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.534 1.533 . . . . 0.0 107.366 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.73 120.28 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -125.46 136.31 53.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.881 -169.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.21 139.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mm -120.55 133.76 66.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -125.99 94.43 4.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.333 1.053 . . . . 0.0 108.696 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.06 124.08 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.82 162.42 55.36 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.41 1.484 . . . . 0.0 107.799 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.02 -59.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.955 1.77 . . . . 0.0 110.315 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.8 m -152.41 160.32 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.581 2.353 . . . . 0.0 106.887 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.29 17.16 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -126.95 14.38 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.891 1.276 . . . . 0.0 110.42 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -73.51 -12.41 60.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.899 1.28 . . . . 0.0 112.713 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.15 -50.77 4.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.808 1.194 . . . . 0.0 110.213 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.68 -25.77 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 118.173 0.987 . . . . 0.0 112.073 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.7 p -53.42 -37.99 63.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.309 1.044 . . . . 0.0 112.257 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.98 -43.75 67.38 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.138 0.975 . . . . 0.0 110.787 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.98 43.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.155 0.982 . . . . 0.0 112.441 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -106.67 -55.01 2.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.189 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -64.78 -40.04 94.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.864 1.211 . . . . 0.0 112.348 -169.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -63.06 -49.3 75.09 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.029 -1.044 . . . . 0.0 109.335 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -67.01 -36.04 81.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.165 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -59.5 -43.86 93.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.75 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -58.08 -46.79 84.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.495 1.043 . . . . 0.0 111.343 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.58 -46.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -69.16 -33.31 73.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.296 -0.878 . . . . 0.0 110.721 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.92 96.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.526 0.603 . . . . 0.0 110.892 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.863 0.756 . . . . 0.0 111.144 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -65.48 -39.76 92.32 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.092 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.02 -45.75 84.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.598 1.09 . . . . 0.0 110.114 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 -4.93 75.22 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.796 1.189 . . . . 0.0 114.433 170.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -153.8 55.1 0.73 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.473 . . . . 0.0 109.831 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.33 168.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -127.76 140.81 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.6 t -137.34 139.79 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -128.71 162.84 26.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.886 0.851 . . . . 0.0 109.502 170.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.63 ' HB ' HG22 ' A' ' 104' ' ' THR . 21.5 m -129.11 143.99 51.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 mt -130.87 134.95 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.4 m -138.95 157.0 46.81 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.414 1.086 . . . . 0.0 110.436 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.99 54.32 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -140.41 162.93 34.15 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.651 1.581 . . . . 0.0 107.891 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.34 137.08 95.32 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.46 -32.08 80.56 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.015 1.81 . . . . 0.0 111.269 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -29.44 62.3 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.275 -0.891 . . . . 0.0 111.461 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -45.23 67.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.96 1.255 . . . . 0.0 109.709 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.26 -44.07 79.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.305 1.042 . . . . 0.0 111.714 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.27 -39.96 95.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.387 -0.821 . . . . 0.0 111.894 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -67.16 -39.06 86.44 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -53.95 -51.81 62.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.433 0.693 . . . . 0.0 109.428 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.0 m -60.11 -36.45 77.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.852 0.751 . . . . 0.0 111.231 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.06 -19.56 72.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.954 -0.914 . . . . 0.0 113.548 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.25 -25.17 24.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.168 1.484 . . . . 0.0 111.571 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -124.13 -16.28 6.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.64 1.176 . . . . 0.0 113.08 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.44 22.24 77.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.242 -0.755 . . . . 0.0 112.198 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mt -55.99 140.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -143.33 -35.89 0.38 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.65 1.18 . . . . 0.0 111.807 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -76.48 -17.14 59.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 111.448 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.26 153.98 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.65 150.64 50.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.1 p -111.77 148.02 34.42 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.1 mt -138.72 145.25 40.05 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.215 1.006 . . . . 0.0 109.192 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.3 m -107.82 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.516 0.674 . . . . 0.0 109.827 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -81.36 -14.55 57.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.512 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -42.43 -39.92 2.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.761 2.424 . . . . 0.0 114.192 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -119.74 24.05 10.79 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.251 1.021 . . . . 0.0 110.266 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -136.26 -45.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.787 0.835 . . . . 0.0 110.461 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.1 -15.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.15 2.98 . . . . 0.0 114.898 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 m -62.86 -50.57 70.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.329 1.422 . . . . 0.0 111.871 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.92 -46.84 85.9 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.214 0.916 . . . . 0.0 110.162 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.36 99.08 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.89 -42.97 80.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.295 -0.532 . . . . 0.0 109.955 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.56 92.06 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.37 -0.831 . . . . 0.0 112.035 -169.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.11 -1.35 52.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.687 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.63 54.06 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 119.385 0.993 . . . . 0.0 112.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.4 28.87 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.993 1.317 . . . . 0.0 110.46 -170.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -119.84 117.41 28.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.85 112.54 19.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.36 -43.53 83.59 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.595 1.958 . . . . 0.0 111.234 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.4 -43.61 66.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.388 0.275 . . . . 0.0 110.476 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.09 -22.09 31.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 56.59 37.62 28.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.889 0.876 . . . . 0.0 108.697 -168.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.162 1.385 . . . . 0.0 108.056 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.9 150.67 42.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.398 0.618 . . . . 0.0 110.75 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -177.21 2.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.554 1.169 . . . . 0.0 112.232 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.45 101.21 7.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 102.034 -3.321 . . . . 0.0 102.034 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -156.51 167.88 29.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -169.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.13 144.93 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -141.04 159.91 41.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.706 0.802 . . . . 0.0 109.825 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.5 t -135.56 144.45 33.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.3 mt -130.24 123.11 29.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.536 1.534 . . . . 0.0 107.961 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.97 166.23 11.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.158 0.983 . . . . 0.0 108.714 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.51 -20.99 59.45 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.153 -0.967 . . . . 0.0 113.397 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -80.45 -10.68 59.74 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.593 -1.317 . . . . 0.0 112.247 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.58 18.05 69.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.399 -0.813 . . . . 0.0 111.179 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -75.66 132.21 40.42 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.34 125.7 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.97 -10.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -153.55 144.06 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.85 138.69 22.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.08 149.94 29.38 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 109.201 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -129.57 108.19 10.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.72 123.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -68.43 -11.29 59.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -135.28 124.87 25.09 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 108.375 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.87 66.09 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 p -84.52 16.6 3.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 112.017 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -137.23 170.32 16.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.161 2.185 . . . . 0.0 107.954 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.25 164.11 42.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.706 1.203 . . . . 0.0 110.617 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.52 173.64 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.305 2.67 . . . . 0.0 112.258 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -113.91 120.11 39.57 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -53.08 -28.48 25.27 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.526 1.53 . . . . 0.0 112.845 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -58.85 -36.18 74.14 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.496 0.589 . . . . 0.0 111.12 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -67.59 -52.95 24.56 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.677 -170.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.98 -32.94 27.31 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.842 1.336 . . . . 0.0 111.846 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.16 -48.3 79.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-N 119.25 0.932 . . . . 0.0 109.54 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.08 -39.55 92.81 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.508 0.594 . . . . 0.0 110.545 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.216 -0.303 . . . . 0.0 111.603 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.57 -52.2 41.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.532 0.733 . . . . 0.0 110.168 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.13 69.58 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.133 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.55 -32.02 69.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.374 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.57 -35.85 19.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.796 0.838 . . . . 0.0 111.556 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.4 -40.43 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.451 0.701 . . . . 0.0 111.302 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 18.7 pttp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.336 0.516 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.95 -179.76 1.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.724 0.693 . . . . 0.0 109.135 169.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -144.47 140.09 28.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.68 150.86 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -77.56 161.33 27.95 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.905 -1.122 . . . . 0.0 108.797 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -138.15 109.38 6.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 39.03 51.3 1.89 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 111.583 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.22 5.47 79.88 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.519 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.08 142.33 13.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 120.299 2.05 . . . . 0.0 109.966 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 149.41 63.27 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 CA-C-N 120.61 2.205 . . . . 0.0 112.006 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.91 141.37 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.095 1.358 . . . . 0.0 109.432 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -78.07 147.79 34.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.391 1.476 . . . . 0.0 110.115 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 119' ' ' VAL . 2.0 mm? -116.04 147.32 41.38 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.871 1.668 . . . . 0.0 106.842 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -67.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.572 0.624 . . . . 0.0 111.222 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 173.02 36.24 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.561 0.534 . . . . 0.0 112.331 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.9 152.3 37.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.78 114.29 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.818 1.19 . . . . 0.0 108.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.5 160.52 20.49 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.98 135.06 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -15.29 60.26 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.736 1.16 . . . . 0.0 112.704 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -70.59 147.23 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.619 1.71 . . . . 0.0 109.137 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -87.03 117.8 25.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 152.1 40.57 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -169.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.42 -24.66 36.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.373 3.382 . . . . 0.0 116.542 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 52.74 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.633 1.973 . . . . 0.0 114.324 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.12 -172.98 2.82 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.411 1.484 . . . . 0.0 108.872 172.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 m -122.92 154.76 37.92 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.946 0.899 . . . . 0.0 110.082 -168.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.02 165.02 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.096 2.158 . . . . 0.0 106.796 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tp -89.59 142.54 27.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -69.16 166.91 17.28 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -65.24 -4.13 4.83 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.71 -1.243 . . . . 0.0 111.941 168.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.3 m -115.01 17.68 16.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.102 2.161 . . . . 0.0 111.332 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.1 mt 65.59 37.77 5.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 113.021 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -122.83 157.09 33.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.03 143.24 35.84 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.739 -1.226 . . . . 0.0 109.167 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.04 142.98 32.91 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -138.51 167.03 22.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.516 -171.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tt -57.78 -35.97 71.53 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.96 -0.463 . . . . 0.0 111.188 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.93 54.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.896 . . . . 0.0 113.073 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.46 -37.87 19.26 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.402 1.081 . . . . 0.0 110.718 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.46 -39.37 91.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.96 0.904 . . . . 0.0 110.244 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -67.5 -0.25 3.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.65 -17.07 40.08 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 120.751 -1.218 . . . . 0.0 113.003 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -144.92 166.63 24.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.299 1.84 . . . . 0.0 106.678 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.18 116.68 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 m -125.51 139.35 53.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.809 0.338 . . . . 0.0 110.635 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 mt -103.13 141.77 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.67 95.81 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 125.92 1.688 . . . . 0.0 107.21 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -73.38 145.51 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.82 137.85 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 pt -141.56 150.12 56.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -48.83 10.15 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.986 1.79 . . . . 0.0 111.951 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -156.07 149.11 24.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 tt -79.33 3.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -89.13 -3.9 58.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.28 1.032 . . . . 0.0 111.964 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -65.5 -10.38 34.0 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.922 -1.111 . . . . 0.0 113.399 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.7 -50.1 4.35 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.323 1.44 . . . . 0.0 111.994 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.7 -2.83 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.919 0.888 . . . . 0.0 112.349 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -49.85 -31.5 12.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.369 1.468 . . . . 0.0 110.058 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.48 -50.74 51.81 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.853 1.261 . . . . 0.0 111.92 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.52 79.71 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.612 0.365 . . . . 0.0 110.921 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -85.43 -8.51 58.35 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.648 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -141.01 -60.91 0.49 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.861 1.21 . . . . 0.0 112.47 -169.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -71.87 -43.72 64.97 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.483 -1.386 . . . . 0.0 110.064 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.56 -35.98 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.998 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -62.46 -36.88 83.85 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.555 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -57.37 -45.98 83.87 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.752 1.16 . . . . 0.0 110.323 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.75 -50.18 65.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.831 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -32.18 72.78 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.134 -0.979 . . . . 0.0 110.929 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.98 93.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.911 0.884 . . . . 0.0 111.166 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.26 99.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.202 0.455 . . . . 0.0 109.947 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -65.13 -35.73 82.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.28 0.632 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -62.42 -19.4 63.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.168 0.987 . . . . 0.0 113.225 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.3 -43.27 3.11 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.497 1.046 . . . . 0.0 112.054 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -149.95 126.3 10.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.851 1.261 . . . . 0.0 108.563 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -165.52 174.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.354 2.262 . . . . 0.0 105.379 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -129.41 138.57 51.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -140.54 140.4 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -134.33 167.35 20.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.493 1.117 . . . . 0.0 109.493 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.4 m -131.63 144.15 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.82 141.85 43.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -142.5 156.78 45.18 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.021 0.528 . . . . 0.0 111.452 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.88 50.95 1.87 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.663 1.185 . . . . 0.0 108.047 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -142.71 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.328 1.451 . . . . 0.0 107.787 -169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.41 140.6 72.47 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 111.882 -168.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.49 -39.72 45.25 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.93 3.087 . . . . 0.0 114.498 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -74.42 -28.04 60.89 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.74 0.7 . . . . 0.0 111.604 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.27 -44.2 84.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.447 1.021 . . . . 0.0 108.941 172.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -48.26 74.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.663 0.785 . . . . 0.0 111.095 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -41.21 97.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.416 0.553 . . . . 0.0 111.451 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -63.77 -41.48 97.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.103 0.561 . . . . 0.0 109.787 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -56.21 -48.48 76.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.416 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 66.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.882 0.764 . . . . 0.0 110.865 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.19 98.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.38 85.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.857 0.829 . . . . 0.0 110.758 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -86.69 -11.07 52.28 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.539 0.736 . . . . 0.0 112.672 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.48 27.85 68.79 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.182 0.901 . . . . 0.0 111.903 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.4 mt -76.54 147.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.188 0.995 . . . . 0.0 108.943 -174.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.65 -39.08 0.47 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 111.849 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -11.18 59.86 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.335 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.32 155.44 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -135.27 134.41 39.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -89.14 151.08 22.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.181 0.992 . . . . 0.0 108.777 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 mt -141.59 166.18 25.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.78 2.032 . . . . 0.0 107.388 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.93 123.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -80.4 36.23 0.36 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.561 1.172 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -66.04 -10.43 39.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.738 1.615 . . . . 0.0 111.671 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -79.1 63.29 3.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.456 1.503 . . . . 0.0 108.743 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t0 47.05 44.83 15.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.818 2.047 . . . . 0.0 112.691 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 83.1 mmm 48.73 23.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.192 2.197 . . . . 0.0 114.127 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -63.64 -37.14 86.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.075 -1.016 . . . . 0.0 112.977 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.65 -48.86 62.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 109.65 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.3 61.63 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.33 -49.51 77.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.891 0.845 . . . . 0.0 109.24 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.7 -39.1 80.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.41 -3.08 21.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 113.2 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.26 62.75 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.322 0.965 . . . . 0.0 112.61 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.436 ' HA ' HD12 ' A' ' 13' ' ' LEU . 26.9 m -121.52 1.08 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.64 1.22 . . . . 0.0 112.449 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -90.89 120.28 31.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.9 mt -82.25 108.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -54.96 -38.53 67.86 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.159 1.383 . . . . 0.0 110.908 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -75.47 -10.85 59.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 112.628 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 mt -134.29 -19.77 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 53.42 42.17 32.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 109.17 -167.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -119.6 148.08 43.75 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.39 1.476 . . . . 0.0 107.249 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 tp -91.9 139.04 31.05 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.04 172.37 10.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.085 0.954 . . . . 0.0 111.13 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ttm105 -101.67 21.17 14.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.922 0.889 . . . . 0.0 111.475 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 m -58.66 176.31 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.285 2.234 . . . . 0.0 113.89 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.47 147.62 16.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.542 -1.349 . . . . 0.0 108.568 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.83 165.18 26.21 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 109.884 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.29 145.02 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.4 mt -131.0 130.21 43.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.431 -168.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.19 168.23 10.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 109.365 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.79 -14.61 22.67 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.207 -0.933 . . . . 0.0 113.511 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -93.8 6.82 47.15 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.539 -1.351 . . . . 0.0 111.743 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.61 22.28 73.29 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.865 -1.147 . . . . 0.0 111.978 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.78 135.53 34.5 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.695 1.248 . . . . 0.0 107.78 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.72 115.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.89 -34.25 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -162.05 144.72 11.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.219 1.808 . . . . 0.0 107.105 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.84 147.94 34.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.895 0.878 . . . . 0.0 108.725 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.26 135.16 26.76 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.053 1.341 . . . . 0.0 107.704 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -106.81 18.7 21.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.051 1.74 . . . . 0.0 112.951 -168.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.1 m 49.21 -16.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 130.193 3.397 . . . . 0.0 118.376 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 m 55.02 -7.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.048 2.939 . . . . 0.0 116.05 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.51 126.15 11.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.056 1.342 . . . . 0.0 112.649 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 80.9 p -93.43 12.8 23.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.148 1.34 . . . . 0.0 112.211 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.17 163.93 15.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.592 1.557 . . . . 0.0 109.765 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -124.65 157.43 65.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.224 1.41 . . . . 0.0 108.714 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.89 -167.49 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.346 2.697 . . . . 0.0 108.646 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -124.2 116.45 22.71 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -47.46 -29.0 2.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.954 2.101 . . . . 0.0 113.897 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.21 -36.49 77.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.15 0.432 . . . . 0.0 110.969 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -58.52 -58.21 20.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.801 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -24.15 23.1 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-O 116.814 -1.411 . . . . 0.0 112.553 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -47.22 94.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 121.332 1.878 . . . . 0.0 109.066 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.53 -34.84 79.17 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 110.855 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.5 62.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.672 0.389 . . . . 0.0 111.625 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.23 -48.44 70.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.631 0.772 . . . . 0.0 111.171 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -31.45 68.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.962 0.505 . . . . 0.0 111.515 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.28 -30.76 71.8 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.054 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.73 -39.29 7.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.682 0.674 . . . . 0.0 112.548 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.22 -23.49 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.161 0.585 . . . . 0.0 111.208 178.535 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.14 153.76 14.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.946 1.298 . . . . 0.0 112.072 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -144.77 -32.7 0.4 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.085 2.154 . . . . 0.0 109.944 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.286 16.2 mt 73.65 162.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.699 2.4 . . . . 0.0 111.068 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 p -125.02 165.87 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.812 2.045 . . . . 0.0 108.767 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -136.5 105.37 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 150' ' ' THR . 16.3 ptpt 31.4 56.81 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.115 2.166 . . . . 0.0 114.545 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.52 13.06 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.608 169.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.78 159.87 29.89 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.327 1.564 . . . . 0.0 110.501 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.16 156.73 37.99 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.108 2.539 . . . . 0.0 112.164 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.18 -161.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.926 1.691 . . . . 0.0 106.862 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.0 m -149.13 152.31 35.9 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.284 -1.51 . . . . 0.0 108.219 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.45 138.06 47.33 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.191 1.397 . . . . 0.0 108.406 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.65 -17.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.1 175.88 24.44 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.41 150.61 44.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.096 0.951 . . . . 0.0 111.794 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.37 123.37 26.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 168.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.75 162.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.892 1.224 . . . . 0.0 110.123 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -123.26 156.39 35.31 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.475 1.51 . . . . 0.0 107.72 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.07 135.1 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.34 68.52 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.473 -1.182 . . . . 0.0 112.998 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.02 149.73 49.78 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 108.976 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.35 128.23 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 169.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -60.98 142.38 92.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.353 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 36.1 Cg_exo -57.42 0.41 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.703 1 C-N-CA 126.102 4.535 . . . . 0.0 119.204 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.28 65.24 1.31 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.816 1.293 . . . . 0.0 111.902 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -74.67 164.54 26.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.568 1.547 . . . . 0.0 109.805 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.0 m -130.58 136.57 49.02 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.93 155.11 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.013 1.725 . . . . 0.0 106.618 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -85.39 139.11 31.81 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -70.99 164.87 24.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -67.08 -3.4 7.3 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.852 -1.155 . . . . 0.0 111.594 168.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -97.87 5.24 49.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.415 1.886 . . . . 0.0 111.836 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 63.31 42.72 6.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.82 1.248 . . . . 0.0 111.294 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.97 164.46 20.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -84.14 144.94 28.68 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 120.729 -1.232 . . . . 0.0 109.872 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -138.23 156.32 47.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.95 2.1 . . . . 0.0 106.092 171.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 p -149.48 169.8 20.06 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.293 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -47.02 -43.89 19.99 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.776 0.83 . . . . 0.0 111.347 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -30.57 66.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.949 0.9 . . . . 0.0 112.8 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.91 -40.27 60.97 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.382 0.673 . . . . 0.0 110.426 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.5 mtt -67.74 -25.08 65.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.283 1.033 . . . . 0.0 111.62 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -55.77 -14.84 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.225 1.01 . . . . 0.0 113.622 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.29 -23.27 57.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.754 -1.026 . . . . 0.0 113.672 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -151.77 156.86 41.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.677 1.739 . . . . 0.0 109.517 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.1 122.21 8.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 168.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.5 m -125.96 130.47 51.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.63 0.372 . . . . 0.0 110.923 -168.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.4 mt -89.71 141.43 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 mm -118.74 131.61 71.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -127.42 84.45 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.418 1.087 . . . . 0.0 108.16 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.9 143.65 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.73 169.95 9.77 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 106.989 169.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.27 -54.88 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.82 1.68 . . . . 0.0 110.812 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 m -151.37 170.37 19.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.409 2.284 . . . . 0.0 107.563 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -149.3 81.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.954 0.883 . . . . 0.0 109.206 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.68 6.42 1.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 t -152.64 -170.03 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.941 1.297 . . . . 0.0 107.782 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.28 -52.44 3.78 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.75 -29.68 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 117.897 0.849 . . . . 0.0 112.316 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.4 -24.7 64.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.688 0.676 . . . . 0.0 112.485 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -139.53 -95.68 0.16 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.191 0.997 . . . . 0.0 108.718 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.54 6.34 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.597 1.959 . . . . 0.0 114.581 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -87.7 -44.43 11.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.463 1.105 . . . . 0.0 108.353 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.0 m -51.31 -41.74 60.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.43 1.092 . . . . 0.0 112.393 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -65.28 -45.27 85.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -69.15 -39.23 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -56.73 -40.86 76.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.221 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -59.59 -46.09 89.95 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-N 119.348 0.977 . . . . 0.0 111.416 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.45 -55.72 16.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.392 0.677 . . . . 0.0 109.354 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 27.2 mm-40 -60.08 -40.97 91.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.859 0.754 . . . . 0.0 110.778 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.17 69.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.203 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.67 70.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.572 1.078 . . . . 0.0 110.299 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.93 -41.65 86.66 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.726 174.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.85 -40.78 92.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 110.551 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 -66.62 2.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.951 1.739 . . . . 0.0 110.939 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.69 45.36 1.19 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.725 1.61 . . . . 0.0 111.782 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.65 166.4 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.152 1.381 . . . . 0.0 107.734 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -132.24 146.08 51.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.28 145.32 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.31 155.37 47.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 108.706 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 104' ' ' THR . 54.4 m -117.23 145.81 43.67 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.29 138.05 53.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -140.48 159.18 42.76 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.973 0.909 . . . . 0.0 110.23 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.01 54.66 1.72 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -143.11 161.54 37.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.887 1.275 . . . . 0.0 108.757 -169.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.86 138.43 85.35 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.015 0.926 . . . . 0.0 108.93 -169.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.25 -34.27 88.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.619 2.213 . . . . 0.0 112.129 -170.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -73.86 -29.05 61.9 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.361 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.97 86.3 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.955 0.798 . . . . 0.0 109.381 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -62.89 -42.64 99.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.328 -0.232 . . . . 0.0 111.123 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.87 84.57 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.696 0.398 . . . . 0.0 111.25 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -63.5 -45.72 89.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -60.66 -40.32 91.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.503 0.321 . . . . 0.0 110.436 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.1 m -63.97 -46.1 86.14 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.005 -0.434 . . . . 0.0 111.315 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.38 94.63 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.65 67.67 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.871 0.868 . . . . 0.0 111.999 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -108.25 -4.89 17.15 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.897 0.879 . . . . 0.0 112.345 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.21 30.65 56.76 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.725 0.679 . . . . 0.0 111.528 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -72.19 143.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.412 1.085 . . . . 0.0 108.675 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.67 -38.38 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.619 1.168 . . . . 0.0 112.87 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -73.35 -21.13 60.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 112.342 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.48 157.79 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.22 143.77 36.18 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.429 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.9 p -96.86 149.96 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.79 0.836 . . . . 0.0 109.521 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.5 mt -137.7 139.4 40.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.592 1.157 . . . . 0.0 108.664 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.7 m -102.06 122.23 43.71 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.427 1.091 . . . . 0.0 108.874 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -104.23 -7.36 20.14 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.669 0.787 . . . . 0.0 111.825 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.51 -27.16 47.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.855 1.262 . . . . 0.0 112.817 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -62.33 -32.04 72.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -146.2 -8.24 0.53 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 50.63 31.02 5.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.421 1.488 . . . . 0.0 112.629 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 m -58.22 -55.47 34.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.296 -0.877 . . . . 0.0 111.136 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -67.26 -40.21 86.19 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.92 -45.09 32.19 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 126.337 1.922 . . . . 0.0 113.118 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.32 -41.31 18.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.903 0.851 . . . . 0.0 109.688 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.97 80.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.574 1.15 . . . . 0.0 112.384 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -105.64 10.79 32.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.812 1.245 . . . . 0.0 110.968 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.24 -3.3 2.46 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.068 -1.407 . . . . 0.0 115.578 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.79 -9.65 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.392 2.096 . . . . 0.0 113.836 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -75.11 120.77 21.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.992 1.269 . . . . 0.0 108.404 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.3 mt -93.7 110.69 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -54.36 -40.84 68.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.871 1.668 . . . . 0.0 111.837 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.24 -6.69 59.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.16 0.584 . . . . 0.0 112.45 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -126.03 -18.54 5.02 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.26 33.41 22.15 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -168.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.6 tp -128.0 171.23 12.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.318 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.3 141.19 47.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.158 0.983 . . . . 0.0 108.748 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 175.89 2.78 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.609 1.164 . . . . 0.0 111.066 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -113.65 18.36 17.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.1 m -63.19 162.35 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 111.727 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.86 147.86 28.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.726 0.81 . . . . 0.0 109.843 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -142.79 155.38 44.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.714 0.805 . . . . 0.0 108.923 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.01 135.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.9 mt -127.93 121.11 29.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.485 1.514 . . . . 0.0 107.276 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.48 160.65 18.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.061 0.945 . . . . 0.0 108.951 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.82 -19.09 15.46 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.772 1.229 . . . . 0.0 113.164 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -73.59 -11.96 60.6 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.534 -1.354 . . . . 0.0 112.465 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.55 43.92 8.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -127.7 131.42 49.75 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.0 109.25 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.974 1.31 . . . . 0.0 108.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.5 -39.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 125.432 1.493 . . . . 0.0 109.331 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -153.76 142.64 21.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.112 1.365 . . . . 0.0 107.504 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.89 139.12 27.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.4 145.26 27.97 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -120.19 131.62 55.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.192 1.397 . . . . 0.0 107.474 -172.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.4 -15.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.3 m 62.55 -12.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.723 2.009 . . . . 0.0 114.658 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -139.74 116.44 10.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.67 1.588 . . . . 0.0 107.029 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.16 66.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.962 1.305 . . . . 0.0 112.676 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.454 HG21 ' HE3' ' A' ' 7' ' ' LYS . 5.6 p -91.05 15.34 11.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.347 1.459 . . . . 0.0 111.545 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -138.52 123.1 18.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.366 1.466 . . . . 0.0 109.201 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 155.34 90.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.997 0.919 . . . . 0.0 112.034 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.65 -167.47 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.421 3.414 . . . . 0.0 109.547 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -124.78 116.65 22.63 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -53.38 -27.36 23.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 112.551 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.88 -34.06 71.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.454 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.19 -57.02 19.55 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.233 0.924 . . . . 0.0 111.761 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.34 -29.27 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.398 1.399 . . . . 0.0 111.873 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 mm -56.11 -48.46 79.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 119.878 1.217 . . . . 0.0 109.668 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -65.5 -28.79 69.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.891 0.769 . . . . 0.0 111.423 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.42 -49.83 57.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.394 0.543 . . . . 0.0 111.348 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.8 74.81 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.486 0.714 . . . . 0.0 111.566 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -20.3 63.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.407 0.683 . . . . 0.0 112.175 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.68 -26.65 67.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.72 0.691 . . . . 0.0 111.393 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.6 mt -107.1 -21.97 12.8 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.866 1.266 . . . . 0.0 113.362 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 m -65.96 -18.8 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 119.123 0.874 . . . . 0.0 112.483 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.406 1.082 . . . . 0.0 110.126 -178.227 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.48 81.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.821 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 45.1 49.08 9.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.96 1.704 . . . . 0.0 111.633 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.46 140.72 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.287 1.035 . . . . 0.0 108.472 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 p -102.1 156.97 17.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.988 0.915 . . . . 0.0 109.777 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -104.43 41.83 1.27 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 63.26 -39.8 0.18 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.606 2.762 . . . . 0.0 114.551 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.03 -36.03 33.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.95 0.786 . . . . 0.0 112.015 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.79 177.31 48.06 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.08 153.1 27.51 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.914 3.076 . . . . 0.0 112.797 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.27 131.63 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.62 1.168 . . . . 0.0 108.752 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -63.03 151.28 40.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.446 1.499 . . . . 0.0 111.105 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 mt -122.65 139.63 53.73 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.981 2.112 . . . . 0.0 106.97 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.91 -16.8 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.93 169.1 28.73 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -71.8 159.4 34.38 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.002 0.906 . . . . 0.0 112.057 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -73.37 149.87 42.22 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.51 148.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -131.85 160.35 35.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 111.142 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 141.85 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.028 1.331 . . . . 0.0 109.646 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -22.51 26.35 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.051 1.31 . . . . 0.0 112.027 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -74.95 151.16 38.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.514 1.157 . . . . 0.0 109.91 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -71.29 123.63 22.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.46 152.03 75.21 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.36 -26.53 44.29 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.797 2.998 . . . . 0.0 116.065 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t0 51.38 86.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.282 1.833 . . . . 0.0 114.303 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -127.14 -176.02 3.6 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.798 1.639 . . . . 0.0 108.814 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 m -124.37 154.2 40.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.198 0.999 . . . . 0.0 111.014 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.65 166.33 26.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.883 2.073 . . . . 0.0 107.811 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 tp -84.89 143.92 28.72 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.4 p -71.22 166.86 20.64 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -67.31 -3.42 7.99 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.024 -1.672 . . . . 0.0 112.156 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 m -110.56 17.1 21.08 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.367 1.867 . . . . 0.0 111.323 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.4 mt 66.51 28.1 9.53 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.347 1.459 . . . . 0.0 112.829 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.76 174.34 5.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.03 146.61 43.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.178 -1.576 . . . . 0.0 109.992 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -141.37 136.28 31.3 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 p -124.01 164.11 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.243 1.017 . . . . 0.0 109.247 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.68 -36.69 69.89 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.08 -0.388 . . . . 0.0 110.254 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.53 54.27 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.48 -39.75 52.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 mtt -64.27 -24.81 67.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.632 1.173 . . . . 0.0 111.323 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -55.85 -14.06 2.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.464 1.106 . . . . 0.0 113.401 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.23 -24.36 44.2 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.424 1.011 . . . . 0.0 113.423 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -151.36 169.01 23.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.908 1.354 . . . . 0.0 108.832 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.5 t -62.71 122.43 13.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.0 m -129.39 135.28 48.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.521 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.42 141.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -127.76 120.21 53.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 125.372 1.469 . . . . 0.0 107.42 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.4 m -116.94 100.32 7.68 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.269 1.028 . . . . 0.0 108.395 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.6 136.66 22.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.74 157.69 74.49 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.81 -60.44 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.833 2.355 . . . . 0.0 110.578 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 m -148.49 152.37 36.77 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.295 1.438 . . . . 0.0 107.958 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.75 -18.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.688 1.195 . . . . 0.0 113.284 -173.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.8 19.17 18.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.893 0.877 . . . . 0.0 111.753 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 p -68.84 -6.37 26.6 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.22 4.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.505 1.526 . . . . 0.0 110.71 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.03 -11.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 122.001 -0.706 . . . . 0.0 111.985 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.14 -21.61 13.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.067 0.947 . . . . 0.0 111.384 169.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -47.77 -47.78 30.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.96 1.304 . . . . 0.0 111.674 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.0 91.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.882 0.473 . . . . 0.0 110.762 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -82.72 -6.58 59.47 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.629 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -136.25 -62.8 0.66 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.676 1.125 . . . . 0.0 111.304 -169.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -83.27 -45.26 14.03 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.798 -1.189 . . . . 0.0 110.998 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -62.97 -32.6 73.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.697 0.68 . . . . 0.0 109.974 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.1 -43.58 87.2 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.327 0.512 . . . . 0.0 111.687 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.15 -45.06 96.2 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.992 0.517 . . . . 0.0 111.342 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.43 -51.03 71.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.46 -38.07 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.627 1.103 . . . . 0.0 110.529 -173.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.05 78.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.46 76.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.04 0.836 . . . . 0.0 110.65 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -70.74 -37.36 73.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.817 0.735 . . . . 0.0 109.77 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.57 -45.07 92.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.627 0.771 . . . . 0.0 109.857 170.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.09 -47.65 1.19 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.191 1.377 . . . . 0.0 110.859 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -140.36 109.52 6.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.301 1.041 . . . . 0.0 109.775 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.1 p -158.75 -175.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.981 2.512 . . . . 0.0 104.97 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.406 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -137.62 138.18 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.84 142.58 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.01 154.74 51.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.697 0.799 . . . . 0.0 109.055 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.5 m -117.67 142.33 47.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.0 mt -131.31 136.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.92 158.69 42.82 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.199 0.999 . . . . 0.0 110.15 -170.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.65 3.16 56.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.669 0.788 . . . . 0.0 111.794 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -101.52 -174.9 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.118 0.967 . . . . 0.0 109.978 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 133.58 90.31 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.79 -37.42 54.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.393 2.729 . . . . 0.0 113.964 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -72.41 -28.64 63.1 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.503 -0.748 . . . . 0.0 111.782 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.59 74.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.13 0.877 . . . . 0.0 109.42 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.36 -49.18 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.262 0.625 . . . . 0.0 110.384 169.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.74 75.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.281 0.491 . . . . 0.0 111.73 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -67.08 -40.5 87.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.356 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.07 -49.29 78.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.99 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.4 m -58.86 -48.25 82.04 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.38 0.536 . . . . 0.0 111.343 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.32 86.1 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.528 -0.596 . . . . 0.0 112.284 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.06 -41.71 70.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.013 0.906 . . . . 0.0 110.567 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -85.98 -22.15 27.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 119.088 -0.482 . . . . 0.0 112.179 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.42 24.17 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.51 143.35 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -146.92 -36.66 0.23 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.642 0.777 . . . . 0.0 112.999 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.45 -21.56 59.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.406 0.548 . . . . 0.0 111.201 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.77 165.2 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.937 1.295 . . . . 0.0 108.247 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -142.7 137.62 30.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 p -85.24 145.99 27.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt -135.12 169.33 17.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.625 1.97 . . . . 0.0 107.276 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -135.66 105.01 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.605 0.762 . . . . 0.0 109.481 -169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.64 -15.46 62.79 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.408 0.683 . . . . 0.0 110.927 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -46.11 -20.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.008 2.523 . . . . 0.0 113.45 169.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -40.8 -60.6 1.13 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.904 1.682 . . . . 0.0 111.497 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.29 15.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.126 0.97 . . . . 0.0 111.071 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.07 18.35 1.7 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.225 1.81 . . . . 0.0 113.325 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -49.68 76.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.928 1.291 . . . . 0.0 112.035 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -77.72 -40.64 40.51 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.931 -0.481 . . . . 0.0 109.843 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.71 -36.79 91.77 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.86 -51.24 69.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 117.544 0.672 . . . . 0.0 109.594 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.9 92.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.75 4.38 44.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.06 0.944 . . . . 0.0 112.423 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.93 39.68 96.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.091 0.853 . . . . 0.0 113.449 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.76 -12.91 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.52 1.128 . . . . 0.0 111.522 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.37 108.75 8.37 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mt -80.1 108.35 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -53.61 -45.75 70.19 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.702 1.201 . . . . 0.0 110.893 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.32 -2.39 24.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.029 0.932 . . . . 0.0 113.236 -173.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -125.92 -18.39 5.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.382 1.073 . . . . 0.0 112.346 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 52.94 39.04 28.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.644 1.178 . . . . 0.0 109.645 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -138.16 150.58 46.93 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.24 1.016 . . . . 0.0 108.31 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.36 145.24 49.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.449 0.643 . . . . 0.0 110.745 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.26 177.11 1.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.007 2.123 . . . . 0.0 111.014 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -115.31 106.39 13.97 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 169.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 m -152.76 169.28 23.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 158' ' ' PRO . 11.8 p -152.53 146.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -138.85 158.81 43.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.265 1.026 . . . . 0.0 109.073 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.82 143.08 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 170.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 mt -129.31 126.37 38.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.915 1.686 . . . . 0.0 107.078 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.52 165.07 21.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.388 0.675 . . . . 0.0 109.454 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.04 -23.56 47.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.975 0.91 . . . . 0.0 112.385 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -76.43 -3.67 38.33 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.966 -1.084 . . . . 0.0 112.126 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.39 24.61 76.02 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.077 0.846 . . . . 0.0 112.045 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.32 142.25 28.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.32 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.8 -15.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.735 0.814 . . . . 0.0 111.556 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -152.38 145.28 24.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.47 141.79 25.18 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -148.68 140.78 23.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -122.41 123.09 40.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.77 133.24 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -68.06 -7.7 31.54 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.066 0.947 . . . . 0.0 113.309 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.03 122.35 13.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.474 1.11 . . . . 0.0 108.303 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.27 -22.71 64.73 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.905 0.882 . . . . 0.0 113.26 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.1 p -76.21 1.44 15.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.013 0.824 . . . . 0.0 111.91 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.48 156.79 44.19 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.917 2.087 . . . . 0.0 107.531 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.5 157.54 74.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.726 0.81 . . . . 0.0 111.951 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.1 168.88 22.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.798 2.332 . . . . 0.0 110.447 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -108.95 118.0 35.66 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -48.99 -28.13 3.68 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.317 2.247 . . . . 0.0 113.381 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.28 -38.51 83.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.575 0.625 . . . . 0.0 111.17 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.51 -53.18 54.08 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.712 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 131' ' ' VAL . 62.1 Cg_endo -68.72 -25.92 33.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.621 1.548 . . . . 0.0 112.063 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -44.59 95.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 120.255 1.389 . . . . 0.0 109.104 171.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.27 -33.04 74.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.197 0.908 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.31 -53.15 39.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.513 0.325 . . . . 0.0 110.986 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.24 76.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.565 0.746 . . . . 0.0 112.08 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.27 67.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.753 0.706 . . . . 0.0 111.649 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -64.78 -30.14 71.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.183 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.02 -31.39 8.77 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.83 -30.32 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.905 0.775 . . . . 0.0 112.249 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 21.2 pttp . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.495 0.718 . . . . 0.0 110.457 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.75 169.29 4.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.999 0.428 . . . . 0.0 109.866 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 142.37 29.36 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.155 0.982 . . . . 0.0 108.386 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.0 mt -140.63 171.26 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.281 2.632 . . . . 0.0 103.98 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 p -117.64 148.25 42.12 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 120.989 -1.069 . . . . 0.0 109.826 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -75.58 -18.34 59.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.875 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt 138.55 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 132.089 4.156 . . . . 0.0 109.586 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.17 -5.6 26.58 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.053 0.835 . . . . 0.0 113.586 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.6 47.16 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.2 164.58 35.22 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.609 2.873 . . . . 0.0 112.439 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.73 139.38 46.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.532 1.533 . . . . 0.0 108.266 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -74.52 148.55 40.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.545 0.738 . . . . 0.0 109.502 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.74 146.85 42.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.743 2.417 . . . . 0.0 105.984 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -74.12 -14.16 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 179.86 21.44 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 119.319 0.963 . . . . 0.0 112.888 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -90.89 148.67 22.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.689 0.796 . . . . 0.0 110.043 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.09 141.52 58.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.45 147.39 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -128.44 165.82 19.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.577 0.703 . . . . 0.0 112.12 -168.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -52.63 140.17 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.799 1.64 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.32 63.44 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.655 -1.08 . . . . 0.0 112.955 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.13 157.31 16.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.133 1.467 . . . . 0.0 109.873 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -66.1 134.92 53.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.15 155.47 84.17 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.24 -25.77 73.61 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.21 2.607 . . . . 0.0 115.841 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.9 t70 51.0 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.586 1.954 . . . . 0.0 114.866 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -129.23 -175.19 3.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.516 1.526 . . . . 0.0 109.225 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.1 m -121.41 151.63 39.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 109.957 -169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.68 163.65 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.764 2.426 . . . . 0.0 106.688 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tp -87.35 147.4 25.5 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 169.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.4 p -72.02 166.85 21.39 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -65.41 -4.44 5.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.689 -1.257 . . . . 0.0 111.571 168.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.9 m -114.66 17.04 17.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.157 2.183 . . . . 0.0 111.322 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.5 mt 66.19 41.13 3.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 112.98 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.63 154.77 41.81 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.83 141.0 40.85 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.76 -1.213 . . . . 0.0 108.798 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.06 144.42 33.58 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.074 1.349 . . . . 0.0 107.499 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 p -139.1 166.21 25.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.54 -35.85 70.85 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.471 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.62 -30.7 43.95 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 113.593 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.81 -40.34 33.18 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.647 0.779 . . . . 0.0 110.67 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.8 mtt -63.36 -24.49 67.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.791 1.237 . . . . 0.0 111.31 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.79 -14.59 2.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.49 1.116 . . . . 0.0 113.319 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.55 56.39 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.519 1.054 . . . . 0.0 114.013 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.68 162.48 41.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.256 1.528 . . . . 0.0 108.212 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.07 119.59 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -124.53 131.02 53.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.481 0.313 . . . . 0.0 111.129 -168.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.6 mt -89.49 143.83 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -126.68 132.91 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.5 m -128.72 88.26 2.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.94 0.896 . . . . 0.0 108.602 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.45 133.95 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.27 73.34 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.56 -60.04 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.028 2.486 . . . . 0.0 113.333 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 m -152.04 164.26 37.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.458 1.903 . . . . 0.0 106.969 -170.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 tp -79.6 -17.87 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.77 -0.582 . . . . 0.0 112.23 -169.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.79 -21.72 54.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.086 -1.008 . . . . 0.0 112.858 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 t -70.6 112.22 6.69 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 0.0 111.191 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.49 -31.32 80.37 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.566 -0.709 . . . . 0.0 112.843 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.23 -15.77 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.464 1.132 . . . . 0.0 112.419 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -105.93 -14.25 15.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.769 0.827 . . . . 0.0 112.336 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.59 -44.03 93.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.736 0.698 . . . . 0.0 109.545 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.41 93.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.424 0.69 . . . . 0.0 111.367 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -58.94 -56.15 25.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.59 0.632 . . . . 0.0 109.483 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.434 HG21 ' HE1' ' A' ' 93' ' ' TRP . 30.5 m -65.88 -35.59 81.06 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.169 0.895 . . . . 0.0 111.404 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -60.61 -49.65 76.68 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.523 1.056 . . . . 0.0 110.686 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.18 -34.44 76.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.911 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.17 -43.31 74.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.146 1.339 . . . . 0.0 110.915 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.51 -47.75 84.17 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.171 0.441 . . . . 0.0 111.606 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -63.45 -49.23 74.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.915 0.886 . . . . 0.0 109.085 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.04 -38.68 91.67 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.006 0.821 . . . . 0.0 110.591 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.99 97.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.974 0.806 . . . . 0.0 111.26 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.82 88.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.138 0.426 . . . . 0.0 111.103 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.07 -39.69 82.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.795 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.83 -40.69 96.16 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.203 0.911 . . . . 0.0 110.292 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.79 -24.44 12.69 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.624 1.107 . . . . 0.0 112.912 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -148.95 102.91 3.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.341 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.47 171.64 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.262 2.225 . . . . 0.0 105.069 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -128.68 143.04 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -153.14 144.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -135.92 158.43 44.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.028 1.331 . . . . 0.0 109.392 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -119.27 148.51 43.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mt -134.31 134.49 54.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.84 158.97 42.04 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.766 0.827 . . . . 0.0 109.881 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.36 41.79 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -129.46 165.75 20.98 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 111.271 -168.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.99 127.38 90.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 126.874 2.069 . . . . 0.0 108.621 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.05 -38.6 32.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.458 2.772 . . . . 0.0 113.94 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.45 -27.96 41.61 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.791 -0.568 . . . . 0.0 112.24 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.72 -42.37 67.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.374 0.988 . . . . 0.0 109.525 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -55.42 -42.92 74.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.176 0.99 . . . . 0.0 111.531 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.62 91.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.015 0.526 . . . . 0.0 111.414 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -66.42 -44.28 83.39 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.709 -0.62 . . . . 0.0 109.546 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' HE1' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -56.6 -43.13 79.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.708 0.803 . . . . 0.0 111.165 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.46 -35.84 34.32 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.823 0.738 . . . . 0.0 111.048 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.72 98.77 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.61 82.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.498 0.719 . . . . 0.0 111.085 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.57 -10.69 59.79 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.47 30.7 59.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 119.399 0.999 . . . . 0.0 111.008 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.0 mm -67.37 148.65 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.525 1.13 . . . . 0.0 108.117 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -137.69 -38.65 0.58 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 111.585 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -87.69 -22.72 24.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.239 1.016 . . . . 0.0 112.621 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.91 162.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -141.16 143.75 34.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 149.41 21.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 mt -135.48 156.23 49.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.916 1.287 . . . . 0.0 109.15 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -120.94 97.91 5.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.836 1.255 . . . . 0.0 109.181 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.23 -7.25 56.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.04 0.536 . . . . 0.0 110.839 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -43.46 -28.0 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.08 2.552 . . . . 0.0 114.018 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -57.42 -46.07 83.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.938 0.895 . . . . 0.0 111.731 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.98 11.47 0.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.5 mmm 53.55 20.45 2.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.205 . . . . 0.0 114.967 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.4 m -58.36 -44.07 88.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.22 0.918 . . . . 0.0 112.364 -171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -70.64 -46.57 63.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.89 -38.13 84.61 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.55 -50.69 72.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.023 0.911 . . . . 0.0 109.509 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.89 -8.2 57.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.384 0.674 . . . . 0.0 112.449 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.8 45.56 57.49 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.459 1.027 . . . . 0.0 112.029 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.1 25.29 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 110.764 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -116.8 119.18 34.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.36 102.21 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.06 -35.81 36.68 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.936 1.694 . . . . 0.0 111.317 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.01 -14.54 61.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.5 mt -130.83 -21.0 2.77 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 59.79 34.94 22.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.828 0.851 . . . . 0.0 110.028 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.62 154.07 45.68 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.647 1.179 . . . . 0.0 108.361 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.69 157.36 36.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.233 0.54 . . . . 0.0 110.163 172.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.04 -178.69 2.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.41 1.484 . . . . 0.0 110.551 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -106.06 13.39 29.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.793 0.837 . . . . 0.0 111.671 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.7 m -63.05 159.19 17.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.337 1.855 . . . . 0.0 112.886 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.79 149.12 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.631 0.773 . . . . 0.0 109.346 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -137.37 163.0 32.07 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.344 1.058 . . . . 0.0 109.774 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.82 140.94 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.9 mt -131.4 128.07 38.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.62 167.16 17.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.968 0.907 . . . . 0.0 109.86 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.89 -23.93 63.86 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.406 -0.809 . . . . 0.0 112.284 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -75.78 -11.44 59.99 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.731 -1.231 . . . . 0.0 111.827 172.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.93 22.44 71.69 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.146 0.879 . . . . 0.0 112.465 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -82.5 145.58 29.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.39 126.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -101.96 -34.84 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.727 1.611 . . . . 0.0 109.394 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -151.6 143.96 24.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 138.45 22.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.89 143.82 33.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.86 100.63 6.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.328 1.851 . . . . 0.0 106.43 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.55 119.42 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 m -71.06 -8.83 56.11 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -139.85 125.9 19.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.613 1.097 . . . . 0.0 108.311 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.19 70.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.785 0.834 . . . . 0.0 112.406 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 p -82.42 6.22 17.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.221 1.008 . . . . 0.0 112.892 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -120.16 162.32 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.251 1.42 . . . . 0.0 109.197 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -117.56 162.78 26.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.445 1.498 . . . . 0.0 110.106 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.17 -171.46 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.137 2.558 . . . . 0.0 109.918 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -128.68 112.4 14.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -56.58 -28.27 59.85 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.913 1.685 . . . . 0.0 112.897 -169.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.39 -31.87 73.2 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.889 -0.507 . . . . 0.0 111.754 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -61.8 -54.61 49.59 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.843 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.09 -26.95 49.94 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 CA-C-N 120.842 1.336 . . . . 0.0 111.822 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -44.05 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 120.218 1.372 . . . . 0.0 109.948 171.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.78 -32.29 73.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.137 0.88 . . . . 0.0 110.45 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.72 -49.64 57.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.3 0.24 . . . . 0.0 111.586 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.14 72.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.076 0.55 . . . . 0.0 112.018 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.49 64.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.496 0.718 . . . . 0.0 112.657 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.6 mt -111.35 -28.68 8.12 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.96 -11.94 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.3 pttt . . . . . 0 C--O 1.249 1.039 0 C-N-CA 125.864 1.665 . . . . 0.0 108.272 -176.474 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.97 -29.43 70.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 45.59 51.78 9.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.025 1.73 . . . . 0.0 111.456 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.02 145.94 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.026 1.33 . . . . 0.0 108.269 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -115.33 153.41 31.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.309 1.444 . . . . 0.0 109.396 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -110.91 42.6 1.58 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.822 1.249 . . . . 0.0 108.99 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm 42.0 64.65 1.04 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.738 2.015 . . . . 0.0 111.755 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.17 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.658 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 172.11 44.17 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.465 1.031 . . . . 0.0 110.573 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.76 159.75 51.64 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.403 2.735 . . . . 0.0 110.995 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.77 129.61 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.415 1.086 . . . . 0.0 108.386 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -61.74 156.36 20.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.492 1.517 . . . . 0.0 111.131 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.82 133.65 41.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.74 1.616 . . . . 0.0 109.284 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.29 161.52 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.75 -159.01 52.74 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.109 -0.994 . . . . 0.0 111.346 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.05 147.65 52.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.175 1.39 . . . . 0.0 109.205 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -66.13 115.42 6.12 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.3 158.37 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.969 1.307 . . . . 0.0 107.617 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -134.49 159.51 40.91 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 111.048 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.28 142.88 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.124 0.97 . . . . 0.0 108.999 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -22.28 24.43 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.03 1.3 . . . . 0.0 112.367 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -74.5 154.41 38.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.64 1.22 . . . . 0.0 109.839 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -70.14 132.69 46.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.71 158.82 48.74 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.74 -3.84 3.99 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.154 3.236 . . . . 0.0 117.548 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t0 53.64 57.76 5.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.978 1.371 . . . . 0.0 111.791 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -79.47 167.03 21.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.361 1.865 . . . . 0.0 110.26 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -135.03 148.29 49.89 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.33 170.74 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.981 2.112 . . . . 0.0 108.251 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -102.08 143.27 32.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.269 1.028 . . . . 0.0 108.808 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -74.05 -15.75 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 102.84 -14.92 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 130.264 3.426 . . . . 0.0 108.129 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -119.07 22.08 12.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.145 1.778 . . . . 0.0 111.052 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp 61.66 40.31 13.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.882 1.673 . . . . 0.0 111.656 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.88 156.05 43.2 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.42 152.37 19.15 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.381 0.61 . . . . 0.0 109.735 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.91 148.7 32.05 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.427 1.891 . . . . 0.0 106.139 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 p -149.97 171.66 16.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.531 0.605 . . . . 0.0 109.821 -169.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -43.47 -45.81 6.55 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 111.552 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.01 -29.01 66.93 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.963 0.905 . . . . 0.0 112.866 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -39.99 21.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.771 0.828 . . . . 0.0 110.717 174.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt -71.36 -34.87 70.86 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.154 0.582 . . . . 0.0 111.008 -170.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -63.85 -3.48 2.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.67 -21.84 23.31 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.146 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.44 168.26 20.97 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.26 1.53 . . . . 0.0 108.631 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.99 124.42 17.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.9 m -131.68 134.05 45.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.141 0.275 . . . . 0.0 111.11 -168.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.0 mt -93.21 141.1 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -123.48 133.54 68.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -129.34 106.05 8.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.4 127.93 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 pt -137.79 137.49 21.74 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.11 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.967 2.444 . . . . 0.0 114.185 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.3 m -159.45 158.25 31.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.882 1.673 . . . . 0.0 106.92 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -90.1 12.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 122.198 -0.314 . . . . 0.0 111.649 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -118.77 15.69 13.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.109 1.364 . . . . 0.0 110.338 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.42 -11.5 60.87 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.303 1.441 . . . . 0.0 113.395 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 -51.8 4.59 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.57 -22.44 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 118.028 0.914 . . . . 0.0 111.878 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.0 p -49.64 -36.21 23.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.272 1.029 . . . . 0.0 112.278 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.93 -38.32 90.53 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.928 0.891 . . . . 0.0 110.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.52 17.38 3.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.395 1.478 . . . . 0.0 112.003 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -132.16 -79.03 0.5 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.206 1.003 . . . . 0.0 108.338 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -52.9 -53.63 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.903 1.281 . . . . 0.0 112.991 -168.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -79.31 -27.9 42.16 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.172 -0.955 . . . . 0.0 112.126 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -62.51 -43.73 98.1 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.767 1.167 . . . . 0.0 109.689 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -58.43 -37.51 75.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.473 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -59.19 -49.57 77.33 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.566 1.076 . . . . 0.0 111.311 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.68 -47.43 66.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -64.0 -36.14 83.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.346 0.975 . . . . 0.0 111.034 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.13 86.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.868 0.758 . . . . 0.0 111.379 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.94 93.96 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.638 0.654 . . . . 0.0 110.273 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -34.4 78.19 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.609 0.641 . . . . 0.0 111.496 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.29 -22.23 65.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.062 0.846 . . . . 0.0 112.074 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 -43.42 3.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.947 1.26 . . . . 0.0 112.075 174.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.64 117.62 5.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.03 1.332 . . . . 0.0 108.928 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 78' ' ' ASN . 12.3 p -158.89 -175.6 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.086 2.154 . . . . 0.0 105.484 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' H ' HG22 ' A' ' 77' ' ' VAL . 48.6 t30 -139.66 138.22 35.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.36 138.87 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -128.81 159.39 35.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 m -126.7 145.92 50.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.95 138.04 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -140.94 152.57 45.1 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 123.51 0.506 . . . . 0.0 111.408 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.99 43.79 0.72 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.679 1.192 . . . . 0.0 108.663 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -131.05 158.7 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.589 1.556 . . . . 0.0 108.925 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.85 134.9 96.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.846 1.258 . . . . 0.0 111.08 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.85 -42.18 6.48 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 124.994 3.796 . . . . 0.0 115.554 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.66 -28.56 60.9 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.11 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.29 70.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.379 0.991 . . . . 0.0 109.419 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.9 -47.31 64.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.919 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.23 70.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.359 0.264 . . . . 0.0 111.364 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -61.76 -45.58 93.27 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.286 0.634 . . . . 0.0 110.789 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.0 -37.88 88.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.896 0.316 . . . . 0.0 110.476 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.2 m -66.84 -41.51 87.3 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.798 -0.564 . . . . 0.0 111.737 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -35.52 92.15 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.34 70.86 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.772 0.786 . . . . 0.0 110.243 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -78.92 -21.52 47.19 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.71 15.42 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.31 144.21 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -145.75 -37.43 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.614 1.166 . . . . 0.0 112.698 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -84.88 -13.37 51.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.559 0.743 . . . . 0.0 112.258 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.03 155.99 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -133.85 124.82 27.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 p -79.47 157.2 27.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.676 0.791 . . . . 0.0 109.339 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.4 mt -144.18 164.57 30.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.785 1.634 . . . . 0.0 108.102 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -118.21 140.98 48.98 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.544 -0.723 . . . . 0.0 109.389 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.54 5.59 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.18 1.792 . . . . 0.0 109.952 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -59.59 -26.72 65.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 111.841 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -60.17 -46.05 91.01 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.961 0.904 . . . . 0.0 111.87 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -156.01 14.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 95.0 mmm 48.12 26.51 1.04 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.849 2.06 . . . . 0.0 113.968 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.39 -50.14 73.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.643 1.177 . . . . 0.0 111.711 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.98 -48.66 75.56 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.145 0.884 . . . . 0.0 109.405 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.34 -47.67 80.88 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.29 -50.15 64.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.255 1.022 . . . . 0.0 109.832 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 7.58 43.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 112.154 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.94 36.57 86.65 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.735 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.7 -13.41 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.553 1.177 . . . . 0.0 111.636 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 104.94 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.78 98.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.36 -34.74 49.0 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.793 1.637 . . . . 0.0 111.108 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.62 -17.08 62.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.7 pp -146.78 16.47 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.962 1.256 . . . . 0.0 114.327 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 48.39 51.13 15.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.197 1.799 . . . . 0.0 111.685 169.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -152.28 150.44 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 51' ' ' VAL . 4.1 pp -81.45 156.02 25.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.688 0.676 . . . . 0.0 110.569 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.48 -155.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.856 2.062 . . . . 0.0 112.538 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.42 118.3 22.89 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 m -162.06 163.16 28.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -170.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.13 147.79 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.013 0.925 . . . . 0.0 108.685 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -138.68 156.83 47.08 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.064 0.945 . . . . 0.0 108.649 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.0 t -135.2 143.73 36.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.8 mt -128.27 126.21 40.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.939 1.695 . . . . 0.0 108.227 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.59 163.62 25.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.607 1.163 . . . . 0.0 110.154 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.25 -15.52 25.51 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.1 10.57 41.18 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.687 1.131 . . . . 0.0 112.225 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.43 76.99 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.978 . . . . 0.0 112.88 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.91 144.25 25.45 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.294 1.047 . . . . 0.0 108.442 173.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.39 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.65 -16.4 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.728 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -151.68 144.38 24.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.77 139.15 23.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -151.66 137.16 17.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -122.31 122.18 38.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.3 t -72.67 123.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.3 m -61.81 -40.67 96.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.584 0.353 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -83.6 109.55 17.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.943 0.897 . . . . 0.0 109.232 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.98 62.7 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.694 -0.629 . . . . 0.0 111.676 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -71.82 -1.08 12.84 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.084 1.354 . . . . 0.0 113.124 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.78 171.22 13.78 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.58 1.552 . . . . 0.0 110.067 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -128.55 156.84 76.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.518 1.527 . . . . 0.0 109.302 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.64 154.18 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.964 1.776 . . . . 0.0 109.391 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -79.61 116.01 19.56 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -52.43 -24.91 8.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.011 1.725 . . . . 0.0 113.459 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -62.34 -35.48 79.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.807 0.73 . . . . 0.0 111.467 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -64.58 -50.8 63.38 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 121.172 -0.955 . . . . 0.0 112.335 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.29 -25.95 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.075 1.42 . . . . 0.0 111.53 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -44.29 97.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 109.597 171.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.62 -33.28 75.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.325 0.966 . . . . 0.0 111.088 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.85 38.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.338 0.255 . . . . 0.0 110.915 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.29 78.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.232 0.613 . . . . 0.0 112.419 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -29.45 67.61 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.665 0.666 . . . . 0.0 111.709 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.1 68.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.219 0.607 . . . . 0.0 112.256 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.94 -28.66 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.38 -12.41 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.059 0.944 . . . . 0.0 110.087 178.041 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.74 95.18 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.504 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 39.45 55.08 2.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.119 1.768 . . . . 0.0 111.418 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.84 153.45 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.804 2.042 . . . . 0.0 109.095 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -94.45 155.3 17.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.504 1.122 . . . . 0.0 108.407 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -132.59 108.26 8.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt 27.14 56.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.668 2.387 . . . . 0.0 115.253 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.73 -2.2 27.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 117.801 -1.555 . . . . 0.0 115.652 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.51 147.18 18.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 120.578 2.189 . . . . 0.0 111.988 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.78 154.32 67.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.056 2.504 . . . . 0.0 110.651 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.0 145.4 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.553 0.692 . . . . 0.0 110.11 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -79.52 156.88 27.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.919 1.288 . . . . 0.0 111.286 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.62 142.13 51.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.099 1.76 . . . . 0.0 108.843 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.17 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.44 -160.96 22.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.12 146.99 52.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.851 0.86 . . . . 0.0 109.266 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -65.56 113.76 4.42 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -73.06 169.53 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.401 0.546 . . . . 0.0 109.708 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.93 160.85 37.33 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.148 0.979 . . . . 0.0 109.065 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.58 137.8 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.32 -16.14 60.54 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.538 -1.146 . . . . 0.0 112.614 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.36 160.32 24.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.318 1.559 . . . . 0.0 109.941 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -99.92 121.84 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -55.05 136.95 67.07 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.595 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 49.9 Cg_exo -58.76 0.51 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.657 1 C-N-CA 126.112 4.541 . . . . 0.0 119.263 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.29 64.88 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.812 1.291 . . . . 0.0 111.447 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -73.62 165.45 25.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.698 1.599 . . . . 0.0 109.929 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.6 m -133.16 149.34 52.07 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.69 162.38 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.759 2.023 . . . . 0.0 106.734 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 tp -88.63 135.86 33.29 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -65.12 162.91 16.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -64.88 -8.52 15.74 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.663 -1.273 . . . . 0.0 111.004 168.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 m -95.27 6.41 49.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.874 2.07 . . . . 0.0 111.696 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.7 mt 70.84 35.88 1.65 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.32 1.448 . . . . 0.0 112.319 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.09 152.34 44.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.52 139.88 40.94 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.763 -1.211 . . . . 0.0 108.968 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -136.95 145.54 44.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.4 p -144.38 170.81 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.165 0.586 . . . . 0.0 109.701 -170.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -46.77 -44.75 19.31 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.374 0.67 . . . . 0.0 110.796 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.19 63.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.817 0.847 . . . . 0.0 113.022 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.31 -41.04 42.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.515 0.726 . . . . 0.0 110.542 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.7 mtt -69.05 -22.73 64.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.214 1.005 . . . . 0.0 111.877 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.08 -16.56 3.04 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.664 1.186 . . . . 0.0 113.291 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.55 53.25 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.763 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -153.13 160.09 42.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.456 1.628 . . . . 0.0 109.15 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.63 120.09 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.1 m -123.56 131.03 53.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.027 0.441 . . . . 0.0 110.639 -168.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.0 mt -89.37 141.58 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.64 137.81 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.7 m -131.31 94.53 3.58 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.86 143.43 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.48 150.02 59.33 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.656 0.783 . . . . 0.0 111.373 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.92 123.35 9.25 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.679 2.253 . . . . 0.0 110.047 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m 48.08 -162.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.471 1.509 . . . . 0.0 113.224 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 90' ' ' GLN . 3.7 tt -148.04 -22.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 120.882 -1.136 . . . . 0.0 111.51 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.92 -24.8 67.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.972 -1.08 . . . . 0.0 112.807 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.6 p -73.0 -17.77 61.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.137 1.375 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.04 -53.15 3.75 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.021 1.296 . . . . 0.0 112.805 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.55 -14.5 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.102 0.951 . . . . 0.0 110.457 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 14.3 p -49.56 -31.31 10.15 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.846 1.658 . . . . 0.0 113.449 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.66 130.57 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.578 1.081 . . . . 0.0 113.49 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.85 -6.43 8.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.498 1.919 . . . . 0.0 108.821 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -33.07 23.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.155 0.982 . . . . 0.0 110.803 -170.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 p -53.55 -48.31 69.22 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.071 1.305 . . . . 0.0 112.327 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -39.15 91.88 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.91 0.777 . . . . 0.0 110.959 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -66.76 -45.34 78.87 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.956 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -57.56 -41.34 80.84 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.88 0.764 . . . . 0.0 111.31 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -60.35 -50.87 71.9 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.653 0.781 . . . . 0.0 110.471 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.02 -41.63 77.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -67.86 -36.19 79.85 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.86 96.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.956 0.798 . . . . 0.0 110.884 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.07 93.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.925 0.33 . . . . 0.0 111.125 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -65.91 -40.98 91.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.43 -40.2 95.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.51 1.05 . . . . 0.0 110.25 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.3 10.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.818 1.199 . . . . 0.0 112.002 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -152.68 112.0 3.86 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.557 1.143 . . . . 0.0 109.121 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.86 176.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.405 2.282 . . . . 0.0 105.275 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -134.5 141.07 46.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.07 141.46 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -134.08 153.24 51.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.817 0.847 . . . . 0.0 109.917 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -108.58 146.67 32.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.23 135.0 57.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 m -131.36 152.51 50.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.307 1.043 . . . . 0.0 109.652 -170.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.37 52.24 1.02 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -140.08 165.06 28.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.98 145.96 96.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 123.268 0.627 . . . . 0.0 110.249 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.27 -32.07 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.623 2.215 . . . . 0.0 112.766 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -79.28 -22.13 45.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.199 0.909 . . . . 0.0 112.212 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.61 53.44 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.173 -0.955 . . . . 0.0 108.718 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' ILE . 66.4 mt-30 -51.36 -56.42 13.24 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.31 1.044 . . . . 0.0 110.492 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.15 -42.32 80.78 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.787 0.835 . . . . 0.0 111.843 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.0 -44.81 62.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.459 ' CE3' HD11 ' A' ' 55' ' ' ILE . 44.7 t90 -63.97 -39.62 94.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.976 0.511 . . . . 0.0 111.134 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.49 -36.29 57.89 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.212 -1.555 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.19 93.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.85 -45.37 82.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.646 0.778 . . . . 0.0 110.537 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -68.4 -24.09 64.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.521 0.728 . . . . 0.0 111.683 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.24 25.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.527 1.06 . . . . 0.0 111.837 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.18 142.87 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.152 0.981 . . . . 0.0 108.435 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -143.6 -44.31 0.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.485 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.67 -11.81 59.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.027 0.931 . . . . 0.0 111.941 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.49 160.94 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -140.6 145.8 37.16 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 p -89.68 139.49 30.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.905 1.682 . . . . 0.0 109.799 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 mt -131.14 168.91 16.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.615 1.966 . . . . 0.0 109.354 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.38 105.95 11.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.686 1.194 . . . . 0.0 111.683 -168.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -72.71 -21.94 60.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -52.57 -14.3 0.49 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.839 2.056 . . . . 0.0 113.121 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -45.91 -57.33 4.45 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.944 1.297 . . . . 0.0 110.821 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -164.59 16.49 0.05 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.2 mmm 55.86 26.35 9.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.761 1.624 . . . . 0.0 111.039 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -38.12 82.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.116 0.966 . . . . 0.0 113.018 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -74.06 -42.47 60.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.106 1.321 . . . . 0.0 108.907 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -41.64 -60.13 2.56 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.396 1.95 . . . . 0.0 111.884 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.8 -39.66 69.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.242 1.017 . . . . 0.0 110.473 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.63 95.42 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.23 0.612 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.43 9.25 37.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 113.208 -169.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.3 37.69 86.6 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.118 0.872 . . . . 0.0 111.972 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.452 HG23 ' HA2' ' A' ' 114' ' ' GLY . 8.1 m -126.54 3.92 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.56 1.144 . . . . 0.0 112.588 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -83.19 108.45 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.532 1.515 . . . . 0.0 107.183 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.91 111.56 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -55.4 -53.55 54.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.176 1.79 . . . . 0.0 111.406 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.79 -29.05 55.87 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.499 0.32 . . . . 0.0 111.255 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -79.5 -22.18 44.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.974 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 56.44 36.28 27.29 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -168.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -135.22 154.73 51.49 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.934 0.894 . . . . 0.0 109.745 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.36 142.69 52.11 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.458 0.703 . . . . 0.0 109.382 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.39 -168.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.801 1.64 . . . . 0.0 111.387 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -127.3 127.8 44.92 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -170.18 170.98 7.07 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.763 1.625 . . . . 0.0 106.968 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.6 145.12 30.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -137.46 156.79 47.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.328 1.051 . . . . 0.0 108.635 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 t -134.74 140.36 45.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.2 mt -129.07 126.39 39.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.434 1.494 . . . . 0.0 107.448 -169.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.94 167.73 9.23 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 109.147 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.12 -21.88 35.64 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.178 -0.951 . . . . 0.0 112.587 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -81.73 -7.5 59.6 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.594 -1.316 . . . . 0.0 112.543 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.03 16.77 80.46 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 120.872 -1.142 . . . . 0.0 112.133 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -77.79 133.66 38.18 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.12 110.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.55 -36.2 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.058 1.343 . . . . 0.0 109.687 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -151.47 145.22 25.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.05 133.6 18.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.99 137.07 22.07 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -104.8 117.21 33.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.9 127.96 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -69.76 -6.21 30.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -140.94 115.9 9.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 120.299 1.409 . . . . 0.0 107.475 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.61 69.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 -24.21 66.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.394 0.678 . . . . 0.0 111.113 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -100.82 126.31 47.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.169 1.388 . . . . 0.0 108.047 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -72.64 149.51 90.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.09 162.12 43.03 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.547 3.498 . . . . 0.0 109.596 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -96.36 120.38 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -55.98 -28.07 55.52 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.337 1.455 . . . . 0.0 112.703 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.16 -34.17 74.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.441 0.564 . . . . 0.0 111.426 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -65.06 -54.46 33.7 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 118.875 0.762 . . . . 0.0 111.692 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -30.44 24.05 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.486 1.458 . . . . 0.0 111.894 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 mm -54.43 -50.14 59.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 119.599 1.091 . . . . 0.0 109.523 169.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.32 -30.5 71.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.672 0.669 . . . . 0.0 111.494 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.09 71.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.164 0.438 . . . . 0.0 111.72 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.8 -45.55 57.91 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.452 0.701 . . . . 0.0 111.824 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -28.79 64.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.45 0.7 . . . . 0.0 111.56 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 -29.33 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 112.534 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 mt -103.63 -29.12 11.3 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.55 -10.64 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.094 0.957 . . . . 0.0 110.144 177.34 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.24 68.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.331 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 45.78 65.34 1.17 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.355 1.862 . . . . 0.0 111.346 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 99.2 mt -54.85 156.73 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.733 1.613 . . . . 0.0 108.817 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.17 128.32 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.907 1.283 . . . . 0.0 108.177 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -84.68 42.58 0.92 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 110.268 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt 38.23 60.29 1.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.885 2.074 . . . . 0.0 112.337 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.75 -24.63 0.14 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.761 0.696 . . . . 0.0 111.646 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.35 169.05 40.58 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.94 155.3 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.144 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 m -136.54 166.37 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 107.949 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.9 m -117.18 161.05 20.08 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.033 0.933 . . . . 0.0 108.971 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 mt -125.54 141.98 51.75 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.852 1.661 . . . . 0.0 106.986 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.43 -65.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.25 165.72 54.77 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.49 165.29 24.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.708 0.766 . . . . 0.0 110.658 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.19 117.52 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.5 t -76.54 154.53 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -130.49 163.85 26.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 121.453 -0.779 . . . . 0.0 110.007 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.51 144.89 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.81 78.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.864 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -118.5 154.84 31.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.911 1.355 . . . . 0.0 108.814 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -65.87 134.86 53.93 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.51 159.24 61.74 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.732 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.23 -29.81 58.72 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.71 2.94 . . . . 0.0 115.845 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t0 46.72 86.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.258 1.823 . . . . 0.0 114.117 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -127.36 -172.79 2.74 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.284 1.433 . . . . 0.0 108.843 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.0 m -120.58 151.65 39.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.679 1.192 . . . . 0.0 110.461 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.61 165.06 27.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.723 2.409 . . . . 0.0 106.85 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.07 135.78 33.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -67.09 162.94 21.15 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.14 -10.41 49.94 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.488 -1.383 . . . . 0.0 110.816 168.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -82.1 3.38 27.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.578 1.951 . . . . 0.0 111.43 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.3 mt 68.44 30.93 5.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.897 2.079 . . . . 0.0 112.211 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.58 140.39 48.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.01 140.41 49.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.325 1.05 . . . . 0.0 111.456 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -141.68 143.48 33.61 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 126.094 1.757 . . . . 0.0 106.823 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -130.99 160.05 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tt -56.88 -33.92 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.257 0.481 . . . . 0.0 110.927 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.45 -29.62 50.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.092 0.957 . . . . 0.0 113.393 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -78.39 -40.34 36.45 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.125 0.97 . . . . 0.0 110.444 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.1 mtt -63.03 -27.29 69.31 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.953 1.301 . . . . 0.0 111.49 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -55.28 -15.46 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.058 . . . . 0.0 113.071 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.77 46.01 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.654 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -149.78 155.99 41.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.688 1.744 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.2 118.18 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.6 m -119.8 148.76 43.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.018 0.527 . . . . 0.0 110.029 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.22 146.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.12 138.57 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -113.17 99.63 7.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.518 1.527 . . . . 0.0 108.088 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.85 125.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 pt -133.55 155.3 80.73 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.281 1.032 . . . . 0.0 109.004 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.57 -58.1 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.95 2.433 . . . . 0.0 111.858 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.3 m -153.04 157.8 41.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.454 1.901 . . . . 0.0 106.732 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.07 -5.7 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.303 0.956 . . . . 0.0 111.52 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.9 -3.24 43.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.417 1.087 . . . . 0.0 112.623 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.3 p -64.29 -16.9 63.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -49.91 3.88 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.398 0.999 . . . . 0.0 111.089 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.72 -8.91 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.328 1.064 . . . . 0.0 112.239 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.3 p -55.21 -36.95 66.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.269 1.027 . . . . 0.0 108.953 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.56 -45.66 91.93 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.506 1.123 . . . . 0.0 111.177 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.61 -0.27 3.77 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 112.489 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -122.84 -87.74 0.63 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -48.89 -49.48 39.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.359 1.864 . . . . 0.0 113.532 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -72.44 -40.83 66.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.66 -1.275 . . . . 0.0 110.723 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.83 -38.48 91.12 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.061 -0.399 . . . . 0.0 110.342 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -60.22 -34.75 74.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.576 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -60.77 -50.29 74.07 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 120.094 1.315 . . . . 0.0 111.114 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.91 -42.59 76.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.302 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.35 -36.56 84.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.904 1.229 . . . . 0.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.56 -21.81 65.43 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.652 -0.655 . . . . 0.0 112.223 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.05 44.48 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.939 0.79 . . . . 0.0 111.194 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -72.19 -41.95 66.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.266 0.626 . . . . 0.0 110.143 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.19 137.22 58.15 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -36.27 80.19 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.765 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.75 79.08 0.86 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.49 1.145 . . . . 0.0 110.162 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.52 171.34 18.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.077 0.951 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -136.68 145.55 44.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.188 1.795 . . . . 0.0 106.802 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.26 151.67 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.306 -0.871 . . . . 0.0 109.749 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -135.42 170.72 15.51 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.513 1.525 . . . . 0.0 109.736 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.8 m -134.85 148.71 50.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.63 137.89 54.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -136.77 153.77 50.74 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.792 0.837 . . . . 0.0 111.427 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.8 46.15 1.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.413 1.485 . . . . 0.0 107.842 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -140.07 170.33 16.04 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.352 1.461 . . . . 0.0 107.863 -168.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.07 144.32 62.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 123.677 0.791 . . . . 0.0 111.181 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.04 -31.13 76.5 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.402 2.068 . . . . 0.0 112.896 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -71.55 -28.94 64.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.727 1.149 . . . . 0.0 111.387 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.09 74.54 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.043 0.838 . . . . 0.0 108.877 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.35 -46.51 69.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.513 0.725 . . . . 0.0 110.93 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.62 51.09 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.23 0.612 . . . . 0.0 111.211 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.12 -34.19 75.9 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.933 -0.479 . . . . 0.0 111.068 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -63.4 -42.5 98.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.124 0.42 . . . . 0.0 110.126 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.1 m -65.12 -42.9 93.47 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 121.77 -0.581 . . . . 0.0 111.37 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.31 98.85 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.33 86.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.571 0.748 . . . . 0.0 110.599 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.06 -24.86 51.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.127 0.571 . . . . 0.0 112.376 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 32.46 22.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.845 0.735 . . . . 0.0 111.432 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.08 144.64 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.8 -34.8 0.23 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.393 1.077 . . . . 0.0 112.677 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -79.21 -16.35 56.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.685 0.794 . . . . 0.0 111.952 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.19 159.1 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.05 134.74 40.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -92.84 145.59 24.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.632 0.773 . . . . 0.0 109.433 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 mt -136.66 166.04 24.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.936 1.695 . . . . 0.0 107.815 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 m -136.91 133.03 35.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.037 0.935 . . . . 0.0 109.352 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.23 -3.95 8.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.499 0.72 . . . . 0.0 112.14 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -57.22 -25.01 58.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.682 -1.261 . . . . 0.0 112.262 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -69.39 -25.11 63.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.272 1.029 . . . . 0.0 112.9 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.71 -19.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mmt 54.15 -0.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.144 2.978 . . . . 0.0 117.582 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 p -59.0 -36.78 75.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.501 1.501 . . . . 0.0 112.614 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.61 -56.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.022 0.529 . . . . 0.0 109.579 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.88 65.65 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.44 -53.65 55.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.467 0.707 . . . . 0.0 109.145 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.37 -31.0 57.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.154 -0.451 . . . . 0.0 112.17 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -4.0 27.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.567 0.621 . . . . 0.0 112.256 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 48.04 52.79 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 119.084 0.856 . . . . 0.0 111.283 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.89 -14.46 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.828 0.851 . . . . 0.0 111.383 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -72.93 111.86 8.43 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.54 112.13 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -54.26 -38.02 65.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.554 1.542 . . . . 0.0 111.425 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.62 -6.28 58.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.583 0.753 . . . . 0.0 112.638 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.7 mt -131.94 -21.24 2.43 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.038 0.935 . . . . 0.0 112.779 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 52.7 42.41 31.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.395 1.078 . . . . 0.0 109.313 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -135.19 153.22 52.03 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.218 1.407 . . . . 0.0 107.714 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.2 mt -84.06 141.94 30.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.327 0.512 . . . . 0.0 110.712 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.59 141.03 57.97 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.702 1.201 . . . . 0.0 109.806 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -68.36 109.09 3.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 p -154.77 165.06 37.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.878 0.763 . . . . 0.0 110.977 -169.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.27 153.52 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.79 156.45 46.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.359 1.063 . . . . 0.0 109.222 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.4 t -131.32 143.25 41.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 38.4 mt -135.2 126.4 28.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.736 1.615 . . . . 0.0 107.697 -169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.78 165.63 23.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.641 0.776 . . . . 0.0 109.085 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.14 -17.16 57.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.261 -0.899 . . . . 0.0 112.764 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -78.04 -11.45 59.91 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.537 -1.352 . . . . 0.0 112.236 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.03 75.87 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.009 -1.057 . . . . 0.0 112.645 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.93 139.28 37.14 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.89 134.26 30.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.48 -29.03 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.632 1.573 . . . . 0.0 109.254 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -155.08 146.28 22.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.61 1.564 . . . . 0.0 106.842 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.61 143.31 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.403 1.081 . . . . 0.0 108.463 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -149.93 146.5 27.09 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.848 1.659 . . . . 0.0 107.099 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -128.71 -15.34 4.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.561 1.545 . . . . 0.0 112.392 -169.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t 50.25 106.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 129.078 2.951 . . . . 0.0 113.093 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -59.14 -28.66 66.77 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.136 0.974 . . . . 0.0 112.797 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.67 105.94 17.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.1 62.4 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.9 p -73.68 -13.29 60.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.433 1.893 . . . . 0.0 112.904 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -109.87 156.45 20.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.557 1.543 . . . . 0.0 109.397 -169.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -106.8 153.46 40.76 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.373 0.669 . . . . 0.0 110.109 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.84 151.47 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.354 2.036 . . . . 0.0 109.488 171.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -82.04 119.39 23.94 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -54.05 -25.61 22.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.783 1.633 . . . . 0.0 112.878 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -60.59 -35.64 76.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.681 0.673 . . . . 0.0 111.138 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.82 -53.32 50.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.529 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.9 -27.8 43.09 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.951 1.375 . . . . 0.0 112.214 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.22 -46.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 120.695 1.588 . . . . 0.0 109.82 172.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.43 -33.77 76.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.907 0.776 . . . . 0.0 110.679 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.66 68.32 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.675 0.274 . . . . 0.0 111.149 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.38 -48.7 66.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.982 0.513 . . . . 0.0 110.795 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -29.05 69.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.746 0.703 . . . . 0.0 111.643 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.88 -31.7 71.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.579 0.627 . . . . 0.0 111.568 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.8 mt -88.29 -24.6 23.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.89 0.876 . . . . 0.0 112.054 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.4 -27.93 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.966 171.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.034 0.934 . . . . 0.0 110.746 176.548 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 118.923 -0.561 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.94 156.65 44.5 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 108.044 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.9 144.6 22.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.32 148.64 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 p -92.87 153.11 19.01 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.601 1.091 . . . . 0.0 110.307 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -112.46 41.31 2.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.091 1.356 . . . . 0.0 108.622 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 44.11 62.99 1.77 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.769 2.028 . . . . 0.0 112.3 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.04 -25.63 0.16 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.55 1.071 . . . . 0.0 110.922 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.49 173.89 45.71 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.979 1.276 . . . . 0.0 110.108 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.56 157.61 58.34 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.157 2.572 . . . . 0.0 111.004 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.47 136.99 48.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.644 1.578 . . . . 0.0 107.471 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -74.32 154.78 38.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.763 1.225 . . . . 0.0 109.878 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.72 138.68 54.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.055 1.742 . . . . 0.0 106.549 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 120' ' ' TYR . 22.3 m -78.71 -173.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.9 -152.83 51.73 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 123.266 0.46 . . . . 0.0 112.967 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -132.23 155.42 48.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.479 1.111 . . . . 0.0 109.697 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.12 154.41 37.8 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 168.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.13 152.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -126.37 157.31 38.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.62 1.168 . . . . 0.0 110.264 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.24 142.71 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.609 1.163 . . . . 0.0 109.377 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.17 -19.44 46.53 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.811 1.196 . . . . 0.0 111.878 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -74.94 149.26 39.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.396 1.098 . . . . 0.0 109.599 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -73.08 120.29 18.51 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 155.26 73.71 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.306 0.242 . . . . 0.0 110.768 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.17 -19.02 15.18 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 125.295 3.997 . . . . 0.0 118.501 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 55.03 65.24 1.55 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.924 1.345 . . . . 0.0 110.692 -168.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -71.58 168.33 17.85 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 110.071 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -131.06 149.21 52.71 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.48 167.43 14.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 125.825 1.65 . . . . 0.0 106.696 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 tp -86.05 147.28 26.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.1 p -72.57 172.0 11.39 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.684 -1.26 . . . . 0.0 107.701 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -67.26 -3.31 7.57 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.835 -1.166 . . . . 0.0 111.498 168.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.1 m -118.58 17.63 13.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.968 2.107 . . . . 0.0 111.276 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 63.86 43.73 5.24 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.402 1.481 . . . . 0.0 112.449 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.87 154.22 45.73 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 142.97 39.04 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.749 -1.219 . . . . 0.0 109.21 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.77 147.47 35.58 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.601 1.56 . . . . 0.0 107.05 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 p -143.06 165.9 26.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.997 0.919 . . . . 0.0 109.175 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.8 -34.49 67.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.354 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.58 -31.24 56.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.021 0.828 . . . . 0.0 112.975 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.87 -35.98 37.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.958 0.903 . . . . 0.0 111.426 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.8 mtt -78.9 -34.97 44.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.936 0.895 . . . . 0.0 112.111 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.77 -3.48 3.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -18.14 23.65 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 118.916 -0.936 . . . . 0.0 112.03 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -139.57 164.61 29.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.109 1.455 . . . . 0.0 109.138 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.51 128.29 20.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.1 m -130.45 136.77 49.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.3 mt -100.29 142.21 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.8 mm -120.33 129.01 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.9 m -124.97 98.59 5.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.418 1.087 . . . . 0.0 108.455 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.14 135.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.58 155.5 75.24 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.476 1.51 . . . . 0.0 107.929 172.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.99 -51.97 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.673 1.582 . . . . 0.0 110.76 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.25 158.88 42.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.258 1.423 . . . . 0.0 107.869 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 90' ' ' GLN . 9.7 tt -106.79 29.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.114 0.966 . . . . 0.0 112.317 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -134.79 16.44 3.58 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.814 0.845 . . . . 0.0 110.422 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.8 p -81.91 -9.43 59.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.225 1.01 . . . . 0.0 112.544 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.14 -50.08 3.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -25.64 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.165 0.982 . . . . 0.0 110.853 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -49.48 -33.83 15.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.449 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.87 -43.61 94.61 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.116 0.967 . . . . 0.0 111.497 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.25 6.29 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.736 1.214 . . . . 0.0 113.023 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.84 -77.82 0.58 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -54.2 -46.61 72.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -65.55 -41.97 92.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.213 0.915 . . . . 0.0 110.13 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -81.1 -25.71 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.999 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -63.36 -38.1 89.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.263 0.938 . . . . 0.0 109.726 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -61.35 -43.16 99.34 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.943 0.792 . . . . 0.0 111.147 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.83 -56.35 16.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.77 -30.69 70.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.297 -0.877 . . . . 0.0 111.87 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.24 89.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.15 0.886 . . . . 0.0 111.088 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.76 80.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.555 0.616 . . . . 0.0 110.664 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -41.25 90.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.091 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.97 -39.63 90.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.571 0.748 . . . . 0.0 110.2 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.95 -27.73 8.7 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.628 1.108 . . . . 0.0 112.048 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -151.62 118.4 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.49 172.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 78' ' ' ASN . 10.5 p -163.1 -176.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.622 1.969 . . . . 0.0 105.749 172.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -138.81 136.03 35.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.59 145.63 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 152.19 51.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.586 0.754 . . . . 0.0 109.977 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 104' ' ' THR . 19.4 m -104.53 146.0 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.3 mt -129.28 132.95 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 m -134.57 149.63 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.577 1.151 . . . . 0.0 109.768 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.66 55.31 2.94 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.03 160.39 40.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.056 1.342 . . . . 0.0 108.098 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.29 146.51 92.2 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.262 -169.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.8 -44.04 43.34 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.269 2.646 . . . . 0.0 112.858 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -77.23 -28.26 53.65 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.754 -0.591 . . . . 0.0 111.855 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.27 83.31 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.128 0.876 . . . . 0.0 109.996 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HA ' HG21 ' A' ' 55' ' ' ILE . 41.8 mt-30 -69.83 -46.43 65.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.252 0.621 . . . . 0.0 111.507 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.94 77.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.439 0.563 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -50.22 74.53 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.703 1.201 . . . . 0.0 108.769 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.44 ' CD1' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -56.62 -45.51 81.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.505 0.322 . . . . 0.0 110.159 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.0 m -64.28 -44.72 90.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.219 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.28 -37.02 90.54 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.15 80.56 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.842 0.821 . . . . 0.0 110.635 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -79.35 -33.08 43.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.162 0.585 . . . . 0.0 111.985 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 37.81 8.86 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.02 144.59 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.77 -37.58 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.694 1.197 . . . . 0.0 112.486 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.71 -16.2 42.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.558 0.743 . . . . 0.0 112.318 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.61 159.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -134.05 140.14 46.46 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.9 p -96.63 145.55 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.0 mt -134.9 158.28 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.29 113.65 22.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.914 1.686 . . . . 0.0 108.346 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.32 10.8 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.839 0.828 . . . . 0.0 111.651 170.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.21 -16.25 5.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.327 1.451 . . . . 0.0 111.214 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.4 ttt-85 -68.43 69.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.945 1.698 . . . . 0.0 109.508 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 46.17 41.15 8.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.284 1.834 . . . . 0.0 113.85 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.9 mmm 50.04 32.02 5.4 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.231 1.812 . . . . 0.0 113.601 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.7 m -53.71 -49.72 67.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.975 0.91 . . . . 0.0 111.751 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -72.03 -43.72 64.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.893 0.77 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.46 92.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.101 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.37 -47.46 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.013 0.907 . . . . 0.0 109.9 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.18 75.58 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.66 4.65 38.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.264 1.026 . . . . 0.0 112.265 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.05 49.5 77.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.482 1.039 . . . . 0.0 113.616 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.16 -12.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.58 1.552 . . . . 0.0 111.251 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CD2' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -67.73 113.63 5.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 169.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.4 mt -75.36 109.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.68 -41.53 55.81 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.658 1.983 . . . . 0.0 111.28 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.8 2.45 53.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.489 -171.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.54 -25.13 3.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.088 0.858 . . . . 0.0 113.311 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 56.06 33.89 22.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.592 0.633 . . . . 0.0 109.884 -168.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.38 164.6 20.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.651 1.58 . . . . 0.0 107.107 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.73 147.58 24.73 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.156 0.503 . . . . 0.0 110.127 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.88 145.26 46.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.411 1.484 . . . . 0.0 110.637 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -79.19 102.57 8.58 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 71.1 m -149.77 168.47 23.59 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.751 1.22 . . . . 0.0 108.46 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.39 149.81 17.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.982 -0.449 . . . . 0.0 109.798 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.6 157.17 45.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.283 1.033 . . . . 0.0 108.692 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -137.93 138.64 43.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.52 133.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.504 1.522 . . . . 0.0 107.408 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.1 176.69 3.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.872 0.869 . . . . 0.0 110.591 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.24 9.57 0.31 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.783 1.233 . . . . 0.0 114.243 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -127.6 4.77 6.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.875 1.67 . . . . 0.0 110.219 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.86 77.98 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.973 0.806 . . . . 0.0 112.553 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -87.4 136.84 32.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 119.452 1.626 . . . . 0.0 107.274 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.74 126.94 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.57 -19.84 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.464 0.705 . . . . 0.0 110.46 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -154.33 144.89 22.3 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.84 140.07 24.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.828 1.651 . . . . 0.0 107.168 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -152.23 147.33 26.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.306 0.503 . . . . 0.0 109.658 171.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.58 104.83 7.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.848 2.059 . . . . 0.0 105.633 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.22 133.61 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -73.39 -13.66 61.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -138.11 113.85 9.78 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.03 68.11 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 p -74.28 -0.66 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.31 0.959 . . . . 0.0 113.155 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.09 167.21 17.87 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.454 1.101 . . . . 0.0 108.957 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -117.88 157.14 49.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.472 0.709 . . . . 0.0 112.263 -168.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.67 152.27 78.13 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.618 2.212 . . . . 0.0 108.783 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -78.79 117.39 19.87 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -56.36 -20.97 21.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.499 1.519 . . . . 0.0 113.279 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.08 -36.62 82.25 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.054 0.843 . . . . 0.0 111.424 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -61.33 -52.62 69.41 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 119.327 0.967 . . . . 0.0 111.945 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.78 -27.86 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 120.797 1.32 . . . . 0.0 111.766 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -45.04 93.78 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 120.11 1.323 . . . . 0.0 109.731 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.19 -35.71 81.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.872 0.76 . . . . 0.0 110.652 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.38 79.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.401 0.143 . . . . 0.0 111.053 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.72 -50.12 46.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.736 0.415 . . . . 0.0 111.2 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -34.11 70.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.679 0.672 . . . . 0.0 111.157 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.33 67.19 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.361 0.528 . . . . 0.0 112.018 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.34 -23.74 16.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 50.2 t -57.13 -36.17 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.583 0.629 . . . . 0.0 110.495 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.717 1.207 . . . . 0.0 110.88 175.654 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.79 160.35 30.04 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.541 1.137 . . . . 0.0 109.674 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -147.04 164.9 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.912 2.885 . . . . 0.0 104.575 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.8 mt -132.73 168.99 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 p -115.93 148.17 40.33 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.88 -1.138 . . . . 0.0 109.011 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -91.69 37.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 63.25 -41.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.876 2.871 . . . . 0.0 114.204 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.79 -31.12 41.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.319 0.961 . . . . 0.0 112.477 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 173.73 46.46 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.234 1.017 . . . . 0.0 111.245 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.6 152.13 50.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 124.0 3.133 . . . . 0.0 113.718 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.51 127.58 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.507 1.923 . . . . 0.0 107.133 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -70.08 153.71 42.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.516 1.526 . . . . 0.0 110.634 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.07 140.42 44.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.42 1.488 . . . . 0.0 108.459 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.13 -16.82 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.42 162.15 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -173.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.89 160.04 33.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.74 0.781 . . . . 0.0 110.442 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 pm0 -74.17 136.96 42.87 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 168.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.53 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -133.66 161.62 34.15 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.271 -0.893 . . . . 0.0 110.427 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.14 140.93 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.87 32.78 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.797 -1.001 . . . . 0.0 112.862 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -70.51 155.54 40.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.179 1.49 . . . . 0.0 109.235 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -76.34 127.55 33.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 158.84 57.92 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.563 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -54.86 -14.95 8.85 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.432 3.421 . . . . 0.0 117.867 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 52.78 56.94 6.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 123.103 1.43 . . . . 0.0 110.169 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -83.26 170.95 14.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.928 2.091 . . . . 0.0 111.32 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 m -131.8 149.22 52.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.823 1.249 . . . . 0.0 107.653 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.89 170.87 10.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.703 2.001 . . . . 0.0 106.956 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tp -87.13 142.6 27.8 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -69.58 166.6 18.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.14 -6.64 18.56 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.634 -1.291 . . . . 0.0 110.897 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -100.24 8.64 43.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.055 2.142 . . . . 0.0 111.688 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.0 mt 68.15 39.52 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.404 1.482 . . . . 0.0 112.688 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -127.48 157.76 39.22 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.31 142.76 48.84 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 120.896 -1.127 . . . . 0.0 108.962 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.9 142.63 33.08 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -135.45 165.18 26.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.902 0.881 . . . . 0.0 108.656 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -53.97 -33.16 56.18 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.38 -0.343 . . . . 0.0 111.465 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.71 -33.56 61.2 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.42 -35.46 70.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.4 mtt -78.81 -29.69 44.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.386 1.474 . . . . 0.0 111.882 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -55.8 -14.86 2.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.635 1.574 . . . . 0.0 114.619 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.39 -17.41 32.24 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.604 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -151.17 157.54 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.26 1.53 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.66 126.51 13.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 46.8 m -118.89 151.66 37.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.424 0.69 . . . . 0.0 109.832 -169.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.7 mt -123.86 146.67 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 mm -130.18 110.66 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.631 1.572 . . . . 0.0 107.398 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 140.32 45.37 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.97 122.15 64.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.65 153.63 68.23 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.56 -57.09 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 111.301 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -146.28 142.5 28.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.556 1.942 . . . . 0.0 105.991 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' CE3' ' A' ' 93' ' ' TRP . 11.6 tt -77.33 -22.79 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -168.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.92 -18.67 62.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.8 p -66.54 149.78 49.95 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.861 0.755 . . . . 0.0 109.643 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.44 -37.41 92.01 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.901 -0.5 . . . . 0.0 111.898 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.46 -43.09 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 117.9 0.85 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -62.42 -42.71 99.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.891 0.769 . . . . 0.0 110.671 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.94 -56.23 24.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.664 1.186 . . . . 0.0 110.84 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.85 79.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.92 0.488 . . . . 0.0 112.248 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -57.17 10.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 173.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -62.46 -44.67 95.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.846 0.748 . . . . 0.0 111.948 -170.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -76.66 -37.57 56.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.194 1.361 . . . . 0.0 112.859 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -62.3 -43.18 99.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.045 0.839 . . . . 0.0 108.878 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.21 -35.36 76.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.944 -0.551 . . . . 0.0 112.003 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.38 -42.91 96.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.575 1.08 . . . . 0.0 112.263 173.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.76 -42.97 99.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 64.6 mm-40 -61.46 -39.08 89.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.864 1.211 . . . . 0.0 111.448 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.63 78.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.444 0.566 . . . . 0.0 111.092 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.37 83.07 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.941 0.791 . . . . 0.0 111.478 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -65.13 -39.46 93.07 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.459 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.7 -49.72 69.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 109.785 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 -61.91 2.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.967 1.746 . . . . 0.0 112.032 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -83.79 55.28 3.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.547 1.539 . . . . 0.0 110.72 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.14 169.91 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.191 1.396 . . . . 0.0 107.778 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 47' ' ' THR . 42.5 t30 -130.15 137.82 50.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.1 t -144.86 145.29 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.177 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -138.16 171.72 13.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.918 1.287 . . . . 0.0 109.689 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 m -132.8 144.42 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.42 1.888 . . . . 0.0 105.905 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -131.47 133.32 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -135.19 152.79 51.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.331 1.052 . . . . 0.0 109.539 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.46 45.12 1.16 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -129.62 164.94 22.78 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 -168.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.9 137.38 96.0 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.49 -42.71 48.0 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.091 2.528 . . . . 0.0 112.196 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -73.31 -32.24 64.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.621 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.39 -43.55 90.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.409 1.004 . . . . 0.0 109.802 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.05 -48.55 79.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.013 1.325 . . . . 0.0 111.908 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.8 86.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.751 0.705 . . . . 0.0 111.158 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -45.64 93.72 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.318 1.047 . . . . 0.0 108.953 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.409 ' CE3' HD11 ' A' ' 55' ' ' ILE . 85.8 t90 -64.69 -40.71 95.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.336 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 m -61.14 -43.66 98.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.606 0.639 . . . . 0.0 110.885 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.15 86.47 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.358 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.21 92.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.061 0.931 . . . . 0.0 110.629 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.96 -13.32 19.16 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.24 37.61 41.78 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.62 143.14 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.952 1.301 . . . . 0.0 108.207 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -139.35 -25.87 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -117.74 -5.04 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.431 1.092 . . . . 0.0 111.984 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.23 158.5 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -143.59 135.6 26.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 p -96.67 142.75 28.33 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.278 1.031 . . . . 0.0 108.358 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.97 150.21 45.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.528 1.531 . . . . 0.0 108.471 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -107.62 106.79 17.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 111.025 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.35 -11.34 59.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 109.843 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -48.64 -28.22 3.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.633 1.173 . . . . 0.0 111.58 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.98 88.11 1.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.075 1.35 . . . . 0.0 110.787 170.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.5 t70 65.03 14.48 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.059 1.744 . . . . 0.0 115.433 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp 44.34 30.7 0.49 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.016 2.527 . . . . 0.0 115.064 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.24 -46.86 88.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.439 0.696 . . . . 0.0 111.38 -173.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -66.32 -50.38 63.81 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -39.18 96.18 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 123.059 0.361 . . . . 0.0 112.202 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.47 -53.6 27.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.711 0.804 . . . . 0.0 109.978 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.08 67.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.93 56.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.597 1.159 . . . . 0.0 111.851 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.06 49.68 65.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.826 0.727 . . . . 0.0 113.296 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -123.4 -11.17 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.867 1.267 . . . . 0.0 111.012 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 108.05 3.72 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 98.4 mt -74.7 115.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.1 -47.54 82.38 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.448 1.099 . . . . 0.0 111.229 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.65 13.93 2.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.122 0.874 . . . . 0.0 113.237 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 40.14 53.82 2.77 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.204 2.201 . . . . 0.0 113.689 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 tp -145.96 169.55 18.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.113 0.965 . . . . 0.0 108.681 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.07 137.25 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.087 0.555 . . . . 0.0 109.984 -173.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.49 149.22 49.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.987 1.315 . . . . 0.0 111.156 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -81.05 115.9 20.73 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 70.8 m -162.18 171.19 17.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.747 1.219 . . . . 0.0 108.825 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.19 144.4 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.501 -0.749 . . . . 0.0 109.622 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -132.66 153.16 51.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.811 0.695 . . . . 0.0 110.479 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.63 134.27 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -125.39 132.57 52.76 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.108 1.363 . . . . 0.0 107.979 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.0 166.0 22.26 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.371 1.068 . . . . 0.0 109.747 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.36 -26.89 43.84 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.382 1.073 . . . . 0.0 112.394 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.61 -0.43 23.35 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.042 -1.036 . . . . 0.0 112.115 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 28.19 73.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.036 0.827 . . . . 0.0 111.887 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.33 147.33 26.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.321 1.06 . . . . 0.0 108.28 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.1 t -71.72 138.15 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.73 -35.66 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.909 1.684 . . . . 0.0 109.419 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -150.18 142.94 24.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 144.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.78 148.51 27.31 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 17' ' ' GLU . 63.8 m-85 -132.0 98.61 4.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.468 2.307 . . . . 0.0 105.982 -169.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.42 131.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -67.79 -15.64 63.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.992 0.917 . . . . 0.0 113.183 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -126.28 118.14 24.49 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.44 69.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.22 0.608 . . . . 0.0 111.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.6 p -68.93 -12.71 61.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.568 1.547 . . . . 0.0 112.679 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -116.64 161.26 19.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.866 1.666 . . . . 0.0 108.674 -170.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -121.94 153.15 60.5 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.776 0.83 . . . . 0.0 110.297 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.85 150.68 55.94 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.666 1.577 . . . . 0.0 108.301 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.19 115.98 20.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -66.7 -8.77 30.2 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.93 -32.05 71.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.997 0.817 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.18 -53.15 34.23 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.306 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.01 -30.43 25.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.494 1.569 . . . . 0.0 111.564 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.94 -51.47 53.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 119.191 0.905 . . . . 0.0 109.44 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.98 -28.97 70.17 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 111.545 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.88 -49.37 46.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.113 0.565 . . . . 0.0 111.427 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.62 65.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.236 0.614 . . . . 0.0 111.192 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -32.54 65.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.49 0.716 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.73 76.52 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.359 0.664 . . . . 0.0 111.316 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.6 mt -79.57 -44.75 20.5 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.216 0.462 . . . . 0.0 110.96 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -84.48 14.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.249 1.069 0 O-C-N 121.53 -0.731 . . . . 0.0 109.583 169.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.79 71.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.109 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.95 48.44 15.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.39 1.876 . . . . 0.0 111.815 171.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.85 147.27 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.768 0.827 . . . . 0.0 109.085 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.3 p -116.08 167.4 11.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.945 1.698 . . . . 0.0 109.135 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -135.8 95.08 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 40.76 33.42 0.2 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.584 2.354 . . . . 0.0 115.921 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.31 -23.96 0.27 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.418 -1.212 . . . . 0.0 114.777 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.78 169.49 40.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.778 1.789 . . . . 0.0 113.006 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.31 154.01 65.91 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.898 3.065 . . . . 0.0 111.831 -173.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.11 128.06 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.274 1.03 . . . . 0.0 108.835 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -61.7 156.31 20.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.48 1.512 . . . . 0.0 111.275 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.7 mt -125.68 141.4 52.03 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.586 1.954 . . . . 0.0 106.942 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.27 -65.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.3 -170.25 46.93 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.269 0.937 . . . . 0.0 112.276 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -108.96 150.19 28.09 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.1 0.96 . . . . 0.0 110.796 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.61 121.22 12.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.96 167.71 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.5 155.93 49.52 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.477 -0.764 . . . . 0.0 109.558 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.44 136.18 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 170.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.95 -18.5 57.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.013 1.292 . . . . 0.0 111.943 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -76.99 157.02 31.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.73 1.265 . . . . 0.0 109.537 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -81.26 126.67 31.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.85 93.67 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.262 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -55.16 -30.27 70.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.36 2.707 . . . . 0.0 116.031 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 50.71 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.391 1.877 . . . . 0.0 113.728 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.35 178.1 6.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.907 1.283 . . . . 0.0 109.616 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -108.1 152.42 24.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.25 1.02 . . . . 0.0 109.564 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -141.61 171.33 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.583 2.353 . . . . 0.0 107.315 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.95 155.68 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.0 p -71.16 -158.35 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.653 1.181 . . . . 0.0 109.366 169.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -72.33 0.14 10.81 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.353 -1.467 . . . . 0.0 113.054 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -126.54 -88.72 0.57 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.508 1.049 . . . . 0.0 108.627 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -157.56 -3.88 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.346 1.858 . . . . 0.0 112.405 -169.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.38 138.35 32.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -72.9 138.88 46.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -137.27 149.26 46.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.999 1.72 . . . . 0.0 106.534 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -137.67 160.2 39.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.97 -30.39 67.89 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.967 -0.458 . . . . 0.0 111.861 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -28.04 68.4 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.832 0.853 . . . . 0.0 112.816 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -75.72 -36.31 59.99 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.487 0.715 . . . . 0.0 110.425 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.8 mtt -73.96 -36.48 64.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -65.67 0.83 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.35 -16.38 20.5 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.005 -1.059 . . . . 0.0 112.73 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -141.02 167.63 21.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.112 1.456 . . . . 0.0 108.263 169.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.47 128.97 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.9 m -131.68 151.36 51.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.409 0.284 . . . . 0.0 110.888 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.4 mt -113.82 139.02 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.45 126.02 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -118.96 98.34 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 0.0 108.745 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 m -74.89 136.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 155.9 80.42 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 169.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.04 -54.92 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.676 2.251 . . . . 0.0 111.775 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -157.37 149.45 22.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.45 -15.72 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.43 -0.793 . . . . 0.0 111.266 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.64 -16.46 61.01 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.166 -0.959 . . . . 0.0 113.289 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.6 p -61.37 -23.8 66.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.716 1.144 . . . . 0.0 114.024 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -42.47 2.16 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.315 0.96 . . . . 0.0 111.436 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.04 -24.54 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.884 1.273 . . . . 0.0 110.421 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 24.1 p -47.48 -32.27 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.257 1.423 . . . . 0.0 113.009 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.6 -33.49 70.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 125.353 1.461 . . . . 0.0 112.253 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.03 -17.4 57.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.271 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -108.57 -80.12 0.58 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.1 m -54.15 -43.39 70.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.529 1.132 . . . . 0.0 113.624 -168.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -63.06 -53.33 55.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.514 0.597 . . . . 0.0 109.596 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -69.54 -36.16 76.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.78 -172.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -59.22 -36.91 76.26 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.88 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -60.18 -46.06 91.0 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.863 1.21 . . . . 0.0 110.477 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.68 -51.34 57.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.56 -38.54 87.86 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 121.285 -0.884 . . . . 0.0 110.94 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.97 -37.37 86.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.888 0.767 . . . . 0.0 111.309 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.83 95.62 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.685 0.675 . . . . 0.0 110.643 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -38.75 83.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.586 0.63 . . . . 0.0 111.367 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.48 -33.33 73.59 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.862 0.865 . . . . 0.0 110.538 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.28 -35.06 3.5 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.81 1.195 . . . . 0.0 111.859 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.48 116.76 5.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.666 1.187 . . . . 0.0 109.207 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.0 p -159.19 -174.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 127.476 2.31 . . . . 0.0 105.409 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.2 t30 -138.85 134.2 33.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -141.39 140.43 31.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 108.7 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.18 159.8 37.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.279 1.032 . . . . 0.0 109.899 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.0 m -122.12 142.8 50.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.52 141.13 46.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.0 t -143.71 155.18 44.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 110.499 -169.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 9.78 41.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.26 177.91 8.31 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -84.82 147.1 47.71 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 123.968 0.907 . . . . 0.0 110.201 -169.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.63 -45.36 27.87 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.858 3.038 . . . . 0.0 113.698 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -67.0 -29.72 69.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.518 -0.739 . . . . 0.0 112.311 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.98 72.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.312 0.96 . . . . 0.0 109.657 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -52.88 -51.36 61.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.559 0.743 . . . . 0.0 109.658 170.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.93 74.81 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 111.164 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -62.75 -45.94 90.35 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.566 0.747 . . . . 0.0 110.25 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -63.48 -43.95 95.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.655 0.382 . . . . 0.0 110.854 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -70.16 -37.87 75.3 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.744 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.52 -38.08 94.38 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.3 79.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.627 0.771 . . . . 0.0 110.216 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -70.74 -31.8 68.75 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.657 0.783 . . . . 0.0 112.694 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.14 35.78 23.06 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.25 144.18 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.53 -35.26 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.699 1.199 . . . . 0.0 112.602 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.66 -10.41 51.39 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.605 0.762 . . . . 0.0 112.471 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.9 159.83 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.72 149.94 52.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 140.09 48.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.797 0.839 . . . . 0.0 110.228 -169.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.3 mt -138.74 163.81 31.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.468 1.507 . . . . 0.0 109.07 -169.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.34 136.15 36.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.099 0.56 . . . . 0.0 109.516 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -122.67 -5.46 8.65 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.603 0.761 . . . . 0.0 111.679 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -57.68 -19.5 27.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -54.46 -43.02 71.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 111.23 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.84 -1.79 0.3 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.394 0.678 . . . . 0.0 112.664 -171.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 64.1 mmm 47.04 28.44 0.9 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.771 2.428 . . . . 0.0 113.601 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -44.81 92.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 111.149 -171.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.84 -46.59 57.51 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -37.19 87.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -46.26 90.69 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.769 -0.842 . . . . 0.0 109.245 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.56 79.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.89 1.71 16.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.643 0.777 . . . . 0.0 112.481 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.79 90.23 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.982 1.265 . . . . 0.0 112.553 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 m -124.91 -2.16 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.116 1.366 . . . . 0.0 111.397 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -79.56 105.99 11.27 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.26 101.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -51.69 -42.23 62.03 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.333 1.453 . . . . 0.0 111.441 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.6 -10.81 60.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -122.61 -17.73 6.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.187 0.995 . . . . 0.0 112.069 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.19 38.13 26.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.048 -168.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 157.27 43.95 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.471 1.108 . . . . 0.0 108.592 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.4 tp -77.79 148.65 34.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.122 0.969 . . . . 0.0 109.279 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.2 -175.06 4.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.492 . . . . 0.0 111.458 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.7 ttm105 -121.73 111.93 17.77 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 m -157.69 169.55 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.483 1.913 . . . . 0.0 106.94 -170.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.35 144.57 18.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -134.18 157.64 45.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.715 1.206 . . . . 0.0 108.542 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.75 134.63 53.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.76 132.16 53.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.941 1.296 . . . . 0.0 108.07 -173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.45 167.52 10.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.601 1.561 . . . . 0.0 109.592 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -58.54 -21.17 51.65 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.449 -0.782 . . . . 0.0 113.024 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -86.9 -0.17 56.05 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.297 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.56 23.29 78.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.04 -1.037 . . . . 0.0 112.299 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -88.14 141.28 28.69 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.826 1.313 . . . . 0.0 107.518 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.3 t -68.57 116.86 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.74 -33.97 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.827 1.251 . . . . 0.0 109.275 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -158.96 146.35 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.32 144.15 27.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -145.52 136.99 25.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -128.6 121.28 28.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.53 135.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -67.79 -5.89 18.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.778 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -147.41 118.8 7.87 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.49 63.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.111 0.964 . . . . 0.0 113.549 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 10.12 20.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.881 1.272 . . . . 0.0 110.414 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -127.77 178.3 6.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.55 2.34 . . . . 0.0 108.132 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -138.3 152.15 70.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 120.623 -1.298 . . . . 0.0 112.147 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.63 149.55 18.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.687 2.258 . . . . 0.0 108.951 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -74.71 115.84 14.73 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -51.73 -26.53 9.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.032 1.733 . . . . 0.0 112.922 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -61.7 -31.31 71.45 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.646 -0.659 . . . . 0.0 111.882 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -48.04 10.63 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.741 1.155 . . . . 0.0 112.07 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.01 -30.65 32.07 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 121.315 1.505 . . . . 0.0 111.646 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.3 mm -55.36 -50.17 67.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.313 0.961 . . . . 0.0 109.42 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.12 -32.73 73.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.39 0.541 . . . . 0.0 111.364 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.01 69.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.097 0.559 . . . . 0.0 111.512 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.13 -46.52 56.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.522 0.729 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -26.22 62.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.783 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.07 65.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.287 1.035 . . . . 0.0 113.175 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.27 -26.96 6.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.15 -13.41 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.184 1.794 . . . . 0.0 108.123 -175.934 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.09 86.03 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 119.089 -0.481 . . . . 0.0 112.282 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 41.84 47.0 3.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.4 1.88 . . . . 0.0 112.049 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 13' ' ' LEU . 40.6 mt -54.0 126.1 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 109.131 -170.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.0 p -76.99 161.87 28.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.444 0.64 . . . . 0.0 110.105 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -116.97 38.93 3.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.153 0.981 . . . . 0.0 109.552 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm 41.83 63.91 1.2 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.596 1.959 . . . . 0.0 111.571 -171.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.1 -28.18 0.11 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.239 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.54 170.46 42.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.618 1.104 . . . . 0.0 110.534 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.9 158.52 55.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.739 2.959 . . . . 0.0 110.761 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.47 142.28 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -67.51 157.08 35.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.513 1.525 . . . . 0.0 110.359 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' HA ' ' H ' ' A' ' 122' ' ' LYS . 4.6 mp -135.18 144.94 47.28 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.911 1.284 . . . . 0.0 107.771 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -82.44 147.91 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.44 -157.15 19.45 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -132.62 161.3 34.26 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.93 115.24 5.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 168.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -83.4 151.44 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -132.67 155.05 49.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.883 0.873 . . . . 0.0 109.888 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.43 141.02 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.049 0.94 . . . . 0.0 109.289 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.55 -21.64 31.54 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.943 1.259 . . . . 0.0 112.175 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.67 152.79 40.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.73 1.265 . . . . 0.0 109.771 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -70.81 126.79 30.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 152.41 73.79 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.152 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.77 -29.0 60.26 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.224 2.616 . . . . 0.0 115.482 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.6 t0 51.9 85.91 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.913 2.085 . . . . 0.0 113.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.37 172.34 12.83 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 110.642 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -87.04 158.99 19.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.771 1.628 . . . . 0.0 110.366 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 p -151.87 159.31 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.043 2.537 . . . . 0.0 105.639 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tp -90.54 145.99 24.44 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.548 -1.345 . . . . 0.0 108.018 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -74.35 165.66 24.81 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.056 -1.028 . . . . 0.0 108.395 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -66.67 -6.61 16.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.871 -1.143 . . . . 0.0 111.368 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -93.54 3.7 55.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.39 1.876 . . . . 0.0 111.893 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp 62.81 44.74 6.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.195 1.398 . . . . 0.0 111.817 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.49 160.76 29.64 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.68 1.192 . . . . 0.0 107.785 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -78.31 142.08 38.01 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.844 -1.16 . . . . 0.0 109.753 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -139.15 163.52 32.22 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.161 1.784 . . . . 0.0 106.55 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 p -151.68 169.22 22.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.969 -1.082 . . . . 0.0 108.51 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.73 -27.6 59.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.512 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -28.64 62.32 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.01 -41.42 35.9 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.361 0.664 . . . . 0.0 109.834 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.4 mtt -65.45 -40.63 93.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.966 0.906 . . . . 0.0 109.105 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -71.1 -0.89 10.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.67 . . . . 0.0 112.381 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.16 -15.72 59.02 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.837 -1.165 . . . . 0.0 111.97 169.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -147.94 168.96 20.93 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.899 1.349 . . . . 0.0 108.428 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.97 120.9 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 168.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -130.14 153.89 48.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 123.156 0.285 . . . . 0.0 110.763 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.03 142.18 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.1 mm -127.85 113.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -112.94 98.44 7.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.141 0.976 . . . . 0.0 109.007 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.41 140.71 15.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.33 -0.857 . . . . 0.0 108.872 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.85 156.03 72.88 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.839 1.256 . . . . 0.0 108.491 169.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.81 -50.03 12.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.644 2.229 . . . . 0.0 112.498 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -160.44 164.62 32.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.936 2.494 . . . . 0.0 106.295 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 tt -98.3 -23.79 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.56 0.618 . . . . 0.0 111.564 -169.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -82.91 54.44 2.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.862 1.265 . . . . 0.0 110.387 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -154.99 -178.15 7.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.184 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.95 179.5 31.24 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.38 0.991 . . . . 0.0 112.271 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.285 19.5 m 53.25 -6.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 129.339 3.055 . . . . 0.0 116.832 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.8 m -65.27 -22.7 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.59 -1.319 . . . . 0.0 110.896 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.27 -31.76 67.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.666 -0.647 . . . . 0.0 111.233 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.46 -58.2 2.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.892 0.769 . . . . 0.0 109.778 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.29 -15.78 63.7 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -128.89 -54.17 1.22 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.79 1.177 . . . . 0.0 110.074 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.97 -52.31 13.24 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.771 1.169 . . . . 0.0 111.556 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.55 79.41 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.388 0.995 . . . . 0.0 109.605 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -44.21 71.9 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.336 0.516 . . . . 0.0 111.67 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.02 -44.08 93.67 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.619 0.767 . . . . 0.0 111.836 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.35 -49.48 77.42 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 73' ' ' LYS . 21.8 mm-40 -64.27 -39.47 94.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.094 0.861 . . . . 0.0 110.863 -176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.974 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.25 -33.55 69.92 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.427 1.012 . . . . 0.0 110.775 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 70' ' ' GLU . 17.3 mmtp -68.84 -40.08 79.59 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 109.346 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.24 -50.43 74.03 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.25 -0.21 60.02 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.769 1.176 . . . . 0.0 114.286 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.92 65.51 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.133 1.373 . . . . 0.0 108.668 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.96 167.7 4.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.024 1.33 . . . . 0.0 107.593 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -120.49 144.44 48.01 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.4 147.08 14.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.954 -1.091 . . . . 0.0 109.748 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -134.13 162.81 31.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.703 1.601 . . . . 0.0 109.417 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -127.84 149.26 50.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.89 136.5 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 m -139.37 158.64 43.8 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.47 48.99 1.43 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -132.4 165.33 24.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.55 1.54 . . . . 0.0 108.889 -169.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.96 136.18 96.69 Favored Pre-proline 0 C--O 1.236 0.387 0 C-N-CA 123.826 0.851 . . . . 0.0 109.826 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.37 -42.8 46.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.352 2.702 . . . . 0.0 112.277 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -73.68 -31.58 63.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.523 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.9 75.05 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.358 0.981 . . . . 0.0 108.993 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -57.7 -42.89 84.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.125 0.97 . . . . 0.0 112.572 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.48 85.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.031 0.832 . . . . 0.0 111.264 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.26 -42.33 93.37 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.306 0.643 . . . . 0.0 109.725 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -60.4 -40.23 90.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.24 0.616 . . . . 0.0 110.527 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -65.23 -47.09 78.02 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.007 -0.433 . . . . 0.0 111.173 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.08 96.84 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.21 97.25 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.744 0.818 . . . . 0.0 110.702 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -85.39 -19.75 30.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 112.702 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.86 38.18 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 mm -64.33 142.81 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -144.91 -37.83 0.28 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.05 0.94 . . . . 0.0 112.652 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -80.81 -25.85 37.54 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.393 0.677 . . . . 0.0 111.226 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.8 157.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.827 1.251 . . . . 0.0 107.668 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -138.06 138.82 39.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 p -95.65 148.19 22.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.5 1.12 . . . . 0.0 108.205 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -137.93 140.19 40.17 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.655 1.182 . . . . 0.0 108.648 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -102.29 105.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.6 1.16 . . . . 0.0 110.06 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.34 -4.47 55.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.754 169.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -51.56 -41.36 61.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.737 1.215 . . . . 0.0 111.589 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.2 -44.76 44.64 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.645 0.778 . . . . 0.0 111.424 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.59 -36.15 11.36 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 55.12 -19.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.719 3.208 . . . . 0.0 115.759 -169.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -59.46 -33.0 70.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.371 1.441 . . . . 0.0 112.678 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -67.54 -54.65 18.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.989 0.813 . . . . 0.0 108.942 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -36.71 73.03 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -32.05 71.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.332 1.053 . . . . 0.0 110.822 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.93 -44.11 10.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.615 0.643 . . . . 0.0 112.319 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.17 13.49 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.57 93.22 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.563 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.77 -10.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.47 1.135 . . . . 0.0 112.149 -168.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -82.11 116.37 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.8 mt -79.6 97.47 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' ' HA ' ' A' ' 13' ' ' LEU . 57.6 tttm -44.68 -55.64 5.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 126.615 1.966 . . . . 0.0 111.869 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -86.11 -11.54 52.4 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 mt -83.54 -21.74 32.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.943 0.792 . . . . 0.0 109.525 168.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 58.36 32.06 21.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.915 1.286 . . . . 0.0 109.354 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -135.79 154.17 51.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 108.516 -177.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.421 ' H ' HD13 ' A' ' 126' ' ' LEU . 14.3 tp -77.37 152.17 34.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.168 0.987 . . . . 0.0 109.778 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 -174.44 5.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.31 1.044 . . . . 0.0 111.258 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -116.43 127.04 54.25 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -167.43 175.15 7.39 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.51 1.924 . . . . 0.0 107.128 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.15 145.92 14.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -137.7 158.41 44.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.859 1.264 . . . . 0.0 109.345 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.26 144.71 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -131.54 128.75 39.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.634 1.573 . . . . 0.0 108.149 -169.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.25 163.43 27.84 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 109.011 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.21 -17.53 42.1 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -81.42 -4.96 57.33 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.296 -1.502 . . . . 0.0 112.378 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.93 27.64 66.3 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.317 -0.865 . . . . 0.0 111.698 -172.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.36 144.11 27.44 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.33 135.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.2 -32.92 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.416 1.486 . . . . 0.0 109.614 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -150.12 144.85 25.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 139.84 24.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -148.22 149.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -125.85 142.83 51.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.348 1.859 . . . . 0.0 106.214 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.96 -10.51 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m 62.99 -21.99 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.241 2.216 . . . . 0.0 115.626 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -143.63 123.97 13.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.218 1.372 . . . . 0.0 107.505 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.05 -18.38 46.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.9 p -77.63 -3.96 43.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.227 0.921 . . . . 0.0 112.905 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 163.11 25.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.402 1.001 . . . . 0.0 110.048 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -118.54 155.97 51.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.632 -170.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.15 155.04 47.19 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 108.2 -1.5 . . . . 0.0 108.2 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -84.65 114.0 21.69 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -49.1 -26.07 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.009 2.124 . . . . 0.0 113.508 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.8 -37.57 82.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.877 0.762 . . . . 0.0 111.242 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -63.98 -51.92 60.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.617 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.59 -27.3 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.806 1.67 . . . . 0.0 112.233 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -59.82 -45.63 94.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-N 120.22 1.373 . . . . 0.0 109.246 171.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.91 -32.85 74.52 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.885 0.766 . . . . 0.0 111.021 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.25 56.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.611 0.364 . . . . 0.0 111.103 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.61 -46.87 71.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.135 0.574 . . . . 0.0 111.639 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -29.1 67.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.72 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.28 77.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.317 0.508 . . . . 0.0 111.696 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.72 -35.65 19.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.439 0.563 . . . . 0.0 112.401 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.91 -9.32 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.736 0.814 . . . . 0.0 110.18 176.257 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.943 -0.021 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.27 158.45 26.25 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.39 141.09 35.61 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.514 HD12 HD21 ' A' ' 13' ' ' LEU . 85.1 mt -137.59 169.66 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 150.49 31.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -143.08 121.84 12.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.61 37.61 3.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.344 1.458 . . . . 0.0 113.166 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.28 12.05 60.39 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.196 -1.336 . . . . 0.0 114.628 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.06 154.43 23.9 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.954 1.877 . . . . 0.0 110.955 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.0 153.93 63.02 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.653 2.236 . . . . 0.0 111.344 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -139.04 129.2 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.526 1.53 . . . . 0.0 108.286 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -74.54 160.39 30.97 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.197 1.399 . . . . 0.0 109.244 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.514 HD21 HD12 ' A' ' 4' ' ' ILE . 4.9 mp -129.54 148.91 51.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 108.944 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 t -82.36 135.26 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.0 -158.28 14.44 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 118.38 0.536 . . . . 0.0 112.785 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -131.62 143.88 50.65 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.316 1.447 . . . . 0.0 108.666 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.86 103.0 7.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.84 157.09 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 108.832 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -127.71 156.5 42.29 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.991 1.316 . . . . 0.0 109.357 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.72 140.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.13 59.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.6 1.095 . . . . 0.0 112.756 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.78 156.8 37.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.32 1.56 . . . . 0.0 109.582 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.37 139.65 32.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.63 159.34 74.82 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -60.4 -7.06 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.449 3.432 . . . . 0.0 117.8 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 52.4 58.58 5.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.833 1.302 . . . . 0.0 110.823 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -85.69 165.78 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.034 1.734 . . . . 0.0 109.712 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -130.9 146.12 52.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.988 1.315 . . . . 0.0 107.514 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.87 168.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.581 1.952 . . . . 0.0 107.235 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.68 146.67 26.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.0 p -74.42 167.11 22.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -63.89 -8.02 9.91 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.062 -1.023 . . . . 0.0 111.656 168.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -109.72 13.9 23.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.836 2.054 . . . . 0.0 111.251 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 64.59 44.99 3.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.167 1.387 . . . . 0.0 111.978 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.14 161.53 29.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.58 144.13 35.82 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.62 -1.3 . . . . 0.0 108.895 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -142.67 145.83 33.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 m -140.37 167.28 22.51 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.671 0.788 . . . . 0.0 109.556 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 tp -47.22 -40.53 16.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.193 0.997 . . . . 0.0 111.958 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.97 -30.95 62.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.72 0.808 . . . . 0.0 113.084 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.55 -40.59 42.02 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.464 0.65 . . . . 0.0 110.577 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.8 mtt -65.34 -27.04 68.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.706 1.202 . . . . 0.0 111.346 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -55.42 -16.08 3.3 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 113.414 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.8 -20.37 56.91 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.845 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -154.47 156.45 36.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.443 1.621 . . . . 0.0 109.0 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.24 122.04 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.7 m -117.2 150.81 38.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 109.975 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.8 mt -121.89 145.64 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.2 mt -126.54 138.94 53.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.23 93.83 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.242 1.817 . . . . 0.0 106.823 -171.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.45 128.32 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 pt -139.27 154.45 72.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.11 -46.49 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 CA-C-N 121.098 1.428 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 p -158.73 173.98 15.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.614 1.966 . . . . 0.0 107.762 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.437 HD11 ' CE3' ' A' ' 93' ' ' TRP . 3.8 tt -113.58 -177.67 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.802 0.841 . . . . 0.0 110.635 -169.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 56.3 43.81 25.78 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.24 1.416 . . . . 0.0 112.894 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -147.27 138.43 23.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -45.55 -46.34 12.37 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.191 1.376 . . . . 0.0 114.56 -169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.21 -25.59 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.434 1.094 . . . . 0.0 112.598 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.46 -40.59 7.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.925 1.69 . . . . 0.0 110.099 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.92 -49.76 74.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 127.15 2.18 . . . . 0.0 110.693 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.31 88.31 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.948 0.499 . . . . 0.0 111.348 -174.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -61.36 2.63 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.7 m -64.33 -39.07 93.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.337 0.517 . . . . 0.0 111.163 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.89 -50.37 69.02 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.219 -0.926 . . . . 0.0 110.253 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.86 -33.59 75.05 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.602 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.31 -39.68 73.12 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 120.142 1.337 . . . . 0.0 112.16 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.94 -48.91 79.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.601 1.091 . . . . 0.0 110.874 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -67.6 -44.09 78.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -63.3 -37.82 88.73 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.03 -1.044 . . . . 0.0 110.819 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.6 92.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.622 -0.674 . . . . 0.0 111.041 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.06 88.6 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.788 0.722 . . . . 0.0 111.227 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -67.66 -40.09 84.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.694 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.7 mp -60.9 -45.41 94.73 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.852 0.751 . . . . 0.0 109.842 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.59 -9.83 61.04 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.961 1.267 . . . . 0.0 114.842 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -153.62 58.66 0.75 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.042 1.421 . . . . 0.0 109.492 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.43 171.9 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.783 1.233 . . . . 0.0 107.789 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.97 141.61 50.74 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 t -138.05 151.95 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.188 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.28 169.69 16.83 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.984 1.314 . . . . 0.0 109.703 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -132.75 143.85 49.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.98 133.88 60.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 m -139.48 158.57 43.91 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.57 1.169 . . . . 0.0 110.879 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.5 54.22 2.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 168.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.43 163.95 31.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 108.244 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.65 135.86 85.89 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -169.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.16 -36.68 79.7 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.986 1.791 . . . . 0.0 110.714 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -75.2 -27.71 59.71 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.776 -0.63 . . . . 0.0 112.101 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.72 71.29 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.52 1.055 . . . . 0.0 108.964 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -60.18 -41.61 93.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.826 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.97 92.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.63 0.65 . . . . 0.0 111.007 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -67.55 -39.25 84.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.174 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.437 ' CE3' HD11 ' A' ' 55' ' ' ILE . 74.9 t90 -69.25 -45.13 70.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.207 0.603 . . . . 0.0 110.934 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -69.76 -33.73 72.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.824 -1.173 . . . . 0.0 110.353 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -33.69 87.92 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.037 -0.868 . . . . 0.0 112.402 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.74 93.41 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.705 1.253 . . . . 0.0 110.206 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -72.83 -27.71 62.11 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.123 0.569 . . . . 0.0 111.968 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.14 53.41 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mt -68.37 145.8 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.263 1.025 . . . . 0.0 108.499 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.89 -34.93 0.42 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.069 1.348 . . . . 0.0 111.976 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.33 -13.62 59.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.645 0.778 . . . . 0.0 111.927 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.16 155.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -134.21 130.81 37.76 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -84.46 151.55 24.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.101 0.56 . . . . 0.0 109.62 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 mt -143.09 150.27 39.29 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.505 1.522 . . . . 0.0 107.255 -173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.4 m -116.01 115.39 26.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.652 1.181 . . . . 0.0 108.505 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.26 -9.7 55.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.581 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.39 -36.42 6.44 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.049 2.139 . . . . 0.0 114.259 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -78.57 -13.39 59.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.891 -173.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -147.64 -16.19 0.37 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -169.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.1 mmm 51.93 9.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.462 2.705 . . . . 0.0 117.213 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.7 m -63.15 -38.25 90.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.751 1.614 . . . . 0.0 112.525 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -64.71 -50.53 66.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.128 1.331 . . . . 0.0 108.952 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.48 97.73 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 -172.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.464 0.706 . . . . 0.0 109.814 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.581 -0.7 . . . . 0.0 111.847 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.57 1.02 40.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.691 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.1 90.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.873 1.215 . . . . 0.0 112.862 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.9 -7.37 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.743 1.217 . . . . 0.0 111.352 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.75 108.3 5.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.058 1.299 . . . . 0.0 107.942 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.86 112.71 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -57.32 -38.09 73.51 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.519 1.527 . . . . 0.0 110.887 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.58 8.51 40.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.965 0.906 . . . . 0.0 112.149 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.66 -23.87 2.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 55.58 37.35 28.76 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 110.037 -168.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.9 mt -130.72 161.15 32.31 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.125 1.37 . . . . 0.0 108.092 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.6 mt -83.27 143.35 30.46 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.14 152.01 41.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 111.01 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -80.7 100.61 8.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 62.0 m -147.97 167.25 25.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.328 1.451 . . . . 0.0 109.417 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 m -141.0 153.41 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.469 -0.769 . . . . 0.0 110.515 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.69 157.12 44.99 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.539 1.136 . . . . 0.0 109.619 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.49 139.51 48.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -133.24 119.49 19.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 107.618 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.01 163.85 21.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.56 0.744 . . . . 0.0 109.528 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.2 -23.33 21.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.078 1.351 . . . . 0.0 112.811 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -76.06 -6.49 51.33 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.805 -1.184 . . . . 0.0 112.377 175.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.17 42.61 35.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -121.46 132.09 54.53 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.81 112.78 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -171.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.28 -33.76 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.692 1.197 . . . . 0.0 109.355 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -154.99 147.04 23.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.839 1.256 . . . . 0.0 108.363 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.33 31.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.776 1.23 . . . . 0.0 107.837 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.1 137.59 21.0 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.886 0.874 . . . . 0.0 108.794 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -131.33 93.97 3.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 105.355 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.54 132.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 m -67.79 -9.67 46.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 113.074 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.15 110.51 11.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.74 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.885 0.874 . . . . 0.0 110.925 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.46 6.02 6.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 112.627 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -122.88 173.24 7.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.196 2.199 . . . . 0.0 107.033 170.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.57 157.44 73.08 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 120.936 -1.103 . . . . 0.0 111.543 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.17 -179.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.742 3.628 . . . . 0.0 113.594 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -124.77 111.7 15.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -52.25 -25.07 8.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.69 1.996 . . . . 0.0 112.948 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.67 -38.04 80.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.995 0.816 . . . . 0.0 111.383 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -60.28 -56.09 38.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.892 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.9 -26.96 31.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.49 1.46 . . . . 0.0 112.059 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -44.38 94.89 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.654 1.57 . . . . 0.0 109.638 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.53 -34.52 78.43 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.16 0.891 . . . . 0.0 110.713 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.57 -49.06 70.23 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.5 0.19 . . . . 0.0 111.258 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.14 -49.4 61.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.026 0.53 . . . . 0.0 111.128 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -33.82 69.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.759 0.708 . . . . 0.0 111.355 -176.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.35 -31.37 69.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.446 0.566 . . . . 0.0 111.784 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.7 mt -89.61 -24.41 21.68 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.698 0.799 . . . . 0.0 112.155 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.91 -32.73 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.483 0.583 . . . . 0.0 110.519 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.183 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.18 171.61 10.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.06 140.21 30.83 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 13' ' ' LEU . 95.5 mt -133.94 170.8 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.16 151.31 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -133.73 113.33 12.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.74 -50.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.877 2.871 . . . . 0.0 115.529 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 17.35 0.06 OUTLIER Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.818 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.75 27.48 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.577 1.689 . . . . 0.0 110.979 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.63 157.69 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.048 2.499 . . . . 0.0 111.874 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.55 124.97 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.144 1.778 . . . . 0.0 107.479 171.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -73.98 158.09 35.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.476 1.51 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD21 HD12 ' A' ' 4' ' ' ILE . 4.8 mp -132.47 136.81 46.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 123.987 0.915 . . . . 0.0 108.889 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.35 127.31 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.55 -167.56 18.94 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 121.415 0.453 . . . . 0.0 112.697 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -109.0 141.6 40.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 108.264 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.25 107.96 10.02 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.08 152.96 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.2 157.49 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 109.881 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -57.4 141.07 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.715 0.806 . . . . 0.0 108.923 175.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -24.23 17.6 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.748 1.166 . . . . 0.0 112.257 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.82 158.85 34.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.295 1.547 . . . . 0.0 110.299 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -76.25 136.49 39.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 153.98 89.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.789 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.28 -28.12 70.09 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.86 3.04 . . . . 0.0 115.907 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.05 80.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.775 1.63 . . . . 0.0 113.756 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -126.09 -172.31 2.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.514 1.526 . . . . 0.0 109.806 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 m -125.17 156.04 39.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.107 . . . . 0.0 110.527 -168.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -141.62 178.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 129.193 2.997 . . . . 0.0 106.604 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.87 149.17 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.0 p -69.29 170.23 10.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.177 -0.952 . . . . 0.0 108.636 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.25 -10.61 33.46 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.777 -1.202 . . . . 0.0 110.767 168.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -97.29 10.51 39.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.976 2.11 . . . . 0.0 111.74 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.8 mt 60.76 42.99 12.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.872 1.669 . . . . 0.0 113.573 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.74 141.56 51.28 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.92 141.15 57.73 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.892 -1.13 . . . . 0.0 110.89 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -142.36 151.36 41.82 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 125.643 1.577 . . . . 0.0 108.034 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 p -138.42 170.52 15.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.602 0.637 . . . . 0.0 110.358 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.65 48.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.284 0.634 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -31.89 66.33 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.28 -37.51 80.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.172 0.987 . . . . 0.0 109.956 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.0 mtt -74.7 5.22 5.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.429 2.292 . . . . 0.0 111.45 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -99.65 -7.95 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.017 1.327 . . . . 0.0 111.234 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.66 68.3 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.09 0.859 . . . . 0.0 112.729 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -153.13 168.07 27.17 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.994 2.118 . . . . 0.0 106.436 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.78 118.7 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.4 m -122.82 135.69 54.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.092 0.557 . . . . 0.0 109.503 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.69 139.64 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.0 131.01 73.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -120.19 97.35 5.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -83.56 119.02 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.75 145.5 53.27 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -62.25 -58.92 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.256 2.637 . . . . 0.0 113.639 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.7 m -158.12 143.95 17.08 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.62 -15.94 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.26 -14.93 62.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.03 1.332 . . . . 0.0 114.439 -172.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -65.37 -22.01 66.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.471 1.032 . . . . 0.0 113.741 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.19 -36.58 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.221 0.915 . . . . 0.0 111.39 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.64 -40.03 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.568 1.184 . . . . 0.0 108.633 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.9 m -61.04 -37.9 84.25 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.925 0.89 . . . . 0.0 111.994 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -61.61 -51.76 67.19 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.442 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -49.48 77.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.975 0.352 . . . . 0.0 110.773 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.41 -54.27 47.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.46 1.104 . . . . 0.0 109.75 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -70.63 -38.89 73.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.646 -0.659 . . . . 0.0 110.949 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -63.21 -43.62 97.62 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 120.894 -1.129 . . . . 0.0 110.944 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -66.72 -42.39 86.39 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.921 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -54.53 -38.05 66.1 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.973 1.26 . . . . 0.0 112.286 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.412 ' HA ' HG23 ' A' ' 102' ' ' VAL . 17.6 t30 -60.26 -51.36 69.88 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.077 0.853 . . . . 0.0 111.099 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.62 -34.09 69.54 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 118.989 -1.084 . . . . 0.0 111.709 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.24 -37.4 87.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 120.209 1.368 . . . . 0.0 109.922 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.42 92.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.839 0.455 . . . . 0.0 111.074 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.47 94.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.75 0.705 . . . . 0.0 111.368 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -65.36 -41.07 94.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.619 0.768 . . . . 0.0 110.103 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -45.7 86.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.18 0.992 . . . . 0.0 110.812 173.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -23.79 4.19 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.993 1.282 . . . . 0.0 113.773 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -147.97 66.14 1.1 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.166 1.386 . . . . 0.0 109.506 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.69 172.65 9.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -130.26 139.85 50.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.04 133.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -130.71 161.34 31.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.664 1.186 . . . . 0.0 109.645 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -128.27 143.43 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.91 135.93 57.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m -142.2 158.81 43.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.906 0.882 . . . . 0.0 111.675 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.76 40.06 0.92 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -126.15 163.84 22.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.259 1.423 . . . . 0.0 109.027 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.89 128.41 93.86 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -169.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.11 -33.78 94.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.742 1.628 . . . . 0.0 111.163 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -73.31 -27.09 61.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.223 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -48.64 63.8 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.834 1.197 . . . . 0.0 109.144 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -57.04 -42.41 80.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.307 0.243 . . . . 0.0 111.578 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.31 -42.26 96.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.662 0.665 . . . . 0.0 111.571 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -65.24 -42.31 93.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -59.69 -39.8 85.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.086 0.554 . . . . 0.0 111.22 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.3 m -60.76 -42.25 97.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.518 1.054 . . . . 0.0 110.505 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.29 -31.86 82.26 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.532 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.82 78.52 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.261 1.03 . . . . 0.0 111.368 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -106.6 -16.03 14.62 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.81 0.844 . . . . 0.0 112.277 -171.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.2 38.34 34.75 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.29 144.97 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.674 1.19 . . . . 0.0 108.207 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -143.83 -35.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.229 1.012 . . . . 0.0 112.405 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -87.13 -14.82 40.23 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.406 0.683 . . . . 0.0 112.313 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 68' ' ' ASN . 69.8 t -113.57 154.44 14.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.33 128.48 33.8 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -86.92 151.01 23.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.427 1.091 . . . . 0.0 109.251 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.1 mt -144.19 152.49 40.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.216 1.807 . . . . 0.0 106.507 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.1 m -121.03 125.97 48.69 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.172 -0.955 . . . . 0.0 109.45 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.59 3.94 48.02 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.031 1.332 . . . . 0.0 110.149 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -48.18 135.42 13.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.716 2.007 . . . . 0.0 111.573 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 63.44 -38.93 0.18 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.805 2.842 . . . . 0.0 114.392 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.36 -39.02 68.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.14 0.882 . . . . 0.0 111.56 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 53.93 9.7 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.712 2.805 . . . . 0.0 116.586 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.7 m -60.93 -43.76 98.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.364 1.893 . . . . 0.0 111.813 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.26 -44.28 68.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.068 0.849 . . . . 0.0 109.824 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -58.04 -47.07 91.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 123.96 0.79 . . . . 0.0 111.319 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.44 -37.58 87.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.505 0.722 . . . . 0.0 110.639 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -35.55 63.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.336 -0.852 . . . . 0.0 112.37 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.18 1.37 41.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.337 1.055 . . . . 0.0 112.168 -174.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.79 35.58 50.32 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.342 0.974 . . . . 0.0 113.003 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG23 ' HA2' ' A' ' 114' ' ' GLY . 21.1 m -131.38 21.38 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.658 1.183 . . . . 0.0 111.548 -169.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -107.89 110.66 22.48 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.5 110.99 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.13 -38.35 73.32 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 126.113 1.765 . . . . 0.0 111.083 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -91.29 4.57 52.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.893 0.877 . . . . 0.0 112.109 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -130.87 -21.81 2.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.361 1.064 . . . . 0.0 112.747 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 53.77 38.99 29.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.67 -168.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -131.4 152.62 50.48 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.075 1.35 . . . . 0.0 107.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.87 155.19 31.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 110.695 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.44 175.48 6.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.328 1.061 . . . . 0.0 111.679 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -113.57 85.31 2.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -141.48 164.57 29.86 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 110.519 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.14 152.43 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 121.636 -0.665 . . . . 0.0 109.424 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.5 159.63 41.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.572 1.149 . . . . 0.0 108.665 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.52 141.65 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -129.9 123.17 30.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.087 1.755 . . . . 0.0 106.854 -169.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.63 164.35 26.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.03 -20.89 26.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.445 1.098 . . . . 0.0 112.785 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -81.4 0.08 39.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.835 -1.166 . . . . 0.0 112.394 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.71 28.3 73.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.367 0.985 . . . . 0.0 111.701 -171.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.03 133.06 43.85 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -75.66 127.26 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.8 t -102.15 -30.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.477 1.511 . . . . 0.0 109.636 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -153.41 147.95 26.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.04 140.39 24.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.2 144.12 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.56 79.68 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.1 123.81 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -63.83 -14.59 54.33 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -122.77 116.42 23.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.06 65.78 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.19 10.81 2.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.959 1.304 . . . . 0.0 112.0 170.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -139.07 170.92 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.989 2.516 . . . . 0.0 107.319 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.92 154.36 79.2 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.145 -0.972 . . . . 0.0 111.085 -173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.47 149.81 37.06 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.915 3.077 . . . . 0.0 112.73 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -91.82 118.55 30.81 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -54.16 -25.4 22.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.046 1.338 . . . . 0.0 113.227 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.35 -37.42 83.26 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.765 0.712 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -60.92 -54.64 52.39 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.115 -172.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.11 -26.64 30.44 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.834 1.334 . . . . 0.0 111.433 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -44.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 120.191 1.36 . . . . 0.0 109.604 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.2 -38.29 90.54 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.27 0.941 . . . . 0.0 110.315 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.8 85.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.366 -0.209 . . . . 0.0 111.393 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.59 -51.38 51.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.447 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.46 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.39 -31.24 69.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.276 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.7 mt -88.8 -34.06 17.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.601 0.761 . . . . 0.0 111.924 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 82.1 t -63.4 -41.82 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.98 0.512 . . . . 0.0 111.063 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 19.0 pttp . . . . . 0 C--O 1.249 1.057 0 CA-C-N 118.292 0.496 . . . . 0.0 111.143 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.58 94.05 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.554 0.342 . . . . 0.0 111.752 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 40.4 51.57 2.85 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.769 2.028 . . . . 0.0 112.684 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.71 146.28 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 p -112.71 160.43 17.93 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.294 1.038 . . . . 0.0 109.74 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -111.83 45.0 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.495 1.118 . . . . 0.0 108.743 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt 42.66 61.71 1.98 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.647 1.979 . . . . 0.0 112.346 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 -26.12 0.11 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.568 1.08 . . . . 0.0 111.019 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.19 176.04 47.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.242 1.401 . . . . 0.0 109.872 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.31 158.62 47.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.158 2.572 . . . . 0.0 110.552 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.42 134.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -66.16 151.26 47.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.263 1.025 . . . . 0.0 111.163 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.03 141.46 49.24 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.144 2.178 . . . . 0.0 105.886 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.66 -70.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.65 0.659 . . . . 0.0 110.013 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.54 54.74 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.516 0.579 . . . . 0.0 112.405 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.11 166.75 22.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.734 0.778 . . . . 0.0 110.967 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -70.23 115.6 9.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 168.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.96 153.66 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -124.83 156.29 38.05 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.804 0.841 . . . . 0.0 109.796 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.29 140.1 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.414 0.686 . . . . 0.0 109.308 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.47 -20.05 48.89 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.431 1.491 . . . . 0.0 112.244 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.39 155.12 39.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.791 1.295 . . . . 0.0 110.038 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -72.9 132.91 44.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.06 160.51 29.71 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.274 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.29 -4.04 2.11 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.499 3.466 . . . . 0.0 117.85 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.91 55.38 9.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.755 1.265 . . . . 0.0 111.375 -174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -89.37 170.52 10.48 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.487 1.515 . . . . 0.0 110.859 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -131.02 151.51 51.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.659 1.184 . . . . 0.0 108.341 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.34 163.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 0.0 107.312 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -86.69 138.69 31.44 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -71.16 166.09 22.2 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.11 -13.88 62.37 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.529 -1.357 . . . . 0.0 110.904 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.46 0.94 40.0 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.909 1.683 . . . . 0.0 111.497 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt 69.1 37.23 2.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.687 1.595 . . . . 0.0 111.687 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.41 164.17 21.02 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.991 1.316 . . . . 0.0 107.897 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.86 141.19 37.89 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.013 -1.054 . . . . 0.0 109.493 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -138.02 143.96 40.82 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -146.44 172.03 14.15 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.25 0.62 . . . . 0.0 109.934 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.4 tp -44.21 -45.96 8.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 111.582 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.13 67.55 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.783 0.833 . . . . 0.0 112.465 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.45 -40.22 21.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.84 0.856 . . . . 0.0 110.795 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.04 -39.04 83.16 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.207 0.603 . . . . 0.0 110.011 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -65.17 -4.63 5.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -19.57 41.47 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 113.025 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.82 158.56 43.6 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.369 1.468 . . . . 0.0 107.074 173.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.9 t -60.88 119.76 5.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.0 m -127.64 128.76 46.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 109.98 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.3 mt -89.84 140.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.15 133.34 68.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -128.57 95.74 4.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.38 134.24 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.26 157.6 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 107.25 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.39 -54.15 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.721 1.614 . . . . 0.0 111.671 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 p -155.5 154.5 31.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.316 1.846 . . . . 0.0 107.187 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' CE3' ' A' ' 93' ' ' TRP . 9.3 tt -78.8 -14.73 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -169.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.52 -34.59 78.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.87 155.31 40.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.465 0.575 . . . . 0.0 111.201 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.13 -39.06 93.95 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.858 -0.526 . . . . 0.0 112.534 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 m -70.04 -40.54 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.174 0.987 . . . . 0.0 110.971 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.07 -43.88 97.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.589 0.755 . . . . 0.0 110.799 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -58.93 -56.16 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.512 1.525 . . . . 0.0 109.929 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.92 88.78 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.159 0.584 . . . . 0.0 111.156 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -56.05 -54.16 48.25 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.321 1.048 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -64.95 -40.91 95.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.193 0.452 . . . . 0.0 110.441 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.3 tpt85 -67.96 -43.08 79.87 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.104 -0.997 . . . . 0.0 111.26 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -70.74 -35.13 72.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.083 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.79 -41.44 74.11 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.263 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.417 ' HA ' HG23 ' A' ' 102' ' ' VAL . 22.3 t30 -61.81 -49.39 76.51 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.331 0.969 . . . . 0.0 111.31 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.91 -38.9 83.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -67.29 -38.25 84.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.99 86.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.425 0.69 . . . . 0.0 111.326 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.58 88.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 111.282 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.43 -41.09 93.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.267 0.627 . . . . 0.0 110.079 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.29 -43.01 92.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.015 0.526 . . . . 0.0 110.444 173.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 -69.5 2.54 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.133 1.825 . . . . 0.0 110.685 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -85.3 67.76 10.26 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.078 1.351 . . . . 0.0 110.142 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.22 162.53 6.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -123.14 141.21 52.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.62 138.53 42.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -131.41 154.46 48.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.819 0.848 . . . . 0.0 109.664 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 104' ' ' THR . 51.5 m -116.05 148.44 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.91 135.67 63.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.1 m -136.57 150.64 48.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.69 49.78 1.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -137.44 162.56 33.33 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.208 2.203 . . . . 0.0 107.537 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.12 138.12 92.13 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-O 119.013 -0.517 . . . . 0.0 111.226 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.67 -37.13 81.57 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.103 1.869 . . . . 0.0 111.654 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -69.35 -33.64 73.4 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.5 -50.81 49.42 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.069 0.849 . . . . 0.0 109.647 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -55.94 -49.12 74.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.147 0.579 . . . . 0.0 110.919 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.06 -45.11 93.73 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.436 0.695 . . . . 0.0 111.873 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 tpt85 -66.4 -36.99 84.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.49 0.586 . . . . 0.0 110.412 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.408 ' CE3' HD11 ' A' ' 55' ' ' ILE . 65.7 t90 -65.53 -41.61 92.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.036 0.534 . . . . 0.0 110.177 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 92.9 m -61.7 -41.67 97.9 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.999 -1.063 . . . . 0.0 110.633 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.03 -32.21 83.42 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.24 0.924 . . . . 0.0 112.378 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.63 95.06 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.437 1.118 . . . . 0.0 110.388 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.11 -20.87 29.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.746 0.818 . . . . 0.0 112.36 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.63 61.2 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.613 0.642 . . . . 0.0 111.724 -172.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mt -69.56 141.84 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.844 1.258 . . . . 0.0 108.095 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -147.97 -32.86 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -75.25 -16.37 60.46 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.728 0.694 . . . . 0.0 111.977 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 68' ' ' ASN . 96.4 t -111.58 150.08 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.39 148.01 49.23 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -105.2 151.73 23.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.3 mt -136.38 152.79 51.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.6 m -124.27 168.61 12.74 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.873 -0.517 . . . . 0.0 112.367 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -47.47 114.34 0.86 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 109.339 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -39.63 75.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.759 -175.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 157.18 -38.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.556 2.343 . . . . 0.0 105.652 -169.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.41 141.97 45.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.162 1.385 . . . . 0.0 107.353 170.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . 97.2 mmm -55.85 19.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 130.059 3.344 . . . . 0.0 115.698 177.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -52.63 -42.11 64.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.863 1.665 . . . . 0.0 112.404 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 111' ' ' MET . 40.6 p90 -56.03 -25.62 45.51 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.662 1.985 . . . . 0.0 114.344 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.6 -35.89 2.95 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 118.565 0.621 . . . . 0.0 111.675 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.32 -49.12 78.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.154 1.382 . . . . 0.0 109.97 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.96 -5.85 59.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.89 0.876 . . . . 0.0 112.415 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.2 10.76 14.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.911 1.284 . . . . 0.0 110.22 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.63 74.36 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.599 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.94 -5.2 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.007 1.404 . . . . 0.0 112.522 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -78.4 105.96 10.01 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.06 97.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -50.15 -41.56 49.25 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.87 1.668 . . . . 0.0 111.998 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.38 -10.18 59.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.863 0.865 . . . . 0.0 113.118 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.63 -20.78 5.4 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.555 1.142 . . . . 0.0 112.074 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 54.42 36.91 26.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.148 1.379 . . . . 0.0 109.944 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.5 mt -117.04 160.01 21.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.466 1.106 . . . . 0.0 108.351 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.45 137.26 32.48 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.76 163.63 25.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.749 0.819 . . . . 0.0 111.216 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.18 110.91 22.61 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 169.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.2 m -166.42 173.05 10.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.437 1.495 . . . . 0.0 108.144 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.12 152.17 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.257 -0.902 . . . . 0.0 110.691 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -136.45 161.31 36.2 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.126 1.37 . . . . 0.0 108.003 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 139.49 46.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.06 116.66 24.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.49 1.516 . . . . 0.0 107.72 -169.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.49 160.32 19.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.868 1.267 . . . . 0.0 108.83 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -64.25 -8.5 12.88 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.86 5.03 53.07 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.652 -1.28 . . . . 0.0 111.827 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.65 26.97 68.23 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.362 0.982 . . . . 0.0 112.086 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -91.67 139.42 30.7 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 108.46 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.37 -22.94 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.544 0.611 . . . . 0.0 110.615 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -153.92 143.71 21.81 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.82 145.02 31.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.59 142.81 29.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -132.53 106.04 7.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.503 1.921 . . . . 0.0 106.178 -170.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.52 131.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -68.59 0.53 4.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 113.058 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -139.16 110.12 6.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.781 2.032 . . . . 0.0 106.042 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.28 -28.55 68.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.146 0.43 . . . . 0.0 111.471 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.0 p -70.43 -9.94 57.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.265 1.826 . . . . 0.0 113.197 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.15 167.65 12.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.82 1.648 . . . . 0.0 108.905 -169.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -128.52 153.21 79.33 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.252 0.933 . . . . 0.0 109.715 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.07 152.07 45.31 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.844 1.696 . . . . 0.0 108.242 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -69.65 119.35 13.75 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -50.61 -27.36 6.71 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.143 1.777 . . . . 0.0 113.331 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -61.14 -34.44 75.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.753 -0.592 . . . . 0.0 111.447 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -66.28 -49.92 51.88 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 117.944 -1.026 . . . . 0.0 112.542 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.05 -27.77 49.71 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 121.403 1.537 . . . . 0.0 111.896 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -44.13 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.93 1.241 . . . . 0.0 109.545 171.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.12 -31.79 73.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.13 0.877 . . . . 0.0 111.179 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.76 -49.6 61.65 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.972 0.351 . . . . 0.0 111.014 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.49 75.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.8 0.44 . . . . 0.0 111.673 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -28.59 68.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.673 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.84 80.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.583 0.629 . . . . 0.0 111.416 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.0 mt -76.69 -43.21 38.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.411 0.551 . . . . 0.0 111.672 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.81 -4.49 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.07 0.85 . . . . 0.0 110.011 174.686 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttm . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.91 146.55 5.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.86 1.264 . . . . 0.0 112.148 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.81 -29.38 0.51 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.344 1.458 . . . . 0.0 110.824 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 5' ' ' THR 0.273 18.1 mt 69.29 171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 126.665 1.986 . . . . 0.0 111.886 169.12 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -141.4 156.89 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.428 2.691 . . . . 0.0 105.903 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -135.93 119.54 17.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HE2' HG21 ' A' ' 150' ' ' THR . 13.1 tppt? 42.14 43.45 2.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.213 1.805 . . . . 0.0 111.591 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.31 85.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.539 -1.145 . . . . 0.0 114.165 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.6 139.54 15.73 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.21 155.37 69.63 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.193 1.929 . . . . 0.0 111.381 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.07 -167.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.473 1.509 . . . . 0.0 108.082 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.3 m -138.68 160.01 40.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 4' ' ' ILE . 1.2 tp -126.77 128.26 46.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.93 1.292 . . . . 0.0 109.686 -170.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.4 157.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.43 -154.5 40.47 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 123.617 0.627 . . . . 0.0 112.168 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.95 155.59 47.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.65 1.18 . . . . 0.0 109.064 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.29 152.25 45.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.72 154.38 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.751 1.62 . . . . 0.0 106.96 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.57 157.86 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.006 0.922 . . . . 0.0 111.764 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.26 144.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.899 1.28 . . . . 0.0 109.332 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 -23.61 18.66 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.685 1.136 . . . . 0.0 111.952 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.49 153.63 40.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.421 1.11 . . . . 0.0 109.519 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -70.28 128.23 35.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.93 153.99 78.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.466 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.68 -31.14 59.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.263 2.642 . . . . 0.0 115.315 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 47.76 84.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.343 1.857 . . . . 0.0 113.357 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.6 177.88 6.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.596 1.158 . . . . 0.0 109.228 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.7 m -109.59 151.05 27.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.651 1.181 . . . . 0.0 109.542 -169.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.21 173.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 128.208 2.603 . . . . 0.0 106.098 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.99 156.85 16.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.2 p -71.82 174.03 7.45 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.088 -1.008 . . . . 0.0 108.847 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -67.2 -11.14 56.58 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.26 -0.9 . . . . 0.0 110.842 168.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m -73.22 -65.82 0.76 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 pp 154.49 12.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 130.581 3.552 . . . . 0.0 112.168 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.82 144.53 30.37 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.732 -1.23 . . . . 0.0 109.181 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.51 133.19 55.86 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.657 -0.652 . . . . 0.0 111.227 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -140.48 147.1 39.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.209 1.804 . . . . 0.0 107.503 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -131.63 159.1 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.03 -31.17 68.59 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.08 66.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.788 0.835 . . . . 0.0 113.191 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.25 -35.66 68.86 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.8 mtt -75.78 -35.85 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.201 1.0 . . . . 0.0 111.177 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -63.97 -3.82 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.05 13.6 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 119.485 1.038 . . . . 0.0 113.009 169.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.49 157.23 45.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.864 1.666 . . . . 0.0 107.113 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.3 t -54.85 124.97 8.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.2 m -120.46 149.31 42.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.463 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.2 mt -116.18 141.42 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.5 mm -123.24 140.15 47.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 84.17 2.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 m -71.93 135.66 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.78 157.05 58.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.709 1.604 . . . . 0.0 108.955 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.56 -61.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.305 2.003 . . . . 0.0 110.641 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -144.25 147.77 34.01 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.39 1.476 . . . . 0.0 107.172 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.8 tt -98.82 -31.38 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.815 0.446 . . . . 0.0 111.438 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.5 -24.91 67.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 t -64.43 -21.25 66.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.218 1.007 . . . . 0.0 112.01 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.54 -11.95 64.56 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.029 -1.044 . . . . 0.0 114.094 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.37 -30.29 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.198 1.499 . . . . 0.0 110.542 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.14 -6.12 1.85 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.337 1.455 . . . . 0.0 113.365 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.38 -43.63 64.84 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.481 1.491 . . . . 0.0 110.15 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.17 4.42 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.153 0.981 . . . . 0.0 112.92 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -129.57 -83.36 0.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -55.59 -51.68 66.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.025 1.33 . . . . 0.0 111.814 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -70.72 -46.31 63.31 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.518 -0.739 . . . . 0.0 110.014 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -41.21 93.95 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.259 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -59.98 -31.19 69.67 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 120.455 1.48 . . . . 0.0 112.354 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.98 -43.66 98.51 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.252 0.933 . . . . 0.0 110.678 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 73' ' ' LYS . 28.3 mt-10 -65.6 -51.4 59.94 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -63.1 -35.17 79.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.768 . . . . 0.0 111.303 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.87 95.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.529 0.604 . . . . 0.0 110.783 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.3 81.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.644 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 69' ' ' GLU . 56.0 mttt -66.02 -41.53 90.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 110.702 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.04 -46.62 86.69 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.964 0.906 . . . . 0.0 109.808 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.53 -33.93 5.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.296 1.426 . . . . 0.0 111.071 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.95 120.9 4.28 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.98 1.312 . . . . 0.0 108.827 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -159.59 171.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.837 2.055 . . . . 0.0 105.715 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -119.04 138.72 52.66 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.4 p -154.3 146.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 120.809 -1.182 . . . . 0.0 110.305 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.55 170.2 16.17 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.781 1.232 . . . . 0.0 110.199 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.4 m -126.51 146.7 50.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.34 131.1 70.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -131.37 144.27 51.1 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.942 0.497 . . . . 0.0 110.978 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.72 48.87 1.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.82 161.67 35.97 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.14 1.776 . . . . 0.0 106.864 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.48 140.46 84.65 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.84 -47.59 20.73 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.045 2.497 . . . . 0.0 112.365 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -72.95 -30.11 63.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.76 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.85 85.66 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.855 0.752 . . . . 0.0 110.166 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.56 -48.87 63.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.975 0.91 . . . . 0.0 110.161 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.66 77.89 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 117.943 0.338 . . . . 0.0 110.508 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -45.06 93.5 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.345 1.058 . . . . 0.0 109.769 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -63.33 -43.46 97.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.94 -44.02 81.69 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.804 -0.56 . . . . 0.0 111.23 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -38.97 96.3 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.628 0.632 . . . . 0.0 111.987 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.62 98.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.788 0.835 . . . . 0.0 110.314 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -78.85 -17.77 55.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.69 0.796 . . . . 0.0 112.429 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.63 62.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.095 0.855 . . . . 0.0 111.733 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.84 141.94 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.789 1.236 . . . . 0.0 108.244 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.73 -28.72 0.43 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.574 1.15 . . . . 0.0 112.542 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -76.82 -24.4 52.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.015 0.825 . . . . 0.0 111.264 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 t -105.63 154.8 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.79 127.56 38.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.44 153.54 31.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.384 0.611 . . . . 0.0 109.797 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.7 mt -142.62 159.92 41.31 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.609 1.964 . . . . 0.0 107.546 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -124.0 130.2 52.18 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.844 1.258 . . . . 0.0 109.485 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.73 26.18 4.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.653 1.181 . . . . 0.0 109.449 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -68.11 -20.54 64.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.805 1.642 . . . . 0.0 113.23 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -146.29 153.28 40.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 46.32 56.07 6.69 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -168.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp -64.63 28.23 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.974 2.909 . . . . 0.0 114.071 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -55.21 -36.25 65.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.935 1.694 . . . . 0.0 112.737 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -70.6 -52.31 22.35 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.876 0.762 . . . . 0.0 110.081 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.12 85.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.17 -56.79 17.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.43 1.092 . . . . 0.0 109.38 170.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.29 73.9 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -2.49 37.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.246 0.618 . . . . 0.0 111.954 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.47 47.99 53.87 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.008 1.289 . . . . 0.0 113.034 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.84 -10.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 117.956 0.878 . . . . 0.0 112.272 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 107.67 0.96 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.1 mt -74.8 110.39 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -52.26 -44.21 64.78 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 110.896 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -3.15 47.33 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.393 0.677 . . . . 0.0 112.457 -171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.76 -25.58 4.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.011 0.924 . . . . 0.0 112.381 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 58.37 35.19 24.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.79 0.836 . . . . 0.0 109.845 -168.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.17 157.5 40.65 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.18 146.09 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.06 30.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.533 0.733 . . . . 0.0 111.361 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -81.2 103.29 10.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -149.45 168.88 22.23 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.221 1.409 . . . . 0.0 107.669 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.94 151.75 20.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 121.564 -0.71 . . . . 0.0 110.059 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -135.96 157.16 47.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.607 1.163 . . . . 0.0 108.722 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.98 139.29 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -125.5 132.69 52.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 108.058 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.31 165.93 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 169.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.69 -20.27 47.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.4 -2.56 57.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.601 -1.312 . . . . 0.0 112.271 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.19 23.24 77.95 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 121.078 -1.014 . . . . 0.0 112.42 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.22 145.36 25.45 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.799 1.3 . . . . 0.0 107.556 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.99 134.21 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.6 t -110.42 -30.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.777 1.631 . . . . 0.0 109.405 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -152.14 145.52 24.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.01 141.31 25.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.44 145.34 27.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -132.08 96.9 4.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.818 2.047 . . . . 0.0 106.109 -169.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.59 140.52 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 p -68.0 -12.78 61.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.778 1.231 . . . . 0.0 113.274 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.97 126.06 15.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.88 -21.06 34.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 7' ' ' LYS . 78.8 p -75.04 -25.54 58.78 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 171.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -80.03 172.6 13.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.462 1.505 . . . . 0.0 107.683 169.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -140.74 157.37 67.89 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 120.702 -1.249 . . . . 0.0 110.109 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 165.8 30.89 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.841 2.361 . . . . 0.0 110.083 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -90.82 118.27 30.1 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -49.72 -28.75 6.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.983 1.713 . . . . 0.0 113.169 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -59.9 -36.09 76.24 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.516 0.598 . . . . 0.0 110.801 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -65.03 -52.94 45.4 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.274 -0.869 . . . . 0.0 112.261 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 -24.97 41.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 121.083 1.423 . . . . 0.0 111.795 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.71 -45.89 97.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 109.869 170.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.94 -32.8 72.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.213 0.915 . . . . 0.0 110.345 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.63 -55.27 12.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.922 0.489 . . . . 0.0 111.614 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.63 83.2 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.161 0.584 . . . . 0.0 112.027 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.81 65.55 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.612 0.765 . . . . 0.0 111.826 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.95 -30.74 70.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.063 0.545 . . . . 0.0 111.914 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.3 mt -98.35 -29.19 13.3 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.23 -8.91 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 123.915 0.886 . . . . 0.0 110.024 176.686 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.22 76.29 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.949 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 42.59 53.55 4.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.21 1.804 . . . . 0.0 111.812 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.91 144.9 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -111.5 161.11 16.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 109.753 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -128.06 54.36 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.704 1.202 . . . . 0.0 108.437 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 41.11 62.33 1.49 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.941 2.096 . . . . 0.0 113.115 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.74 0.18 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.591 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.95 46.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.271 0.939 . . . . 0.0 110.767 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.3 164.36 6.97 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.97 3.113 . . . . 0.0 113.188 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.91 139.78 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.916 1.286 . . . . 0.0 108.632 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 m -65.48 149.95 49.17 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.466 0.651 . . . . 0.0 109.347 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -129.41 134.66 47.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.65 1.98 . . . . 0.0 107.941 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.66 140.65 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 -166.68 42.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.75 48.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.155 1.382 . . . . 0.0 109.224 -176.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.16 112.34 2.61 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 m -73.17 169.0 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.49 158.27 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.636 -0.665 . . . . 0.0 109.506 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 133.52 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.98 -18.88 56.48 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.933 1.254 . . . . 0.0 112.257 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -70.96 153.38 42.71 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.065 1.432 . . . . 0.0 109.843 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -80.42 130.0 34.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.59 157.38 27.22 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.169 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.54 -7.0 4.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.458 3.438 . . . . 0.0 118.44 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t0 53.5 56.17 7.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.939 1.352 . . . . 0.0 110.894 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -86.01 169.78 12.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.667 1.987 . . . . 0.0 110.192 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -130.78 147.81 52.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.442 1.097 . . . . 0.0 108.189 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.37 162.38 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.297 1.839 . . . . 0.0 107.034 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.03 141.65 29.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -69.66 162.78 26.99 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -64.57 -17.5 64.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.051 -1.656 . . . . 0.0 111.399 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -85.1 3.18 40.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.539 1.936 . . . . 0.0 112.129 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt 73.62 33.47 1.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.398 1.879 . . . . 0.0 113.032 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -115.45 164.54 14.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.085 1.354 . . . . 0.0 108.021 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.22 143.42 35.36 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 120.445 -1.409 . . . . 0.0 109.12 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -141.14 146.08 36.56 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 p -147.66 169.68 19.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -47.69 -41.88 23.63 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.38 0.672 . . . . 0.0 111.651 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.44 64.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 112.751 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -77.96 -40.45 39.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.827 0.851 . . . . 0.0 110.607 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -66.8 -24.59 66.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.179 0.991 . . . . 0.0 111.583 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -55.95 -14.02 2.24 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.541 1.137 . . . . 0.0 113.631 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -27.42 50.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.312 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -155.01 169.47 24.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.959 1.379 . . . . 0.0 109.516 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.21 125.25 17.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 168.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.3 m -129.69 131.93 46.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.887 0.475 . . . . 0.0 111.038 -168.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.4 mt -89.68 141.96 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -118.83 136.33 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 172.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -128.11 90.33 3.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 108.037 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.79 139.05 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.63 144.69 45.79 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.97 -45.03 34.88 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.292 2.661 . . . . 0.0 112.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -160.04 168.15 26.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 106.542 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 tt -107.61 172.48 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.375 0.67 . . . . 0.0 110.14 -170.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.3 25.52 11.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.499 1.52 . . . . 0.0 113.396 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -75.23 -15.36 60.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.079 . . . . 0.0 112.253 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.79 0.1 86.13 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.226 0.917 . . . . 0.0 112.406 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.16 -46.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.748 1.274 . . . . 0.0 109.076 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.07 -28.57 69.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.281 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.96 -32.71 54.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.423 1.489 . . . . 0.0 111.982 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.55 60.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.601 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -55.69 -59.08 5.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.803 0.841 . . . . 0.0 110.424 -169.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -64.38 -40.78 96.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.021 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -74.71 -30.84 61.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.432 1.469 . . . . 0.0 111.45 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -63.52 -42.44 98.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.191 170.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.83 -37.63 79.76 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 120.069 1.304 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -60.41 -48.65 80.84 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.776 0.716 . . . . 0.0 111.036 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.57 -53.48 54.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.02 0.928 . . . . 0.0 109.51 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.7 -39.11 83.48 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.553 0.741 . . . . 0.0 111.363 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.05 87.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.265 0.484 . . . . 0.0 111.104 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.26 -33.82 73.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -69.73 -41.34 75.41 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.007 0.821 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -43.54 98.55 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.496 0.589 . . . . 0.0 110.268 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.44 -21.23 39.31 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.676 1.132 . . . . 0.0 112.686 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -153.04 100.74 2.51 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.735 1.214 . . . . 0.0 109.111 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.9 174.35 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 126.913 2.085 . . . . 0.0 105.433 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -129.65 142.73 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.6 p -151.98 144.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.85 166.17 23.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 0.0 108.974 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -126.3 142.01 51.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mt -128.59 137.92 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -147.36 165.41 30.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 111.76 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.09 -6.93 59.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.67 164.02 25.88 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.523 1.129 . . . . 0.0 110.462 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.5 135.04 96.08 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.25 -34.03 88.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.893 1.728 . . . . 0.0 111.522 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -70.08 -31.12 68.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.505 0.593 . . . . 0.0 111.697 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.82 75.23 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.069 0.85 . . . . 0.0 109.273 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.66 -43.37 93.98 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.582 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.86 -41.94 88.21 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.704 0.684 . . . . 0.0 111.153 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -69.37 -39.18 78.2 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 121.828 -0.545 . . . . 0.0 110.235 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -64.32 -40.25 95.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.795 0.438 . . . . 0.0 110.298 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.16 -38.47 83.25 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.122 -0.986 . . . . 0.0 110.828 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.98 -29.09 74.46 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.764 175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.8 71.6 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.712 1.256 . . . . 0.0 110.21 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -89.06 -17.88 28.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.05 39.27 24.19 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.74 143.99 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.362 1.065 . . . . 0.0 108.152 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -144.12 -38.07 0.31 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.577 1.151 . . . . 0.0 112.405 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -83.9 -18.72 36.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.428 0.691 . . . . 0.0 112.179 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.55 161.72 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -136.01 128.0 29.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p -80.85 149.11 29.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.609 0.764 . . . . 0.0 109.278 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.0 mt -142.67 148.73 37.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.137 1.775 . . . . 0.0 106.239 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.2 m -119.04 126.47 51.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.541 1.064 . . . . 0.0 110.182 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -82.99 -21.23 34.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.764 1.626 . . . . 0.0 109.779 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.7 t60 31.68 -73.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 1 C-N-CA 132.221 4.208 . . . . 0.0 117.413 173.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -139.99 -0.44 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.169 1.387 . . . . 0.0 111.65 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.31 -38.72 63.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.281 0.946 . . . . 0.0 109.882 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 34.0 mmm 53.29 8.73 0.12 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.904 2.882 . . . . 0.0 116.595 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 p -59.79 -41.33 90.92 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 122.407 2.367 . . . . 0.0 111.693 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -60.57 -59.71 4.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.45 -41.59 99.58 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-O 119.994 -0.337 . . . . 0.0 112.61 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.36 -41.96 85.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.439 1.496 . . . . 0.0 110.521 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.24 -23.22 15.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -169.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.33 1.41 45.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.818 1.19 . . . . 0.0 112.749 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.18 28.03 62.93 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.106 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.4 -8.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 119.629 1.715 . . . . 0.0 113.493 -171.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.67 102.69 6.28 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.19 104.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.0 -38.35 67.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.45 1.1 . . . . 0.0 110.796 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -65.63 -16.08 63.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.135 0.974 . . . . 0.0 112.869 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.2 mt -127.3 -18.76 4.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.691 1.196 . . . . 0.0 112.502 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.51 40.08 30.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.523 1.129 . . . . 0.0 109.23 -168.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -136.44 153.71 50.99 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.623 1.169 . . . . 0.0 107.953 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.63 156.43 34.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.592 0.633 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.73 -172.39 1.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.435 1.494 . . . . 0.0 110.513 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -117.95 17.63 14.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.903 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -64.71 170.24 4.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.733 2.013 . . . . 0.0 113.417 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.08 151.66 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.332 1.053 . . . . 0.0 109.816 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -141.72 162.28 35.88 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.26 145.6 31.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 171.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.72 128.11 43.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.982 1.713 . . . . 0.0 107.191 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.42 167.12 15.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.842 0.857 . . . . 0.0 109.815 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.18 -24.15 52.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.128 0.971 . . . . 0.0 112.609 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.41 -4.13 46.77 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.796 -1.19 . . . . 0.0 112.189 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.52 24.5 76.77 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.184 -0.948 . . . . 0.0 112.246 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -91.78 142.69 27.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.17 129.71 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.26 -15.71 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.685 0.794 . . . . 0.0 111.636 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -153.05 144.36 23.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.46 137.51 28.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.77 130.07 13.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -106.8 144.38 33.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.32 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 61.72 -15.27 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.299 2.24 . . . . 0.0 115.204 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -149.4 113.96 5.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.06 -31.53 67.16 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.145 0.578 . . . . 0.0 111.872 -174.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 p -73.46 7.23 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.744 1.218 . . . . 0.0 113.718 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.83 176.64 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.786 1.176 . . . . 0.0 110.516 172.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.77 150.6 70.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.494 1.118 . . . . 0.0 110.282 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.09 154.51 42.13 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.472 2.781 . . . . 0.0 110.388 -169.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -79.2 115.25 18.74 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -52.78 -26.44 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.852 1.661 . . . . 0.0 113.198 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -61.57 -36.08 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.049 0.84 . . . . 0.0 111.404 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -58.49 -57.84 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.596 0.634 . . . . 0.0 112.033 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.24 -24.34 32.17 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.118 1.212 . . . . 0.0 111.684 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 120.139 1.336 . . . . 0.0 109.605 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.27 -33.36 75.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.084 0.856 . . . . 0.0 110.494 -177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.63 -56.9 10.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.373 0.269 . . . . 0.0 111.361 172.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.37 88.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.422 0.689 . . . . 0.0 112.307 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -26.43 67.67 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.53 0.605 . . . . 0.0 111.986 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.63 65.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.089 0.556 . . . . 0.0 112.228 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.5 mt -102.46 -28.2 12.34 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.67 -18.47 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.386 1.075 . . . . 0.0 109.938 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.66 173.26 7.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.066 0.936 . . . . 0.0 110.78 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.39 157.62 43.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.323 3.449 . . . . 0.0 104.451 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 13' ' ' LEU . 51.5 mt -140.98 143.8 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -169.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p -82.49 158.81 23.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.839 1.2 . . . . 0.0 110.621 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -132.12 85.85 2.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt 43.03 37.59 1.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.297 2.239 . . . . 0.0 115.441 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.96 -26.61 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.665 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.09 171.03 44.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.773 1.287 . . . . 0.0 112.054 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.83 151.82 51.71 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.842 3.028 . . . . 0.0 111.696 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.37 145.75 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.852 1.661 . . . . 0.0 108.519 171.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -76.45 141.67 41.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.928 1.691 . . . . 0.0 111.103 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 4' ' ' ILE . 12.2 mt -85.94 137.82 32.46 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 169.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -75.67 -21.0 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.54 -177.38 19.34 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.418 0.532 . . . . 0.0 112.243 -169.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -64.23 138.22 58.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.804 1.242 . . . . 0.0 111.142 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -78.82 143.07 36.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.3 153.94 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.94 157.12 43.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.358 1.063 . . . . 0.0 110.731 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.3 t -58.75 143.0 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.001 0.92 . . . . 0.0 109.034 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.57 -24.0 13.94 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.872 1.225 . . . . 0.0 112.42 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -73.79 155.21 39.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.718 1.259 . . . . 0.0 109.848 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -70.77 128.86 37.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.85 153.74 78.56 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.247 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.23 -32.03 69.07 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.65 2.9 . . . . 0.0 114.655 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.16 81.4 0.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.486 1.915 . . . . 0.0 113.138 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -127.59 -174.77 3.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.738 1.615 . . . . 0.0 109.564 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -115.64 155.91 26.82 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.856 1.262 . . . . 0.0 110.251 -168.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.12 159.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.836 2.454 . . . . 0.0 106.555 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.18 140.65 29.26 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.958 -1.089 . . . . 0.0 109.323 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.5 p -73.33 170.0 15.94 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -68.08 -13.95 62.6 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.516 -1.365 . . . . 0.0 111.45 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.05 0.4 40.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.254 1.421 . . . . 0.0 111.622 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp 58.03 47.1 15.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.039 1.336 . . . . 0.0 111.346 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.22 166.56 16.86 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.192 1.397 . . . . 0.0 107.528 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.02 141.98 29.91 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -138.93 150.88 46.42 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 126.257 1.823 . . . . 0.0 106.155 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 p -146.07 168.52 20.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.297 -0.877 . . . . 0.0 109.304 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.64 -31.53 68.22 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.864 -0.522 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . . . -50.4 -28.62 8.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 113.828 170.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.73 -38.7 13.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.91 1.284 . . . . 0.0 110.804 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.0 mtt -68.66 -36.77 79.0 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.652 0.781 . . . . 0.0 110.614 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 40' ' ' ALA . 15.6 ptpt -62.8 -3.57 1.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.77 30.46 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.659 1.118 . . . . 0.0 113.107 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -148.2 166.01 29.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.49 1.645 . . . . 0.0 109.118 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.49 117.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.0 m -127.41 129.63 47.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.314 0.384 . . . . 0.0 111.37 -168.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.8 mt -89.18 137.91 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.02 100.5 9.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.94 140.9 45.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 t -126.42 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 118.493 0.588 . . . . 0.0 109.493 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 159.64 67.45 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.495 1.518 . . . . 0.0 108.263 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.72 -53.67 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.618 1.545 . . . . 0.0 111.373 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -147.29 154.14 40.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.752 2.021 . . . . 0.0 106.566 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.0 tt -98.7 -6.5 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -168.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.1 -28.06 68.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.529 -0.732 . . . . 0.0 112.425 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -73.28 142.08 47.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.394 0.678 . . . . 0.0 110.581 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.6 -16.25 65.23 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.137 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.88 -29.28 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.996 1.398 . . . . 0.0 111.125 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.8 m -63.76 -12.82 38.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.537 0.735 . . . . 0.0 112.843 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.72 -45.3 77.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.668 1.122 . . . . 0.0 110.828 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.43 7.24 2.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.315 1.046 . . . . 0.0 112.612 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -129.06 -87.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -53.08 -54.18 39.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.808 1.643 . . . . 0.0 112.967 -169.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.69 -42.21 67.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.978 -1.077 . . . . 0.0 110.569 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpp85 -60.23 -38.19 82.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.648 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -64.99 -32.41 74.13 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.209 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.43 -48.19 81.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.674 1.579 . . . . 0.0 110.216 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.27 -57.14 9.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.325 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -61.58 -40.53 95.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.434 0.561 . . . . 0.0 111.028 -172.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.17 78.26 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.848 0.749 . . . . 0.0 111.482 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.07 79.4 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.112 0.869 . . . . 0.0 110.803 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -70.18 -39.88 74.98 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.505 0.593 . . . . 0.0 109.552 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.4 -47.24 82.81 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.195 0.598 . . . . 0.0 110.141 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.51 9.08 84.59 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.864 1.221 . . . . 0.0 113.949 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -151.99 35.61 0.54 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.391 1.595 . . . . 0.0 112.322 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.88 173.48 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -123.62 151.0 43.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.476 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -149.8 149.71 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.691 -1.256 . . . . 0.0 110.171 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -135.23 172.52 12.9 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.746 1.619 . . . . 0.0 108.982 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.412 ' HB ' HG22 ' A' ' 104' ' ' THR . 23.6 m -132.5 144.04 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.64 137.71 56.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.59 147.87 36.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.14 0.976 . . . . 0.0 109.826 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.26 56.03 2.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -144.9 170.06 16.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.606 1.562 . . . . 0.0 107.143 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.04 142.11 63.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.132 -0.98 . . . . 0.0 112.468 -168.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -47.64 -41.03 30.9 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.34 3.36 . . . . 0.0 115.028 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -73.43 -29.4 62.54 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.95 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.39 82.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.525 1.057 . . . . 0.0 109.334 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -47.8 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.125 172.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.37 80.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.417 0.553 . . . . 0.0 111.09 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -59.75 -43.83 94.11 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.59 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -58.95 -52.05 67.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.533 0.606 . . . . 0.0 110.171 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.6 m -65.13 -44.96 86.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.95 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.59 -41.66 83.38 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.342 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.13 -39.78 82.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.12 0.96 . . . . 0.0 110.538 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -79.69 -19.17 49.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.957 0.503 . . . . 0.0 112.274 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.74 64.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 118.831 0.741 . . . . 0.0 111.425 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.03 146.78 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.587 1.155 . . . . 0.0 108.179 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -139.02 -35.8 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 112.172 -173.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -81.43 -18.74 44.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.025 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.21 158.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -139.76 130.1 25.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 168.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 81' ' ' THR . 3.2 p -84.26 155.94 22.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 mt -143.44 162.98 34.37 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.893 1.277 . . . . 0.0 108.406 -170.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.3 m -129.82 107.67 9.57 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.503 0.721 . . . . 0.0 109.586 -169.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -95.28 56.19 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -136.62 33.44 2.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.324 1.05 . . . . 0.0 112.693 -168.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -122.86 -48.33 2.02 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -144.65 121.12 11.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 101.871 -3.381 . . . . 0.0 101.871 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.1 mtp -73.69 36.87 0.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.734 1.613 . . . . 0.0 112.801 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -57.87 -41.71 83.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.859 1.264 . . . . 0.0 111.782 -169.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.13 -46.22 62.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.767 0.712 . . . . 0.0 109.581 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.82 -33.58 62.97 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.534 0.588 . . . . 0.0 111.868 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.96 -48.85 72.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.806 0.803 . . . . 0.0 109.367 171.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.55 72.69 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.3 3.52 53.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.597 1.159 . . . . 0.0 111.527 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.86 -13.8 8.27 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.081 1.801 . . . . 0.0 115.351 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.68 -23.39 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.559 1.544 . . . . 0.0 112.741 -173.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 110.57 1.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.28 113.43 17.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -53.29 -45.21 68.85 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.585 1.554 . . . . 0.0 111.331 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.72 0.14 51.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.361 0.665 . . . . 0.0 112.567 -169.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.24 -22.64 3.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.871 0.759 . . . . 0.0 112.976 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.36 37.15 28.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.195 0.998 . . . . 0.0 111.943 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.68 162.83 24.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.173 -0.954 . . . . 0.0 108.814 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -88.47 134.18 33.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.63 141.32 32.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.74 1.216 . . . . 0.0 110.471 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -73.32 112.63 9.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 168.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -154.65 170.06 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.447 1.499 . . . . 0.0 107.098 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG21 ' HG3' ' A' ' 158' ' ' PRO . 14.8 p -153.99 146.83 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -134.71 162.72 31.53 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 124.022 0.826 . . . . 0.0 110.139 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.5 t -134.8 145.81 31.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.16 130.55 41.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.452 1.501 . . . . 0.0 107.477 -169.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.67 165.09 25.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.007 1.323 . . . . 0.0 109.54 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.65 -6.49 3.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.09 12.31 23.57 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.952 -1.092 . . . . 0.0 112.448 169.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.68 78.75 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.029 0.823 . . . . 0.0 112.849 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -88.99 145.82 25.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.34 139.75 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.45 -26.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.564 1.546 . . . . 0.0 109.397 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -147.77 147.07 29.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -150.96 133.87 15.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 169.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.78 147.37 29.79 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -127.66 102.4 6.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.81 136.21 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -66.3 -13.52 60.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -134.93 125.58 26.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.991 1.716 . . . . 0.0 106.833 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.87 66.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.141 0.577 . . . . 0.0 111.827 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -79.5 12.96 2.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.146 1.378 . . . . 0.0 111.366 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -134.69 167.02 21.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.952 2.101 . . . . 0.0 107.857 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -128.31 154.73 79.06 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 110.923 -170.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.17 160.61 48.53 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.622 2.215 . . . . 0.0 109.65 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -87.06 117.44 25.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -51.51 -28.32 13.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.128 1.771 . . . . 0.0 112.857 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -60.14 -32.11 70.71 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.567 0.621 . . . . 0.0 111.695 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.73 -51.85 11.24 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.443 -171.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.416 ' HG3' HG21 ' A' ' 131' ' ' VAL . 55.9 Cg_endo -67.68 -30.56 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.452 1.434 . . . . 0.0 111.729 174.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.44 -49.01 79.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 119.838 1.199 . . . . 0.0 109.904 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.75 -32.17 73.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.514 0.597 . . . . 0.0 110.771 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.66 71.51 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.209 0.459 . . . . 0.0 111.437 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.92 64.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.857 0.463 . . . . 0.0 110.01 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -26.76 68.88 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.442 -0.786 . . . . 0.0 111.797 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.64 71.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.988 0.813 . . . . 0.0 111.626 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.59 -29.13 28.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.15 0.58 . . . . 0.0 111.512 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.04 -51.97 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.368 0.531 . . . . 0.0 110.371 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.1 pttp . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.052 -175.692 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptt? . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 111.11 0.041 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.3 169.42 12.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.97 135.73 36.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 mt -146.13 155.37 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -169.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -117.51 168.51 10.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.852 1.261 . . . . 0.0 110.753 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -141.05 56.95 1.55 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.93 1.292 . . . . 0.0 108.619 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 37.74 71.21 0.16 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.082 2.153 . . . . 0.0 113.782 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -16.98 0.59 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.098 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.93 174.76 41.06 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.01 162.91 41.08 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.391 2.728 . . . . 0.0 111.151 178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.96 135.16 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.283 1.433 . . . . 0.0 107.395 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.2 m -67.12 152.0 46.57 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 110.385 -176.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.59 135.3 50.1 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.641 1.576 . . . . 0.0 108.661 -175.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.44 136.71 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 -163.68 13.51 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.424 0.556 . . . . 0.0 113.33 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -123.24 138.85 54.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.294 1.437 . . . . 0.0 110.385 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.7 114.67 14.55 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.43 170.38 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.936 0.789 . . . . 0.0 109.887 174.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 161.33 35.74 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.191 0.997 . . . . 0.0 109.094 174.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 129.93 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 174.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.15 -13.08 60.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.797 1.189 . . . . 0.0 112.383 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.62 140.03 58.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.629 1.715 . . . . 0.0 110.214 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -89.88 108.15 19.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 172.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.34 148.72 92.93 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.149 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -57.95 -8.92 5.16 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 125.245 3.963 . . . . 0.0 118.536 -178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 52.79 70.61 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.872 1.32 . . . . 0.0 111.74 -169.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -73.3 166.68 22.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.22 1.408 . . . . 0.0 109.827 177.198 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 m -127.97 144.92 51.11 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.33 163.12 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.208 2.203 . . . . 0.0 106.69 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.35 137.52 32.25 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -63.67 165.18 8.61 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -64.88 -3.48 3.46 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.699 -1.251 . . . . 0.0 111.864 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 m -114.48 17.97 17.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.127 2.171 . . . . 0.0 111.239 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 mt 65.93 39.85 4.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.133 1.373 . . . . 0.0 112.884 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.58 148.87 49.7 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.62 141.04 44.71 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.904 1.229 . . . . 0.0 109.128 172.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -138.33 144.99 40.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -134.02 165.96 23.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -53.49 -34.7 59.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.972 0.509 . . . . 0.0 110.442 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.97 46.09 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.12 -42.62 59.76 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.584 0.707 . . . . 0.0 110.441 173.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.6 mtt -64.7 -25.8 68.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.074 1.35 . . . . 0.0 111.643 -177.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -54.69 -16.75 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.592 1.157 . . . . 0.0 113.258 174.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.65 47.06 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.677 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -151.97 159.18 43.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.752 1.776 . . . . 0.0 109.695 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.49 119.46 6.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.8 m -124.95 134.23 52.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.446 0.299 . . . . 0.0 110.883 -168.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.11 142.59 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mm -120.89 138.08 52.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -126.92 102.37 6.98 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.109 0.964 . . . . 0.0 108.601 -169.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.04 134.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.81 157.31 61.76 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 107.984 169.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.39 -55.64 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.28 1.987 . . . . 0.0 111.59 -172.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -161.27 150.07 16.15 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 127.962 2.505 . . . . 0.0 104.833 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 tt -73.17 -10.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 118.92 0.782 . . . . 0.0 112.517 -169.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -32.35 73.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.868 1.267 . . . . 0.0 113.013 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.27 114.29 10.23 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.58 -17.99 43.02 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.408 1.004 . . . . 0.0 113.61 -174.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.33 -21.79 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 118.511 1.156 . . . . 0.0 111.311 174.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 64.3 m -58.75 -19.86 44.27 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.788 1.176 . . . . 0.0 112.8 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.7 -29.35 69.29 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.142 0.977 . . . . 0.0 111.828 173.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.58 5.94 22.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.622 1.169 . . . . 0.0 112.441 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -124.82 -83.83 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -57.68 -45.85 85.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.561 1.144 . . . . 0.0 111.885 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -68.6 -45.5 71.81 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.552 -0.717 . . . . 0.0 111.02 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.02 -37.43 87.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -57.98 -37.47 74.28 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.232 0.923 . . . . 0.0 112.207 171.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.53 -48.41 81.77 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.485 1.039 . . . . 0.0 110.825 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.48 -47.3 70.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.72 -40.07 96.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.378 0.99 . . . . 0.0 110.713 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.7 78.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.919 0.781 . . . . 0.0 111.627 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.16 87.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.701 0.682 . . . . 0.0 111.725 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -70.48 -40.05 73.85 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.443 0.697 . . . . 0.0 111.067 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.38 149.45 33.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.894 1.278 . . . . 0.0 108.805 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.53 -44.42 97.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.132 -178.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.23 137.24 7.04 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.677 1.591 . . . . 0.0 107.57 174.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -162.73 175.31 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.654 1.582 . . . . 0.0 106.956 174.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -136.54 140.62 43.09 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.51 146.52 23.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.05 163.37 29.71 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.962 1.305 . . . . 0.0 109.209 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.4 m -121.29 146.18 47.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 169.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.57 140.68 47.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 m -140.27 149.13 42.44 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.665 1.186 . . . . 0.0 109.939 -169.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.89 45.75 1.24 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.21 -176.63 3.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.136 1.375 . . . . 0.0 110.87 -168.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.43 140.52 26.92 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.275 -174.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.14 -41.48 57.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.874 3.049 . . . . 0.0 113.97 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -78.62 -29.44 45.94 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.509 -0.745 . . . . 0.0 112.083 -174.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.39 73.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.281 0.946 . . . . 0.0 109.102 175.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -51.05 -50.49 58.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.538 1.535 . . . . 0.0 111.11 171.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.683 0.393 . . . . 0.0 111.518 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -63.84 -44.41 93.28 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.033 0.533 . . . . 0.0 110.044 -174.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -61.69 -39.86 92.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.556 0.342 . . . . 0.0 110.565 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.4 m -65.35 -44.05 88.92 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.92 -0.487 . . . . 0.0 111.224 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.66 94.87 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.56 -44.3 87.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.696 0.748 . . . . 0.0 110.463 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -77.31 -23.49 51.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.281 0.632 . . . . 0.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.59 22.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.807 0.718 . . . . 0.0 111.325 -178.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.46 144.1 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.45 -37.9 0.23 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.176 1.391 . . . . 0.0 111.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -80.44 -16.49 54.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.08 0.952 . . . . 0.0 111.919 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.4 160.79 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.93 146.1 40.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 p -99.25 142.62 30.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.391 1.076 . . . . 0.0 108.63 -177.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 mt -129.02 155.66 45.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.051 1.34 . . . . 0.0 107.984 -174.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.66 125.6 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.258 1.423 . . . . 0.0 109.441 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -118.66 -2.54 10.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 111.966 -176.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -55.59 -23.29 26.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.518 1.527 . . . . 0.0 113.006 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -59.08 -45.48 90.72 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.119 0.968 . . . . 0.0 111.864 -176.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -154.95 7.37 0.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -171.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 mmm 51.77 28.47 4.95 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.128 1.771 . . . . 0.0 113.873 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -51.72 -51.33 56.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 111.928 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.66 -44.8 69.8 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.513 0.597 . . . . 0.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.22 -43.56 64.02 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.795 1.188 . . . . 0.0 112.672 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -74.35 -42.23 59.73 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.986 0.915 . . . . 0.0 110.213 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.79 86.5 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 0.0 112.034 -173.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -109.95 6.3 23.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.474 1.51 . . . . 0.0 112.581 -176.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.9 78.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.563 1.074 . . . . 0.0 113.109 171.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.95 1.59 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.282 . . . . 0.0 112.679 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -82.67 108.48 16.07 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 120.534 1.515 . . . . 0.0 107.48 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.64 105.0 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -51.48 -49.51 61.68 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 126.337 1.855 . . . . 0.0 110.981 -171.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -74.28 -35.61 63.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.407 0.683 . . . . 0.0 111.711 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.74 -23.69 42.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.765 0.711 . . . . 0.0 112.148 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? 57.99 34.57 24.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.132 0.973 . . . . 0.0 109.075 -168.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.4 mt -130.16 160.96 32.22 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.794 1.238 . . . . 0.0 108.688 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -75.32 158.25 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.09 -167.55 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.167 1.387 . . . . 0.0 111.307 175.078 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -124.66 123.57 40.33 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 169.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -166.55 169.12 14.04 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.924 1.69 . . . . 0.0 106.908 -169.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.46 143.23 23.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.22 156.9 47.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.016 0.926 . . . . 0.0 108.693 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 t -136.54 138.91 46.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.3 mt -130.84 124.51 31.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.401 1.481 . . . . 0.0 107.838 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.81 164.64 14.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.282 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.75 -21.13 10.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.655 1.182 . . . . 0.0 112.822 174.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -76.18 -2.85 33.17 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.586 -1.321 . . . . 0.0 112.502 174.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.35 76.53 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -171.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -116.68 129.7 56.3 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.73 129.27 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -173.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.94 -18.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.799 0.84 . . . . 0.0 111.406 177.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -153.61 143.13 21.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.632 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 144.91 27.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.22 144.9 23.43 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.218 1.007 . . . . 0.0 108.87 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -132.86 126.0 31.23 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.742 1.617 . . . . 0.0 106.82 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 148' ' ' GLU . 13.5 t -75.82 137.12 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.381 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -70.76 -3.69 20.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.444 0.698 . . . . 0.0 112.88 177.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.419 ' H ' HG12 ' A' ' 146' ' ' VAL . 6.7 mt-10 -137.92 125.38 21.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.94 1.696 . . . . 0.0 107.252 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.32 -23.48 62.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 169.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.02 3.79 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.222 2.609 . . . . 0.0 112.986 173.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -140.91 171.14 14.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.534 1.934 . . . . 0.0 108.191 -176.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -131.51 155.98 80.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.357 1.063 . . . . 0.0 110.791 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.07 170.41 19.77 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.792 2.328 . . . . 0.0 109.9 176.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -97.9 118.74 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -55.75 -24.22 34.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.909 1.684 . . . . 0.0 112.922 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -61.64 -35.24 77.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.254 0.933 . . . . 0.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -62.07 -54.06 53.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.171 -174.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -31.36 16.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.957 1.771 . . . . 0.0 112.279 177.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mm -53.62 -50.28 51.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 119.67 1.123 . . . . 0.0 109.623 172.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.844 0.293 . . . . 0.0 110.688 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.39 91.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.916 0.325 . . . . 0.0 111.568 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.71 -53.81 24.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.208 0.603 . . . . 0.0 110.921 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -24.46 67.91 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.437 1.017 . . . . 0.0 112.186 -177.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.35 66.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.024 0.829 . . . . 0.0 111.565 170.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.78 -24.25 12.93 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.506 1.122 . . . . 0.0 112.545 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . 0.258 7.1 p -126.36 74.71 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 122.695 1.236 . . . . 0.0 108.351 177.031 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.997 172.29 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.69 150.52 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -97.91 155.54 17.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 123.038 1.399 . . . . 0.0 108.748 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -120.87 66.49 0.85 Allowed 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HE3' HG21 ' A' ' 150' ' ' THR . 2.0 ttmt 57.35 36.75 27.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.55 -21.27 0.27 Allowed Glycine 0 CA--C 1.497 -1.088 0 O-C-N 118.751 -2.468 . . . . 0.0 111.116 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.33 163.61 34.02 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.64 157.46 55.48 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.986 3.124 . . . . 0.0 110.118 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.42 137.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.248 1.419 . . . . 0.0 107.317 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.656 ' H ' ' HG3' ' A' ' 123' ' ' GLU . 27.1 m -74.99 151.18 38.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.605 1.162 . . . . 0.0 109.138 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 121' ' ' ILE . 22.2 mt -113.09 143.92 43.52 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.4 165.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 158.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.73 -172.41 14.51 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.449 1.027 . . . . 0.0 113.3 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -116.63 158.52 23.6 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.304 1.441 . . . . 0.0 107.659 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.45 127.27 32.05 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 117' ' ' PHE . 1.8 t -89.76 163.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 127.441 2.297 . . . . 0.0 107.505 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -137.04 169.29 18.03 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.339 -0.851 . . . . 0.0 111.487 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.97 137.09 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.397 165.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.37 -23.25 30.83 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.312 1.91 . . . . 0.0 112.387 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -71.84 151.09 43.7 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.648 0.779 . . . . 0.0 109.856 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -73.86 126.97 31.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 146.93 93.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 118.023 -0.989 . . . . 0.0 108.371 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 31.4 Cg_exo -52.81 -25.77 28.31 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 121.943 1.762 . . . . 0.0 115.528 -172.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' CE1' ' A' ' 27' ' ' PHE . 26.1 t0 61.26 89.47 0.08 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 129.375 3.07 . . . . 0.0 118.232 -170.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.727 ' CE1' ' HB2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -131.19 -166.76 1.75 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.437 -2.04 . . . . 0.0 107.175 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 5.4 m -125.08 143.57 50.85 Favored 'General case' 0 N--CA 1.406 -2.651 1 C-N-CA 134.53 5.132 . . . . 0.0 107.21 -170.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.58 171.07 18.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 129.253 3.021 . . . . 0.0 103.768 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.33 146.34 25.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -67.17 162.36 22.66 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 119.822 1.192 . . . . 0.0 108.106 162.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.38 -11.63 4.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.67 165.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 m -98.06 4.8 49.19 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.951 2.1 . . . . 0.0 112.795 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 75.42 33.89 0.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.852 1.661 . . . . 0.0 112.094 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.18 153.8 35.72 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.51 141.74 48.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.092 -1.005 . . . . 0.0 108.921 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' THR . 13.5 ttmm -139.64 145.1 38.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 168.42 18.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.251 0.621 . . . . 0.0 111.247 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 134' ' ' LEU . 0.9 OUTLIER -54.89 -37.13 65.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.343 177.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.27 -35.07 49.14 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.7 -42.51 61.15 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.318 1.056 . . . . 0.0 109.845 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.87 -30.09 71.07 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 112.05 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -10.73 19.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.563 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -11.99 6.22 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.041 1.292 . . . . 0.0 112.878 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.68 164.79 34.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.661 1.73 . . . . 0.0 107.073 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.06 120.42 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -126.72 138.9 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.5 mt -100.88 144.82 12.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.27 132.16 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -121.32 100.09 6.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.08 134.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 60' ' ' CYS . 0.4 OUTLIER -137.6 161.54 59.83 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.66 -57.38 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.151 1.901 . . . . 0.0 111.594 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 164.4 33.08 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.844 2.058 . . . . 0.0 106.38 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.4 HG12 ' CG ' ' A' ' 93' ' ' TRP . 10.3 tt -94.93 -15.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.656 1.571 . . . . 0.0 112.985 -168.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.97 -1.75 53.33 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -78.99 3.41 17.27 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 118.815 -2.428 . . . . 0.0 115.318 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.36 -52.37 0.83 Allowed Glycine 0 CA--C 1.54 1.61 0 CA-C-O 117.771 -1.571 . . . . 0.0 113.194 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -30.29 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 122.282 3.041 . . . . 0.0 111.34 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 52' ' ' ILE . 1.9 m -58.65 -31.89 68.58 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.673 -0.642 . . . . 0.0 112.035 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.706 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 15.1 t70 -55.54 -50.3 70.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.885 0.874 . . . . 0.0 108.753 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.93 -13.79 5.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.622 0.576 . . . . 0.0 112.306 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.554 HE22 ' HG2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -99.28 -75.81 0.56 Allowed 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -59.43 -40.2 86.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 123.597 1.665 . . . . 0.0 111.489 -159.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.262 1.7 tpt180 -76.1 -49.89 16.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.176 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -57.34 -38.72 74.54 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -58.45 -41.1 84.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.763 0.825 . . . . 0.0 109.945 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -57.5 -45.26 85.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.326 0.966 . . . . 0.0 111.556 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -70.98 -48.63 52.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.026 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.35 -38.21 86.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.572 0.349 . . . . 0.0 110.671 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.04 86.05 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.507 -0.745 . . . . 0.0 111.402 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.69 88.49 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.762 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -70.75 -36.4 73.11 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.587 0.755 . . . . 0.0 111.396 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mp -62.4 -41.48 98.7 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 123.192 0.597 . . . . 0.0 109.97 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 -37.36 3.4 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.491 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG11 ' A' ' 166' ' ' VAL . 43.6 t0 -140.23 85.32 2.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.34 1.07 . . . . 0.0 109.575 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.29 172.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -127.93 144.2 51.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.4 t -144.41 139.22 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.51 161.26 35.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.464 0.65 . . . . 0.0 109.312 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.6 m -122.01 148.5 44.74 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.8 mt -132.9 134.74 57.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 m -132.13 159.9 37.57 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.438 0.695 . . . . 0.0 110.671 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.49 39.62 0.92 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 109.18 167.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -133.66 168.69 18.23 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.107 1.363 . . . . 0.0 108.804 -166.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 136.04 96.45 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.073 0.949 . . . . 0.0 110.536 -171.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.97 -42.39 64.71 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.365 2.043 . . . . 0.0 111.903 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -72.84 -30.07 63.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.059 -1.026 . . . . 0.0 112.672 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.87 98.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.503 1.047 . . . . 0.0 108.627 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.1 -46.23 78.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.09 75.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.79 0.805 . . . . 0.0 108.982 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 92' ' ' ARG . 18.9 ttp85 -70.3 -44.95 67.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.775 -172.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 61' ' ' ASP . 69.3 t90 -53.98 -41.44 67.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.1 -46.98 84.83 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.265 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.25 -38.89 97.19 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.839 0.712 . . . . 0.0 111.753 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.13 93.4 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.738 0.815 . . . . 0.0 110.751 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -87.7 -17.15 32.39 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.84 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.72 56.08 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 119.29 0.95 . . . . 0.0 112.132 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mm -71.35 142.76 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.279 1.432 . . . . 0.0 107.443 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.66 -36.59 0.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.09 1.356 . . . . 0.0 110.637 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -79.86 -18.62 50.28 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.838 -1.164 . . . . 0.0 112.988 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -117.13 150.29 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.38 138.97 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 p -93.88 150.62 20.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.713 1.205 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.6 mt -141.65 157.51 44.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.339 1.456 . . . . 0.0 107.406 -170.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -121.64 109.72 15.1 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.518 -1.364 . . . . 0.0 109.09 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 109' ' ' ARG . 25.0 t0 -84.06 -10.1 58.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.927 1.291 . . . . 0.0 110.333 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -32.55 -25.34 0.0 OUTLIER 'General case' 0 C--N 1.347 0.458 1 C-N-CA 132.148 4.179 . . . . 0.0 115.246 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -97.82 -38.12 9.57 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -151.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.21 -7.72 0.62 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 125.82 1.95 . . . . 0.0 107.859 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mmm 59.09 12.67 2.55 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 125.494 1.518 . . . . 0.0 109.561 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.1 -42.74 77.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.692 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -64.79 -57.63 8.4 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 125.052 1.341 . . . . 0.0 110.573 177.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -60.43 -37.9 93.94 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 118.9 -1.619 . . . . 0.0 111.474 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.2 -53.28 51.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.666 1.186 . . . . 0.0 109.778 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.37 77.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -83.7 0.66 46.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.026 177.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.19 44.62 95.37 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.55 1.068 . . . . 0.0 111.712 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.417 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.2 m -125.92 -6.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.882 0.873 . . . . 0.0 112.168 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.84 118.82 14.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 165.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 13' ' ' LEU . 51.2 mt -82.06 105.94 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -53.14 -41.34 65.02 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 112.037 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.656 ' HG3' ' H ' ' A' ' 12' ' ' THR . 1.5 mm-40 -80.1 -11.77 59.73 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.727 1.211 . . . . 0.0 111.632 -171.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.08 -23.06 6.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.886 0.766 . . . . 0.0 112.54 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 61.15 38.9 16.56 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.935 1.35 . . . . 0.0 114.332 -168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.76 145.35 48.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -168.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.08 142.57 52.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.1 17.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.624 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -95.98 111.69 23.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 m -150.78 168.13 25.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.445 HG13 ' CG ' ' A' ' 153' ' ' PRO . 3.0 m -138.79 156.87 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.153 0.888 . . . . 0.0 109.316 171.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -141.41 159.73 41.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.57 1.148 . . . . 0.0 108.015 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.02 143.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 39' ' ' LEU . 69.5 mt -134.65 125.28 26.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -165.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.69 164.57 23.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.614 1.165 . . . . 0.0 109.087 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.32 -14.13 16.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.481 1.912 . . . . 0.0 112.988 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.96 -9.69 59.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.499 -1.376 . . . . 0.0 111.977 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.14 25.95 65.25 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.453 -1.405 . . . . 0.0 111.476 -168.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -89.71 142.51 27.62 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 118.821 1.311 . . . . 0.0 108.973 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.2 t -72.56 122.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 t -94.77 -31.59 4.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 126.27 1.828 . . . . 0.0 108.845 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -152.99 149.22 27.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.31 144.65 28.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 168.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.28 142.29 23.95 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.353 1.061 . . . . 0.0 108.525 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.46 108.17 10.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 153' ' ' PRO . 17.5 t -62.8 123.94 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -60.82 -12.6 11.37 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.264 -1.35 . . . . 0.0 112.646 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -134.74 115.18 13.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.54 1.536 . . . . 0.0 107.381 -172.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.16 -25.88 68.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.212 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -80.69 1.72 28.95 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.616 1.566 . . . . 0.0 113.95 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.36 164.26 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.94 2.496 . . . . 0.0 106.429 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -129.95 155.06 81.18 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 121.4 -0.812 . . . . 0.0 109.187 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.554 ' HG2' HE22 ' A' ' 63' ' ' GLN . 37.9 Cg_endo -66.86 168.89 15.87 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.536 2.157 . . . . 0.0 110.24 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.82 122.08 38.23 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.162 -1.586 . . . . 0.0 107.098 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 66' ' ' ARG . 19.7 p90 -59.3 -23.2 62.24 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.226 1.81 . . . . 0.0 112.824 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.43 -36.15 71.0 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.699 1.136 . . . . 0.0 109.842 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -60.22 -57.69 24.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.023 0.929 . . . . 0.0 113.16 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.59 -26.77 28.04 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 120.663 0.909 . . . . 0.0 111.224 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -49.42 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 108.493 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -63.96 -34.14 77.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.006 0.821 . . . . 0.0 111.204 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.31 66.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.59 0.756 . . . . 0.0 110.934 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.18 -44.99 67.61 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.444 -0.785 . . . . 0.0 110.421 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.428 ' HA ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -62.13 -23.61 66.66 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.67 -28.03 65.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.477 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.0 -25.79 13.94 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.002 -1.475 . . . . 0.0 113.702 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 163' ' ' LYS . 35.5 m -73.53 -13.37 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.113 1.324 . . . . 0.0 113.031 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 163' ' ' LYS . 7.1 mmtt . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.659 -2.115 . . . . 0.0 110.624 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 122.766 1.269 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.92 151.63 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.659 169.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -113.84 160.78 18.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.337 1.055 . . . . 0.0 109.687 173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.87 46.84 1.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.493 1.117 . . . . 0.0 108.673 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 42.33 63.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.608 1.963 . . . . 0.0 111.94 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.1 -25.58 0.18 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.571 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 171.81 43.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.271 0.938 . . . . 0.0 110.822 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.09 159.71 52.2 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.567 2.844 . . . . 0.0 111.076 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.54 133.61 45.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 124.125 0.97 . . . . 0.0 109.119 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -68.83 134.64 49.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.695 0.798 . . . . 0.0 110.481 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.23 146.59 23.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.398 1.479 . . . . 0.0 108.496 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -74.33 -65.02 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.25 169.52 54.65 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.509 0.576 . . . . 0.0 112.047 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.61 166.3 22.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.759 0.79 . . . . 0.0 110.611 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.48 120.09 18.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.75 152.5 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -128.15 158.06 39.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.251 1.02 . . . . 0.0 110.642 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.38 144.51 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.962 0.905 . . . . 0.0 108.813 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.38 19.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.646 1.117 . . . . 0.0 112.451 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.15 155.97 39.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.62 1.21 . . . . 0.0 109.872 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -74.02 136.19 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 157.92 30.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 122.987 0.515 . . . . 0.0 111.21 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -53.52 -27.42 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.969 3.113 . . . . 0.0 116.985 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 t0 51.91 78.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.255 1.422 . . . . 0.0 113.548 -169.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -139.15 -176.9 4.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.771 1.228 . . . . 0.0 110.636 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -125.64 152.31 45.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 110.994 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 m -140.39 170.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.791 2.436 . . . . 0.0 106.909 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.26 147.67 22.71 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.971 -1.08 . . . . 0.0 108.184 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.9 p -70.81 170.58 12.22 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -61.79 -9.25 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.633 -1.292 . . . . 0.0 112.524 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 m -105.83 12.09 31.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.476 1.91 . . . . 0.0 111.204 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.41 47.4 8.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.172 1.789 . . . . 0.0 111.209 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.9 140.44 51.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.99 135.09 56.25 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.537 -0.727 . . . . 0.0 111.153 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -137.29 141.57 41.93 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -126.65 157.21 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -169.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -54.48 -34.44 61.59 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.48 1.112 . . . . 0.0 111.132 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.56 67.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.51 -38.11 62.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.68 0.792 . . . . 0.0 110.331 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 mtt -66.43 -27.05 67.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.62 1.168 . . . . 0.0 111.013 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.19 -15.48 3.87 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.776 0.83 . . . . 0.0 113.142 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.54 -18.79 56.91 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.4 1.0 . . . . 0.0 113.849 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -152.48 160.56 43.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.347 1.573 . . . . 0.0 108.758 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.92 118.87 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.9 m -126.64 132.52 51.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.492 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.2 mt -93.05 142.51 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -126.89 128.62 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 125.553 1.541 . . . . 0.0 106.944 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 m -126.32 98.53 5.49 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.292 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.16 131.33 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.7 147.17 47.65 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.929 0.786 . . . . 0.0 111.827 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -65.21 133.54 35.68 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.3 2.0 . . . . 0.0 108.545 168.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m 44.44 -133.4 0.71 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.349 1.06 . . . . 0.0 111.073 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.5 tt -163.46 178.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.208 2.203 . . . . 0.0 106.15 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t0 56.09 38.98 30.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.072 1.749 . . . . 0.0 112.245 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.1 p -81.8 11.94 4.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.468 1.107 . . . . 0.0 111.646 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 -59.68 4.78 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 125.408 1.48 . . . . 0.0 109.761 -169.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.38 -8.7 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.55 -23.9 63.27 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.551 1.069 . . . . 0.0 111.274 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.19 -33.61 76.14 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.852 -1.155 . . . . 0.0 111.444 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.25 11.9 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.043 0.937 . . . . 0.0 111.899 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -134.92 -91.51 0.32 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.429 1.092 . . . . 0.0 108.481 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -54.59 -44.25 72.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.41 1.484 . . . . 0.0 112.297 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -67.61 -52.04 43.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -42.6 85.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.663 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.48 -37.87 79.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.378 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -59.58 -46.16 89.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.897 1.226 . . . . 0.0 111.609 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.74 -51.77 31.26 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.56 -36.52 84.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.502 -0.749 . . . . 0.0 111.078 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.655 -0.653 . . . . 0.0 111.668 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.16 66.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.486 1.039 . . . . 0.0 110.761 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -69.63 -41.49 75.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 0.0 110.058 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.2 -39.77 93.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.627 0.771 . . . . 0.0 110.144 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -73.49 2.67 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 125.821 1.677 . . . . 0.0 110.33 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -88.42 41.31 1.0 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.559 1.143 . . . . 0.0 112.088 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 164.7 15.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.467 1.107 . . . . 0.0 108.109 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.51 145.25 50.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.53 145.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.474 -0.766 . . . . 0.0 108.941 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -131.54 158.39 41.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.607 1.163 . . . . 0.0 108.544 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' HG22 ' A' ' 104' ' ' THR . 55.1 m -127.59 144.84 51.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.44 113.68 23.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 p -76.15 162.31 28.1 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.87 0.843 . . . . 0.0 110.123 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 -9.96 59.72 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -154.03 -31.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -169.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.83 111.26 10.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 120.412 1.46 . . . . 0.0 111.835 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.41 -31.65 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.903 1.735 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -71.26 -38.52 71.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.01 74.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.006 1.275 . . . . 0.0 110.844 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.13 -27.04 68.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.535 . . . . 0.0 111.438 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.19 82.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.465 0.575 . . . . 0.0 110.391 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -74.33 -39.96 62.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.549 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -52.66 -45.94 66.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.443 0.565 . . . . 0.0 109.81 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.78 -45.75 73.94 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.212 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.2 94.05 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.68 76.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.695 0.747 . . . . 0.0 110.406 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -73.77 -33.69 64.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.312 0.645 . . . . 0.0 112.34 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.24 37.71 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.72 145.02 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.11 -38.63 0.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.214 1.005 . . . . 0.0 112.789 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -74.74 -24.45 58.72 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.809 0.732 . . . . 0.0 112.408 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.1 158.94 10.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.25 134.45 34.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 81' ' ' THR . 7.0 p -87.56 154.37 20.67 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 mt -146.84 171.62 14.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 128.523 2.729 . . . . 0.0 106.076 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -150.97 142.33 23.36 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 119.656 -1.902 . . . . 0.0 109.06 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.63 -33.38 73.84 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 168.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.5 t60 55.79 -67.1 0.02 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 129.734 3.214 . . . . 0.0 113.981 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -149.44 0.11 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.302 1.441 . . . . 0.0 112.15 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.15 -39.9 90.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.253 0.933 . . . . 0.0 110.515 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 62.42 -23.55 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 129.523 3.129 . . . . 0.0 114.72 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.84 -43.96 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 121.05 1.75 . . . . 0.0 111.203 -170.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -64.65 -55.31 20.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.48 93.07 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 122.951 0.31 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.04 -47.59 73.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.615 -0.932 . . . . 0.0 110.273 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.06 -31.03 58.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.894 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.88 9.99 3.14 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.26 0.482 . . . . 0.0 112.071 172.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.91 -15.41 5.11 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 120.8 -1.187 . . . . 0.0 114.363 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.94 -25.49 30.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.053 1.427 . . . . 0.0 112.051 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.98 109.04 1.98 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.45 1.477 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.81 107.33 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -49.98 -45.66 51.84 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.75 1.22 . . . . 0.0 110.139 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.57 -16.27 62.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.519 1.128 . . . . 0.0 113.107 -171.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 mt -128.27 -16.82 4.38 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.517 1.127 . . . . 0.0 112.393 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.14 36.77 27.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.425 1.09 . . . . 0.0 109.417 -168.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.3 tp -126.08 147.06 49.67 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.159 1.383 . . . . 0.0 107.714 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.27 134.27 35.57 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.73 156.31 17.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.908 1.683 . . . . 0.0 111.955 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -83.22 116.66 22.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -162.14 168.44 22.54 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.935 0.894 . . . . 0.0 109.092 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.71 145.99 18.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 O-C-N 121.791 -0.568 . . . . 0.0 109.917 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -140.82 161.31 38.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.307 1.043 . . . . 0.0 109.581 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t -136.06 140.75 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.15 136.07 52.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.785 1.634 . . . . 0.0 108.122 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -75.77 166.76 23.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.213 1.005 . . . . 0.0 108.886 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.61 -23.01 57.91 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.254 -0.904 . . . . 0.0 112.588 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -76.06 -3.47 36.08 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.822 -1.174 . . . . 0.0 112.124 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.47 75.34 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.125 0.869 . . . . 0.0 112.096 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -92.56 143.94 25.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.45 130.86 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.4 t -104.93 -31.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.917 1.687 . . . . 0.0 109.409 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -152.28 149.12 28.34 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.82 139.23 24.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -149.08 134.13 18.13 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -114.29 126.05 54.59 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.5 t -70.0 136.69 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -67.48 -9.97 47.21 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.12 117.36 18.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.49 67.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 111.838 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.3 p -72.03 -10.59 59.99 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.88 1.672 . . . . 0.0 112.726 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -120.06 158.46 26.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 109.617 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -106.49 152.73 40.74 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.857 0.863 . . . . 0.0 111.082 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.08 154.58 57.43 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.592 2.194 . . . . 0.0 109.373 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.27 121.39 25.02 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -53.84 -26.56 25.02 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.262 1.425 . . . . 0.0 113.262 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -62.17 -33.61 74.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.778 0.717 . . . . 0.0 111.16 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -59.32 -56.79 32.36 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.178 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.57 -28.52 31.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 121.046 1.409 . . . . 0.0 111.851 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -48.45 88.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.529 1.059 . . . . 0.0 108.81 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.01 -31.06 72.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.888 0.767 . . . . 0.0 111.12 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -51.09 35.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.646 0.378 . . . . 0.0 111.36 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.47 -44.5 71.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -29.31 65.16 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.485 0.714 . . . . 0.0 111.67 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.58 71.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.498 0.719 . . . . 0.0 112.019 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.4 mt -99.16 -36.05 9.8 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.63 0.91 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.703 0.801 . . . . 0.0 109.897 173.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 87.0 mt -137.69 166.48 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -115.37 155.25 27.71 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.068 1.304 . . . . 0.0 110.195 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -124.88 65.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.789 1.236 . . . . 0.0 108.175 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 pttt 39.09 50.44 1.81 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.813 2.045 . . . . 0.0 113.972 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.92 -27.3 0.13 Allowed Glycine 0 CA--C 1.523 0.594 0 CA-C-O 119.523 -0.598 . . . . 0.0 112.669 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.71 45.71 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 117.998 0.899 . . . . 0.0 111.294 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.09 157.8 28.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.599 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.37 131.8 40.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 126.553 1.941 . . . . 0.0 106.378 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -76.0 160.6 29.67 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.13 0.972 . . . . 0.0 109.858 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 138.04 54.25 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.23 128.42 38.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.69 -159.73 18.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 123.555 0.598 . . . . 0.0 112.201 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -126.03 155.09 42.03 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.289 1.036 . . . . 0.0 109.045 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.54 152.76 43.62 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 168.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.64 146.33 31.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.19 158.94 34.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.44 0.696 . . . . 0.0 110.837 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.37 139.54 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.077 0.951 . . . . 0.0 108.856 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -18.15 53.33 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.792 1.187 . . . . 0.0 112.346 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -77.21 153.95 33.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.013 1.406 . . . . 0.0 109.98 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -75.29 127.61 33.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 169.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.29 150.78 78.73 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.653 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.17 -30.3 49.98 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.816 3.01 . . . . 0.0 115.625 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 51.63 88.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.557 1.943 . . . . 0.0 113.965 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.02 168.27 19.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.376 1.07 . . . . 0.0 110.405 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.2 157.34 19.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.321 1.448 . . . . 0.0 112.375 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.85 157.69 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.942 2.497 . . . . 0.0 106.279 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tp -86.22 138.08 32.14 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.954 -1.091 . . . . 0.0 108.972 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.8 p -71.18 167.44 19.37 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -65.44 -17.03 64.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.476 -1.39 . . . . 0.0 110.887 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -81.08 0.78 34.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.805 1.642 . . . . 0.0 111.374 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 mt 69.26 34.06 3.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.54 1.536 . . . . 0.0 111.404 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.77 163.06 20.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.668 1.187 . . . . 0.0 108.264 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.3 137.21 37.26 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -134.03 149.94 51.2 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -143.04 165.47 27.28 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.91 -35.57 64.28 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 111.939 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.1 -29.11 56.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.204 1.002 . . . . 0.0 113.146 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -81.14 -40.45 23.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.395 1.078 . . . . 0.0 110.762 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.69 -42.3 91.37 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -66.19 -0.79 2.71 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.67 -16.5 30.45 Favored Glycine 0 CA--C 1.54 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 112.488 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -140.25 158.54 43.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.534 1.533 . . . . 0.0 107.366 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.73 120.28 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -125.46 136.31 53.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.881 -169.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.21 139.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mm -120.55 133.76 66.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -125.99 94.43 4.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.333 1.053 . . . . 0.0 108.696 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.06 124.08 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.82 162.42 55.36 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.41 1.484 . . . . 0.0 107.799 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.02 -59.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.955 1.77 . . . . 0.0 110.315 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.8 m -152.41 160.32 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.581 2.353 . . . . 0.0 106.887 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.29 17.16 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -126.95 14.38 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.891 1.276 . . . . 0.0 110.42 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -73.51 -12.41 60.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.899 1.28 . . . . 0.0 112.713 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.15 -50.77 4.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.808 1.194 . . . . 0.0 110.213 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.68 -25.77 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 118.173 0.987 . . . . 0.0 112.073 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.7 p -53.42 -37.99 63.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.309 1.044 . . . . 0.0 112.257 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.98 -43.75 67.38 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.138 0.975 . . . . 0.0 110.787 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.98 43.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.155 0.982 . . . . 0.0 112.441 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -106.67 -55.01 2.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.189 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -64.78 -40.04 94.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.864 1.211 . . . . 0.0 112.348 -169.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -63.06 -49.3 75.09 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.029 -1.044 . . . . 0.0 109.335 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -67.01 -36.04 81.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.165 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -59.5 -43.86 93.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.75 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -58.08 -46.79 84.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.495 1.043 . . . . 0.0 111.343 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.58 -46.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -69.16 -33.31 73.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.296 -0.878 . . . . 0.0 110.721 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.92 96.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.526 0.603 . . . . 0.0 110.892 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.863 0.756 . . . . 0.0 111.144 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -65.48 -39.76 92.32 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.092 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.02 -45.75 84.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.598 1.09 . . . . 0.0 110.114 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 -4.93 75.22 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.796 1.189 . . . . 0.0 114.433 170.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -153.8 55.1 0.73 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.473 . . . . 0.0 109.831 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.33 168.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -127.76 140.81 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.6 t -137.34 139.79 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -128.71 162.84 26.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.886 0.851 . . . . 0.0 109.502 170.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.63 ' HB ' HG22 ' A' ' 104' ' ' THR . 21.5 m -129.11 143.99 51.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 mt -130.87 134.95 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.4 m -138.95 157.0 46.81 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.414 1.086 . . . . 0.0 110.436 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.99 54.32 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -140.41 162.93 34.15 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.651 1.581 . . . . 0.0 107.891 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.34 137.08 95.32 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.46 -32.08 80.56 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.015 1.81 . . . . 0.0 111.269 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -29.44 62.3 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.275 -0.891 . . . . 0.0 111.461 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -45.23 67.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.96 1.255 . . . . 0.0 109.709 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.26 -44.07 79.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.305 1.042 . . . . 0.0 111.714 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.27 -39.96 95.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.387 -0.821 . . . . 0.0 111.894 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -67.16 -39.06 86.44 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -53.95 -51.81 62.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.433 0.693 . . . . 0.0 109.428 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.0 m -60.11 -36.45 77.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.852 0.751 . . . . 0.0 111.231 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.06 -19.56 72.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.954 -0.914 . . . . 0.0 113.548 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.25 -25.17 24.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.168 1.484 . . . . 0.0 111.571 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -124.13 -16.28 6.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.64 1.176 . . . . 0.0 113.08 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.44 22.24 77.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.242 -0.755 . . . . 0.0 112.198 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mt -55.99 140.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -143.33 -35.89 0.38 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.65 1.18 . . . . 0.0 111.807 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -76.48 -17.14 59.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 111.448 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.26 153.98 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.65 150.64 50.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.1 p -111.77 148.02 34.42 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.1 mt -138.72 145.25 40.05 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.215 1.006 . . . . 0.0 109.192 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.3 m -107.82 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.516 0.674 . . . . 0.0 109.827 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -81.36 -14.55 57.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.512 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -42.43 -39.92 2.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.761 2.424 . . . . 0.0 114.192 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -119.74 24.05 10.79 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.251 1.021 . . . . 0.0 110.266 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -136.26 -45.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.787 0.835 . . . . 0.0 110.461 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.1 -15.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.15 2.98 . . . . 0.0 114.898 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 m -62.86 -50.57 70.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.329 1.422 . . . . 0.0 111.871 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.92 -46.84 85.9 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.214 0.916 . . . . 0.0 110.162 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.36 99.08 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.89 -42.97 80.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.295 -0.532 . . . . 0.0 109.955 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.56 92.06 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.37 -0.831 . . . . 0.0 112.035 -169.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.11 -1.35 52.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.687 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.63 54.06 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 119.385 0.993 . . . . 0.0 112.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.4 28.87 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.993 1.317 . . . . 0.0 110.46 -170.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -119.84 117.41 28.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.85 112.54 19.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.36 -43.53 83.59 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.595 1.958 . . . . 0.0 111.234 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.4 -43.61 66.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.388 0.275 . . . . 0.0 110.476 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.09 -22.09 31.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 56.59 37.62 28.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.889 0.876 . . . . 0.0 108.697 -168.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.162 1.385 . . . . 0.0 108.056 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.9 150.67 42.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.398 0.618 . . . . 0.0 110.75 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -177.21 2.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.554 1.169 . . . . 0.0 112.232 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.45 101.21 7.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 102.034 -3.321 . . . . 0.0 102.034 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -156.51 167.88 29.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -169.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.13 144.93 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -141.04 159.91 41.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.706 0.802 . . . . 0.0 109.825 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.5 t -135.56 144.45 33.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.3 mt -130.24 123.11 29.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.536 1.534 . . . . 0.0 107.961 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.97 166.23 11.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.158 0.983 . . . . 0.0 108.714 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.51 -20.99 59.45 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.153 -0.967 . . . . 0.0 113.397 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -80.45 -10.68 59.74 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.593 -1.317 . . . . 0.0 112.247 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.58 18.05 69.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.399 -0.813 . . . . 0.0 111.179 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -75.66 132.21 40.42 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.34 125.7 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.97 -10.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -153.55 144.06 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.85 138.69 22.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.08 149.94 29.38 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 109.201 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -129.57 108.19 10.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.72 123.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -68.43 -11.29 59.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -135.28 124.87 25.09 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 108.375 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.87 66.09 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 p -84.52 16.6 3.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 112.017 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -137.23 170.32 16.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.161 2.185 . . . . 0.0 107.954 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.25 164.11 42.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.706 1.203 . . . . 0.0 110.617 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.52 173.64 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.305 2.67 . . . . 0.0 112.258 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -113.91 120.11 39.57 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -53.08 -28.48 25.27 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.526 1.53 . . . . 0.0 112.845 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -58.85 -36.18 74.14 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.496 0.589 . . . . 0.0 111.12 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -67.59 -52.95 24.56 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.677 -170.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.98 -32.94 27.31 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.842 1.336 . . . . 0.0 111.846 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.16 -48.3 79.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-N 119.25 0.932 . . . . 0.0 109.54 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.08 -39.55 92.81 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.508 0.594 . . . . 0.0 110.545 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.216 -0.303 . . . . 0.0 111.603 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.57 -52.2 41.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.532 0.733 . . . . 0.0 110.168 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.13 69.58 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.133 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.55 -32.02 69.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.374 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.57 -35.85 19.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.796 0.838 . . . . 0.0 111.556 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.4 -40.43 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.451 0.701 . . . . 0.0 111.302 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 18.7 pttp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.336 0.516 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.68 150.86 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -77.56 161.33 27.95 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.905 -1.122 . . . . 0.0 108.797 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -138.15 109.38 6.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 39.03 51.3 1.89 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 111.583 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.22 5.47 79.88 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.519 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.08 142.33 13.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 120.299 2.05 . . . . 0.0 109.966 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 149.41 63.27 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 CA-C-N 120.61 2.205 . . . . 0.0 112.006 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.91 141.37 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.095 1.358 . . . . 0.0 109.432 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -78.07 147.79 34.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.391 1.476 . . . . 0.0 110.115 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 119' ' ' VAL . 2.0 mm? -116.04 147.32 41.38 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.871 1.668 . . . . 0.0 106.842 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -67.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.572 0.624 . . . . 0.0 111.222 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 173.02 36.24 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.561 0.534 . . . . 0.0 112.331 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.9 152.3 37.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.78 114.29 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.818 1.19 . . . . 0.0 108.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.5 160.52 20.49 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.98 135.06 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -15.29 60.26 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.736 1.16 . . . . 0.0 112.704 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -70.59 147.23 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.619 1.71 . . . . 0.0 109.137 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -87.03 117.8 25.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 152.1 40.57 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -169.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.42 -24.66 36.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.373 3.382 . . . . 0.0 116.542 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 52.74 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.633 1.973 . . . . 0.0 114.324 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.12 -172.98 2.82 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.411 1.484 . . . . 0.0 108.872 172.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 m -122.92 154.76 37.92 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.946 0.899 . . . . 0.0 110.082 -168.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.02 165.02 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.096 2.158 . . . . 0.0 106.796 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tp -89.59 142.54 27.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -69.16 166.91 17.28 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -65.24 -4.13 4.83 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.71 -1.243 . . . . 0.0 111.941 168.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.3 m -115.01 17.68 16.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.102 2.161 . . . . 0.0 111.332 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.1 mt 65.59 37.77 5.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 113.021 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -122.83 157.09 33.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.03 143.24 35.84 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.739 -1.226 . . . . 0.0 109.167 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.04 142.98 32.91 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -138.51 167.03 22.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.516 -171.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tt -57.78 -35.97 71.53 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.96 -0.463 . . . . 0.0 111.188 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.93 54.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.896 . . . . 0.0 113.073 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.46 -37.87 19.26 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.402 1.081 . . . . 0.0 110.718 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.46 -39.37 91.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.96 0.904 . . . . 0.0 110.244 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -67.5 -0.25 3.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.65 -17.07 40.08 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 120.751 -1.218 . . . . 0.0 113.003 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -144.92 166.63 24.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.299 1.84 . . . . 0.0 106.678 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.18 116.68 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 m -125.51 139.35 53.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.809 0.338 . . . . 0.0 110.635 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 mt -103.13 141.77 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.67 95.81 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 125.92 1.688 . . . . 0.0 107.21 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -73.38 145.51 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.82 137.85 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 pt -141.56 150.12 56.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -48.83 10.15 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.986 1.79 . . . . 0.0 111.951 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -156.07 149.11 24.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 tt -79.33 3.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -89.13 -3.9 58.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.28 1.032 . . . . 0.0 111.964 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -65.5 -10.38 34.0 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.922 -1.111 . . . . 0.0 113.399 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.7 -50.1 4.35 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.323 1.44 . . . . 0.0 111.994 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.7 -2.83 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.919 0.888 . . . . 0.0 112.349 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -49.85 -31.5 12.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.369 1.468 . . . . 0.0 110.058 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.48 -50.74 51.81 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.853 1.261 . . . . 0.0 111.92 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.52 79.71 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.612 0.365 . . . . 0.0 110.921 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -85.43 -8.51 58.35 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.648 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -141.01 -60.91 0.49 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.861 1.21 . . . . 0.0 112.47 -169.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -71.87 -43.72 64.97 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.483 -1.386 . . . . 0.0 110.064 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.56 -35.98 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.998 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -62.46 -36.88 83.85 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.555 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -57.37 -45.98 83.87 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.752 1.16 . . . . 0.0 110.323 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.75 -50.18 65.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.831 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -32.18 72.78 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.134 -0.979 . . . . 0.0 110.929 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.98 93.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.911 0.884 . . . . 0.0 111.166 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.26 99.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.202 0.455 . . . . 0.0 109.947 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -65.13 -35.73 82.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.28 0.632 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -62.42 -19.4 63.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.168 0.987 . . . . 0.0 113.225 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.3 -43.27 3.11 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.497 1.046 . . . . 0.0 112.054 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -149.95 126.3 10.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.851 1.261 . . . . 0.0 108.563 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -165.52 174.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.354 2.262 . . . . 0.0 105.379 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -129.41 138.57 51.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -140.54 140.4 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -134.33 167.35 20.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.493 1.117 . . . . 0.0 109.493 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.4 m -131.63 144.15 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.82 141.85 43.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -142.5 156.78 45.18 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.021 0.528 . . . . 0.0 111.452 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.88 50.95 1.87 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.663 1.185 . . . . 0.0 108.047 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -142.71 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.328 1.451 . . . . 0.0 107.787 -169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.41 140.6 72.47 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 111.882 -168.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.49 -39.72 45.25 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.93 3.087 . . . . 0.0 114.498 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -74.42 -28.04 60.89 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.74 0.7 . . . . 0.0 111.604 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.27 -44.2 84.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.447 1.021 . . . . 0.0 108.941 172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -48.26 74.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.663 0.785 . . . . 0.0 111.095 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -41.21 97.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.416 0.553 . . . . 0.0 111.451 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -63.77 -41.48 97.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.103 0.561 . . . . 0.0 109.787 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -56.21 -48.48 76.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.416 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 66.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.882 0.764 . . . . 0.0 110.865 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.19 98.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.38 85.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.857 0.829 . . . . 0.0 110.758 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -86.69 -11.07 52.28 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.539 0.736 . . . . 0.0 112.672 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.48 27.85 68.79 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.182 0.901 . . . . 0.0 111.903 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.4 mt -76.54 147.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.188 0.995 . . . . 0.0 108.943 -174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.65 -39.08 0.47 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 111.849 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -11.18 59.86 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.335 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.32 155.44 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -135.27 134.41 39.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -89.14 151.08 22.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.181 0.992 . . . . 0.0 108.777 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 mt -141.59 166.18 25.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.78 2.032 . . . . 0.0 107.388 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.93 123.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -80.4 36.23 0.36 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.561 1.172 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -66.04 -10.43 39.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.738 1.615 . . . . 0.0 111.671 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -79.1 63.29 3.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.456 1.503 . . . . 0.0 108.743 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t0 47.05 44.83 15.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.818 2.047 . . . . 0.0 112.691 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 83.1 mmm 48.73 23.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.192 2.197 . . . . 0.0 114.127 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -63.64 -37.14 86.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.075 -1.016 . . . . 0.0 112.977 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.65 -48.86 62.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 109.65 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.3 61.63 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.33 -49.51 77.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.891 0.845 . . . . 0.0 109.24 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.7 -39.1 80.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.41 -3.08 21.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 113.2 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.26 62.75 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.322 0.965 . . . . 0.0 112.61 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.436 ' HA ' HD12 ' A' ' 13' ' ' LEU . 26.9 m -121.52 1.08 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.64 1.22 . . . . 0.0 112.449 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -90.89 120.28 31.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.9 mt -82.25 108.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -54.96 -38.53 67.86 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.159 1.383 . . . . 0.0 110.908 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -75.47 -10.85 59.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 112.628 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 mt -134.29 -19.77 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 53.42 42.17 32.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 109.17 -167.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -119.6 148.08 43.75 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.39 1.476 . . . . 0.0 107.249 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 tp -91.9 139.04 31.05 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.04 172.37 10.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.085 0.954 . . . . 0.0 111.13 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ttm105 -101.67 21.17 14.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.922 0.889 . . . . 0.0 111.475 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 m -58.66 176.31 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.285 2.234 . . . . 0.0 113.89 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.47 147.62 16.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.542 -1.349 . . . . 0.0 108.568 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.83 165.18 26.21 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 109.884 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.29 145.02 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.4 mt -131.0 130.21 43.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.431 -168.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.19 168.23 10.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 109.365 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.79 -14.61 22.67 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.207 -0.933 . . . . 0.0 113.511 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -93.8 6.82 47.15 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.539 -1.351 . . . . 0.0 111.743 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.61 22.28 73.29 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.865 -1.147 . . . . 0.0 111.978 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.78 135.53 34.5 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.695 1.248 . . . . 0.0 107.78 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.72 115.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.89 -34.25 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -162.05 144.72 11.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.219 1.808 . . . . 0.0 107.105 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.84 147.94 34.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.895 0.878 . . . . 0.0 108.725 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.26 135.16 26.76 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.053 1.341 . . . . 0.0 107.704 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -106.81 18.7 21.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.051 1.74 . . . . 0.0 112.951 -168.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.1 m 49.21 -16.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 130.193 3.397 . . . . 0.0 118.376 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 m 55.02 -7.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.048 2.939 . . . . 0.0 116.05 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.51 126.15 11.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.056 1.342 . . . . 0.0 112.649 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 80.9 p -93.43 12.8 23.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.148 1.34 . . . . 0.0 112.211 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.17 163.93 15.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.592 1.557 . . . . 0.0 109.765 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -124.65 157.43 65.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.224 1.41 . . . . 0.0 108.714 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.89 -167.49 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.346 2.697 . . . . 0.0 108.646 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -124.2 116.45 22.71 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -47.46 -29.0 2.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.954 2.101 . . . . 0.0 113.897 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.21 -36.49 77.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.15 0.432 . . . . 0.0 110.969 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -58.52 -58.21 20.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.801 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -24.15 23.1 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-O 116.814 -1.411 . . . . 0.0 112.553 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -47.22 94.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 121.332 1.878 . . . . 0.0 109.066 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.53 -34.84 79.17 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 110.855 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.5 62.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.672 0.389 . . . . 0.0 111.625 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.23 -48.44 70.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.631 0.772 . . . . 0.0 111.171 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -31.45 68.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.962 0.505 . . . . 0.0 111.515 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.28 -30.76 71.8 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.054 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.73 -39.29 7.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.682 0.674 . . . . 0.0 112.548 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.22 -23.49 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.161 0.585 . . . . 0.0 111.208 178.535 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 CA--C 1.534 0.352 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.286 16.2 mt 73.65 162.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.699 2.4 . . . . 0.0 111.068 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 p -125.02 165.87 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.812 2.045 . . . . 0.0 108.767 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -136.5 105.37 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 150' ' ' THR . 16.3 ptpt 31.4 56.81 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.115 2.166 . . . . 0.0 114.545 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.52 13.06 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.608 169.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.78 159.87 29.89 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.327 1.564 . . . . 0.0 110.501 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.16 156.73 37.99 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.108 2.539 . . . . 0.0 112.164 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.18 -161.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.926 1.691 . . . . 0.0 106.862 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.0 m -149.13 152.31 35.9 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.284 -1.51 . . . . 0.0 108.219 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.45 138.06 47.33 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.191 1.397 . . . . 0.0 108.406 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.65 -17.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.1 175.88 24.44 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.41 150.61 44.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.096 0.951 . . . . 0.0 111.794 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.37 123.37 26.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 168.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.75 162.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.892 1.224 . . . . 0.0 110.123 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -123.26 156.39 35.31 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.475 1.51 . . . . 0.0 107.72 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.07 135.1 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.34 68.52 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.473 -1.182 . . . . 0.0 112.998 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.02 149.73 49.78 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 108.976 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.35 128.23 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 169.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -60.98 142.38 92.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.353 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 36.1 Cg_exo -57.42 0.41 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.703 1 C-N-CA 126.102 4.535 . . . . 0.0 119.204 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.28 65.24 1.31 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.816 1.293 . . . . 0.0 111.902 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -74.67 164.54 26.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.568 1.547 . . . . 0.0 109.805 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.0 m -130.58 136.57 49.02 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.93 155.11 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.013 1.725 . . . . 0.0 106.618 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -85.39 139.11 31.81 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -70.99 164.87 24.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -67.08 -3.4 7.3 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.852 -1.155 . . . . 0.0 111.594 168.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -97.87 5.24 49.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.415 1.886 . . . . 0.0 111.836 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 63.31 42.72 6.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.82 1.248 . . . . 0.0 111.294 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.97 164.46 20.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -84.14 144.94 28.68 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 120.729 -1.232 . . . . 0.0 109.872 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -138.23 156.32 47.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.95 2.1 . . . . 0.0 106.092 171.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 p -149.48 169.8 20.06 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.293 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -47.02 -43.89 19.99 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.776 0.83 . . . . 0.0 111.347 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -30.57 66.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.949 0.9 . . . . 0.0 112.8 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.91 -40.27 60.97 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.382 0.673 . . . . 0.0 110.426 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.5 mtt -67.74 -25.08 65.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.283 1.033 . . . . 0.0 111.62 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -55.77 -14.84 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.225 1.01 . . . . 0.0 113.622 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.29 -23.27 57.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.754 -1.026 . . . . 0.0 113.672 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -151.77 156.86 41.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.677 1.739 . . . . 0.0 109.517 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.1 122.21 8.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 168.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.5 m -125.96 130.47 51.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.63 0.372 . . . . 0.0 110.923 -168.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.4 mt -89.71 141.43 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 mm -118.74 131.61 71.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -127.42 84.45 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.418 1.087 . . . . 0.0 108.16 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.9 143.65 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.73 169.95 9.77 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 106.989 169.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.27 -54.88 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.82 1.68 . . . . 0.0 110.812 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 m -151.37 170.37 19.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.409 2.284 . . . . 0.0 107.563 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -149.3 81.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.954 0.883 . . . . 0.0 109.206 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.68 6.42 1.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 t -152.64 -170.03 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.941 1.297 . . . . 0.0 107.782 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.28 -52.44 3.78 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.75 -29.68 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 117.897 0.849 . . . . 0.0 112.316 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.4 -24.7 64.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.688 0.676 . . . . 0.0 112.485 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -139.53 -95.68 0.16 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.191 0.997 . . . . 0.0 108.718 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.54 6.34 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.597 1.959 . . . . 0.0 114.581 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -87.7 -44.43 11.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.463 1.105 . . . . 0.0 108.353 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.0 m -51.31 -41.74 60.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.43 1.092 . . . . 0.0 112.393 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -65.28 -45.27 85.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -69.15 -39.23 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -56.73 -40.86 76.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.221 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -59.59 -46.09 89.95 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-N 119.348 0.977 . . . . 0.0 111.416 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.45 -55.72 16.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.392 0.677 . . . . 0.0 109.354 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 27.2 mm-40 -60.08 -40.97 91.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.859 0.754 . . . . 0.0 110.778 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.17 69.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.203 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.67 70.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.572 1.078 . . . . 0.0 110.299 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.93 -41.65 86.66 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.726 174.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.85 -40.78 92.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 110.551 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 -66.62 2.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.951 1.739 . . . . 0.0 110.939 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.69 45.36 1.19 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.725 1.61 . . . . 0.0 111.782 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.65 166.4 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.152 1.381 . . . . 0.0 107.734 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -132.24 146.08 51.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.28 145.32 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.31 155.37 47.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 108.706 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 104' ' ' THR . 54.4 m -117.23 145.81 43.67 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.29 138.05 53.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -140.48 159.18 42.76 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.973 0.909 . . . . 0.0 110.23 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.01 54.66 1.72 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -143.11 161.54 37.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.887 1.275 . . . . 0.0 108.757 -169.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.86 138.43 85.35 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.015 0.926 . . . . 0.0 108.93 -169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.25 -34.27 88.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.619 2.213 . . . . 0.0 112.129 -170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -73.86 -29.05 61.9 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.361 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.97 86.3 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.955 0.798 . . . . 0.0 109.381 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -62.89 -42.64 99.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.328 -0.232 . . . . 0.0 111.123 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.87 84.57 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.696 0.398 . . . . 0.0 111.25 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -63.5 -45.72 89.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -60.66 -40.32 91.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.503 0.321 . . . . 0.0 110.436 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.1 m -63.97 -46.1 86.14 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.005 -0.434 . . . . 0.0 111.315 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.38 94.63 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.65 67.67 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.871 0.868 . . . . 0.0 111.999 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -108.25 -4.89 17.15 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.897 0.879 . . . . 0.0 112.345 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.21 30.65 56.76 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.725 0.679 . . . . 0.0 111.528 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -72.19 143.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.412 1.085 . . . . 0.0 108.675 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.67 -38.38 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.619 1.168 . . . . 0.0 112.87 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -73.35 -21.13 60.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 112.342 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.48 157.79 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.22 143.77 36.18 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.429 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.9 p -96.86 149.96 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.79 0.836 . . . . 0.0 109.521 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.5 mt -137.7 139.4 40.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.592 1.157 . . . . 0.0 108.664 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.7 m -102.06 122.23 43.71 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.427 1.091 . . . . 0.0 108.874 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -104.23 -7.36 20.14 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.669 0.787 . . . . 0.0 111.825 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.51 -27.16 47.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.855 1.262 . . . . 0.0 112.817 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -62.33 -32.04 72.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -146.2 -8.24 0.53 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 50.63 31.02 5.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.421 1.488 . . . . 0.0 112.629 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 m -58.22 -55.47 34.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.296 -0.877 . . . . 0.0 111.136 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -67.26 -40.21 86.19 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.92 -45.09 32.19 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 126.337 1.922 . . . . 0.0 113.118 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.32 -41.31 18.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.903 0.851 . . . . 0.0 109.688 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.97 80.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.574 1.15 . . . . 0.0 112.384 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -105.64 10.79 32.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.812 1.245 . . . . 0.0 110.968 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.24 -3.3 2.46 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.068 -1.407 . . . . 0.0 115.578 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.79 -9.65 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.392 2.096 . . . . 0.0 113.836 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -75.11 120.77 21.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.992 1.269 . . . . 0.0 108.404 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.3 mt -93.7 110.69 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -54.36 -40.84 68.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.871 1.668 . . . . 0.0 111.837 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.24 -6.69 59.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.16 0.584 . . . . 0.0 112.45 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -126.03 -18.54 5.02 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.26 33.41 22.15 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -168.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.6 tp -128.0 171.23 12.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.318 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.3 141.19 47.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.158 0.983 . . . . 0.0 108.748 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 175.89 2.78 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.609 1.164 . . . . 0.0 111.066 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -113.65 18.36 17.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.1 m -63.19 162.35 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 111.727 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.86 147.86 28.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.726 0.81 . . . . 0.0 109.843 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -142.79 155.38 44.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.714 0.805 . . . . 0.0 108.923 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.01 135.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.9 mt -127.93 121.11 29.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.485 1.514 . . . . 0.0 107.276 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.48 160.65 18.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.061 0.945 . . . . 0.0 108.951 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.82 -19.09 15.46 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.772 1.229 . . . . 0.0 113.164 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -73.59 -11.96 60.6 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.534 -1.354 . . . . 0.0 112.465 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.55 43.92 8.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -127.7 131.42 49.75 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.0 109.25 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.974 1.31 . . . . 0.0 108.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.5 -39.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 125.432 1.493 . . . . 0.0 109.331 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -153.76 142.64 21.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.112 1.365 . . . . 0.0 107.504 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.89 139.12 27.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.4 145.26 27.97 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -120.19 131.62 55.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.192 1.397 . . . . 0.0 107.474 -172.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.4 -15.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.3 m 62.55 -12.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.723 2.009 . . . . 0.0 114.658 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -139.74 116.44 10.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.67 1.588 . . . . 0.0 107.029 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.16 66.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.962 1.305 . . . . 0.0 112.676 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.454 HG21 ' HE3' ' A' ' 7' ' ' LYS . 5.6 p -91.05 15.34 11.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.347 1.459 . . . . 0.0 111.545 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -138.52 123.1 18.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.366 1.466 . . . . 0.0 109.201 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 155.34 90.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.997 0.919 . . . . 0.0 112.034 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.65 -167.47 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.421 3.414 . . . . 0.0 109.547 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -124.78 116.65 22.63 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -53.38 -27.36 23.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 112.551 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.88 -34.06 71.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.454 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.19 -57.02 19.55 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.233 0.924 . . . . 0.0 111.761 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.34 -29.27 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.398 1.399 . . . . 0.0 111.873 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 mm -56.11 -48.46 79.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 119.878 1.217 . . . . 0.0 109.668 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -65.5 -28.79 69.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.891 0.769 . . . . 0.0 111.423 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.42 -49.83 57.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.394 0.543 . . . . 0.0 111.348 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.8 74.81 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.486 0.714 . . . . 0.0 111.566 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -20.3 63.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.407 0.683 . . . . 0.0 112.175 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.68 -26.65 67.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.72 0.691 . . . . 0.0 111.393 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.6 mt -107.1 -21.97 12.8 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.866 1.266 . . . . 0.0 113.362 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 m -65.96 -18.8 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 119.123 0.874 . . . . 0.0 112.483 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.406 1.082 . . . . 0.0 110.126 -178.227 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 122.18 0.991 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.46 140.72 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.287 1.035 . . . . 0.0 108.472 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 p -102.1 156.97 17.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.988 0.915 . . . . 0.0 109.777 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -104.43 41.83 1.27 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 63.26 -39.8 0.18 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.606 2.762 . . . . 0.0 114.551 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.03 -36.03 33.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.95 0.786 . . . . 0.0 112.015 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.79 177.31 48.06 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.08 153.1 27.51 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.914 3.076 . . . . 0.0 112.797 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.27 131.63 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.62 1.168 . . . . 0.0 108.752 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -63.03 151.28 40.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.446 1.499 . . . . 0.0 111.105 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 mt -122.65 139.63 53.73 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.981 2.112 . . . . 0.0 106.97 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.91 -16.8 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.93 169.1 28.73 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -71.8 159.4 34.38 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.002 0.906 . . . . 0.0 112.057 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -73.37 149.87 42.22 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.51 148.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -131.85 160.35 35.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 111.142 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 141.85 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.028 1.331 . . . . 0.0 109.646 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -22.51 26.35 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.051 1.31 . . . . 0.0 112.027 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -74.95 151.16 38.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.514 1.157 . . . . 0.0 109.91 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -71.29 123.63 22.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.46 152.03 75.21 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.36 -26.53 44.29 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.797 2.998 . . . . 0.0 116.065 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t0 51.38 86.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.282 1.833 . . . . 0.0 114.303 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -127.14 -176.02 3.6 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.798 1.639 . . . . 0.0 108.814 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 m -124.37 154.2 40.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.198 0.999 . . . . 0.0 111.014 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.65 166.33 26.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.883 2.073 . . . . 0.0 107.811 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 tp -84.89 143.92 28.72 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.4 p -71.22 166.86 20.64 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -67.31 -3.42 7.99 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.024 -1.672 . . . . 0.0 112.156 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 m -110.56 17.1 21.08 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.367 1.867 . . . . 0.0 111.323 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.4 mt 66.51 28.1 9.53 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.347 1.459 . . . . 0.0 112.829 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.76 174.34 5.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.03 146.61 43.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.178 -1.576 . . . . 0.0 109.992 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -141.37 136.28 31.3 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 p -124.01 164.11 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.243 1.017 . . . . 0.0 109.247 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.68 -36.69 69.89 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.08 -0.388 . . . . 0.0 110.254 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.53 54.27 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.48 -39.75 52.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 mtt -64.27 -24.81 67.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.632 1.173 . . . . 0.0 111.323 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -55.85 -14.06 2.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.464 1.106 . . . . 0.0 113.401 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.23 -24.36 44.2 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.424 1.011 . . . . 0.0 113.423 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -151.36 169.01 23.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.908 1.354 . . . . 0.0 108.832 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.5 t -62.71 122.43 13.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.0 m -129.39 135.28 48.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.521 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.42 141.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -127.76 120.21 53.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 125.372 1.469 . . . . 0.0 107.42 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.4 m -116.94 100.32 7.68 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.269 1.028 . . . . 0.0 108.395 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.6 136.66 22.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.74 157.69 74.49 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.81 -60.44 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.833 2.355 . . . . 0.0 110.578 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 m -148.49 152.37 36.77 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.295 1.438 . . . . 0.0 107.958 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.75 -18.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.688 1.195 . . . . 0.0 113.284 -173.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.8 19.17 18.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.893 0.877 . . . . 0.0 111.753 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 p -68.84 -6.37 26.6 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.22 4.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.505 1.526 . . . . 0.0 110.71 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.03 -11.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 122.001 -0.706 . . . . 0.0 111.985 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.14 -21.61 13.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.067 0.947 . . . . 0.0 111.384 169.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -47.77 -47.78 30.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.96 1.304 . . . . 0.0 111.674 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.0 91.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.882 0.473 . . . . 0.0 110.762 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -82.72 -6.58 59.47 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.629 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -136.25 -62.8 0.66 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.676 1.125 . . . . 0.0 111.304 -169.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -83.27 -45.26 14.03 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.798 -1.189 . . . . 0.0 110.998 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -62.97 -32.6 73.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.697 0.68 . . . . 0.0 109.974 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.1 -43.58 87.2 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.327 0.512 . . . . 0.0 111.687 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.15 -45.06 96.2 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.992 0.517 . . . . 0.0 111.342 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.43 -51.03 71.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.46 -38.07 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.627 1.103 . . . . 0.0 110.529 -173.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.05 78.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.46 76.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.04 0.836 . . . . 0.0 110.65 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -70.74 -37.36 73.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.817 0.735 . . . . 0.0 109.77 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.57 -45.07 92.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.627 0.771 . . . . 0.0 109.857 170.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.09 -47.65 1.19 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.191 1.377 . . . . 0.0 110.859 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -140.36 109.52 6.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.301 1.041 . . . . 0.0 109.775 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.1 p -158.75 -175.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.981 2.512 . . . . 0.0 104.97 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.406 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -137.62 138.18 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.84 142.58 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.01 154.74 51.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.697 0.799 . . . . 0.0 109.055 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.5 m -117.67 142.33 47.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.0 mt -131.31 136.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.92 158.69 42.82 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.199 0.999 . . . . 0.0 110.15 -170.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.65 3.16 56.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.669 0.788 . . . . 0.0 111.794 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -101.52 -174.9 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.118 0.967 . . . . 0.0 109.978 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 133.58 90.31 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.79 -37.42 54.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.393 2.729 . . . . 0.0 113.964 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -72.41 -28.64 63.1 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.503 -0.748 . . . . 0.0 111.782 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.59 74.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.13 0.877 . . . . 0.0 109.42 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.36 -49.18 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.262 0.625 . . . . 0.0 110.384 169.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.74 75.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.281 0.491 . . . . 0.0 111.73 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -67.08 -40.5 87.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.356 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.07 -49.29 78.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.99 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.4 m -58.86 -48.25 82.04 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.38 0.536 . . . . 0.0 111.343 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.32 86.1 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.528 -0.596 . . . . 0.0 112.284 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.06 -41.71 70.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.013 0.906 . . . . 0.0 110.567 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -85.98 -22.15 27.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 119.088 -0.482 . . . . 0.0 112.179 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.42 24.17 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.51 143.35 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -146.92 -36.66 0.23 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.642 0.777 . . . . 0.0 112.999 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.45 -21.56 59.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.406 0.548 . . . . 0.0 111.201 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.77 165.2 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.937 1.295 . . . . 0.0 108.247 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -142.7 137.62 30.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 p -85.24 145.99 27.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt -135.12 169.33 17.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.625 1.97 . . . . 0.0 107.276 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -135.66 105.01 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.605 0.762 . . . . 0.0 109.481 -169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.64 -15.46 62.79 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.408 0.683 . . . . 0.0 110.927 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -46.11 -20.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.008 2.523 . . . . 0.0 113.45 169.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -40.8 -60.6 1.13 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.904 1.682 . . . . 0.0 111.497 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.29 15.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.126 0.97 . . . . 0.0 111.071 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.07 18.35 1.7 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.225 1.81 . . . . 0.0 113.325 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -49.68 76.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.928 1.291 . . . . 0.0 112.035 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -77.72 -40.64 40.51 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.931 -0.481 . . . . 0.0 109.843 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.71 -36.79 91.77 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.86 -51.24 69.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 117.544 0.672 . . . . 0.0 109.594 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.9 92.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.75 4.38 44.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.06 0.944 . . . . 0.0 112.423 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.93 39.68 96.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.091 0.853 . . . . 0.0 113.449 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.76 -12.91 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.52 1.128 . . . . 0.0 111.522 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.37 108.75 8.37 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mt -80.1 108.35 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -53.61 -45.75 70.19 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.702 1.201 . . . . 0.0 110.893 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.32 -2.39 24.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.029 0.932 . . . . 0.0 113.236 -173.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -125.92 -18.39 5.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.382 1.073 . . . . 0.0 112.346 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 52.94 39.04 28.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.644 1.178 . . . . 0.0 109.645 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -138.16 150.58 46.93 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.24 1.016 . . . . 0.0 108.31 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.36 145.24 49.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.449 0.643 . . . . 0.0 110.745 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.26 177.11 1.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.007 2.123 . . . . 0.0 111.014 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -115.31 106.39 13.97 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 169.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 m -152.76 169.28 23.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 158' ' ' PRO . 11.8 p -152.53 146.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -138.85 158.81 43.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.265 1.026 . . . . 0.0 109.073 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.82 143.08 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 170.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 mt -129.31 126.37 38.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.915 1.686 . . . . 0.0 107.078 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.52 165.07 21.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.388 0.675 . . . . 0.0 109.454 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.04 -23.56 47.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.975 0.91 . . . . 0.0 112.385 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -76.43 -3.67 38.33 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.966 -1.084 . . . . 0.0 112.126 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.39 24.61 76.02 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.077 0.846 . . . . 0.0 112.045 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.32 142.25 28.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.32 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.8 -15.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.735 0.814 . . . . 0.0 111.556 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -152.38 145.28 24.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.47 141.79 25.18 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -148.68 140.78 23.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -122.41 123.09 40.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.77 133.24 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -68.06 -7.7 31.54 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.066 0.947 . . . . 0.0 113.309 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.03 122.35 13.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.474 1.11 . . . . 0.0 108.303 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.27 -22.71 64.73 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.905 0.882 . . . . 0.0 113.26 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.1 p -76.21 1.44 15.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.013 0.824 . . . . 0.0 111.91 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.48 156.79 44.19 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.917 2.087 . . . . 0.0 107.531 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.5 157.54 74.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.726 0.81 . . . . 0.0 111.951 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.1 168.88 22.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.798 2.332 . . . . 0.0 110.447 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -108.95 118.0 35.66 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -48.99 -28.13 3.68 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.317 2.247 . . . . 0.0 113.381 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.28 -38.51 83.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.575 0.625 . . . . 0.0 111.17 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.51 -53.18 54.08 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.712 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 131' ' ' VAL . 62.1 Cg_endo -68.72 -25.92 33.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.621 1.548 . . . . 0.0 112.063 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -44.59 95.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 120.255 1.389 . . . . 0.0 109.104 171.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.27 -33.04 74.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.197 0.908 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.31 -53.15 39.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.513 0.325 . . . . 0.0 110.986 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.24 76.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.565 0.746 . . . . 0.0 112.08 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.27 67.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.753 0.706 . . . . 0.0 111.649 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -64.78 -30.14 71.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.183 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.02 -31.39 8.77 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.83 -30.32 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.905 0.775 . . . . 0.0 112.249 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 21.2 pttp . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.495 0.718 . . . . 0.0 110.457 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.0 mt -140.63 171.26 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.281 2.632 . . . . 0.0 103.98 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 p -117.64 148.25 42.12 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 120.989 -1.069 . . . . 0.0 109.826 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -75.58 -18.34 59.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.875 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt 138.55 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 132.089 4.156 . . . . 0.0 109.586 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.17 -5.6 26.58 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.053 0.835 . . . . 0.0 113.586 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.6 47.16 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.2 164.58 35.22 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.609 2.873 . . . . 0.0 112.439 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.73 139.38 46.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.532 1.533 . . . . 0.0 108.266 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -74.52 148.55 40.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.545 0.738 . . . . 0.0 109.502 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.74 146.85 42.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.743 2.417 . . . . 0.0 105.984 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -74.12 -14.16 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 179.86 21.44 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 119.319 0.963 . . . . 0.0 112.888 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -90.89 148.67 22.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.689 0.796 . . . . 0.0 110.043 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.09 141.52 58.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.45 147.39 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -128.44 165.82 19.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.577 0.703 . . . . 0.0 112.12 -168.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -52.63 140.17 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.799 1.64 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.32 63.44 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.655 -1.08 . . . . 0.0 112.955 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.13 157.31 16.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.133 1.467 . . . . 0.0 109.873 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -66.1 134.92 53.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.15 155.47 84.17 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.24 -25.77 73.61 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.21 2.607 . . . . 0.0 115.841 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.9 t70 51.0 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.586 1.954 . . . . 0.0 114.866 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -129.23 -175.19 3.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.516 1.526 . . . . 0.0 109.225 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.1 m -121.41 151.63 39.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 109.957 -169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.68 163.65 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.764 2.426 . . . . 0.0 106.688 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tp -87.35 147.4 25.5 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 169.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.4 p -72.02 166.85 21.39 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -65.41 -4.44 5.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.689 -1.257 . . . . 0.0 111.571 168.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.9 m -114.66 17.04 17.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.157 2.183 . . . . 0.0 111.322 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.5 mt 66.19 41.13 3.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 112.98 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.63 154.77 41.81 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.83 141.0 40.85 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.76 -1.213 . . . . 0.0 108.798 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.06 144.42 33.58 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.074 1.349 . . . . 0.0 107.499 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 p -139.1 166.21 25.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.54 -35.85 70.85 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.471 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.62 -30.7 43.95 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 113.593 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.81 -40.34 33.18 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.647 0.779 . . . . 0.0 110.67 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.8 mtt -63.36 -24.49 67.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.791 1.237 . . . . 0.0 111.31 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.79 -14.59 2.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.49 1.116 . . . . 0.0 113.319 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.55 56.39 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.519 1.054 . . . . 0.0 114.013 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.68 162.48 41.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.256 1.528 . . . . 0.0 108.212 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.07 119.59 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -124.53 131.02 53.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.481 0.313 . . . . 0.0 111.129 -168.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.6 mt -89.49 143.83 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -126.68 132.91 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.5 m -128.72 88.26 2.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.94 0.896 . . . . 0.0 108.602 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.45 133.95 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.27 73.34 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.56 -60.04 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.028 2.486 . . . . 0.0 113.333 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 m -152.04 164.26 37.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.458 1.903 . . . . 0.0 106.969 -170.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 tp -79.6 -17.87 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.77 -0.582 . . . . 0.0 112.23 -169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.79 -21.72 54.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.086 -1.008 . . . . 0.0 112.858 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 t -70.6 112.22 6.69 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 0.0 111.191 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.49 -31.32 80.37 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.566 -0.709 . . . . 0.0 112.843 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.23 -15.77 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.464 1.132 . . . . 0.0 112.419 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -105.93 -14.25 15.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.769 0.827 . . . . 0.0 112.336 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.59 -44.03 93.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.736 0.698 . . . . 0.0 109.545 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.41 93.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.424 0.69 . . . . 0.0 111.367 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -58.94 -56.15 25.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.59 0.632 . . . . 0.0 109.483 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.434 HG21 ' HE1' ' A' ' 93' ' ' TRP . 30.5 m -65.88 -35.59 81.06 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.169 0.895 . . . . 0.0 111.404 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -60.61 -49.65 76.68 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.523 1.056 . . . . 0.0 110.686 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.18 -34.44 76.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.911 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.17 -43.31 74.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.146 1.339 . . . . 0.0 110.915 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.51 -47.75 84.17 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.171 0.441 . . . . 0.0 111.606 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -63.45 -49.23 74.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.915 0.886 . . . . 0.0 109.085 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.04 -38.68 91.67 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.006 0.821 . . . . 0.0 110.591 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.99 97.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.974 0.806 . . . . 0.0 111.26 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.82 88.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.138 0.426 . . . . 0.0 111.103 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.07 -39.69 82.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.795 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.83 -40.69 96.16 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.203 0.911 . . . . 0.0 110.292 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.79 -24.44 12.69 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.624 1.107 . . . . 0.0 112.912 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -148.95 102.91 3.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.341 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.47 171.64 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.262 2.225 . . . . 0.0 105.069 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -128.68 143.04 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -153.14 144.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -135.92 158.43 44.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.028 1.331 . . . . 0.0 109.392 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -119.27 148.51 43.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mt -134.31 134.49 54.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.84 158.97 42.04 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.766 0.827 . . . . 0.0 109.881 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.36 41.79 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -129.46 165.75 20.98 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 111.271 -168.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.99 127.38 90.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 126.874 2.069 . . . . 0.0 108.621 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.05 -38.6 32.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.458 2.772 . . . . 0.0 113.94 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.45 -27.96 41.61 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.791 -0.568 . . . . 0.0 112.24 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.72 -42.37 67.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.374 0.988 . . . . 0.0 109.525 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -55.42 -42.92 74.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.176 0.99 . . . . 0.0 111.531 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.62 91.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.015 0.526 . . . . 0.0 111.414 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -66.42 -44.28 83.39 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.709 -0.62 . . . . 0.0 109.546 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.434 ' HE1' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -56.6 -43.13 79.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.708 0.803 . . . . 0.0 111.165 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.46 -35.84 34.32 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.823 0.738 . . . . 0.0 111.048 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.72 98.77 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.61 82.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.498 0.719 . . . . 0.0 111.085 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.57 -10.69 59.79 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.47 30.7 59.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 119.399 0.999 . . . . 0.0 111.008 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.0 mm -67.37 148.65 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.525 1.13 . . . . 0.0 108.117 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -137.69 -38.65 0.58 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 111.585 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -87.69 -22.72 24.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.239 1.016 . . . . 0.0 112.621 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.91 162.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -141.16 143.75 34.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 149.41 21.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 mt -135.48 156.23 49.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.916 1.287 . . . . 0.0 109.15 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -120.94 97.91 5.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.836 1.255 . . . . 0.0 109.181 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.23 -7.25 56.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.04 0.536 . . . . 0.0 110.839 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -43.46 -28.0 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.08 2.552 . . . . 0.0 114.018 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -57.42 -46.07 83.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.938 0.895 . . . . 0.0 111.731 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.98 11.47 0.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.5 mmm 53.55 20.45 2.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.205 . . . . 0.0 114.967 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.4 m -58.36 -44.07 88.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.22 0.918 . . . . 0.0 112.364 -171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -70.64 -46.57 63.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.89 -38.13 84.61 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.55 -50.69 72.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.023 0.911 . . . . 0.0 109.509 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.89 -8.2 57.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.384 0.674 . . . . 0.0 112.449 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.8 45.56 57.49 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.459 1.027 . . . . 0.0 112.029 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.1 25.29 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 110.764 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -116.8 119.18 34.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.36 102.21 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.06 -35.81 36.68 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.936 1.694 . . . . 0.0 111.317 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.01 -14.54 61.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.5 mt -130.83 -21.0 2.77 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 59.79 34.94 22.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.828 0.851 . . . . 0.0 110.028 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.62 154.07 45.68 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.647 1.179 . . . . 0.0 108.361 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.69 157.36 36.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.233 0.54 . . . . 0.0 110.163 172.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.04 -178.69 2.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.41 1.484 . . . . 0.0 110.551 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -106.06 13.39 29.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.793 0.837 . . . . 0.0 111.671 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.7 m -63.05 159.19 17.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.337 1.855 . . . . 0.0 112.886 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.79 149.12 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.631 0.773 . . . . 0.0 109.346 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -137.37 163.0 32.07 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.344 1.058 . . . . 0.0 109.774 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.82 140.94 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.9 mt -131.4 128.07 38.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.62 167.16 17.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.968 0.907 . . . . 0.0 109.86 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.89 -23.93 63.86 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.406 -0.809 . . . . 0.0 112.284 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -75.78 -11.44 59.99 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.731 -1.231 . . . . 0.0 111.827 172.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.93 22.44 71.69 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.146 0.879 . . . . 0.0 112.465 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -82.5 145.58 29.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.39 126.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -101.96 -34.84 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.727 1.611 . . . . 0.0 109.394 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -151.6 143.96 24.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 138.45 22.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.89 143.82 33.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.86 100.63 6.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.328 1.851 . . . . 0.0 106.43 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.55 119.42 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 m -71.06 -8.83 56.11 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -139.85 125.9 19.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.613 1.097 . . . . 0.0 108.311 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.19 70.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.785 0.834 . . . . 0.0 112.406 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 p -82.42 6.22 17.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.221 1.008 . . . . 0.0 112.892 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -120.16 162.32 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.251 1.42 . . . . 0.0 109.197 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -117.56 162.78 26.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.445 1.498 . . . . 0.0 110.106 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.17 -171.46 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.137 2.558 . . . . 0.0 109.918 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -128.68 112.4 14.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -56.58 -28.27 59.85 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.913 1.685 . . . . 0.0 112.897 -169.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.39 -31.87 73.2 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.889 -0.507 . . . . 0.0 111.754 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -61.8 -54.61 49.59 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.843 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.09 -26.95 49.94 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 CA-C-N 120.842 1.336 . . . . 0.0 111.822 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -44.05 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 120.218 1.372 . . . . 0.0 109.948 171.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.78 -32.29 73.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.137 0.88 . . . . 0.0 110.45 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.72 -49.64 57.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.3 0.24 . . . . 0.0 111.586 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.14 72.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.076 0.55 . . . . 0.0 112.018 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.49 64.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.496 0.718 . . . . 0.0 112.657 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.6 mt -111.35 -28.68 8.12 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.96 -11.94 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.3 pttt . . . . . 0 C--O 1.249 1.039 0 C-N-CA 125.864 1.665 . . . . 0.0 108.272 -176.474 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 122.427 1.108 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.02 145.94 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.026 1.33 . . . . 0.0 108.269 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -115.33 153.41 31.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.309 1.444 . . . . 0.0 109.396 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -110.91 42.6 1.58 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.822 1.249 . . . . 0.0 108.99 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm 42.0 64.65 1.04 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.738 2.015 . . . . 0.0 111.755 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.17 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.658 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 172.11 44.17 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.465 1.031 . . . . 0.0 110.573 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.76 159.75 51.64 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.403 2.735 . . . . 0.0 110.995 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.77 129.61 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.415 1.086 . . . . 0.0 108.386 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -61.74 156.36 20.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.492 1.517 . . . . 0.0 111.131 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.82 133.65 41.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.74 1.616 . . . . 0.0 109.284 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.29 161.52 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.75 -159.01 52.74 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.109 -0.994 . . . . 0.0 111.346 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.05 147.65 52.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.175 1.39 . . . . 0.0 109.205 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -66.13 115.42 6.12 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.3 158.37 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.969 1.307 . . . . 0.0 107.617 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -134.49 159.51 40.91 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 111.048 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.28 142.88 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.124 0.97 . . . . 0.0 108.999 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -22.28 24.43 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.03 1.3 . . . . 0.0 112.367 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -74.5 154.41 38.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.64 1.22 . . . . 0.0 109.839 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -70.14 132.69 46.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.71 158.82 48.74 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.74 -3.84 3.99 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.154 3.236 . . . . 0.0 117.548 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t0 53.64 57.76 5.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.978 1.371 . . . . 0.0 111.791 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -79.47 167.03 21.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.361 1.865 . . . . 0.0 110.26 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -135.03 148.29 49.89 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.33 170.74 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.981 2.112 . . . . 0.0 108.251 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -102.08 143.27 32.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.269 1.028 . . . . 0.0 108.808 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -74.05 -15.75 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 102.84 -14.92 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 130.264 3.426 . . . . 0.0 108.129 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -119.07 22.08 12.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.145 1.778 . . . . 0.0 111.052 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp 61.66 40.31 13.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.882 1.673 . . . . 0.0 111.656 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.88 156.05 43.2 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.42 152.37 19.15 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.381 0.61 . . . . 0.0 109.735 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.91 148.7 32.05 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.427 1.891 . . . . 0.0 106.139 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 p -149.97 171.66 16.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.531 0.605 . . . . 0.0 109.821 -169.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -43.47 -45.81 6.55 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 111.552 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.01 -29.01 66.93 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.963 0.905 . . . . 0.0 112.866 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -39.99 21.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.771 0.828 . . . . 0.0 110.717 174.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt -71.36 -34.87 70.86 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.154 0.582 . . . . 0.0 111.008 -170.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -63.85 -3.48 2.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.67 -21.84 23.31 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.146 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.44 168.26 20.97 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.26 1.53 . . . . 0.0 108.631 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.99 124.42 17.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.9 m -131.68 134.05 45.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.141 0.275 . . . . 0.0 111.11 -168.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.0 mt -93.21 141.1 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -123.48 133.54 68.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -129.34 106.05 8.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.4 127.93 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 pt -137.79 137.49 21.74 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.11 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.967 2.444 . . . . 0.0 114.185 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.3 m -159.45 158.25 31.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.882 1.673 . . . . 0.0 106.92 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -90.1 12.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 122.198 -0.314 . . . . 0.0 111.649 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -118.77 15.69 13.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.109 1.364 . . . . 0.0 110.338 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.42 -11.5 60.87 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.303 1.441 . . . . 0.0 113.395 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 -51.8 4.59 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.57 -22.44 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 118.028 0.914 . . . . 0.0 111.878 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.0 p -49.64 -36.21 23.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.272 1.029 . . . . 0.0 112.278 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.93 -38.32 90.53 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.928 0.891 . . . . 0.0 110.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.52 17.38 3.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.395 1.478 . . . . 0.0 112.003 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -132.16 -79.03 0.5 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.206 1.003 . . . . 0.0 108.338 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -52.9 -53.63 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.903 1.281 . . . . 0.0 112.991 -168.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -79.31 -27.9 42.16 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.172 -0.955 . . . . 0.0 112.126 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -62.51 -43.73 98.1 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.767 1.167 . . . . 0.0 109.689 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -58.43 -37.51 75.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.473 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -59.19 -49.57 77.33 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.566 1.076 . . . . 0.0 111.311 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.68 -47.43 66.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -64.0 -36.14 83.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.346 0.975 . . . . 0.0 111.034 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.13 86.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.868 0.758 . . . . 0.0 111.379 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.94 93.96 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.638 0.654 . . . . 0.0 110.273 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -34.4 78.19 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.609 0.641 . . . . 0.0 111.496 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.29 -22.23 65.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.062 0.846 . . . . 0.0 112.074 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 -43.42 3.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.947 1.26 . . . . 0.0 112.075 174.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.64 117.62 5.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.03 1.332 . . . . 0.0 108.928 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 78' ' ' ASN . 12.3 p -158.89 -175.6 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.086 2.154 . . . . 0.0 105.484 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.462 ' H ' HG22 ' A' ' 77' ' ' VAL . 48.6 t30 -139.66 138.22 35.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.36 138.87 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -128.81 159.39 35.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 m -126.7 145.92 50.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.95 138.04 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -140.94 152.57 45.1 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 123.51 0.506 . . . . 0.0 111.408 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.99 43.79 0.72 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.679 1.192 . . . . 0.0 108.663 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -131.05 158.7 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.589 1.556 . . . . 0.0 108.925 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.85 134.9 96.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.846 1.258 . . . . 0.0 111.08 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.85 -42.18 6.48 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 124.994 3.796 . . . . 0.0 115.554 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.66 -28.56 60.9 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.11 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.29 70.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.379 0.991 . . . . 0.0 109.419 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.9 -47.31 64.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.919 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.23 70.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.359 0.264 . . . . 0.0 111.364 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -61.76 -45.58 93.27 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.286 0.634 . . . . 0.0 110.789 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.0 -37.88 88.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.896 0.316 . . . . 0.0 110.476 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.2 m -66.84 -41.51 87.3 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.798 -0.564 . . . . 0.0 111.737 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -35.52 92.15 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.34 70.86 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.772 0.786 . . . . 0.0 110.243 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -78.92 -21.52 47.19 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.71 15.42 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.31 144.21 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -145.75 -37.43 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.614 1.166 . . . . 0.0 112.698 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -84.88 -13.37 51.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.559 0.743 . . . . 0.0 112.258 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.03 155.99 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -133.85 124.82 27.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 p -79.47 157.2 27.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.676 0.791 . . . . 0.0 109.339 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.4 mt -144.18 164.57 30.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.785 1.634 . . . . 0.0 108.102 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -118.21 140.98 48.98 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.544 -0.723 . . . . 0.0 109.389 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.54 5.59 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.18 1.792 . . . . 0.0 109.952 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -59.59 -26.72 65.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 111.841 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -60.17 -46.05 91.01 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.961 0.904 . . . . 0.0 111.87 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -156.01 14.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 95.0 mmm 48.12 26.51 1.04 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.849 2.06 . . . . 0.0 113.968 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.39 -50.14 73.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.643 1.177 . . . . 0.0 111.711 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.98 -48.66 75.56 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.145 0.884 . . . . 0.0 109.405 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.34 -47.67 80.88 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.29 -50.15 64.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.255 1.022 . . . . 0.0 109.832 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 7.58 43.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 112.154 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.94 36.57 86.65 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.735 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.7 -13.41 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.553 1.177 . . . . 0.0 111.636 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 104.94 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.78 98.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.36 -34.74 49.0 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.793 1.637 . . . . 0.0 111.108 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.62 -17.08 62.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.7 pp -146.78 16.47 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.962 1.256 . . . . 0.0 114.327 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 48.39 51.13 15.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.197 1.799 . . . . 0.0 111.685 169.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -152.28 150.44 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 51' ' ' VAL . 4.1 pp -81.45 156.02 25.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.688 0.676 . . . . 0.0 110.569 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.48 -155.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.856 2.062 . . . . 0.0 112.538 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.42 118.3 22.89 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 m -162.06 163.16 28.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -170.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.13 147.79 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.013 0.925 . . . . 0.0 108.685 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -138.68 156.83 47.08 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.064 0.945 . . . . 0.0 108.649 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.0 t -135.2 143.73 36.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.8 mt -128.27 126.21 40.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.939 1.695 . . . . 0.0 108.227 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.59 163.62 25.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.607 1.163 . . . . 0.0 110.154 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.25 -15.52 25.51 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.1 10.57 41.18 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.687 1.131 . . . . 0.0 112.225 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.43 76.99 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.978 . . . . 0.0 112.88 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.91 144.25 25.45 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.294 1.047 . . . . 0.0 108.442 173.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.39 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.65 -16.4 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.728 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -151.68 144.38 24.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.77 139.15 23.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -151.66 137.16 17.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -122.31 122.18 38.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.3 t -72.67 123.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.3 m -61.81 -40.67 96.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.584 0.353 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -83.6 109.55 17.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.943 0.897 . . . . 0.0 109.232 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.98 62.7 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.694 -0.629 . . . . 0.0 111.676 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -71.82 -1.08 12.84 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.084 1.354 . . . . 0.0 113.124 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.78 171.22 13.78 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.58 1.552 . . . . 0.0 110.067 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -128.55 156.84 76.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.518 1.527 . . . . 0.0 109.302 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.64 154.18 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.964 1.776 . . . . 0.0 109.391 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -79.61 116.01 19.56 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -52.43 -24.91 8.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.011 1.725 . . . . 0.0 113.459 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -62.34 -35.48 79.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.807 0.73 . . . . 0.0 111.467 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -64.58 -50.8 63.38 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 121.172 -0.955 . . . . 0.0 112.335 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.29 -25.95 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.075 1.42 . . . . 0.0 111.53 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -44.29 97.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 109.597 171.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.62 -33.28 75.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.325 0.966 . . . . 0.0 111.088 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.85 38.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.338 0.255 . . . . 0.0 110.915 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.29 78.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.232 0.613 . . . . 0.0 112.419 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -29.45 67.61 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.665 0.666 . . . . 0.0 111.709 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.1 68.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.219 0.607 . . . . 0.0 112.256 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.94 -28.66 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.38 -12.41 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.059 0.944 . . . . 0.0 110.087 178.041 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 122.852 1.311 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.84 153.45 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.804 2.042 . . . . 0.0 109.095 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -94.45 155.3 17.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.504 1.122 . . . . 0.0 108.407 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -132.59 108.26 8.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt 27.14 56.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.668 2.387 . . . . 0.0 115.253 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.73 -2.2 27.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 117.801 -1.555 . . . . 0.0 115.652 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.51 147.18 18.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 120.578 2.189 . . . . 0.0 111.988 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.78 154.32 67.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.056 2.504 . . . . 0.0 110.651 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.0 145.4 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.553 0.692 . . . . 0.0 110.11 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -79.52 156.88 27.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.919 1.288 . . . . 0.0 111.286 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.62 142.13 51.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.099 1.76 . . . . 0.0 108.843 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.17 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.44 -160.96 22.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.12 146.99 52.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.851 0.86 . . . . 0.0 109.266 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -65.56 113.76 4.42 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -73.06 169.53 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.401 0.546 . . . . 0.0 109.708 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.93 160.85 37.33 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.148 0.979 . . . . 0.0 109.065 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.58 137.8 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.32 -16.14 60.54 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.538 -1.146 . . . . 0.0 112.614 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.36 160.32 24.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.318 1.559 . . . . 0.0 109.941 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -99.92 121.84 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -55.05 136.95 67.07 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.595 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 49.9 Cg_exo -58.76 0.51 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.657 1 C-N-CA 126.112 4.541 . . . . 0.0 119.263 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.29 64.88 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.812 1.291 . . . . 0.0 111.447 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -73.62 165.45 25.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.698 1.599 . . . . 0.0 109.929 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.6 m -133.16 149.34 52.07 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.69 162.38 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.759 2.023 . . . . 0.0 106.734 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 tp -88.63 135.86 33.29 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -65.12 162.91 16.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -64.88 -8.52 15.74 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.663 -1.273 . . . . 0.0 111.004 168.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 m -95.27 6.41 49.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.874 2.07 . . . . 0.0 111.696 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.7 mt 70.84 35.88 1.65 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.32 1.448 . . . . 0.0 112.319 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.09 152.34 44.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.52 139.88 40.94 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.763 -1.211 . . . . 0.0 108.968 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -136.95 145.54 44.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.4 p -144.38 170.81 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.165 0.586 . . . . 0.0 109.701 -170.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -46.77 -44.75 19.31 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.374 0.67 . . . . 0.0 110.796 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.19 63.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.817 0.847 . . . . 0.0 113.022 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.31 -41.04 42.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.515 0.726 . . . . 0.0 110.542 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.7 mtt -69.05 -22.73 64.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.214 1.005 . . . . 0.0 111.877 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.08 -16.56 3.04 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.664 1.186 . . . . 0.0 113.291 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.55 53.25 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.763 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -153.13 160.09 42.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.456 1.628 . . . . 0.0 109.15 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.63 120.09 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.1 m -123.56 131.03 53.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.027 0.441 . . . . 0.0 110.639 -168.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.0 mt -89.37 141.58 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.64 137.81 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.7 m -131.31 94.53 3.58 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.86 143.43 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.48 150.02 59.33 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.656 0.783 . . . . 0.0 111.373 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.92 123.35 9.25 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.679 2.253 . . . . 0.0 110.047 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m 48.08 -162.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.471 1.509 . . . . 0.0 113.224 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 90' ' ' GLN . 3.7 tt -148.04 -22.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 120.882 -1.136 . . . . 0.0 111.51 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.92 -24.8 67.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.972 -1.08 . . . . 0.0 112.807 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.6 p -73.0 -17.77 61.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.137 1.375 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.04 -53.15 3.75 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.021 1.296 . . . . 0.0 112.805 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.55 -14.5 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.102 0.951 . . . . 0.0 110.457 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 14.3 p -49.56 -31.31 10.15 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.846 1.658 . . . . 0.0 113.449 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.66 130.57 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.578 1.081 . . . . 0.0 113.49 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.85 -6.43 8.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.498 1.919 . . . . 0.0 108.821 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -33.07 23.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.155 0.982 . . . . 0.0 110.803 -170.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 p -53.55 -48.31 69.22 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.071 1.305 . . . . 0.0 112.327 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -39.15 91.88 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.91 0.777 . . . . 0.0 110.959 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -66.76 -45.34 78.87 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.956 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -57.56 -41.34 80.84 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.88 0.764 . . . . 0.0 111.31 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -60.35 -50.87 71.9 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.653 0.781 . . . . 0.0 110.471 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.02 -41.63 77.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -67.86 -36.19 79.85 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.86 96.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.956 0.798 . . . . 0.0 110.884 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.07 93.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.925 0.33 . . . . 0.0 111.125 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -65.91 -40.98 91.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.43 -40.2 95.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.51 1.05 . . . . 0.0 110.25 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.3 10.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.818 1.199 . . . . 0.0 112.002 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -152.68 112.0 3.86 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.557 1.143 . . . . 0.0 109.121 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.86 176.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.405 2.282 . . . . 0.0 105.275 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -134.5 141.07 46.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.07 141.46 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -134.08 153.24 51.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.817 0.847 . . . . 0.0 109.917 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -108.58 146.67 32.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.23 135.0 57.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 m -131.36 152.51 50.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.307 1.043 . . . . 0.0 109.652 -170.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.37 52.24 1.02 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -140.08 165.06 28.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.98 145.96 96.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 123.268 0.627 . . . . 0.0 110.249 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.27 -32.07 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.623 2.215 . . . . 0.0 112.766 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -79.28 -22.13 45.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.199 0.909 . . . . 0.0 112.212 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.61 53.44 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.173 -0.955 . . . . 0.0 108.718 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' ILE . 66.4 mt-30 -51.36 -56.42 13.24 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.31 1.044 . . . . 0.0 110.492 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.15 -42.32 80.78 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.787 0.835 . . . . 0.0 111.843 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.0 -44.81 62.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.459 ' CE3' HD11 ' A' ' 55' ' ' ILE . 44.7 t90 -63.97 -39.62 94.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.976 0.511 . . . . 0.0 111.134 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.49 -36.29 57.89 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.212 -1.555 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.19 93.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.85 -45.37 82.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.646 0.778 . . . . 0.0 110.537 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -68.4 -24.09 64.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.521 0.728 . . . . 0.0 111.683 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.24 25.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.527 1.06 . . . . 0.0 111.837 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.18 142.87 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.152 0.981 . . . . 0.0 108.435 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -143.6 -44.31 0.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.485 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.67 -11.81 59.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.027 0.931 . . . . 0.0 111.941 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.49 160.94 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -140.6 145.8 37.16 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 p -89.68 139.49 30.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.905 1.682 . . . . 0.0 109.799 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 mt -131.14 168.91 16.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.615 1.966 . . . . 0.0 109.354 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.38 105.95 11.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.686 1.194 . . . . 0.0 111.683 -168.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -72.71 -21.94 60.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -52.57 -14.3 0.49 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.839 2.056 . . . . 0.0 113.121 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -45.91 -57.33 4.45 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.944 1.297 . . . . 0.0 110.821 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -164.59 16.49 0.05 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.2 mmm 55.86 26.35 9.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.761 1.624 . . . . 0.0 111.039 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -38.12 82.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.116 0.966 . . . . 0.0 113.018 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -74.06 -42.47 60.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.106 1.321 . . . . 0.0 108.907 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -41.64 -60.13 2.56 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.396 1.95 . . . . 0.0 111.884 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.8 -39.66 69.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.242 1.017 . . . . 0.0 110.473 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.63 95.42 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.23 0.612 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.43 9.25 37.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 113.208 -169.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.3 37.69 86.6 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.118 0.872 . . . . 0.0 111.972 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.452 HG23 ' HA2' ' A' ' 114' ' ' GLY . 8.1 m -126.54 3.92 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.56 1.144 . . . . 0.0 112.588 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -83.19 108.45 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.532 1.515 . . . . 0.0 107.183 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.91 111.56 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -55.4 -53.55 54.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.176 1.79 . . . . 0.0 111.406 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.79 -29.05 55.87 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.499 0.32 . . . . 0.0 111.255 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -79.5 -22.18 44.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.974 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 56.44 36.28 27.29 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -168.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -135.22 154.73 51.49 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.934 0.894 . . . . 0.0 109.745 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.36 142.69 52.11 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.458 0.703 . . . . 0.0 109.382 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.39 -168.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.801 1.64 . . . . 0.0 111.387 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -127.3 127.8 44.92 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -170.18 170.98 7.07 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.763 1.625 . . . . 0.0 106.968 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.6 145.12 30.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -137.46 156.79 47.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.328 1.051 . . . . 0.0 108.635 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 t -134.74 140.36 45.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.2 mt -129.07 126.39 39.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.434 1.494 . . . . 0.0 107.448 -169.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.94 167.73 9.23 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 109.147 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.12 -21.88 35.64 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.178 -0.951 . . . . 0.0 112.587 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -81.73 -7.5 59.6 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.594 -1.316 . . . . 0.0 112.543 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.03 16.77 80.46 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 120.872 -1.142 . . . . 0.0 112.133 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -77.79 133.66 38.18 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.12 110.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.55 -36.2 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.058 1.343 . . . . 0.0 109.687 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -151.47 145.22 25.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.05 133.6 18.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.99 137.07 22.07 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -104.8 117.21 33.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.9 127.96 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -69.76 -6.21 30.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -140.94 115.9 9.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 120.299 1.409 . . . . 0.0 107.475 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.61 69.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 -24.21 66.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.394 0.678 . . . . 0.0 111.113 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -100.82 126.31 47.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.169 1.388 . . . . 0.0 108.047 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -72.64 149.51 90.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.09 162.12 43.03 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.547 3.498 . . . . 0.0 109.596 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -96.36 120.38 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -55.98 -28.07 55.52 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.337 1.455 . . . . 0.0 112.703 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.16 -34.17 74.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.441 0.564 . . . . 0.0 111.426 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -65.06 -54.46 33.7 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 118.875 0.762 . . . . 0.0 111.692 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -30.44 24.05 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.486 1.458 . . . . 0.0 111.894 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 mm -54.43 -50.14 59.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 119.599 1.091 . . . . 0.0 109.523 169.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.32 -30.5 71.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.672 0.669 . . . . 0.0 111.494 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.09 71.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.164 0.438 . . . . 0.0 111.72 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.8 -45.55 57.91 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.452 0.701 . . . . 0.0 111.824 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -28.79 64.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.45 0.7 . . . . 0.0 111.56 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 -29.33 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 112.534 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 mt -103.63 -29.12 11.3 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.55 -10.64 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.094 0.957 . . . . 0.0 110.144 177.34 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 122.679 1.228 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 99.2 mt -54.85 156.73 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.733 1.613 . . . . 0.0 108.817 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.17 128.32 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.907 1.283 . . . . 0.0 108.177 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -84.68 42.58 0.92 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 110.268 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt 38.23 60.29 1.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.885 2.074 . . . . 0.0 112.337 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.75 -24.63 0.14 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.761 0.696 . . . . 0.0 111.646 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.35 169.05 40.58 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.94 155.3 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.144 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 m -136.54 166.37 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 107.949 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.9 m -117.18 161.05 20.08 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.033 0.933 . . . . 0.0 108.971 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 mt -125.54 141.98 51.75 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.852 1.661 . . . . 0.0 106.986 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.43 -65.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.25 165.72 54.77 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.49 165.29 24.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.708 0.766 . . . . 0.0 110.658 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.19 117.52 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.5 t -76.54 154.53 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -130.49 163.85 26.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 121.453 -0.779 . . . . 0.0 110.007 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.51 144.89 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.81 78.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.864 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -118.5 154.84 31.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.911 1.355 . . . . 0.0 108.814 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -65.87 134.86 53.93 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.51 159.24 61.74 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.732 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.23 -29.81 58.72 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.71 2.94 . . . . 0.0 115.845 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t0 46.72 86.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.258 1.823 . . . . 0.0 114.117 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -127.36 -172.79 2.74 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.284 1.433 . . . . 0.0 108.843 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.0 m -120.58 151.65 39.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.679 1.192 . . . . 0.0 110.461 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.61 165.06 27.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.723 2.409 . . . . 0.0 106.85 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.07 135.78 33.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -67.09 162.94 21.15 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.14 -10.41 49.94 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.488 -1.383 . . . . 0.0 110.816 168.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -82.1 3.38 27.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.578 1.951 . . . . 0.0 111.43 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.3 mt 68.44 30.93 5.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.897 2.079 . . . . 0.0 112.211 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.58 140.39 48.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.01 140.41 49.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.325 1.05 . . . . 0.0 111.456 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -141.68 143.48 33.61 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 126.094 1.757 . . . . 0.0 106.823 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -130.99 160.05 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tt -56.88 -33.92 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.257 0.481 . . . . 0.0 110.927 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.45 -29.62 50.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.092 0.957 . . . . 0.0 113.393 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -78.39 -40.34 36.45 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.125 0.97 . . . . 0.0 110.444 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.1 mtt -63.03 -27.29 69.31 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.953 1.301 . . . . 0.0 111.49 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -55.28 -15.46 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.058 . . . . 0.0 113.071 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.77 46.01 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.654 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -149.78 155.99 41.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.688 1.744 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.2 118.18 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.6 m -119.8 148.76 43.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.018 0.527 . . . . 0.0 110.029 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.22 146.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.12 138.57 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -113.17 99.63 7.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.518 1.527 . . . . 0.0 108.088 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.85 125.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 pt -133.55 155.3 80.73 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.281 1.032 . . . . 0.0 109.004 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.57 -58.1 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.95 2.433 . . . . 0.0 111.858 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.3 m -153.04 157.8 41.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.454 1.901 . . . . 0.0 106.732 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.07 -5.7 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.303 0.956 . . . . 0.0 111.52 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.9 -3.24 43.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.417 1.087 . . . . 0.0 112.623 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.3 p -64.29 -16.9 63.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -49.91 3.88 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.398 0.999 . . . . 0.0 111.089 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.72 -8.91 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.328 1.064 . . . . 0.0 112.239 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.3 p -55.21 -36.95 66.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.269 1.027 . . . . 0.0 108.953 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.56 -45.66 91.93 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.506 1.123 . . . . 0.0 111.177 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.61 -0.27 3.77 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 112.489 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -122.84 -87.74 0.63 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -48.89 -49.48 39.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.359 1.864 . . . . 0.0 113.532 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -72.44 -40.83 66.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.66 -1.275 . . . . 0.0 110.723 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.83 -38.48 91.12 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.061 -0.399 . . . . 0.0 110.342 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -60.22 -34.75 74.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.576 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -60.77 -50.29 74.07 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 120.094 1.315 . . . . 0.0 111.114 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.91 -42.59 76.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.302 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.35 -36.56 84.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.904 1.229 . . . . 0.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.56 -21.81 65.43 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.652 -0.655 . . . . 0.0 112.223 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.05 44.48 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.939 0.79 . . . . 0.0 111.194 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -72.19 -41.95 66.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.266 0.626 . . . . 0.0 110.143 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.19 137.22 58.15 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -36.27 80.19 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.765 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.75 79.08 0.86 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.49 1.145 . . . . 0.0 110.162 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.52 171.34 18.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.077 0.951 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -136.68 145.55 44.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.188 1.795 . . . . 0.0 106.802 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.26 151.67 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.306 -0.871 . . . . 0.0 109.749 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -135.42 170.72 15.51 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.513 1.525 . . . . 0.0 109.736 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.8 m -134.85 148.71 50.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.63 137.89 54.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -136.77 153.77 50.74 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.792 0.837 . . . . 0.0 111.427 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.8 46.15 1.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.413 1.485 . . . . 0.0 107.842 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -140.07 170.33 16.04 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.352 1.461 . . . . 0.0 107.863 -168.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.07 144.32 62.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 123.677 0.791 . . . . 0.0 111.181 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.04 -31.13 76.5 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.402 2.068 . . . . 0.0 112.896 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -71.55 -28.94 64.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.727 1.149 . . . . 0.0 111.387 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.09 74.54 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.043 0.838 . . . . 0.0 108.877 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.35 -46.51 69.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.513 0.725 . . . . 0.0 110.93 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.62 51.09 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.23 0.612 . . . . 0.0 111.211 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.12 -34.19 75.9 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.933 -0.479 . . . . 0.0 111.068 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -63.4 -42.5 98.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.124 0.42 . . . . 0.0 110.126 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.1 m -65.12 -42.9 93.47 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 121.77 -0.581 . . . . 0.0 111.37 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.31 98.85 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.33 86.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.571 0.748 . . . . 0.0 110.599 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.06 -24.86 51.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.127 0.571 . . . . 0.0 112.376 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 32.46 22.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.845 0.735 . . . . 0.0 111.432 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.08 144.64 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.8 -34.8 0.23 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.393 1.077 . . . . 0.0 112.677 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -79.21 -16.35 56.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.685 0.794 . . . . 0.0 111.952 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.19 159.1 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.05 134.74 40.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -92.84 145.59 24.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.632 0.773 . . . . 0.0 109.433 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 mt -136.66 166.04 24.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.936 1.695 . . . . 0.0 107.815 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 m -136.91 133.03 35.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.037 0.935 . . . . 0.0 109.352 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.23 -3.95 8.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.499 0.72 . . . . 0.0 112.14 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -57.22 -25.01 58.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.682 -1.261 . . . . 0.0 112.262 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -69.39 -25.11 63.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.272 1.029 . . . . 0.0 112.9 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.71 -19.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mmt 54.15 -0.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.144 2.978 . . . . 0.0 117.582 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 p -59.0 -36.78 75.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.501 1.501 . . . . 0.0 112.614 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.61 -56.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.022 0.529 . . . . 0.0 109.579 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.88 65.65 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.44 -53.65 55.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.467 0.707 . . . . 0.0 109.145 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.37 -31.0 57.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.154 -0.451 . . . . 0.0 112.17 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -4.0 27.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.567 0.621 . . . . 0.0 112.256 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 48.04 52.79 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 119.084 0.856 . . . . 0.0 111.283 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.89 -14.46 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.828 0.851 . . . . 0.0 111.383 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -72.93 111.86 8.43 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.54 112.13 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -54.26 -38.02 65.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.554 1.542 . . . . 0.0 111.425 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.62 -6.28 58.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.583 0.753 . . . . 0.0 112.638 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.7 mt -131.94 -21.24 2.43 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.038 0.935 . . . . 0.0 112.779 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 52.7 42.41 31.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.395 1.078 . . . . 0.0 109.313 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -135.19 153.22 52.03 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.218 1.407 . . . . 0.0 107.714 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.2 mt -84.06 141.94 30.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.327 0.512 . . . . 0.0 110.712 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.59 141.03 57.97 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.702 1.201 . . . . 0.0 109.806 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -68.36 109.09 3.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 p -154.77 165.06 37.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.878 0.763 . . . . 0.0 110.977 -169.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.27 153.52 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.79 156.45 46.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.359 1.063 . . . . 0.0 109.222 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.4 t -131.32 143.25 41.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 38.4 mt -135.2 126.4 28.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.736 1.615 . . . . 0.0 107.697 -169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.78 165.63 23.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.641 0.776 . . . . 0.0 109.085 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.14 -17.16 57.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.261 -0.899 . . . . 0.0 112.764 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -78.04 -11.45 59.91 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.537 -1.352 . . . . 0.0 112.236 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.03 75.87 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.009 -1.057 . . . . 0.0 112.645 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.93 139.28 37.14 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.89 134.26 30.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.48 -29.03 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.632 1.573 . . . . 0.0 109.254 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -155.08 146.28 22.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.61 1.564 . . . . 0.0 106.842 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.61 143.31 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.403 1.081 . . . . 0.0 108.463 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -149.93 146.5 27.09 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.848 1.659 . . . . 0.0 107.099 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -128.71 -15.34 4.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.561 1.545 . . . . 0.0 112.392 -169.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t 50.25 106.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 129.078 2.951 . . . . 0.0 113.093 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -59.14 -28.66 66.77 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.136 0.974 . . . . 0.0 112.797 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.67 105.94 17.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.1 62.4 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.9 p -73.68 -13.29 60.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.433 1.893 . . . . 0.0 112.904 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -109.87 156.45 20.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.557 1.543 . . . . 0.0 109.397 -169.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -106.8 153.46 40.76 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.373 0.669 . . . . 0.0 110.109 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.84 151.47 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.354 2.036 . . . . 0.0 109.488 171.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -82.04 119.39 23.94 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -54.05 -25.61 22.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.783 1.633 . . . . 0.0 112.878 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -60.59 -35.64 76.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.681 0.673 . . . . 0.0 111.138 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.82 -53.32 50.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.529 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.9 -27.8 43.09 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.951 1.375 . . . . 0.0 112.214 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.22 -46.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 120.695 1.588 . . . . 0.0 109.82 172.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.43 -33.77 76.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.907 0.776 . . . . 0.0 110.679 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.66 68.32 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.675 0.274 . . . . 0.0 111.149 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.38 -48.7 66.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.982 0.513 . . . . 0.0 110.795 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -29.05 69.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.746 0.703 . . . . 0.0 111.643 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.88 -31.7 71.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.579 0.627 . . . . 0.0 111.568 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.8 mt -88.29 -24.6 23.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.89 0.876 . . . . 0.0 112.054 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.4 -27.93 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.966 171.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.034 0.934 . . . . 0.0 110.746 176.548 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--O 1.236 0.351 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.32 148.64 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 p -92.87 153.11 19.01 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.601 1.091 . . . . 0.0 110.307 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -112.46 41.31 2.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.091 1.356 . . . . 0.0 108.622 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 44.11 62.99 1.77 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.769 2.028 . . . . 0.0 112.3 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.04 -25.63 0.16 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.55 1.071 . . . . 0.0 110.922 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.49 173.89 45.71 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.979 1.276 . . . . 0.0 110.108 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.56 157.61 58.34 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.157 2.572 . . . . 0.0 111.004 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.47 136.99 48.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.644 1.578 . . . . 0.0 107.471 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -74.32 154.78 38.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.763 1.225 . . . . 0.0 109.878 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.72 138.68 54.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.055 1.742 . . . . 0.0 106.549 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 120' ' ' TYR . 22.3 m -78.71 -173.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.9 -152.83 51.73 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 123.266 0.46 . . . . 0.0 112.967 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -132.23 155.42 48.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.479 1.111 . . . . 0.0 109.697 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.12 154.41 37.8 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 168.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.13 152.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -126.37 157.31 38.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.62 1.168 . . . . 0.0 110.264 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.24 142.71 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.609 1.163 . . . . 0.0 109.377 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.17 -19.44 46.53 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.811 1.196 . . . . 0.0 111.878 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -74.94 149.26 39.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.396 1.098 . . . . 0.0 109.599 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -73.08 120.29 18.51 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 155.26 73.71 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.306 0.242 . . . . 0.0 110.768 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.17 -19.02 15.18 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 125.295 3.997 . . . . 0.0 118.501 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 55.03 65.24 1.55 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.924 1.345 . . . . 0.0 110.692 -168.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -71.58 168.33 17.85 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 110.071 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -131.06 149.21 52.71 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.48 167.43 14.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 125.825 1.65 . . . . 0.0 106.696 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 tp -86.05 147.28 26.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.1 p -72.57 172.0 11.39 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.684 -1.26 . . . . 0.0 107.701 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -67.26 -3.31 7.57 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.835 -1.166 . . . . 0.0 111.498 168.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.1 m -118.58 17.63 13.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.968 2.107 . . . . 0.0 111.276 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 63.86 43.73 5.24 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.402 1.481 . . . . 0.0 112.449 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.87 154.22 45.73 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 142.97 39.04 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.749 -1.219 . . . . 0.0 109.21 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.77 147.47 35.58 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.601 1.56 . . . . 0.0 107.05 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 p -143.06 165.9 26.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.997 0.919 . . . . 0.0 109.175 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.8 -34.49 67.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.354 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.58 -31.24 56.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.021 0.828 . . . . 0.0 112.975 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.87 -35.98 37.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.958 0.903 . . . . 0.0 111.426 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.8 mtt -78.9 -34.97 44.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.936 0.895 . . . . 0.0 112.111 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.77 -3.48 3.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -18.14 23.65 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 118.916 -0.936 . . . . 0.0 112.03 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -139.57 164.61 29.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.109 1.455 . . . . 0.0 109.138 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.51 128.29 20.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.1 m -130.45 136.77 49.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.3 mt -100.29 142.21 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.8 mm -120.33 129.01 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.9 m -124.97 98.59 5.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.418 1.087 . . . . 0.0 108.455 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.14 135.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.58 155.5 75.24 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.476 1.51 . . . . 0.0 107.929 172.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.99 -51.97 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.673 1.582 . . . . 0.0 110.76 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.25 158.88 42.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.258 1.423 . . . . 0.0 107.869 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 90' ' ' GLN . 9.7 tt -106.79 29.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.114 0.966 . . . . 0.0 112.317 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -134.79 16.44 3.58 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.814 0.845 . . . . 0.0 110.422 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.8 p -81.91 -9.43 59.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.225 1.01 . . . . 0.0 112.544 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.14 -50.08 3.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -25.64 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.165 0.982 . . . . 0.0 110.853 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -49.48 -33.83 15.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.449 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.87 -43.61 94.61 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.116 0.967 . . . . 0.0 111.497 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.25 6.29 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.736 1.214 . . . . 0.0 113.023 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.84 -77.82 0.58 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -54.2 -46.61 72.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -65.55 -41.97 92.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.213 0.915 . . . . 0.0 110.13 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -81.1 -25.71 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.999 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -63.36 -38.1 89.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.263 0.938 . . . . 0.0 109.726 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -61.35 -43.16 99.34 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.943 0.792 . . . . 0.0 111.147 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.83 -56.35 16.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.77 -30.69 70.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.297 -0.877 . . . . 0.0 111.87 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.24 89.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.15 0.886 . . . . 0.0 111.088 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.76 80.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.555 0.616 . . . . 0.0 110.664 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -41.25 90.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.091 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.97 -39.63 90.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.571 0.748 . . . . 0.0 110.2 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.95 -27.73 8.7 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.628 1.108 . . . . 0.0 112.048 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -151.62 118.4 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.49 172.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 78' ' ' ASN . 10.5 p -163.1 -176.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.622 1.969 . . . . 0.0 105.749 172.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -138.81 136.03 35.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.59 145.63 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 152.19 51.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.586 0.754 . . . . 0.0 109.977 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 104' ' ' THR . 19.4 m -104.53 146.0 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.3 mt -129.28 132.95 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 m -134.57 149.63 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.577 1.151 . . . . 0.0 109.768 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.66 55.31 2.94 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.03 160.39 40.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.056 1.342 . . . . 0.0 108.098 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.29 146.51 92.2 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.262 -169.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.8 -44.04 43.34 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.269 2.646 . . . . 0.0 112.858 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -77.23 -28.26 53.65 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.754 -0.591 . . . . 0.0 111.855 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.27 83.31 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.128 0.876 . . . . 0.0 109.996 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HA ' HG21 ' A' ' 55' ' ' ILE . 41.8 mt-30 -69.83 -46.43 65.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.252 0.621 . . . . 0.0 111.507 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.94 77.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.439 0.563 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -50.22 74.53 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.703 1.201 . . . . 0.0 108.769 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.44 ' CD1' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -56.62 -45.51 81.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.505 0.322 . . . . 0.0 110.159 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.0 m -64.28 -44.72 90.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.219 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.28 -37.02 90.54 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.15 80.56 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.842 0.821 . . . . 0.0 110.635 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -79.35 -33.08 43.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.162 0.585 . . . . 0.0 111.985 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 37.81 8.86 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.02 144.59 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.77 -37.58 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.694 1.197 . . . . 0.0 112.486 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.71 -16.2 42.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.558 0.743 . . . . 0.0 112.318 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.61 159.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -134.05 140.14 46.46 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.9 p -96.63 145.55 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.0 mt -134.9 158.28 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.29 113.65 22.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.914 1.686 . . . . 0.0 108.346 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.32 10.8 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.839 0.828 . . . . 0.0 111.651 170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.21 -16.25 5.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.327 1.451 . . . . 0.0 111.214 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.4 ttt-85 -68.43 69.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.945 1.698 . . . . 0.0 109.508 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 46.17 41.15 8.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.284 1.834 . . . . 0.0 113.85 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.9 mmm 50.04 32.02 5.4 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.231 1.812 . . . . 0.0 113.601 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.7 m -53.71 -49.72 67.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.975 0.91 . . . . 0.0 111.751 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -72.03 -43.72 64.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.893 0.77 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.46 92.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.101 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.37 -47.46 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.013 0.907 . . . . 0.0 109.9 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.18 75.58 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.66 4.65 38.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.264 1.026 . . . . 0.0 112.265 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.05 49.5 77.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.482 1.039 . . . . 0.0 113.616 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.16 -12.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.58 1.552 . . . . 0.0 111.251 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CD2' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -67.73 113.63 5.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 169.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.4 mt -75.36 109.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.68 -41.53 55.81 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.658 1.983 . . . . 0.0 111.28 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.8 2.45 53.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.489 -171.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.54 -25.13 3.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.088 0.858 . . . . 0.0 113.311 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 56.06 33.89 22.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.592 0.633 . . . . 0.0 109.884 -168.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.38 164.6 20.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.651 1.58 . . . . 0.0 107.107 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.73 147.58 24.73 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.156 0.503 . . . . 0.0 110.127 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.88 145.26 46.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.411 1.484 . . . . 0.0 110.637 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -79.19 102.57 8.58 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 71.1 m -149.77 168.47 23.59 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.751 1.22 . . . . 0.0 108.46 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.39 149.81 17.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.982 -0.449 . . . . 0.0 109.798 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.6 157.17 45.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.283 1.033 . . . . 0.0 108.692 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -137.93 138.64 43.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.52 133.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.504 1.522 . . . . 0.0 107.408 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.1 176.69 3.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.872 0.869 . . . . 0.0 110.591 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.24 9.57 0.31 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.783 1.233 . . . . 0.0 114.243 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -127.6 4.77 6.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.875 1.67 . . . . 0.0 110.219 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.86 77.98 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.973 0.806 . . . . 0.0 112.553 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -87.4 136.84 32.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 119.452 1.626 . . . . 0.0 107.274 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.74 126.94 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.57 -19.84 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.464 0.705 . . . . 0.0 110.46 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -154.33 144.89 22.3 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.84 140.07 24.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.828 1.651 . . . . 0.0 107.168 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -152.23 147.33 26.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.306 0.503 . . . . 0.0 109.658 171.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.58 104.83 7.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.848 2.059 . . . . 0.0 105.633 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.22 133.61 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -73.39 -13.66 61.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -138.11 113.85 9.78 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.03 68.11 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 p -74.28 -0.66 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.31 0.959 . . . . 0.0 113.155 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.09 167.21 17.87 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.454 1.101 . . . . 0.0 108.957 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -117.88 157.14 49.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.472 0.709 . . . . 0.0 112.263 -168.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.67 152.27 78.13 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.618 2.212 . . . . 0.0 108.783 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -78.79 117.39 19.87 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -56.36 -20.97 21.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.499 1.519 . . . . 0.0 113.279 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.08 -36.62 82.25 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.054 0.843 . . . . 0.0 111.424 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -61.33 -52.62 69.41 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 119.327 0.967 . . . . 0.0 111.945 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.78 -27.86 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 120.797 1.32 . . . . 0.0 111.766 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -45.04 93.78 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 120.11 1.323 . . . . 0.0 109.731 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.19 -35.71 81.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.872 0.76 . . . . 0.0 110.652 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.38 79.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.401 0.143 . . . . 0.0 111.053 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.72 -50.12 46.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.736 0.415 . . . . 0.0 111.2 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -34.11 70.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.679 0.672 . . . . 0.0 111.157 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.33 67.19 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.361 0.528 . . . . 0.0 112.018 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.34 -23.74 16.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 50.2 t -57.13 -36.17 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.583 0.629 . . . . 0.0 110.495 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.717 1.207 . . . . 0.0 110.88 175.654 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.8 mt -132.73 168.99 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 p -115.93 148.17 40.33 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.88 -1.138 . . . . 0.0 109.011 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -91.69 37.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 63.25 -41.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.876 2.871 . . . . 0.0 114.204 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.79 -31.12 41.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.319 0.961 . . . . 0.0 112.477 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 173.73 46.46 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.234 1.017 . . . . 0.0 111.245 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.6 152.13 50.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 124.0 3.133 . . . . 0.0 113.718 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.51 127.58 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.507 1.923 . . . . 0.0 107.133 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -70.08 153.71 42.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.516 1.526 . . . . 0.0 110.634 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.07 140.42 44.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.42 1.488 . . . . 0.0 108.459 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.13 -16.82 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.42 162.15 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.89 160.04 33.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.74 0.781 . . . . 0.0 110.442 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 pm0 -74.17 136.96 42.87 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 168.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.53 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -133.66 161.62 34.15 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.271 -0.893 . . . . 0.0 110.427 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.14 140.93 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.87 32.78 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.797 -1.001 . . . . 0.0 112.862 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -70.51 155.54 40.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.179 1.49 . . . . 0.0 109.235 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -76.34 127.55 33.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 158.84 57.92 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.563 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -54.86 -14.95 8.85 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.432 3.421 . . . . 0.0 117.867 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 52.78 56.94 6.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 123.103 1.43 . . . . 0.0 110.169 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -83.26 170.95 14.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.928 2.091 . . . . 0.0 111.32 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 m -131.8 149.22 52.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.823 1.249 . . . . 0.0 107.653 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.89 170.87 10.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.703 2.001 . . . . 0.0 106.956 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tp -87.13 142.6 27.8 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -69.58 166.6 18.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.14 -6.64 18.56 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.634 -1.291 . . . . 0.0 110.897 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -100.24 8.64 43.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.055 2.142 . . . . 0.0 111.688 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.0 mt 68.15 39.52 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.404 1.482 . . . . 0.0 112.688 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -127.48 157.76 39.22 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.31 142.76 48.84 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 120.896 -1.127 . . . . 0.0 108.962 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.9 142.63 33.08 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -135.45 165.18 26.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.902 0.881 . . . . 0.0 108.656 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -53.97 -33.16 56.18 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.38 -0.343 . . . . 0.0 111.465 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.71 -33.56 61.2 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.42 -35.46 70.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.4 mtt -78.81 -29.69 44.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.386 1.474 . . . . 0.0 111.882 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -55.8 -14.86 2.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.635 1.574 . . . . 0.0 114.619 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.39 -17.41 32.24 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.604 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -151.17 157.54 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.26 1.53 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.66 126.51 13.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 46.8 m -118.89 151.66 37.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.424 0.69 . . . . 0.0 109.832 -169.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.7 mt -123.86 146.67 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 mm -130.18 110.66 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.631 1.572 . . . . 0.0 107.398 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 140.32 45.37 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.97 122.15 64.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.65 153.63 68.23 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.56 -57.09 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 111.301 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -146.28 142.5 28.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.556 1.942 . . . . 0.0 105.991 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' CE3' ' A' ' 93' ' ' TRP . 11.6 tt -77.33 -22.79 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -168.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.92 -18.67 62.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.8 p -66.54 149.78 49.95 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.861 0.755 . . . . 0.0 109.643 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.44 -37.41 92.01 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.901 -0.5 . . . . 0.0 111.898 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.46 -43.09 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 117.9 0.85 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -62.42 -42.71 99.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.891 0.769 . . . . 0.0 110.671 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.94 -56.23 24.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.664 1.186 . . . . 0.0 110.84 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.85 79.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.92 0.488 . . . . 0.0 112.248 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -57.17 10.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 173.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -62.46 -44.67 95.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.846 0.748 . . . . 0.0 111.948 -170.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -76.66 -37.57 56.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.194 1.361 . . . . 0.0 112.859 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -62.3 -43.18 99.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.045 0.839 . . . . 0.0 108.878 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.21 -35.36 76.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.944 -0.551 . . . . 0.0 112.003 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.38 -42.91 96.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.575 1.08 . . . . 0.0 112.263 173.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.76 -42.97 99.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 64.6 mm-40 -61.46 -39.08 89.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.864 1.211 . . . . 0.0 111.448 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.63 78.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.444 0.566 . . . . 0.0 111.092 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.37 83.07 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.941 0.791 . . . . 0.0 111.478 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -65.13 -39.46 93.07 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.459 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.7 -49.72 69.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 109.785 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 -61.91 2.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.967 1.746 . . . . 0.0 112.032 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -83.79 55.28 3.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.547 1.539 . . . . 0.0 110.72 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.14 169.91 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.191 1.396 . . . . 0.0 107.778 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 47' ' ' THR . 42.5 t30 -130.15 137.82 50.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.1 t -144.86 145.29 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.177 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -138.16 171.72 13.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.918 1.287 . . . . 0.0 109.689 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 m -132.8 144.42 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.42 1.888 . . . . 0.0 105.905 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -131.47 133.32 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -135.19 152.79 51.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.331 1.052 . . . . 0.0 109.539 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.46 45.12 1.16 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -129.62 164.94 22.78 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 -168.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.9 137.38 96.0 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.49 -42.71 48.0 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.091 2.528 . . . . 0.0 112.196 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -73.31 -32.24 64.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.621 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.39 -43.55 90.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.409 1.004 . . . . 0.0 109.802 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.05 -48.55 79.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.013 1.325 . . . . 0.0 111.908 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.8 86.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.751 0.705 . . . . 0.0 111.158 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -45.64 93.72 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.318 1.047 . . . . 0.0 108.953 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.409 ' CE3' HD11 ' A' ' 55' ' ' ILE . 85.8 t90 -64.69 -40.71 95.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.336 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 m -61.14 -43.66 98.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.606 0.639 . . . . 0.0 110.885 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.15 86.47 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.358 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.21 92.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.061 0.931 . . . . 0.0 110.629 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.96 -13.32 19.16 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.24 37.61 41.78 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.62 143.14 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.952 1.301 . . . . 0.0 108.207 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -139.35 -25.87 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -117.74 -5.04 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.431 1.092 . . . . 0.0 111.984 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.23 158.5 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -143.59 135.6 26.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 p -96.67 142.75 28.33 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.278 1.031 . . . . 0.0 108.358 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.97 150.21 45.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.528 1.531 . . . . 0.0 108.471 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -107.62 106.79 17.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 111.025 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.35 -11.34 59.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 109.843 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -48.64 -28.22 3.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.633 1.173 . . . . 0.0 111.58 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.98 88.11 1.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.075 1.35 . . . . 0.0 110.787 170.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.5 t70 65.03 14.48 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.059 1.744 . . . . 0.0 115.433 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp 44.34 30.7 0.49 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.016 2.527 . . . . 0.0 115.064 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.24 -46.86 88.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.439 0.696 . . . . 0.0 111.38 -173.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -66.32 -50.38 63.81 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -39.18 96.18 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 123.059 0.361 . . . . 0.0 112.202 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.47 -53.6 27.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.711 0.804 . . . . 0.0 109.978 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.08 67.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.93 56.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.597 1.159 . . . . 0.0 111.851 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.06 49.68 65.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.826 0.727 . . . . 0.0 113.296 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -123.4 -11.17 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.867 1.267 . . . . 0.0 111.012 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 108.05 3.72 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 98.4 mt -74.7 115.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.1 -47.54 82.38 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.448 1.099 . . . . 0.0 111.229 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.65 13.93 2.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.122 0.874 . . . . 0.0 113.237 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 40.14 53.82 2.77 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.204 2.201 . . . . 0.0 113.689 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 tp -145.96 169.55 18.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.113 0.965 . . . . 0.0 108.681 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.07 137.25 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.087 0.555 . . . . 0.0 109.984 -173.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.49 149.22 49.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.987 1.315 . . . . 0.0 111.156 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -81.05 115.9 20.73 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 70.8 m -162.18 171.19 17.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.747 1.219 . . . . 0.0 108.825 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.19 144.4 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.501 -0.749 . . . . 0.0 109.622 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -132.66 153.16 51.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.811 0.695 . . . . 0.0 110.479 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.63 134.27 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -125.39 132.57 52.76 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.108 1.363 . . . . 0.0 107.979 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.0 166.0 22.26 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.371 1.068 . . . . 0.0 109.747 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.36 -26.89 43.84 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.382 1.073 . . . . 0.0 112.394 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.61 -0.43 23.35 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.042 -1.036 . . . . 0.0 112.115 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 28.19 73.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.036 0.827 . . . . 0.0 111.887 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.33 147.33 26.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.321 1.06 . . . . 0.0 108.28 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.1 t -71.72 138.15 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.73 -35.66 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.909 1.684 . . . . 0.0 109.419 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -150.18 142.94 24.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 144.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.78 148.51 27.31 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 17' ' ' GLU . 63.8 m-85 -132.0 98.61 4.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.468 2.307 . . . . 0.0 105.982 -169.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.42 131.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -67.79 -15.64 63.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.992 0.917 . . . . 0.0 113.183 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -126.28 118.14 24.49 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.44 69.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.22 0.608 . . . . 0.0 111.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.6 p -68.93 -12.71 61.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.568 1.547 . . . . 0.0 112.679 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -116.64 161.26 19.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.866 1.666 . . . . 0.0 108.674 -170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -121.94 153.15 60.5 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.776 0.83 . . . . 0.0 110.297 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.85 150.68 55.94 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.666 1.577 . . . . 0.0 108.301 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.19 115.98 20.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -66.7 -8.77 30.2 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.93 -32.05 71.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.997 0.817 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.18 -53.15 34.23 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.306 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.01 -30.43 25.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.494 1.569 . . . . 0.0 111.564 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.94 -51.47 53.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 119.191 0.905 . . . . 0.0 109.44 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.98 -28.97 70.17 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 111.545 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.88 -49.37 46.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.113 0.565 . . . . 0.0 111.427 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.62 65.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.236 0.614 . . . . 0.0 111.192 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -32.54 65.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.49 0.716 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.73 76.52 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.359 0.664 . . . . 0.0 111.316 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.6 mt -79.57 -44.75 20.5 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.216 0.462 . . . . 0.0 110.96 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -84.48 14.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.249 1.069 0 O-C-N 121.53 -0.731 . . . . 0.0 109.583 169.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 122.032 0.92 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.85 147.27 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.768 0.827 . . . . 0.0 109.085 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.3 p -116.08 167.4 11.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.945 1.698 . . . . 0.0 109.135 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -135.8 95.08 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 40.76 33.42 0.2 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.584 2.354 . . . . 0.0 115.921 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.31 -23.96 0.27 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.418 -1.212 . . . . 0.0 114.777 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.78 169.49 40.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.778 1.789 . . . . 0.0 113.006 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.31 154.01 65.91 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.898 3.065 . . . . 0.0 111.831 -173.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.11 128.06 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.274 1.03 . . . . 0.0 108.835 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -61.7 156.31 20.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.48 1.512 . . . . 0.0 111.275 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.7 mt -125.68 141.4 52.03 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.586 1.954 . . . . 0.0 106.942 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.27 -65.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.3 -170.25 46.93 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.269 0.937 . . . . 0.0 112.276 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -108.96 150.19 28.09 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.1 0.96 . . . . 0.0 110.796 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.61 121.22 12.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.96 167.71 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.5 155.93 49.52 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.477 -0.764 . . . . 0.0 109.558 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.44 136.18 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 170.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.95 -18.5 57.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.013 1.292 . . . . 0.0 111.943 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -76.99 157.02 31.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.73 1.265 . . . . 0.0 109.537 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -81.26 126.67 31.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.85 93.67 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.262 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -55.16 -30.27 70.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.36 2.707 . . . . 0.0 116.031 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 50.71 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.391 1.877 . . . . 0.0 113.728 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.35 178.1 6.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.907 1.283 . . . . 0.0 109.616 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -108.1 152.42 24.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.25 1.02 . . . . 0.0 109.564 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -141.61 171.33 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.583 2.353 . . . . 0.0 107.315 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.95 155.68 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.0 p -71.16 -158.35 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.653 1.181 . . . . 0.0 109.366 169.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -72.33 0.14 10.81 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.353 -1.467 . . . . 0.0 113.054 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -126.54 -88.72 0.57 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.508 1.049 . . . . 0.0 108.627 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -157.56 -3.88 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.346 1.858 . . . . 0.0 112.405 -169.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.38 138.35 32.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -72.9 138.88 46.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -137.27 149.26 46.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.999 1.72 . . . . 0.0 106.534 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -137.67 160.2 39.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.97 -30.39 67.89 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.967 -0.458 . . . . 0.0 111.861 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -28.04 68.4 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.832 0.853 . . . . 0.0 112.816 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -75.72 -36.31 59.99 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.487 0.715 . . . . 0.0 110.425 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.8 mtt -73.96 -36.48 64.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -65.67 0.83 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.35 -16.38 20.5 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.005 -1.059 . . . . 0.0 112.73 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -141.02 167.63 21.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.112 1.456 . . . . 0.0 108.263 169.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.47 128.97 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.9 m -131.68 151.36 51.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.409 0.284 . . . . 0.0 110.888 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.4 mt -113.82 139.02 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.45 126.02 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -118.96 98.34 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 0.0 108.745 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 m -74.89 136.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 155.9 80.42 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 169.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.04 -54.92 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.676 2.251 . . . . 0.0 111.775 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -157.37 149.45 22.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.45 -15.72 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.43 -0.793 . . . . 0.0 111.266 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.64 -16.46 61.01 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.166 -0.959 . . . . 0.0 113.289 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.6 p -61.37 -23.8 66.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.716 1.144 . . . . 0.0 114.024 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -42.47 2.16 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.315 0.96 . . . . 0.0 111.436 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.04 -24.54 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.884 1.273 . . . . 0.0 110.421 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 24.1 p -47.48 -32.27 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.257 1.423 . . . . 0.0 113.009 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.6 -33.49 70.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 125.353 1.461 . . . . 0.0 112.253 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.03 -17.4 57.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.271 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -108.57 -80.12 0.58 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.1 m -54.15 -43.39 70.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.529 1.132 . . . . 0.0 113.624 -168.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -63.06 -53.33 55.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.514 0.597 . . . . 0.0 109.596 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -69.54 -36.16 76.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.78 -172.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -59.22 -36.91 76.26 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.88 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -60.18 -46.06 91.0 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.863 1.21 . . . . 0.0 110.477 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.68 -51.34 57.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.56 -38.54 87.86 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 121.285 -0.884 . . . . 0.0 110.94 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.97 -37.37 86.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.888 0.767 . . . . 0.0 111.309 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.83 95.62 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.685 0.675 . . . . 0.0 110.643 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -38.75 83.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.586 0.63 . . . . 0.0 111.367 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.48 -33.33 73.59 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.862 0.865 . . . . 0.0 110.538 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.28 -35.06 3.5 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.81 1.195 . . . . 0.0 111.859 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.48 116.76 5.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.666 1.187 . . . . 0.0 109.207 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.0 p -159.19 -174.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 127.476 2.31 . . . . 0.0 105.409 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.2 t30 -138.85 134.2 33.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -141.39 140.43 31.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 108.7 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.18 159.8 37.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.279 1.032 . . . . 0.0 109.899 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.0 m -122.12 142.8 50.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.52 141.13 46.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.0 t -143.71 155.18 44.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 110.499 -169.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 9.78 41.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.26 177.91 8.31 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -84.82 147.1 47.71 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 123.968 0.907 . . . . 0.0 110.201 -169.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.63 -45.36 27.87 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.858 3.038 . . . . 0.0 113.698 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -67.0 -29.72 69.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.518 -0.739 . . . . 0.0 112.311 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.98 72.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.312 0.96 . . . . 0.0 109.657 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -52.88 -51.36 61.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.559 0.743 . . . . 0.0 109.658 170.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.93 74.81 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 111.164 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -62.75 -45.94 90.35 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.566 0.747 . . . . 0.0 110.25 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -63.48 -43.95 95.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.655 0.382 . . . . 0.0 110.854 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -70.16 -37.87 75.3 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.744 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.52 -38.08 94.38 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.3 79.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.627 0.771 . . . . 0.0 110.216 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -70.74 -31.8 68.75 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.657 0.783 . . . . 0.0 112.694 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.14 35.78 23.06 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.25 144.18 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.53 -35.26 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.699 1.199 . . . . 0.0 112.602 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.66 -10.41 51.39 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.605 0.762 . . . . 0.0 112.471 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.9 159.83 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.72 149.94 52.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 140.09 48.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.797 0.839 . . . . 0.0 110.228 -169.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.3 mt -138.74 163.81 31.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.468 1.507 . . . . 0.0 109.07 -169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.34 136.15 36.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.099 0.56 . . . . 0.0 109.516 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -122.67 -5.46 8.65 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.603 0.761 . . . . 0.0 111.679 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -57.68 -19.5 27.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -54.46 -43.02 71.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 111.23 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.84 -1.79 0.3 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.394 0.678 . . . . 0.0 112.664 -171.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 64.1 mmm 47.04 28.44 0.9 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.771 2.428 . . . . 0.0 113.601 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -44.81 92.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 111.149 -171.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.84 -46.59 57.51 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -37.19 87.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -46.26 90.69 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.769 -0.842 . . . . 0.0 109.245 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.56 79.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.89 1.71 16.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.643 0.777 . . . . 0.0 112.481 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.79 90.23 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.982 1.265 . . . . 0.0 112.553 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 m -124.91 -2.16 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.116 1.366 . . . . 0.0 111.397 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -79.56 105.99 11.27 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.26 101.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -51.69 -42.23 62.03 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.333 1.453 . . . . 0.0 111.441 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.6 -10.81 60.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -122.61 -17.73 6.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.187 0.995 . . . . 0.0 112.069 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.19 38.13 26.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.048 -168.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 157.27 43.95 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.471 1.108 . . . . 0.0 108.592 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.4 tp -77.79 148.65 34.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.122 0.969 . . . . 0.0 109.279 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.2 -175.06 4.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.492 . . . . 0.0 111.458 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.7 ttm105 -121.73 111.93 17.77 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 m -157.69 169.55 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.483 1.913 . . . . 0.0 106.94 -170.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.35 144.57 18.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -134.18 157.64 45.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.715 1.206 . . . . 0.0 108.542 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.75 134.63 53.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.76 132.16 53.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.941 1.296 . . . . 0.0 108.07 -173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.45 167.52 10.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.601 1.561 . . . . 0.0 109.592 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -58.54 -21.17 51.65 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.449 -0.782 . . . . 0.0 113.024 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -86.9 -0.17 56.05 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.297 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.56 23.29 78.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.04 -1.037 . . . . 0.0 112.299 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -88.14 141.28 28.69 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.826 1.313 . . . . 0.0 107.518 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.3 t -68.57 116.86 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.74 -33.97 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.827 1.251 . . . . 0.0 109.275 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -158.96 146.35 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.32 144.15 27.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -145.52 136.99 25.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -128.6 121.28 28.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.53 135.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -67.79 -5.89 18.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.778 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -147.41 118.8 7.87 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.49 63.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.111 0.964 . . . . 0.0 113.549 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 10.12 20.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.881 1.272 . . . . 0.0 110.414 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -127.77 178.3 6.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.55 2.34 . . . . 0.0 108.132 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -138.3 152.15 70.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 120.623 -1.298 . . . . 0.0 112.147 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.63 149.55 18.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.687 2.258 . . . . 0.0 108.951 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -74.71 115.84 14.73 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -51.73 -26.53 9.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.032 1.733 . . . . 0.0 112.922 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -61.7 -31.31 71.45 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.646 -0.659 . . . . 0.0 111.882 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -48.04 10.63 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.741 1.155 . . . . 0.0 112.07 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.01 -30.65 32.07 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 121.315 1.505 . . . . 0.0 111.646 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.3 mm -55.36 -50.17 67.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.313 0.961 . . . . 0.0 109.42 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.12 -32.73 73.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.39 0.541 . . . . 0.0 111.364 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.01 69.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.097 0.559 . . . . 0.0 111.512 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.13 -46.52 56.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.522 0.729 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -26.22 62.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.783 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.07 65.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.287 1.035 . . . . 0.0 113.175 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.27 -26.96 6.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.15 -13.41 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.184 1.794 . . . . 0.0 108.123 -175.934 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 CA--C 1.545 0.783 0 CA-C-O 122.047 0.927 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 13' ' ' LEU . 40.6 mt -54.0 126.1 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 109.131 -170.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.0 p -76.99 161.87 28.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.444 0.64 . . . . 0.0 110.105 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -116.97 38.93 3.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.153 0.981 . . . . 0.0 109.552 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm 41.83 63.91 1.2 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.596 1.959 . . . . 0.0 111.571 -171.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.1 -28.18 0.11 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.239 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.54 170.46 42.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.618 1.104 . . . . 0.0 110.534 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.9 158.52 55.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.739 2.959 . . . . 0.0 110.761 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.47 142.28 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -67.51 157.08 35.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.513 1.525 . . . . 0.0 110.359 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.437 ' HA ' ' H ' ' A' ' 122' ' ' LYS . 4.6 mp -135.18 144.94 47.28 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.911 1.284 . . . . 0.0 107.771 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -82.44 147.91 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.44 -157.15 19.45 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -132.62 161.3 34.26 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.93 115.24 5.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 168.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -83.4 151.44 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -132.67 155.05 49.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.883 0.873 . . . . 0.0 109.888 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.43 141.02 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.049 0.94 . . . . 0.0 109.289 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.55 -21.64 31.54 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.943 1.259 . . . . 0.0 112.175 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.67 152.79 40.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.73 1.265 . . . . 0.0 109.771 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -70.81 126.79 30.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 152.41 73.79 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.152 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.77 -29.0 60.26 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.224 2.616 . . . . 0.0 115.482 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.6 t0 51.9 85.91 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.913 2.085 . . . . 0.0 113.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.37 172.34 12.83 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 110.642 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -87.04 158.99 19.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.771 1.628 . . . . 0.0 110.366 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 p -151.87 159.31 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.043 2.537 . . . . 0.0 105.639 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tp -90.54 145.99 24.44 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.548 -1.345 . . . . 0.0 108.018 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -74.35 165.66 24.81 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.056 -1.028 . . . . 0.0 108.395 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -66.67 -6.61 16.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.871 -1.143 . . . . 0.0 111.368 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -93.54 3.7 55.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.39 1.876 . . . . 0.0 111.893 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp 62.81 44.74 6.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.195 1.398 . . . . 0.0 111.817 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.49 160.76 29.64 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.68 1.192 . . . . 0.0 107.785 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -78.31 142.08 38.01 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.844 -1.16 . . . . 0.0 109.753 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -139.15 163.52 32.22 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.161 1.784 . . . . 0.0 106.55 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 p -151.68 169.22 22.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.969 -1.082 . . . . 0.0 108.51 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.73 -27.6 59.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.512 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -28.64 62.32 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.01 -41.42 35.9 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.361 0.664 . . . . 0.0 109.834 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.4 mtt -65.45 -40.63 93.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.966 0.906 . . . . 0.0 109.105 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -71.1 -0.89 10.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.67 . . . . 0.0 112.381 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.16 -15.72 59.02 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.837 -1.165 . . . . 0.0 111.97 169.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -147.94 168.96 20.93 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.899 1.349 . . . . 0.0 108.428 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.97 120.9 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 168.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -130.14 153.89 48.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 123.156 0.285 . . . . 0.0 110.763 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.03 142.18 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.1 mm -127.85 113.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -112.94 98.44 7.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.141 0.976 . . . . 0.0 109.007 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.41 140.71 15.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.33 -0.857 . . . . 0.0 108.872 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.85 156.03 72.88 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.839 1.256 . . . . 0.0 108.491 169.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.81 -50.03 12.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.644 2.229 . . . . 0.0 112.498 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -160.44 164.62 32.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.936 2.494 . . . . 0.0 106.295 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 tt -98.3 -23.79 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.56 0.618 . . . . 0.0 111.564 -169.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -82.91 54.44 2.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.862 1.265 . . . . 0.0 110.387 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -154.99 -178.15 7.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.184 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.95 179.5 31.24 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.38 0.991 . . . . 0.0 112.271 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.285 19.5 m 53.25 -6.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 129.339 3.055 . . . . 0.0 116.832 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.8 m -65.27 -22.7 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.59 -1.319 . . . . 0.0 110.896 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.27 -31.76 67.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.666 -0.647 . . . . 0.0 111.233 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.46 -58.2 2.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.892 0.769 . . . . 0.0 109.778 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.29 -15.78 63.7 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -128.89 -54.17 1.22 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.79 1.177 . . . . 0.0 110.074 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.97 -52.31 13.24 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.771 1.169 . . . . 0.0 111.556 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.55 79.41 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.388 0.995 . . . . 0.0 109.605 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -44.21 71.9 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.336 0.516 . . . . 0.0 111.67 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.02 -44.08 93.67 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.619 0.767 . . . . 0.0 111.836 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.35 -49.48 77.42 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 73' ' ' LYS . 21.8 mm-40 -64.27 -39.47 94.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.094 0.861 . . . . 0.0 110.863 -176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.974 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.25 -33.55 69.92 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.427 1.012 . . . . 0.0 110.775 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 70' ' ' GLU . 17.3 mmtp -68.84 -40.08 79.59 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 109.346 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.24 -50.43 74.03 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.25 -0.21 60.02 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.769 1.176 . . . . 0.0 114.286 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.92 65.51 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.133 1.373 . . . . 0.0 108.668 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.96 167.7 4.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.024 1.33 . . . . 0.0 107.593 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -120.49 144.44 48.01 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.4 147.08 14.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.954 -1.091 . . . . 0.0 109.748 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -134.13 162.81 31.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.703 1.601 . . . . 0.0 109.417 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -127.84 149.26 50.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.89 136.5 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 m -139.37 158.64 43.8 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.47 48.99 1.43 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -132.4 165.33 24.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.55 1.54 . . . . 0.0 108.889 -169.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.96 136.18 96.69 Favored Pre-proline 0 C--O 1.236 0.387 0 C-N-CA 123.826 0.851 . . . . 0.0 109.826 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.37 -42.8 46.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.352 2.702 . . . . 0.0 112.277 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -73.68 -31.58 63.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.523 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.9 75.05 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.358 0.981 . . . . 0.0 108.993 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -57.7 -42.89 84.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.125 0.97 . . . . 0.0 112.572 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.48 85.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.031 0.832 . . . . 0.0 111.264 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.26 -42.33 93.37 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.306 0.643 . . . . 0.0 109.725 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -60.4 -40.23 90.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.24 0.616 . . . . 0.0 110.527 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -65.23 -47.09 78.02 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.007 -0.433 . . . . 0.0 111.173 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.08 96.84 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.21 97.25 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.744 0.818 . . . . 0.0 110.702 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -85.39 -19.75 30.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 112.702 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.86 38.18 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 mm -64.33 142.81 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -144.91 -37.83 0.28 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.05 0.94 . . . . 0.0 112.652 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -80.81 -25.85 37.54 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.393 0.677 . . . . 0.0 111.226 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.8 157.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.827 1.251 . . . . 0.0 107.668 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -138.06 138.82 39.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 p -95.65 148.19 22.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.5 1.12 . . . . 0.0 108.205 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -137.93 140.19 40.17 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.655 1.182 . . . . 0.0 108.648 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -102.29 105.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.6 1.16 . . . . 0.0 110.06 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.34 -4.47 55.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.754 169.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -51.56 -41.36 61.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.737 1.215 . . . . 0.0 111.589 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.2 -44.76 44.64 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.645 0.778 . . . . 0.0 111.424 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.59 -36.15 11.36 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 55.12 -19.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.719 3.208 . . . . 0.0 115.759 -169.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -59.46 -33.0 70.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.371 1.441 . . . . 0.0 112.678 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -67.54 -54.65 18.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.989 0.813 . . . . 0.0 108.942 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -36.71 73.03 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -32.05 71.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.332 1.053 . . . . 0.0 110.822 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.93 -44.11 10.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.615 0.643 . . . . 0.0 112.319 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.17 13.49 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.57 93.22 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.563 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.77 -10.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.47 1.135 . . . . 0.0 112.149 -168.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -82.11 116.37 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.8 mt -79.6 97.47 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' ' HA ' ' A' ' 13' ' ' LEU . 57.6 tttm -44.68 -55.64 5.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 126.615 1.966 . . . . 0.0 111.869 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -86.11 -11.54 52.4 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 mt -83.54 -21.74 32.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.943 0.792 . . . . 0.0 109.525 168.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 58.36 32.06 21.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.915 1.286 . . . . 0.0 109.354 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -135.79 154.17 51.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 108.516 -177.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.421 ' H ' HD13 ' A' ' 126' ' ' LEU . 14.3 tp -77.37 152.17 34.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.168 0.987 . . . . 0.0 109.778 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 -174.44 5.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.31 1.044 . . . . 0.0 111.258 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -116.43 127.04 54.25 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -167.43 175.15 7.39 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.51 1.924 . . . . 0.0 107.128 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.15 145.92 14.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -137.7 158.41 44.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.859 1.264 . . . . 0.0 109.345 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.26 144.71 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -131.54 128.75 39.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.634 1.573 . . . . 0.0 108.149 -169.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.25 163.43 27.84 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 109.011 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.21 -17.53 42.1 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -81.42 -4.96 57.33 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.296 -1.502 . . . . 0.0 112.378 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.93 27.64 66.3 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.317 -0.865 . . . . 0.0 111.698 -172.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.36 144.11 27.44 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.33 135.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.2 -32.92 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.416 1.486 . . . . 0.0 109.614 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -150.12 144.85 25.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 139.84 24.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -148.22 149.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -125.85 142.83 51.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.348 1.859 . . . . 0.0 106.214 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.96 -10.51 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m 62.99 -21.99 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.241 2.216 . . . . 0.0 115.626 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -143.63 123.97 13.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.218 1.372 . . . . 0.0 107.505 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.05 -18.38 46.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.9 p -77.63 -3.96 43.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.227 0.921 . . . . 0.0 112.905 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 163.11 25.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.402 1.001 . . . . 0.0 110.048 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -118.54 155.97 51.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.632 -170.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.15 155.04 47.19 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 108.2 -1.5 . . . . 0.0 108.2 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -84.65 114.0 21.69 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -49.1 -26.07 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.009 2.124 . . . . 0.0 113.508 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.8 -37.57 82.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.877 0.762 . . . . 0.0 111.242 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -63.98 -51.92 60.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.617 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.59 -27.3 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.806 1.67 . . . . 0.0 112.233 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -59.82 -45.63 94.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-N 120.22 1.373 . . . . 0.0 109.246 171.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.91 -32.85 74.52 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.885 0.766 . . . . 0.0 111.021 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.25 56.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.611 0.364 . . . . 0.0 111.103 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.61 -46.87 71.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.135 0.574 . . . . 0.0 111.639 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -29.1 67.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.72 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.28 77.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.317 0.508 . . . . 0.0 111.696 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.72 -35.65 19.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.439 0.563 . . . . 0.0 112.401 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.91 -9.32 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.736 0.814 . . . . 0.0 110.18 176.257 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.235 0.303 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.514 HD12 HD21 ' A' ' 13' ' ' LEU . 85.1 mt -137.59 169.66 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 150.49 31.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -143.08 121.84 12.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.61 37.61 3.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.344 1.458 . . . . 0.0 113.166 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.28 12.05 60.39 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.196 -1.336 . . . . 0.0 114.628 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.06 154.43 23.9 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.954 1.877 . . . . 0.0 110.955 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.0 153.93 63.02 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.653 2.236 . . . . 0.0 111.344 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -139.04 129.2 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.526 1.53 . . . . 0.0 108.286 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -74.54 160.39 30.97 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.197 1.399 . . . . 0.0 109.244 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.514 HD21 HD12 ' A' ' 4' ' ' ILE . 4.9 mp -129.54 148.91 51.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 108.944 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 t -82.36 135.26 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.0 -158.28 14.44 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 118.38 0.536 . . . . 0.0 112.785 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -131.62 143.88 50.65 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.316 1.447 . . . . 0.0 108.666 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.86 103.0 7.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.84 157.09 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 108.832 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -127.71 156.5 42.29 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.991 1.316 . . . . 0.0 109.357 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.72 140.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.13 59.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.6 1.095 . . . . 0.0 112.756 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.78 156.8 37.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.32 1.56 . . . . 0.0 109.582 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.37 139.65 32.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.63 159.34 74.82 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -60.4 -7.06 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.449 3.432 . . . . 0.0 117.8 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 52.4 58.58 5.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.833 1.302 . . . . 0.0 110.823 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -85.69 165.78 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.034 1.734 . . . . 0.0 109.712 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -130.9 146.12 52.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.988 1.315 . . . . 0.0 107.514 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.87 168.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.581 1.952 . . . . 0.0 107.235 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.68 146.67 26.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.0 p -74.42 167.11 22.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -63.89 -8.02 9.91 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.062 -1.023 . . . . 0.0 111.656 168.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -109.72 13.9 23.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.836 2.054 . . . . 0.0 111.251 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 64.59 44.99 3.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.167 1.387 . . . . 0.0 111.978 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.14 161.53 29.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.58 144.13 35.82 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.62 -1.3 . . . . 0.0 108.895 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -142.67 145.83 33.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 m -140.37 167.28 22.51 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.671 0.788 . . . . 0.0 109.556 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 tp -47.22 -40.53 16.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.193 0.997 . . . . 0.0 111.958 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.97 -30.95 62.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.72 0.808 . . . . 0.0 113.084 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.55 -40.59 42.02 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.464 0.65 . . . . 0.0 110.577 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.8 mtt -65.34 -27.04 68.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.706 1.202 . . . . 0.0 111.346 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -55.42 -16.08 3.3 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 113.414 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.8 -20.37 56.91 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.845 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -154.47 156.45 36.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.443 1.621 . . . . 0.0 109.0 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.24 122.04 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.7 m -117.2 150.81 38.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 109.975 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.8 mt -121.89 145.64 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.2 mt -126.54 138.94 53.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.23 93.83 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.242 1.817 . . . . 0.0 106.823 -171.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.45 128.32 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 pt -139.27 154.45 72.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.11 -46.49 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 CA-C-N 121.098 1.428 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 p -158.73 173.98 15.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.614 1.966 . . . . 0.0 107.762 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.437 HD11 ' CE3' ' A' ' 93' ' ' TRP . 3.8 tt -113.58 -177.67 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.802 0.841 . . . . 0.0 110.635 -169.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 56.3 43.81 25.78 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.24 1.416 . . . . 0.0 112.894 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -147.27 138.43 23.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -45.55 -46.34 12.37 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.191 1.376 . . . . 0.0 114.56 -169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.21 -25.59 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.434 1.094 . . . . 0.0 112.598 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.46 -40.59 7.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.925 1.69 . . . . 0.0 110.099 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.92 -49.76 74.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 127.15 2.18 . . . . 0.0 110.693 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.31 88.31 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.948 0.499 . . . . 0.0 111.348 -174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -61.36 2.63 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.7 m -64.33 -39.07 93.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.337 0.517 . . . . 0.0 111.163 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.89 -50.37 69.02 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.219 -0.926 . . . . 0.0 110.253 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.86 -33.59 75.05 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.602 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.31 -39.68 73.12 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 120.142 1.337 . . . . 0.0 112.16 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.94 -48.91 79.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.601 1.091 . . . . 0.0 110.874 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -67.6 -44.09 78.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -63.3 -37.82 88.73 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.03 -1.044 . . . . 0.0 110.819 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.6 92.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.622 -0.674 . . . . 0.0 111.041 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.06 88.6 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.788 0.722 . . . . 0.0 111.227 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -67.66 -40.09 84.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.694 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.7 mp -60.9 -45.41 94.73 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.852 0.751 . . . . 0.0 109.842 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.59 -9.83 61.04 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.961 1.267 . . . . 0.0 114.842 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -153.62 58.66 0.75 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.042 1.421 . . . . 0.0 109.492 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.43 171.9 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.783 1.233 . . . . 0.0 107.789 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.97 141.61 50.74 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 t -138.05 151.95 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.188 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.28 169.69 16.83 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.984 1.314 . . . . 0.0 109.703 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -132.75 143.85 49.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.98 133.88 60.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 m -139.48 158.57 43.91 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.57 1.169 . . . . 0.0 110.879 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.5 54.22 2.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 168.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.43 163.95 31.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 108.244 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.65 135.86 85.89 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -169.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.16 -36.68 79.7 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.986 1.791 . . . . 0.0 110.714 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -75.2 -27.71 59.71 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.776 -0.63 . . . . 0.0 112.101 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.72 71.29 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.52 1.055 . . . . 0.0 108.964 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -60.18 -41.61 93.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.826 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.97 92.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.63 0.65 . . . . 0.0 111.007 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -67.55 -39.25 84.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.174 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.437 ' CE3' HD11 ' A' ' 55' ' ' ILE . 74.9 t90 -69.25 -45.13 70.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.207 0.603 . . . . 0.0 110.934 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -69.76 -33.73 72.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.824 -1.173 . . . . 0.0 110.353 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -33.69 87.92 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.037 -0.868 . . . . 0.0 112.402 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.74 93.41 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.705 1.253 . . . . 0.0 110.206 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -72.83 -27.71 62.11 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.123 0.569 . . . . 0.0 111.968 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.14 53.41 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mt -68.37 145.8 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.263 1.025 . . . . 0.0 108.499 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.89 -34.93 0.42 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.069 1.348 . . . . 0.0 111.976 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.33 -13.62 59.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.645 0.778 . . . . 0.0 111.927 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.16 155.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -134.21 130.81 37.76 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -84.46 151.55 24.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.101 0.56 . . . . 0.0 109.62 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 mt -143.09 150.27 39.29 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.505 1.522 . . . . 0.0 107.255 -173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.4 m -116.01 115.39 26.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.652 1.181 . . . . 0.0 108.505 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.26 -9.7 55.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.581 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.39 -36.42 6.44 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.049 2.139 . . . . 0.0 114.259 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -78.57 -13.39 59.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.891 -173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -147.64 -16.19 0.37 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -169.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.1 mmm 51.93 9.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.462 2.705 . . . . 0.0 117.213 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.7 m -63.15 -38.25 90.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.751 1.614 . . . . 0.0 112.525 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -64.71 -50.53 66.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.128 1.331 . . . . 0.0 108.952 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.48 97.73 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 -172.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.464 0.706 . . . . 0.0 109.814 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.581 -0.7 . . . . 0.0 111.847 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.57 1.02 40.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.691 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.1 90.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.873 1.215 . . . . 0.0 112.862 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.9 -7.37 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.743 1.217 . . . . 0.0 111.352 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.75 108.3 5.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.058 1.299 . . . . 0.0 107.942 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.86 112.71 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -57.32 -38.09 73.51 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.519 1.527 . . . . 0.0 110.887 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.58 8.51 40.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.965 0.906 . . . . 0.0 112.149 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.66 -23.87 2.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 55.58 37.35 28.76 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 110.037 -168.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.9 mt -130.72 161.15 32.31 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.125 1.37 . . . . 0.0 108.092 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.6 mt -83.27 143.35 30.46 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.14 152.01 41.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 111.01 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -80.7 100.61 8.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 62.0 m -147.97 167.25 25.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.328 1.451 . . . . 0.0 109.417 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 m -141.0 153.41 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.469 -0.769 . . . . 0.0 110.515 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.69 157.12 44.99 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.539 1.136 . . . . 0.0 109.619 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.49 139.51 48.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -133.24 119.49 19.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 107.618 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.01 163.85 21.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.56 0.744 . . . . 0.0 109.528 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.2 -23.33 21.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.078 1.351 . . . . 0.0 112.811 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -76.06 -6.49 51.33 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.805 -1.184 . . . . 0.0 112.377 175.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.17 42.61 35.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -121.46 132.09 54.53 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.81 112.78 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -171.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.28 -33.76 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.692 1.197 . . . . 0.0 109.355 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -154.99 147.04 23.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.839 1.256 . . . . 0.0 108.363 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.33 31.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.776 1.23 . . . . 0.0 107.837 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.1 137.59 21.0 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.886 0.874 . . . . 0.0 108.794 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -131.33 93.97 3.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 105.355 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.54 132.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 m -67.79 -9.67 46.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 113.074 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.15 110.51 11.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.74 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.885 0.874 . . . . 0.0 110.925 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.46 6.02 6.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 112.627 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -122.88 173.24 7.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.196 2.199 . . . . 0.0 107.033 170.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.57 157.44 73.08 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 120.936 -1.103 . . . . 0.0 111.543 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.17 -179.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.742 3.628 . . . . 0.0 113.594 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -124.77 111.7 15.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -52.25 -25.07 8.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.69 1.996 . . . . 0.0 112.948 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.67 -38.04 80.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.995 0.816 . . . . 0.0 111.383 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -60.28 -56.09 38.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.892 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.9 -26.96 31.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.49 1.46 . . . . 0.0 112.059 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -44.38 94.89 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.654 1.57 . . . . 0.0 109.638 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.53 -34.52 78.43 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.16 0.891 . . . . 0.0 110.713 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.57 -49.06 70.23 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.5 0.19 . . . . 0.0 111.258 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.14 -49.4 61.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.026 0.53 . . . . 0.0 111.128 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -33.82 69.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.759 0.708 . . . . 0.0 111.355 -176.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.35 -31.37 69.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.446 0.566 . . . . 0.0 111.784 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.7 mt -89.61 -24.41 21.68 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.698 0.799 . . . . 0.0 112.155 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.91 -32.73 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.483 0.583 . . . . 0.0 110.519 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.183 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 13' ' ' LEU . 95.5 mt -133.94 170.8 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.16 151.31 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -133.73 113.33 12.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.74 -50.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.877 2.871 . . . . 0.0 115.529 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 17.35 0.06 OUTLIER Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.818 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.75 27.48 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.577 1.689 . . . . 0.0 110.979 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.63 157.69 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.048 2.499 . . . . 0.0 111.874 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.55 124.97 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.144 1.778 . . . . 0.0 107.479 171.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -73.98 158.09 35.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.476 1.51 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.538 HD21 HD12 ' A' ' 4' ' ' ILE . 4.8 mp -132.47 136.81 46.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 123.987 0.915 . . . . 0.0 108.889 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.35 127.31 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.55 -167.56 18.94 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 121.415 0.453 . . . . 0.0 112.697 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -109.0 141.6 40.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 108.264 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.25 107.96 10.02 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.08 152.96 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.2 157.49 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 109.881 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -57.4 141.07 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.715 0.806 . . . . 0.0 108.923 175.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -24.23 17.6 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.748 1.166 . . . . 0.0 112.257 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.82 158.85 34.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.295 1.547 . . . . 0.0 110.299 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -76.25 136.49 39.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 153.98 89.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.789 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.28 -28.12 70.09 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.86 3.04 . . . . 0.0 115.907 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.05 80.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.775 1.63 . . . . 0.0 113.756 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -126.09 -172.31 2.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.514 1.526 . . . . 0.0 109.806 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 m -125.17 156.04 39.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.107 . . . . 0.0 110.527 -168.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -141.62 178.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 129.193 2.997 . . . . 0.0 106.604 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.87 149.17 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.0 p -69.29 170.23 10.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.177 -0.952 . . . . 0.0 108.636 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.25 -10.61 33.46 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.777 -1.202 . . . . 0.0 110.767 168.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -97.29 10.51 39.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.976 2.11 . . . . 0.0 111.74 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.8 mt 60.76 42.99 12.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.872 1.669 . . . . 0.0 113.573 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.74 141.56 51.28 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.92 141.15 57.73 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.892 -1.13 . . . . 0.0 110.89 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -142.36 151.36 41.82 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 125.643 1.577 . . . . 0.0 108.034 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 p -138.42 170.52 15.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.602 0.637 . . . . 0.0 110.358 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.65 48.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.284 0.634 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -31.89 66.33 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.28 -37.51 80.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.172 0.987 . . . . 0.0 109.956 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.0 mtt -74.7 5.22 5.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.429 2.292 . . . . 0.0 111.45 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -99.65 -7.95 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.017 1.327 . . . . 0.0 111.234 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.66 68.3 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.09 0.859 . . . . 0.0 112.729 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -153.13 168.07 27.17 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.994 2.118 . . . . 0.0 106.436 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.78 118.7 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.4 m -122.82 135.69 54.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.092 0.557 . . . . 0.0 109.503 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.69 139.64 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.0 131.01 73.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -120.19 97.35 5.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -83.56 119.02 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.75 145.5 53.27 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -62.25 -58.92 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.256 2.637 . . . . 0.0 113.639 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.7 m -158.12 143.95 17.08 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.62 -15.94 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.26 -14.93 62.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.03 1.332 . . . . 0.0 114.439 -172.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -65.37 -22.01 66.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.471 1.032 . . . . 0.0 113.741 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.19 -36.58 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.221 0.915 . . . . 0.0 111.39 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.64 -40.03 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.568 1.184 . . . . 0.0 108.633 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.9 m -61.04 -37.9 84.25 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.925 0.89 . . . . 0.0 111.994 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -61.61 -51.76 67.19 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.442 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -49.48 77.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.975 0.352 . . . . 0.0 110.773 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.41 -54.27 47.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.46 1.104 . . . . 0.0 109.75 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -70.63 -38.89 73.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.646 -0.659 . . . . 0.0 110.949 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -63.21 -43.62 97.62 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 120.894 -1.129 . . . . 0.0 110.944 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -66.72 -42.39 86.39 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.921 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -54.53 -38.05 66.1 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.973 1.26 . . . . 0.0 112.286 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.412 ' HA ' HG23 ' A' ' 102' ' ' VAL . 17.6 t30 -60.26 -51.36 69.88 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.077 0.853 . . . . 0.0 111.099 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.62 -34.09 69.54 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 118.989 -1.084 . . . . 0.0 111.709 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.24 -37.4 87.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 120.209 1.368 . . . . 0.0 109.922 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.42 92.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.839 0.455 . . . . 0.0 111.074 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.47 94.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.75 0.705 . . . . 0.0 111.368 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -65.36 -41.07 94.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.619 0.768 . . . . 0.0 110.103 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -45.7 86.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.18 0.992 . . . . 0.0 110.812 173.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -23.79 4.19 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.993 1.282 . . . . 0.0 113.773 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -147.97 66.14 1.1 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.166 1.386 . . . . 0.0 109.506 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.69 172.65 9.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -130.26 139.85 50.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.04 133.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -130.71 161.34 31.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.664 1.186 . . . . 0.0 109.645 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -128.27 143.43 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.91 135.93 57.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m -142.2 158.81 43.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.906 0.882 . . . . 0.0 111.675 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.76 40.06 0.92 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -126.15 163.84 22.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.259 1.423 . . . . 0.0 109.027 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.89 128.41 93.86 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -169.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.11 -33.78 94.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.742 1.628 . . . . 0.0 111.163 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -73.31 -27.09 61.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.223 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -48.64 63.8 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.834 1.197 . . . . 0.0 109.144 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -57.04 -42.41 80.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.307 0.243 . . . . 0.0 111.578 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.31 -42.26 96.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.662 0.665 . . . . 0.0 111.571 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -65.24 -42.31 93.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -59.69 -39.8 85.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.086 0.554 . . . . 0.0 111.22 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.3 m -60.76 -42.25 97.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.518 1.054 . . . . 0.0 110.505 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.29 -31.86 82.26 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.532 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.82 78.52 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.261 1.03 . . . . 0.0 111.368 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -106.6 -16.03 14.62 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.81 0.844 . . . . 0.0 112.277 -171.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.2 38.34 34.75 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.29 144.97 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.674 1.19 . . . . 0.0 108.207 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -143.83 -35.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.229 1.012 . . . . 0.0 112.405 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -87.13 -14.82 40.23 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.406 0.683 . . . . 0.0 112.313 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 68' ' ' ASN . 69.8 t -113.57 154.44 14.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.33 128.48 33.8 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -86.92 151.01 23.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.427 1.091 . . . . 0.0 109.251 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.1 mt -144.19 152.49 40.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.216 1.807 . . . . 0.0 106.507 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.1 m -121.03 125.97 48.69 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.172 -0.955 . . . . 0.0 109.45 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.59 3.94 48.02 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.031 1.332 . . . . 0.0 110.149 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -48.18 135.42 13.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.716 2.007 . . . . 0.0 111.573 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 63.44 -38.93 0.18 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.805 2.842 . . . . 0.0 114.392 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.36 -39.02 68.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.14 0.882 . . . . 0.0 111.56 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 53.93 9.7 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.712 2.805 . . . . 0.0 116.586 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.7 m -60.93 -43.76 98.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.364 1.893 . . . . 0.0 111.813 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.26 -44.28 68.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.068 0.849 . . . . 0.0 109.824 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -58.04 -47.07 91.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 123.96 0.79 . . . . 0.0 111.319 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.44 -37.58 87.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.505 0.722 . . . . 0.0 110.639 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -35.55 63.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.336 -0.852 . . . . 0.0 112.37 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.18 1.37 41.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.337 1.055 . . . . 0.0 112.168 -174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.79 35.58 50.32 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.342 0.974 . . . . 0.0 113.003 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG23 ' HA2' ' A' ' 114' ' ' GLY . 21.1 m -131.38 21.38 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.658 1.183 . . . . 0.0 111.548 -169.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -107.89 110.66 22.48 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.5 110.99 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.13 -38.35 73.32 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 126.113 1.765 . . . . 0.0 111.083 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -91.29 4.57 52.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.893 0.877 . . . . 0.0 112.109 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -130.87 -21.81 2.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.361 1.064 . . . . 0.0 112.747 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 53.77 38.99 29.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.67 -168.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -131.4 152.62 50.48 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.075 1.35 . . . . 0.0 107.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.87 155.19 31.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 110.695 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.44 175.48 6.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.328 1.061 . . . . 0.0 111.679 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -113.57 85.31 2.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -141.48 164.57 29.86 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 110.519 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.14 152.43 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 121.636 -0.665 . . . . 0.0 109.424 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.5 159.63 41.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.572 1.149 . . . . 0.0 108.665 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.52 141.65 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -129.9 123.17 30.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.087 1.755 . . . . 0.0 106.854 -169.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.63 164.35 26.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.03 -20.89 26.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.445 1.098 . . . . 0.0 112.785 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -81.4 0.08 39.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.835 -1.166 . . . . 0.0 112.394 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.71 28.3 73.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.367 0.985 . . . . 0.0 111.701 -171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.03 133.06 43.85 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -75.66 127.26 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.8 t -102.15 -30.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.477 1.511 . . . . 0.0 109.636 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -153.41 147.95 26.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.04 140.39 24.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.2 144.12 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.56 79.68 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.1 123.81 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -63.83 -14.59 54.33 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -122.77 116.42 23.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.06 65.78 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.19 10.81 2.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.959 1.304 . . . . 0.0 112.0 170.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -139.07 170.92 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.989 2.516 . . . . 0.0 107.319 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.92 154.36 79.2 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.145 -0.972 . . . . 0.0 111.085 -173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.47 149.81 37.06 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.915 3.077 . . . . 0.0 112.73 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -91.82 118.55 30.81 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -54.16 -25.4 22.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.046 1.338 . . . . 0.0 113.227 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.35 -37.42 83.26 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.765 0.712 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -60.92 -54.64 52.39 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.115 -172.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.11 -26.64 30.44 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.834 1.334 . . . . 0.0 111.433 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -44.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 120.191 1.36 . . . . 0.0 109.604 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.2 -38.29 90.54 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.27 0.941 . . . . 0.0 110.315 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.8 85.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.366 -0.209 . . . . 0.0 111.393 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.59 -51.38 51.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.447 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.46 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.39 -31.24 69.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.276 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.7 mt -88.8 -34.06 17.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.601 0.761 . . . . 0.0 111.924 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 82.1 t -63.4 -41.82 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.98 0.512 . . . . 0.0 111.063 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 19.0 pttp . . . . . 0 C--O 1.249 1.057 0 CA-C-N 118.292 0.496 . . . . 0.0 111.143 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 122.071 0.938 . . . . 0.0 112.684 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.71 146.28 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 p -112.71 160.43 17.93 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.294 1.038 . . . . 0.0 109.74 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -111.83 45.0 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.495 1.118 . . . . 0.0 108.743 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt 42.66 61.71 1.98 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.647 1.979 . . . . 0.0 112.346 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 -26.12 0.11 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.568 1.08 . . . . 0.0 111.019 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.19 176.04 47.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.242 1.401 . . . . 0.0 109.872 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.31 158.62 47.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.158 2.572 . . . . 0.0 110.552 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.42 134.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -66.16 151.26 47.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.263 1.025 . . . . 0.0 111.163 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.03 141.46 49.24 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.144 2.178 . . . . 0.0 105.886 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.66 -70.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.65 0.659 . . . . 0.0 110.013 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.54 54.74 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.516 0.579 . . . . 0.0 112.405 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.11 166.75 22.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.734 0.778 . . . . 0.0 110.967 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -70.23 115.6 9.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 168.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.96 153.66 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -124.83 156.29 38.05 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.804 0.841 . . . . 0.0 109.796 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.29 140.1 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.414 0.686 . . . . 0.0 109.308 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.47 -20.05 48.89 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.431 1.491 . . . . 0.0 112.244 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.39 155.12 39.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.791 1.295 . . . . 0.0 110.038 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -72.9 132.91 44.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.06 160.51 29.71 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.274 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.29 -4.04 2.11 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.499 3.466 . . . . 0.0 117.85 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.91 55.38 9.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.755 1.265 . . . . 0.0 111.375 -174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -89.37 170.52 10.48 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.487 1.515 . . . . 0.0 110.859 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -131.02 151.51 51.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.659 1.184 . . . . 0.0 108.341 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.34 163.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 0.0 107.312 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -86.69 138.69 31.44 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -71.16 166.09 22.2 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.11 -13.88 62.37 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.529 -1.357 . . . . 0.0 110.904 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.46 0.94 40.0 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.909 1.683 . . . . 0.0 111.497 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt 69.1 37.23 2.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.687 1.595 . . . . 0.0 111.687 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.41 164.17 21.02 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.991 1.316 . . . . 0.0 107.897 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.86 141.19 37.89 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.013 -1.054 . . . . 0.0 109.493 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -138.02 143.96 40.82 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -146.44 172.03 14.15 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.25 0.62 . . . . 0.0 109.934 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.4 tp -44.21 -45.96 8.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 111.582 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.13 67.55 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.783 0.833 . . . . 0.0 112.465 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.45 -40.22 21.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.84 0.856 . . . . 0.0 110.795 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.04 -39.04 83.16 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.207 0.603 . . . . 0.0 110.011 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -65.17 -4.63 5.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -19.57 41.47 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 113.025 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.82 158.56 43.6 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.369 1.468 . . . . 0.0 107.074 173.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.9 t -60.88 119.76 5.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.0 m -127.64 128.76 46.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 109.98 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.3 mt -89.84 140.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.15 133.34 68.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -128.57 95.74 4.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.38 134.24 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.26 157.6 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 107.25 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.39 -54.15 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.721 1.614 . . . . 0.0 111.671 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 p -155.5 154.5 31.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.316 1.846 . . . . 0.0 107.187 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' CE3' ' A' ' 93' ' ' TRP . 9.3 tt -78.8 -14.73 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -169.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.52 -34.59 78.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.87 155.31 40.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.465 0.575 . . . . 0.0 111.201 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.13 -39.06 93.95 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.858 -0.526 . . . . 0.0 112.534 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 m -70.04 -40.54 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.174 0.987 . . . . 0.0 110.971 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.07 -43.88 97.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.589 0.755 . . . . 0.0 110.799 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -58.93 -56.16 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.512 1.525 . . . . 0.0 109.929 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.92 88.78 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.159 0.584 . . . . 0.0 111.156 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -56.05 -54.16 48.25 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.321 1.048 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -64.95 -40.91 95.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.193 0.452 . . . . 0.0 110.441 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.3 tpt85 -67.96 -43.08 79.87 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.104 -0.997 . . . . 0.0 111.26 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -70.74 -35.13 72.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.083 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.79 -41.44 74.11 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.263 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.417 ' HA ' HG23 ' A' ' 102' ' ' VAL . 22.3 t30 -61.81 -49.39 76.51 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.331 0.969 . . . . 0.0 111.31 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.91 -38.9 83.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -67.29 -38.25 84.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.99 86.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.425 0.69 . . . . 0.0 111.326 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.58 88.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 111.282 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.43 -41.09 93.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.267 0.627 . . . . 0.0 110.079 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.29 -43.01 92.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.015 0.526 . . . . 0.0 110.444 173.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 -69.5 2.54 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.133 1.825 . . . . 0.0 110.685 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -85.3 67.76 10.26 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.078 1.351 . . . . 0.0 110.142 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.22 162.53 6.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -123.14 141.21 52.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.62 138.53 42.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -131.41 154.46 48.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.819 0.848 . . . . 0.0 109.664 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 104' ' ' THR . 51.5 m -116.05 148.44 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.91 135.67 63.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.1 m -136.57 150.64 48.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.69 49.78 1.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -137.44 162.56 33.33 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.208 2.203 . . . . 0.0 107.537 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.12 138.12 92.13 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-O 119.013 -0.517 . . . . 0.0 111.226 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.67 -37.13 81.57 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.103 1.869 . . . . 0.0 111.654 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -69.35 -33.64 73.4 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.5 -50.81 49.42 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.069 0.849 . . . . 0.0 109.647 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -55.94 -49.12 74.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.147 0.579 . . . . 0.0 110.919 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.06 -45.11 93.73 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.436 0.695 . . . . 0.0 111.873 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 tpt85 -66.4 -36.99 84.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.49 0.586 . . . . 0.0 110.412 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.408 ' CE3' HD11 ' A' ' 55' ' ' ILE . 65.7 t90 -65.53 -41.61 92.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.036 0.534 . . . . 0.0 110.177 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 92.9 m -61.7 -41.67 97.9 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.999 -1.063 . . . . 0.0 110.633 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.03 -32.21 83.42 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.24 0.924 . . . . 0.0 112.378 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.63 95.06 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.437 1.118 . . . . 0.0 110.388 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.11 -20.87 29.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.746 0.818 . . . . 0.0 112.36 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.63 61.2 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.613 0.642 . . . . 0.0 111.724 -172.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mt -69.56 141.84 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.844 1.258 . . . . 0.0 108.095 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -147.97 -32.86 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -75.25 -16.37 60.46 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.728 0.694 . . . . 0.0 111.977 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 68' ' ' ASN . 96.4 t -111.58 150.08 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.39 148.01 49.23 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -105.2 151.73 23.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.3 mt -136.38 152.79 51.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.6 m -124.27 168.61 12.74 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.873 -0.517 . . . . 0.0 112.367 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -47.47 114.34 0.86 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 109.339 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -39.63 75.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.759 -175.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 157.18 -38.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.556 2.343 . . . . 0.0 105.652 -169.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.41 141.97 45.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.162 1.385 . . . . 0.0 107.353 170.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . 97.2 mmm -55.85 19.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 130.059 3.344 . . . . 0.0 115.698 177.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -52.63 -42.11 64.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.863 1.665 . . . . 0.0 112.404 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 111' ' ' MET . 40.6 p90 -56.03 -25.62 45.51 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.662 1.985 . . . . 0.0 114.344 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.6 -35.89 2.95 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 118.565 0.621 . . . . 0.0 111.675 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.32 -49.12 78.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.154 1.382 . . . . 0.0 109.97 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.96 -5.85 59.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.89 0.876 . . . . 0.0 112.415 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.2 10.76 14.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.911 1.284 . . . . 0.0 110.22 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.63 74.36 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.599 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.94 -5.2 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.007 1.404 . . . . 0.0 112.522 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -78.4 105.96 10.01 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.06 97.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -50.15 -41.56 49.25 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.87 1.668 . . . . 0.0 111.998 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.38 -10.18 59.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.863 0.865 . . . . 0.0 113.118 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.63 -20.78 5.4 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.555 1.142 . . . . 0.0 112.074 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 54.42 36.91 26.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.148 1.379 . . . . 0.0 109.944 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.5 mt -117.04 160.01 21.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.466 1.106 . . . . 0.0 108.351 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.45 137.26 32.48 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.76 163.63 25.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.749 0.819 . . . . 0.0 111.216 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.18 110.91 22.61 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 169.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.2 m -166.42 173.05 10.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.437 1.495 . . . . 0.0 108.144 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.12 152.17 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.257 -0.902 . . . . 0.0 110.691 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -136.45 161.31 36.2 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.126 1.37 . . . . 0.0 108.003 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 139.49 46.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.06 116.66 24.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.49 1.516 . . . . 0.0 107.72 -169.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.49 160.32 19.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.868 1.267 . . . . 0.0 108.83 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -64.25 -8.5 12.88 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.86 5.03 53.07 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.652 -1.28 . . . . 0.0 111.827 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.65 26.97 68.23 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.362 0.982 . . . . 0.0 112.086 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -91.67 139.42 30.7 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 108.46 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.37 -22.94 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.544 0.611 . . . . 0.0 110.615 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -153.92 143.71 21.81 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.82 145.02 31.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.59 142.81 29.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -132.53 106.04 7.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.503 1.921 . . . . 0.0 106.178 -170.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.52 131.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -68.59 0.53 4.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 113.058 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -139.16 110.12 6.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.781 2.032 . . . . 0.0 106.042 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.28 -28.55 68.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.146 0.43 . . . . 0.0 111.471 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.0 p -70.43 -9.94 57.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.265 1.826 . . . . 0.0 113.197 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.15 167.65 12.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.82 1.648 . . . . 0.0 108.905 -169.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -128.52 153.21 79.33 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.252 0.933 . . . . 0.0 109.715 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.07 152.07 45.31 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.844 1.696 . . . . 0.0 108.242 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -69.65 119.35 13.75 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -50.61 -27.36 6.71 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.143 1.777 . . . . 0.0 113.331 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -61.14 -34.44 75.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.753 -0.592 . . . . 0.0 111.447 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -66.28 -49.92 51.88 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 117.944 -1.026 . . . . 0.0 112.542 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.05 -27.77 49.71 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 121.403 1.537 . . . . 0.0 111.896 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -44.13 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.93 1.241 . . . . 0.0 109.545 171.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.12 -31.79 73.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.13 0.877 . . . . 0.0 111.179 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.76 -49.6 61.65 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.972 0.351 . . . . 0.0 111.014 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.49 75.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.8 0.44 . . . . 0.0 111.673 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -28.59 68.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.673 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.84 80.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.583 0.629 . . . . 0.0 111.416 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.0 mt -76.69 -43.21 38.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.411 0.551 . . . . 0.0 111.672 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.81 -4.49 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.07 0.85 . . . . 0.0 110.011 174.686 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 119.279 -0.391 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 5' ' ' THR 0.273 18.1 mt 69.29 171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 126.665 1.986 . . . . 0.0 111.886 169.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -141.4 156.89 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.428 2.691 . . . . 0.0 105.903 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -135.93 119.54 17.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HE2' HG21 ' A' ' 150' ' ' THR . 13.1 tppt? 42.14 43.45 2.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.213 1.805 . . . . 0.0 111.591 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.31 85.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.539 -1.145 . . . . 0.0 114.165 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.6 139.54 15.73 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.21 155.37 69.63 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.193 1.929 . . . . 0.0 111.381 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.07 -167.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.473 1.509 . . . . 0.0 108.082 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.3 m -138.68 160.01 40.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 4' ' ' ILE . 1.2 tp -126.77 128.26 46.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.93 1.292 . . . . 0.0 109.686 -170.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.4 157.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.43 -154.5 40.47 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 123.617 0.627 . . . . 0.0 112.168 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.95 155.59 47.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.65 1.18 . . . . 0.0 109.064 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.29 152.25 45.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.72 154.38 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.751 1.62 . . . . 0.0 106.96 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.57 157.86 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.006 0.922 . . . . 0.0 111.764 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.26 144.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.899 1.28 . . . . 0.0 109.332 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 -23.61 18.66 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.685 1.136 . . . . 0.0 111.952 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.49 153.63 40.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.421 1.11 . . . . 0.0 109.519 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -70.28 128.23 35.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.93 153.99 78.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.466 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.68 -31.14 59.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.263 2.642 . . . . 0.0 115.315 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 47.76 84.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.343 1.857 . . . . 0.0 113.357 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.6 177.88 6.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.596 1.158 . . . . 0.0 109.228 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.7 m -109.59 151.05 27.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.651 1.181 . . . . 0.0 109.542 -169.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.21 173.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 128.208 2.603 . . . . 0.0 106.098 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.99 156.85 16.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.2 p -71.82 174.03 7.45 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.088 -1.008 . . . . 0.0 108.847 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -67.2 -11.14 56.58 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.26 -0.9 . . . . 0.0 110.842 168.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m -73.22 -65.82 0.76 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 pp 154.49 12.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 130.581 3.552 . . . . 0.0 112.168 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.82 144.53 30.37 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.732 -1.23 . . . . 0.0 109.181 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.51 133.19 55.86 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.657 -0.652 . . . . 0.0 111.227 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -140.48 147.1 39.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.209 1.804 . . . . 0.0 107.503 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -131.63 159.1 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.03 -31.17 68.59 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.08 66.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.788 0.835 . . . . 0.0 113.191 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.25 -35.66 68.86 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.8 mtt -75.78 -35.85 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.201 1.0 . . . . 0.0 111.177 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -63.97 -3.82 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.05 13.6 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 119.485 1.038 . . . . 0.0 113.009 169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.49 157.23 45.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.864 1.666 . . . . 0.0 107.113 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.3 t -54.85 124.97 8.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.2 m -120.46 149.31 42.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.463 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.2 mt -116.18 141.42 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.5 mm -123.24 140.15 47.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 84.17 2.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 m -71.93 135.66 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.78 157.05 58.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.709 1.604 . . . . 0.0 108.955 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.56 -61.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.305 2.003 . . . . 0.0 110.641 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -144.25 147.77 34.01 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.39 1.476 . . . . 0.0 107.172 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.8 tt -98.82 -31.38 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.815 0.446 . . . . 0.0 111.438 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.5 -24.91 67.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 t -64.43 -21.25 66.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.218 1.007 . . . . 0.0 112.01 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.54 -11.95 64.56 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.029 -1.044 . . . . 0.0 114.094 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.37 -30.29 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.198 1.499 . . . . 0.0 110.542 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.14 -6.12 1.85 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.337 1.455 . . . . 0.0 113.365 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.38 -43.63 64.84 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.481 1.491 . . . . 0.0 110.15 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.17 4.42 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.153 0.981 . . . . 0.0 112.92 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -129.57 -83.36 0.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -55.59 -51.68 66.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.025 1.33 . . . . 0.0 111.814 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -70.72 -46.31 63.31 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.518 -0.739 . . . . 0.0 110.014 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -41.21 93.95 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.259 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -59.98 -31.19 69.67 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 120.455 1.48 . . . . 0.0 112.354 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.98 -43.66 98.51 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.252 0.933 . . . . 0.0 110.678 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 73' ' ' LYS . 28.3 mt-10 -65.6 -51.4 59.94 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -63.1 -35.17 79.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.768 . . . . 0.0 111.303 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.87 95.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.529 0.604 . . . . 0.0 110.783 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.3 81.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.644 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 69' ' ' GLU . 56.0 mttt -66.02 -41.53 90.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 110.702 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.04 -46.62 86.69 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.964 0.906 . . . . 0.0 109.808 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.53 -33.93 5.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.296 1.426 . . . . 0.0 111.071 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.95 120.9 4.28 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.98 1.312 . . . . 0.0 108.827 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -159.59 171.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.837 2.055 . . . . 0.0 105.715 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -119.04 138.72 52.66 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.4 p -154.3 146.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 120.809 -1.182 . . . . 0.0 110.305 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.55 170.2 16.17 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.781 1.232 . . . . 0.0 110.199 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.4 m -126.51 146.7 50.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.34 131.1 70.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -131.37 144.27 51.1 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.942 0.497 . . . . 0.0 110.978 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.72 48.87 1.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.82 161.67 35.97 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.14 1.776 . . . . 0.0 106.864 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.48 140.46 84.65 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.84 -47.59 20.73 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.045 2.497 . . . . 0.0 112.365 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -72.95 -30.11 63.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.76 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.85 85.66 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.855 0.752 . . . . 0.0 110.166 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.56 -48.87 63.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.975 0.91 . . . . 0.0 110.161 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.66 77.89 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 117.943 0.338 . . . . 0.0 110.508 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -45.06 93.5 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.345 1.058 . . . . 0.0 109.769 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -63.33 -43.46 97.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.94 -44.02 81.69 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.804 -0.56 . . . . 0.0 111.23 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -38.97 96.3 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.628 0.632 . . . . 0.0 111.987 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.62 98.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.788 0.835 . . . . 0.0 110.314 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -78.85 -17.77 55.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.69 0.796 . . . . 0.0 112.429 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.63 62.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.095 0.855 . . . . 0.0 111.733 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.84 141.94 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.789 1.236 . . . . 0.0 108.244 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.73 -28.72 0.43 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.574 1.15 . . . . 0.0 112.542 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -76.82 -24.4 52.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.015 0.825 . . . . 0.0 111.264 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 t -105.63 154.8 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.79 127.56 38.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.44 153.54 31.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.384 0.611 . . . . 0.0 109.797 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.7 mt -142.62 159.92 41.31 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.609 1.964 . . . . 0.0 107.546 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -124.0 130.2 52.18 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.844 1.258 . . . . 0.0 109.485 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.73 26.18 4.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.653 1.181 . . . . 0.0 109.449 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -68.11 -20.54 64.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.805 1.642 . . . . 0.0 113.23 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -146.29 153.28 40.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 46.32 56.07 6.69 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -168.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp -64.63 28.23 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.974 2.909 . . . . 0.0 114.071 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -55.21 -36.25 65.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.935 1.694 . . . . 0.0 112.737 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -70.6 -52.31 22.35 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.876 0.762 . . . . 0.0 110.081 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.12 85.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.17 -56.79 17.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.43 1.092 . . . . 0.0 109.38 170.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.29 73.9 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -2.49 37.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.246 0.618 . . . . 0.0 111.954 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.47 47.99 53.87 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.008 1.289 . . . . 0.0 113.034 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.84 -10.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 117.956 0.878 . . . . 0.0 112.272 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 107.67 0.96 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.1 mt -74.8 110.39 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -52.26 -44.21 64.78 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 110.896 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -3.15 47.33 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.393 0.677 . . . . 0.0 112.457 -171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.76 -25.58 4.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.011 0.924 . . . . 0.0 112.381 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 58.37 35.19 24.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.79 0.836 . . . . 0.0 109.845 -168.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.17 157.5 40.65 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.18 146.09 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.06 30.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.533 0.733 . . . . 0.0 111.361 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -81.2 103.29 10.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -149.45 168.88 22.23 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.221 1.409 . . . . 0.0 107.669 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.94 151.75 20.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 121.564 -0.71 . . . . 0.0 110.059 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -135.96 157.16 47.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.607 1.163 . . . . 0.0 108.722 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.98 139.29 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -125.5 132.69 52.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 108.058 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.31 165.93 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 169.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.69 -20.27 47.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.4 -2.56 57.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.601 -1.312 . . . . 0.0 112.271 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.19 23.24 77.95 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 121.078 -1.014 . . . . 0.0 112.42 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.22 145.36 25.45 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.799 1.3 . . . . 0.0 107.556 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.99 134.21 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.6 t -110.42 -30.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.777 1.631 . . . . 0.0 109.405 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -152.14 145.52 24.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.01 141.31 25.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.44 145.34 27.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -132.08 96.9 4.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.818 2.047 . . . . 0.0 106.109 -169.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.59 140.52 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 p -68.0 -12.78 61.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.778 1.231 . . . . 0.0 113.274 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.97 126.06 15.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.88 -21.06 34.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 7' ' ' LYS . 78.8 p -75.04 -25.54 58.78 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 171.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -80.03 172.6 13.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.462 1.505 . . . . 0.0 107.683 169.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -140.74 157.37 67.89 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 120.702 -1.249 . . . . 0.0 110.109 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 165.8 30.89 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.841 2.361 . . . . 0.0 110.083 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -90.82 118.27 30.1 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -49.72 -28.75 6.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.983 1.713 . . . . 0.0 113.169 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -59.9 -36.09 76.24 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.516 0.598 . . . . 0.0 110.801 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -65.03 -52.94 45.4 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.274 -0.869 . . . . 0.0 112.261 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 -24.97 41.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 121.083 1.423 . . . . 0.0 111.795 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.71 -45.89 97.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 109.869 170.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.94 -32.8 72.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.213 0.915 . . . . 0.0 110.345 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.63 -55.27 12.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.922 0.489 . . . . 0.0 111.614 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.63 83.2 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.161 0.584 . . . . 0.0 112.027 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.81 65.55 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.612 0.765 . . . . 0.0 111.826 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.95 -30.74 70.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.063 0.545 . . . . 0.0 111.914 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.3 mt -98.35 -29.19 13.3 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.23 -8.91 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 123.915 0.886 . . . . 0.0 110.024 176.686 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.541 0.616 0 CA-C-O 121.803 0.811 . . . . 0.0 111.812 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.91 144.9 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -111.5 161.11 16.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 109.753 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -128.06 54.36 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.704 1.202 . . . . 0.0 108.437 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 41.11 62.33 1.49 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.941 2.096 . . . . 0.0 113.115 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.74 0.18 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.591 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.95 46.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.271 0.939 . . . . 0.0 110.767 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.3 164.36 6.97 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.97 3.113 . . . . 0.0 113.188 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.91 139.78 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.916 1.286 . . . . 0.0 108.632 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 m -65.48 149.95 49.17 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.466 0.651 . . . . 0.0 109.347 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -129.41 134.66 47.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.65 1.98 . . . . 0.0 107.941 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.66 140.65 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 -166.68 42.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.75 48.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.155 1.382 . . . . 0.0 109.224 -176.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.16 112.34 2.61 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 m -73.17 169.0 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.49 158.27 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.636 -0.665 . . . . 0.0 109.506 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 133.52 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.98 -18.88 56.48 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.933 1.254 . . . . 0.0 112.257 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -70.96 153.38 42.71 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.065 1.432 . . . . 0.0 109.843 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -80.42 130.0 34.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.59 157.38 27.22 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.169 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.54 -7.0 4.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.458 3.438 . . . . 0.0 118.44 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t0 53.5 56.17 7.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.939 1.352 . . . . 0.0 110.894 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -86.01 169.78 12.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.667 1.987 . . . . 0.0 110.192 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -130.78 147.81 52.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.442 1.097 . . . . 0.0 108.189 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.37 162.38 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.297 1.839 . . . . 0.0 107.034 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.03 141.65 29.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -69.66 162.78 26.99 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -64.57 -17.5 64.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.051 -1.656 . . . . 0.0 111.399 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -85.1 3.18 40.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.539 1.936 . . . . 0.0 112.129 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt 73.62 33.47 1.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.398 1.879 . . . . 0.0 113.032 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -115.45 164.54 14.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.085 1.354 . . . . 0.0 108.021 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.22 143.42 35.36 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 120.445 -1.409 . . . . 0.0 109.12 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -141.14 146.08 36.56 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 p -147.66 169.68 19.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -47.69 -41.88 23.63 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.38 0.672 . . . . 0.0 111.651 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.44 64.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 112.751 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -77.96 -40.45 39.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.827 0.851 . . . . 0.0 110.607 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -66.8 -24.59 66.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.179 0.991 . . . . 0.0 111.583 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -55.95 -14.02 2.24 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.541 1.137 . . . . 0.0 113.631 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -27.42 50.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.312 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -155.01 169.47 24.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.959 1.379 . . . . 0.0 109.516 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.21 125.25 17.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 168.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.3 m -129.69 131.93 46.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.887 0.475 . . . . 0.0 111.038 -168.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.4 mt -89.68 141.96 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -118.83 136.33 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 172.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -128.11 90.33 3.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 108.037 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.79 139.05 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.63 144.69 45.79 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.97 -45.03 34.88 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.292 2.661 . . . . 0.0 112.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -160.04 168.15 26.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 106.542 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 tt -107.61 172.48 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.375 0.67 . . . . 0.0 110.14 -170.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.3 25.52 11.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.499 1.52 . . . . 0.0 113.396 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -75.23 -15.36 60.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.079 . . . . 0.0 112.253 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.79 0.1 86.13 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.226 0.917 . . . . 0.0 112.406 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.16 -46.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.748 1.274 . . . . 0.0 109.076 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.07 -28.57 69.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.281 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.96 -32.71 54.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.423 1.489 . . . . 0.0 111.982 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.55 60.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.601 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -55.69 -59.08 5.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.803 0.841 . . . . 0.0 110.424 -169.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -64.38 -40.78 96.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.021 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -74.71 -30.84 61.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.432 1.469 . . . . 0.0 111.45 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -63.52 -42.44 98.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.191 170.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.83 -37.63 79.76 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 120.069 1.304 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -60.41 -48.65 80.84 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.776 0.716 . . . . 0.0 111.036 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.57 -53.48 54.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.02 0.928 . . . . 0.0 109.51 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.7 -39.11 83.48 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.553 0.741 . . . . 0.0 111.363 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.05 87.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.265 0.484 . . . . 0.0 111.104 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.26 -33.82 73.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -69.73 -41.34 75.41 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.007 0.821 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -43.54 98.55 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.496 0.589 . . . . 0.0 110.268 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.44 -21.23 39.31 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.676 1.132 . . . . 0.0 112.686 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -153.04 100.74 2.51 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.735 1.214 . . . . 0.0 109.111 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.9 174.35 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 126.913 2.085 . . . . 0.0 105.433 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -129.65 142.73 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.6 p -151.98 144.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.85 166.17 23.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 0.0 108.974 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -126.3 142.01 51.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mt -128.59 137.92 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -147.36 165.41 30.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 111.76 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.09 -6.93 59.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.67 164.02 25.88 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.523 1.129 . . . . 0.0 110.462 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.5 135.04 96.08 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.25 -34.03 88.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.893 1.728 . . . . 0.0 111.522 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -70.08 -31.12 68.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.505 0.593 . . . . 0.0 111.697 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.82 75.23 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.069 0.85 . . . . 0.0 109.273 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.66 -43.37 93.98 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.582 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.86 -41.94 88.21 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.704 0.684 . . . . 0.0 111.153 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -69.37 -39.18 78.2 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 121.828 -0.545 . . . . 0.0 110.235 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -64.32 -40.25 95.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.795 0.438 . . . . 0.0 110.298 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.16 -38.47 83.25 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.122 -0.986 . . . . 0.0 110.828 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.98 -29.09 74.46 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.764 175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.8 71.6 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.712 1.256 . . . . 0.0 110.21 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -89.06 -17.88 28.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.05 39.27 24.19 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.74 143.99 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.362 1.065 . . . . 0.0 108.152 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -144.12 -38.07 0.31 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.577 1.151 . . . . 0.0 112.405 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -83.9 -18.72 36.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.428 0.691 . . . . 0.0 112.179 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.55 161.72 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -136.01 128.0 29.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p -80.85 149.11 29.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.609 0.764 . . . . 0.0 109.278 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.0 mt -142.67 148.73 37.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.137 1.775 . . . . 0.0 106.239 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.2 m -119.04 126.47 51.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.541 1.064 . . . . 0.0 110.182 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -82.99 -21.23 34.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.764 1.626 . . . . 0.0 109.779 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.7 t60 31.68 -73.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 1 C-N-CA 132.221 4.208 . . . . 0.0 117.413 173.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -139.99 -0.44 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.169 1.387 . . . . 0.0 111.65 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.31 -38.72 63.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.281 0.946 . . . . 0.0 109.882 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 34.0 mmm 53.29 8.73 0.12 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.904 2.882 . . . . 0.0 116.595 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 p -59.79 -41.33 90.92 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 122.407 2.367 . . . . 0.0 111.693 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -60.57 -59.71 4.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.45 -41.59 99.58 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-O 119.994 -0.337 . . . . 0.0 112.61 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.36 -41.96 85.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.439 1.496 . . . . 0.0 110.521 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.24 -23.22 15.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -169.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.33 1.41 45.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.818 1.19 . . . . 0.0 112.749 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.18 28.03 62.93 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.106 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.4 -8.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 119.629 1.715 . . . . 0.0 113.493 -171.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.67 102.69 6.28 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.19 104.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.0 -38.35 67.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.45 1.1 . . . . 0.0 110.796 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -65.63 -16.08 63.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.135 0.974 . . . . 0.0 112.869 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.2 mt -127.3 -18.76 4.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.691 1.196 . . . . 0.0 112.502 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.51 40.08 30.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.523 1.129 . . . . 0.0 109.23 -168.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -136.44 153.71 50.99 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.623 1.169 . . . . 0.0 107.953 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.63 156.43 34.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.592 0.633 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.73 -172.39 1.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.435 1.494 . . . . 0.0 110.513 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -117.95 17.63 14.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.903 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -64.71 170.24 4.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.733 2.013 . . . . 0.0 113.417 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.08 151.66 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.332 1.053 . . . . 0.0 109.816 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -141.72 162.28 35.88 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.26 145.6 31.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 171.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.72 128.11 43.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.982 1.713 . . . . 0.0 107.191 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.42 167.12 15.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.842 0.857 . . . . 0.0 109.815 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.18 -24.15 52.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.128 0.971 . . . . 0.0 112.609 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.41 -4.13 46.77 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.796 -1.19 . . . . 0.0 112.189 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.52 24.5 76.77 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.184 -0.948 . . . . 0.0 112.246 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -91.78 142.69 27.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.17 129.71 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.26 -15.71 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.685 0.794 . . . . 0.0 111.636 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -153.05 144.36 23.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.46 137.51 28.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.77 130.07 13.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -106.8 144.38 33.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.32 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 61.72 -15.27 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.299 2.24 . . . . 0.0 115.204 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -149.4 113.96 5.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.06 -31.53 67.16 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.145 0.578 . . . . 0.0 111.872 -174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 p -73.46 7.23 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.744 1.218 . . . . 0.0 113.718 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.83 176.64 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.786 1.176 . . . . 0.0 110.516 172.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.77 150.6 70.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.494 1.118 . . . . 0.0 110.282 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.09 154.51 42.13 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.472 2.781 . . . . 0.0 110.388 -169.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -79.2 115.25 18.74 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -52.78 -26.44 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.852 1.661 . . . . 0.0 113.198 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -61.57 -36.08 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.049 0.84 . . . . 0.0 111.404 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -58.49 -57.84 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.596 0.634 . . . . 0.0 112.033 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.24 -24.34 32.17 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.118 1.212 . . . . 0.0 111.684 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 120.139 1.336 . . . . 0.0 109.605 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.27 -33.36 75.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.084 0.856 . . . . 0.0 110.494 -177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.63 -56.9 10.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.373 0.269 . . . . 0.0 111.361 172.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.37 88.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.422 0.689 . . . . 0.0 112.307 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -26.43 67.67 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.53 0.605 . . . . 0.0 111.986 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.63 65.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.089 0.556 . . . . 0.0 112.228 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.5 mt -102.46 -28.2 12.34 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.67 -18.47 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.386 1.075 . . . . 0.0 109.938 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.237 0.429 0 N-CA-C 104.451 -2.425 . . . . 0.0 104.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 13' ' ' LEU . 51.5 mt -140.98 143.8 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -169.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p -82.49 158.81 23.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.839 1.2 . . . . 0.0 110.621 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -132.12 85.85 2.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt 43.03 37.59 1.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.297 2.239 . . . . 0.0 115.441 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.96 -26.61 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.665 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.09 171.03 44.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.773 1.287 . . . . 0.0 112.054 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.83 151.82 51.71 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.842 3.028 . . . . 0.0 111.696 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.37 145.75 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.852 1.661 . . . . 0.0 108.519 171.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -76.45 141.67 41.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.928 1.691 . . . . 0.0 111.103 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 4' ' ' ILE . 12.2 mt -85.94 137.82 32.46 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 169.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -75.67 -21.0 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.54 -177.38 19.34 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.418 0.532 . . . . 0.0 112.243 -169.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -64.23 138.22 58.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.804 1.242 . . . . 0.0 111.142 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -78.82 143.07 36.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.3 153.94 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.94 157.12 43.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.358 1.063 . . . . 0.0 110.731 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.3 t -58.75 143.0 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.001 0.92 . . . . 0.0 109.034 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.57 -24.0 13.94 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.872 1.225 . . . . 0.0 112.42 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -73.79 155.21 39.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.718 1.259 . . . . 0.0 109.848 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -70.77 128.86 37.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.85 153.74 78.56 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.247 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.23 -32.03 69.07 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.65 2.9 . . . . 0.0 114.655 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.16 81.4 0.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.486 1.915 . . . . 0.0 113.138 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -127.59 -174.77 3.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.738 1.615 . . . . 0.0 109.564 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -115.64 155.91 26.82 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.856 1.262 . . . . 0.0 110.251 -168.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.12 159.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.836 2.454 . . . . 0.0 106.555 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.18 140.65 29.26 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.958 -1.089 . . . . 0.0 109.323 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.5 p -73.33 170.0 15.94 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -68.08 -13.95 62.6 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.516 -1.365 . . . . 0.0 111.45 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.05 0.4 40.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.254 1.421 . . . . 0.0 111.622 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp 58.03 47.1 15.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.039 1.336 . . . . 0.0 111.346 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.22 166.56 16.86 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.192 1.397 . . . . 0.0 107.528 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.02 141.98 29.91 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -138.93 150.88 46.42 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 126.257 1.823 . . . . 0.0 106.155 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 p -146.07 168.52 20.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.297 -0.877 . . . . 0.0 109.304 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.64 -31.53 68.22 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.864 -0.522 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . . . -50.4 -28.62 8.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 113.828 170.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.73 -38.7 13.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.91 1.284 . . . . 0.0 110.804 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.0 mtt -68.66 -36.77 79.0 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.652 0.781 . . . . 0.0 110.614 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 40' ' ' ALA . 15.6 ptpt -62.8 -3.57 1.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.77 30.46 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.659 1.118 . . . . 0.0 113.107 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -148.2 166.01 29.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.49 1.645 . . . . 0.0 109.118 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.49 117.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.0 m -127.41 129.63 47.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.314 0.384 . . . . 0.0 111.37 -168.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.8 mt -89.18 137.91 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.02 100.5 9.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.94 140.9 45.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 t -126.42 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 118.493 0.588 . . . . 0.0 109.493 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 159.64 67.45 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.495 1.518 . . . . 0.0 108.263 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.72 -53.67 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.618 1.545 . . . . 0.0 111.373 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -147.29 154.14 40.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.752 2.021 . . . . 0.0 106.566 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.0 tt -98.7 -6.5 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -168.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.1 -28.06 68.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.529 -0.732 . . . . 0.0 112.425 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -73.28 142.08 47.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.394 0.678 . . . . 0.0 110.581 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.6 -16.25 65.23 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.137 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.88 -29.28 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.996 1.398 . . . . 0.0 111.125 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.8 m -63.76 -12.82 38.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.537 0.735 . . . . 0.0 112.843 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.72 -45.3 77.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.668 1.122 . . . . 0.0 110.828 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.43 7.24 2.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.315 1.046 . . . . 0.0 112.612 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -129.06 -87.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -53.08 -54.18 39.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.808 1.643 . . . . 0.0 112.967 -169.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.69 -42.21 67.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.978 -1.077 . . . . 0.0 110.569 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpp85 -60.23 -38.19 82.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.648 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -64.99 -32.41 74.13 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.209 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.43 -48.19 81.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.674 1.579 . . . . 0.0 110.216 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.27 -57.14 9.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.325 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -61.58 -40.53 95.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.434 0.561 . . . . 0.0 111.028 -172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.17 78.26 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.848 0.749 . . . . 0.0 111.482 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.07 79.4 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.112 0.869 . . . . 0.0 110.803 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -70.18 -39.88 74.98 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.505 0.593 . . . . 0.0 109.552 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.4 -47.24 82.81 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.195 0.598 . . . . 0.0 110.141 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.51 9.08 84.59 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.864 1.221 . . . . 0.0 113.949 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -151.99 35.61 0.54 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.391 1.595 . . . . 0.0 112.322 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.88 173.48 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -123.62 151.0 43.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.476 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -149.8 149.71 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.691 -1.256 . . . . 0.0 110.171 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -135.23 172.52 12.9 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.746 1.619 . . . . 0.0 108.982 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.412 ' HB ' HG22 ' A' ' 104' ' ' THR . 23.6 m -132.5 144.04 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.64 137.71 56.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.59 147.87 36.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.14 0.976 . . . . 0.0 109.826 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.26 56.03 2.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -144.9 170.06 16.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.606 1.562 . . . . 0.0 107.143 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.04 142.11 63.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.132 -0.98 . . . . 0.0 112.468 -168.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -47.64 -41.03 30.9 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.34 3.36 . . . . 0.0 115.028 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -73.43 -29.4 62.54 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.95 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.39 82.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.525 1.057 . . . . 0.0 109.334 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -47.8 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.125 172.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.37 80.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.417 0.553 . . . . 0.0 111.09 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -59.75 -43.83 94.11 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.59 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -58.95 -52.05 67.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.533 0.606 . . . . 0.0 110.171 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.6 m -65.13 -44.96 86.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.95 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.59 -41.66 83.38 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.342 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.13 -39.78 82.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.12 0.96 . . . . 0.0 110.538 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -79.69 -19.17 49.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.957 0.503 . . . . 0.0 112.274 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.74 64.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 118.831 0.741 . . . . 0.0 111.425 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.03 146.78 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.587 1.155 . . . . 0.0 108.179 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -139.02 -35.8 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 112.172 -173.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -81.43 -18.74 44.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.025 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.21 158.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -139.76 130.1 25.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 168.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 81' ' ' THR . 3.2 p -84.26 155.94 22.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 mt -143.44 162.98 34.37 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.893 1.277 . . . . 0.0 108.406 -170.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.3 m -129.82 107.67 9.57 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.503 0.721 . . . . 0.0 109.586 -169.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -95.28 56.19 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -136.62 33.44 2.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.324 1.05 . . . . 0.0 112.693 -168.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -122.86 -48.33 2.02 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -144.65 121.12 11.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 101.871 -3.381 . . . . 0.0 101.871 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.1 mtp -73.69 36.87 0.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.734 1.613 . . . . 0.0 112.801 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -57.87 -41.71 83.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.859 1.264 . . . . 0.0 111.782 -169.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.13 -46.22 62.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.767 0.712 . . . . 0.0 109.581 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.82 -33.58 62.97 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.534 0.588 . . . . 0.0 111.868 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.96 -48.85 72.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.806 0.803 . . . . 0.0 109.367 171.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.55 72.69 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.3 3.52 53.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.597 1.159 . . . . 0.0 111.527 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.86 -13.8 8.27 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.081 1.801 . . . . 0.0 115.351 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.68 -23.39 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.559 1.544 . . . . 0.0 112.741 -173.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 110.57 1.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.28 113.43 17.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -53.29 -45.21 68.85 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.585 1.554 . . . . 0.0 111.331 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.72 0.14 51.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.361 0.665 . . . . 0.0 112.567 -169.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.24 -22.64 3.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.871 0.759 . . . . 0.0 112.976 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.36 37.15 28.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.195 0.998 . . . . 0.0 111.943 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.68 162.83 24.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.173 -0.954 . . . . 0.0 108.814 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -88.47 134.18 33.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.63 141.32 32.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.74 1.216 . . . . 0.0 110.471 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -73.32 112.63 9.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 168.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -154.65 170.06 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.447 1.499 . . . . 0.0 107.098 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG21 ' HG3' ' A' ' 158' ' ' PRO . 14.8 p -153.99 146.83 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -134.71 162.72 31.53 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 124.022 0.826 . . . . 0.0 110.139 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.5 t -134.8 145.81 31.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.16 130.55 41.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.452 1.501 . . . . 0.0 107.477 -169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.67 165.09 25.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.007 1.323 . . . . 0.0 109.54 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.65 -6.49 3.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.09 12.31 23.57 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.952 -1.092 . . . . 0.0 112.448 169.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.68 78.75 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.029 0.823 . . . . 0.0 112.849 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -88.99 145.82 25.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.34 139.75 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.45 -26.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.564 1.546 . . . . 0.0 109.397 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -147.77 147.07 29.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -150.96 133.87 15.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 169.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.78 147.37 29.79 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -127.66 102.4 6.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.81 136.21 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -66.3 -13.52 60.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -134.93 125.58 26.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.991 1.716 . . . . 0.0 106.833 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.87 66.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.141 0.577 . . . . 0.0 111.827 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -79.5 12.96 2.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.146 1.378 . . . . 0.0 111.366 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -134.69 167.02 21.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.952 2.101 . . . . 0.0 107.857 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -128.31 154.73 79.06 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 110.923 -170.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.17 160.61 48.53 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.622 2.215 . . . . 0.0 109.65 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -87.06 117.44 25.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -51.51 -28.32 13.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.128 1.771 . . . . 0.0 112.857 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -60.14 -32.11 70.71 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.567 0.621 . . . . 0.0 111.695 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.73 -51.85 11.24 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.443 -171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.416 ' HG3' HG21 ' A' ' 131' ' ' VAL . 55.9 Cg_endo -67.68 -30.56 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.452 1.434 . . . . 0.0 111.729 174.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.44 -49.01 79.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 119.838 1.199 . . . . 0.0 109.904 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.75 -32.17 73.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.514 0.597 . . . . 0.0 110.771 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.66 71.51 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.209 0.459 . . . . 0.0 111.437 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.92 64.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.857 0.463 . . . . 0.0 110.01 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -26.76 68.88 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.442 -0.786 . . . . 0.0 111.797 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.64 71.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.988 0.813 . . . . 0.0 111.626 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.59 -29.13 28.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.15 0.58 . . . . 0.0 111.512 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.04 -51.97 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.368 0.531 . . . . 0.0 110.371 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.1 pttp . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.052 -175.692 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 mt -146.13 155.37 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -169.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -117.51 168.51 10.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.852 1.261 . . . . 0.0 110.753 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -141.05 56.95 1.55 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.93 1.292 . . . . 0.0 108.619 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 37.74 71.21 0.16 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.082 2.153 . . . . 0.0 113.782 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -16.98 0.59 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.098 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.93 174.76 41.06 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.01 162.91 41.08 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.391 2.728 . . . . 0.0 111.151 178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.96 135.16 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.283 1.433 . . . . 0.0 107.395 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.2 m -67.12 152.0 46.57 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 110.385 -176.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.59 135.3 50.1 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.641 1.576 . . . . 0.0 108.661 -175.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.44 136.71 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 -163.68 13.51 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.424 0.556 . . . . 0.0 113.33 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -123.24 138.85 54.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.294 1.437 . . . . 0.0 110.385 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.7 114.67 14.55 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.43 170.38 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.936 0.789 . . . . 0.0 109.887 174.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 161.33 35.74 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.191 0.997 . . . . 0.0 109.094 174.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 129.93 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 174.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.15 -13.08 60.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.797 1.189 . . . . 0.0 112.383 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.62 140.03 58.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.629 1.715 . . . . 0.0 110.214 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -89.88 108.15 19.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 172.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.34 148.72 92.93 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.149 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -57.95 -8.92 5.16 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 125.245 3.963 . . . . 0.0 118.536 -178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 52.79 70.61 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.872 1.32 . . . . 0.0 111.74 -169.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -73.3 166.68 22.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.22 1.408 . . . . 0.0 109.827 177.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 m -127.97 144.92 51.11 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.33 163.12 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.208 2.203 . . . . 0.0 106.69 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.35 137.52 32.25 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -63.67 165.18 8.61 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -64.88 -3.48 3.46 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.699 -1.251 . . . . 0.0 111.864 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 m -114.48 17.97 17.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.127 2.171 . . . . 0.0 111.239 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 mt 65.93 39.85 4.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.133 1.373 . . . . 0.0 112.884 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.58 148.87 49.7 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.62 141.04 44.71 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.904 1.229 . . . . 0.0 109.128 172.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -138.33 144.99 40.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -134.02 165.96 23.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -53.49 -34.7 59.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.972 0.509 . . . . 0.0 110.442 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.97 46.09 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.12 -42.62 59.76 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.584 0.707 . . . . 0.0 110.441 173.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.6 mtt -64.7 -25.8 68.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.074 1.35 . . . . 0.0 111.643 -177.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -54.69 -16.75 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.592 1.157 . . . . 0.0 113.258 174.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.65 47.06 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.677 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -151.97 159.18 43.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.752 1.776 . . . . 0.0 109.695 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.49 119.46 6.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.8 m -124.95 134.23 52.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.446 0.299 . . . . 0.0 110.883 -168.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.11 142.59 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mm -120.89 138.08 52.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -126.92 102.37 6.98 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.109 0.964 . . . . 0.0 108.601 -169.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.04 134.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.81 157.31 61.76 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 107.984 169.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.39 -55.64 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.28 1.987 . . . . 0.0 111.59 -172.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -161.27 150.07 16.15 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 127.962 2.505 . . . . 0.0 104.833 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 tt -73.17 -10.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 118.92 0.782 . . . . 0.0 112.517 -169.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -32.35 73.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.868 1.267 . . . . 0.0 113.013 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.27 114.29 10.23 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.58 -17.99 43.02 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.408 1.004 . . . . 0.0 113.61 -174.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.33 -21.79 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 118.511 1.156 . . . . 0.0 111.311 174.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 64.3 m -58.75 -19.86 44.27 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.788 1.176 . . . . 0.0 112.8 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.7 -29.35 69.29 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.142 0.977 . . . . 0.0 111.828 173.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.58 5.94 22.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.622 1.169 . . . . 0.0 112.441 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -124.82 -83.83 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -57.68 -45.85 85.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.561 1.144 . . . . 0.0 111.885 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -68.6 -45.5 71.81 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.552 -0.717 . . . . 0.0 111.02 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.02 -37.43 87.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -57.98 -37.47 74.28 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.232 0.923 . . . . 0.0 112.207 171.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.53 -48.41 81.77 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.485 1.039 . . . . 0.0 110.825 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.48 -47.3 70.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.72 -40.07 96.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.378 0.99 . . . . 0.0 110.713 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.7 78.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.919 0.781 . . . . 0.0 111.627 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.16 87.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.701 0.682 . . . . 0.0 111.725 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -70.48 -40.05 73.85 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.443 0.697 . . . . 0.0 111.067 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.38 149.45 33.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.894 1.278 . . . . 0.0 108.805 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.53 -44.42 97.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.132 -178.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.23 137.24 7.04 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.677 1.591 . . . . 0.0 107.57 174.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -162.73 175.31 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.654 1.582 . . . . 0.0 106.956 174.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -136.54 140.62 43.09 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.51 146.52 23.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.05 163.37 29.71 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.962 1.305 . . . . 0.0 109.209 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.4 m -121.29 146.18 47.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 169.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.57 140.68 47.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 m -140.27 149.13 42.44 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.665 1.186 . . . . 0.0 109.939 -169.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.89 45.75 1.24 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.21 -176.63 3.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.136 1.375 . . . . 0.0 110.87 -168.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.43 140.52 26.92 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.275 -174.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.14 -41.48 57.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.874 3.049 . . . . 0.0 113.97 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -78.62 -29.44 45.94 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.509 -0.745 . . . . 0.0 112.083 -174.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.39 73.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.281 0.946 . . . . 0.0 109.102 175.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -51.05 -50.49 58.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.538 1.535 . . . . 0.0 111.11 171.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.683 0.393 . . . . 0.0 111.518 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -63.84 -44.41 93.28 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.033 0.533 . . . . 0.0 110.044 -174.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -61.69 -39.86 92.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.556 0.342 . . . . 0.0 110.565 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.4 m -65.35 -44.05 88.92 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.92 -0.487 . . . . 0.0 111.224 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.66 94.87 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.56 -44.3 87.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.696 0.748 . . . . 0.0 110.463 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -77.31 -23.49 51.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.281 0.632 . . . . 0.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.59 22.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.807 0.718 . . . . 0.0 111.325 -178.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.46 144.1 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.45 -37.9 0.23 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.176 1.391 . . . . 0.0 111.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -80.44 -16.49 54.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.08 0.952 . . . . 0.0 111.919 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.4 160.79 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.93 146.1 40.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 p -99.25 142.62 30.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.391 1.076 . . . . 0.0 108.63 -177.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 mt -129.02 155.66 45.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.051 1.34 . . . . 0.0 107.984 -174.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.66 125.6 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.258 1.423 . . . . 0.0 109.441 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -118.66 -2.54 10.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 111.966 -176.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -55.59 -23.29 26.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.518 1.527 . . . . 0.0 113.006 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -59.08 -45.48 90.72 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.119 0.968 . . . . 0.0 111.864 -176.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -154.95 7.37 0.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -171.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 mmm 51.77 28.47 4.95 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.128 1.771 . . . . 0.0 113.873 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -51.72 -51.33 56.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 111.928 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.66 -44.8 69.8 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.513 0.597 . . . . 0.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.22 -43.56 64.02 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.795 1.188 . . . . 0.0 112.672 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -74.35 -42.23 59.73 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.986 0.915 . . . . 0.0 110.213 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.79 86.5 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 0.0 112.034 -173.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -109.95 6.3 23.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.474 1.51 . . . . 0.0 112.581 -176.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.9 78.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.563 1.074 . . . . 0.0 113.109 171.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.95 1.59 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.282 . . . . 0.0 112.679 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -82.67 108.48 16.07 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 120.534 1.515 . . . . 0.0 107.48 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.64 105.0 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -51.48 -49.51 61.68 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 126.337 1.855 . . . . 0.0 110.981 -171.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -74.28 -35.61 63.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.407 0.683 . . . . 0.0 111.711 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.74 -23.69 42.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.765 0.711 . . . . 0.0 112.148 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? 57.99 34.57 24.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.132 0.973 . . . . 0.0 109.075 -168.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.4 mt -130.16 160.96 32.22 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.794 1.238 . . . . 0.0 108.688 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -75.32 158.25 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.09 -167.55 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.167 1.387 . . . . 0.0 111.307 175.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -124.66 123.57 40.33 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 169.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -166.55 169.12 14.04 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.924 1.69 . . . . 0.0 106.908 -169.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.46 143.23 23.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.22 156.9 47.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.016 0.926 . . . . 0.0 108.693 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 t -136.54 138.91 46.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.3 mt -130.84 124.51 31.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.401 1.481 . . . . 0.0 107.838 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.81 164.64 14.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.75 -21.13 10.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.655 1.182 . . . . 0.0 112.822 174.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -76.18 -2.85 33.17 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.586 -1.321 . . . . 0.0 112.502 174.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.35 76.53 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -171.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -116.68 129.7 56.3 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.73 129.27 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -173.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.94 -18.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.799 0.84 . . . . 0.0 111.406 177.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -153.61 143.13 21.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 144.91 27.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.22 144.9 23.43 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.218 1.007 . . . . 0.0 108.87 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -132.86 126.0 31.23 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.742 1.617 . . . . 0.0 106.82 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 148' ' ' GLU . 13.5 t -75.82 137.12 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -70.76 -3.69 20.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.444 0.698 . . . . 0.0 112.88 177.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.419 ' H ' HG12 ' A' ' 146' ' ' VAL . 6.7 mt-10 -137.92 125.38 21.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.94 1.696 . . . . 0.0 107.252 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.32 -23.48 62.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 169.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.02 3.79 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.222 2.609 . . . . 0.0 112.986 173.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -140.91 171.14 14.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.534 1.934 . . . . 0.0 108.191 -176.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -131.51 155.98 80.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.357 1.063 . . . . 0.0 110.791 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.07 170.41 19.77 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.792 2.328 . . . . 0.0 109.9 176.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -97.9 118.74 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -55.75 -24.22 34.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.909 1.684 . . . . 0.0 112.922 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -61.64 -35.24 77.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.254 0.933 . . . . 0.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -62.07 -54.06 53.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.171 -174.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -31.36 16.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.957 1.771 . . . . 0.0 112.279 177.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mm -53.62 -50.28 51.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 119.67 1.123 . . . . 0.0 109.623 172.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.844 0.293 . . . . 0.0 110.688 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.39 91.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.916 0.325 . . . . 0.0 111.568 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.71 -53.81 24.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.208 0.603 . . . . 0.0 110.921 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -24.46 67.91 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.437 1.017 . . . . 0.0 112.186 -177.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.35 66.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.024 0.829 . . . . 0.0 111.565 170.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.78 -24.25 12.93 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.506 1.122 . . . . 0.0 112.545 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . 0.258 7.1 p -126.36 74.71 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 122.695 1.236 . . . . 0.0 108.351 177.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.997 172.29 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 tpp . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.11 134.75 39.91 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 158.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -127.84 98.85 5.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 103.368 -2.827 . . . . 0.0 103.368 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.4 mt -89.69 150.52 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 -172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 p -97.91 155.54 17.02 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 123.038 1.399 . . . . 0.0 108.748 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -120.87 66.49 0.85 Allowed 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 174.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.527 ' HE3' HG21 ' A' ' 150' ' ' THR . 2.0 ttmt 57.35 36.75 27.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 168.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.55 -21.27 0.27 Allowed Glycine 0 CA--C 1.497 -1.088 0 O-C-N 118.751 -2.468 . . . . 0.0 111.116 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -160.33 163.61 34.02 Favored Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.64 157.46 55.48 Favored 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 123.986 3.124 . . . . 0.0 110.118 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.4 m -137.42 137.87 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.248 1.419 . . . . 0.0 107.317 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.656 ' H ' ' HG3' ' A' ' 123' ' ' GLU . 27.1 m -74.99 151.18 38.82 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 124.605 1.162 . . . . 0.0 109.138 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' CD2' HG12 ' A' ' 121' ' ' ILE . 22.2 mt -113.09 143.92 43.52 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -71.4 165.78 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 158.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 63.73 -172.41 14.51 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-O 122.449 1.027 . . . . 0.0 113.3 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -116.63 158.52 23.6 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.304 1.441 . . . . 0.0 107.659 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.45 127.27 32.05 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 117' ' ' PHE . 1.8 t -89.76 163.54 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 127.441 2.297 . . . . 0.0 107.505 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -137.04 169.29 18.03 Favored 'General case' 0 CA--C 1.499 -0.982 0 O-C-N 121.339 -0.851 . . . . 0.0 111.487 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.97 137.09 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.397 165.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.37 -23.25 30.83 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.312 1.91 . . . . 0.0 112.387 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -71.84 151.09 43.7 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.648 0.779 . . . . 0.0 109.856 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.3 tp60 -73.86 126.97 31.6 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.63 146.93 93.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-O 118.023 -0.989 . . . . 0.0 108.371 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 31.4 Cg_exo -52.81 -25.77 28.31 Favored 'Trans proline' 0 CA--C 1.57 2.3 0 C-N-CA 121.943 1.762 . . . . 0.0 115.528 -172.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' CE1' ' A' ' 27' ' ' PHE . 26.1 t0 61.26 89.47 0.08 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 129.375 3.07 . . . . 0.0 118.232 -170.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.727 ' CE1' ' HB2' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -131.19 -166.76 1.75 Allowed 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.437 -2.04 . . . . 0.0 107.175 174.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 37' ' ' LYS . 5.4 m -125.08 143.57 50.85 Favored 'General case' 0 N--CA 1.406 -2.651 1 C-N-CA 134.53 5.132 . . . . 0.0 107.21 -170.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -133.58 171.07 18.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 129.253 3.021 . . . . 0.0 103.768 166.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -87.33 146.34 25.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 169.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.7 p -67.17 162.36 22.66 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 119.822 1.192 . . . . 0.0 108.106 162.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -59.38 -11.63 4.63 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 117.94 -1.029 . . . . 0.0 112.67 165.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 m -98.06 4.8 49.19 Favored 'General case' 0 C--N 1.344 0.351 0 C-N-CA 126.951 2.1 . . . . 0.0 112.795 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mt 75.42 33.89 0.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.852 1.661 . . . . 0.0 112.094 171.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -120.18 153.8 35.72 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -72.51 141.74 48.52 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.092 -1.005 . . . . 0.0 108.921 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 28' ' ' THR . 13.5 ttmm -139.64 145.1 38.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 105.607 -1.998 . . . . 0.0 105.607 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.96 168.42 18.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.251 0.621 . . . . 0.0 111.247 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 134' ' ' LEU . 0.9 OUTLIER -54.89 -37.13 65.91 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.893 -0.575 . . . . 0.0 110.343 177.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.27 -35.07 49.14 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -73.7 -42.51 61.15 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.318 1.056 . . . . 0.0 109.845 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.5 mtt -64.87 -30.09 71.07 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.813 0.845 . . . . 0.0 112.05 -173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -10.73 19.9 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 117.92 -1.038 . . . . 0.0 112.563 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -11.99 6.22 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.041 1.292 . . . . 0.0 112.878 175.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -149.68 164.79 34.25 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.661 1.73 . . . . 0.0 107.073 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.06 120.42 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 158.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 55.0 m -126.72 138.9 53.45 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -169.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 52.5 mt -100.88 144.82 12.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.7 mm -124.27 132.16 71.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -121.32 100.09 6.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.08 134.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 HD12 ' HB3' ' A' ' 60' ' ' CYS . 0.4 OUTLIER -137.6 161.54 59.83 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.66 -57.38 0.17 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.151 1.901 . . . . 0.0 111.594 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.95 164.4 33.08 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.844 2.058 . . . . 0.0 106.38 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.4 HG12 ' CG ' ' A' ' 93' ' ' TRP . 10.3 tt -94.93 -15.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-N 120.656 1.571 . . . . 0.0 112.985 -168.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -82.97 -1.75 53.33 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -171.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 p -78.99 3.41 17.27 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 118.815 -2.428 . . . . 0.0 115.318 -162.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.36 -52.37 0.83 Allowed Glycine 0 CA--C 1.54 1.61 0 CA-C-O 117.771 -1.571 . . . . 0.0 113.194 -170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -30.29 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 122.282 3.041 . . . . 0.0 111.34 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . 0.464 ' HB3' HD12 ' A' ' 52' ' ' ILE . 1.9 m -58.65 -31.89 68.58 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.673 -0.642 . . . . 0.0 112.035 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.706 ' HA ' ' CZ2' ' A' ' 93' ' ' TRP . 15.1 t70 -55.54 -50.3 70.37 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.885 0.874 . . . . 0.0 108.753 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.93 -13.79 5.14 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.622 0.576 . . . . 0.0 112.306 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.554 HE22 ' HG2' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -99.28 -75.81 0.56 Allowed 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 179.012 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -59.43 -40.2 86.0 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 123.597 1.665 . . . . 0.0 111.489 -159.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . 0.262 1.7 tpt180 -76.1 -49.89 16.16 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 114.096 -1.411 . . . . 0.0 110.176 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.584 ' HG2' ' CZ ' ' A' ' 155' ' ' TYR . 0.2 OUTLIER -57.34 -38.72 74.54 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.093 -1.004 . . . . 0.0 110.074 177.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -58.45 -41.1 84.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.763 0.825 . . . . 0.0 109.945 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -57.5 -45.26 85.11 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.326 0.966 . . . . 0.0 111.556 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -70.98 -48.63 52.2 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.026 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -61.35 -38.21 86.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.572 0.349 . . . . 0.0 110.671 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.04 86.05 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.507 -0.745 . . . . 0.0 111.402 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.69 88.49 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.762 173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.2 mtmt -70.75 -36.4 73.11 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.587 0.755 . . . . 0.0 111.396 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.6 mp -62.4 -41.48 98.7 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 123.192 0.597 . . . . 0.0 109.97 172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.28 -37.36 3.4 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 118.68 -1.067 . . . . 0.0 111.491 174.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' O ' HG11 ' A' ' 166' ' ' VAL . 43.6 t0 -140.23 85.32 2.01 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 118.34 1.07 . . . . 0.0 109.575 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 p -146.29 172.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 171.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -127.93 144.2 51.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 97.4 t -144.41 139.22 23.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -133.51 161.26 35.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.464 0.65 . . . . 0.0 109.312 170.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.6 m -122.01 148.5 44.74 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.8 mt -132.9 134.74 57.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.5 m -132.13 159.9 37.57 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.438 0.695 . . . . 0.0 110.671 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.49 39.62 0.92 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.83 1.252 . . . . 0.0 109.18 167.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -133.66 168.69 18.23 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 125.107 1.363 . . . . 0.0 108.804 -166.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.16 136.04 96.45 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.073 0.949 . . . . 0.0 110.536 -171.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -52.97 -42.39 64.71 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.365 2.043 . . . . 0.0 111.903 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -72.84 -30.07 63.73 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.059 -1.026 . . . . 0.0 112.672 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.87 98.44 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.503 1.047 . . . . 0.0 108.627 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -66.1 -46.23 78.38 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.09 75.8 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 121.79 0.805 . . . . 0.0 108.982 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 92' ' ' ARG . 18.9 ttp85 -70.3 -44.95 67.27 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.775 -172.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.706 ' CZ2' ' HA ' ' A' ' 61' ' ' ASP . 69.3 t90 -53.98 -41.44 67.89 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 85.3 m -63.1 -46.98 84.83 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.904 -0.569 . . . . 0.0 111.265 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.25 -38.89 97.19 Favored Glycine 0 CA--C 1.526 0.779 0 O-C-N 123.839 0.712 . . . . 0.0 111.753 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.06 -39.13 93.4 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.738 0.815 . . . . 0.0 110.751 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -87.7 -17.15 32.39 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.029 -0.986 . . . . 0.0 112.84 -176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.72 56.08 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 119.29 0.95 . . . . 0.0 112.132 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.1 mm -71.35 142.76 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.279 1.432 . . . . 0.0 107.443 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.66 -36.59 0.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.09 1.356 . . . . 0.0 110.637 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -79.86 -18.62 50.28 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.838 -1.164 . . . . 0.0 112.988 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.8 t -117.13 150.29 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -128.38 138.97 52.6 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 p -93.88 150.62 20.21 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.713 1.205 . . . . 0.0 109.233 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 46.6 mt -141.65 157.51 44.99 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.339 1.456 . . . . 0.0 107.406 -170.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.8 m -121.64 109.72 15.1 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 120.518 -1.364 . . . . 0.0 109.09 -174.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 109' ' ' ARG . 25.0 t0 -84.06 -10.1 58.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.927 1.291 . . . . 0.0 110.333 173.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -32.55 -25.34 0.0 OUTLIER 'General case' 0 C--N 1.347 0.458 1 C-N-CA 132.148 4.179 . . . . 0.0 115.246 -175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -97.82 -38.12 9.57 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -151.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -145.21 -7.72 0.62 Allowed 'General case' 0 C--N 1.309 -1.172 0 O-C-N 125.82 1.95 . . . . 0.0 107.859 -170.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mmm 59.09 12.67 2.55 Favored 'General case' 0 N--CA 1.426 -1.654 0 C-N-CA 125.494 1.518 . . . . 0.0 109.561 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.1 -42.74 77.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.692 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -64.79 -57.63 8.4 Favored 'General case' 0 CA--C 1.487 -1.469 0 C-N-CA 125.052 1.341 . . . . 0.0 110.573 177.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -60.43 -37.9 93.94 Favored Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 118.9 -1.619 . . . . 0.0 111.474 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.2 -53.28 51.75 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.666 1.186 . . . . 0.0 109.778 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.54 -37.37 77.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.477 ' CD1' HG21 ' A' ' 18' ' ' VAL . 0.9 OUTLIER -83.7 0.66 46.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.026 177.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.19 44.62 95.37 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 119.55 1.068 . . . . 0.0 111.712 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.417 HG23 ' HA2' ' A' ' 114' ' ' GLY . 17.2 m -125.92 -6.39 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.882 0.873 . . . . 0.0 112.168 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -70.84 118.82 14.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 165.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.415 HG12 ' CD2' ' A' ' 13' ' ' LEU . 51.2 mt -82.06 105.94 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 174.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -53.14 -41.34 65.02 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.61 1.564 . . . . 0.0 112.037 -175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.656 ' HG3' ' H ' ' A' ' 12' ' ' THR . 1.5 mm-40 -80.1 -11.77 59.73 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.727 1.211 . . . . 0.0 111.632 -171.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.9 mt -120.08 -23.06 6.44 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.886 0.766 . . . . 0.0 112.54 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 61.15 38.9 16.56 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 122.935 1.35 . . . . 0.0 114.332 -168.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.76 145.35 48.35 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -168.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.5 tp -70.08 142.57 52.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.44 167.1 17.34 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.624 167.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -95.98 111.69 23.63 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 166.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.7 m -150.78 168.13 25.33 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.445 HG13 ' CG ' ' A' ' 153' ' ' PRO . 3.0 m -138.79 156.87 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.153 0.888 . . . . 0.0 109.316 171.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -141.41 159.73 41.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.57 1.148 . . . . 0.0 108.015 177.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.3 t -136.02 143.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 39' ' ' LEU . 69.5 mt -134.65 125.28 26.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -165.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.69 164.57 23.15 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.614 1.165 . . . . 0.0 109.087 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -60.32 -14.13 16.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.481 1.912 . . . . 0.0 112.988 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.96 -9.69 59.17 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 120.499 -1.376 . . . . 0.0 111.977 170.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.14 25.95 65.25 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.453 -1.405 . . . . 0.0 111.476 -168.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -89.71 142.51 27.62 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 118.821 1.311 . . . . 0.0 108.973 172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 52.2 t -72.56 122.86 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 6.2 t -94.77 -31.59 4.36 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 C-N-CA 126.27 1.828 . . . . 0.0 108.845 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -152.99 149.22 27.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.31 144.65 28.94 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 168.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.28 142.29 23.95 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.353 1.061 . . . . 0.0 108.525 173.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -127.46 108.17 10.59 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 -174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.49 HG21 ' HD3' ' A' ' 153' ' ' PRO . 17.5 t -62.8 123.94 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -60.82 -12.6 11.37 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.264 -1.35 . . . . 0.0 112.646 -176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -134.74 115.18 13.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.54 1.536 . . . . 0.0 107.381 -172.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.16 -25.88 68.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.672 -0.68 . . . . 0.0 112.212 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.527 HG21 ' HE3' ' A' ' 7' ' ' LYS . 0.7 OUTLIER -80.69 1.72 28.95 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.616 1.566 . . . . 0.0 113.95 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -127.36 164.26 22.21 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 127.94 2.496 . . . . 0.0 106.429 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.2 p80 -129.95 155.06 81.18 Favored Pre-proline 0 N--CA 1.45 -0.454 0 O-C-N 121.4 -0.812 . . . . 0.0 109.187 -170.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.554 ' HG2' HE22 ' A' ' 63' ' ' GLN . 37.9 Cg_endo -66.86 168.89 15.87 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.536 2.157 . . . . 0.0 110.24 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -95.82 122.08 38.23 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.162 -1.586 . . . . 0.0 107.098 168.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.584 ' CZ ' ' HG2' ' A' ' 66' ' ' ARG . 19.7 p90 -59.3 -23.2 62.24 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.226 1.81 . . . . 0.0 112.824 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -57.43 -36.15 71.0 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.699 1.136 . . . . 0.0 109.842 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -60.22 -57.69 24.85 Favored Pre-proline 0 CA--C 1.531 0.238 0 C-N-CA 124.023 0.929 . . . . 0.0 113.16 -174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.59 -26.77 28.04 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 120.663 0.909 . . . . 0.0 111.224 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -49.42 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.582 1.083 . . . . 0.0 108.493 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -63.96 -34.14 77.3 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.006 0.821 . . . . 0.0 111.204 -175.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.95 -48.31 66.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.59 0.756 . . . . 0.0 110.934 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.18 -44.99 67.61 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 121.444 -0.785 . . . . 0.0 110.421 -174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.428 ' HA ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -62.13 -23.61 66.66 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.426 0.69 . . . . 0.0 111.774 -178.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.67 -28.03 65.52 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.477 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.0 -25.79 13.94 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.002 -1.475 . . . . 0.0 113.702 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 163' ' ' LYS . 35.5 m -73.53 -13.37 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 120.113 1.324 . . . . 0.0 113.031 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.401 ' HE2' ' O ' ' A' ' 163' ' ' LYS . 7.1 mmtt . . . . . 0 C--O 1.251 1.136 0 CA-C-O 115.659 -2.115 . . . . 0.0 110.624 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptt? . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.37 0.128 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.24 -24.51 67.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.576 0.751 . . . . 0.0 112.914 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 56.06 55.74 6.57 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.603 1.561 . . . . 0.0 110.798 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.0 mt -56.92 151.63 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 114.441 -1.254 . . . . 0.0 107.659 169.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.5 p -113.84 160.78 18.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.337 1.055 . . . . 0.0 109.687 173.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.87 46.84 1.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.493 1.117 . . . . 0.0 108.673 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 42.33 63.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.608 1.963 . . . . 0.0 111.94 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.1 -25.58 0.18 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.571 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 171.81 43.84 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.271 0.938 . . . . 0.0 110.822 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.09 159.71 52.2 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.567 2.844 . . . . 0.0 111.076 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.54 133.61 45.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 C-N-CA 124.125 0.97 . . . . 0.0 109.119 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -68.83 134.64 49.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.695 0.798 . . . . 0.0 110.481 -179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 mt -93.23 146.59 23.58 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.398 1.479 . . . . 0.0 108.496 169.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -74.33 -65.02 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.25 169.52 54.65 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 123.509 0.576 . . . . 0.0 112.047 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -71.61 166.3 22.16 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.759 0.79 . . . . 0.0 110.611 174.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -73.48 120.09 18.6 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 168.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -75.75 152.5 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -128.15 158.06 39.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 124.251 1.02 . . . . 0.0 110.642 -173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.38 144.51 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 123.962 0.905 . . . . 0.0 108.813 170.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.64 -23.38 19.86 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.646 1.117 . . . . 0.0 112.451 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -70.15 155.97 39.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 118.62 1.21 . . . . 0.0 109.872 174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -74.02 136.19 43.12 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 157.92 30.65 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 122.987 0.515 . . . . 0.0 111.21 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -53.52 -27.42 40.7 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.969 3.113 . . . . 0.0 116.985 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 t0 51.91 78.9 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.255 1.422 . . . . 0.0 113.548 -169.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -139.15 -176.9 4.67 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.771 1.228 . . . . 0.0 110.636 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.6 m -125.64 152.31 45.35 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 110.994 -169.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 m -140.39 170.91 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 127.791 2.436 . . . . 0.0 106.909 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 mt -93.26 147.67 22.71 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 120.971 -1.08 . . . . 0.0 108.184 169.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 57.9 p -70.81 170.58 12.22 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 169.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -61.79 -9.25 6.11 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.633 -1.292 . . . . 0.0 112.524 168.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 m -105.83 12.09 31.17 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.476 1.91 . . . . 0.0 111.204 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mp 60.41 47.4 8.85 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.172 1.789 . . . . 0.0 111.209 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.9 140.44 51.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.99 135.09 56.25 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.537 -0.727 . . . . 0.0 111.153 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -137.29 141.57 41.93 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 169.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.0 m -126.65 157.21 39.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -169.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -54.48 -34.44 61.59 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.48 1.112 . . . . 0.0 111.132 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.82 -28.56 67.58 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -74.51 -38.11 62.92 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.68 0.792 . . . . 0.0 110.331 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 40.7 mtt -66.43 -27.05 67.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.62 1.168 . . . . 0.0 111.013 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -56.19 -15.48 3.87 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.776 0.83 . . . . 0.0 113.142 171.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.54 -18.79 56.91 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 119.4 1.0 . . . . 0.0 113.849 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -152.48 160.56 43.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.347 1.573 . . . . 0.0 108.758 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.1 t -59.92 118.87 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 103.617 -2.735 . . . . 0.0 103.617 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.9 m -126.64 132.52 51.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.492 -168.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 73.2 mt -93.05 142.51 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.4 mm -126.89 128.62 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 125.553 1.541 . . . . 0.0 106.944 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.6 m -126.32 98.53 5.49 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.292 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 14.4 t -85.16 131.33 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.7 147.17 47.65 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 118.929 0.786 . . . . 0.0 111.827 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -65.21 133.54 35.68 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.3 2.0 . . . . 0.0 108.545 168.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.2 m 44.44 -133.4 0.71 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.349 1.06 . . . . 0.0 111.073 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.5 tt -163.46 178.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 127.208 2.203 . . . . 0.0 106.15 169.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.2 t0 56.09 38.98 30.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.072 1.749 . . . . 0.0 112.245 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.1 p -81.8 11.94 4.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.468 1.107 . . . . 0.0 111.646 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.33 -59.68 4.78 Favored Glycine 0 C--N 1.339 0.74 0 C-N-CA 125.408 1.48 . . . . 0.0 109.761 -169.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.38 -8.7 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 92.6 m -59.55 -23.9 63.27 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.551 1.069 . . . . 0.0 111.274 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -66.19 -33.61 76.14 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 120.852 -1.155 . . . . 0.0 111.444 174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -81.25 11.9 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.043 0.937 . . . . 0.0 111.899 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -134.92 -91.51 0.32 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.429 1.092 . . . . 0.0 108.481 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -54.59 -44.25 72.85 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.41 1.484 . . . . 0.0 112.297 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -67.61 -52.04 43.06 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -42.6 85.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.785 -0.626 . . . . 0.0 110.663 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.48 -37.87 79.35 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.378 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -59.58 -46.16 89.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 119.897 1.226 . . . . 0.0 111.609 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.74 -51.77 31.26 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.56 -36.52 84.05 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.502 -0.749 . . . . 0.0 111.078 -174.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -28.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 121.655 -0.653 . . . . 0.0 111.668 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.16 66.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.486 1.039 . . . . 0.0 110.761 172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -69.63 -41.49 75.55 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.304 0.642 . . . . 0.0 110.058 178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.9 mp -65.2 -39.77 93.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.627 0.771 . . . . 0.0 110.144 169.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.01 -73.49 2.67 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 125.821 1.677 . . . . 0.0 110.33 176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -88.42 41.31 1.0 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.559 1.143 . . . . 0.0 112.088 -169.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 164.7 15.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.467 1.107 . . . . 0.0 108.109 175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -127.51 145.25 50.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -135.53 145.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 O-C-N 121.474 -0.766 . . . . 0.0 108.941 176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -131.54 158.39 41.08 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.607 1.163 . . . . 0.0 108.544 169.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' HG22 ' A' ' 104' ' ' THR . 55.1 m -127.59 144.84 51.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.44 113.68 23.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 70.9 p -76.15 162.31 28.1 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.87 0.843 . . . . 0.0 110.123 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.73 -9.96 59.72 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -154.03 -31.58 0.11 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 -169.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -135.83 111.26 10.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 120.412 1.46 . . . . 0.0 111.835 -169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -71.41 -31.65 13.63 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 121.903 1.735 . . . . 0.0 112.47 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -71.26 -38.52 71.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.99 -34.01 74.61 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 120.006 1.275 . . . . 0.0 110.844 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -65.13 -27.04 68.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.036 0.535 . . . . 0.0 111.438 178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.81 -36.19 82.35 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.465 0.575 . . . . 0.0 110.391 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -74.33 -39.96 62.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.549 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -52.66 -45.94 66.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 118.443 0.565 . . . . 0.0 109.81 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.78 -45.75 73.94 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 119.108 -0.472 . . . . 0.0 111.212 -175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.88 -38.2 94.05 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.659 -0.523 . . . . 0.0 111.907 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.68 76.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.695 0.747 . . . . 0.0 110.406 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -73.77 -33.69 64.38 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.312 0.645 . . . . 0.0 112.34 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.24 37.71 14.51 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -63.72 145.02 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -143.11 -38.63 0.34 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.214 1.005 . . . . 0.0 112.789 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -74.74 -24.45 58.72 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.809 0.732 . . . . 0.0 112.408 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.1 158.94 10.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.25 134.45 34.4 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 169.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.464 HG22 ' HB ' ' A' ' 81' ' ' THR . 7.0 p -87.56 154.37 20.67 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 mt -146.84 171.62 14.92 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 128.523 2.729 . . . . 0.0 106.076 -171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 t -150.97 142.33 23.36 Favored 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 119.656 -1.902 . . . . 0.0 109.06 169.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.63 -33.38 73.84 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 168.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 40.5 t60 55.79 -67.1 0.02 OUTLIER 'General case' 0 C--N 1.344 0.337 0 C-N-CA 129.734 3.214 . . . . 0.0 113.981 175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -149.44 0.11 0.49 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.302 1.441 . . . . 0.0 112.15 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -66.15 -39.9 90.15 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.253 0.933 . . . . 0.0 110.515 -175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 62.42 -23.55 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 129.523 3.129 . . . . 0.0 114.72 -174.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.84 -43.96 91.34 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 121.05 1.75 . . . . 0.0 111.203 -170.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -64.65 -55.31 20.96 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.48 93.07 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 122.951 0.31 . . . . 0.0 112.853 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.04 -47.59 73.88 Favored 'General case' 0 N--CA 1.453 -0.312 0 O-C-N 121.615 -0.932 . . . . 0.0 110.273 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.06 -31.03 58.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 119.352 -0.356 . . . . 0.0 111.894 -169.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.88 9.99 3.14 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.26 0.482 . . . . 0.0 112.071 172.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.91 -15.41 5.11 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 120.8 -1.187 . . . . 0.0 114.363 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.7 m -68.94 -25.49 30.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.053 1.427 . . . . 0.0 112.051 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -64.98 109.04 1.98 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 120.45 1.477 . . . . 0.0 109.952 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.81 107.33 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -49.98 -45.66 51.84 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.75 1.22 . . . . 0.0 110.139 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.57 -16.27 62.38 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.519 1.128 . . . . 0.0 113.107 -171.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.8 mt -128.27 -16.82 4.38 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.517 1.127 . . . . 0.0 112.393 -172.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 55.14 36.77 27.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.425 1.09 . . . . 0.0 109.417 -168.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 35.3 tp -126.08 147.06 49.67 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.159 1.383 . . . . 0.0 107.714 -176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.27 134.27 35.57 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.73 156.31 17.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.908 1.683 . . . . 0.0 111.955 177.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -83.22 116.66 22.49 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -162.14 168.44 22.54 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.935 0.894 . . . . 0.0 109.092 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.71 145.99 18.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 O-C-N 121.791 -0.568 . . . . 0.0 109.917 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -140.82 161.31 38.1 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 124.307 1.043 . . . . 0.0 109.581 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 40.8 t -136.06 140.75 43.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -126.15 136.07 52.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.785 1.634 . . . . 0.0 108.122 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -75.77 166.76 23.05 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.213 1.005 . . . . 0.0 108.886 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -58.61 -23.01 57.91 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.254 -0.904 . . . . 0.0 112.588 174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -76.06 -3.47 36.08 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.822 -1.174 . . . . 0.0 112.124 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.64 24.47 75.34 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.125 0.869 . . . . 0.0 112.096 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -92.56 143.94 25.84 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.45 130.86 35.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 86.4 t -104.93 -31.52 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 C-N-CA 125.917 1.687 . . . . 0.0 109.409 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -152.28 149.12 28.34 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.82 139.23 24.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -149.08 134.13 18.13 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -114.29 126.05 54.59 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.5 t -70.0 136.69 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -67.48 -9.97 47.21 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -131.12 117.36 18.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.76 -24.49 67.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.274 0.488 . . . . 0.0 111.838 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.3 p -72.03 -10.59 59.99 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.88 1.672 . . . . 0.0 112.726 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -120.06 158.46 26.79 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 109.617 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -106.49 152.73 40.74 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.857 0.863 . . . . 0.0 111.082 -169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -72.08 154.58 57.43 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.592 2.194 . . . . 0.0 109.373 170.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -79.27 121.39 25.02 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -53.84 -26.56 25.02 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.262 1.425 . . . . 0.0 113.262 177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -62.17 -33.61 74.86 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.778 0.717 . . . . 0.0 111.16 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -59.32 -56.79 32.36 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.178 -174.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.57 -28.52 31.56 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 CA-C-N 121.046 1.409 . . . . 0.0 111.851 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -48.45 88.22 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 CA-C-N 119.529 1.059 . . . . 0.0 108.81 174.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.01 -31.06 72.11 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.888 0.767 . . . . 0.0 111.12 -177.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -51.09 35.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.646 0.378 . . . . 0.0 111.36 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.47 -44.5 71.05 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.462 0.705 . . . . 0.0 111.495 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.99 -29.31 65.16 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.485 0.714 . . . . 0.0 111.67 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.81 -30.58 71.59 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.498 0.719 . . . . 0.0 112.019 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.4 mt -99.16 -36.05 9.8 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 123.652 0.781 . . . . 0.0 112.537 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.9 m -76.63 0.91 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.703 0.801 . . . . 0.0 109.897 173.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.318 0.104 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.18 167.44 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.181 0.515 . . . . 0.0 110.366 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -149.12 142.5 25.22 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 87.0 mt -137.69 166.48 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.5 p -115.37 155.25 27.71 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 120.068 1.304 . . . . 0.0 110.195 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -124.88 65.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.789 1.236 . . . . 0.0 108.175 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.1 pttt 39.09 50.44 1.81 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.813 2.045 . . . . 0.0 113.972 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.92 -27.3 0.13 Allowed Glycine 0 CA--C 1.523 0.594 0 CA-C-O 119.523 -0.598 . . . . 0.0 112.669 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.9 172.71 45.71 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 117.998 0.899 . . . . 0.0 111.294 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -59.09 157.8 28.21 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.763 2.976 . . . . 0.0 113.599 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 m -138.37 131.8 40.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 126.553 1.941 . . . . 0.0 106.378 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -76.0 160.6 29.67 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.13 0.972 . . . . 0.0 109.858 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -124.93 138.04 54.25 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.23 128.42 38.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.69 -159.73 18.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 123.555 0.598 . . . . 0.0 112.201 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -126.03 155.09 42.03 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.289 1.036 . . . . 0.0 109.045 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.54 152.76 43.62 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 168.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.6 t -125.64 146.33 31.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -126.19 158.94 34.3 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.44 0.696 . . . . 0.0 110.837 -169.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.8 t -57.37 139.54 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.077 0.951 . . . . 0.0 108.856 174.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.44 -18.15 53.33 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.792 1.187 . . . . 0.0 112.346 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -77.21 153.95 33.55 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 119.013 1.406 . . . . 0.0 109.98 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -75.29 127.61 33.55 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 169.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.29 150.78 78.73 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.653 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.17 -30.3 49.98 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.816 3.01 . . . . 0.0 115.625 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 51.63 88.04 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.557 1.943 . . . . 0.0 113.965 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.02 168.27 19.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.376 1.07 . . . . 0.0 110.405 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.2 157.34 19.36 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.321 1.448 . . . . 0.0 112.375 -169.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -148.85 157.69 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 127.942 2.497 . . . . 0.0 106.279 173.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 tp -86.22 138.08 32.14 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 120.954 -1.091 . . . . 0.0 108.972 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.8 p -71.18 167.44 19.37 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -65.44 -17.03 64.23 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.476 -1.39 . . . . 0.0 110.887 168.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.8 m -81.08 0.78 34.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.805 1.642 . . . . 0.0 111.374 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 17.2 mt 69.26 34.06 3.07 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.54 1.536 . . . . 0.0 111.404 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -122.77 163.06 20.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.668 1.187 . . . . 0.0 108.264 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -79.3 137.21 37.26 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -134.03 149.94 51.2 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 169.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.9 p -143.04 165.47 27.28 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 tt -54.91 -35.57 64.28 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.917 0.487 . . . . 0.0 111.939 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.1 -29.11 56.94 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.204 1.002 . . . . 0.0 113.146 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -81.14 -40.45 23.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.395 1.078 . . . . 0.0 110.762 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.69 -42.3 91.37 Favored 'General case' 0 CA--C 1.523 -0.074 0 C-N-CA 123.879 0.872 . . . . 0.0 110.2 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 pttt -66.19 -0.79 2.71 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.67 -16.5 30.45 Favored Glycine 0 CA--C 1.54 1.612 0 O-C-N 121.125 -0.984 . . . . 0.0 112.488 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -140.25 158.54 43.87 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.534 1.533 . . . . 0.0 107.366 170.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.8 t -58.73 120.28 4.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 94.0 m -125.46 136.31 53.25 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.897 0.38 . . . . 0.0 110.881 -169.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 83.3 mt -97.21 139.53 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.5 mm -120.55 133.76 66.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -125.99 94.43 4.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.333 1.053 . . . . 0.0 108.696 -169.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -80.06 124.08 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.82 162.42 55.36 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 125.41 1.484 . . . . 0.0 107.799 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -70.02 -59.69 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 121.955 1.77 . . . . 0.0 110.315 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.8 m -152.41 160.32 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 127.581 2.353 . . . . 0.0 106.887 -176.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.2 tt -94.29 17.16 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -169.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -126.95 14.38 7.37 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.891 1.276 . . . . 0.0 110.42 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 17.9 p -73.51 -12.41 60.77 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.899 1.28 . . . . 0.0 112.713 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.15 -50.77 4.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.808 1.194 . . . . 0.0 110.213 -173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.68 -25.77 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 118.173 0.987 . . . . 0.0 112.073 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.7 p -53.42 -37.99 63.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.309 1.044 . . . . 0.0 112.257 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -70.98 -43.75 67.38 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.138 0.975 . . . . 0.0 110.787 -172.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.98 43.33 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.155 0.982 . . . . 0.0 112.441 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -106.67 -55.01 2.39 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.618 -0.706 . . . . 0.0 110.189 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 m -64.78 -40.04 94.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.864 1.211 . . . . 0.0 112.348 -169.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -63.06 -49.3 75.09 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.029 -1.044 . . . . 0.0 109.335 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.1 ttp180 -67.01 -36.04 81.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.165 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -59.5 -43.86 93.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.75 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -58.08 -46.79 84.89 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.495 1.043 . . . . 0.0 111.343 -177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -67.58 -46.68 71.94 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -69.16 -33.31 73.21 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.296 -0.878 . . . . 0.0 110.721 -175.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.25 -41.92 96.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.526 0.603 . . . . 0.0 110.892 173.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.77 91.0 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.863 0.756 . . . . 0.0 111.144 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.0 mtmt -65.48 -39.76 92.32 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.092 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.7 mt -65.02 -45.75 84.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.598 1.09 . . . . 0.0 110.114 172.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.35 -4.93 75.22 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.796 1.189 . . . . 0.0 114.433 170.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -153.8 55.1 0.73 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.145 1.473 . . . . 0.0 109.831 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -135.33 168.88 22.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -127.76 140.81 51.83 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.6 t -137.34 139.79 43.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -128.71 162.84 26.44 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.886 0.851 . . . . 0.0 109.502 170.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.63 ' HB ' HG22 ' A' ' 104' ' ' THR . 21.5 m -129.11 143.99 51.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.3 mt -130.87 134.95 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.4 m -138.95 157.0 46.81 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.414 1.086 . . . . 0.0 110.436 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.99 54.32 1.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 168.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -140.41 162.93 34.15 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.651 1.581 . . . . 0.0 107.891 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.34 137.08 95.32 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -169.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.46 -32.08 80.56 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.015 1.81 . . . . 0.0 111.269 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.68 -29.44 62.3 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.275 -0.891 . . . . 0.0 111.461 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.09 -45.23 67.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 119.96 1.255 . . . . 0.0 109.709 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -56.26 -44.07 79.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.305 1.042 . . . . 0.0 111.714 172.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.27 -39.96 95.0 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.387 -0.821 . . . . 0.0 111.894 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 -67.16 -39.06 86.44 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.598 -0.689 . . . . 0.0 109.849 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 2.0 t-105 -53.95 -51.81 62.67 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.433 0.693 . . . . 0.0 109.428 170.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 84.0 m -60.11 -36.45 77.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.852 0.751 . . . . 0.0 111.231 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.06 -19.56 72.04 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.954 -0.914 . . . . 0.0 113.548 177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.25 -25.17 24.11 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 119.168 1.484 . . . . 0.0 111.571 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -124.13 -16.28 6.54 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 124.64 1.176 . . . . 0.0 113.08 -169.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.44 22.24 77.7 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 119.242 -0.755 . . . . 0.0 112.198 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.7 mt -55.99 140.76 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -143.33 -35.89 0.38 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.65 1.18 . . . . 0.0 111.807 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -76.48 -17.14 59.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.79 0.836 . . . . 0.0 111.448 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -112.26 153.98 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 170.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -134.65 150.64 50.67 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 169.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.63 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.1 p -111.77 148.02 34.42 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -171.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.1 mt -138.72 145.25 40.05 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.215 1.006 . . . . 0.0 109.192 -168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.3 m -107.82 108.89 20.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.516 0.674 . . . . 0.0 109.827 -173.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -81.36 -14.55 57.11 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.512 168.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -42.43 -39.92 2.38 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.761 2.424 . . . . 0.0 114.192 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -119.74 24.05 10.79 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.251 1.021 . . . . 0.0 110.266 -171.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -136.26 -45.89 0.63 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.787 0.835 . . . . 0.0 110.461 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 60.1 -15.77 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 129.15 2.98 . . . . 0.0 114.898 -174.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.9 m -62.86 -50.57 70.39 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.329 1.422 . . . . 0.0 111.871 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.92 -46.84 85.9 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.214 0.916 . . . . 0.0 110.162 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -63.43 -42.36 99.08 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -174.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.89 -42.97 80.39 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.295 -0.532 . . . . 0.0 109.955 174.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.79 -40.56 92.06 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.37 -0.831 . . . . 0.0 112.035 -169.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -83.11 -1.35 52.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.687 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.63 54.06 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 119.385 0.993 . . . . 0.0 112.403 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.5 m -131.4 28.87 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.993 1.317 . . . . 0.0 110.46 -170.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -119.84 117.41 28.07 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 76.6 mt -81.85 112.54 19.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 -169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -57.36 -43.53 83.59 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.595 1.958 . . . . 0.0 111.234 -173.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -71.4 -43.61 66.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.388 0.275 . . . . 0.0 110.476 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 83.1 mt -84.09 -22.09 31.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 56.59 37.62 28.95 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.889 0.876 . . . . 0.0 108.697 -168.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.6 tp -135.12 153.97 51.82 Favored 'General case' 0 C--N 1.345 0.378 0 C-N-CA 125.162 1.385 . . . . 0.0 108.056 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 tp -72.9 150.67 42.4 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.398 0.618 . . . . 0.0 110.75 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -177.21 2.71 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.554 1.169 . . . . 0.0 112.232 178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -123.45 101.21 7.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 102.034 -3.321 . . . . 0.0 102.034 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.0 m -156.51 167.88 29.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -169.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -152.13 144.93 15.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -141.04 159.91 41.21 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.706 0.802 . . . . 0.0 109.825 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 36.5 t -135.56 144.45 33.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.3 mt -130.24 123.11 29.37 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.536 1.534 . . . . 0.0 107.961 -169.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.97 166.23 11.82 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.158 0.983 . . . . 0.0 108.714 169.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.51 -20.99 59.45 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.153 -0.967 . . . . 0.0 113.397 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -80.45 -10.68 59.74 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.593 -1.317 . . . . 0.0 112.247 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.58 18.05 69.36 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 121.399 -0.813 . . . . 0.0 111.179 -169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -75.66 132.21 40.42 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.7 t -71.34 125.7 30.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.5 m -112.97 -10.95 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.372 0.669 . . . . 0.0 111.724 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -153.55 144.06 22.47 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.85 138.69 22.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -152.08 149.94 29.38 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.371 0.668 . . . . 0.0 109.201 170.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -129.57 108.19 10.04 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 -175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.72 123.68 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.9 m -68.43 -11.29 59.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -135.28 124.87 25.09 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.897 1.279 . . . . 0.0 108.375 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.87 66.09 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.257 1.023 . . . . 0.0 112.889 -174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.0 p -84.52 16.6 3.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.254 -0.904 . . . . 0.0 112.017 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -137.23 170.32 16.29 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.161 2.185 . . . . 0.0 107.954 -174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -138.25 164.11 42.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.706 1.203 . . . . 0.0 110.617 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.52 173.64 1.45 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.305 2.67 . . . . 0.0 112.258 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -113.91 120.11 39.57 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 169.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -53.08 -28.48 25.27 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.526 1.53 . . . . 0.0 112.845 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -58.85 -36.18 74.14 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.496 0.589 . . . . 0.0 111.12 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -67.59 -52.95 24.56 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.677 -170.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.98 -32.94 27.31 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.842 1.336 . . . . 0.0 111.846 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.0 mm -56.16 -48.3 79.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-N 119.25 0.932 . . . . 0.0 109.54 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.08 -39.55 92.81 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.508 0.594 . . . . 0.0 110.545 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.22 -46.7 79.58 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.216 -0.303 . . . . 0.0 111.603 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.57 -52.2 41.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.532 0.733 . . . . 0.0 110.168 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.13 69.58 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.133 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.55 -32.02 69.95 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.374 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 64.2 mt -86.57 -35.85 19.24 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.796 0.838 . . . . 0.0 111.556 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 69.4 t -65.4 -40.43 88.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.451 0.701 . . . . 0.0 111.302 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 18.7 pttp . . . . . 0 C--O 1.249 1.06 0 CA-C-N 118.336 0.516 . . . . 0.0 111.171 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 119.501 -0.285 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.95 -179.76 1.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 118.724 0.693 . . . . 0.0 109.135 169.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -144.47 140.09 28.72 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.3 mt -139.68 150.86 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -77.56 161.33 27.95 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.905 -1.122 . . . . 0.0 108.797 172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -138.15 109.38 6.86 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? 39.03 51.3 1.89 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.36 1.864 . . . . 0.0 111.583 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.22 5.47 79.88 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 117.974 -1.459 . . . . 0.0 115.519 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.08 142.33 13.42 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 120.299 2.05 . . . . 0.0 109.966 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.32 149.41 63.27 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 CA-C-N 120.61 2.205 . . . . 0.0 112.006 -174.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 m -136.91 141.37 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 125.095 1.358 . . . . 0.0 109.432 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -78.07 147.79 34.55 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 125.391 1.476 . . . . 0.0 110.115 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 119' ' ' VAL . 2.0 mm? -116.04 147.32 41.38 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 125.871 1.668 . . . . 0.0 106.842 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.72 -67.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 118.572 0.624 . . . . 0.0 111.222 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.09 173.02 36.24 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.561 0.534 . . . . 0.0 112.331 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.9 152.3 37.17 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 172.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -69.78 114.29 7.84 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 168.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.4 m -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.818 1.19 . . . . 0.0 108.12 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.5 160.52 20.49 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.73 -0.606 . . . . 0.0 109.46 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.98 135.06 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 174.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -15.29 60.26 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.736 1.16 . . . . 0.0 112.704 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -70.59 147.23 49.47 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.619 1.71 . . . . 0.0 109.137 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -87.03 117.8 25.99 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 152.1 40.57 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -169.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -54.42 -24.66 36.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 124.373 3.382 . . . . 0.0 116.542 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 52.74 90.76 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.633 1.973 . . . . 0.0 114.324 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -128.12 -172.98 2.82 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.411 1.484 . . . . 0.0 108.872 172.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.5 m -122.92 154.76 37.92 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.946 0.899 . . . . 0.0 110.082 -168.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.3 m -137.02 165.02 28.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 127.096 2.158 . . . . 0.0 106.796 173.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.7 tp -89.59 142.54 27.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.5 p -69.16 166.91 17.28 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -65.24 -4.13 4.83 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 120.71 -1.243 . . . . 0.0 111.941 168.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.3 m -115.01 17.68 16.72 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.102 2.161 . . . . 0.0 111.332 -175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 43.1 mt 65.59 37.77 5.78 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 113.021 169.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -122.83 157.09 33.22 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 169.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.03 143.24 35.84 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 120.739 -1.226 . . . . 0.0 109.167 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.04 142.98 32.91 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 p -138.51 167.03 22.79 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.478 0.711 . . . . 0.0 109.516 -171.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.9 tt -57.78 -35.97 71.53 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.96 -0.463 . . . . 0.0 111.188 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.91 -27.93 54.4 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.939 0.896 . . . . 0.0 113.073 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -85.46 -37.87 19.26 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.402 1.081 . . . . 0.0 110.718 174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.1 mtt -65.46 -39.37 91.93 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 123.96 0.904 . . . . 0.0 110.244 -175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -67.5 -0.25 3.63 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.65 -17.07 40.08 Favored Glycine 0 CA--C 1.538 1.522 0 O-C-N 120.751 -1.218 . . . . 0.0 113.003 169.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -144.92 166.63 24.74 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.299 1.84 . . . . 0.0 106.678 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.4 t -66.18 116.68 5.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.08 -2.933 . . . . 0.0 103.08 168.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.5 m -125.51 139.35 53.69 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.809 0.338 . . . . 0.0 110.635 -168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.4 mt -103.13 141.77 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.67 95.81 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 125.92 1.688 . . . . 0.0 107.21 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.5 m -73.38 145.51 45.83 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.82 137.85 56.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 170.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.6 pt -141.56 150.12 56.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -48.83 10.15 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 121.986 1.79 . . . . 0.0 111.951 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.2 m -156.07 149.11 24.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 tt -79.33 3.27 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -169.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -89.13 -3.9 58.47 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.28 1.032 . . . . 0.0 111.964 170.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 t -65.5 -10.38 34.0 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 120.922 -1.111 . . . . 0.0 113.399 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.7 -50.1 4.35 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 125.323 1.44 . . . . 0.0 111.994 169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.7 -2.83 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.919 0.888 . . . . 0.0 112.349 171.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.8 m -49.85 -31.5 12.13 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 125.369 1.468 . . . . 0.0 110.058 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -50.48 -50.74 51.81 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.853 1.261 . . . . 0.0 111.92 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.25 -35.52 79.71 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.612 0.365 . . . . 0.0 110.921 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -85.43 -8.51 58.35 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.648 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 m -141.01 -60.91 0.49 Allowed 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.861 1.21 . . . . 0.0 112.47 -169.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -71.87 -43.72 64.97 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.483 -1.386 . . . . 0.0 110.064 -176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -62.56 -35.98 81.21 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.998 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -62.46 -36.88 83.85 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 118.058 -0.972 . . . . 0.0 112.555 174.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -57.37 -45.98 83.87 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.752 1.16 . . . . 0.0 110.323 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.75 -50.18 65.69 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.831 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.55 -32.18 72.78 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.134 -0.979 . . . . 0.0 110.929 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.36 -39.98 93.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.911 0.884 . . . . 0.0 111.166 174.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.06 -42.26 99.66 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.202 0.455 . . . . 0.0 109.947 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -65.13 -35.73 82.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.28 0.632 . . . . 0.0 110.947 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 mp -62.42 -19.4 63.42 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.168 0.987 . . . . 0.0 113.225 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.3 -43.27 3.11 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.497 1.046 . . . . 0.0 112.054 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -149.95 126.3 10.78 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.851 1.261 . . . . 0.0 108.563 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.5 p -165.52 174.79 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 127.354 2.262 . . . . 0.0 105.379 169.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -129.41 138.57 51.56 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 46.4 t -140.54 140.4 34.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -134.33 167.35 20.87 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.493 1.117 . . . . 0.0 109.493 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 94.4 m -131.63 144.15 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.8 mt -124.82 141.85 43.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -142.5 156.78 45.18 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.021 0.528 . . . . 0.0 111.452 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.88 50.95 1.87 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.663 1.185 . . . . 0.0 108.047 169.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -142.71 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.328 1.451 . . . . 0.0 107.787 -169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.4 mp -75.41 140.6 72.47 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 121.655 -0.653 . . . . 0.0 111.882 -168.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.49 -39.72 45.25 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.93 3.087 . . . . 0.0 114.498 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -74.42 -28.04 60.89 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.74 0.7 . . . . 0.0 111.604 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.27 -44.2 84.27 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.447 1.021 . . . . 0.0 108.941 172.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -48.26 74.32 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.663 0.785 . . . . 0.0 111.095 173.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.96 -41.21 97.64 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.416 0.553 . . . . 0.0 111.451 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -63.77 -41.48 97.96 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 123.103 0.561 . . . . 0.0 109.787 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -56.21 -48.48 76.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.091 -0.481 . . . . 0.0 110.416 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 66.7 m -62.47 -43.6 98.42 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.882 0.764 . . . . 0.0 110.865 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.47 -40.19 98.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.39 -40.38 85.63 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.857 0.829 . . . . 0.0 110.758 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -86.69 -11.07 52.28 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.539 0.736 . . . . 0.0 112.672 -175.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.48 27.85 68.79 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 119.182 0.901 . . . . 0.0 111.903 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 70.4 mt -76.54 147.17 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 124.188 0.995 . . . . 0.0 108.943 -174.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -139.65 -39.08 0.47 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 111.849 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -11.18 59.86 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.335 -176.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.32 155.44 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -135.27 134.41 39.92 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 169.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 p -89.14 151.08 22.4 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.181 0.992 . . . . 0.0 108.777 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 mt -141.59 166.18 25.45 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.78 2.032 . . . . 0.0 107.388 -169.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -136.93 123.93 21.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -80.4 36.23 0.36 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 122.561 1.172 . . . . 0.0 111.401 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -66.04 -10.43 39.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.738 1.615 . . . . 0.0 111.671 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -79.1 63.29 3.72 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.456 1.503 . . . . 0.0 108.743 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.2 t0 47.05 44.83 15.46 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.818 2.047 . . . . 0.0 112.691 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 83.1 mmm 48.73 23.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.192 2.197 . . . . 0.0 114.127 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 p -63.64 -37.14 86.22 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.075 -1.016 . . . . 0.0 112.977 -169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -68.65 -48.86 62.94 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 118.964 0.802 . . . . 0.0 109.65 -176.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.92 -35.3 61.63 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -59.33 -49.51 77.53 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.891 0.845 . . . . 0.0 109.24 173.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.7 -39.1 80.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -72.41 -3.08 21.99 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.042 0.937 . . . . 0.0 113.2 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.41 37.26 62.75 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.322 0.965 . . . . 0.0 112.61 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.436 ' HA ' HD12 ' A' ' 13' ' ' LEU . 26.9 m -121.52 1.08 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 118.64 1.22 . . . . 0.0 112.449 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -90.89 120.28 31.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.9 mt -82.25 108.87 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -54.96 -38.53 67.86 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.159 1.383 . . . . 0.0 110.908 -176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -75.47 -10.85 59.81 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.557 0.743 . . . . 0.0 112.628 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 55.7 mt -134.29 -19.77 1.92 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -169.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.6 mtt-85 53.42 42.17 32.03 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.778 0.831 . . . . 0.0 109.17 -167.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -119.6 148.08 43.75 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 125.39 1.476 . . . . 0.0 107.249 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.4 tp -91.9 139.04 31.05 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -72.04 172.37 10.19 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.085 0.954 . . . . 0.0 111.13 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 21.2 ttm105 -101.67 21.17 14.87 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.922 0.889 . . . . 0.0 111.475 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 m -58.66 176.31 0.2 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.285 2.234 . . . . 0.0 113.89 -176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.47 147.62 16.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 O-C-N 120.542 -1.349 . . . . 0.0 108.568 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -135.83 165.18 26.21 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.405 0.682 . . . . 0.0 109.884 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.29 145.02 27.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 169.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 54.4 mt -131.0 130.21 43.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.431 -168.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -67.19 168.23 10.72 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.022 1.329 . . . . 0.0 109.365 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -60.79 -14.61 22.67 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.207 -0.933 . . . . 0.0 113.511 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -93.8 6.82 47.15 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.539 -1.351 . . . . 0.0 111.743 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.61 22.28 73.29 Favored Glycine 0 CA--C 1.528 0.861 0 O-C-N 120.865 -1.147 . . . . 0.0 111.978 -174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -83.78 135.53 34.5 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 118.695 1.248 . . . . 0.0 107.78 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.72 115.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.89 -34.25 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 175.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -162.05 144.72 11.56 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 126.219 1.808 . . . . 0.0 107.105 177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.84 147.94 34.79 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.895 0.878 . . . . 0.0 108.725 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -143.26 135.16 26.76 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.053 1.341 . . . . 0.0 107.704 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -106.81 18.7 21.51 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.051 1.74 . . . . 0.0 112.951 -168.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 30.1 m 49.21 -16.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 130.193 3.397 . . . . 0.0 118.376 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.0 m 55.02 -7.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.048 2.939 . . . . 0.0 116.05 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.51 126.15 11.01 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.58 -18.14 63.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.056 1.342 . . . . 0.0 112.649 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 80.9 p -93.43 12.8 23.68 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 120.148 1.34 . . . . 0.0 112.211 172.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.17 163.93 15.92 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.592 1.557 . . . . 0.0 109.765 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -124.65 157.43 65.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.224 1.41 . . . . 0.0 108.714 176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.89 -167.49 0.49 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.346 2.697 . . . . 0.0 108.646 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -124.2 116.45 22.71 Favored 'General case' 0 CA--C 1.528 0.117 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -47.46 -29.0 2.41 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 126.954 2.101 . . . . 0.0 113.897 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -60.21 -36.49 77.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.15 0.432 . . . . 0.0 110.969 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -58.52 -58.21 20.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.801 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -24.15 23.1 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 CA-C-O 116.814 -1.411 . . . . 0.0 112.553 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.15 -47.22 94.54 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 CA-C-N 121.332 1.878 . . . . 0.0 109.066 173.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.53 -34.84 79.17 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.647 0.658 . . . . 0.0 110.855 -177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.69 -47.5 62.97 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.672 0.389 . . . . 0.0 111.625 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.23 -48.44 70.54 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.631 0.772 . . . . 0.0 111.171 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.94 -31.45 68.71 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.962 0.505 . . . . 0.0 111.515 -177.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.28 -30.76 71.8 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.881 -0.581 . . . . 0.0 112.054 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.73 -39.29 7.91 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.682 0.674 . . . . 0.0 112.548 -174.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -74.22 -23.49 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -170.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.062 0 C-N-CA 123.161 0.585 . . . . 0.0 111.208 178.535 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.7 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.14 153.76 14.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.946 1.298 . . . . 0.0 112.072 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -144.77 -32.7 0.4 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.085 2.154 . . . . 0.0 109.944 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.286 16.2 mt 73.65 162.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 127.699 2.4 . . . . 0.0 111.068 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.4 p -125.02 165.87 17.39 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.812 2.045 . . . . 0.0 108.767 174.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -136.5 105.37 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 150' ' ' THR . 16.3 ptpt 31.4 56.81 0.28 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 127.115 2.166 . . . . 0.0 114.545 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.33 21.52 13.06 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-O 118.877 -0.957 . . . . 0.0 114.608 169.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.78 159.87 29.89 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.327 1.564 . . . . 0.0 110.501 171.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.16 156.73 37.99 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.108 2.539 . . . . 0.0 112.164 -176.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.18 -161.85 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 125.926 1.691 . . . . 0.0 106.862 169.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.0 m -149.13 152.31 35.9 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 120.284 -1.51 . . . . 0.0 108.219 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 11.8 mt -110.45 138.06 47.33 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.191 1.397 . . . . 0.0 108.406 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.65 -17.71 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.1 175.88 24.44 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -71.41 150.61 44.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.096 0.951 . . . . 0.0 111.794 -170.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -77.37 123.37 26.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.726 -2.694 . . . . 0.0 103.726 168.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -72.75 162.46 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 119.892 1.224 . . . . 0.0 110.123 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -123.26 156.39 35.31 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.475 1.51 . . . . 0.0 107.72 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.1 t -57.07 135.1 21.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 170.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.02 -12.34 68.52 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.473 -1.182 . . . . 0.0 112.998 -178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -66.02 149.73 49.78 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 119.614 1.707 . . . . 0.0 108.976 172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.35 128.23 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 169.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -60.98 142.38 92.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.353 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 36.1 Cg_exo -57.42 0.41 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.703 1 C-N-CA 126.102 4.535 . . . . 0.0 119.204 -178.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 58.28 65.24 1.31 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.816 1.293 . . . . 0.0 111.902 -175.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -74.67 164.54 26.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.568 1.547 . . . . 0.0 109.805 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.0 m -130.58 136.57 49.02 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 170.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.93 155.11 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.013 1.725 . . . . 0.0 106.618 -169.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -85.39 139.11 31.81 Favored 'General case' 0 C--O 1.23 0.077 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.8 p -70.99 164.87 24.65 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.0 p30 -67.08 -3.4 7.3 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.852 -1.155 . . . . 0.0 111.594 168.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 m -97.87 5.24 49.25 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.415 1.886 . . . . 0.0 111.836 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp 63.31 42.72 6.69 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.82 1.248 . . . . 0.0 111.294 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.97 164.46 20.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -84.14 144.94 28.68 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 120.729 -1.232 . . . . 0.0 109.872 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -138.23 156.32 47.8 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 126.95 2.1 . . . . 0.0 106.092 171.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 p -149.48 169.8 20.06 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.285 -0.884 . . . . 0.0 109.293 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 51.9 tp -47.02 -43.89 19.99 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 123.776 0.83 . . . . 0.0 111.347 175.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.09 -30.57 66.36 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.949 0.9 . . . . 0.0 112.8 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -74.91 -40.27 60.97 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.382 0.673 . . . . 0.0 110.426 174.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 45.5 mtt -67.74 -25.08 65.46 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.283 1.033 . . . . 0.0 111.62 -177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -55.77 -14.84 2.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.225 1.01 . . . . 0.0 113.622 175.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.29 -23.27 57.51 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-O 118.754 -1.026 . . . . 0.0 113.672 176.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -151.77 156.86 41.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.677 1.739 . . . . 0.0 109.517 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.1 122.21 8.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 168.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.5 m -125.96 130.47 51.3 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.63 0.372 . . . . 0.0 110.923 -168.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 77.4 mt -89.71 141.43 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 mm -118.74 131.61 71.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 170.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -127.42 84.45 2.26 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.418 1.087 . . . . 0.0 108.16 -172.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.9 t -74.9 143.65 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.73 169.95 9.77 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.974 1.71 . . . . 0.0 106.989 169.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -70.27 -54.88 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.82 1.68 . . . . 0.0 110.812 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 m -151.37 170.37 19.72 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.409 2.284 . . . . 0.0 107.563 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -149.3 81.37 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.954 0.883 . . . . 0.0 109.206 -169.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -145.68 6.42 1.07 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.3 t -152.64 -170.03 3.52 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.941 1.297 . . . . 0.0 107.782 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.28 -52.44 3.78 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.75 -29.68 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 117.897 0.849 . . . . 0.0 112.316 -169.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 26.5 p -68.4 -24.7 64.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.688 0.676 . . . . 0.0 112.485 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -139.53 -95.68 0.16 Allowed 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.191 0.997 . . . . 0.0 108.718 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.54 6.34 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.597 1.959 . . . . 0.0 114.581 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -87.7 -44.43 11.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.463 1.105 . . . . 0.0 108.353 173.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 39.0 m -51.31 -41.74 60.73 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.43 1.092 . . . . 0.0 112.393 -174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -65.28 -45.27 85.12 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.969 -1.082 . . . . 0.0 111.472 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -69.15 -39.23 78.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -56.73 -40.86 76.48 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.221 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -59.59 -46.09 89.95 Favored 'General case' 0 CA--C 1.523 -0.088 0 CA-C-N 119.348 0.977 . . . . 0.0 111.416 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -65.45 -55.72 16.39 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.392 0.677 . . . . 0.0 109.354 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 27.2 mm-40 -60.08 -40.97 91.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.859 0.754 . . . . 0.0 110.778 -174.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.17 69.57 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.203 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.62 -37.67 70.89 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.572 1.078 . . . . 0.0 110.299 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -66.93 -41.65 86.66 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.726 174.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.4 mt -65.85 -40.78 92.04 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.302 0.956 . . . . 0.0 110.551 175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.71 -66.62 2.72 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 125.951 1.739 . . . . 0.0 110.939 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -85.69 45.36 1.19 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.725 1.61 . . . . 0.0 111.782 -171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -130.65 166.4 28.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.152 1.381 . . . . 0.0 107.734 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -132.24 146.08 51.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 170.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 23.4 t -138.28 145.32 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.31 155.37 47.31 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.105 0.962 . . . . 0.0 108.706 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 104' ' ' THR . 54.4 m -117.23 145.81 43.67 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -132.29 138.05 53.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.8 m -140.48 159.18 42.76 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.973 0.909 . . . . 0.0 110.23 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -95.01 54.66 1.72 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 168.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -143.11 161.54 37.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.887 1.275 . . . . 0.0 108.757 -169.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.86 138.43 85.35 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 124.015 0.926 . . . . 0.0 108.93 -169.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.25 -34.27 88.44 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.619 2.213 . . . . 0.0 112.129 -170.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -73.86 -29.05 61.9 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.361 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.97 86.3 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.955 0.798 . . . . 0.0 109.381 173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -62.89 -42.64 99.85 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.328 -0.232 . . . . 0.0 111.123 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.87 84.57 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.696 0.398 . . . . 0.0 111.25 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttp-105 -63.5 -45.72 89.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -60.66 -40.32 91.63 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.503 0.321 . . . . 0.0 110.436 177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.1 m -63.97 -46.1 86.14 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 122.005 -0.434 . . . . 0.0 111.315 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.69 -37.38 94.63 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.9 -27.65 67.67 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.871 0.868 . . . . 0.0 111.999 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -108.25 -4.89 17.15 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 123.897 0.879 . . . . 0.0 112.345 -173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.21 30.65 56.76 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.725 0.679 . . . . 0.0 111.528 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -72.19 143.3 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.412 1.085 . . . . 0.0 108.675 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -146.67 -38.38 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.619 1.168 . . . . 0.0 112.87 176.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -73.35 -21.13 60.61 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 112.342 176.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.48 157.79 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -140.22 143.77 36.18 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 169.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.429 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.9 p -96.86 149.96 21.28 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.79 0.836 . . . . 0.0 109.521 -177.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.5 mt -137.7 139.4 40.16 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.592 1.157 . . . . 0.0 108.664 -172.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 40.7 m -102.06 122.23 43.71 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.427 1.091 . . . . 0.0 108.874 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -104.23 -7.36 20.14 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.669 0.787 . . . . 0.0 111.825 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -55.51 -27.16 47.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.855 1.262 . . . . 0.0 112.817 -177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -62.33 -32.04 72.74 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.283 0.633 . . . . 0.0 112.058 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -146.2 -8.24 0.53 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 50.63 31.02 5.32 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.421 1.488 . . . . 0.0 112.629 -169.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.3 m -58.22 -55.47 34.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.296 -0.877 . . . . 0.0 111.136 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -67.26 -40.21 86.19 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -48.92 -45.09 32.19 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 126.337 1.922 . . . . 0.0 113.118 176.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -83.32 -41.31 18.4 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 117.903 0.851 . . . . 0.0 109.688 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.97 80.05 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.574 1.15 . . . . 0.0 112.384 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -105.64 10.79 32.82 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.812 1.245 . . . . 0.0 110.968 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.24 -3.3 2.46 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-O 118.068 -1.407 . . . . 0.0 115.578 -177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.7 m -66.79 -9.65 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 120.392 2.096 . . . . 0.0 113.836 -169.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -75.11 120.77 21.08 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.992 1.269 . . . . 0.0 108.404 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.3 mt -93.7 110.69 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -169.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -54.36 -40.84 68.49 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.871 1.668 . . . . 0.0 111.837 -171.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -82.24 -6.69 59.4 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.16 0.584 . . . . 0.0 112.45 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 87.8 mt -126.03 -18.54 5.02 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -170.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.9 ttp180 56.26 33.41 22.15 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -168.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.6 tp -128.0 171.23 12.03 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.318 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.2 tp -113.3 141.19 47.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.158 0.983 . . . . 0.0 108.748 -173.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.8 175.89 2.78 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.609 1.164 . . . . 0.0 111.066 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.7 mtt180 -113.65 18.36 17.57 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.1 m -63.19 162.35 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 0.0 111.727 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.86 147.86 28.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 123.726 0.81 . . . . 0.0 109.843 -173.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -142.79 155.38 44.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.714 0.805 . . . . 0.0 108.923 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.7 t -135.01 135.43 52.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.9 mt -127.93 121.11 29.11 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.485 1.514 . . . . 0.0 107.276 -169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.48 160.65 18.84 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.061 0.945 . . . . 0.0 108.951 169.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.82 -19.09 15.46 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.772 1.229 . . . . 0.0 113.164 177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -73.59 -11.96 60.6 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 120.534 -1.354 . . . . 0.0 112.465 172.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.55 43.92 8.94 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -127.7 131.42 49.75 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -169.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.0 109.25 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.974 1.31 . . . . 0.0 108.998 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 72.1 t -77.5 -39.42 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 125.432 1.493 . . . . 0.0 109.331 171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -153.76 142.64 21.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.112 1.365 . . . . 0.0 107.504 -176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.89 139.12 27.43 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.4 145.26 27.97 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -120.19 131.62 55.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.192 1.397 . . . . 0.0 107.474 -172.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.4 -15.86 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.3 m 62.55 -12.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.723 2.009 . . . . 0.0 114.658 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -139.74 116.44 10.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.67 1.588 . . . . 0.0 107.029 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.69 -21.16 66.52 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.962 1.305 . . . . 0.0 112.676 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.454 HG21 ' HE3' ' A' ' 7' ' ' LYS . 5.6 p -91.05 15.34 11.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.347 1.459 . . . . 0.0 111.545 -177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -138.52 123.1 18.54 Favored 'General case' 0 C--N 1.343 0.32 0 C-N-CA 125.366 1.466 . . . . 0.0 109.201 -173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 155.34 90.05 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.997 0.919 . . . . 0.0 112.034 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.65 -167.47 0.38 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.421 3.414 . . . . 0.0 109.547 173.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -124.78 116.65 22.63 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 168.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -53.38 -27.36 23.55 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.777 1.631 . . . . 0.0 112.551 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -58.88 -34.06 71.2 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.454 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -64.19 -57.02 19.55 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 119.233 0.924 . . . . 0.0 111.761 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.34 -29.27 26.13 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 121.398 1.399 . . . . 0.0 111.873 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 9.9 mm -56.11 -48.46 79.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 119.878 1.217 . . . . 0.0 109.668 170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -65.5 -28.79 69.44 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.891 0.769 . . . . 0.0 111.423 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.42 -49.83 57.12 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.394 0.543 . . . . 0.0 111.348 169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.82 -43.8 74.81 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 123.486 0.714 . . . . 0.0 111.566 -173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -20.3 63.45 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.407 0.683 . . . . 0.0 112.175 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -65.68 -26.65 67.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.72 0.691 . . . . 0.0 111.393 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.6 mt -107.1 -21.97 12.8 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 124.866 1.266 . . . . 0.0 113.362 -169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.2 m -65.96 -18.8 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 119.123 0.874 . . . . 0.0 112.483 174.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.406 1.082 . . . . 0.0 110.126 -178.227 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.48 81.0 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.821 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 45.1 49.08 9.73 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.96 1.704 . . . . 0.0 111.633 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.46 140.72 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.287 1.035 . . . . 0.0 108.472 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 p -102.1 156.97 17.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.988 0.915 . . . . 0.0 109.777 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -104.43 41.83 1.27 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 63.26 -39.8 0.18 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 128.606 2.762 . . . . 0.0 114.551 -170.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -78.03 -36.03 33.02 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.95 0.786 . . . . 0.0 112.015 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.79 177.31 48.06 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.08 153.1 27.51 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 123.914 3.076 . . . . 0.0 112.797 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.27 131.63 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.62 1.168 . . . . 0.0 108.752 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.8 m -63.03 151.28 40.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.446 1.499 . . . . 0.0 111.105 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 64.2 mt -122.65 139.63 53.73 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.981 2.112 . . . . 0.0 106.97 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -74.91 -16.8 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.93 169.1 28.73 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -169.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -71.8 159.4 34.38 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.002 0.906 . . . . 0.0 112.057 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -73.37 149.87 42.22 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 168.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.5 t -119.51 148.51 22.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -131.85 160.35 35.91 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 111.142 -169.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.8 t -55.97 141.85 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.028 1.331 . . . . 0.0 109.646 175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -22.51 26.35 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.051 1.31 . . . . 0.0 112.027 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -74.95 151.16 38.86 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 118.514 1.157 . . . . 0.0 109.91 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -71.29 123.63 22.7 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.46 152.03 75.21 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.381 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.36 -26.53 44.29 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.797 2.998 . . . . 0.0 116.065 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.9 t0 51.38 86.38 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.282 1.833 . . . . 0.0 114.303 -173.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -127.14 -176.02 3.6 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.798 1.639 . . . . 0.0 108.814 174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 m -124.37 154.2 40.72 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.198 0.999 . . . . 0.0 111.014 -168.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.65 166.33 26.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 126.883 2.073 . . . . 0.0 107.811 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 tp -84.89 143.92 28.72 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.4 p -71.22 166.86 20.64 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -67.31 -3.42 7.99 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 120.024 -1.672 . . . . 0.0 112.156 169.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 m -110.56 17.1 21.08 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.367 1.867 . . . . 0.0 111.323 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.4 mt 66.51 28.1 9.53 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.347 1.459 . . . . 0.0 112.829 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -111.76 174.34 5.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 168.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -118.03 146.61 43.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.178 -1.576 . . . . 0.0 109.992 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -141.37 136.28 31.3 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -169.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.7 p -124.01 164.11 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.243 1.017 . . . . 0.0 109.247 -172.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -56.68 -36.69 69.89 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.08 -0.388 . . . . 0.0 110.254 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.98 -32.53 54.27 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 173.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -76.48 -39.75 52.28 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.571 0.748 . . . . 0.0 110.931 172.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.3 mtt -64.27 -24.81 67.79 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.632 1.173 . . . . 0.0 111.323 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -55.85 -14.06 2.17 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.464 1.106 . . . . 0.0 113.401 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.23 -24.36 44.2 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.424 1.011 . . . . 0.0 113.423 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -151.36 169.01 23.04 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 118.908 1.354 . . . . 0.0 108.832 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 64.5 t -62.71 122.43 13.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 103.267 -2.864 . . . . 0.0 103.267 168.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.0 m -129.39 135.28 48.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.789 0.328 . . . . 0.0 110.521 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -95.42 141.42 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -127.76 120.21 53.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 C-N-CA 125.372 1.469 . . . . 0.0 107.42 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.4 m -116.94 100.32 7.68 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.269 1.028 . . . . 0.0 108.395 -176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.4 m -81.6 136.66 22.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.74 157.69 74.49 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.81 -60.44 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.833 2.355 . . . . 0.0 110.578 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 m -148.49 152.37 36.77 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.295 1.438 . . . . 0.0 107.958 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.3 tp -62.75 -18.39 20.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.688 1.195 . . . . 0.0 113.284 -173.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.8 19.17 18.86 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.893 0.877 . . . . 0.0 111.753 -169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 16.8 p -68.84 -6.37 26.6 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.22 4.73 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 125.505 1.526 . . . . 0.0 110.71 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -66.03 -11.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 122.001 -0.706 . . . . 0.0 111.985 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.14 -21.61 13.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.067 0.947 . . . . 0.0 111.384 169.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -47.77 -47.78 30.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.96 1.304 . . . . 0.0 111.674 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.91 -40.0 91.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.882 0.473 . . . . 0.0 110.762 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -82.72 -6.58 59.47 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 118.424 -0.798 . . . . 0.0 112.629 -175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.8 m -136.25 -62.8 0.66 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.676 1.125 . . . . 0.0 111.304 -169.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -83.27 -45.26 14.03 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.798 -1.189 . . . . 0.0 110.998 -170.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 tpp85 -62.97 -32.6 73.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.697 0.68 . . . . 0.0 109.974 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.1 -43.58 87.2 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.327 0.512 . . . . 0.0 111.687 172.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -61.15 -45.06 96.2 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 122.992 0.517 . . . . 0.0 111.342 178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.43 -51.03 71.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -65.46 -38.07 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.627 1.103 . . . . 0.0 110.529 -173.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.83 -35.05 78.66 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.674 0.79 . . . . 0.0 111.72 173.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.46 76.14 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.04 0.836 . . . . 0.0 110.65 173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -70.74 -37.36 73.46 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.817 0.735 . . . . 0.0 109.77 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.57 -45.07 92.91 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.627 0.771 . . . . 0.0 109.857 170.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.09 -47.65 1.19 Allowed Glycine 0 CA--C 1.524 0.614 0 C-N-CA 125.191 1.377 . . . . 0.0 110.859 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -140.36 109.52 6.14 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.301 1.041 . . . . 0.0 109.775 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.1 p -158.75 -175.87 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 127.981 2.512 . . . . 0.0 104.97 176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.406 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -137.62 138.18 39.23 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 169.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.84 142.58 28.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -135.01 154.74 51.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.697 0.799 . . . . 0.0 109.055 169.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.5 m -117.67 142.33 47.36 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.0 mt -131.31 136.92 56.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.92 158.69 42.82 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.199 0.999 . . . . 0.0 110.15 -170.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.65 3.16 56.11 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.669 0.788 . . . . 0.0 111.794 172.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -101.52 -174.9 2.71 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.118 0.967 . . . . 0.0 109.978 -170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.82 133.58 90.31 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 110.88 -169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -50.79 -37.42 54.73 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.393 2.729 . . . . 0.0 113.964 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -72.41 -28.64 63.1 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.503 -0.748 . . . . 0.0 111.782 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.59 74.26 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.13 0.877 . . . . 0.0 109.42 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.36 -49.18 70.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.262 0.625 . . . . 0.0 110.384 169.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.58 -33.74 75.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.281 0.491 . . . . 0.0 111.73 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -67.08 -40.5 87.01 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 118.692 -0.671 . . . . 0.0 109.356 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 13.0 t-105 -59.07 -49.29 78.46 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.99 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 51.4 m -58.86 -48.25 82.04 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 118.38 0.536 . . . . 0.0 111.343 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.73 -39.32 86.1 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 119.528 -0.596 . . . . 0.0 112.284 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.06 -41.71 70.36 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.013 0.906 . . . . 0.0 110.567 -177.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -85.98 -22.15 27.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 119.088 -0.482 . . . . 0.0 112.179 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 80.26 36.42 24.17 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 43.4 mm -66.51 143.35 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -146.92 -36.66 0.23 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.642 0.777 . . . . 0.0 112.999 -178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -74.45 -21.56 59.54 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.406 0.548 . . . . 0.0 111.201 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.9 t -117.77 165.2 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.937 1.295 . . . . 0.0 108.247 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -142.7 137.62 30.0 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 168.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.2 p -85.24 145.99 27.29 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.8 mt -135.12 169.33 17.6 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 126.625 1.97 . . . . 0.0 107.276 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -135.66 105.01 5.99 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.605 0.762 . . . . 0.0 109.481 -169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.64 -15.46 62.79 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.408 0.683 . . . . 0.0 110.927 169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -46.11 -20.01 0.09 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 128.008 2.523 . . . . 0.0 113.45 169.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.8 ttt-85 -40.8 -60.6 1.13 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 125.904 1.682 . . . . 0.0 111.497 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -166.29 15.28 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.126 0.97 . . . . 0.0 111.071 -170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.07 18.35 1.7 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.225 1.81 . . . . 0.0 113.325 -169.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.37 -49.68 76.89 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.928 1.291 . . . . 0.0 112.035 -169.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -77.72 -40.64 40.51 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 121.931 -0.481 . . . . 0.0 109.843 -176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -66.71 -36.79 91.77 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -61.86 -51.24 69.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 117.544 0.672 . . . . 0.0 109.594 170.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.9 92.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -87.75 4.38 44.48 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.06 0.944 . . . . 0.0 112.423 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.93 39.68 96.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.091 0.853 . . . . 0.0 113.449 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -120.76 -12.91 8.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.52 1.128 . . . . 0.0 111.522 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -75.37 108.75 8.37 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 169.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mt -80.1 108.35 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -53.61 -45.75 70.19 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.702 1.201 . . . . 0.0 110.893 -174.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.32 -2.39 24.95 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.029 0.932 . . . . 0.0 113.236 -173.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 68.3 mt -125.92 -18.39 5.11 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.382 1.073 . . . . 0.0 112.346 176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 52.94 39.04 28.58 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.644 1.178 . . . . 0.0 109.645 -168.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -138.16 150.58 46.93 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.24 1.016 . . . . 0.0 108.31 -175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.0 mt -71.36 145.24 49.52 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.449 0.643 . . . . 0.0 110.745 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.26 177.11 1.54 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.007 2.123 . . . . 0.0 111.014 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -115.31 106.39 13.97 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 169.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.9 m -152.76 169.28 23.15 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 158' ' ' PRO . 11.8 p -152.53 146.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 O-C-N 121.587 -0.696 . . . . 0.0 109.331 -177.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -138.85 158.81 43.53 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.265 1.026 . . . . 0.0 109.073 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.82 143.08 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 170.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 51.0 mt -129.31 126.37 38.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.915 1.686 . . . . 0.0 107.078 -169.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -69.52 165.07 21.77 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.388 0.675 . . . . 0.0 109.454 169.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -57.04 -23.56 47.36 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.975 0.91 . . . . 0.0 112.385 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -76.43 -3.67 38.33 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.966 -1.084 . . . . 0.0 112.126 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 69.39 24.61 76.02 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.077 0.846 . . . . 0.0 112.045 -173.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -96.32 142.25 28.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.32 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.7 m -114.8 -15.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 123.735 0.814 . . . . 0.0 111.556 177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -152.38 145.28 24.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 169.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.47 141.79 25.18 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 170.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -148.68 140.78 23.96 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 170.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -122.41 123.09 40.53 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.77 133.24 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.4 m -68.06 -7.7 31.54 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.066 0.947 . . . . 0.0 113.309 -176.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -143.03 122.35 13.05 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.474 1.11 . . . . 0.0 108.303 -175.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.27 -22.71 64.73 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.905 0.882 . . . . 0.0 113.26 -174.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.1 p -76.21 1.44 15.89 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.013 0.824 . . . . 0.0 111.91 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -130.48 156.79 44.19 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.917 2.087 . . . . 0.0 107.531 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -128.5 157.54 74.56 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.726 0.81 . . . . 0.0 111.951 -168.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.1 168.88 22.82 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.798 2.332 . . . . 0.0 110.447 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -108.95 118.0 35.66 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -48.99 -28.13 3.68 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.317 2.247 . . . . 0.0 113.381 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.28 -38.51 83.79 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.575 0.625 . . . . 0.0 111.17 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -63.51 -53.18 54.08 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.659 -0.686 . . . . 0.0 111.712 -173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 131' ' ' VAL . 62.1 Cg_endo -68.72 -25.92 33.4 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.621 1.548 . . . . 0.0 112.063 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -44.59 95.01 Favored 'Isoleucine or valine' 0 C--N 1.343 0.316 0 CA-C-N 120.255 1.389 . . . . 0.0 109.104 171.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.27 -33.04 74.9 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.197 0.908 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.31 -53.15 39.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.513 0.325 . . . . 0.0 110.986 174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.24 76.24 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.565 0.746 . . . . 0.0 112.08 -176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -27.27 67.04 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 118.753 0.706 . . . . 0.0 111.649 -176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -64.78 -30.14 71.14 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.875 -0.583 . . . . 0.0 112.183 175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.02 -31.39 8.77 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -169.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.83 -30.32 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.905 0.775 . . . . 0.0 112.249 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 21.2 pttp . . . . . 0 C--O 1.248 1.023 0 C-N-CA 123.495 0.718 . . . . 0.0 110.457 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.75 169.29 4.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.999 0.428 . . . . 0.0 109.866 169.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -145.32 142.37 29.36 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 124.155 0.982 . . . . 0.0 108.386 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.0 mt -140.63 171.26 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 128.281 2.632 . . . . 0.0 103.98 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 p -117.64 148.25 42.12 Favored 'General case' 0 C--N 1.332 -0.178 0 O-C-N 120.989 -1.069 . . . . 0.0 109.826 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -75.58 -18.34 59.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 118.57 -0.728 . . . . 0.0 111.875 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt 138.55 -38.25 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 132.089 4.156 . . . . 0.0 109.586 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.17 -5.6 26.58 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.053 0.835 . . . . 0.0 113.586 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.6 47.16 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.2 164.58 35.22 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.609 2.873 . . . . 0.0 112.439 -175.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -135.73 139.38 46.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 125.532 1.533 . . . . 0.0 108.266 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -74.52 148.55 40.82 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.545 0.738 . . . . 0.0 109.502 174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.74 146.85 42.52 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 127.743 2.417 . . . . 0.0 105.984 174.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.3 m -74.12 -14.16 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.52 179.86 21.44 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 119.319 0.963 . . . . 0.0 112.888 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -90.89 148.67 22.31 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.689 0.796 . . . . 0.0 110.043 -172.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -65.09 141.52 58.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 p -120.45 147.39 24.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -128.44 165.82 19.93 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.577 0.703 . . . . 0.0 112.12 -168.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.9 t -52.63 140.17 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 125.799 1.64 . . . . 0.0 110.089 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.1 -15.32 63.44 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 118.655 -1.08 . . . . 0.0 112.955 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -92.13 157.31 16.8 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.133 1.467 . . . . 0.0 109.873 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -66.1 134.92 53.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 169.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.15 155.47 84.17 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.288 173.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.24 -25.77 73.61 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.21 2.607 . . . . 0.0 115.841 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.9 t70 51.0 92.06 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.586 1.954 . . . . 0.0 114.866 -176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -129.23 -175.19 3.49 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.516 1.526 . . . . 0.0 109.225 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.1 m -121.41 151.63 39.97 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 109.957 -169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.68 163.65 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 127.764 2.426 . . . . 0.0 106.688 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.1 tp -87.35 147.4 25.5 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 169.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.4 p -72.02 166.85 21.39 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 169.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.3 p30 -65.41 -4.44 5.66 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.689 -1.257 . . . . 0.0 111.571 168.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.9 m -114.66 17.04 17.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.157 2.183 . . . . 0.0 111.322 -174.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 45.5 mt 66.19 41.13 3.59 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 112.98 169.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -125.63 154.77 41.81 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 169.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.83 141.0 40.85 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 120.76 -1.213 . . . . 0.0 108.798 173.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -142.06 144.42 33.58 Favored 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 125.074 1.349 . . . . 0.0 107.499 174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.9 p -139.1 166.21 25.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -173.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 tt -57.54 -35.85 70.85 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.471 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.62 -30.7 43.95 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 113.593 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -78.81 -40.34 33.18 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 123.647 0.779 . . . . 0.0 110.67 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 56.8 mtt -63.36 -24.49 67.87 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.791 1.237 . . . . 0.0 111.31 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -55.79 -14.59 2.43 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.49 1.116 . . . . 0.0 113.319 172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.08 -21.55 56.39 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 119.519 1.054 . . . . 0.0 114.013 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -152.68 162.48 41.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.256 1.528 . . . . 0.0 108.212 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.07 119.59 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 168.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.3 m -124.53 131.02 53.49 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.481 0.313 . . . . 0.0 111.129 -168.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.482 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.6 mt -89.49 143.83 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 171.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -126.68 132.91 69.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.5 m -128.72 88.26 2.7 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.94 0.896 . . . . 0.0 108.602 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.5 t -74.45 133.95 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.79 158.27 73.34 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 169.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.56 -60.04 0.55 Allowed 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.028 2.486 . . . . 0.0 113.333 -171.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.9 m -152.04 164.26 37.59 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.458 1.903 . . . . 0.0 106.969 -170.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 tp -79.6 -17.87 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 O-C-N 121.77 -0.582 . . . . 0.0 112.23 -169.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.79 -21.72 54.74 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.086 -1.008 . . . . 0.0 112.858 -172.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.3 t -70.6 112.22 6.69 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 122.025 0.917 . . . . 0.0 111.191 -169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.49 -31.32 80.37 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.566 -0.709 . . . . 0.0 112.843 -174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.4 m -65.23 -15.77 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 118.464 1.132 . . . . 0.0 112.419 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.2 m -105.93 -14.25 15.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.769 0.827 . . . . 0.0 112.336 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -59.59 -44.03 93.49 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.736 0.698 . . . . 0.0 109.545 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.41 -41.41 93.86 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.424 0.69 . . . . 0.0 111.367 173.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mm-40 -58.94 -56.15 25.97 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 118.59 0.632 . . . . 0.0 109.483 -178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.434 HG21 ' HE1' ' A' ' 93' ' ' TRP . 30.5 m -65.88 -35.59 81.06 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.169 0.895 . . . . 0.0 111.404 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -60.61 -49.65 76.68 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.523 1.056 . . . . 0.0 110.686 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -68.18 -34.44 76.29 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.911 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -55.17 -43.31 74.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.146 1.339 . . . . 0.0 110.915 172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -61.51 -47.75 84.17 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 118.171 0.441 . . . . 0.0 111.606 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -63.45 -49.23 74.47 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.915 0.886 . . . . 0.0 109.085 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.04 -38.68 91.67 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.006 0.821 . . . . 0.0 110.591 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.99 97.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.974 0.806 . . . . 0.0 111.26 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.82 88.74 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.138 0.426 . . . . 0.0 111.103 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.07 -39.69 82.89 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.795 177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.83 -40.69 96.16 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 119.203 0.911 . . . . 0.0 110.292 172.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.79 -24.44 12.69 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.624 1.107 . . . . 0.0 112.912 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -148.95 102.91 3.31 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.06 1.344 . . . . 0.0 108.341 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.6 p -158.47 171.64 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 127.262 2.225 . . . . 0.0 105.069 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -128.68 143.04 50.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 169.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.482 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -153.14 144.54 14.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -174.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -135.92 158.43 44.42 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.028 1.331 . . . . 0.0 109.392 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.0 m -119.27 148.51 43.06 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mt -134.31 134.49 54.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.84 158.97 42.04 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.766 0.827 . . . . 0.0 109.881 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.36 41.79 0.96 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -129.46 165.75 20.98 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 111.271 -168.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -62.99 127.38 90.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 C-N-CA 126.874 2.069 . . . . 0.0 108.621 -169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.05 -38.6 32.28 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.458 2.772 . . . . 0.0 113.94 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.45 -27.96 41.61 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.791 -0.568 . . . . 0.0 112.24 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.72 -42.37 67.4 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.374 0.988 . . . . 0.0 109.525 171.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -55.42 -42.92 74.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.176 0.99 . . . . 0.0 111.531 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.62 91.66 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.015 0.526 . . . . 0.0 111.414 175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.1 ttp-105 -66.42 -44.28 83.39 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 121.709 -0.62 . . . . 0.0 109.546 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.434 ' HE1' HG21 ' A' ' 64' ' ' THR . 0.0 OUTLIER -56.6 -43.13 79.83 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.708 0.803 . . . . 0.0 111.165 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 8.0 p -80.46 -35.84 34.32 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.823 0.738 . . . . 0.0 111.048 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.72 98.77 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.61 82.63 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.498 0.719 . . . . 0.0 111.085 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.57 -10.69 59.79 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 118.597 -0.716 . . . . 0.0 112.518 178.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.47 30.7 59.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 119.399 0.999 . . . . 0.0 111.008 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.0 mm -67.37 148.65 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.525 1.13 . . . . 0.0 108.117 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -137.69 -38.65 0.58 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 111.585 175.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.5 mmtm -87.69 -22.72 24.49 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.239 1.016 . . . . 0.0 112.621 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.91 162.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -141.16 143.75 34.42 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.0 p -93.86 149.41 21.26 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 30.6 mt -135.48 156.23 49.23 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.916 1.287 . . . . 0.0 109.15 -174.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 9.8 m -120.94 97.91 5.75 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.836 1.255 . . . . 0.0 109.181 -169.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.23 -7.25 56.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.04 0.536 . . . . 0.0 110.839 169.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -43.46 -28.0 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.08 2.552 . . . . 0.0 114.018 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -57.42 -46.07 83.92 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 123.938 0.895 . . . . 0.0 111.731 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -158.98 11.47 0.14 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.5 mmm 53.55 20.45 2.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.214 2.205 . . . . 0.0 114.967 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.4 m -58.36 -44.07 88.65 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.22 0.918 . . . . 0.0 112.364 -171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -70.64 -46.57 63.04 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -68.89 -38.13 84.61 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -59.55 -50.69 72.92 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.023 0.911 . . . . 0.0 109.509 174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.36 -37.26 82.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -171.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.89 -8.2 57.76 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.384 0.674 . . . . 0.0 112.449 174.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.8 45.56 57.49 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.459 1.027 . . . . 0.0 112.029 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.3 m -134.1 25.29 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 110.764 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -116.8 119.18 34.61 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.36 102.21 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.06 -35.81 36.68 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 125.936 1.694 . . . . 0.0 111.317 176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -72.01 -14.54 61.91 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.5 mt -130.83 -21.0 2.77 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -169.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 59.79 34.94 22.0 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.828 0.851 . . . . 0.0 110.028 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 88.9 mt -127.62 154.07 45.68 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.647 1.179 . . . . 0.0 108.361 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.2 mt -73.69 157.36 36.68 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.233 0.54 . . . . 0.0 110.163 172.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.04 -178.69 2.92 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.41 1.484 . . . . 0.0 110.551 169.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -106.06 13.39 29.22 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.793 0.837 . . . . 0.0 111.671 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.7 m -63.05 159.19 17.73 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.337 1.855 . . . . 0.0 112.886 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.79 149.12 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.631 0.773 . . . . 0.0 109.346 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -137.37 163.0 32.07 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.344 1.058 . . . . 0.0 109.774 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.82 140.94 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 169.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 63.9 mt -131.4 128.07 38.8 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -169.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.62 167.16 17.51 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.968 0.907 . . . . 0.0 109.86 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.89 -23.93 63.86 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.406 -0.809 . . . . 0.0 112.284 171.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -75.78 -11.44 59.99 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.731 -1.231 . . . . 0.0 111.827 172.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 76.93 22.44 71.69 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 124.146 0.879 . . . . 0.0 112.465 -170.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -82.5 145.58 29.71 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 169.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.5 t -67.39 126.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 53.3 t -101.96 -34.84 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.727 1.611 . . . . 0.0 109.394 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -151.6 143.96 24.11 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 138.45 22.52 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 169.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.89 143.82 33.51 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.86 100.63 6.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.328 1.851 . . . . 0.0 106.43 -168.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.55 119.42 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.5 m -71.06 -8.83 56.11 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -139.85 125.9 19.79 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 119.613 1.097 . . . . 0.0 108.311 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.57 -29.19 70.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.785 0.834 . . . . 0.0 112.406 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.3 p -82.42 6.22 17.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.221 1.008 . . . . 0.0 112.892 177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -120.16 162.32 19.55 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.251 1.42 . . . . 0.0 109.197 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -117.56 162.78 26.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.445 1.498 . . . . 0.0 110.106 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.17 -171.46 0.51 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.137 2.558 . . . . 0.0 109.918 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -128.68 112.4 14.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -56.58 -28.27 59.85 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.913 1.685 . . . . 0.0 112.897 -169.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.39 -31.87 73.2 Favored 'General case' 0 C--O 1.225 -0.218 0 O-C-N 121.889 -0.507 . . . . 0.0 111.754 -178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -61.8 -54.61 49.59 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.843 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -66.09 -26.95 49.94 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 CA-C-N 120.842 1.336 . . . . 0.0 111.822 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.94 -44.05 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 120.218 1.372 . . . . 0.0 109.948 171.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -62.78 -32.29 73.43 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.137 0.88 . . . . 0.0 110.45 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.72 -49.64 57.25 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.3 0.24 . . . . 0.0 111.586 172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.63 -45.14 72.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.076 0.55 . . . . 0.0 112.018 -174.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.07 -25.04 63.41 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.535 0.734 . . . . 0.0 111.982 -178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.49 64.75 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.496 0.718 . . . . 0.0 112.657 176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.6 mt -111.35 -28.68 8.12 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.2 m -65.96 -11.94 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.3 pttt . . . . . 0 C--O 1.249 1.039 0 C-N-CA 125.864 1.665 . . . . 0.0 108.272 -176.474 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.97 -29.43 70.59 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 45.59 51.78 9.75 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.025 1.73 . . . . 0.0 111.456 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.02 145.94 9.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 125.026 1.33 . . . . 0.0 108.269 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.1 p -115.33 153.41 31.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.309 1.444 . . . . 0.0 109.396 178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -110.91 42.6 1.58 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.822 1.249 . . . . 0.0 108.99 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm 42.0 64.65 1.04 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.738 2.015 . . . . 0.0 111.755 -174.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.17 0.17 Allowed Glycine 0 CA--C 1.527 0.826 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.658 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.14 172.11 44.17 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 124.465 1.031 . . . . 0.0 110.573 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.76 159.75 51.64 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.403 2.735 . . . . 0.0 110.995 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.77 129.61 55.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.415 1.086 . . . . 0.0 108.386 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 m -61.74 156.36 20.49 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.492 1.517 . . . . 0.0 111.131 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.0 mt -133.82 133.65 41.88 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.74 1.616 . . . . 0.0 109.284 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 t -73.29 161.52 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 168.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.75 -159.01 52.74 Favored Glycine 0 CA--C 1.524 0.633 0 O-C-N 121.109 -0.994 . . . . 0.0 111.346 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -132.05 147.65 52.46 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.175 1.39 . . . . 0.0 109.205 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -66.13 115.42 6.12 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.3 158.37 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.969 1.307 . . . . 0.0 107.617 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -134.49 159.51 40.91 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 111.048 -173.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.5 t -59.28 142.88 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.124 0.97 . . . . 0.0 108.999 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.37 -22.28 24.43 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.03 1.3 . . . . 0.0 112.367 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -74.5 154.41 38.69 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.64 1.22 . . . . 0.0 109.839 177.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -70.14 132.69 46.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.71 158.82 48.74 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 119.428 -0.32 . . . . 0.0 111.077 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.74 -3.84 3.99 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 124.154 3.236 . . . . 0.0 117.548 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.2 t0 53.64 57.76 5.8 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.978 1.371 . . . . 0.0 111.791 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -79.47 167.03 21.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.361 1.865 . . . . 0.0 110.26 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -135.03 148.29 49.89 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 171.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -146.33 170.74 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.981 2.112 . . . . 0.0 108.251 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tp -102.08 143.27 32.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.269 1.028 . . . . 0.0 108.808 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -74.05 -15.75 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -169.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 102.84 -14.92 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 130.264 3.426 . . . . 0.0 108.129 -168.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -119.07 22.08 12.04 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.145 1.778 . . . . 0.0 111.052 -169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.2 mp 61.66 40.31 13.42 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.882 1.673 . . . . 0.0 111.656 175.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.88 156.05 43.2 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 169.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.42 152.37 19.15 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.381 0.61 . . . . 0.0 109.735 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -146.91 148.7 32.05 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 126.427 1.891 . . . . 0.0 106.139 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 p -149.97 171.66 16.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.531 0.605 . . . . 0.0 109.821 -169.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -43.47 -45.81 6.55 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.205 1.002 . . . . 0.0 111.552 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.01 -29.01 66.93 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.963 0.905 . . . . 0.0 112.866 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.38 -39.99 21.94 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.771 0.828 . . . . 0.0 110.717 174.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.8 mtt -71.36 -34.87 70.86 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 123.154 0.582 . . . . 0.0 111.008 -170.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -63.85 -3.48 2.48 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -54.67 -21.84 23.31 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-O 118.836 -0.98 . . . . 0.0 113.146 169.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -145.44 168.26 20.97 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.26 1.53 . . . . 0.0 108.631 169.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.99 124.42 17.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.9 m -131.68 134.05 45.53 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.141 0.275 . . . . 0.0 111.11 -168.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 66.0 mt -93.21 141.1 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 172.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.1 mm -123.48 133.54 68.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 m -129.34 106.05 8.54 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG22 HD13 ' A' ' 127' ' ' LEU . 0.5 OUTLIER -90.4 127.93 42.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -176.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.9 pt -137.79 137.49 21.74 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -54.11 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.967 2.444 . . . . 0.0 114.185 -170.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.3 m -159.45 158.25 31.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.882 1.673 . . . . 0.0 106.92 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 8.5 tt -90.1 12.5 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 O-C-N 122.198 -0.314 . . . . 0.0 111.649 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -118.77 15.69 13.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.109 1.364 . . . . 0.0 110.338 175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.42 -11.5 60.87 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.303 1.441 . . . . 0.0 113.395 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.62 -51.8 4.59 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -173.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.6 m -61.57 -22.44 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 118.028 0.914 . . . . 0.0 111.878 173.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 10.0 p -49.64 -36.21 23.81 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.272 1.029 . . . . 0.0 112.278 170.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -62.93 -38.32 90.53 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.928 0.891 . . . . 0.0 110.99 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.52 17.38 3.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.395 1.478 . . . . 0.0 112.003 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -132.16 -79.03 0.5 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.206 1.003 . . . . 0.0 108.338 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -52.9 -53.63 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.903 1.281 . . . . 0.0 112.991 -168.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 48.6 ptt85 -79.31 -27.9 42.16 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.172 -0.955 . . . . 0.0 112.126 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -62.51 -43.73 98.1 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.767 1.167 . . . . 0.0 109.689 170.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -58.43 -37.51 75.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 118.349 -0.834 . . . . 0.0 111.473 173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -59.19 -49.57 77.33 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 119.566 1.076 . . . . 0.0 111.311 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -68.68 -47.43 66.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -64.0 -36.14 83.01 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.346 0.975 . . . . 0.0 111.034 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.13 86.15 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.868 0.758 . . . . 0.0 111.379 173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.06 -43.94 93.96 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.638 0.654 . . . . 0.0 110.273 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -34.4 78.19 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.609 0.641 . . . . 0.0 111.496 178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -62.29 -22.23 65.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.062 0.846 . . . . 0.0 112.074 173.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.39 -43.42 3.03 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.947 1.26 . . . . 0.0 112.075 174.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.64 117.62 5.9 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.03 1.332 . . . . 0.0 108.928 173.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 78' ' ' ASN . 12.3 p -158.89 -175.6 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 127.086 2.154 . . . . 0.0 105.484 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.462 ' H ' HG22 ' A' ' 77' ' ' VAL . 48.6 t30 -139.66 138.22 35.89 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.7 t -142.36 138.87 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -128.81 159.39 35.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.154 0.982 . . . . 0.0 109.239 169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 66.6 m -126.7 145.92 50.4 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 77.1 mt -133.95 138.04 51.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.6 m -140.94 152.57 45.1 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 123.51 0.506 . . . . 0.0 111.408 175.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.99 43.79 0.72 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.679 1.192 . . . . 0.0 108.663 169.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -131.05 158.7 39.65 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.589 1.556 . . . . 0.0 108.925 -169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.85 134.9 96.07 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.846 1.258 . . . . 0.0 111.08 -168.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.85 -42.18 6.48 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 124.994 3.796 . . . . 0.0 115.554 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -74.66 -28.56 60.9 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.11 -175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.29 70.97 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.379 0.991 . . . . 0.0 109.419 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -51.9 -47.31 64.63 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.57 1.148 . . . . 0.0 110.919 174.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.23 70.69 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.359 0.264 . . . . 0.0 111.364 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 79.7 ttt-85 -61.76 -45.58 93.27 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.286 0.634 . . . . 0.0 110.789 -174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 34.8 t90 -63.0 -37.88 88.94 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.896 0.316 . . . . 0.0 110.476 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 79.2 m -66.84 -41.51 87.3 Favored 'General case' 0 C--O 1.231 0.107 0 O-C-N 121.798 -0.564 . . . . 0.0 111.737 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -63.63 -35.52 92.15 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.31 -47.34 70.86 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.772 0.786 . . . . 0.0 110.243 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -78.92 -21.52 47.19 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.69 36.71 15.42 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 34.1 mm -67.31 144.21 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -145.75 -37.43 0.26 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.614 1.166 . . . . 0.0 112.698 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -84.88 -13.37 51.13 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.559 0.743 . . . . 0.0 112.258 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.03 155.99 18.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -133.85 124.82 27.15 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 169.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 14.4 p -79.47 157.2 27.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.676 0.791 . . . . 0.0 109.339 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 60.4 mt -144.18 164.57 30.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.785 1.634 . . . . 0.0 108.102 -174.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -118.21 140.98 48.98 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.544 -0.723 . . . . 0.0 109.389 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -119.54 5.59 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.18 1.792 . . . . 0.0 109.952 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -59.59 -26.72 65.67 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.942 1.297 . . . . 0.0 111.841 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -60.17 -46.05 91.01 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.961 0.904 . . . . 0.0 111.87 -174.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -156.01 14.73 0.34 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 95.0 mmm 48.12 26.51 1.04 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.849 2.06 . . . . 0.0 113.968 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -57.39 -50.14 73.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.643 1.177 . . . . 0.0 111.711 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -63.98 -48.66 75.56 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.145 0.884 . . . . 0.0 109.405 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -56.34 -47.67 80.88 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 -173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.29 -50.15 64.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.255 1.022 . . . . 0.0 109.832 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.93 -35.17 77.98 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 7.58 43.89 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.013 0.925 . . . . 0.0 112.154 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.94 36.57 86.65 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.918 -0.934 . . . . 0.0 113.735 175.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.7 -13.41 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 118.553 1.177 . . . . 0.0 111.636 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.23 104.94 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.78 98.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 174.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.36 -34.74 49.0 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 125.793 1.637 . . . . 0.0 111.108 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -70.62 -17.08 62.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . 0.282 1.7 pp -146.78 16.47 1.25 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.962 1.256 . . . . 0.0 114.327 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 48.39 51.13 15.67 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.197 1.799 . . . . 0.0 111.685 169.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.2 tp -152.28 150.44 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.509 HD13 HG22 ' A' ' 51' ' ' VAL . 4.1 pp -81.45 156.02 25.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.688 0.676 . . . . 0.0 110.569 175.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.48 -155.06 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.856 2.062 . . . . 0.0 112.538 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.42 118.3 22.89 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.693 -2.706 . . . . 0.0 103.693 169.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.3 m -162.06 163.16 28.86 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -170.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -139.13 147.79 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.013 0.925 . . . . 0.0 108.685 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -138.68 156.83 47.08 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.064 0.945 . . . . 0.0 108.649 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.0 t -135.2 143.73 36.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 57.8 mt -128.27 126.21 40.4 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.939 1.695 . . . . 0.0 108.227 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -69.59 163.62 25.08 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.607 1.163 . . . . 0.0 110.154 169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.25 -15.52 25.51 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.1 10.57 41.18 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.687 1.131 . . . . 0.0 112.225 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.43 76.99 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.978 . . . . 0.0 112.88 173.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -92.91 144.25 25.45 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 118.294 1.047 . . . . 0.0 108.442 173.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.39 133.44 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 33.1 m -114.65 -16.4 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.7 0.8 . . . . 0.0 111.728 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -151.68 144.38 24.32 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.77 139.15 23.67 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -151.66 137.16 17.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -122.31 122.18 38.47 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.3 t -72.67 123.71 27.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.3 m -61.81 -40.67 96.07 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.584 0.353 . . . . 0.0 110.558 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -83.6 109.55 17.51 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.943 0.897 . . . . 0.0 109.232 176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.39 -25.98 62.7 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.694 -0.629 . . . . 0.0 111.676 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 p -71.82 -1.08 12.84 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.084 1.354 . . . . 0.0 113.124 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.78 171.22 13.78 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.58 1.552 . . . . 0.0 110.067 -169.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -128.55 156.84 76.59 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 125.518 1.527 . . . . 0.0 109.302 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.64 154.18 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 121.964 1.776 . . . . 0.0 109.391 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -79.61 116.01 19.56 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -52.43 -24.91 8.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.011 1.725 . . . . 0.0 113.459 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -62.34 -35.48 79.23 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 118.807 0.73 . . . . 0.0 111.467 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? -64.58 -50.8 63.38 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 121.172 -0.955 . . . . 0.0 112.335 -172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.29 -25.95 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 121.075 1.42 . . . . 0.0 111.53 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -44.29 97.87 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 CA-C-N 119.67 1.123 . . . . 0.0 109.597 171.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -63.62 -33.28 75.26 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.325 0.966 . . . . 0.0 111.088 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.14 -53.85 38.87 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.338 0.255 . . . . 0.0 110.915 173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.81 -45.29 78.8 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.232 0.613 . . . . 0.0 112.419 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.29 -29.45 67.61 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 118.665 0.666 . . . . 0.0 111.709 -175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.85 -29.1 68.93 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.219 0.607 . . . . 0.0 112.256 177.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 95.6 mt -99.94 -28.66 12.98 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.38 -12.41 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 1.006 0 C-N-CA 124.059 0.944 . . . . 0.0 110.087 178.041 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 tpp . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.56 -39.74 95.18 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 118.71 -0.662 . . . . 0.0 112.504 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 39.45 55.08 2.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.119 1.768 . . . . 0.0 111.418 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.9 mt -56.84 153.45 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 126.804 2.042 . . . . 0.0 109.095 -176.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -94.45 155.3 17.01 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.504 1.122 . . . . 0.0 108.407 176.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -132.59 108.26 8.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.355 -2.091 . . . . 0.0 105.355 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt 27.14 56.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.668 2.387 . . . . 0.0 115.253 -177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.73 -2.2 27.5 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 117.801 -1.555 . . . . 0.0 115.652 169.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.51 147.18 18.28 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 120.578 2.189 . . . . 0.0 111.988 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -69.78 154.32 67.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.056 2.504 . . . . 0.0 110.651 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.0 145.4 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.553 0.692 . . . . 0.0 110.11 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 m -79.52 156.88 27.58 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.919 1.288 . . . . 0.0 111.286 -171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -124.62 142.13 51.59 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.099 1.76 . . . . 0.0 108.843 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.17 150.53 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 169.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.44 -160.96 22.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -174.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -132.12 146.99 52.41 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.851 0.86 . . . . 0.0 109.266 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -65.56 113.76 4.42 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -73.06 169.53 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.401 0.546 . . . . 0.0 109.708 175.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.93 160.85 37.33 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.148 0.979 . . . . 0.0 109.065 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.58 137.8 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 170.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.32 -16.14 60.54 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 118.538 -1.146 . . . . 0.0 112.614 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -66.36 160.32 24.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 119.318 1.559 . . . . 0.0 109.941 175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -99.92 121.84 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -55.05 136.95 67.07 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.423 -0.798 . . . . 0.0 110.595 176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 24' ' ' ALA . 49.9 Cg_exo -58.76 0.51 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.657 1 C-N-CA 126.112 4.541 . . . . 0.0 119.263 -176.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.5 t70 59.29 64.88 1.27 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 122.812 1.291 . . . . 0.0 111.447 -169.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -73.62 165.45 25.07 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.698 1.599 . . . . 0.0 109.929 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.6 m -133.16 149.34 52.07 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.3 m -142.69 162.38 18.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 126.759 2.023 . . . . 0.0 106.734 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 tp -88.63 135.86 33.29 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 172.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.3 p -65.12 162.91 16.0 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 169.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -64.88 -8.52 15.74 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 120.663 -1.273 . . . . 0.0 111.004 168.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.6 m -95.27 6.41 49.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.874 2.07 . . . . 0.0 111.696 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 25.7 mt 70.84 35.88 1.65 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.32 1.448 . . . . 0.0 112.319 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.09 152.34 44.49 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 173.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.52 139.88 40.94 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 120.763 -1.211 . . . . 0.0 108.968 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttmm -136.95 145.54 44.34 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.4 p -144.38 170.81 15.31 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.165 0.586 . . . . 0.0 109.701 -170.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.1 tp -46.77 -44.75 19.31 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.374 0.67 . . . . 0.0 110.796 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.53 -31.19 63.9 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.817 0.847 . . . . 0.0 113.022 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.31 -41.04 42.21 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.515 0.726 . . . . 0.0 110.542 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 55.7 mtt -69.05 -22.73 64.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.214 1.005 . . . . 0.0 111.877 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -55.08 -16.56 3.04 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.664 1.186 . . . . 0.0 113.291 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.06 -21.55 53.25 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.721 -1.044 . . . . 0.0 113.763 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -153.13 160.09 42.83 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.456 1.628 . . . . 0.0 109.15 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.63 120.09 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 168.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.1 m -123.56 131.03 53.52 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.027 0.441 . . . . 0.0 110.639 -168.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 81.0 mt -89.37 141.58 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 170.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.5 mm -123.64 137.81 55.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 172.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.7 m -131.31 94.53 3.58 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -73.86 143.43 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 176.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.8 pt -140.48 150.02 59.33 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 123.656 0.783 . . . . 0.0 111.373 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.92 123.35 9.25 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.679 2.253 . . . . 0.0 110.047 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m 48.08 -162.95 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.471 1.509 . . . . 0.0 113.224 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 90' ' ' GLN . 3.7 tt -148.04 -22.73 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 O-C-N 120.882 -1.136 . . . . 0.0 111.51 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.92 -24.8 67.87 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 120.972 -1.08 . . . . 0.0 112.807 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.6 p -73.0 -17.77 61.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.137 1.375 . . . . 0.0 113.682 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.04 -53.15 3.75 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.021 1.296 . . . . 0.0 112.805 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 t -64.55 -14.5 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 118.102 0.951 . . . . 0.0 110.457 173.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 14.3 p -49.56 -31.31 10.15 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 125.846 1.658 . . . . 0.0 113.449 169.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -157.66 130.57 7.52 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.578 1.081 . . . . 0.0 113.49 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.85 -6.43 8.5 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.498 1.919 . . . . 0.0 108.821 168.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -33.07 23.71 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.155 0.982 . . . . 0.0 110.803 -170.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.9 p -53.55 -48.31 69.22 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 120.071 1.305 . . . . 0.0 112.327 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -39.15 91.88 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.91 0.777 . . . . 0.0 110.959 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -66.76 -45.34 78.87 Favored 'General case' 0 C--O 1.227 -0.116 0 CA-C-O 118.755 -0.64 . . . . 0.0 109.956 177.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -57.56 -41.34 80.84 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 118.88 0.764 . . . . 0.0 111.31 173.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -60.35 -50.87 71.9 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.653 0.781 . . . . 0.0 110.471 -177.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.02 -41.63 77.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -67.86 -36.19 79.85 Favored 'General case' 0 C--O 1.225 -0.224 0 O-C-N 121.283 -0.885 . . . . 0.0 110.358 -176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.59 -43.86 96.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.956 0.798 . . . . 0.0 110.884 173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.07 93.33 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 117.925 0.33 . . . . 0.0 111.125 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.9 mtmt -65.91 -40.98 91.97 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.407 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -62.43 -40.2 95.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.51 1.05 . . . . 0.0 110.25 173.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.3 10.26 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.818 1.199 . . . . 0.0 112.002 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -152.68 112.0 3.86 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.557 1.143 . . . . 0.0 109.121 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.1 p -158.86 176.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 127.405 2.282 . . . . 0.0 105.275 171.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -134.5 141.07 46.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.7 t -143.07 141.46 26.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -134.08 153.24 51.93 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.817 0.847 . . . . 0.0 109.917 169.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -108.58 146.67 32.95 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.905 -2.258 . . . . 0.0 104.905 169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.23 135.0 57.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.7 m -131.36 152.51 50.54 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.307 1.043 . . . . 0.0 109.652 -170.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.37 52.24 1.02 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -140.08 165.06 28.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.98 145.96 96.99 Favored Pre-proline 0 C--N 1.325 -0.484 0 C-N-CA 123.268 0.627 . . . . 0.0 110.249 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.27 -32.07 89.88 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.623 2.215 . . . . 0.0 112.766 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -79.28 -22.13 45.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.199 0.909 . . . . 0.0 112.212 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.76 -48.61 53.44 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.173 -0.955 . . . . 0.0 108.718 169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.481 ' HA ' HD13 ' A' ' 55' ' ' ILE . 66.4 mt-30 -51.36 -56.42 13.24 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.31 1.044 . . . . 0.0 110.492 174.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.15 -42.32 80.78 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.787 0.835 . . . . 0.0 111.843 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -72.0 -44.81 62.87 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.459 ' CE3' HD11 ' A' ' 55' ' ' ILE . 44.7 t90 -63.97 -39.62 94.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 122.976 0.511 . . . . 0.0 111.134 -176.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -76.49 -36.29 57.89 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.212 -1.555 . . . . 0.0 110.982 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -61.71 -37.19 93.85 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.85 -45.37 82.43 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.646 0.778 . . . . 0.0 110.537 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -68.4 -24.09 64.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.521 0.728 . . . . 0.0 111.683 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.35 27.24 25.82 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 124.527 1.06 . . . . 0.0 111.837 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.18 142.87 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.152 0.981 . . . . 0.0 108.435 -175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -143.6 -44.31 0.28 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.145 1.378 . . . . 0.0 112.485 -175.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.67 -11.81 59.58 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.027 0.931 . . . . 0.0 111.941 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.49 160.94 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -140.6 145.8 37.16 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 p -89.68 139.49 30.5 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.905 1.682 . . . . 0.0 109.799 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.3 mt -131.14 168.91 16.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.615 1.966 . . . . 0.0 109.354 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.38 105.95 11.8 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.686 1.194 . . . . 0.0 111.683 -168.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -72.71 -21.94 60.96 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 168.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -52.57 -14.3 0.49 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.839 2.056 . . . . 0.0 113.121 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -45.91 -57.33 4.45 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 124.944 1.297 . . . . 0.0 110.821 169.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -164.59 16.49 0.05 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.836 0.854 . . . . 0.0 111.424 -171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.2 mmm 55.86 26.35 9.58 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.761 1.624 . . . . 0.0 111.039 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.81 -38.12 82.87 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.116 0.966 . . . . 0.0 113.018 -169.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -74.06 -42.47 60.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.106 1.321 . . . . 0.0 108.907 170.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -41.64 -60.13 2.56 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 126.396 1.95 . . . . 0.0 111.884 176.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.8 -39.66 69.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.242 1.017 . . . . 0.0 110.473 -177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -60.1 -43.63 95.42 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 123.23 0.612 . . . . 0.0 112.258 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -103.43 9.25 37.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.976 0.91 . . . . 0.0 113.208 -169.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.3 37.69 86.6 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.118 0.872 . . . . 0.0 111.972 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.452 HG23 ' HA2' ' A' ' 114' ' ' GLY . 8.1 m -126.54 3.92 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.56 1.144 . . . . 0.0 112.588 -173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -83.19 108.45 16.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.532 1.515 . . . . 0.0 107.183 169.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.91 111.56 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -55.4 -53.55 54.87 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 126.176 1.79 . . . . 0.0 111.406 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -76.79 -29.05 55.87 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.499 0.32 . . . . 0.0 111.255 -169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 90.0 mt -79.5 -22.18 44.34 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.974 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 56.44 36.28 27.29 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -168.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -135.22 154.73 51.49 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 123.934 0.894 . . . . 0.0 109.745 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.36 142.69 52.11 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.458 0.703 . . . . 0.0 109.382 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.39 -168.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.801 1.64 . . . . 0.0 111.387 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -127.3 127.8 44.92 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 169.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -170.18 170.98 7.07 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.763 1.625 . . . . 0.0 106.968 -177.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.4 m -136.6 145.12 30.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -137.46 156.79 47.76 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.328 1.051 . . . . 0.0 108.635 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 33.3 t -134.74 140.36 45.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 69.2 mt -129.07 126.39 39.31 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.434 1.494 . . . . 0.0 107.448 -169.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.94 167.73 9.23 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 109.147 169.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.12 -21.88 35.64 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.178 -0.951 . . . . 0.0 112.587 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -81.73 -7.5 59.6 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 120.594 -1.316 . . . . 0.0 112.543 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.03 16.77 80.46 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 120.872 -1.142 . . . . 0.0 112.133 -169.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -77.79 133.66 38.18 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 175.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.4 t -69.12 110.26 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.55 -36.2 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.058 1.343 . . . . 0.0 109.687 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -151.47 145.22 25.05 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.05 133.6 18.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 169.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -147.99 137.07 22.07 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -104.8 117.21 33.48 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.118 -2.179 . . . . 0.0 105.118 177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.9 127.96 29.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -69.76 -6.21 30.47 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -169.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -140.94 115.9 9.78 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 120.299 1.409 . . . . 0.0 107.475 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -64.1 -27.61 69.21 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.104 0.562 . . . . 0.0 112.431 -172.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 -24.21 66.79 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.394 0.678 . . . . 0.0 111.113 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -100.82 126.31 47.4 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.169 1.388 . . . . 0.0 108.047 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -72.64 149.51 90.74 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -172.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.09 162.12 43.03 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.547 3.498 . . . . 0.0 109.596 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -96.36 120.38 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -55.98 -28.07 55.52 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.337 1.455 . . . . 0.0 112.703 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -61.16 -34.17 74.6 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.441 0.564 . . . . 0.0 111.426 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -65.06 -54.46 33.7 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 118.875 0.762 . . . . 0.0 111.692 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.38 -30.44 24.05 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.486 1.458 . . . . 0.0 111.894 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.3 mm -54.43 -50.14 59.99 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-N 119.599 1.091 . . . . 0.0 109.523 169.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -65.32 -30.5 71.36 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.672 0.669 . . . . 0.0 111.494 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.32 -47.09 71.58 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.164 0.438 . . . . 0.0 111.72 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.8 -45.55 57.91 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.452 0.701 . . . . 0.0 111.824 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.09 -28.79 64.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.45 0.7 . . . . 0.0 111.56 -178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.96 -29.33 70.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.855 0.862 . . . . 0.0 112.534 177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 59.5 mt -103.63 -29.12 11.3 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -169.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.0 m -70.55 -10.64 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.25 1.079 0 C-N-CA 124.094 0.957 . . . . 0.0 110.144 177.34 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.65 -28.24 68.96 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 118.943 -0.551 . . . . 0.0 112.331 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 45.78 65.34 1.17 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.355 1.862 . . . . 0.0 111.346 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 99.2 mt -54.85 156.73 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.733 1.613 . . . . 0.0 108.817 174.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.17 128.32 56.31 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.907 1.283 . . . . 0.0 108.177 174.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -84.68 42.58 0.92 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.256 1.422 . . . . 0.0 110.268 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt 38.23 60.29 1.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.885 2.074 . . . . 0.0 112.337 -173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.75 -24.63 0.14 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 123.761 0.696 . . . . 0.0 111.646 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.35 169.05 40.58 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.94 155.3 62.31 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.902 2.401 . . . . 0.0 111.144 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.9 m -136.54 166.37 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.847 1.659 . . . . 0.0 107.949 170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.9 m -117.18 161.05 20.08 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.033 0.933 . . . . 0.0 108.971 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 mt -125.54 141.98 51.75 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.852 1.661 . . . . 0.0 106.986 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -70.43 -65.59 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.25 165.72 54.77 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -71.49 165.29 24.15 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.708 0.766 . . . . 0.0 110.658 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -69.19 117.52 10.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 168.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.5 t -76.54 154.53 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -130.49 163.85 26.11 Favored 'General case' 0 CA--C 1.52 -0.196 0 O-C-N 121.453 -0.779 . . . . 0.0 110.007 -173.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.9 t -60.51 144.89 12.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.28 17.81 78.96 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.864 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -118.5 154.84 31.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.911 1.355 . . . . 0.0 108.814 170.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -65.87 134.86 53.93 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.51 159.24 61.74 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.732 173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -54.23 -29.81 58.72 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.71 2.94 . . . . 0.0 115.845 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.3 t0 46.72 86.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.258 1.823 . . . . 0.0 114.117 -171.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -127.36 -172.79 2.74 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.284 1.433 . . . . 0.0 108.843 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.0 m -120.58 151.65 39.15 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.679 1.192 . . . . 0.0 110.461 -169.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.61 165.06 27.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.723 2.409 . . . . 0.0 106.85 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.07 135.78 33.53 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.7 p -67.09 162.94 21.15 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 169.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -67.14 -10.41 49.94 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.488 -1.383 . . . . 0.0 110.816 168.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.6 m -82.1 3.38 27.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.578 1.951 . . . . 0.0 111.43 174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.3 mt 68.44 30.93 5.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.897 2.079 . . . . 0.0 112.211 175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -132.58 140.39 48.23 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -57.01 140.41 49.11 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.325 1.05 . . . . 0.0 111.456 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -141.68 143.48 33.61 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 126.094 1.757 . . . . 0.0 106.823 173.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.9 m -130.99 160.05 35.7 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 tt -56.88 -33.92 67.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.257 0.481 . . . . 0.0 110.927 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.45 -29.62 50.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.092 0.957 . . . . 0.0 113.393 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -78.39 -40.34 36.45 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.125 0.97 . . . . 0.0 110.444 173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.1 mtt -63.03 -27.29 69.31 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.953 1.301 . . . . 0.0 111.49 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -55.28 -15.46 2.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.346 1.058 . . . . 0.0 113.071 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -22.77 46.01 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.654 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -149.78 155.99 41.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.688 1.744 . . . . 0.0 110.299 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -56.2 118.18 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.6 m -119.8 148.76 43.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.018 0.527 . . . . 0.0 110.029 -168.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 53.1 mt -118.22 146.42 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 169.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.12 138.57 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -113.17 99.63 7.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.518 1.527 . . . . 0.0 108.088 173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 63.2 t -82.85 125.65 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.1 pt -133.55 155.3 80.73 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.281 1.032 . . . . 0.0 109.004 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.57 -58.1 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.95 2.433 . . . . 0.0 111.858 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 29.3 m -153.04 157.8 41.02 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.454 1.901 . . . . 0.0 106.732 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 tt -82.07 -5.7 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.303 0.956 . . . . 0.0 111.52 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -78.9 -3.24 43.76 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.417 1.087 . . . . 0.0 112.623 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.3 p -64.29 -16.9 63.03 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -169.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.27 -49.91 3.88 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.398 0.999 . . . . 0.0 111.089 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.72 -8.91 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.328 1.064 . . . . 0.0 112.239 170.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 6.3 p -55.21 -36.95 66.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.269 1.027 . . . . 0.0 108.953 168.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.56 -45.66 91.93 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.506 1.123 . . . . 0.0 111.177 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.61 -0.27 3.77 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.776 1.23 . . . . 0.0 112.489 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -122.84 -87.74 0.63 Allowed 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.6 m -48.89 -49.48 39.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.359 1.864 . . . . 0.0 113.532 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -72.44 -40.83 66.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.66 -1.275 . . . . 0.0 110.723 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.83 -38.48 91.12 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 122.061 -0.399 . . . . 0.0 110.342 177.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -60.22 -34.75 74.08 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.576 170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -60.77 -50.29 74.07 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 120.094 1.315 . . . . 0.0 111.114 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.91 -42.59 76.63 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 119.025 -0.512 . . . . 0.0 110.302 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -63.35 -36.56 84.11 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.904 1.229 . . . . 0.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.56 -21.81 65.43 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.652 -0.655 . . . . 0.0 112.223 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.05 44.48 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.939 0.79 . . . . 0.0 111.194 169.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.4 mttt -72.19 -41.95 66.39 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.266 0.626 . . . . 0.0 110.143 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mp -63.19 137.22 58.15 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 169.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -36.27 80.19 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.251 -0.749 . . . . 0.0 113.765 -169.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -157.75 79.08 0.86 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.49 1.145 . . . . 0.0 110.162 -173.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -132.52 171.34 18.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 124.077 0.951 . . . . 0.0 108.807 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -136.68 145.55 44.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.188 1.795 . . . . 0.0 106.802 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.26 151.67 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 O-C-N 121.306 -0.871 . . . . 0.0 109.749 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -135.42 170.72 15.51 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.513 1.525 . . . . 0.0 109.736 173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.8 m -134.85 148.71 50.2 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 169.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -131.63 137.89 54.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -136.77 153.77 50.74 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.792 0.837 . . . . 0.0 111.427 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.8 46.15 1.34 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.413 1.485 . . . . 0.0 107.842 169.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -140.07 170.33 16.04 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.352 1.461 . . . . 0.0 107.863 -168.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.07 144.32 62.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 123.677 0.791 . . . . 0.0 111.181 -168.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.04 -31.13 76.5 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.402 2.068 . . . . 0.0 112.896 -175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -71.55 -28.94 64.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.727 1.149 . . . . 0.0 111.387 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.35 -47.09 74.54 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 119.043 0.838 . . . . 0.0 108.877 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -53.35 -46.51 69.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.513 0.725 . . . . 0.0 110.93 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.54 -52.62 51.09 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.23 0.612 . . . . 0.0 111.211 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -68.12 -34.19 75.9 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 121.933 -0.479 . . . . 0.0 111.068 -170.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -63.4 -42.5 98.79 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.124 0.42 . . . . 0.0 110.126 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.1 m -65.12 -42.9 93.47 Favored 'General case' 0 C--O 1.232 0.136 0 O-C-N 121.77 -0.581 . . . . 0.0 111.37 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.28 -40.31 98.85 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.87 -0.492 . . . . 0.0 111.87 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.33 86.02 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.571 0.748 . . . . 0.0 110.599 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.06 -24.86 51.92 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.127 0.571 . . . . 0.0 112.376 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.24 32.46 22.89 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.845 0.735 . . . . 0.0 111.432 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.2 mm -69.08 144.64 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.8 -34.8 0.23 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.393 1.077 . . . . 0.0 112.677 176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -79.21 -16.35 56.66 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.685 0.794 . . . . 0.0 111.952 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -111.19 159.1 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -135.05 134.74 40.69 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 169.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -92.84 145.59 24.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 123.632 0.773 . . . . 0.0 109.433 -176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 18.8 mt -136.66 166.04 24.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.936 1.695 . . . . 0.0 107.815 -170.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.8 m -136.91 133.03 35.29 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.037 0.935 . . . . 0.0 109.352 -169.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -123.23 -3.95 8.44 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.499 0.72 . . . . 0.0 112.14 -175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -57.22 -25.01 58.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 120.682 -1.261 . . . . 0.0 112.262 177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -69.39 -25.11 63.99 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.272 1.029 . . . . 0.0 112.9 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -150.71 -19.74 0.22 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -171.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mmt 54.15 -0.52 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.144 2.978 . . . . 0.0 117.582 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.4 p -59.0 -36.78 75.49 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 120.501 1.501 . . . . 0.0 112.614 -173.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.61 -56.06 16.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.022 0.529 . . . . 0.0 109.579 -178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.88 65.65 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 112.046 -0.422 . . . . 0.0 112.046 -176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -59.44 -53.65 55.67 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.467 0.707 . . . . 0.0 109.145 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.37 -31.0 57.77 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 119.154 -0.451 . . . . 0.0 112.17 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.38 -4.0 27.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 118.567 0.621 . . . . 0.0 112.256 173.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.6 48.04 52.79 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 119.084 0.856 . . . . 0.0 111.283 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.89 -14.46 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.828 0.851 . . . . 0.0 111.383 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -72.93 111.86 8.43 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 82.9 mt -78.54 112.13 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 -175.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -54.26 -38.02 65.34 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.554 1.542 . . . . 0.0 111.425 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.62 -6.28 58.09 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.583 0.753 . . . . 0.0 112.638 -173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.7 mt -131.94 -21.24 2.43 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.038 0.935 . . . . 0.0 112.779 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 52.7 42.41 31.68 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.395 1.078 . . . . 0.0 109.313 -168.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -135.19 153.22 52.03 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.218 1.407 . . . . 0.0 107.714 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.2 mt -84.06 141.94 30.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.327 0.512 . . . . 0.0 110.712 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.59 141.03 57.97 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.702 1.201 . . . . 0.0 109.806 169.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -68.36 109.09 3.49 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 169.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.0 p -154.77 165.06 37.77 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.878 0.763 . . . . 0.0 110.977 -169.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.27 153.52 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 O-C-N 121.446 -0.784 . . . . 0.0 109.863 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.79 156.45 46.16 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.359 1.063 . . . . 0.0 109.222 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 44.4 t -131.32 143.25 41.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 38.4 mt -135.2 126.4 28.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.736 1.615 . . . . 0.0 107.697 -169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -71.78 165.63 23.68 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.641 0.776 . . . . 0.0 109.085 170.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.14 -17.16 57.02 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.261 -0.899 . . . . 0.0 112.764 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -78.04 -11.45 59.91 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.537 -1.352 . . . . 0.0 112.236 170.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.99 19.03 75.87 Favored Glycine 0 CA--C 1.528 0.855 0 O-C-N 121.009 -1.057 . . . . 0.0 112.645 -169.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.93 139.28 37.14 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 170.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.89 134.26 30.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 43.9 t -110.48 -29.03 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.632 1.573 . . . . 0.0 109.254 -174.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -155.08 146.28 22.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.61 1.564 . . . . 0.0 106.842 175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.61 143.31 31.43 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.403 1.081 . . . . 0.0 108.463 172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -149.93 146.5 27.09 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.848 1.659 . . . . 0.0 107.099 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -128.71 -15.34 4.43 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.561 1.545 . . . . 0.0 112.392 -169.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.5 t 50.25 106.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 129.078 2.951 . . . . 0.0 113.093 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.7 m -59.14 -28.66 66.77 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.136 0.974 . . . . 0.0 112.797 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -93.67 105.94 17.94 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.1 62.4 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.9 p -73.68 -13.29 60.96 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.433 1.893 . . . . 0.0 112.904 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -109.87 156.45 20.37 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.557 1.543 . . . . 0.0 109.397 -169.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -106.8 153.46 40.76 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.373 0.669 . . . . 0.0 110.109 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.84 151.47 78.4 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.354 2.036 . . . . 0.0 109.488 171.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -82.04 119.39 23.94 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 171.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -54.05 -25.61 22.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.783 1.633 . . . . 0.0 112.878 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -60.59 -35.64 76.59 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.681 0.673 . . . . 0.0 111.138 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -63.82 -53.32 50.76 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.529 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.9 -27.8 43.09 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.951 1.375 . . . . 0.0 112.214 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -59.22 -46.38 92.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 120.695 1.588 . . . . 0.0 109.82 172.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.43 -33.77 76.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.907 0.776 . . . . 0.0 110.679 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.79 -48.66 68.32 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 120.675 0.274 . . . . 0.0 111.149 174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.38 -48.7 66.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.982 0.513 . . . . 0.0 110.795 -175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -29.05 69.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.746 0.703 . . . . 0.0 111.643 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -60.88 -31.7 71.17 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.579 0.627 . . . . 0.0 111.568 174.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 53.8 mt -88.29 -24.6 23.14 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.89 0.876 . . . . 0.0 112.054 176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.4 -27.93 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.966 171.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.248 1.005 0 C-N-CA 124.034 0.934 . . . . 0.0 110.746 176.548 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 mmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 118.923 -0.561 . . . . 0.0 110.348 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.94 156.65 44.5 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 108.044 175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.9 144.6 22.51 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.5 mt -140.32 148.64 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 -171.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.8 p -92.87 153.11 19.01 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.601 1.091 . . . . 0.0 110.307 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -112.46 41.31 2.04 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.091 1.356 . . . . 0.0 108.622 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt 44.11 62.99 1.77 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.769 2.028 . . . . 0.0 112.3 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.04 -25.63 0.16 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.55 1.071 . . . . 0.0 110.922 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.49 173.89 45.71 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.979 1.276 . . . . 0.0 110.108 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.56 157.61 58.34 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.157 2.572 . . . . 0.0 111.004 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.47 136.99 48.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 125.644 1.578 . . . . 0.0 107.471 170.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 m -74.32 154.78 38.75 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.763 1.225 . . . . 0.0 109.878 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -122.72 138.68 54.55 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 126.055 1.742 . . . . 0.0 106.549 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 120' ' ' TYR . 22.3 m -78.71 -173.86 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 169.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.9 -152.83 51.73 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 123.266 0.46 . . . . 0.0 112.967 169.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -132.23 155.42 48.3 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.479 1.111 . . . . 0.0 109.697 175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.12 154.41 37.8 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 168.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.6 t -126.13 152.42 33.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mmtm -126.37 157.31 38.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.62 1.168 . . . . 0.0 110.264 -172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.3 t -59.24 142.71 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 124.609 1.163 . . . . 0.0 109.377 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.17 -19.44 46.53 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.811 1.196 . . . . 0.0 111.878 176.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -74.94 149.26 39.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 118.396 1.098 . . . . 0.0 109.599 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -73.08 120.29 18.51 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 169.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 155.26 73.71 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 122.306 0.242 . . . . 0.0 110.768 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -54.17 -19.02 15.18 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 125.295 3.997 . . . . 0.0 118.501 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 55.03 65.24 1.55 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 122.924 1.345 . . . . 0.0 110.692 -168.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -71.58 168.33 17.85 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.682 1.593 . . . . 0.0 110.071 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.4 m -131.06 149.21 52.71 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -142.48 167.43 14.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 125.825 1.65 . . . . 0.0 106.696 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 tp -86.05 147.28 26.26 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 169.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.1 p -72.57 172.0 11.39 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.684 -1.26 . . . . 0.0 107.701 169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -67.26 -3.31 7.57 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.835 -1.166 . . . . 0.0 111.498 168.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.1 m -118.58 17.63 13.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.968 2.107 . . . . 0.0 111.276 -173.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.7 mp 63.86 43.73 5.24 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.402 1.481 . . . . 0.0 112.449 169.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -127.87 154.22 45.73 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.37 142.97 39.04 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.749 -1.219 . . . . 0.0 109.21 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -142.77 147.47 35.58 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 125.601 1.56 . . . . 0.0 107.05 173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.1 p -143.06 165.9 26.13 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 123.997 0.919 . . . . 0.0 109.175 -174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 tp -56.8 -34.49 67.72 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.354 177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.58 -31.24 56.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.021 0.828 . . . . 0.0 112.975 174.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -79.87 -35.98 37.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.958 0.903 . . . . 0.0 111.426 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.8 mtt -78.9 -34.97 44.28 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.936 0.895 . . . . 0.0 112.111 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -64.77 -3.48 3.34 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -169.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.75 -18.14 23.65 Favored Glycine 0 CA--C 1.537 1.444 0 CA-C-O 118.916 -0.936 . . . . 0.0 112.03 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -139.57 164.61 29.44 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.109 1.455 . . . . 0.0 109.138 169.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.51 128.29 20.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.1 m -130.45 136.77 49.35 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 58.3 mt -100.29 142.21 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.8 mm -120.33 129.01 76.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 173.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.9 m -124.97 98.59 5.75 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.418 1.087 . . . . 0.0 108.455 -169.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.1 t -85.14 135.36 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.58 155.5 75.24 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.476 1.51 . . . . 0.0 107.929 172.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -66.99 -51.97 0.73 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.673 1.582 . . . . 0.0 110.76 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.25 158.88 42.32 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.258 1.423 . . . . 0.0 107.869 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 90' ' ' GLN . 9.7 tt -106.79 29.38 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.114 0.966 . . . . 0.0 112.317 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -134.79 16.44 3.58 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.814 0.845 . . . . 0.0 110.422 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 38.8 p -81.91 -9.43 59.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.225 1.01 . . . . 0.0 112.544 -173.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.14 -50.08 3.64 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -171.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.63 -25.64 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 118.165 0.982 . . . . 0.0 110.853 176.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 8.5 p -49.48 -33.83 15.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.298 1.039 . . . . 0.0 112.449 169.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -59.87 -43.61 94.61 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.116 0.967 . . . . 0.0 111.497 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.25 6.29 0.79 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.736 1.214 . . . . 0.0 113.023 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.84 -77.82 0.58 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 m -54.2 -46.61 72.49 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 40.0 tpt85 -65.55 -41.97 92.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.213 0.915 . . . . 0.0 110.13 -177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -81.1 -25.71 36.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.999 -171.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -63.36 -38.1 89.83 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.263 0.938 . . . . 0.0 109.726 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -61.35 -43.16 99.34 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.943 0.792 . . . . 0.0 111.147 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -63.83 -56.35 16.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.77 -30.69 70.96 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.297 -0.877 . . . . 0.0 111.87 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.24 89.08 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 119.15 0.886 . . . . 0.0 111.088 173.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.76 80.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.555 0.616 . . . . 0.0 110.664 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.16 -41.25 90.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.091 175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.97 -39.63 90.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.571 0.748 . . . . 0.0 110.2 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.95 -27.73 8.7 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.628 1.108 . . . . 0.0 112.048 174.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -151.62 118.4 5.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.886 1.274 . . . . 0.0 108.49 172.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 78' ' ' ASN . 10.5 p -163.1 -176.23 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.622 1.969 . . . . 0.0 105.749 172.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.411 ' H ' HG22 ' A' ' 77' ' ' VAL . 56.9 t30 -138.81 136.03 35.22 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 169.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.3 t -144.59 145.63 21.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 152.19 51.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.586 0.754 . . . . 0.0 109.977 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.492 ' HB ' HG22 ' A' ' 104' ' ' THR . 19.4 m -104.53 146.0 29.51 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 169.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.3 mt -129.28 132.95 66.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.2 m -134.57 149.63 50.64 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.577 1.151 . . . . 0.0 109.768 -174.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.66 55.31 2.94 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -142.03 160.39 40.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.056 1.342 . . . . 0.0 108.098 -169.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.29 146.51 92.2 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-O 119.028 -0.511 . . . . 0.0 110.262 -169.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.8 -44.04 43.34 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.269 2.646 . . . . 0.0 112.858 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -77.23 -28.26 53.65 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.754 -0.591 . . . . 0.0 111.855 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.27 83.31 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.128 0.876 . . . . 0.0 109.996 174.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.523 ' HA ' HG21 ' A' ' 55' ' ' ILE . 41.8 mt-30 -69.83 -46.43 65.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.252 0.621 . . . . 0.0 111.507 173.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.86 -35.94 77.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.439 0.563 . . . . 0.0 111.121 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -50.22 74.53 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.703 1.201 . . . . 0.0 108.769 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.44 ' CD1' HD11 ' A' ' 55' ' ' ILE . 0.9 OUTLIER -56.62 -45.51 81.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.505 0.322 . . . . 0.0 110.159 177.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 61.0 m -64.28 -44.72 90.82 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 119.084 -0.484 . . . . 0.0 111.219 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -67.28 -37.02 90.54 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.607 -0.552 . . . . 0.0 111.893 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.14 -44.15 80.56 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.842 0.821 . . . . 0.0 110.635 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -79.35 -33.08 43.31 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.162 0.585 . . . . 0.0 111.985 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 86.18 37.81 8.86 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.4 mm -66.02 144.59 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -146.77 -37.58 0.22 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.694 1.197 . . . . 0.0 112.486 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.71 -16.2 42.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.558 0.743 . . . . 0.0 112.318 -178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.1 t -112.61 159.38 12.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -134.05 140.14 46.46 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 169.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.492 HG22 ' HB ' ' A' ' 81' ' ' THR . 4.9 p -96.63 145.55 25.65 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.0 mt -134.9 158.28 44.67 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.222 1.409 . . . . 0.0 109.072 -173.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.29 113.65 22.46 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.914 1.686 . . . . 0.0 108.346 -169.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -80.32 10.8 4.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.839 0.828 . . . . 0.0 111.651 170.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -56.21 -16.25 5.06 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.327 1.451 . . . . 0.0 111.214 169.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 51.4 ttt-85 -68.43 69.55 0.15 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.945 1.698 . . . . 0.0 109.508 169.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.1 t70 46.17 41.15 8.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.284 1.834 . . . . 0.0 113.85 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 11.9 mmm 50.04 32.02 5.4 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.231 1.812 . . . . 0.0 113.601 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.7 m -53.71 -49.72 67.47 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.975 0.91 . . . . 0.0 111.751 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -72.03 -43.72 64.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 118.893 0.77 . . . . 0.0 110.211 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.2 -37.46 92.98 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-O 119.392 -0.671 . . . . 0.0 112.101 -174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.37 -47.46 27.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.013 0.907 . . . . 0.0 109.9 172.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.89 -42.18 75.58 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.66 4.65 38.46 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.264 1.026 . . . . 0.0 112.265 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.05 49.5 77.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.482 1.039 . . . . 0.0 113.616 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.16 -12.04 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 125.58 1.552 . . . . 0.0 111.251 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.461 ' CD2' HG21 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -67.73 113.63 5.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 169.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.4 mt -75.36 109.28 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -50.68 -41.53 55.81 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 126.658 1.983 . . . . 0.0 111.28 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -88.8 2.45 53.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.862 0.865 . . . . 0.0 112.489 -171.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.54 -25.13 3.21 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.088 0.858 . . . . 0.0 113.311 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 82.1 mtt85 56.06 33.89 22.74 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.592 0.633 . . . . 0.0 109.884 -168.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.38 164.6 20.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.651 1.58 . . . . 0.0 107.107 171.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.3 mt -98.73 147.58 24.73 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.156 0.503 . . . . 0.0 110.127 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.88 145.26 46.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 125.411 1.484 . . . . 0.0 110.637 170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -79.19 102.57 8.58 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 169.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 71.1 m -149.77 168.47 23.59 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.751 1.22 . . . . 0.0 108.46 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.39 149.81 17.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 O-C-N 121.982 -0.449 . . . . 0.0 109.798 -178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -140.6 157.17 45.86 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.283 1.033 . . . . 0.0 108.692 175.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.7 t -137.93 138.64 43.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -122.52 133.9 54.57 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.504 1.522 . . . . 0.0 107.408 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.1 176.69 3.64 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.872 0.869 . . . . 0.0 110.591 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -68.24 9.57 0.31 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.783 1.233 . . . . 0.0 114.243 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -127.6 4.77 6.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.875 1.67 . . . . 0.0 110.219 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.71 21.86 77.98 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 118.973 0.806 . . . . 0.0 112.553 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -87.4 136.84 32.78 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 119.452 1.626 . . . . 0.0 107.274 170.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.74 126.94 28.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.57 -19.84 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.464 0.705 . . . . 0.0 110.46 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -154.33 144.89 22.3 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.84 140.07 24.32 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.828 1.651 . . . . 0.0 107.168 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -152.23 147.33 26.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.306 0.503 . . . . 0.0 109.658 171.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.58 104.83 7.89 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.848 2.059 . . . . 0.0 105.633 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.22 133.61 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -73.39 -13.66 61.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -169.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -138.11 113.85 9.78 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 -176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.16 -27.03 68.11 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 20.1 p -74.28 -0.66 17.74 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.31 0.959 . . . . 0.0 113.155 -175.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.09 167.21 17.87 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.454 1.101 . . . . 0.0 108.957 176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -117.88 157.14 49.05 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 123.472 0.709 . . . . 0.0 112.263 -168.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.67 152.27 78.13 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.618 2.212 . . . . 0.0 108.783 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -78.79 117.39 19.87 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -56.36 -20.97 21.67 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.499 1.519 . . . . 0.0 113.279 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -62.08 -36.62 82.25 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.054 0.843 . . . . 0.0 111.424 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -61.33 -52.62 69.41 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-N 119.327 0.967 . . . . 0.0 111.945 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.78 -27.86 37.27 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 120.797 1.32 . . . . 0.0 111.766 175.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.38 -45.04 93.78 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 CA-C-N 120.11 1.323 . . . . 0.0 109.731 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.19 -35.71 81.68 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.872 0.76 . . . . 0.0 110.652 -178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -66.69 -45.38 79.03 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.401 0.143 . . . . 0.0 111.053 175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.72 -50.12 46.67 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 122.736 0.415 . . . . 0.0 111.2 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -34.11 70.07 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.679 0.672 . . . . 0.0 111.157 -177.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -31.33 67.19 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.361 0.528 . . . . 0.0 112.018 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.3 mt -96.34 -23.74 16.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 50.2 t -57.13 -36.17 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-N 118.583 0.629 . . . . 0.0 110.495 171.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.248 1.008 0 C-N-CA 124.717 1.207 . . . . 0.0 110.88 175.654 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.79 160.35 30.04 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.541 1.137 . . . . 0.0 109.674 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -147.04 164.9 31.53 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.912 2.885 . . . . 0.0 104.575 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.8 mt -132.73 168.99 22.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 26.6 p -115.93 148.17 40.33 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 120.88 -1.138 . . . . 0.0 109.011 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -91.69 37.2 0.96 Allowed 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm 63.25 -41.15 0.2 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 128.876 2.871 . . . . 0.0 114.204 -169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.79 -31.12 41.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.319 0.961 . . . . 0.0 112.477 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 173.73 46.46 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.234 1.017 . . . . 0.0 111.245 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.6 152.13 50.26 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 124.0 3.133 . . . . 0.0 113.718 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.1 m -140.51 127.58 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.507 1.923 . . . . 0.0 107.133 169.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -70.08 153.71 42.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.516 1.526 . . . . 0.0 110.634 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.1 mt -110.07 140.42 44.14 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.42 1.488 . . . . 0.0 108.459 171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.7 m -72.13 -16.82 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 113.377 0.881 . . . . 0.0 113.377 -176.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.42 162.15 27.94 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -173.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -71.89 160.04 33.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.74 0.781 . . . . 0.0 110.442 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 145' ' ' TYR . 10.3 pm0 -74.17 136.96 42.87 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 168.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -81.53 173.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 172.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -133.66 161.62 34.15 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.271 -0.893 . . . . 0.0 110.427 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.14 140.93 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.48 -14.87 32.78 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.797 -1.001 . . . . 0.0 112.862 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -70.51 155.54 40.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.179 1.49 . . . . 0.0 109.235 172.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -76.34 127.55 33.1 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 170.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 158.84 57.92 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.303 -0.38 . . . . 0.0 110.563 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -54.86 -14.95 8.85 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.432 3.421 . . . . 0.0 117.867 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 52.78 56.94 6.9 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 123.103 1.43 . . . . 0.0 110.169 -174.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -83.26 170.95 14.11 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.928 2.091 . . . . 0.0 111.32 -169.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.2 m -131.8 149.22 52.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.823 1.249 . . . . 0.0 107.653 169.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.89 170.87 10.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 126.703 2.001 . . . . 0.0 106.956 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.6 tp -87.13 142.6 27.8 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 169.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.8 p -69.58 166.6 18.63 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 169.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -67.14 -6.64 18.56 Favored 'General case' 0 CA--C 1.546 0.814 0 O-C-N 120.634 -1.291 . . . . 0.0 110.897 168.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.7 m -100.24 8.64 43.64 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.055 2.142 . . . . 0.0 111.688 -178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.0 mt 68.15 39.52 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.404 1.482 . . . . 0.0 112.688 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -127.48 157.76 39.22 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -72.31 142.76 48.84 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 120.896 -1.127 . . . . 0.0 108.962 171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.9 142.63 33.08 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -135.45 165.18 26.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 123.902 0.881 . . . . 0.0 108.656 -173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -53.97 -33.16 56.18 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 119.38 -0.343 . . . . 0.0 111.465 178.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.71 -33.56 61.2 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -71.42 -35.46 70.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.39 0.614 . . . . 0.0 111.031 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 41.4 mtt -78.81 -29.69 44.99 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.386 1.474 . . . . 0.0 111.882 -172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -55.8 -14.86 2.6 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.635 1.574 . . . . 0.0 114.619 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.39 -17.41 32.24 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.604 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -151.17 157.54 42.82 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.26 1.53 . . . . 0.0 108.379 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.66 126.51 13.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ASN . 46.8 m -118.89 151.66 37.71 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.424 0.69 . . . . 0.0 109.832 -169.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.7 mt -123.86 146.67 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 170.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.7 mm -130.18 110.66 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 125.631 1.572 . . . . 0.0 107.398 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 140.32 45.37 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.9 t -122.97 122.15 64.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 169.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -140.65 153.63 68.23 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -67.56 -57.09 0.18 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.531 2.154 . . . . 0.0 111.301 -176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -146.28 142.5 28.38 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.556 1.942 . . . . 0.0 105.991 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 HD11 ' CE3' ' A' ' 93' ' ' TRP . 11.6 tt -77.33 -22.79 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -168.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.92 -18.67 62.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.8 p -66.54 149.78 49.95 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.861 0.755 . . . . 0.0 109.643 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.44 -37.41 92.01 Favored Glycine 0 CA--C 1.529 0.967 0 O-C-N 121.901 -0.5 . . . . 0.0 111.898 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -69.46 -43.09 81.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 117.9 0.85 . . . . 0.0 110.561 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 68.9 m -62.42 -42.71 99.65 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.891 0.769 . . . . 0.0 110.671 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.94 -56.23 24.27 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.664 1.186 . . . . 0.0 110.84 176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.31 -34.85 79.08 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.92 0.488 . . . . 0.0 112.248 -174.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.77 -57.17 10.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 173.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.8 m -62.46 -44.67 95.84 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.846 0.748 . . . . 0.0 111.948 -170.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 20.0 ptt85 -76.66 -37.57 56.02 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 120.194 1.361 . . . . 0.0 112.859 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.3 mtp-105 -62.3 -43.18 99.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.045 0.839 . . . . 0.0 108.878 173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -61.21 -35.36 76.98 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 118.944 -0.551 . . . . 0.0 112.003 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.38 -42.91 96.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.575 1.08 . . . . 0.0 112.263 173.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.76 -42.97 99.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.44 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 64.6 mm-40 -61.46 -39.08 89.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.864 1.211 . . . . 0.0 111.448 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.9 -35.63 78.94 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.444 0.566 . . . . 0.0 111.092 173.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.37 83.07 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.941 0.791 . . . . 0.0 111.478 174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -65.13 -39.46 93.07 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.768 -0.634 . . . . 0.0 110.459 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.7 -49.72 69.8 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.788 0.722 . . . . 0.0 109.785 173.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.77 -61.91 2.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 125.967 1.746 . . . . 0.0 112.032 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -83.79 55.28 3.19 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.547 1.539 . . . . 0.0 110.72 -177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.7 p -143.14 169.91 11.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.191 1.396 . . . . 0.0 107.778 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 47' ' ' THR . 42.5 t30 -130.15 137.82 50.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.1 t -144.86 145.29 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 121.215 -0.928 . . . . 0.0 110.177 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -138.16 171.72 13.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.918 1.287 . . . . 0.0 109.689 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.9 m -132.8 144.42 50.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.42 1.888 . . . . 0.0 105.905 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.9 mt -131.47 133.32 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -177.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.5 m -135.19 152.79 51.91 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.331 1.052 . . . . 0.0 109.539 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.46 45.12 1.16 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 169.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -129.62 164.94 22.78 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.346 1.458 . . . . 0.0 110.075 -168.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.9 137.38 96.0 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 124.002 0.921 . . . . 0.0 109.239 -170.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.49 -42.71 48.0 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.091 2.528 . . . . 0.0 112.196 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -73.31 -32.24 64.48 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 118.773 -0.632 . . . . 0.0 111.621 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.39 -43.55 90.28 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.409 1.004 . . . . 0.0 109.802 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.05 -48.55 79.76 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.013 1.325 . . . . 0.0 111.908 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.98 -43.8 86.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.751 0.705 . . . . 0.0 111.158 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -45.64 93.72 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.318 1.047 . . . . 0.0 108.953 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.409 ' CE3' HD11 ' A' ' 55' ' ' ILE . 85.8 t90 -64.69 -40.71 95.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 119.573 -0.251 . . . . 0.0 110.336 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 19.6 m -61.14 -43.66 98.53 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 118.606 0.639 . . . . 0.0 110.885 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.8 -33.15 86.47 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.358 178.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.11 -39.21 92.78 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.061 0.931 . . . . 0.0 110.629 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -99.96 -13.32 19.16 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -171.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.24 37.61 41.78 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.8 mm -64.62 143.14 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.952 1.301 . . . . 0.0 108.207 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -139.35 -25.87 0.84 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -117.74 -5.04 11.12 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.431 1.092 . . . . 0.0 111.984 -174.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.23 158.5 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -143.59 135.6 26.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 174.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 18.5 p -96.67 142.75 28.33 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.278 1.031 . . . . 0.0 108.358 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.2 mt -138.97 150.21 45.6 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.528 1.531 . . . . 0.0 108.471 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.8 m -107.62 106.79 17.3 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.397 1.079 . . . . 0.0 111.025 -171.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.35 -11.34 59.82 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.922 0.889 . . . . 0.0 109.843 168.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -48.64 -28.22 3.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.633 1.173 . . . . 0.0 111.58 169.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.98 88.11 1.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.075 1.35 . . . . 0.0 110.787 170.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.5 t70 65.03 14.48 9.39 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.059 1.744 . . . . 0.0 115.433 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp 44.34 30.7 0.49 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 128.016 2.527 . . . . 0.0 115.064 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.5 m -60.24 -46.86 88.32 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.439 0.696 . . . . 0.0 111.38 -173.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -66.32 -50.38 63.81 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.62 -39.18 96.18 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 123.059 0.361 . . . . 0.0 112.202 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -67.47 -53.6 27.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.711 0.804 . . . . 0.0 109.978 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.09 -33.08 67.6 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -169.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.93 56.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.597 1.159 . . . . 0.0 111.851 173.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.06 49.68 65.47 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.826 0.727 . . . . 0.0 113.296 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.1 m -123.4 -11.17 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.867 1.267 . . . . 0.0 111.012 176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.7 108.05 3.72 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 169.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 98.4 mt -74.7 115.31 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 175.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -63.1 -47.54 82.38 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.448 1.099 . . . . 0.0 111.229 -171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -168.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 pp -137.65 13.93 2.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.122 0.874 . . . . 0.0 113.237 177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 40.14 53.82 2.77 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.204 2.201 . . . . 0.0 113.689 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 11.5 tp -145.96 169.55 18.39 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.113 0.965 . . . . 0.0 108.681 -178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.07 137.25 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.087 0.555 . . . . 0.0 109.984 -173.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.49 149.22 49.02 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.987 1.315 . . . . 0.0 111.156 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 70.6 mtt85 -81.05 115.9 20.73 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 168.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 70.8 m -162.18 171.19 17.8 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.747 1.219 . . . . 0.0 108.825 -170.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.19 144.4 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.501 -0.749 . . . . 0.0 109.622 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -132.66 153.16 51.37 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.811 0.695 . . . . 0.0 110.479 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.63 134.27 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -125.39 132.57 52.76 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.108 1.363 . . . . 0.0 107.979 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -71.0 166.0 22.26 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.371 1.068 . . . . 0.0 109.747 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.36 -26.89 43.84 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.382 1.073 . . . . 0.0 112.394 173.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -76.61 -0.43 23.35 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.042 -1.036 . . . . 0.0 112.115 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 67.58 28.19 73.57 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.036 0.827 . . . . 0.0 111.887 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.33 147.33 26.82 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.321 1.06 . . . . 0.0 108.28 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 51.1 t -71.72 138.15 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 -176.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 92.6 t -112.73 -35.66 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.909 1.684 . . . . 0.0 109.419 -177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -150.18 142.94 24.67 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 144.37 28.07 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 169.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -152.78 148.51 27.31 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.426 ' CE1' ' HB2' ' A' ' 17' ' ' GLU . 63.8 m-85 -132.0 98.61 4.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 127.468 2.307 . . . . 0.0 105.982 -169.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.2 t -62.42 131.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.5 m -67.79 -15.64 63.73 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.992 0.917 . . . . 0.0 113.183 -174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -126.28 118.14 24.49 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -62.67 -27.44 69.24 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.22 0.608 . . . . 0.0 111.447 178.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 12.6 p -68.93 -12.71 61.88 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.568 1.547 . . . . 0.0 112.679 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -116.64 161.26 19.46 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.866 1.666 . . . . 0.0 108.674 -170.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -121.94 153.15 60.5 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 123.776 0.83 . . . . 0.0 110.297 -171.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.85 150.68 55.94 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.666 1.577 . . . . 0.0 108.301 169.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -80.19 115.98 20.04 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -66.7 -8.77 30.2 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -175.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.93 -32.05 71.56 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.997 0.817 . . . . 0.0 110.789 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -66.18 -53.15 34.23 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.306 -174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.01 -30.43 25.78 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 121.494 1.569 . . . . 0.0 111.564 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 10.1 mm -54.94 -51.47 53.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.233 0 CA-C-N 119.191 0.905 . . . . 0.0 109.44 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -63.98 -28.97 70.17 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.001 0.52 . . . . 0.0 111.545 -175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.88 -49.37 46.69 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.113 0.565 . . . . 0.0 111.427 172.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.05 -48.62 65.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.236 0.614 . . . . 0.0 111.192 -174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -32.54 65.39 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.49 0.716 . . . . 0.0 111.218 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -64.35 -33.73 76.52 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.359 0.664 . . . . 0.0 111.316 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.6 mt -79.57 -44.75 20.5 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.216 0.462 . . . . 0.0 110.96 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -84.48 14.26 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -171.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 C--O 1.249 1.069 0 O-C-N 121.53 -0.731 . . . . 0.0 109.583 169.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 ttm . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.87 -30.79 71.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 119.193 -0.432 . . . . 0.0 112.109 -177.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 46.95 48.44 15.3 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.39 1.876 . . . . 0.0 111.815 171.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.85 147.27 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.768 0.827 . . . . 0.0 109.085 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.3 p -116.08 167.4 11.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.945 1.698 . . . . 0.0 109.135 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -135.8 95.08 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt 40.76 33.42 0.2 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.584 2.354 . . . . 0.0 115.921 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.31 -23.96 0.27 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.418 -1.212 . . . . 0.0 114.777 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.78 169.49 40.14 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 119.778 1.789 . . . . 0.0 113.006 -176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.31 154.01 65.91 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.898 3.065 . . . . 0.0 111.831 -173.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -139.11 128.06 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.274 1.03 . . . . 0.0 108.835 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.8 m -61.7 156.31 20.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.48 1.512 . . . . 0.0 111.275 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.7 mt -125.68 141.4 52.03 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 126.586 1.954 . . . . 0.0 106.942 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.6 t -70.27 -65.48 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.3 -170.25 46.93 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.269 0.937 . . . . 0.0 112.276 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -108.96 150.19 28.09 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.1 0.96 . . . . 0.0 110.796 -174.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -62.61 121.22 12.81 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 m -82.96 167.71 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 171.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -134.5 155.93 49.52 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.477 -0.764 . . . . 0.0 109.558 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.44 136.18 16.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 170.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.95 -18.5 57.08 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.013 1.292 . . . . 0.0 111.943 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -76.99 157.02 31.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.73 1.265 . . . . 0.0 109.537 176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -81.26 126.67 31.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.04 147.85 93.67 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-O 119.035 -0.507 . . . . 0.0 110.262 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -55.16 -30.27 70.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.36 2.707 . . . . 0.0 116.031 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 t70 50.71 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.391 1.877 . . . . 0.0 113.728 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -129.35 178.1 6.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.907 1.283 . . . . 0.0 109.616 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -108.1 152.42 24.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.25 1.02 . . . . 0.0 109.564 -169.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.9 m -141.61 171.33 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.583 2.353 . . . . 0.0 107.315 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -92.95 155.68 17.41 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 169.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.0 p -71.16 -158.35 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.653 1.181 . . . . 0.0 109.366 169.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -72.33 0.14 10.81 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.353 -1.467 . . . . 0.0 113.054 169.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.6 m -126.54 -88.72 0.57 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 119.508 1.049 . . . . 0.0 108.627 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.8 mt -157.56 -3.88 0.1 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.346 1.858 . . . . 0.0 112.405 -169.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.38 138.35 32.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -72.9 138.88 46.49 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -137.27 149.26 46.99 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 125.999 1.72 . . . . 0.0 106.534 169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 m -137.67 160.2 39.87 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.97 -30.39 67.89 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.967 -0.458 . . . . 0.0 111.861 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.75 -28.04 68.4 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.832 0.853 . . . . 0.0 112.816 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -75.72 -36.31 59.99 Favored 'General case' 0 C--O 1.231 0.079 0 C-N-CA 123.487 0.715 . . . . 0.0 110.425 174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 53.8 mtt -73.96 -36.48 64.59 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 124.109 0.964 . . . . 0.0 111.123 -173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -65.67 0.83 1.48 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.35 -16.38 20.5 Favored Glycine 0 CA--C 1.539 1.54 0 O-C-N 121.005 -1.059 . . . . 0.0 112.73 169.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -141.02 167.63 21.74 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.112 1.456 . . . . 0.0 108.263 169.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.47 128.97 27.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.9 m -131.68 151.36 51.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.409 0.284 . . . . 0.0 110.888 -168.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 65.4 mt -113.82 139.02 41.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.6 mm -127.45 126.02 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.2 m -118.96 98.34 6.14 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.128 0.971 . . . . 0.0 108.745 -176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 m -74.89 136.31 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.25 155.9 80.42 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 169.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -57.04 -54.92 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.676 2.251 . . . . 0.0 111.775 -175.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -157.37 149.45 22.56 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.9 tt -70.45 -15.72 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 121.43 -0.793 . . . . 0.0 111.266 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -63.64 -16.46 61.01 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.166 -0.959 . . . . 0.0 113.289 169.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.6 p -61.37 -23.8 66.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.716 1.144 . . . . 0.0 114.024 -170.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.3 -42.47 2.16 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.315 0.96 . . . . 0.0 111.436 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.04 -24.54 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.884 1.273 . . . . 0.0 110.421 169.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 24.1 p -47.48 -32.27 5.02 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.257 1.423 . . . . 0.0 113.009 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.6 -33.49 70.05 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 125.353 1.461 . . . . 0.0 112.253 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.03 -17.4 57.21 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.271 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -108.57 -80.12 0.58 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.1 m -54.15 -43.39 70.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.529 1.132 . . . . 0.0 113.624 -168.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -63.06 -53.33 55.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.514 0.597 . . . . 0.0 109.596 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -69.54 -36.16 76.11 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.78 -172.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -59.22 -36.91 76.26 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.88 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -60.18 -46.06 91.0 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 119.863 1.21 . . . . 0.0 110.477 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.68 -51.34 57.19 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.56 -38.54 87.86 Favored 'General case' 0 C--O 1.227 -0.082 0 O-C-N 121.285 -0.884 . . . . 0.0 110.94 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.97 -37.37 86.82 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.888 0.767 . . . . 0.0 111.309 175.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.83 95.62 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.685 0.675 . . . . 0.0 110.643 175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 -38.75 83.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.586 0.63 . . . . 0.0 111.367 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mp -61.48 -33.33 73.59 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.862 0.865 . . . . 0.0 110.538 174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.28 -35.06 3.5 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.81 1.195 . . . . 0.0 111.859 173.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.48 116.76 5.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.666 1.187 . . . . 0.0 109.207 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG22 ' H ' ' A' ' 78' ' ' ASN . 14.0 p -159.19 -174.9 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 127.476 2.31 . . . . 0.0 105.409 173.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.479 ' H ' HG22 ' A' ' 77' ' ' VAL . 52.2 t30 -138.85 134.2 33.01 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 169.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -141.39 140.43 31.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.335 0.97 . . . . 0.0 108.7 -176.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -132.18 159.8 37.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.279 1.032 . . . . 0.0 109.899 172.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.0 m -122.12 142.8 50.01 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 170.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.4 mt -126.52 141.13 46.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.0 t -143.71 155.18 44.12 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.643 0.777 . . . . 0.0 110.499 -169.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.51 9.78 41.53 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 168.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -83.26 177.91 8.31 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -84.82 147.1 47.71 Favored Pre-proline 0 C--N 1.326 -0.428 0 C-N-CA 123.968 0.907 . . . . 0.0 110.201 -169.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.63 -45.36 27.87 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.858 3.038 . . . . 0.0 113.698 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -67.0 -29.72 69.63 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.518 -0.739 . . . . 0.0 112.311 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.98 72.78 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.312 0.96 . . . . 0.0 109.657 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -52.88 -51.36 61.39 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.559 0.743 . . . . 0.0 109.658 170.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.6 -49.93 74.81 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.295 0.638 . . . . 0.0 111.164 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -62.75 -45.94 90.35 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 123.566 0.747 . . . . 0.0 110.25 -172.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -63.48 -43.95 95.8 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.655 0.382 . . . . 0.0 110.854 -176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 23.5 m -70.16 -37.87 75.3 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.744 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.52 -38.08 94.38 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.3 79.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.627 0.771 . . . . 0.0 110.216 177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -70.74 -31.8 68.75 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.657 0.783 . . . . 0.0 112.694 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.14 35.78 23.06 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 -171.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.5 mm -65.25 144.18 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.53 -35.26 0.31 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.699 1.199 . . . . 0.0 112.602 -178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -87.66 -10.41 51.39 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.605 0.762 . . . . 0.0 112.471 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.9 159.83 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.72 149.94 52.22 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 171.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.42 140.09 48.36 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.797 0.839 . . . . 0.0 110.228 -169.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.3 mt -138.74 163.81 31.19 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.468 1.507 . . . . 0.0 109.07 -169.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.34 136.15 36.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.099 0.56 . . . . 0.0 109.516 -169.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -122.67 -5.46 8.65 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.603 0.761 . . . . 0.0 111.679 -171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -57.68 -19.5 27.3 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -54.46 -43.02 71.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.566 1.146 . . . . 0.0 111.23 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.84 -1.79 0.3 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.394 0.678 . . . . 0.0 112.664 -171.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 64.1 mmm 47.04 28.44 0.9 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 127.771 2.428 . . . . 0.0 113.601 -173.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.27 -44.81 92.41 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.862 0.865 . . . . 0.0 111.149 -171.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -71.84 -46.59 57.51 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.95 -37.19 87.66 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -60.44 -46.26 90.69 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 121.769 -0.842 . . . . 0.0 109.245 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.5 -41.56 79.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -76.89 1.71 16.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.643 0.777 . . . . 0.0 112.481 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.79 90.23 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 119.982 1.265 . . . . 0.0 112.553 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.1 m -124.91 -2.16 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.116 1.366 . . . . 0.0 111.397 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -79.56 105.99 11.27 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 169.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.26 101.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -51.69 -42.23 62.03 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.333 1.453 . . . . 0.0 111.441 -176.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.6 -10.81 60.2 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 69.0 mt -122.61 -17.73 6.84 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.187 0.995 . . . . 0.0 112.069 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.19 38.13 26.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.655 1.182 . . . . 0.0 109.048 -168.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 157.27 43.95 Favored 'General case' 0 C--N 1.344 0.368 0 C-N-CA 124.471 1.108 . . . . 0.0 108.592 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.4 tp -77.79 148.65 34.67 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.122 0.969 . . . . 0.0 109.279 176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -79.2 -175.06 4.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.429 1.492 . . . . 0.0 111.458 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.7 ttm105 -121.73 111.93 17.77 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.2 m -157.69 169.55 24.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.483 1.913 . . . . 0.0 106.94 -170.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.35 144.57 18.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 121.311 -0.868 . . . . 0.0 110.012 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -134.18 157.64 45.7 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.715 1.206 . . . . 0.0 108.542 -174.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.4 t -134.75 134.63 53.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -123.76 132.16 53.75 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.941 1.296 . . . . 0.0 108.07 -173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.45 167.52 10.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.601 1.561 . . . . 0.0 109.592 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -58.54 -21.17 51.65 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.449 -0.782 . . . . 0.0 113.024 174.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -86.9 -0.17 56.05 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 120.636 -1.29 . . . . 0.0 112.297 174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 72.56 23.29 78.17 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.04 -1.037 . . . . 0.0 112.299 -173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -88.14 141.28 28.69 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.826 1.313 . . . . 0.0 107.518 172.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.3 t -68.57 116.86 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 84.2 t -84.74 -33.97 8.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.827 1.251 . . . . 0.0 109.275 174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -158.96 146.35 17.52 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.32 144.15 27.38 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -145.52 136.99 25.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -128.6 121.28 28.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.261 -2.126 . . . . 0.0 105.261 -173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.2 t -72.53 135.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -67.79 -5.89 18.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.778 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -147.41 118.8 7.87 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.49 63.39 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.111 0.964 . . . . 0.0 113.549 -170.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.3 10.12 20.86 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.881 1.272 . . . . 0.0 110.414 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -127.77 178.3 6.24 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.55 2.34 . . . . 0.0 108.132 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -138.3 152.15 70.91 Favored Pre-proline 0 CA--C 1.542 0.64 0 O-C-N 120.623 -1.298 . . . . 0.0 112.147 -169.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.63 149.55 18.59 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.687 2.258 . . . . 0.0 108.951 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -74.71 115.84 14.73 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -51.73 -26.53 9.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.032 1.733 . . . . 0.0 112.922 177.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -61.7 -31.31 71.45 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.646 -0.659 . . . . 0.0 111.882 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -48.04 10.63 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-N 119.741 1.155 . . . . 0.0 112.07 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -68.01 -30.65 32.07 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 CA-C-N 121.315 1.505 . . . . 0.0 111.646 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.3 mm -55.36 -50.17 67.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 CA-C-N 119.313 0.961 . . . . 0.0 109.42 169.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -62.12 -32.73 73.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.39 0.541 . . . . 0.0 111.364 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.97 -46.01 69.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.097 0.559 . . . . 0.0 111.512 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.13 -46.52 56.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.522 0.729 . . . . 0.0 111.92 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 -26.22 62.86 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.731 0.696 . . . . 0.0 111.783 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.43 -24.07 65.6 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.287 1.035 . . . . 0.0 113.175 176.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.27 -26.96 6.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.7 m -65.15 -13.41 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.6 pttt . . . . . 0 C--O 1.248 0.99 0 C-N-CA 126.184 1.794 . . . . 0.0 108.123 -175.934 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.7 -37.09 86.03 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 119.089 -0.481 . . . . 0.0 112.282 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 41.84 47.0 3.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.4 1.88 . . . . 0.0 112.049 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 13' ' ' LEU . 40.6 mt -54.0 126.1 9.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.853 1.661 . . . . 0.0 109.131 -170.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.0 p -76.99 161.87 28.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.444 0.64 . . . . 0.0 110.105 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -116.97 38.93 3.36 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.153 0.981 . . . . 0.0 109.552 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm 41.83 63.91 1.2 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 126.596 1.959 . . . . 0.0 111.571 -171.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.1 -28.18 0.11 Allowed Glycine 0 CA--C 1.527 0.821 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.239 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.54 170.46 42.46 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.618 1.104 . . . . 0.0 110.534 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.9 158.52 55.25 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.739 2.959 . . . . 0.0 110.761 176.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.47 142.28 35.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.4 m -67.51 157.08 35.13 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.513 1.525 . . . . 0.0 110.359 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.437 ' HA ' ' H ' ' A' ' 122' ' ' LYS . 4.6 mp -135.18 144.94 47.28 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.911 1.284 . . . . 0.0 107.771 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 t -82.44 147.91 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 172.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.44 -157.15 19.45 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -132.62 161.3 34.26 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -64.93 115.24 5.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 168.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 t -83.4 151.44 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -132.67 155.05 49.48 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.883 0.873 . . . . 0.0 109.888 -171.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 97.4 t -58.43 141.02 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.049 0.94 . . . . 0.0 109.289 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.55 -21.64 31.54 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.943 1.259 . . . . 0.0 112.175 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.67 152.79 40.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 118.73 1.265 . . . . 0.0 109.771 177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -70.81 126.79 30.56 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.45 152.41 73.79 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-O 118.904 -0.57 . . . . 0.0 110.152 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.77 -29.0 60.26 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.224 2.616 . . . . 0.0 115.482 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.6 t0 51.9 85.91 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.913 2.085 . . . . 0.0 113.983 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -133.37 172.34 12.83 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.35 1.46 . . . . 0.0 110.642 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -87.04 158.99 19.11 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.771 1.628 . . . . 0.0 110.366 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.5 p -151.87 159.31 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 128.043 2.537 . . . . 0.0 105.639 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.0 tp -90.54 145.99 24.44 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 120.548 -1.345 . . . . 0.0 108.018 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -74.35 165.66 24.81 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.056 -1.028 . . . . 0.0 108.395 169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.3 p30 -66.67 -6.61 16.21 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.871 -1.143 . . . . 0.0 111.368 168.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.7 m -93.54 3.7 55.13 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.39 1.876 . . . . 0.0 111.893 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.1 mp 62.81 44.74 6.13 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.195 1.398 . . . . 0.0 111.817 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -126.49 160.76 29.64 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.68 1.192 . . . . 0.0 107.785 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -78.31 142.08 38.01 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.844 -1.16 . . . . 0.0 109.753 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -139.15 163.52 32.22 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 126.161 1.784 . . . . 0.0 106.55 169.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.7 p -151.68 169.22 22.71 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 120.969 -1.082 . . . . 0.0 108.51 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -56.73 -27.6 59.56 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 119.157 -0.449 . . . . 0.0 111.512 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.93 -28.64 62.32 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 174.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.01 -41.42 35.9 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.361 0.664 . . . . 0.0 109.834 172.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 46.4 mtt -65.45 -40.63 93.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.966 0.906 . . . . 0.0 109.105 -173.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 28.8 pttt -71.1 -0.89 10.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.376 0.67 . . . . 0.0 112.381 176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.16 -15.72 59.02 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.837 -1.165 . . . . 0.0 111.97 169.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -147.94 168.96 20.93 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.899 1.349 . . . . 0.0 108.428 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.97 120.9 15.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 168.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.5 m -130.14 153.89 48.06 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 123.156 0.285 . . . . 0.0 110.763 -169.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.5 mt -118.03 142.18 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.1 mm -127.85 113.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -112.94 98.44 7.18 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 124.141 0.976 . . . . 0.0 109.007 -172.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -84.41 140.71 15.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.33 -0.857 . . . . 0.0 108.872 -174.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.85 156.03 72.88 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.839 1.256 . . . . 0.0 108.491 169.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.81 -50.03 12.82 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.644 2.229 . . . . 0.0 112.498 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -160.44 164.62 32.11 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.936 2.494 . . . . 0.0 106.295 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.2 tt -98.3 -23.79 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 118.56 0.618 . . . . 0.0 111.564 -169.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -82.91 54.44 2.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.862 1.265 . . . . 0.0 110.387 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.5 t -154.99 -178.15 7.04 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.184 -175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.95 179.5 31.24 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.38 0.991 . . . . 0.0 112.271 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.285 19.5 m 53.25 -6.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 129.339 3.055 . . . . 0.0 116.832 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.8 m -65.27 -22.7 66.88 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.59 -1.319 . . . . 0.0 110.896 170.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.27 -31.76 67.75 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.666 -0.647 . . . . 0.0 111.233 169.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.46 -58.2 2.71 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.892 0.769 . . . . 0.0 109.778 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -68.29 -15.78 63.7 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.877 1.066 . . . . 0.0 113.877 -169.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -128.89 -54.17 1.22 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.79 1.177 . . . . 0.0 110.074 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -73.97 -52.31 13.24 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.771 1.169 . . . . 0.0 111.556 -171.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.55 79.41 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 119.388 0.995 . . . . 0.0 109.605 174.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.34 -44.21 71.9 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.336 0.516 . . . . 0.0 111.67 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -64.02 -44.08 93.67 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 123.619 0.767 . . . . 0.0 111.836 177.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -60.35 -49.48 77.42 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 73' ' ' LYS . 21.8 mm-40 -64.27 -39.47 94.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 119.094 0.861 . . . . 0.0 110.863 -176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.896 -0.573 . . . . 0.0 111.974 172.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.25 -33.55 69.92 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.427 1.012 . . . . 0.0 110.775 176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 70' ' ' GLU . 17.3 mmtp -68.84 -40.08 79.59 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.937 0.79 . . . . 0.0 109.346 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.2 mp -59.24 -50.43 74.03 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 172.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.25 -0.21 60.02 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.769 1.176 . . . . 0.0 114.286 170.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -155.92 65.51 0.59 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.133 1.373 . . . . 0.0 108.668 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.2 p -147.96 167.7 4.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.024 1.33 . . . . 0.0 107.593 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -120.49 144.44 48.01 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 169.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 p -153.4 147.08 14.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 120.954 -1.091 . . . . 0.0 109.748 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -134.13 162.81 31.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.703 1.601 . . . . 0.0 109.417 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.9 m -127.84 149.26 50.36 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 175.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.8 mt -134.89 136.5 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.1 m -139.37 158.64 43.8 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -92.47 48.99 1.43 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 168.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -132.4 165.33 24.52 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.55 1.54 . . . . 0.0 108.889 -169.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.96 136.18 96.69 Favored Pre-proline 0 C--O 1.236 0.387 0 C-N-CA 123.826 0.851 . . . . 0.0 109.826 -169.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.37 -42.8 46.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.352 2.702 . . . . 0.0 112.277 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -73.68 -31.58 63.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.523 -175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.29 -47.9 75.05 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.358 0.981 . . . . 0.0 108.993 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -57.7 -42.89 84.63 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.125 0.97 . . . . 0.0 112.572 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.48 85.73 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.031 0.832 . . . . 0.0 111.264 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -65.26 -42.33 93.37 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.306 0.643 . . . . 0.0 109.725 -174.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -60.4 -40.23 90.21 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.24 0.616 . . . . 0.0 110.527 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 94.2 m -65.23 -47.09 78.02 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 122.007 -0.433 . . . . 0.0 111.173 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.1 -39.08 96.84 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.15 -41.21 97.25 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.744 0.818 . . . . 0.0 110.702 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 44.1 m-20 -85.39 -19.75 30.91 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.377 0.671 . . . . 0.0 112.702 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.92 31.86 38.18 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.6 mm -64.33 142.81 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -144.91 -37.83 0.28 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.05 0.94 . . . . 0.0 112.652 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -80.81 -25.85 37.54 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.393 0.677 . . . . 0.0 111.226 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.8 157.7 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.827 1.251 . . . . 0.0 107.668 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -138.06 138.82 39.15 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 13.1 p -95.65 148.19 22.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.5 1.12 . . . . 0.0 108.205 -177.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -137.93 140.19 40.17 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.655 1.182 . . . . 0.0 108.648 -169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.4 m -102.29 105.8 16.49 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.6 1.16 . . . . 0.0 110.06 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -81.34 -4.47 55.77 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.754 169.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -51.56 -41.36 61.05 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.737 1.215 . . . . 0.0 111.589 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -75.2 -44.76 44.64 Favored 'General case' 0 CA--C 1.521 -0.17 0 C-N-CA 123.645 0.778 . . . . 0.0 111.424 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.59 -36.15 11.36 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -168.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 55.12 -19.54 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 129.719 3.208 . . . . 0.0 115.759 -169.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.1 m -59.46 -33.0 70.75 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.371 1.441 . . . . 0.0 112.678 -172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -67.54 -54.65 18.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.989 0.813 . . . . 0.0 108.942 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -70.02 -36.71 73.03 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -176.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -61.33 -32.05 71.92 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.332 1.053 . . . . 0.0 110.822 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.93 -44.11 10.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 118.615 0.643 . . . . 0.0 112.319 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.17 13.49 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -171.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 66.07 37.57 93.22 Favored Glycine 0 C--N 1.34 0.754 0 CA-C-O 118.757 -1.024 . . . . 0.0 111.563 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.77 -10.63 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 118.47 1.135 . . . . 0.0 112.149 -168.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -82.11 116.37 21.66 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.8 mt -79.6 97.47 2.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' H ' ' HA ' ' A' ' 13' ' ' LEU . 57.6 tttm -44.68 -55.64 5.08 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 126.615 1.966 . . . . 0.0 111.869 -169.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -86.11 -11.54 52.4 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -169.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 67.4 mt -83.54 -21.74 32.61 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.943 0.792 . . . . 0.0 109.525 168.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 58.36 32.06 21.63 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.915 1.286 . . . . 0.0 109.354 -168.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 127' ' ' LEU . 0.1 OUTLIER -135.79 154.17 51.3 Favored 'General case' 0 C--N 1.346 0.431 0 C-N-CA 124.531 1.132 . . . . 0.0 108.516 -177.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.421 ' H ' HD13 ' A' ' 126' ' ' LEU . 14.3 tp -77.37 152.17 34.52 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.168 0.987 . . . . 0.0 109.778 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.78 -174.44 5.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.31 1.044 . . . . 0.0 111.258 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.8 ptp85 -116.43 127.04 54.25 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.3 m -167.43 175.15 7.39 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.51 1.924 . . . . 0.0 107.128 -172.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.15 145.92 14.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -137.7 158.41 44.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.859 1.264 . . . . 0.0 109.345 -177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.0 t -130.26 144.71 37.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 172.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 72.5 mt -131.54 128.75 39.94 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.634 1.573 . . . . 0.0 108.149 -169.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -74.25 163.43 27.84 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 109.011 169.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -60.21 -17.53 42.1 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -81.42 -4.96 57.33 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.296 -1.502 . . . . 0.0 112.378 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.93 27.64 66.3 Favored Glycine 0 CA--C 1.526 0.743 0 O-C-N 121.317 -0.865 . . . . 0.0 111.698 -172.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.36 144.11 27.44 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 173.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.33 135.58 26.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 85.0 t -109.2 -32.92 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 125.416 1.486 . . . . 0.0 109.614 -176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -150.12 144.85 25.97 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 173.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -147.86 139.84 24.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 169.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -148.22 149.41 31.87 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -125.85 142.83 51.33 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.348 1.859 . . . . 0.0 106.214 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.2 m -75.96 -10.51 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -169.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.7 m 62.99 -21.99 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.241 2.216 . . . . 0.0 115.626 -177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -143.63 123.97 13.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.218 1.372 . . . . 0.0 107.505 170.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.05 -18.38 46.13 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -169.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 27.9 p -77.63 -3.96 43.55 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.227 0.921 . . . . 0.0 112.905 -177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.77 163.11 25.87 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 119.402 1.001 . . . . 0.0 110.048 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -118.54 155.97 51.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.573 1.149 . . . . 0.0 109.632 -170.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.15 155.04 47.19 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 N-CA-C 108.2 -1.5 . . . . 0.0 108.2 175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -84.65 114.0 21.69 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -49.1 -26.07 2.49 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 127.009 2.124 . . . . 0.0 113.508 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -60.8 -37.57 82.41 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.877 0.762 . . . . 0.0 111.242 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -63.98 -51.92 60.12 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 118.54 -0.743 . . . . 0.0 111.617 -173.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.59 -27.3 39.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.806 1.67 . . . . 0.0 112.233 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -59.82 -45.63 94.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-N 120.22 1.373 . . . . 0.0 109.246 171.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.91 -32.85 74.52 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.885 0.766 . . . . 0.0 111.021 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.05 -51.25 56.94 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.611 0.364 . . . . 0.0 111.103 174.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.61 -46.87 71.27 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.135 0.574 . . . . 0.0 111.639 -175.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -29.1 67.8 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.72 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.41 -34.28 77.6 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.317 0.508 . . . . 0.0 111.696 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 29.7 mt -86.72 -35.65 19.13 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.439 0.563 . . . . 0.0 112.401 -172.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.1 m -71.91 -9.32 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 -173.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 C--O 1.25 1.101 0 C-N-CA 123.736 0.814 . . . . 0.0 110.18 176.257 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.943 -0.021 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.27 158.45 26.25 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 170.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -140.39 141.09 35.61 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 171.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.514 HD12 HD21 ' A' ' 13' ' ' LEU . 85.1 mt -137.59 169.66 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 -175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 150.49 31.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -143.08 121.84 12.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.61 37.61 3.37 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.344 1.458 . . . . 0.0 113.166 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.28 12.05 60.39 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-O 118.196 -1.336 . . . . 0.0 114.628 172.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.06 154.43 23.9 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.954 1.877 . . . . 0.0 110.955 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.0 153.93 63.02 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.653 2.236 . . . . 0.0 111.344 -176.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -139.04 129.2 32.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 125.526 1.53 . . . . 0.0 108.286 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -74.54 160.39 30.97 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.197 1.399 . . . . 0.0 109.244 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.514 HD21 HD12 ' A' ' 4' ' ' ILE . 4.9 mp -129.54 148.91 51.49 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.059 0.944 . . . . 0.0 108.944 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.6 t -82.36 135.26 25.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.0 -158.28 14.44 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 118.38 0.536 . . . . 0.0 112.785 170.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -131.62 143.88 50.65 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.316 1.447 . . . . 0.0 108.666 -175.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -77.86 103.0 7.53 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.0 t -65.84 157.09 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.894 1.278 . . . . 0.0 108.832 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -127.71 156.5 42.29 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.991 1.316 . . . . 0.0 109.357 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.0 t -58.72 140.49 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.51 -16.13 59.78 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.6 1.095 . . . . 0.0 112.756 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -73.78 156.8 37.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 119.32 1.56 . . . . 0.0 109.582 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.37 139.65 32.88 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 169.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.63 159.34 74.82 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.316 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -60.4 -7.06 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.449 3.432 . . . . 0.0 117.8 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 52.4 58.58 5.25 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 122.833 1.302 . . . . 0.0 110.823 -169.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -85.69 165.78 16.69 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.034 1.734 . . . . 0.0 109.712 -174.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 92.8 m -130.9 146.12 52.22 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.988 1.315 . . . . 0.0 107.514 171.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.87 168.64 16.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.581 1.952 . . . . 0.0 107.235 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 tp -85.68 146.67 26.72 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 169.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 80.0 p -74.42 167.11 22.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.5 p30 -63.89 -8.02 9.91 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.062 -1.023 . . . . 0.0 111.656 168.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -109.72 13.9 23.54 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.836 2.054 . . . . 0.0 111.251 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.9 mp 64.59 44.99 3.72 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.167 1.387 . . . . 0.0 111.978 170.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -128.14 161.53 29.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 169.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -78.58 144.13 35.82 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 120.62 -1.3 . . . . 0.0 108.895 172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -142.67 145.83 33.83 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.7 m -140.37 167.28 22.51 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.671 0.788 . . . . 0.0 109.556 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 48.5 tp -47.22 -40.53 16.47 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.193 0.997 . . . . 0.0 111.958 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.97 -30.95 62.53 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.72 0.808 . . . . 0.0 113.084 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -77.55 -40.59 42.02 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 121.464 0.65 . . . . 0.0 110.577 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 47.8 mtt -65.34 -27.04 68.31 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.706 1.202 . . . . 0.0 111.346 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -55.42 -16.08 3.3 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 113.414 174.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.8 -20.37 56.91 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-O 118.767 -1.018 . . . . 0.0 113.845 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -154.47 156.45 36.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.443 1.621 . . . . 0.0 109.0 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.24 122.04 4.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 169.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 23.7 m -117.2 150.81 38.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 123.885 0.874 . . . . 0.0 109.975 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 57.8 mt -121.89 145.64 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 169.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.2 mt -126.54 138.94 53.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.23 93.83 4.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.242 1.817 . . . . 0.0 106.823 -171.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -84.45 128.32 39.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 pt -139.27 154.45 72.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 176.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -67.11 -46.49 3.04 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 CA-C-N 121.098 1.428 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 p -158.73 173.98 15.73 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.614 1.966 . . . . 0.0 107.762 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.437 HD11 ' CE3' ' A' ' 93' ' ' TRP . 3.8 tt -113.58 -177.67 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 123.802 0.841 . . . . 0.0 110.635 -169.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 56.3 43.81 25.78 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.24 1.416 . . . . 0.0 112.894 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.8 t -147.27 138.43 23.81 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -45.55 -46.34 12.37 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.191 1.376 . . . . 0.0 114.56 -169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.21 -25.59 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 124.434 1.094 . . . . 0.0 112.598 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.46 -40.59 7.78 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.925 1.69 . . . . 0.0 110.099 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.92 -49.76 74.61 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 127.15 2.18 . . . . 0.0 110.693 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.77 -39.31 88.31 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 122.948 0.499 . . . . 0.0 111.348 -174.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -60.98 -61.36 2.63 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.7 m -64.33 -39.07 93.18 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.337 0.517 . . . . 0.0 111.163 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -63.89 -50.37 69.02 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 121.219 -0.926 . . . . 0.0 110.253 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.86 -33.59 75.05 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.779 -1.105 . . . . 0.0 109.602 -178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -56.31 -39.68 73.12 Favored 'General case' 0 C--O 1.227 -0.091 0 CA-C-N 120.142 1.337 . . . . 0.0 112.16 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -60.94 -48.91 79.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 119.601 1.091 . . . . 0.0 110.874 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -67.6 -44.09 78.91 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -63.3 -37.82 88.73 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.03 -1.044 . . . . 0.0 110.819 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -39.6 92.08 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.622 -0.674 . . . . 0.0 111.041 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.06 88.6 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.788 0.722 . . . . 0.0 111.227 172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -67.66 -40.09 84.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.694 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.7 mp -60.9 -45.41 94.73 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.852 0.751 . . . . 0.0 109.842 171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.59 -9.83 61.04 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 124.961 1.267 . . . . 0.0 114.842 169.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -153.62 58.66 0.75 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.042 1.421 . . . . 0.0 109.492 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 p -139.43 171.9 13.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 124.783 1.233 . . . . 0.0 107.789 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -129.97 141.61 50.74 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 173.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.5 t -138.05 151.95 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.484 -0.76 . . . . 0.0 109.188 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -134.28 169.69 16.83 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.984 1.314 . . . . 0.0 109.703 171.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -132.75 143.85 49.87 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.4 mt -131.98 133.88 60.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.4 m -139.48 158.57 43.91 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.57 1.169 . . . . 0.0 110.879 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -93.5 54.22 2.01 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 168.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -139.43 163.95 31.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.591 1.157 . . . . 0.0 108.244 -169.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.9 mt -70.65 135.86 85.89 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -169.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.16 -36.68 79.7 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 121.986 1.791 . . . . 0.0 110.714 -175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -75.2 -27.71 59.71 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.776 -0.63 . . . . 0.0 112.101 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.78 -47.72 71.29 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.52 1.055 . . . . 0.0 108.964 173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -60.18 -41.61 93.24 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.174 -0.441 . . . . 0.0 111.826 174.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.25 -43.97 92.4 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.63 0.65 . . . . 0.0 111.007 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -67.55 -39.25 84.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 119.072 -0.49 . . . . 0.0 110.174 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.437 ' CE3' HD11 ' A' ' 55' ' ' ILE . 74.9 t90 -69.25 -45.13 70.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.207 0.603 . . . . 0.0 110.934 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 26.5 p -69.76 -33.73 72.83 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 120.824 -1.173 . . . . 0.0 110.353 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.53 -33.69 87.92 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.037 -0.868 . . . . 0.0 112.402 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.74 93.41 Favored 'General case' 0 C--N 1.342 0.28 0 CA-C-N 118.705 1.253 . . . . 0.0 110.206 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -72.83 -27.71 62.11 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.123 0.569 . . . . 0.0 111.968 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.1 32.14 53.41 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -170.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.6 mt -68.37 145.8 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.263 1.025 . . . . 0.0 108.499 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -142.89 -34.93 0.42 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.069 1.348 . . . . 0.0 111.976 -173.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.33 -13.62 59.03 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.645 0.778 . . . . 0.0 111.927 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -116.16 155.61 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -134.21 130.81 37.76 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 169.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.8 p -84.46 151.55 24.55 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.101 0.56 . . . . 0.0 109.62 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 mt -143.09 150.27 39.29 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.505 1.522 . . . . 0.0 107.255 -173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.4 m -116.01 115.39 26.05 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.652 1.181 . . . . 0.0 108.505 -177.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.26 -9.7 55.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.575 0.75 . . . . 0.0 110.581 170.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.39 -36.42 6.44 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.049 2.139 . . . . 0.0 114.259 -173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -78.57 -13.39 59.85 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 117.98 -1.009 . . . . 0.0 112.891 -173.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -147.64 -16.19 0.37 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -169.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.1 mmm 51.93 9.22 0.08 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 128.462 2.705 . . . . 0.0 117.213 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 53.7 m -63.15 -38.25 90.45 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.751 1.614 . . . . 0.0 112.525 -175.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -64.71 -50.53 66.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 120.128 1.331 . . . . 0.0 108.952 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.33 -42.48 97.73 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 -172.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.464 0.706 . . . . 0.0 109.814 176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.581 -0.7 . . . . 0.0 111.847 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -82.57 1.02 40.08 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.691 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.67 40.1 90.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-N 119.873 1.215 . . . . 0.0 112.862 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 m -126.9 -7.37 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.743 1.217 . . . . 0.0 111.352 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.75 108.3 5.66 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 120.058 1.299 . . . . 0.0 107.942 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 90.9 mt -74.86 112.71 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -57.32 -38.09 73.51 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 125.519 1.527 . . . . 0.0 110.887 -173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.58 8.51 40.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.965 0.906 . . . . 0.0 112.149 -172.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.66 -23.87 2.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.273 1.029 . . . . 0.0 112.536 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 55.58 37.35 28.76 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.593 1.157 . . . . 0.0 110.037 -168.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.9 mt -130.72 161.15 32.31 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.125 1.37 . . . . 0.0 108.092 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 67.6 mt -83.27 143.35 30.46 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.14 152.01 41.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.985 1.314 . . . . 0.0 111.01 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.7 mtt85 -80.7 100.61 8.8 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 62.0 m -147.97 167.25 25.36 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.328 1.451 . . . . 0.0 109.417 -169.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.7 m -141.0 153.41 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.469 -0.769 . . . . 0.0 110.515 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -142.69 157.12 44.99 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.539 1.136 . . . . 0.0 109.619 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.49 139.51 48.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 66.7 mt -133.24 119.49 19.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.521 1.528 . . . . 0.0 107.618 -169.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.01 163.85 21.37 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.56 0.744 . . . . 0.0 109.528 171.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.2 -23.33 21.44 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.078 1.351 . . . . 0.0 112.811 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -76.06 -6.49 51.33 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.805 -1.184 . . . . 0.0 112.377 175.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.17 42.61 35.32 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -169.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -121.46 132.09 54.53 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -172.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 61.0 t -72.81 112.78 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -171.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.2 t -84.28 -33.76 9.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 124.692 1.197 . . . . 0.0 109.355 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -154.99 147.04 23.64 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.839 1.256 . . . . 0.0 108.363 -177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.92 145.33 31.51 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.776 1.23 . . . . 0.0 107.837 170.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -149.1 137.59 21.0 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.886 0.874 . . . . 0.0 108.794 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -131.33 93.97 3.47 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 105.355 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.9 t -63.54 132.37 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.6 m -67.79 -9.67 46.23 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.963 0.905 . . . . 0.0 113.074 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -131.15 110.51 11.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.31 -27.74 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.885 0.874 . . . . 0.0 110.925 175.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -76.46 6.02 6.38 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.955 1.302 . . . . 0.0 112.627 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -122.88 173.24 7.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.196 2.199 . . . . 0.0 107.033 170.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.57 157.44 73.08 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 120.936 -1.103 . . . . 0.0 111.543 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.17 -179.02 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 124.742 3.628 . . . . 0.0 113.594 169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -124.77 111.7 15.85 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 169.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -52.25 -25.07 8.4 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.69 1.996 . . . . 0.0 112.948 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -59.67 -38.04 80.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.995 0.816 . . . . 0.0 111.383 175.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -60.28 -56.09 38.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.892 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -68.9 -26.96 31.28 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 121.49 1.46 . . . . 0.0 112.059 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -60.09 -44.38 94.89 Favored 'Isoleucine or valine' 0 C--N 1.343 0.322 0 CA-C-N 120.654 1.57 . . . . 0.0 109.638 172.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.53 -34.52 78.43 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.16 0.891 . . . . 0.0 110.713 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -65.57 -49.06 70.23 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.5 0.19 . . . . 0.0 111.258 173.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.14 -49.4 61.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.026 0.53 . . . . 0.0 111.128 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -33.82 69.11 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.759 0.708 . . . . 0.0 111.355 -176.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.35 -31.37 69.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.446 0.566 . . . . 0.0 111.784 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.7 mt -89.61 -24.41 21.68 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.698 0.799 . . . . 0.0 112.155 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 95.6 t -62.91 -32.73 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 118.483 0.583 . . . . 0.0 110.519 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.385 -0.817 . . . . 0.0 110.183 174.714 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.18 171.61 10.71 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 169.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.06 140.21 30.83 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.538 HD12 HD21 ' A' ' 13' ' ' LEU . 95.5 mt -133.94 170.8 19.07 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.16 151.31 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -133.73 113.33 12.2 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 59.74 -50.69 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.877 2.871 . . . . 0.0 115.529 -178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.65 17.35 0.06 OUTLIER Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.641 -1.088 . . . . 0.0 113.818 -176.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.73 157.75 27.48 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.577 1.689 . . . . 0.0 110.979 173.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.63 157.69 51.96 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.048 2.499 . . . . 0.0 111.874 -175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 m -138.55 124.97 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 126.144 1.778 . . . . 0.0 107.479 171.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -73.98 158.09 35.0 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.476 1.51 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.538 HD21 HD12 ' A' ' 4' ' ' ILE . 4.8 mp -132.47 136.81 46.95 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 123.987 0.915 . . . . 0.0 108.889 176.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.4 t -71.35 127.31 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.55 -167.56 18.94 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-O 121.415 0.453 . . . . 0.0 112.697 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -109.0 141.6 40.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.351 1.46 . . . . 0.0 108.264 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.25 107.96 10.02 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.08 152.96 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.2 157.49 45.24 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.722 0.809 . . . . 0.0 109.881 -172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.4 t -57.4 141.07 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 123.715 0.806 . . . . 0.0 108.923 175.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.32 -24.23 17.6 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.748 1.166 . . . . 0.0 112.257 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -72.82 158.85 34.76 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.295 1.547 . . . . 0.0 110.299 177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -76.25 136.49 39.67 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 169.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.51 153.98 89.1 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.346 -0.359 . . . . 0.0 110.789 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -56.28 -28.12 70.09 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.86 3.04 . . . . 0.0 115.907 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.1 t0 53.05 80.8 0.1 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.775 1.63 . . . . 0.0 113.756 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -126.09 -172.31 2.59 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.514 1.526 . . . . 0.0 109.806 175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 m -125.17 156.04 39.04 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.469 1.107 . . . . 0.0 110.527 -168.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.1 m -141.62 178.67 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 129.193 2.997 . . . . 0.0 106.604 175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -102.87 149.17 24.77 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 168.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 66.0 p -69.29 170.23 10.68 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.177 -0.952 . . . . 0.0 108.636 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.25 -10.61 33.46 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.777 -1.202 . . . . 0.0 110.767 168.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.3 m -97.29 10.51 39.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.976 2.11 . . . . 0.0 111.74 177.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.8 mt 60.76 42.99 12.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.872 1.669 . . . . 0.0 113.573 174.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.74 141.56 51.28 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 169.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -66.92 141.15 57.73 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 120.892 -1.13 . . . . 0.0 110.89 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -142.36 151.36 41.82 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 125.643 1.577 . . . . 0.0 108.034 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 p -138.42 170.52 15.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.602 0.637 . . . . 0.0 110.358 -171.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.35 -27.65 48.67 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.284 0.634 . . . . 0.0 112.418 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -31.89 66.33 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.132 0.789 . . . . 0.0 113.132 175.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -68.28 -37.51 80.75 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 122.172 0.987 . . . . 0.0 109.956 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.0 mtt -74.7 5.22 5.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.429 2.292 . . . . 0.0 111.45 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -99.65 -7.95 25.05 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.017 1.327 . . . . 0.0 111.234 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.24 -23.66 68.3 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 119.09 0.859 . . . . 0.0 112.729 -175.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -153.13 168.07 27.17 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.994 2.118 . . . . 0.0 106.436 174.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.78 118.7 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 168.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 89.4 m -122.82 135.69 54.62 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.092 0.557 . . . . 0.0 109.503 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.69 139.64 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.0 131.01 73.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 174.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -120.19 97.35 5.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 t -83.56 119.02 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 pt -135.75 145.5 53.27 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -62.25 -58.92 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.256 2.637 . . . . 0.0 113.639 -169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.7 m -158.12 143.95 17.08 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.62 -15.94 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -168.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.26 -14.93 62.39 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.03 1.332 . . . . 0.0 114.439 -172.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.4 p -65.37 -22.01 66.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.471 1.032 . . . . 0.0 113.741 -169.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.19 -36.58 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.221 0.915 . . . . 0.0 111.39 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 t -66.64 -40.03 85.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 118.568 1.184 . . . . 0.0 108.633 170.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 56.9 m -61.04 -37.9 84.25 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.925 0.89 . . . . 0.0 111.994 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -61.61 -51.76 67.19 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 118.848 -0.596 . . . . 0.0 109.442 175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -49.48 77.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.975 0.352 . . . . 0.0 110.773 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -56.41 -54.27 47.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.46 1.104 . . . . 0.0 109.75 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.5 m -70.63 -38.89 73.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.646 -0.659 . . . . 0.0 110.949 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -63.21 -43.62 97.62 Favored 'General case' 0 C--O 1.239 0.528 0 O-C-N 120.894 -1.129 . . . . 0.0 110.944 177.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 mmp_? -66.72 -42.39 86.39 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 117.887 -1.054 . . . . 0.0 108.921 177.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -54.53 -38.05 66.1 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.973 1.26 . . . . 0.0 112.286 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.412 ' HA ' HG23 ' A' ' 102' ' ' VAL . 17.6 t30 -60.26 -51.36 69.88 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.077 0.853 . . . . 0.0 111.099 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.62 -34.09 69.54 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 118.989 -1.084 . . . . 0.0 111.709 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.24 -37.4 87.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 120.209 1.368 . . . . 0.0 109.922 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.42 92.81 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.839 0.455 . . . . 0.0 111.074 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.47 94.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.75 0.705 . . . . 0.0 111.368 173.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -65.36 -41.07 94.19 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.619 0.768 . . . . 0.0 110.103 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.01 -45.7 86.46 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.18 0.992 . . . . 0.0 110.812 173.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.87 -23.79 4.19 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.993 1.282 . . . . 0.0 113.773 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -147.97 66.14 1.1 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.166 1.386 . . . . 0.0 109.506 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.4 p -141.69 172.65 9.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -130.26 139.85 50.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.6 t -141.04 133.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -177.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -130.71 161.34 31.87 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.664 1.186 . . . . 0.0 109.645 176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 m -128.27 143.43 51.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -177.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.5 mt -131.91 135.93 57.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.0 m -142.2 158.81 43.31 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.906 0.882 . . . . 0.0 111.675 176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.76 40.06 0.92 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -126.15 163.84 22.24 Favored 'General case' 0 CA--C 1.516 -0.358 0 C-N-CA 125.259 1.423 . . . . 0.0 109.027 -168.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.9 mt -66.89 128.41 93.86 Favored Pre-proline 0 N--CA 1.444 -0.742 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -169.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.11 -33.78 94.91 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.742 1.628 . . . . 0.0 111.163 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -73.31 -27.09 61.34 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.51 -0.757 . . . . 0.0 112.223 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -48.64 63.8 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.834 1.197 . . . . 0.0 109.144 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -57.04 -42.41 80.45 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 122.307 0.243 . . . . 0.0 111.578 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.31 -42.26 96.43 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.662 0.665 . . . . 0.0 111.571 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.3 ttt85 -65.24 -42.31 93.48 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -59.69 -39.8 85.76 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.086 0.554 . . . . 0.0 111.22 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 90.3 m -60.76 -42.25 97.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.518 1.054 . . . . 0.0 110.505 176.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.29 -31.86 82.26 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-O 119.465 -0.631 . . . . 0.0 112.532 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.82 78.52 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.261 1.03 . . . . 0.0 111.368 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -106.6 -16.03 14.62 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.81 0.844 . . . . 0.0 112.277 -171.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 76.2 38.34 34.75 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 32.9 mm -67.29 144.97 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.674 1.19 . . . . 0.0 108.207 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -143.83 -35.37 0.37 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.229 1.012 . . . . 0.0 112.405 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -87.13 -14.82 40.23 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.406 0.683 . . . . 0.0 112.313 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.412 HG23 ' HA ' ' A' ' 68' ' ' ASN . 69.8 t -113.57 154.44 14.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -134.33 128.48 33.8 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 106.986 -1.486 . . . . 0.0 106.986 171.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.2 p -86.92 151.01 23.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.427 1.091 . . . . 0.0 109.251 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.1 mt -144.19 152.49 40.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.216 1.807 . . . . 0.0 106.507 -174.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 21.1 m -121.03 125.97 48.69 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 121.172 -0.955 . . . . 0.0 109.45 -176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.59 3.94 48.02 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.031 1.332 . . . . 0.0 110.149 169.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 66.0 t60 -48.18 135.42 13.27 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.716 2.007 . . . . 0.0 111.573 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 63.44 -38.93 0.18 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 128.805 2.842 . . . . 0.0 114.392 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -72.36 -39.02 68.39 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.14 0.882 . . . . 0.0 111.56 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 8.2 mmm 53.93 9.7 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.712 2.805 . . . . 0.0 116.586 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.7 m -60.93 -43.76 98.2 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 121.364 1.893 . . . . 0.0 111.813 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.26 -44.28 68.8 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 119.068 0.849 . . . . 0.0 109.824 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 119' ' ' VAL . . . -58.04 -47.07 91.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 123.96 0.79 . . . . 0.0 111.319 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -65.44 -37.58 87.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.505 0.722 . . . . 0.0 110.639 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.26 -35.55 63.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.336 -0.852 . . . . 0.0 112.37 -173.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -100.18 1.37 41.93 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.337 1.055 . . . . 0.0 112.168 -174.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.79 35.58 50.32 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.342 0.974 . . . . 0.0 113.003 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG23 ' HA2' ' A' ' 114' ' ' GLY . 21.1 m -131.38 21.38 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 124.658 1.183 . . . . 0.0 111.548 -169.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -107.89 110.66 22.48 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 72.2 mt -74.5 110.99 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -57.13 -38.35 73.32 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 126.113 1.765 . . . . 0.0 111.083 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -91.29 4.57 52.01 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.893 0.877 . . . . 0.0 112.109 -172.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 86.0 mt -130.87 -21.81 2.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.361 1.064 . . . . 0.0 112.747 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 53.77 38.99 29.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.597 1.159 . . . . 0.0 109.67 -168.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.8 tp -131.4 152.62 50.48 Favored 'General case' 0 C--N 1.342 0.248 0 C-N-CA 125.075 1.35 . . . . 0.0 107.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.87 155.19 31.12 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.551 0.691 . . . . 0.0 110.695 -173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.44 175.48 6.95 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.328 1.061 . . . . 0.0 111.679 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -113.57 85.31 2.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.6 m -141.48 164.57 29.86 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.594 0.758 . . . . 0.0 110.519 -168.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.14 152.43 20.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 O-C-N 121.636 -0.665 . . . . 0.0 109.424 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.5 159.63 41.85 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.572 1.149 . . . . 0.0 108.665 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 48.6 t -134.52 141.65 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 171.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 71.5 mt -129.9 123.17 30.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.087 1.755 . . . . 0.0 106.854 -169.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.63 164.35 26.06 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 169.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.03 -20.89 26.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.445 1.098 . . . . 0.0 112.785 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -81.4 0.08 39.11 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 120.835 -1.166 . . . . 0.0 112.394 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.71 28.3 73.22 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 119.367 0.985 . . . . 0.0 111.701 -171.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -99.03 133.06 43.85 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.5 t -75.66 127.26 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.8 t -102.15 -30.57 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.477 1.511 . . . . 0.0 109.636 -174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -153.41 147.95 26.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.04 140.39 24.34 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.2 144.12 27.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -130.56 79.68 1.91 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.657 -2.719 . . . . 0.0 103.657 -173.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 60.1 t -52.1 123.81 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -169.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -63.83 -14.59 54.33 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -169.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.2 mp0 -122.77 116.42 23.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.06 65.78 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.041 1.336 . . . . 0.0 111.242 169.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.19 10.81 2.18 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.959 1.304 . . . . 0.0 112.0 170.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -139.07 170.92 15.11 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.989 2.516 . . . . 0.0 107.319 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -134.92 154.36 79.2 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.145 -0.972 . . . . 0.0 111.085 -173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -54.47 149.81 37.06 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.915 3.077 . . . . 0.0 112.73 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -91.82 118.55 30.81 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 169.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -54.16 -25.4 22.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.046 1.338 . . . . 0.0 113.227 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -61.35 -37.42 83.26 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.765 0.712 . . . . 0.0 111.532 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -60.92 -54.64 52.39 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.189 -0.91 . . . . 0.0 112.115 -172.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.11 -26.64 30.44 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 CA-C-N 120.834 1.334 . . . . 0.0 111.433 176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -44.04 92.82 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 CA-C-N 120.191 1.36 . . . . 0.0 109.604 172.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.2 -38.29 90.54 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.27 0.941 . . . . 0.0 110.315 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.45 -45.8 85.9 Favored 'General case' 0 N--CA 1.456 -0.13 0 O-C-N 122.366 -0.209 . . . . 0.0 111.393 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.59 -51.38 51.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 118.635 -0.697 . . . . 0.0 111.447 -177.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.46 ' HA ' ' HE3' ' A' ' 167' ' ' LYS . . . -59.39 -31.24 69.06 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.276 174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 38.7 mt -88.8 -34.06 17.21 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.601 0.761 . . . . 0.0 111.924 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 82.1 t -63.4 -41.82 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.98 0.512 . . . . 0.0 111.063 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 164' ' ' ALA . 19.0 pttp . . . . . 0 C--O 1.249 1.057 0 CA-C-N 118.292 0.496 . . . . 0.0 111.143 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.46 -44.58 94.05 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.554 0.342 . . . . 0.0 111.752 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 40.4 51.57 2.85 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.769 2.028 . . . . 0.0 112.684 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 mt -63.71 146.28 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.9 p -112.71 160.43 17.93 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.294 1.038 . . . . 0.0 109.74 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -111.83 45.0 1.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.495 1.118 . . . . 0.0 108.743 174.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt 42.66 61.71 1.98 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.647 1.979 . . . . 0.0 112.346 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.44 -26.12 0.11 Allowed Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.568 1.08 . . . . 0.0 111.019 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.19 176.04 47.59 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 125.242 1.401 . . . . 0.0 109.872 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -64.31 158.62 47.84 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.158 2.572 . . . . 0.0 110.552 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.4 p -137.42 134.46 46.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -66.16 151.26 47.34 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.263 1.025 . . . . 0.0 111.163 -171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.2 mt -132.03 141.46 49.24 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 127.144 2.178 . . . . 0.0 105.886 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.66 -70.07 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.65 0.659 . . . . 0.0 110.013 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -77.67 169.54 54.74 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.516 0.579 . . . . 0.0 112.405 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -74.11 166.75 22.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.734 0.778 . . . . 0.0 110.967 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -70.23 115.6 9.6 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 168.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.8 t -74.96 153.66 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -124.83 156.29 38.05 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.804 0.841 . . . . 0.0 109.796 -169.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -57.29 140.1 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 123.414 0.686 . . . . 0.0 109.308 172.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.47 -20.05 48.89 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 125.431 1.491 . . . . 0.0 112.244 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -73.39 155.12 39.68 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.791 1.295 . . . . 0.0 110.038 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -72.9 132.91 44.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.77 -2.308 . . . . 0.0 104.77 169.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.06 160.51 29.71 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.274 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -59.29 -4.04 2.11 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.499 3.466 . . . . 0.0 117.85 -175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t0 52.91 55.38 9.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.755 1.265 . . . . 0.0 111.375 -174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -89.37 170.52 10.48 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.487 1.515 . . . . 0.0 110.859 -174.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.5 m -131.02 151.51 51.33 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.659 1.184 . . . . 0.0 108.341 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.34 163.78 18.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 127.691 2.397 . . . . 0.0 107.312 173.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 tp -86.69 138.69 31.44 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.0 p -71.16 166.09 22.2 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.11 -13.88 62.37 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 120.529 -1.357 . . . . 0.0 110.904 168.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.46 0.94 40.0 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.909 1.683 . . . . 0.0 111.497 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 21.0 mt 69.1 37.23 2.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.687 1.595 . . . . 0.0 111.687 176.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -125.41 164.17 21.02 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.991 1.316 . . . . 0.0 107.897 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -78.86 141.19 37.89 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.013 -1.054 . . . . 0.0 109.493 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -138.02 143.96 40.82 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 169.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.4 p -146.44 172.03 14.15 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.25 0.62 . . . . 0.0 109.934 -169.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.4 tp -44.21 -45.96 8.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.069 0.948 . . . . 0.0 111.582 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.89 -30.13 67.55 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.783 0.833 . . . . 0.0 112.465 -175.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -82.45 -40.22 21.48 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.84 0.856 . . . . 0.0 110.795 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -68.04 -39.04 83.16 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 123.207 0.603 . . . . 0.0 110.011 -171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -65.17 -4.63 5.29 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.45 -19.57 41.47 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.126 -0.984 . . . . 0.0 113.025 169.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.82 158.56 43.6 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.369 1.468 . . . . 0.0 107.074 173.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.9 t -60.88 119.76 5.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 169.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 99.0 m -127.64 128.76 46.05 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.007 0.432 . . . . 0.0 109.98 -169.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 71.3 mt -89.84 140.6 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.1 mm -121.15 133.34 68.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -128.57 95.74 4.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 -175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.8 m -77.38 134.24 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -143.26 157.6 59.72 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 126.083 1.753 . . . . 0.0 107.25 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -67.39 -54.15 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 121.721 1.614 . . . . 0.0 111.671 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 p -155.5 154.5 31.9 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.316 1.846 . . . . 0.0 107.187 -177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.408 HD11 ' CE3' ' A' ' 93' ' ' TRP . 9.3 tt -78.8 -14.73 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -169.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.52 -34.59 78.59 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -169.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 7.0 p -69.87 155.31 40.75 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.465 0.575 . . . . 0.0 111.201 -169.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.13 -39.06 93.95 Favored Glycine 0 CA--C 1.529 0.94 0 O-C-N 121.858 -0.526 . . . . 0.0 112.534 -178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.8 m -70.04 -40.54 78.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 118.174 0.987 . . . . 0.0 110.971 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 74.1 m -62.07 -43.88 97.89 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.589 0.755 . . . . 0.0 110.799 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -58.93 -56.16 25.8 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.512 1.525 . . . . 0.0 109.929 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.92 88.78 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.159 0.584 . . . . 0.0 111.156 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -56.05 -54.16 48.25 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.321 1.048 . . . . 0.0 109.697 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 18.8 m -64.95 -40.91 95.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.193 0.452 . . . . 0.0 110.441 -174.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.3 tpt85 -67.96 -43.08 79.87 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 121.104 -0.997 . . . . 0.0 111.26 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -70.74 -35.13 72.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.083 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.79 -41.44 74.11 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.263 169.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.417 ' HA ' HG23 ' A' ' 102' ' ' VAL . 22.3 t30 -61.81 -49.39 76.51 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 119.331 0.969 . . . . 0.0 111.31 -178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -67.91 -38.9 83.53 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.734 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -67.29 -38.25 84.72 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.091 1.314 . . . . 0.0 109.958 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.77 -36.99 86.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.425 0.69 . . . . 0.0 111.326 172.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.58 88.11 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 111.282 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.43 -41.09 93.9 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.267 0.627 . . . . 0.0 110.079 177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.29 -43.01 92.51 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.015 0.526 . . . . 0.0 110.444 173.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 -69.5 2.54 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 126.133 1.825 . . . . 0.0 110.685 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -85.3 67.76 10.26 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.078 1.351 . . . . 0.0 110.142 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.2 p -148.22 162.53 6.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -123.14 141.21 52.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 170.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.62 138.53 42.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -131.41 154.46 48.62 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.819 0.848 . . . . 0.0 109.664 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.543 ' HB ' HG22 ' A' ' 104' ' ' THR . 51.5 m -116.05 148.44 40.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 174.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 72.6 mt -126.91 135.67 63.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 174.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.1 m -136.57 150.64 48.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -84.69 49.78 1.78 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 169.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -137.44 162.56 33.33 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 127.208 2.203 . . . . 0.0 107.537 -169.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.12 138.12 92.13 Favored Pre-proline 0 N--CA 1.45 -0.439 0 CA-C-O 119.013 -0.517 . . . . 0.0 111.226 -168.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.67 -37.13 81.57 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.103 1.869 . . . . 0.0 111.654 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -69.35 -33.64 73.4 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.933 -0.556 . . . . 0.0 111.106 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.5 -50.81 49.42 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.069 0.849 . . . . 0.0 109.647 177.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -55.94 -49.12 74.37 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.147 0.579 . . . . 0.0 110.919 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.06 -45.11 93.73 Favored 'General case' 0 CA--C 1.527 0.069 0 C-N-CA 123.436 0.695 . . . . 0.0 111.873 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 tpt85 -66.4 -36.99 84.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.49 0.586 . . . . 0.0 110.412 -175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.408 ' CE3' HD11 ' A' ' 55' ' ' ILE . 65.7 t90 -65.53 -41.61 92.89 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.036 0.534 . . . . 0.0 110.177 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 92.9 m -61.7 -41.67 97.9 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 120.999 -1.063 . . . . 0.0 110.633 176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.03 -32.21 83.42 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.24 0.924 . . . . 0.0 112.378 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.89 -39.63 95.06 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.437 1.118 . . . . 0.0 110.388 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -85.11 -20.87 29.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.746 0.818 . . . . 0.0 112.36 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.63 29.63 61.2 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 118.613 0.642 . . . . 0.0 111.724 -172.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mt -69.56 141.84 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.844 1.258 . . . . 0.0 108.095 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -147.97 -32.86 0.26 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -75.25 -16.37 60.46 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.728 0.694 . . . . 0.0 111.977 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 68' ' ' ASN . 96.4 t -111.58 150.08 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 169.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.39 148.01 49.23 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 169.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.543 HG22 ' HB ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -105.2 151.73 23.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -175.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.3 mt -136.38 152.79 51.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.6 m -124.27 168.61 12.74 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.873 -0.517 . . . . 0.0 112.367 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -47.47 114.34 0.86 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.008 0.923 . . . . 0.0 109.339 172.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -39.63 75.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.759 -175.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 20.9 ttp180 157.18 -38.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.556 2.343 . . . . 0.0 105.652 -169.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.41 141.97 45.56 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.162 1.385 . . . . 0.0 107.353 170.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.413 ' HA ' ' CE2' ' A' ' 113' ' ' PHE . 97.2 mmm -55.85 19.04 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 130.059 3.344 . . . . 0.0 115.698 177.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -52.63 -42.11 64.32 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 120.863 1.665 . . . . 0.0 112.404 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 111' ' ' MET . 40.6 p90 -56.03 -25.62 45.51 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.662 1.985 . . . . 0.0 114.344 176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.6 -35.89 2.95 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 118.565 0.621 . . . . 0.0 111.675 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.32 -49.12 78.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.154 1.382 . . . . 0.0 109.97 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.96 -5.85 59.3 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.89 0.876 . . . . 0.0 112.415 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.2 10.76 14.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.911 1.284 . . . . 0.0 110.22 -175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.63 74.36 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.762 -1.021 . . . . 0.0 114.599 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.9 m -126.94 -5.2 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 119.007 1.404 . . . . 0.0 112.522 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -78.4 105.96 10.01 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 168.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.9 mt -76.06 97.13 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 -175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -50.15 -41.56 49.25 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.87 1.668 . . . . 0.0 111.998 -173.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -73.38 -10.18 59.47 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.863 0.865 . . . . 0.0 113.118 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 54.4 mt -123.63 -20.78 5.4 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.555 1.142 . . . . 0.0 112.074 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 54.42 36.91 26.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.148 1.379 . . . . 0.0 109.944 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 85.5 mt -117.04 160.01 21.65 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.466 1.106 . . . . 0.0 108.351 173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.45 137.26 32.48 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.76 163.63 25.33 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.749 0.819 . . . . 0.0 111.216 177.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -94.18 110.91 22.61 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 169.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 36.2 m -166.42 173.05 10.29 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.437 1.495 . . . . 0.0 108.144 -172.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 m -143.12 152.17 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 121.257 -0.902 . . . . 0.0 110.691 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -136.45 161.31 36.2 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.126 1.37 . . . . 0.0 108.003 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.23 139.49 46.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 171.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.06 116.66 24.65 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.49 1.516 . . . . 0.0 107.72 -169.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -64.49 160.32 19.6 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.868 1.267 . . . . 0.0 108.83 169.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -64.25 -8.5 12.88 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -94.86 5.03 53.07 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.652 -1.28 . . . . 0.0 111.827 171.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.65 26.97 68.23 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.362 0.982 . . . . 0.0 112.086 -175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -91.67 139.42 30.7 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.2 t -73.9 108.46 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.37 -22.94 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 118.544 0.611 . . . . 0.0 110.615 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -153.92 143.71 21.81 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -144.82 145.02 31.44 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.59 142.81 29.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -132.53 106.04 7.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.503 1.921 . . . . 0.0 106.178 -170.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 13.9 t -67.52 131.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 m -68.59 0.53 4.02 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.823 0.849 . . . . 0.0 113.058 178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -139.16 110.12 6.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 126.781 2.032 . . . . 0.0 106.042 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -60.28 -28.55 68.17 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.146 0.43 . . . . 0.0 111.471 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.0 p -70.43 -9.94 57.79 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.265 1.826 . . . . 0.0 113.197 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -122.15 167.65 12.92 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.82 1.648 . . . . 0.0 108.905 -169.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -128.52 153.21 79.33 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.252 0.933 . . . . 0.0 109.715 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -74.07 152.07 45.31 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.844 1.696 . . . . 0.0 108.242 174.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -69.65 119.35 13.75 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 173.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -50.61 -27.36 6.71 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.143 1.777 . . . . 0.0 113.331 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -61.14 -34.44 75.01 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.753 -0.592 . . . . 0.0 111.447 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -66.28 -49.92 51.88 Favored Pre-proline 0 N--CA 1.467 0.423 0 CA-C-O 117.944 -1.026 . . . . 0.0 112.542 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.05 -27.77 49.71 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 CA-C-N 121.403 1.537 . . . . 0.0 111.896 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -44.13 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 119.93 1.241 . . . . 0.0 109.545 171.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -64.12 -31.79 73.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.13 0.877 . . . . 0.0 111.179 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.76 -49.6 61.65 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 117.972 0.351 . . . . 0.0 111.014 172.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.64 -46.49 75.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.8 0.44 . . . . 0.0 111.673 -174.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.19 -28.59 68.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.673 -178.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.06 -35.84 80.72 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.583 0.629 . . . . 0.0 111.416 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 25.0 mt -76.69 -43.21 38.62 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.411 0.551 . . . . 0.0 111.672 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.81 -4.49 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -169.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.07 0.85 . . . . 0.0 110.011 174.686 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttm . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.91 146.55 5.9 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.86 1.264 . . . . 0.0 112.148 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -143.81 -29.38 0.51 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.344 1.458 . . . . 0.0 110.824 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 5' ' ' THR 0.273 18.1 mt 69.29 171.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 126.665 1.986 . . . . 0.0 111.886 169.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 4' ' ' ILE . 1.8 m -141.4 156.89 45.76 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 128.428 2.691 . . . . 0.0 105.903 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -135.93 119.54 17.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HE2' HG21 ' A' ' 150' ' ' THR . 13.1 tppt? 42.14 43.45 2.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.213 1.805 . . . . 0.0 111.591 -172.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.7 11.31 85.44 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 118.539 -1.145 . . . . 0.0 114.165 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.6 139.54 15.73 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 170.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.21 155.37 69.63 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.193 1.929 . . . . 0.0 111.381 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -135.07 -167.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.473 1.509 . . . . 0.0 108.082 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.3 m -138.68 160.01 40.69 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 4' ' ' ILE . 1.2 tp -126.77 128.26 46.33 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.93 1.292 . . . . 0.0 109.686 -170.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 66.2 t -70.4 157.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.43 -154.5 40.47 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 123.617 0.627 . . . . 0.0 112.168 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -131.95 155.59 47.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.65 1.18 . . . . 0.0 109.064 173.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.29 152.25 45.72 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 169.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.2 t -123.72 154.38 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.751 1.62 . . . . 0.0 106.96 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 57.8 pttt -128.57 157.86 40.06 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.006 0.922 . . . . 0.0 111.764 -169.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.6 t -58.26 144.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.899 1.28 . . . . 0.0 109.332 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.61 -23.61 18.66 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.685 1.136 . . . . 0.0 111.952 176.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -73.49 153.63 40.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.421 1.11 . . . . 0.0 109.519 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.4 tp60 -70.28 128.23 35.52 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.93 153.99 78.17 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.466 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.68 -31.14 59.17 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.263 2.642 . . . . 0.0 115.315 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.2 t70 47.76 84.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.343 1.857 . . . . 0.0 113.357 -173.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -126.6 177.88 6.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.596 1.158 . . . . 0.0 109.228 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.7 m -109.59 151.05 27.32 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.651 1.181 . . . . 0.0 109.542 -169.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.21 173.76 12.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 128.208 2.603 . . . . 0.0 106.098 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -96.99 156.85 16.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 168.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.2 p -71.82 174.03 7.45 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.088 -1.008 . . . . 0.0 108.847 169.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -67.2 -11.14 56.58 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.26 -0.9 . . . . 0.0 110.842 168.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m -73.22 -65.82 0.76 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 169.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 pp 154.49 12.89 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 130.581 3.552 . . . . 0.0 112.168 174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.82 144.53 30.37 Favored 'General case' 0 N--CA 1.463 0.208 0 O-C-N 120.732 -1.23 . . . . 0.0 109.181 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -60.51 133.19 55.86 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.657 -0.652 . . . . 0.0 111.227 -177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -140.48 147.1 39.09 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 126.209 1.804 . . . . 0.0 107.503 169.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -131.63 159.1 39.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -59.03 -31.17 68.59 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.08 66.25 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.788 0.835 . . . . 0.0 113.191 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -72.25 -35.66 68.86 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.428 0.632 . . . . 0.0 110.656 175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 51.8 mtt -75.78 -35.85 59.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.201 1.0 . . . . 0.0 111.177 -171.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -63.97 -3.82 2.87 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -171.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.37 -16.05 13.6 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 119.485 1.038 . . . . 0.0 113.009 169.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -141.49 157.23 45.4 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.864 1.666 . . . . 0.0 107.113 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 81.3 t -54.85 124.97 8.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.2 m -120.46 149.31 42.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.021 0.528 . . . . 0.0 110.829 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.463 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.2 mt -116.18 141.42 33.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.5 mm -123.24 140.15 47.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 84.17 2.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.2 m -71.93 135.66 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.78 157.05 58.99 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 125.709 1.604 . . . . 0.0 108.955 177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -73.56 -61.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.305 2.003 . . . . 0.0 110.641 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.5 p -144.25 147.77 34.01 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.39 1.476 . . . . 0.0 107.172 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.8 tt -98.82 -31.38 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 122.815 0.446 . . . . 0.0 111.438 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -64.5 -24.91 67.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.2 t -64.43 -21.25 66.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.218 1.007 . . . . 0.0 112.01 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.54 -11.95 64.56 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 121.029 -1.044 . . . . 0.0 114.094 171.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.37 -30.29 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.198 1.499 . . . . 0.0 110.542 174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 59.1 m -61.14 -6.12 1.85 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.337 1.455 . . . . 0.0 113.365 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -52.38 -43.63 64.84 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 120.481 1.491 . . . . 0.0 110.15 169.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.17 4.42 5.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.153 0.981 . . . . 0.0 112.92 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -129.57 -83.36 0.56 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.6 m -55.59 -51.68 66.33 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.025 1.33 . . . . 0.0 111.814 -170.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -70.72 -46.31 63.31 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 121.518 -0.739 . . . . 0.0 110.014 -175.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -41.21 93.95 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.259 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -59.98 -31.19 69.67 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 120.455 1.48 . . . . 0.0 112.354 177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 t30 -60.98 -43.66 98.51 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.252 0.933 . . . . 0.0 110.678 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HB3' ' HE3' ' A' ' 73' ' ' LYS . 28.3 mt-10 -65.6 -51.4 59.94 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 174.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -63.1 -35.17 79.36 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.621 0.768 . . . . 0.0 111.303 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.17 -42.87 95.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 118.529 0.604 . . . . 0.0 110.783 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.38 -36.3 81.07 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 119.153 -0.451 . . . . 0.0 111.644 174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 69' ' ' GLU . 56.0 mttt -66.02 -41.53 90.87 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 118.911 0.778 . . . . 0.0 110.702 178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.04 -46.62 86.69 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.964 0.906 . . . . 0.0 109.808 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.53 -33.93 5.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.296 1.426 . . . . 0.0 111.071 176.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -156.95 120.9 4.28 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.98 1.312 . . . . 0.0 108.827 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.4 p -159.59 171.31 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 126.837 2.055 . . . . 0.0 105.715 169.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -119.04 138.72 52.66 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 169.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.4 p -154.3 146.7 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 O-C-N 120.809 -1.182 . . . . 0.0 110.305 -174.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -141.55 170.2 16.17 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.781 1.232 . . . . 0.0 110.199 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.4 m -126.51 146.7 50.01 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 169.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 73.0 mt -127.34 131.1 70.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -131.37 144.27 51.1 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 122.942 0.497 . . . . 0.0 110.978 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -90.72 48.87 1.58 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -137.82 161.67 35.97 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.14 1.776 . . . . 0.0 106.864 -169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -71.48 140.46 84.65 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -169.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.84 -47.59 20.73 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.045 2.497 . . . . 0.0 112.365 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -72.95 -30.11 63.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 119.161 -0.447 . . . . 0.0 111.76 -173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.82 -36.85 85.66 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.855 0.752 . . . . 0.0 110.166 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -68.56 -48.87 63.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.975 0.91 . . . . 0.0 110.161 174.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.66 77.89 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 117.943 0.338 . . . . 0.0 110.508 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.2 -45.06 93.5 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 124.345 1.058 . . . . 0.0 109.769 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 28.4 t90 -63.33 -43.46 97.71 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 98.5 m -66.94 -44.02 81.69 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.804 -0.56 . . . . 0.0 111.23 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.72 -38.97 96.3 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.628 0.632 . . . . 0.0 111.987 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.62 98.89 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.788 0.835 . . . . 0.0 110.314 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -78.85 -17.77 55.09 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.69 0.796 . . . . 0.0 112.429 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 77.59 25.63 62.63 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.095 0.855 . . . . 0.0 111.733 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 77.7 mt -69.84 141.94 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.789 1.236 . . . . 0.0 108.244 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.73 -28.72 0.43 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.574 1.15 . . . . 0.0 112.542 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -76.82 -24.4 52.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.015 0.825 . . . . 0.0 111.264 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 t -105.63 154.8 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -130.79 127.56 38.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.44 153.54 31.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.384 0.611 . . . . 0.0 109.797 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.7 mt -142.62 159.92 41.31 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.609 1.964 . . . . 0.0 107.546 -174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 m -124.0 130.2 52.18 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.844 1.258 . . . . 0.0 109.485 -169.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -133.73 26.18 4.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.653 1.181 . . . . 0.0 109.449 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -68.11 -20.54 64.93 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.805 1.642 . . . . 0.0 113.23 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -146.29 153.28 40.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 46.32 56.07 6.69 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -168.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 60.2 mtp -64.63 28.23 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.974 2.909 . . . . 0.0 114.071 -169.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.8 m -55.21 -36.25 65.75 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 125.935 1.694 . . . . 0.0 112.737 -169.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -70.6 -52.31 22.35 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.876 0.762 . . . . 0.0 110.081 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.12 85.31 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 -178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.17 -56.79 17.23 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.43 1.092 . . . . 0.0 109.38 170.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.43 -40.29 73.9 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -169.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -2.49 37.25 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.246 0.618 . . . . 0.0 111.954 176.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 68.47 47.99 53.87 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 125.008 1.289 . . . . 0.0 113.034 173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.4 m -127.84 -10.64 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 117.956 0.878 . . . . 0.0 112.272 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.37 107.67 0.96 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 169.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 88.1 mt -74.8 110.39 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -52.26 -44.21 64.78 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 125.647 1.579 . . . . 0.0 110.896 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -80.04 -3.15 47.33 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.393 0.677 . . . . 0.0 112.457 -171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.6 mt -123.76 -25.58 4.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.011 0.924 . . . . 0.0 112.381 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 58.37 35.19 24.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.79 0.836 . . . . 0.0 109.845 -168.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.1 mt -128.17 157.5 40.65 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.18 146.09 28.02 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.74 159.06 30.93 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.533 0.733 . . . . 0.0 111.361 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -81.2 103.29 10.89 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 169.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -149.45 168.88 22.23 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.221 1.409 . . . . 0.0 107.669 -174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.94 151.75 20.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 121.564 -0.71 . . . . 0.0 110.059 -177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -135.96 157.16 47.5 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.607 1.163 . . . . 0.0 108.722 174.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.98 139.29 49.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -125.5 132.69 52.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.974 1.31 . . . . 0.0 108.058 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.31 165.93 17.56 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 125.065 1.346 . . . . 0.0 109.188 169.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -58.69 -20.27 47.01 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -84.4 -2.56 57.36 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.601 -1.312 . . . . 0.0 112.271 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 73.19 23.24 77.95 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 121.078 -1.014 . . . . 0.0 112.42 -172.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -89.22 145.36 25.45 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.799 1.3 . . . . 0.0 107.556 170.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.8 t -71.99 134.21 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 99.6 t -110.42 -30.82 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 125.777 1.631 . . . . 0.0 109.405 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -152.14 145.52 24.78 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.01 141.31 25.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 169.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.44 145.34 27.95 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -132.08 96.9 4.01 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.818 2.047 . . . . 0.0 106.109 -169.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -65.59 140.52 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -175.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 p -68.0 -12.78 61.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.778 1.231 . . . . 0.0 113.274 -176.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -143.97 126.06 15.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -174.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.88 -21.06 34.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.522 HG21 ' HE2' ' A' ' 7' ' ' LYS . 78.8 p -75.04 -25.54 58.78 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.412 -0.805 . . . . 0.0 109.955 171.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -80.03 172.6 13.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.462 1.505 . . . . 0.0 107.683 169.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -140.74 157.37 67.89 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 120.702 -1.249 . . . . 0.0 110.109 -174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 165.8 30.89 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.841 2.361 . . . . 0.0 110.083 173.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -90.82 118.27 30.1 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 172.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -49.72 -28.75 6.48 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.983 1.713 . . . . 0.0 113.169 176.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -59.9 -36.09 76.24 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 118.516 0.598 . . . . 0.0 110.801 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -65.03 -52.94 45.4 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 118.274 -0.869 . . . . 0.0 112.261 -172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.61 -24.97 41.05 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 CA-C-N 121.083 1.423 . . . . 0.0 111.795 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.71 -45.89 97.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 CA-C-N 120.215 1.371 . . . . 0.0 109.869 170.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.94 -32.8 72.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.213 0.915 . . . . 0.0 110.345 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.63 -55.27 12.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.922 0.489 . . . . 0.0 111.614 172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.35 -42.63 83.2 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.161 0.584 . . . . 0.0 112.027 -171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.98 -29.81 65.55 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.612 0.765 . . . . 0.0 111.826 -177.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -66.95 -30.74 70.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.063 0.545 . . . . 0.0 111.914 178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 57.3 mt -98.35 -29.19 13.3 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.3 m -73.23 -8.91 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 C--O 1.25 1.088 0 C-N-CA 123.915 0.886 . . . . 0.0 110.024 176.686 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.22 76.29 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.949 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 42.59 53.55 4.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.21 1.804 . . . . 0.0 111.812 176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.5 mt -58.91 144.9 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.2 p -111.5 161.11 16.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.998 1.319 . . . . 0.0 109.753 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -128.06 54.36 1.73 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.704 1.202 . . . . 0.0 108.437 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt 41.11 62.33 1.49 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.941 2.096 . . . . 0.0 113.115 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 165.47 -26.74 0.18 Allowed Glycine 0 CA--C 1.526 0.731 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.591 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.68 174.95 46.09 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.271 0.939 . . . . 0.0 110.767 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.3 164.36 6.97 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 123.97 3.113 . . . . 0.0 113.188 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.91 139.78 49.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.916 1.286 . . . . 0.0 108.632 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.6 m -65.48 149.95 49.17 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.466 0.651 . . . . 0.0 109.347 173.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.2 mt -129.41 134.66 47.96 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 126.65 1.98 . . . . 0.0 107.941 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.66 140.65 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.07 -166.68 42.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.73 155.75 48.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.155 1.382 . . . . 0.0 109.224 -176.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -63.16 112.34 2.61 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 m -73.17 169.0 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.49 158.27 44.35 Favored 'General case' 0 C--O 1.233 0.21 0 O-C-N 121.636 -0.665 . . . . 0.0 109.506 -177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.9 t -56.29 133.52 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.98 -18.88 56.48 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.933 1.254 . . . . 0.0 112.257 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -70.96 153.38 42.71 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 119.065 1.432 . . . . 0.0 109.843 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.7 tp60 -80.42 130.0 34.88 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 172.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.59 157.38 27.22 Favored Pre-proline 0 CA--C 1.544 0.733 0 CA-C-O 119.327 -0.368 . . . . 0.0 111.169 173.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -59.54 -7.0 4.84 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 124.458 3.438 . . . . 0.0 118.44 -174.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.3 t0 53.5 56.17 7.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.939 1.352 . . . . 0.0 110.894 -169.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -86.01 169.78 12.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.667 1.987 . . . . 0.0 110.192 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 m -130.78 147.81 52.48 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.442 1.097 . . . . 0.0 108.189 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.9 m -141.37 162.38 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 126.297 1.839 . . . . 0.0 107.034 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.03 141.65 29.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -69.66 162.78 26.99 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -64.57 -17.5 64.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 120.051 -1.656 . . . . 0.0 111.399 169.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 p -85.1 3.18 40.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.539 1.936 . . . . 0.0 112.129 175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 22.0 mt 73.62 33.47 1.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.398 1.879 . . . . 0.0 113.032 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -115.45 164.54 14.13 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.085 1.354 . . . . 0.0 108.021 171.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.22 143.42 35.36 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 120.445 -1.409 . . . . 0.0 109.12 172.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -141.14 146.08 36.56 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 12.5 p -147.66 169.68 19.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.0 tp -47.69 -41.88 23.63 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.38 0.672 . . . . 0.0 111.651 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.44 64.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.776 0.83 . . . . 0.0 112.751 -178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -77.96 -40.45 39.38 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.827 0.851 . . . . 0.0 110.607 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.7 mtt -66.8 -24.59 66.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.179 0.991 . . . . 0.0 111.583 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -55.95 -14.02 2.24 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.541 1.137 . . . . 0.0 113.631 172.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.86 -27.42 50.28 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.312 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -155.01 169.47 24.02 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 118.959 1.379 . . . . 0.0 109.516 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.21 125.25 17.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 168.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.3 m -129.69 131.93 46.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.887 0.475 . . . . 0.0 111.038 -168.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.554 ' HB ' HG23 ' A' ' 79' ' ' VAL . 5.4 mt -89.68 141.96 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 172.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -118.83 136.33 56.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 172.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.2 m -128.11 90.33 3.07 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.578 1.151 . . . . 0.0 108.037 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.79 139.05 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.63 144.69 45.79 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 168.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.97 -45.03 34.88 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.292 2.661 . . . . 0.0 112.465 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -160.04 168.15 26.24 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 106.542 174.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 tt -107.61 172.48 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.375 0.67 . . . . 0.0 110.14 -170.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.3 25.52 11.25 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.499 1.52 . . . . 0.0 113.396 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.2 p -75.23 -15.36 60.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.399 1.079 . . . . 0.0 112.253 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.79 0.1 86.13 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.226 0.917 . . . . 0.0 112.406 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -129.16 -46.75 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 118.748 1.274 . . . . 0.0 109.076 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.3 m -65.07 -28.57 69.55 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.281 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -53.96 -32.71 54.71 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.423 1.489 . . . . 0.0 111.982 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.63 -52.55 60.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.521 0.601 . . . . 0.0 111.369 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -55.69 -59.08 5.36 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 123.803 0.841 . . . . 0.0 110.424 -169.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -64.38 -40.78 96.49 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.024 -0.513 . . . . 0.0 112.021 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -74.71 -30.84 61.68 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.432 1.469 . . . . 0.0 111.45 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -63.52 -42.44 98.45 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.191 170.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -59.83 -37.63 79.76 Favored 'General case' 0 C--N 1.334 -0.067 0 CA-C-N 120.069 1.304 . . . . 0.0 111.852 174.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -60.41 -48.65 80.84 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 118.776 0.716 . . . . 0.0 111.036 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.57 -53.48 54.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.02 0.928 . . . . 0.0 109.51 176.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.7 -39.11 83.48 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 123.553 0.741 . . . . 0.0 111.363 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.79 -39.05 87.45 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 118.265 0.484 . . . . 0.0 111.104 176.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.26 -33.82 73.83 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.943 -0.551 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 mmtt -69.73 -41.34 75.41 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.007 0.821 . . . . 0.0 109.939 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.56 -43.54 98.55 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.496 0.589 . . . . 0.0 110.268 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.44 -21.23 39.31 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 124.676 1.132 . . . . 0.0 112.686 175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -153.04 100.74 2.51 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 124.735 1.214 . . . . 0.0 109.111 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.9 174.35 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 126.913 2.085 . . . . 0.0 105.433 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -129.65 142.73 50.67 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 169.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.6 p -151.98 144.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.85 166.17 23.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.242 1.417 . . . . 0.0 108.974 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.7 m -126.3 142.01 51.69 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.5 mt -128.59 137.92 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.1 t -147.36 165.41 30.27 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.247 0.546 . . . . 0.0 111.76 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.09 -6.93 59.67 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.494 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -70.67 164.02 25.88 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.523 1.129 . . . . 0.0 110.462 -174.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.5 135.04 96.08 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.25 -34.03 88.89 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.893 1.728 . . . . 0.0 111.522 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -70.08 -31.12 68.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.505 0.593 . . . . 0.0 111.697 177.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.82 75.23 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.069 0.85 . . . . 0.0 109.273 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -59.66 -43.37 93.98 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 119.038 -0.506 . . . . 0.0 111.582 174.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.86 -41.94 88.21 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.704 0.684 . . . . 0.0 111.153 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.5 tpt85 -69.37 -39.18 78.2 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 121.828 -0.545 . . . . 0.0 110.235 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -64.32 -40.25 95.53 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.795 0.438 . . . . 0.0 110.298 174.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 56.7 m -60.16 -38.47 83.25 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 121.122 -0.986 . . . . 0.0 110.828 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.98 -29.09 74.46 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.109 -0.829 . . . . 0.0 112.764 175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.8 71.6 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.712 1.256 . . . . 0.0 110.21 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -89.06 -17.88 28.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.05 39.27 24.19 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.7 mm -65.74 143.99 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.362 1.065 . . . . 0.0 108.152 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -144.12 -38.07 0.31 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.577 1.151 . . . . 0.0 112.405 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -83.9 -18.72 36.46 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.428 0.691 . . . . 0.0 112.179 -177.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.55 161.72 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -136.01 128.0 29.56 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.6 p -80.85 149.11 29.65 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.609 0.764 . . . . 0.0 109.278 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.0 mt -142.67 148.73 37.84 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.137 1.775 . . . . 0.0 106.239 -175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 74.2 m -119.04 126.47 51.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.541 1.064 . . . . 0.0 110.182 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -82.99 -21.23 34.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.764 1.626 . . . . 0.0 109.779 169.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.7 t60 31.68 -73.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.397 1 C-N-CA 132.221 4.208 . . . . 0.0 117.413 173.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -139.99 -0.44 1.67 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.169 1.387 . . . . 0.0 111.65 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -74.31 -38.72 63.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.281 0.946 . . . . 0.0 109.882 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 34.0 mmm 53.29 8.73 0.12 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 128.904 2.882 . . . . 0.0 116.595 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 45.9 p -59.79 -41.33 90.92 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 122.407 2.367 . . . . 0.0 111.693 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -60.57 -59.71 4.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.45 -41.59 99.58 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-O 119.994 -0.337 . . . . 0.0 112.61 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -58.36 -41.96 85.89 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.439 1.496 . . . . 0.0 110.521 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -98.24 -23.22 15.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -169.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -84.33 1.41 45.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.818 1.19 . . . . 0.0 112.749 177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 75.18 28.03 62.93 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-O 118.257 -1.302 . . . . 0.0 113.106 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.6 m -125.4 -8.39 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 119.629 1.715 . . . . 0.0 113.493 -171.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -76.67 102.69 6.28 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 169.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.19 104.14 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -175.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -55.0 -38.35 67.74 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.45 1.1 . . . . 0.0 110.796 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -65.63 -16.08 63.38 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.135 0.974 . . . . 0.0 112.869 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 61.2 mt -127.3 -18.76 4.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.691 1.196 . . . . 0.0 112.502 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 53.51 40.08 30.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.523 1.129 . . . . 0.0 109.23 -168.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.2 tp -136.44 153.71 50.99 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.623 1.169 . . . . 0.0 107.953 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.9 mt -75.63 156.43 34.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.592 0.633 . . . . 0.0 111.017 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -74.73 -172.39 1.54 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.435 1.494 . . . . 0.0 110.513 169.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -117.95 17.63 14.12 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.343 1.057 . . . . 0.0 111.903 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 7.2 m -64.71 170.24 4.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.733 2.013 . . . . 0.0 113.417 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.08 151.66 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.332 1.053 . . . . 0.0 109.816 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -141.72 162.28 35.88 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.26 145.6 31.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 171.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 74.1 mt -128.72 128.11 43.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.982 1.713 . . . . 0.0 107.191 -169.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -68.42 167.12 15.35 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.842 0.857 . . . . 0.0 109.815 169.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.18 -24.15 52.45 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.128 0.971 . . . . 0.0 112.609 171.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -78.41 -4.13 46.77 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.796 -1.19 . . . . 0.0 112.189 174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 70.52 24.5 76.77 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 121.184 -0.948 . . . . 0.0 112.246 -172.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -91.78 142.69 27.31 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.17 129.71 32.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.26 -15.71 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.685 0.794 . . . . 0.0 111.636 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -153.05 144.36 23.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 169.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -143.46 137.51 28.63 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -149.77 130.07 13.73 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -106.8 144.38 33.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.83 -14.32 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.8 m 61.72 -15.27 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 127.299 2.24 . . . . 0.0 115.204 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -149.4 113.96 5.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -58.06 -31.53 67.16 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.145 0.578 . . . . 0.0 111.872 -174.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 p -73.46 7.23 2.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.744 1.218 . . . . 0.0 113.718 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -129.83 176.64 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 119.786 1.176 . . . . 0.0 110.516 172.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.77 150.6 70.46 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.494 1.118 . . . . 0.0 110.282 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.09 154.51 42.13 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.472 2.781 . . . . 0.0 110.388 -169.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -79.2 115.25 18.74 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -52.78 -26.44 14.31 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.852 1.661 . . . . 0.0 113.198 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -61.57 -36.08 79.63 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.049 0.84 . . . . 0.0 111.404 178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -58.49 -57.84 23.51 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.596 0.634 . . . . 0.0 112.033 -172.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.24 -24.34 32.17 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.118 1.212 . . . . 0.0 111.684 177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.99 -45.26 99.11 Favored 'Isoleucine or valine' 0 C--N 1.343 0.326 0 CA-C-N 120.139 1.336 . . . . 0.0 109.605 171.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.27 -33.36 75.35 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.084 0.856 . . . . 0.0 110.494 -177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -64.63 -56.9 10.92 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.373 0.269 . . . . 0.0 111.361 172.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.1 -45.37 88.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.422 0.689 . . . . 0.0 112.307 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -26.43 67.67 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 118.53 0.605 . . . . 0.0 111.986 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.75 -27.63 65.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.089 0.556 . . . . 0.0 112.228 176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 91.5 mt -102.46 -28.2 12.34 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -169.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.7 m -68.67 -18.47 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.386 1.075 . . . . 0.0 109.938 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.66 173.26 7.12 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.066 0.936 . . . . 0.0 110.78 -173.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -149.39 157.62 43.47 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.323 3.449 . . . . 0.0 104.451 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.442 HD12 HD21 ' A' ' 13' ' ' LEU . 51.5 mt -140.98 143.8 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 -169.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.5 p -82.49 158.81 23.05 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.839 1.2 . . . . 0.0 110.621 174.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -132.12 85.85 2.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt 43.03 37.59 1.19 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 127.297 2.239 . . . . 0.0 115.441 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.96 -26.61 0.16 Allowed Glycine 0 CA--C 1.525 0.711 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.665 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -173.09 171.03 44.17 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.773 1.287 . . . . 0.0 112.054 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.83 151.82 51.71 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.842 3.028 . . . . 0.0 111.696 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.37 145.75 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 125.852 1.661 . . . . 0.0 108.519 171.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.8 m -76.45 141.67 41.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.928 1.691 . . . . 0.0 111.103 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.442 HD21 HD12 ' A' ' 4' ' ' ILE . 12.2 mt -85.94 137.82 32.46 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 169.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 p -75.67 -21.0 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.54 -177.38 19.34 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.418 0.532 . . . . 0.0 112.243 -169.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -64.23 138.22 58.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.804 1.242 . . . . 0.0 111.142 -172.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -78.82 143.07 36.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.3 153.94 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -130.94 157.12 43.81 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.358 1.063 . . . . 0.0 110.731 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 80.3 t -58.75 143.0 13.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.001 0.92 . . . . 0.0 109.034 173.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.57 -24.0 13.94 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.872 1.225 . . . . 0.0 112.42 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -73.79 155.21 39.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 118.718 1.259 . . . . 0.0 109.848 176.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -70.77 128.86 37.51 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 169.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.85 153.74 78.56 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 119.134 -0.46 . . . . 0.0 110.247 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.23 -32.03 69.07 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.65 2.9 . . . . 0.0 114.655 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 57.16 81.4 0.14 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.486 1.915 . . . . 0.0 113.138 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -127.59 -174.77 3.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.738 1.615 . . . . 0.0 109.564 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -115.64 155.91 26.82 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.856 1.262 . . . . 0.0 110.251 -168.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.12 159.48 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 127.836 2.454 . . . . 0.0 106.555 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 tp -88.18 140.65 29.26 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 120.958 -1.089 . . . . 0.0 109.323 176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 76.5 p -73.33 170.0 15.94 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -68.08 -13.95 62.6 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.516 -1.365 . . . . 0.0 111.45 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 m -82.05 0.4 40.58 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.254 1.421 . . . . 0.0 111.622 178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp 58.03 47.1 15.31 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.039 1.336 . . . . 0.0 111.346 -173.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.22 166.56 16.86 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.192 1.397 . . . . 0.0 107.528 169.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -85.02 141.98 29.91 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.101 -0.999 . . . . 0.0 109.742 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -138.93 150.88 46.42 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 126.257 1.823 . . . . 0.0 106.155 169.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.2 p -146.07 168.52 20.73 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.297 -0.877 . . . . 0.0 109.304 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 tt -58.64 -31.53 68.22 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.864 -0.522 . . . . 0.0 111.193 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . . . -50.4 -28.62 8.47 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 113.828 170.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -89.73 -38.7 13.65 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.91 1.284 . . . . 0.0 110.804 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.0 mtt -68.66 -36.77 79.0 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.652 0.781 . . . . 0.0 110.614 -172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' HE3' ' HA ' ' A' ' 40' ' ' ALA . 15.6 ptpt -62.8 -3.57 1.64 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -56.29 -20.77 30.46 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-N 119.659 1.118 . . . . 0.0 113.107 169.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -148.2 166.01 29.19 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.49 1.645 . . . . 0.0 109.118 174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.3 t -61.49 117.89 3.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 103.843 -2.651 . . . . 0.0 103.843 169.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.0 m -127.41 129.63 47.88 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 123.314 0.384 . . . . 0.0 111.37 -168.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.476 ' HB ' HG23 ' A' ' 79' ' ' VAL . 4.8 mt -89.18 137.91 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.4 mm -120.02 100.5 9.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.94 140.9 45.89 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 170.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.7 t -126.42 136.11 61.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 118.493 0.588 . . . . 0.0 109.493 169.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.12 159.64 67.45 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.495 1.518 . . . . 0.0 108.263 171.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.72 -53.67 0.7 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.618 1.545 . . . . 0.0 111.373 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 p -147.29 154.14 40.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.752 2.021 . . . . 0.0 106.566 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.0 tt -98.7 -6.5 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -168.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.1 -28.06 68.53 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.529 -0.732 . . . . 0.0 112.425 -176.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.3 t -73.28 142.08 47.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.394 0.678 . . . . 0.0 110.581 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.6 -16.25 65.23 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 119.048 -0.862 . . . . 0.0 113.137 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.1 t -54.88 -29.28 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 118.996 1.398 . . . . 0.0 111.125 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 11.8 m -63.76 -12.82 38.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.537 0.735 . . . . 0.0 112.843 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.72 -45.3 77.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.668 1.122 . . . . 0.0 110.828 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.43 7.24 2.42 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.315 1.046 . . . . 0.0 112.612 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -129.06 -87.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -53.08 -54.18 39.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.808 1.643 . . . . 0.0 112.967 -169.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.6 ttp180 -71.69 -42.21 67.71 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 120.978 -1.077 . . . . 0.0 110.569 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.2 tpp85 -60.23 -38.19 82.65 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 118.737 -0.649 . . . . 0.0 110.648 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -64.99 -32.41 74.13 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 117.363 -1.303 . . . . 0.0 112.209 175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -58.43 -48.19 81.5 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 120.674 1.579 . . . . 0.0 110.216 174.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -65.27 -57.14 9.19 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.325 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -61.58 -40.53 95.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.434 0.561 . . . . 0.0 111.028 -172.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.33 -35.17 78.26 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.848 0.749 . . . . 0.0 111.482 176.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.64 -37.07 79.4 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.112 0.869 . . . . 0.0 110.803 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -70.18 -39.88 74.98 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.505 0.593 . . . . 0.0 109.552 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.7 mt -63.4 -47.24 82.81 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.195 0.598 . . . . 0.0 110.141 171.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.51 9.08 84.59 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.864 1.221 . . . . 0.0 113.949 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -151.99 35.61 0.54 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.391 1.595 . . . . 0.0 112.322 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 m -127.88 173.48 13.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -123.62 151.0 43.47 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 169.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.476 HG23 ' HB ' ' A' ' 48' ' ' ILE . 2.1 p -149.8 149.71 14.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 120.691 -1.256 . . . . 0.0 110.171 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -135.23 172.52 12.9 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.746 1.619 . . . . 0.0 108.982 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.412 ' HB ' HG22 ' A' ' 104' ' ' THR . 23.6 m -132.5 144.04 50.17 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 169.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 52.5 mt -126.64 137.71 56.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.59 147.87 36.57 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.14 0.976 . . . . 0.0 109.826 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.26 56.03 2.12 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -144.9 170.06 16.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.606 1.562 . . . . 0.0 107.143 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.04 142.11 63.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 121.132 -0.98 . . . . 0.0 112.468 -168.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -47.64 -41.03 30.9 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.34 3.36 . . . . 0.0 115.028 178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -73.43 -29.4 62.54 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.95 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.39 82.19 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.525 1.057 . . . . 0.0 109.334 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.85 -47.8 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.069 -0.491 . . . . 0.0 111.125 172.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.37 80.22 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.417 0.553 . . . . 0.0 111.09 178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -59.75 -43.83 94.11 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-O 118.524 -0.751 . . . . 0.0 109.59 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -58.95 -52.05 67.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 118.533 0.606 . . . . 0.0 110.171 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 67.6 m -65.13 -44.96 86.99 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.95 -177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.59 -41.66 83.38 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.342 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.13 -39.78 82.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 118.12 0.96 . . . . 0.0 110.538 -178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -79.69 -19.17 49.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.957 0.503 . . . . 0.0 112.274 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.23 30.74 64.61 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-N 118.831 0.741 . . . . 0.0 111.425 -174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mt -68.03 146.78 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.587 1.155 . . . . 0.0 108.179 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -139.02 -35.8 0.55 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.971 1.308 . . . . 0.0 112.172 -173.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -81.43 -18.74 44.29 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 118.633 -0.698 . . . . 0.0 112.025 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -111.21 158.63 11.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -139.76 130.1 25.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 103.531 -2.766 . . . . 0.0 103.531 168.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 81' ' ' THR . 3.2 p -84.26 155.94 22.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.4 mt -143.44 162.98 34.37 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.893 1.277 . . . . 0.0 108.406 -170.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.3 m -129.82 107.67 9.57 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.503 0.721 . . . . 0.0 109.586 -169.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -95.28 56.19 1.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -136.62 33.44 2.72 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.324 1.05 . . . . 0.0 112.693 -168.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -122.86 -48.33 2.02 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 169.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -144.65 121.12 11.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 101.871 -3.381 . . . . 0.0 101.871 168.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 87.1 mtp -73.69 36.87 0.09 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.734 1.613 . . . . 0.0 112.801 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.3 m -57.87 -41.71 83.04 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.859 1.264 . . . . 0.0 111.782 -169.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -71.13 -46.22 62.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.767 0.712 . . . . 0.0 109.581 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.82 -33.58 62.97 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 123.534 0.588 . . . . 0.0 111.868 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -64.96 -48.85 72.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.806 0.803 . . . . 0.0 109.367 171.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.4 -32.55 72.69 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -172.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -90.3 3.52 53.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.597 1.159 . . . . 0.0 111.527 173.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.86 -13.8 8.27 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.081 1.801 . . . . 0.0 115.351 173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 m -63.68 -23.39 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 125.559 1.544 . . . . 0.0 112.741 -173.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.79 110.57 1.19 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 171.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.2 mt -78.28 113.43 17.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -53.29 -45.21 68.85 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.585 1.554 . . . . 0.0 111.331 -171.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -84.72 0.14 51.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.361 0.665 . . . . 0.0 112.567 -169.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 62.5 mt -127.24 -22.64 3.69 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.871 0.759 . . . . 0.0 112.976 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 56.36 37.15 28.57 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.195 0.998 . . . . 0.0 111.943 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.68 162.83 24.13 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.173 -0.954 . . . . 0.0 108.814 169.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -88.47 134.18 33.92 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.63 141.32 32.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.74 1.216 . . . . 0.0 110.471 169.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -73.32 112.63 9.56 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 168.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.9 m -154.65 170.06 22.41 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.447 1.499 . . . . 0.0 107.098 -169.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG21 ' HG3' ' A' ' 158' ' ' PRO . 14.8 p -153.99 146.83 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -134.71 162.72 31.53 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 124.022 0.826 . . . . 0.0 110.139 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 64.5 t -134.8 145.81 31.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 82.4 mt -132.16 130.55 41.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.452 1.501 . . . . 0.0 107.477 -169.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -74.67 165.09 25.8 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.007 1.323 . . . . 0.0 109.54 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.65 -6.49 3.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.09 12.31 23.57 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.952 -1.092 . . . . 0.0 112.448 169.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.13 21.68 78.75 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.029 0.823 . . . . 0.0 112.849 175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -88.99 145.82 25.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -77.34 139.75 18.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 11.4 t -119.45 -26.08 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 125.564 1.546 . . . . 0.0 109.397 -174.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -147.77 147.07 29.47 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -150.96 133.87 15.86 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 169.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -147.78 147.37 29.79 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -127.66 102.4 6.81 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -61.81 136.21 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -66.3 -13.52 60.61 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -134.93 125.58 26.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 125.991 1.716 . . . . 0.0 106.833 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.25 -26.87 66.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.141 0.577 . . . . 0.0 111.827 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 m -79.5 12.96 2.19 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.146 1.378 . . . . 0.0 111.366 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -134.69 167.02 21.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.952 2.101 . . . . 0.0 107.857 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 33.8 p80 -128.31 154.73 79.06 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.403 1.081 . . . . 0.0 110.923 -170.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.17 160.61 48.53 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.622 2.215 . . . . 0.0 109.65 173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -87.06 117.44 25.79 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -51.51 -28.32 13.17 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.128 1.771 . . . . 0.0 112.857 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -60.14 -32.11 70.71 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.567 0.621 . . . . 0.0 111.695 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.73 -51.85 11.24 Favored Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.443 -171.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.416 ' HG3' HG21 ' A' ' 131' ' ' VAL . 55.9 Cg_endo -67.68 -30.56 34.39 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.452 1.434 . . . . 0.0 111.729 174.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.6 mm -56.44 -49.01 79.12 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-N 119.838 1.199 . . . . 0.0 109.904 171.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -63.75 -32.17 73.58 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.514 0.597 . . . . 0.0 110.771 -178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -67.74 -46.66 71.51 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.209 0.459 . . . . 0.0 111.437 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.8 -49.92 64.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.857 0.463 . . . . 0.0 110.01 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.43 -26.76 68.88 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 121.442 -0.786 . . . . 0.0 111.797 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.64 71.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 118.988 0.813 . . . . 0.0 111.626 172.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 58.6 mt -83.59 -29.13 28.01 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.15 0.58 . . . . 0.0 111.512 174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.04 -51.97 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.368 0.531 . . . . 0.0 110.371 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.1 pttp . . . . . 0 C--O 1.248 1.004 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.052 -175.692 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptt? . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 111.11 0.041 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.3 169.42 12.26 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -137.97 135.73 36.27 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.8 mt -146.13 155.37 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -169.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -117.51 168.51 10.32 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.852 1.261 . . . . 0.0 110.753 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -141.05 56.95 1.55 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.93 1.292 . . . . 0.0 108.619 -175.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.3 mttm 37.74 71.21 0.16 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.082 2.153 . . . . 0.0 113.782 -175.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.41 -16.98 0.59 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.098 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.93 174.76 41.06 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.01 162.91 41.08 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.391 2.728 . . . . 0.0 111.151 178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.96 135.16 55.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.283 1.433 . . . . 0.0 107.395 172.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.2 m -67.12 152.0 46.57 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.334 1.454 . . . . 0.0 110.385 -176.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -127.59 135.3 50.1 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 125.641 1.576 . . . . 0.0 108.661 -175.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.6 t -85.44 136.71 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 168.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.55 -163.68 13.51 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 118.424 0.556 . . . . 0.0 113.33 169.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -123.24 138.85 54.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.294 1.437 . . . . 0.0 110.385 -169.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -75.7 114.67 14.55 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.43 170.38 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 118.936 0.789 . . . . 0.0 109.887 174.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.39 161.33 35.74 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.191 0.997 . . . . 0.0 109.094 174.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 129.93 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 174.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.15 -13.08 60.41 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.797 1.189 . . . . 0.0 112.383 -175.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.62 140.03 58.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 119.629 1.715 . . . . 0.0 110.214 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -89.88 108.15 19.54 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 172.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.34 148.72 92.93 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-O 119.009 -0.519 . . . . 0.0 112.149 -169.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -57.95 -8.92 5.16 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 125.245 3.963 . . . . 0.0 118.536 -178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.4 t0 52.79 70.61 0.56 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 122.872 1.32 . . . . 0.0 111.74 -169.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -73.3 166.68 22.71 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.22 1.408 . . . . 0.0 109.827 177.198 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 58.1 m -127.97 144.92 51.11 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.33 163.12 18.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.208 2.203 . . . . 0.0 106.69 179.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.35 137.52 32.25 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 169.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -63.67 165.18 8.61 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 54.9 p30 -64.88 -3.48 3.46 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.699 -1.251 . . . . 0.0 111.864 168.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.9 m -114.48 17.97 17.08 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.127 2.171 . . . . 0.0 111.239 -175.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 52.0 mt 65.93 39.85 4.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.133 1.373 . . . . 0.0 112.884 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -126.58 148.87 49.7 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 170.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.62 141.04 44.71 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.904 1.229 . . . . 0.0 109.128 172.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -138.33 144.99 40.63 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 175.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 m -134.02 165.96 23.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -178.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 tt -53.49 -34.7 59.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.972 0.509 . . . . 0.0 110.442 176.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.75 -32.97 46.09 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 175.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -74.12 -42.62 59.76 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.584 0.707 . . . . 0.0 110.441 173.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.6 mtt -64.7 -25.8 68.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.074 1.35 . . . . 0.0 111.643 -177.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -54.69 -16.75 2.72 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.592 1.157 . . . . 0.0 113.258 174.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.3 -17.65 47.06 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-O 118.628 -1.095 . . . . 0.0 113.677 176.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -151.97 159.18 43.83 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 119.752 1.776 . . . . 0.0 109.695 179.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 97.2 t -62.49 119.46 6.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 103.69 -2.708 . . . . 0.0 103.69 168.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.8 m -124.95 134.23 52.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.446 0.299 . . . . 0.0 110.883 -168.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 69.6 mt -93.11 142.59 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mm -120.89 138.08 52.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 173.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 m -126.92 102.37 6.98 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 124.109 0.964 . . . . 0.0 108.601 -169.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 t -81.04 134.84 26.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.81 157.31 61.76 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 125.113 1.365 . . . . 0.0 107.984 169.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -67.39 -55.64 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.28 1.987 . . . . 0.0 111.59 -172.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -161.27 150.07 16.15 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 127.962 2.505 . . . . 0.0 104.833 176.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 tt -73.17 -10.04 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-N 118.92 0.782 . . . . 0.0 112.517 -169.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.62 -32.35 73.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.868 1.267 . . . . 0.0 113.013 176.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.27 114.29 10.23 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 174.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.58 -17.99 43.02 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.408 1.004 . . . . 0.0 113.61 -174.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.33 -21.79 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-N 118.511 1.156 . . . . 0.0 111.311 174.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 64.3 m -58.75 -19.86 44.27 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.788 1.176 . . . . 0.0 112.8 172.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -60.7 -29.35 69.29 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.142 0.977 . . . . 0.0 111.828 173.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.58 5.94 22.4 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.622 1.169 . . . . 0.0 112.441 175.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -124.82 -83.83 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -57.68 -45.85 85.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.561 1.144 . . . . 0.0 111.885 -169.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.0 ttp85 -68.6 -45.5 71.81 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.552 -0.717 . . . . 0.0 111.02 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -64.02 -37.43 87.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.987 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -57.98 -37.47 74.28 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 119.232 0.923 . . . . 0.0 112.207 171.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -59.53 -48.41 81.77 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.485 1.039 . . . . 0.0 110.825 178.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -67.48 -47.3 70.44 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -62.72 -40.07 96.03 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.378 0.99 . . . . 0.0 110.713 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.7 78.93 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.919 0.781 . . . . 0.0 111.627 178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.16 87.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.701 0.682 . . . . 0.0 111.725 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -70.48 -40.05 73.85 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.443 0.697 . . . . 0.0 111.067 -178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.38 149.45 33.86 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.894 1.278 . . . . 0.0 108.805 174.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.53 -44.42 97.6 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.132 -178.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -162.23 137.24 7.04 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.677 1.591 . . . . 0.0 107.57 174.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.0 p -162.73 175.31 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.654 1.582 . . . . 0.0 106.956 174.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -136.54 140.62 43.09 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 169.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.8 t -141.51 146.52 23.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -178.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.05 163.37 29.71 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.962 1.305 . . . . 0.0 109.209 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.4 m -121.29 146.18 47.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 169.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.3 mt -131.57 140.68 47.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 m -140.27 149.13 42.44 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.665 1.186 . . . . 0.0 109.939 -169.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.89 45.75 1.24 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -128.21 -176.63 3.86 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.136 1.375 . . . . 0.0 110.87 -168.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.3 mp -90.43 140.52 26.92 Favored Pre-proline 0 C--O 1.238 0.472 0 C-N-CA 124.738 1.215 . . . . 0.0 109.275 -174.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -51.14 -41.48 57.42 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.874 3.049 . . . . 0.0 113.97 178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -78.62 -29.44 45.94 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.509 -0.745 . . . . 0.0 112.083 -174.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.39 73.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.281 0.946 . . . . 0.0 109.102 175.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -51.05 -50.49 58.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.538 1.535 . . . . 0.0 111.11 171.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.29 -44.97 90.02 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.683 0.393 . . . . 0.0 111.518 -179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.5 ttt85 -63.84 -44.41 93.28 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.033 0.533 . . . . 0.0 110.044 -174.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 39.9 t90 -61.69 -39.86 92.95 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.556 0.342 . . . . 0.0 110.565 178.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 95.4 m -65.35 -44.05 88.92 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 121.92 -0.487 . . . . 0.0 111.224 176.524 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -64.15 -37.66 94.87 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.771 -0.532 . . . . 0.0 111.771 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.56 -44.3 87.2 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.696 0.748 . . . . 0.0 110.463 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -77.31 -23.49 51.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.281 0.632 . . . . 0.0 112.371 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.31 32.59 22.36 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 123.807 0.718 . . . . 0.0 111.325 -178.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 31.5 mm -67.46 144.1 14.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -146.45 -37.9 0.23 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.176 1.391 . . . . 0.0 111.935 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -80.44 -16.49 54.26 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.08 0.952 . . . . 0.0 111.919 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.8 t -115.4 160.79 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 174.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -138.93 146.1 40.63 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 169.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 2.0 p -99.25 142.62 30.5 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.391 1.076 . . . . 0.0 108.63 -177.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 24.4 mt -129.02 155.66 45.04 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.051 1.34 . . . . 0.0 107.984 -174.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.66 125.6 50.07 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.258 1.423 . . . . 0.0 109.441 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -118.66 -2.54 10.95 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.072 0.949 . . . . 0.0 111.966 -176.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -55.59 -23.29 26.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.518 1.527 . . . . 0.0 113.006 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -59.08 -45.48 90.72 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.119 0.968 . . . . 0.0 111.864 -176.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -154.95 7.37 0.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -171.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 7.9 mmm 51.77 28.47 4.95 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.128 1.771 . . . . 0.0 113.873 -175.31 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.5 m -51.72 -51.33 56.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.257 1.023 . . . . 0.0 111.928 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.66 -44.8 69.8 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.513 0.597 . . . . 0.0 110.244 178.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -53.22 -43.56 64.02 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 124.795 1.188 . . . . 0.0 112.672 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -74.35 -42.23 59.73 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.986 0.915 . . . . 0.0 110.213 175.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.88 -39.79 86.5 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.701 0.8 . . . . 0.0 112.034 -173.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -109.95 6.3 23.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.474 1.51 . . . . 0.0 112.581 -176.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.9 78.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 119.563 1.074 . . . . 0.0 113.109 171.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.95 1.59 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.282 . . . . 0.0 112.679 -177.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -82.67 108.48 16.07 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 120.534 1.515 . . . . 0.0 107.48 169.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.64 105.0 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 -178.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -51.48 -49.51 61.68 Favored 'General case' 0 C--N 1.334 -0.087 0 C-N-CA 126.337 1.855 . . . . 0.0 110.981 -171.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -74.28 -35.61 63.76 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.407 0.683 . . . . 0.0 111.711 -172.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.74 -23.69 42.09 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.765 0.711 . . . . 0.0 112.148 177.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? 57.99 34.57 24.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.132 0.973 . . . . 0.0 109.075 -168.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.4 mt -130.16 160.96 32.22 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.794 1.238 . . . . 0.0 108.688 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.1 tp -75.32 158.25 33.1 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 171.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.09 -167.55 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.167 1.387 . . . . 0.0 111.307 175.078 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -124.66 123.57 40.33 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 169.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.4 m -166.55 169.12 14.04 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.924 1.69 . . . . 0.0 106.908 -169.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.46 143.23 23.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 175.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.22 156.9 47.55 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.016 0.926 . . . . 0.0 108.693 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.6 t -136.54 138.91 46.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.3 mt -130.84 124.51 31.43 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 125.401 1.481 . . . . 0.0 107.838 -169.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -65.81 164.64 14.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.282 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -54.75 -21.13 10.05 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.655 1.182 . . . . 0.0 112.822 174.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -76.18 -2.85 33.17 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.586 -1.321 . . . . 0.0 112.502 174.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.35 76.53 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 121.166 -0.959 . . . . 0.0 111.206 -171.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -116.68 129.7 56.3 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 -172.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.73 129.27 32.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -173.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.5 m -111.94 -18.55 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 123.799 0.84 . . . . 0.0 111.406 177.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -153.61 143.13 21.71 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 169.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.34 144.91 27.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -153.22 144.9 23.43 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.218 1.007 . . . . 0.0 108.87 -176.386 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -132.86 126.0 31.23 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.742 1.617 . . . . 0.0 106.82 -174.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 148' ' ' GLU . 13.5 t -75.82 137.12 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.381 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.0 m -70.76 -3.69 20.02 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.444 0.698 . . . . 0.0 112.88 177.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.419 ' H ' HG12 ' A' ' 146' ' ' VAL . 6.7 mt-10 -137.92 125.38 21.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 125.94 1.696 . . . . 0.0 107.252 -178.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.32 -23.48 62.85 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.453 0.644 . . . . 0.0 110.27 169.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.02 3.79 4.06 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.222 2.609 . . . . 0.0 112.986 173.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -140.91 171.14 14.49 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.534 1.934 . . . . 0.0 108.191 -176.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -131.51 155.98 80.73 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.357 1.063 . . . . 0.0 110.791 -172.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -77.07 170.41 19.77 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.792 2.328 . . . . 0.0 109.9 176.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -97.9 118.74 35.15 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -55.75 -24.22 34.01 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.909 1.684 . . . . 0.0 112.922 177.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -61.64 -35.24 77.36 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.254 0.933 . . . . 0.0 111.424 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -62.07 -54.06 53.57 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.171 -174.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.74 -31.36 16.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 121.957 1.771 . . . . 0.0 112.279 177.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mm -53.62 -50.28 51.29 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 119.67 1.123 . . . . 0.0 109.623 172.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -65.1 -36.24 83.69 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 117.844 0.293 . . . . 0.0 110.688 -177.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.33 -45.39 91.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.916 0.325 . . . . 0.0 111.568 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.71 -53.81 24.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.208 0.603 . . . . 0.0 110.921 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -24.46 67.91 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.437 1.017 . . . . 0.0 112.186 -177.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.19 -30.35 66.37 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 119.024 0.829 . . . . 0.0 111.565 170.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 88.3 mt -104.78 -24.25 12.93 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.506 1.122 . . . . 0.0 112.545 -176.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . 0.258 7.1 p -126.36 74.71 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 122.695 1.236 . . . . 0.0 108.351 177.031 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp . . . . . 0 C--O 1.248 0.98 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.997 172.29 . . . . . . . . 0 0 . 1 stop_ save_